Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,pulmonary valve development (GO:0003177),-0.703716336996724,-2.0453546937570106,0.0,0.19675165352170323,0.144,12/18,15.09%,NOTCH2;ROBO1;SMAD6;NOS3;BMP4;SLIT2;BMPR2;JAG1;STRA6;TNFRSF1A;TGFB2;HEY2
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.46836330486377564,-2.013188578147944,0.0,0.16082789655847093,0.222,49/91,26.95%,RPS14;RPL24;RPL18A;RPS16;RPL38;RPL28;RPS19;RPL37;RPS2;RPL19;RPL5;RPL34;RPS25;RPS15;RPLP1;RPL31;RPL3;RPS6;SRPRA;RPS8;SRP14;RPL11;RPL12;SSR2;RPL13;RPL7A;SRP68;RPS21;RPL35A;RPL26;RPL32;RPS9;RPS29;RPS23;RPL8;RPLP2;RPL41;SRP72;RPS17;SIL1;RPS5;RPS15A;RPL37A;UBA52;RPS10;SRP19;RPL6;RPL9;RPS27
prerank,eosinophil migration (GO:0072677),0.8638532881929589,1.9516647574797192,0.0014771048744460858,0.09431915606372007,0.15,3/14,4.22%,CCL11;LGALS3;CCL4
prerank,eosinophil chemotaxis (GO:0048245),0.8638532881929589,1.9516647574797192,0.0014771048744460858,0.09431915606372007,0.15,3/14,4.22%,CCL11;LGALS3;CCL4
prerank,protein localization to cell-cell junction (GO:0150105),-0.6998493358478578,-1.9414068061961884,0.0,0.27044141139500033,0.467,7/15,11.89%,TJP1;CGNL1;CDH5;TJP2;PAK2;MPP7;ACTG1
prerank,pulmonary valve morphogenesis (GO:0003184),-0.6754480038115557,-1.9221475909857577,0.0,0.2600327330953971,0.548,10/17,15.09%,NOTCH2;ROBO1;SMAD6;NOS3;BMP4;SLIT2;JAG1;STRA6;TGFB2;HEY2
prerank,vascular process in circulatory system (GO:0003018),-0.7396033436945054,-1.9066694106016837,0.0,0.21112115630699618,0.625,6/13,7.78%,ROCK2;ROCK1;NOS3;NPR1;ACE;AGTR1
prerank,regulation of tube diameter (GO:0035296),-0.7396033436945054,-1.9066694106016837,0.0,0.21112115630699618,0.625,6/13,7.78%,ROCK2;ROCK1;NOS3;NPR1;ACE;AGTR1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.7238373575047617,1.9033218048977856,0.0,0.19669977845767259,0.39,13/33,10.09%,RELN;CEL;NGF;NRG3;GRIK3;CACNA1A;GRIK2;GRIK5;GRID2;LRRC4C;NLGN1;GRIK1;PXK
prerank,regulation of glucose import (GO:0046324),-0.5624828774381773,-1.8975710359855826,0.004694835680751174,0.2019625721141721,0.657,13/30,9.68%,PRKAG2;OSBPL8;SORBS1;IGF1;OCLN;APPL2;GRB10;CREBL2;INSR;PRKCI;RHOQ;ARPP19;GSK3A
prerank,somite development (GO:0061053),0.8877980797582661,1.8960873300150511,0.0,0.17074185687432403,0.43,7/11,8.76%,PTCH1;MEOX1;MEOX2;SOX11;LOXL3;SMO;PPP2R3A
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.6330426890637979,-1.8682679842391772,0.007168458781362007,0.2574075354711609,0.792,7/18,10.15%,PTN;MTUS1;SLC8B1;SLIT2;LYN;CAMK1D;IL6R
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.8501053700185378,1.8523455102995967,0.0015408320493066256,0.3263926487784528,0.717,3/12,3.54%,DCN;ADAMTS12;CADM4
prerank,neuronal action potential (GO:0019228),0.7458062019366611,1.8475728343309794,0.0013404825737265416,0.2965007316259507,0.747,9/22,8.59%,ANK3;KCNA2;SCN7A;SCN2A;KCNA1;SCN5A;SCN3A;KCNMB2;KCNMB3
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.6982024054197717,1.842189989164668,0.0,0.27818968667585126,0.778,9/35,9.71%,DCHS1;CDH19;CDH10;CDH22;PCDHGB4;CDH8;NLGN1;CDH20;CDH7
prerank,regulation of chondrocyte differentiation (GO:0032330),0.7353068474850072,1.8401375338828863,0.0,0.2513968275083,0.79,11/24,10.88%,SOX6;ADAMTS12;EFEMP1;PKDCC;SOX9;MBOAT2;PTHLH;TRPS1;ZBTB16;SOX5;PTPN11
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.6915825266087643,-1.828137595052942,0.0,0.3522370426343601,0.904,6/13,4.30%,BMP6;DAB2;RBPMS;BMP4;NUP93;TGFBR1
prerank,regulation of lymphocyte proliferation (GO:0050670),0.7755336186799529,1.8070472349579678,0.0,0.38501563193190347,0.916,4/16,4.42%,LGALS3;FGF10;PTPN22;SOX11
prerank,response to sterol (GO:0036314),0.8376123805948277,1.8018025336998822,0.001564945226917058,0.3741810211840709,0.929,4/11,6.49%,RORA;TGFB1;TGFBR2;RORC
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.7634832382820312,1.789108978008013,0.005427408412483039,0.419049677056994,0.952,6/18,5.87%,RELN;TSHZ3;CACNG7;NRXN1;CCR2;NLGN1
prerank,regulation of T cell activation (GO:0050863),0.65411741225402,1.7846447362716806,0.0012422360248447205,0.4110541681785543,0.961,10/42,9.87%,LGALS3;PRKCQ;PYCARD;PTPN22;FGL1;TNFAIP8L2;CCR2;METTL3;LAX1;IL4I1
prerank,connective tissue development (GO:0061448),0.6665294159215579,1.7836921251467228,0.0037831021437578815,0.3856853537501073,0.963,13/35,8.46%,SOX6;SULF1;SOX8;SOX9;PGRMC2;ITGB8;HOXD3;CREB3L2;RORC;ZBTB16;DYRK1B;SOX5;TRIP11
prerank,spinal cord development (GO:0021510),0.8317620622540738,1.7737272101266996,0.0,0.4199102647613383,0.98,7/12,8.98%,RELN;VIT;GLI2;SOX11;NF1;LOXL3;SOX12
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.8019829946465615,1.7727104123484467,0.0077279752704791345,0.39720456902321494,0.98,5/12,13.86%,APOD;CBLB;PTPRJ;CBL;SNCA
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.6917160262660432,1.7705464408831262,0.0039946737683089215,0.3863457738763918,0.982,10/26,11.06%,RORA;SULF1;EIF2AK3;TGFB1;CCR2;CYP1B1;NOX1;BRCA1;HIF1A;IL6ST
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.677427221679721,-1.7695195399739745,0.0028169014084507044,0.5765486656006764,0.986,5/13,8.04%,PTGIS;NAMPT;NAXD;PARP10;PTGS2
prerank,myeloid cell development (GO:0061515),-0.5957477590999454,-1.7681879681837243,0.01056338028169014,0.5307672287546663,0.988,5/18,13.05%,FOXP1;KIT;ALAS1;APP;NCKAP1L
prerank,lysine catabolic process (GO:0006554),0.8023167962822165,1.7642505637689145,0.0015503875968992248,0.37200979958579505,0.984,5/12,3.34%,AADAT;AASS;GCDH;SLC25A21;DLST
prerank,lysine metabolic process (GO:0006553),0.8023167962822165,1.7642505637689145,0.0015503875968992248,0.37200979958579505,0.984,5/12,3.34%,AADAT;AASS;GCDH;SLC25A21;DLST
prerank,regulation of T cell migration (GO:2000404),0.7540856482905164,1.7604088600436247,0.0027624309392265192,0.37142145397292187,0.987,3/18,1.42%,APOD;CXCL10;PYCARD
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.7026681481636621,1.7556059513088877,0.005509641873278237,0.37688967387102906,0.991,9/24,11.06%,RORA;SULF1;EIF2AK3;TGFB1;CYP1B1;NOX1;BRCA1;HIF1A;IL6ST
prerank,smoothened signaling pathway (GO:0007224),0.6674457881689446,1.7546370898467674,0.0012642225031605564,0.3628120503823488,0.992,8/32,8.53%,PTCH1;PTCH2;GLI2;DHH;STK36;CC2D2A;GLI1;SMO
prerank,alpha-amino acid catabolic process (GO:1901606),0.6787905410081264,1.7511269540529384,0.001303780964797914,0.36373336082008967,0.994,8/29,9.87%,AADAT;KYNU;CBS;DAO;SARDH;GOT2;MTRR;IL4I1
prerank,endochondral bone morphogenesis (GO:0060350),-0.6909004355384445,-1.75101925148354,0.015432098765432098,0.5641872087174309,0.995,6/11,16.22%,COL13A1;BMP4;BMPR2;INPPL1;TRPV4;TMEM119
prerank,contractile actin filament bundle assembly (GO:0030038),-0.6099457617596582,-1.749384224606904,0.009287925696594427,0.4903790208761231,0.995,7/15,12.60%,SORBS1;PHACTR1;TNFAIP1;ITGB5;RHOA;PDLIM1;FAM171A1
prerank,stress fiber assembly (GO:0043149),-0.6099457617596582,-1.749384224606904,0.009287925696594427,0.4903790208761231,0.995,7/15,12.60%,SORBS1;PHACTR1;TNFAIP1;ITGB5;RHOA;PDLIM1;FAM171A1
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.4161294739633828,-1.7492597267446783,0.0,0.4585713632455278,0.995,47/87,26.95%,RPS14;RPL24;RPL18A;RPS16;RPL38;RPL28;RPS19;RPL37;RPS2;RPL19;RPL5;RPL34;RPS25;RPS15;RPLP1;RPL31;RPL3;RPS6;SEC61B;RPS8;SRP14;RPL11;RPL12;RPL13;RPL7A;SRP68;RPS21;RPL35A;RPL26;RPL32;RPS9;RPS29;RPS23;RPL8;RPLP2;RPL41;SRP72;RPS17;RPS5;RPS15A;RPL37A;UBA52;RPS10;SRP19;RPL6;RPL9;RPS27
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.578230785953598,-1.7471611756708125,0.00392156862745098,0.4366808995472915,0.995,6/21,4.30%,BMP6;DAB2;RBPMS;BMP4;NUP93;TGFBR1
prerank,regulation of NMDA receptor activity (GO:2000310),0.6722258323789666,1.7436565995407354,0.00625,0.38581476859420477,0.996,10/32,5.87%,RELN;CRH;GRIA1;EPHB2;CAPN1;GRIA3;GRIN2B;CCR2;DLG2;NLGN1
prerank,cellular response to sterol (GO:0036315),0.7731865466602476,1.7370015082396595,0.008968609865470852,0.4043228437928102,0.997,8/13,15.91%,RORA;PTCH1;GRAMD1A;RORC;SMO;GRAMD1C;GRAMD1B;GPLD1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.8201590167232716,1.7342234005307982,0.00625,0.40208014385973956,0.997,2/10,3.54%,DCN;CADM4
prerank,aspartate family amino acid catabolic process (GO:0009068),0.7245381693039268,1.7331699443103545,0.00424929178470255,0.3923453651644686,0.997,7/19,11.99%,AADAT;AASS;GCDH;SLC25A21;DLST;GOT2;PHYKPL
prerank,negative regulation of lymphocyte activation (GO:0051250),0.7151923696398894,1.7331239833886418,0.005383580080753701,0.37781405534356244,0.997,8/21,9.87%,LGALS3;PTPN22;FGL1;SOX11;TNFAIP8L2;SAMSN1;LAX1;IL4I1
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.5742364661532421,-1.7328791378301813,0.006535947712418301,0.46899196194713993,0.997,11/20,12.75%,IGF1;NRP1;VTN;SLIT2;IGFBP3;IGFBP5;S100A11;ACE;PDGFRB;SERPINE1;CCN4
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.8120318318132057,1.7283092827211575,0.0015822784810126582,0.38916152890173733,0.997,5/10,8.46%,SOX6;PKDCC;SOX9;ZBTB16;SOX5
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.820941018056757,1.7276358253956814,0.001610305958132045,0.37871100929846646,0.997,3/10,2.76%,APOD;LRP1;PTPN2
prerank,myelination in peripheral nervous system (GO:0022011),0.781650097050041,1.7241538340990965,0.007204610951008645,0.3829841424166849,1.0,4/13,5.10%,LGI4;PRX;NF1;ARHGEF10
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.5192193719407426,-1.7238460723131404,0.008620689655172414,0.47873779365018676,0.997,12/25,22.82%,TLR4;INSR;KLF2;PTGS2;KLF4;DDAH2;HSP90AA1;ASS1;EDN1;HSP90AB1;CLU;AKT1
prerank,artery development (GO:0060840),-0.5413812476451322,-1.7122255875295465,0.0038314176245210726,0.5024090123635214,0.998,13/23,12.75%,ROBO1;NRP1;ACVRL1;SMAD7;ENG;BMPR2;TGFBR1;TBX1;EFEMP2;HECTD1;STRA6;PDE2A;SLC2A10
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.6288429002784472,1.7105539447209337,0.007471980074719801,0.4374723734846291,1.0,13/39,15.73%,FXYD3;WNK2;ANK3;FGF13;UTRN;WNK3;FGF12;FGF14;STK39;FXYD6;FXYD1;NEDD4L;NETO1
prerank,protein homotrimerization (GO:0070207),0.7522183185018401,1.7094367687562282,0.004411764705882353,0.4171442395607572,1.0,3/14,1.57%,SCARA5;STEAP4;SLC1A5
prerank,protein trimerization (GO:0070206),0.7522183185018401,1.7094367687562282,0.004411764705882353,0.4171442395607572,1.0,3/14,1.57%,SCARA5;STEAP4;SLC1A5
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.7197125355533985,1.7088242127313418,0.004347826086956522,0.40828955943118644,1.0,5/17,10.49%,LGALS3;PTPN22;PTPN2;PRNP;PTPRJ
prerank,neuron migration (GO:0001764),0.6062786356866499,1.7087562959990328,0.0023584905660377358,0.39692817589189267,1.0,19/48,12.02%,RELN;FGF13;ASTN2;MAP1B;NRCAM;VEGFA;SEMA3A;AUTS2;NTRK2;CEP85L;NAV1;CDKL5;DISC1;SDCCAG8;FGFR1;GPM6A;ADGRL3;POMGNT2;CDK5R1
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.7343312150244549,1.704076916845888,0.008438818565400843,0.40868947138835277,1.0,5/16,10.27%,SEC16B;ANK2;PPP1R15A;GBF1;VAPA
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.6327362120799405,1.7039835227256879,0.0012165450121654502,0.39800984414636464,1.0,14/39,17.17%,FXYD3;CHRM3;UTRN;ANK2;WNK3;FGF12;STK39;FXYD6;FXYD1;AHCYL1;TCAF1;NEDD4L;HOMER1;RIPK1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.8012215681913134,1.6991434753960755,0.009104704097116844,0.4113638982007159,1.0,3/11,1.09%,ANK3;PRKCA;PRKCQ
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.6825629211278788,-1.695065086983181,0.011111111111111112,0.5547733421491172,0.998,4/10,7.38%,IGF2;PCGF3;PRMT7;PCGF5
prerank,negative regulation of T cell activation (GO:0050868),0.6350550870997085,1.692135028843097,0.006273525721455458,0.43832052775857916,1.0,8/35,9.87%,LGALS3;GLMN;PTPN22;FGL1;TNFAIP8L2;SDC4;LAX1;IL4I1
prerank,acylglycerol homeostasis (GO:0055090),0.7009404384350694,1.6917604328009086,0.005689900426742532,0.4291521600899263,1.0,6/20,15.00%,RORA;MLXIPL;IL18;LIPC;PNPLA8;MTLN
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.6173242169334537,-1.6901606770639026,0.018633540372670808,0.5523047352603617,1.0,8/15,24.48%,PRKCD;SIRT3;RACK1;TNFRSF1A;ORMDL3;SPHK1;ORMDL1;SPHK2
prerank,macrophage migration (GO:1905517),0.7535649336964133,1.6886785709175347,0.010479041916167664,0.4345405621577317,1.0,5/13,13.60%,LGALS3;CCR2;TAFA4;CKLF;P2RY12
prerank,modified amino acid transport (GO:0072337),-0.6183169566833178,-1.6855038716495807,0.009966777408637873,0.5507137063971883,1.0,5/15,14.24%,SLC16A12;SLC6A13;PDPN;SLC5A6;MGST1
prerank,pyroptosis (GO:0070269),-0.6161934166862818,-1.6853583798063174,0.006269592476489028,0.5274424517344145,1.0,10/15,36.47%,CASP4;AIM2;CASP8;GSDMD;GSDME;APIP;CASP1;ZBP1;NLRC4;TREM2
prerank,cytoplasmic translation (GO:0002181),-0.38269261798704785,-1.6780355973735777,0.0,0.5376128397843731,1.0,45/91,26.95%,RPS14;GSPT1;RPL24;RPL18A;DRG1;RPS16;RPL38;RPL28;RPS19;RPL37;RPS2;FTSJ1;RPL19;RPL5;RPL34;RPS25;RPS15;RPLP1;RPL31;RPL3;DRG2;RPS6;RPS8;RPL11;RPL12;RPL13;RPL7A;RPS21;RPL35A;RPL26;RPL32;RPS9;RPS29;RPS23;RPL8;RPL41;RPS17;RPS5;RPS15A;RPL37A;UBA52;RPS10;RPL6;RPL9;RPS27
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.6201794193092446,1.6779274241245707,0.0038510911424903724,0.48168412961186263,1.0,9/37,8.44%,DCHS1;TENM2;TENM3;IL1RAPL1;GRID2;NLGN1;CADM3;HMCN1;CADM1
prerank,aortic valve development (GO:0003176),-0.48260553567992626,-1.6775486389734748,0.0,0.5178326665272334,1.0,10/34,3.88%,ROBO1;ROCK2;ELN;SMAD6;ROCK1;NOS3;BMP4;SLIT2;BMPR2;TIE1
prerank,sprouting angiogenesis (GO:0002040),-0.4418495026893453,-1.6736301163981249,0.007246376811594203,0.5132208213729477,1.0,18/51,5.72%,ROBO1;TEK;NRP1;CCBE1;VEGFC;PIK3R3;ANGPT1;RSPO3;CDH13;ACVRL1;BMP4;VEGFD;ENG;SLIT2;EPHB4;KDR;RNF213;THBS1
prerank,extracellular matrix assembly (GO:0085029),0.6782901963981831,1.6718343864389116,0.009776536312849162,0.5051727249638245,1.0,8/23,7.11%,NTN4;HAS2;PXDN;GPM6B;TGFB1;TNXB;NTNG2;NTNG1
prerank,action potential (GO:0001508),0.6204850119547753,1.6683209715784877,0.004842615012106538,0.514819897060156,1.0,13/44,11.02%,ANK3;GNA14;KCNA2;SCN7A;SCN2A;KCNA1;CHRNA4;SCN5A;KCND2;SCN3A;KCNMB2;KCNMB3;AKAP6
prerank,cartilage development (GO:0051216),0.5982418712853925,1.6668266434014256,0.008284023668639054,0.5119138605915363,1.0,13/49,9.91%,OSR2;SOX6;SULF1;FGF2;SOX9;TGFB1;ITGB8;HOXD3;CREB3L2;ZBTB16;SOX5;TRIP11;AMELX
prerank,lymphocyte chemotaxis (GO:0048247),0.6371203122934134,1.6648600406025638,0.007712082262210797,0.5127513184271176,1.0,6/34,9.66%,CCL11;CXCL10;CCL4;SLC12A2;CYP7B1;CKLF
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.6524501819953266,1.664844630779111,0.007782101167315175,0.5019240457762962,1.0,5/29,6.79%,LGALS3;CXCL10;ANO6;CCR2;PLA2G7
prerank,presynapse assembly (GO:0099054),0.7225721620964465,1.663922628833541,0.008633093525179856,0.4968684772638791,1.0,6/16,5.87%,CEL;LRP4;PTEN;IL1RAPL1;WNT5A;NLGN1
prerank,aortic valve morphogenesis (GO:0003180),-0.49210772944702935,-1.6626724279665408,0.004524886877828055,0.5415787816143596,1.0,9/30,3.88%,ROBO1;ROCK2;ELN;SMAD6;ROCK1;NOS3;BMP4;SLIT2;TIE1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.6378866406867825,-1.660214865796803,0.009523809523809525,0.5322242762398882,1.0,5/12,14.33%,FOXP1;MAP2K5;TLR4;KLF4;TIRAP
prerank,blood vessel diameter maintenance (GO:0097746),-0.48676470360538426,-1.6600749192185045,0.005050505050505051,0.5143290996942781,1.0,14/34,20.69%,ROCK2;ROCK1;NOS3;KLF2;NPR1;ACE;AGTR1;ECE1;NOS1;EDNRB;EDN1;GCLC;GPER1;ACE2
prerank,homocysteine metabolic process (GO:0050667),0.7807395024073865,1.6569452975926957,0.019908116385911178,0.5241598311861366,1.0,5/11,8.60%,CTH;TST;DPEP1;CBS;MTRR
prerank,cellular amino acid catabolic process (GO:0009063),0.5542379074449159,1.6556612495735379,0.0010976948408342481,0.520719131548505,1.0,35/87,22.49%,AADAT;AASS;GCDH;KYNU;CBS;IVD;SLC25A21;DLST;BCKDHB;MCCC1;DAO;HMGCLL1;SARDH;GOT2;MTRR;MCCC2;IL4I1;HIBADH;PHYKPL;HIBCH;ALDH5A1;DBT;GLS;GLS2;GSTZ1;AMT;AUH;ALDH7A1;BCKDK;ASPA;HYKK;GLUD1;DDAH1;ALDH6A1;CARNS1
prerank,endothelial cell differentiation (GO:0045446),-0.6347901280895876,-1.653177295423754,0.02476780185758514,0.523971023358079,1.0,7/12,11.73%,ACVRL1;BMPR2;TIE1;KDR;KDM6B;JAG1;PROX1
prerank,regulation of synapse maturation (GO:0090128),0.7866575424392718,1.6522091455111536,0.014084507042253521,0.5294960767257406,1.0,4/10,12.04%,RELN;NRXN1;YWHAZ;ANAPC2
prerank,type I interferon signaling pathway (GO:0060337),-0.44025817665518113,-1.6521731953346075,0.005405405405405406,0.49554059364858755,1.0,18/41,21.73%,SP100;IFIT2;IFI27;IFITM3;IRF2;SAMHD1;IRF1;IFITM2;OAS2;IRF9;STAT2;IFI35;ISG15;IFIT1;BST2;IFNAR1;RSAD2;IFNAR2
prerank,cellular response to type I interferon (GO:0071357),-0.44025817665518113,-1.6521731953346075,0.005405405405405406,0.49554059364858755,1.0,18/41,21.73%,SP100;IFIT2;IFI27;IFITM3;IRF2;SAMHD1;IRF1;IFITM2;OAS2;IRF9;STAT2;IFI35;ISG15;IFIT1;BST2;IFNAR1;RSAD2;IFNAR2
prerank,peripheral nervous system development (GO:0007422),0.6750680127738117,1.651852942760868,0.007926023778071334,0.521434245623276,1.0,7/23,11.35%,ERBB3;SOX8;NGF;NF1;PMP22;GDNF;GPC1
prerank,positive regulation of glucose import (GO:0046326),-0.5526507009740405,-1.6466731835423016,0.007782101167315175,0.5010233628494445,1.0,9/21,9.30%,OSBPL8;SORBS1;IGF1;OCLN;CREBL2;INSR;PRKCI;RHOQ;ARPP19
prerank,acyl-CoA biosynthetic process (GO:0071616),0.7181922344131169,1.6441350093399845,0.008658008658008658,0.55664272907117,1.0,8/16,11.49%,GCDH;ACACA;ACSS1;SCD5;FASN;ACLY;PPT2;DIP2A
prerank,response to cholesterol (GO:0070723),0.690384499264757,1.640414154753395,0.018518518518518517,0.5674376578002531,1.0,8/17,15.91%,PTCH1;TGFB1;GRAMD1A;TGFBR2;SMO;GRAMD1C;GRAMD1B;GPLD1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.6781626544382751,1.637794297538658,0.018651362984218076,0.5727217454073384,1.0,5/19,6.39%,RELN;IL1RAPL1;OBSL1;CDKL5;CDKL3
prerank,cellular response to increased oxygen levels (GO:0036295),-0.6572391316859709,-1.6362676200630462,0.028328611898016998,0.5289082371355899,1.0,9/11,30.40%,ATP6V0D1;ATP6AP1;CAV1;ATP6V0A2;TMEM199;FAS;ATP6V1G1;CCDC115;ATP6V1A
prerank,epithelial structure maintenance (GO:0010669),-0.663548040448636,-1.6358974711077654,0.01881720430107527,0.5153756394575723,1.0,3/11,8.37%,RBP4;CXADR;STRAP
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.49730670390457926,-1.6338645256266553,0.014760147601476014,0.49495617909923767,1.0,10/24,23.71%,FOXK1;PFKP;PGK1;GPI;PGAM1;PFKM;PFKL;ENO1;GAPDHS;ENO3
prerank,canonical glycolysis (GO:0061621),-0.49730670390457926,-1.6338645256266553,0.014760147601476014,0.49495617909923767,1.0,10/24,23.71%,FOXK1;PFKP;PGK1;GPI;PGAM1;PFKM;PFKL;ENO1;GAPDHS;ENO3
prerank,negative regulation of nervous system development (GO:0051961),0.6982401559712209,1.6319969027018562,0.02112676056338028,0.5985984241611773,1.0,2/17,4.86%,CCL11;PCM1
prerank,regulation of keratinocyte migration (GO:0051547),0.746274489797029,1.6319322501821905,0.0182648401826484,0.5883852130585895,1.0,4/12,2.90%,EPB41L4B;FGF10;PTEN;MAP4K4
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.5266919981777115,-1.6316970746506951,0.02456140350877193,0.4892321201332831,1.0,5/20,10.41%,WNT4;CLK2;SIK1;GSK3A;C1QTNF3
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.6108003661316092,1.6311658170321932,0.0085995085995086,0.5824604010711285,1.0,13/38,18.79%,RORA;PYCARD;TLE1;OTUD7B;NLRX1;PPM1B;ESR1;RHOH;PER1;RIPK1;OTUD7A;ZMYND11;MAPKBP1
prerank,macrophage chemotaxis (GO:0048246),0.7762122210024797,1.6302229891319282,0.017432646592709985,0.5778185795465551,1.0,3/10,9.66%,LGALS3;TAFA4;CKLF
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.6900898433894895,1.6275850607719098,0.016783216783216783,0.5833115807229621,1.0,4/18,3.74%,RELN;VEGFA;CRTC1;RPS6KA4
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.7138923335240343,1.6272910257013948,0.012802275960170697,0.5755252614894434,1.0,4/16,7.30%,RORA;PRKN;RORC;PDK3
prerank,muscle organ development (GO:0007517),0.569734264722433,1.6267973278513774,0.008111239860950173,0.5692695465649009,1.0,14/54,11.55%,LAMA2;SOX6;CXCL10;CHODL;UTRN;SGCD;EGR3;EVC;ITGB1BP2;MKX;SGCE;CHD2;MRAS;EMD
prerank,diol biosynthetic process (GO:0034312),-0.6116817061445112,-1.6265990647421091,0.019867549668874173,0.4951668306939898,1.0,8/15,24.97%,ACER2;SPTLC2;ASAH2;SPR;SPHK1;QDPR;SPHK2;SPTLC1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.6948278588285881,1.6261953880090285,0.017142857142857144,0.5643179982902362,1.0,6/14,13.38%,SULF1;CREB3L1;FGF2;SHISA2;GPC1;GATA3
prerank,neutrophil chemotaxis (GO:0030593),0.5725011905784779,1.6250556330614796,0.007067137809187279,0.5618338190526402,1.0,8/53,9.69%,CCL11;LGALS3;CXCL10;CCL4;PDE4B;GBF1;CKLF;EDN3
prerank,negative regulation of signal transduction (GO:0009968),0.5098965595694964,1.6243724011844918,0.0,0.5571639046244556,1.0,37/249,6.31%,APOD;DCN;GPC3;PTCH1;SOSTDC1;BMP5;UBASH3B;ADAMTS12;SULF1;PTCH2;ERBB3;CREB3L1;PRKCQ;TAX1BP3;FGF2;PTEN;RNF157;BCL2;VGLL4;LRP1;ERBB2;EGFR;PTPRT;FRZB;ACVR1;PTPN2;IRAK3;CADM4;TLE1;SOCS5;FBXW7;SLC27A4;WIF1;HHIP;SOCS1;SHISA2;METTL3
prerank,protein targeting to ER (GO:0045047),-0.3768581458871993,-1.6240165185317021,0.0,0.4925147079659153,1.0,50/99,26.95%,RPS14;RPL24;RPL18A;RPS16;RPL38;RPL28;RPS19;RPL37;SPCS2;RPS2;RPL19;RPL5;RPL34;RPS25;RPS15;RPLP1;RPL31;RPL3;RPS6;SRPRA;RPS8;SRP14;RPL11;RPL12;ZFAND2A;RPL13;RPL7A;SRP68;RPS21;RPL35A;RPL26;RPL32;RPS9;RPS29;RPS23;RPL8;RPLP2;RPL41;SRP72;RPS17;RPS5;RPS15A;RPL37A;UBA52;GET3;RPS10;SRP19;RPL6;RPL9;RPS27
prerank,axonogenesis (GO:0007409),0.5072261163960269,1.621348270249029,0.0,0.5658123359017537,1.0,64/237,13.35%,LAMA2;RELN;GFRA1;NTN4;ANK3;PRKCA;DOCK7;LGR6;ENAH;EFNA4;PRKCQ;GLI2;PTEN;SEMA3E;IRS2;EPHB6;GFRA4;EFNA5;SEMA6C;MAP1B;NRCAM;EPHB2;MAPK7;SEMA3A;AUTS2;NRXN1;CTNNA2;WNT5A;SPTBN1;BAIAP2;PPP3CB;NTNG2;NTNG1;S100A6;CNTN6;GAB2;FYN;CNTN2;TNR;DOK6;PALLD;DSCAM;SPG11;DOK4;PIK3R1;DCC;GDNF;KIF5C;USP33;PTPN11;OPHN1;MAPK1;GPC1;EFNB1;PLPPR4;PTPRA;CDK5R1;NRP2;UNC5C;EFNB3;SH3KBP1;RAB3A;DRD2;LYPLA2
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.6956207039536002,1.6200975654761727,0.017391304347826087,0.5564118901906816,1.0,3/16,1.62%,APOD;DLC1;PTEN
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.6956207039536002,1.6200975654761727,0.017391304347826087,0.5564118901906816,1.0,3/16,1.62%,APOD;DLC1;PTEN
prerank,regulation of T cell differentiation (GO:0045580),0.6077291859104782,1.6198438704396314,0.018963337547408345,0.549595724541641,1.0,11/33,17.28%,IL2RA;CBFB;CCR2;METTL3;ZMIZ1;RUNX1;RHOH;ZBTB1;GATA3;ABL1;MDK
prerank,negative regulation of cell communication (GO:0010648),0.6796213582927774,1.6178096949296765,0.022972972972972974,0.5527586233313809,1.0,6/21,9.51%,UBASH3B;ERBB3;ACVR1;SOCS5;HHIP;PTPN1
prerank,aggrephagy (GO:0035973),0.635438898547791,1.6151387955805525,0.02040816326530612,0.5597700552866558,1.0,15/27,22.18%,DYNLL1;PRKN;WDFY3;ACBD5;ATG5;DYNC1I1;HDAC6;DYNC1I2;UBB;PARK7;PCNT;WDR81;DYNC1H1;UBQLN1;VIM
prerank,urogenital system development (GO:0001655),0.7464419273091987,1.612845179265041,0.02021772939346812,0.565081918194863,1.0,3/11,3.30%,OSR2;SOX9;EPHB2
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.7526513297277276,1.6120183540244113,0.0183206106870229,0.5619659221909626,1.0,4/12,12.90%,PRKCQ;CCR2;CARD9;ZBTB1
prerank,regulation of cartilage development (GO:0061035),0.684773702319124,1.610448889898168,0.015427769985974754,0.5633396247060137,1.0,7/18,8.46%,SOX6;SOX9;MBOAT2;PTHLH;TRPS1;ZBTB16;SOX5
prerank,regulation of smoothened signaling pathway (GO:0008589),0.5871438764173185,1.609560826373791,0.004678362573099415,0.5610909549303092,1.0,11/50,8.53%,RORA;GPC3;PTCH1;PTCH2;STK36;EVC;GLI1;HHIP;UCHL5;RAB34;SMO
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.5451982805471365,-1.6083952025003532,0.02922077922077922,0.5386271972746108,1.0,6/19,1.88%,TJP1;ROCK2;PRKCH;ROCK1;CLDN5;OCLN
prerank,negative regulation of lipid metabolic process (GO:0045833),0.644943897566673,1.6060025278916703,0.023545706371191136,0.5732593564968637,1.0,3/22,8.25%,APOD;PDE3B;ASXL3
prerank,chondrocyte differentiation (GO:0002062),0.6105479931771879,1.6059546073924118,0.01139240506329114,0.5661285128928876,1.0,10/32,11.81%,OSR2;SOX6;SULF1;SOX9;EIF2AK3;TGFB1;CREB3L2;SOX5;AMELX;RUNX1
prerank,regulation of nervous system development (GO:0051960),0.5951322882392427,1.60341388063605,0.014962593516209476,0.5722772936552577,1.0,3/37,0.77%,LGI4;NKX6-2;DOCK7
prerank,cardiac atrium morphogenesis (GO:0003209),-0.5654985559206198,-1.6019534156756214,0.025559105431309903,0.5512257066629314,1.0,7/16,19.16%,NOTCH2;ENG;BMPR2;PROX1;TGFB2;HEY2;ZFPM1
prerank,sulfur compound catabolic process (GO:0044273),0.5957326318378675,1.6012869943831471,0.012254901960784314,0.5766417887954094,1.0,8/38,7.28%,DCN;VCAN;LUM;CTH;TST;DPEP1;GALNS;BCAN
prerank,granulocyte chemotaxis (GO:0071621),0.5600209195329737,1.6010474400940429,0.011641443538998836,0.5710541211678435,1.0,8/55,9.69%,CCL11;LGALS3;CXCL10;CCL4;PDE4B;GBF1;CKLF;EDN3
prerank,cellular response to ATP (GO:0071318),0.7157636458122776,1.6003459916898117,0.024390243902439025,0.5677660879100034,1.0,8/14,21.44%,P2RY2;HSP90B1;P2RY12;SSH1;P2RY1;TAF1;RYR3;P2RX7
prerank,sulfur amino acid catabolic process (GO:0000098),0.7756672395941848,1.59943729092104,0.02457757296466974,0.565796963704317,1.0,4/10,8.60%,CTH;TST;CBS;MTRR
prerank,myelination (GO:0042552),0.5771039305698447,1.5991945083649037,0.00935672514619883,0.5603437832654271,1.0,12/46,12.91%,LGI4;MPZ;SCN2A;PLP1;NF1;ARHGEF10;EIF2B5;KLK6;EPB41L3;PMP22;GPC1;MYOC
prerank,skeletal system development (GO:0001501),0.5078399360096053,1.5971015639180783,0.0010224948875255625,0.5650396914664665,1.0,39/148,12.91%,SOX6;BMP5;SULF1;VCAN;ANKH;GLI2;PKDCC;SOX9;AKAP13;FRZB;PTHLH;EIF2AK3;ITGB8;EVC;SOX11;PAPSS2;EXT1;WNT5A;HHIP;HOXD3;TRPS1;COL9A2;CREB3L2;ZBTB16;BCAN;FGFR1;SOX5;TRIP11;ADAMTS4;BPNT2;COL1A2;SLC10A7;NCAN;MMP16;BMP7;KIAA1217;COL1A1;VKORC1;MYOC
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.48241075707612485,-1.5961831989896973,0.0078125,0.5613103091585984,1.0,12/25,29.52%,FOXK1;PFKP;PGK1;GPI;PGAM1;PFKM;PFKL;ENO1;GAPDHS;ENO3;ADPGK;PKM
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.7041719226891205,1.5950688985298622,0.02335766423357664,0.5699323918381868,1.0,3/14,3.60%,WNK2;ANK3;WNK3
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.6792853712784235,1.5947699123252357,0.02510460251046025,0.5648463234036616,1.0,3/18,2.42%,FFAR4;CRH;PRKN
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5608715054726601,1.5931097420356086,0.009313154831199068,0.567616183759597,1.0,21/55,18.50%,DCN;GPC3;HSPG2;VCAN;LUM;FGF2;TGFB1;SDC2;SDC4;GALNS;BCAN;NCAN;GPC1;GPC4;SDC3;IDS;SLC9A1;SPAM1;HYAL1;CSPG4;SGSH
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.7059294295680559,1.5917524924044644,0.03353658536585366,0.5679486244792653,1.0,4/14,8.10%,PTPN22;CCR2;TGFBR2;IL18
prerank,membrane depolarization (GO:0051899),0.6035249041355392,1.590213705046352,0.026854219948849106,0.5696322687215647,1.0,8/32,7.11%,CACNA1E;SCN7A;SCN2A;CACNA1A;CHRNA4;SCN5A;CACNB4;SCN3A
prerank,regulation of cholesterol esterification (GO:0010872),-0.6542277843627736,-1.5885629667104595,0.04261363636363636,0.5778700569407227,1.0,6/10,23.25%,AGTR1;ABCG1;STARD4;LAMTOR1;APOE;AGT
prerank,regulation of protein export from nucleus (GO:0046825),-0.49851795603669247,-1.5872652492387371,0.025,0.5703095994340707,1.0,6/23,8.14%,SP100;PTPN14;XPO4;IFI27;CAMK1;GSK3B
prerank,extracellular matrix organization (GO:0030198),0.4952042019645602,1.586477169566323,0.0,0.5837898943918891,1.0,53/276,9.37%,LAMA2;VIT;DCN;COL15A1;TGFBI;MMP2;HSPG2;ADAMTS12;VCAN;A2M;ADAM19;LUM;CREB3L1;HAS2;ADAMTS20;COL5A3;FGF2;COL20A1;LAMC1;GSN;COL28A1;COL5A2;P4HA1;COL27A1;PXDN;COL4A2;HTRA1;RECK;GPM6B;CAPN1;COL26A1;TGFB1;ITGB8;NF1;TLL2;NID1;CYP1B1;COLGALT2;POSTN;COL9A2;MMP15;PLEC;ADAMTS1;CTSK;COL18A1;LOXL3;BCAN;COL3A1;TNR;ADAMTS4;SPARC;PLOD1;COL1A2
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.7046234245645469,1.5852222243312337,0.03056768558951965,0.5839655339586738,1.0,2/13,0.79%,APOD;MDFIC
prerank,negative regulation of neurogenesis (GO:0050768),0.6030363901507501,1.5846201955080166,0.02132998745294856,0.5808566889761382,1.0,6/34,4.96%,CCL11;LRP4;PTEN;GORASP1;PCM1;NF1
prerank,ephrin receptor signaling pathway (GO:0048013),0.5307568449411102,1.583996705543742,0.0033149171270718232,0.5780643462838836,1.0,28/82,14.33%,SIPA1L1;MMP2;DNM1;EFNA4;ARPC1B;EPHB6;EFNA5;EPHB2;ARHGEF28;PSEN1;SDC2;GRIN2B;PAK1;RASA1;CHN1;ITSN1;FYN;VAV3;ANKS1B;NCSTN;PTPN11;EFNB1;CDK5R1;ANKS1A;APH1A;EFNB3;EPHA10;PSEN2
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.7044442755246032,1.5837177840517946,0.017830609212481426,0.5733246245837256,1.0,4/14,3.59%,ADAMTS12;EFEMP1;SOX9;PTHLH
prerank,glial cell differentiation (GO:0010001),0.6214077864983435,1.5820093218873035,0.01937984496124031,0.5759756463624506,1.0,9/28,12.58%,RELN;ERBB3;SOX8;FGF10;SOX9;SOX11;EIF2B5;GPC1;PTPRZ1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.694033875265789,1.579912246454126,0.014265335235378032,0.5808185722603376,1.0,2/16,1.42%,APOD;PYCARD
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.4279188655952491,-1.5791676169365925,0.01015228426395939,0.591288219126594,1.0,17/45,21.93%,SP100;PRKCD;TRIM25;IRF2;CAMK2G;TRIM5;ICAM1;IRF1;CAMK2A;OAS2;PML;VCAM1;IRF9;TRIM21;TRIM68;MT2A;IFNGR2
prerank,negative regulation of chemokine production (GO:0032682),0.7014146227505624,1.5756036537146716,0.03139013452914798,0.5992046369311649,1.0,1/14,0.04%,APOD
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.502088748077236,1.575500385810142,0.0,0.5936529613471612,1.0,23/151,7.56%,ROR2;CCL11;FFAR4;ROR1;PRKCA;PDGFRA;GLIPR2;NTRK3;FGF2;PYCARD;FGF10;PTPN22;GAREM1;EGFR;FBXW7;TGFB1;CCL4;NTRK2;MT3;ALKAL2;CARD9;ACKR3;RAP1A
prerank,membrane assembly (GO:0071709),0.5975294609177103,1.5752323675526954,0.01982651796778191,0.5891808167850883,1.0,9/34,8.13%,ANK3;CEL;LRP4;PTEN;IL1RAPL1;NRXN1;SPTBN1;NLGN1;GAK
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.6369183619371495,1.5748361306195795,0.02638888888888889,0.5853108243728596,1.0,6/20,13.96%,SULF1;CREB3L1;FGF2;SHISA2;GPC1;SMOC2
prerank,ubiquinone biosynthetic process (GO:0006744),-0.5573408426688695,-1.5744405928332805,0.04487179487179487,0.5969340747893702,1.0,10/15,26.40%,COQ8B;COQ10B;PDSS1;COQ9;COQ3;NDUFA9;FDXR;PDSS2;COQ6;COQ8A
prerank,bicellular tight junction assembly (GO:0070830),-0.4199765697355736,-1.5743206060779757,0.0,0.5850045653166374,1.0,12/46,8.69%,AFDN;PARD6G;CDH5;PECAM1;CLDN5;OCLN;ESAM;PARD3;PRKCI;CLDN14;PAK2;MPP7
prerank,triglyceride homeostasis (GO:0070328),0.6189890562527509,1.573535462543796,0.031081081081081083,0.5858946022415658,1.0,6/26,15.00%,RORA;MLXIPL;IL18;LIPC;PNPLA8;MTLN
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.49315885796757963,1.573005293984421,0.0,0.5831949265631245,1.0,35/214,7.56%,ROR2;CCL11;FFAR4;ROR1;WNK2;PRKCA;PDGFRA;GLIPR2;NTRK3;FGF2;PYCARD;FGF10;PTEN;PTPN22;GAREM1;DUSP4;ERBB2;EGFR;PTPN2;EPHB2;FBXW7;TGFB1;CCL4;NTRK2;MT3;CNKSR3;DUSP6;YWHAZ;ALKAL2;SPRED2;LMO3;SPRED1;CARD9;ACKR3;RAP1A
prerank,negative regulation of cartilage development (GO:0061037),0.7128679311922742,1.5726092755777852,0.016442451420029897,0.579486375815935,1.0,4/13,3.59%,ADAMTS12;EFEMP1;SOX9;PTHLH
prerank,prostanoid biosynthetic process (GO:0046457),-0.5683747652308482,-1.5725509197660756,0.033444816053511704,0.5796075424887231,1.0,5/15,8.04%,PLA2G4A;PTGIS;PTGDS;PTGS1;PTGS2
prerank,actomyosin structure organization (GO:0031032),-0.3745794606130732,-1.5714655701000064,0.0,0.5716630346536768,1.0,16/75,7.72%,TJP1;SORBS1;PHACTR1;ROCK2;FRMD5;TMOD3;PGM5;MYH9;ROCK1;TNFAIP1;ITGB5;EPB41L5;EPB41;CIT;TPM1;ACTN2
prerank,camera-type eye morphogenesis (GO:0048593),0.7450473765999397,1.5699975780869868,0.03255813953488372,0.5880157563830499,1.0,3/10,4.96%,TENM3;VEGFA;NF1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.6427243449478836,1.5693351920617273,0.03234501347708895,0.5858152418375228,1.0,9/21,18.64%,CREB3L1;PRKN;EIF2AK3;SELENOS;HERPUD1;NCK1;OPA1;BCL2L11;PARK7
prerank,regulation of neuron projection development (GO:0010975),0.49585585710142216,1.5674485559425382,0.001026694045174538,0.5907199161773075,1.0,38/163,12.02%,ROR2;RELN;SIPA1L1;ROR1;TENM3;NTRK3;PTEN;IL1RAPL1;LPAR1;FRMD7;NCS1;SEMA3A;PSEN1;CSMD3;NTRK2;MT3;TANC2;CTNNA2;WNT5A;FBXO7;LRRC4C;PAK1;ALKAL2;CHN1;CDKL5;DISC1;NTNG2;NTNG1;RAP1A;GAK;BAG5;DCC;HDAC2;PPFIA2;FKBP4;MAGI2;MYLIP;CDK5R1
prerank,organophosphate catabolic process (GO:0046434),0.7411964645468785,1.56742329479718,0.0330188679245283,0.585307660058973,1.0,2/11,2.72%,PLBD1;NUDT15
prerank,ERBB2 signaling pathway (GO:0038128),0.6060307513217562,1.566641334502303,0.02356020942408377,0.5838113916354365,1.0,16/31,22.43%,PRKCA;ERBB3;ERBB2;EGFR;ERBIN;BTC;PIK3R1;ERBB4;PTPN18;MYOC;GAB1;HBEGF;GRB2;SOS1;CPNE3;NRG1
prerank,neutrophil migration (GO:1990266),0.5417036874704743,1.5659828953067858,0.011494252873563218,0.581836702176563,1.0,8/58,9.69%,CCL11;LGALS3;CXCL10;CCL4;PDE4B;GBF1;CKLF;EDN3
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.5659573433974525,1.564884168417539,0.016568047337278107,0.5824306823112403,1.0,12/46,10.11%,WNK2;PTEN;DUSP4;PTPN2;EPHB2;CNKSR3;DUSP6;SPRED2;LMO3;SPRED1;PTPN1;SPRED3
prerank,protein localization to cell junction (GO:1902414),-0.5077538031063711,-1.5640247461462713,0.02564102564102564,0.5894747160699807,1.0,6/22,8.21%,TJP1;CGNL1;NLGN2;JAM3;TJP2;PAK2
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.7096427329839716,1.5638833430960994,0.03851851851851852,0.5823603276959947,1.0,1/13,0.13%,SEC16B
prerank,positive regulation of mitochondrial fission (GO:0090141),0.6506467712496412,1.5632685007906904,0.036535859269282815,0.5800282606504631,1.0,4/18,7.90%,DCN;SPIRE1;PRKN;BNIP3
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5972077889528828,1.5622356812134304,0.02454780361757106,0.5801944328483322,1.0,8/32,7.97%,APOD;DLC1;PTEN;SEMA3E;MAP4K4;HOXA7;RASA1;NF2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.7377647513202944,1.5621057578092457,0.03622047244094488,0.5758093255834268,1.0,3/11,13.43%,PRKCQ;CARD9;MALT1
prerank,negative regulation of cell projection organization (GO:0031345),0.5610495918646664,1.561424771917054,0.01325301204819277,0.5742511935648529,1.0,20/48,20.04%,PTEN;GORASP1;LPAR1;SEMA3A;PRNP;MT3;GRIN2B;GAK;FYN;BAG5;DCC;HDAC2;FKBP4;MYLIP;STX1B;EFNB2;RTN4RL1;DENND5A;KANK1;PTPRS
prerank,negative regulation of intracellular protein transport (GO:0090317),0.6340837830021084,1.5600377115996427,0.036734693877551024,0.5763559251879594,1.0,2/22,0.79%,APOD;MDFIC
prerank,external encapsulating structure organization (GO:0045229),0.49373579068963636,1.5588879769913082,0.0,0.5772423300976214,1.0,39/205,10.26%,LAMA2;VIT;DCN;COL15A1;TGFBI;MMP2;HSPG2;ADAMTS12;VCAN;ADAM19;LUM;ADAMTS20;COL5A3;FGF2;LAMC1;COL28A1;TGM1;COL5A2;COL27A1;PXDN;COL4A2;RECK;ITGB8;NF1;NID1;POSTN;COL9A2;MMP15;ADAMTS1;COL18A1;BCAN;COL3A1;TNR;ADAMTS4;HRNR;SPARC;COL1A2;NCAN;MMP16
prerank,muscle tissue morphogenesis (GO:0060415),-0.5516927912354921,-1.5586191855158176,0.05389221556886228,0.5992040148145303,1.0,7/16,19.16%,BMP4;MYLK;TBX1;EFEMP2;PROX1;HEY2;ZFPM1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.6128435654135266,1.5580299065608783,0.017150395778364115,0.5769085902963966,1.0,10/27,7.11%,PTEN;IL1RAPL1;FRMD7;NCS1;PSEN1;CTNNA2;FBXO7;DISC1;NTNG2;NTNG1
prerank,base conversion or substitution editing (GO:0016553),0.7305840943472308,1.555427202738996,0.040372670807453416,0.5858152418375228,1.0,4/11,13.10%,METTL3;APOBEC1;ADARB2;ADARB1
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.44040533040148044,-1.5536123825053219,0.03571428571428571,0.6080656360058067,1.0,22/39,26.95%,RPS14;NPM1;RPS16;RPS19;WDR3;RIOK3;RPS25;RPS15;RPS6;EMG1;SURF6;MRPS7;RIOK1;MRPS11;RPS17;SNU13;DDX52;RPS5;TSR3;RIOK2;PWP2;RPS27
prerank,positive regulation of neuron projection development (GO:0010976),0.5173322173399332,1.5530180670214364,0.012087912087912088,0.5929289100549294,1.0,10/85,7.56%,ROR2;RELN;ROR1;BMP5;TENM3;NTRK3;NTRK2;WNT5A;ALKAL2;RAP1A
prerank,positive regulation of sodium ion transport (GO:0010765),0.7181769012753122,1.5519464437006893,0.0310192023633678,0.5937130042469997,1.0,6/12,15.37%,ANK3;WNK3;CNKSR3;SCN5A;AHCYL1;PKP2
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.6880336514314412,1.5505505103669397,0.03924418604651163,0.5962366221988538,1.0,14/14,31.26%,SEC24D;SEC31B;SEC24C;RAB1A;TBC1D20;SEC24A;SEC23B;MIA3;SEC23A;SCAP;SEC31A;SAR1A;SEC13;SEC24B
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.567263882926093,1.550340736375533,0.01764705882352941,0.5925295725398879,1.0,13/46,13.01%,RELN;TSHZ3;CACNG7;GRIK3;NRXN1;CCR2;SYT1;NLGN1;GRIK1;GRM5;DGKI;OPHN1;DRD2
prerank,indolalkylamine catabolic process (GO:0046218),0.7352263175294679,1.5496311862282115,0.035541195476575124,0.5912773496464356,1.0,3/10,9.87%,AADAT;KYNU;IL4I1
prerank,bicarbonate transport (GO:0015701),-0.49046651077771475,-1.54935765572724,0.027237354085603113,0.6137538055758167,1.0,11/25,24.30%,SLC26A7;SLC4A10;SLC4A3;SLC39A8;CYB5R4;CA4;SLC4A8;CYB5R1;SLC26A6;CA2;CYB5RL
prerank,positive regulation of calcium ion import (GO:0090280),0.7118162462992484,1.5486996755090685,0.043478260869565216,0.5909119311791053,1.0,1/12,0.38%,LGALS3
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.6247640704212745,1.5486205196221432,0.026134800550206328,0.5866674539924331,1.0,4/22,4.77%,LGALS3;PTPN22;PTPN2;PRNP
prerank,eye morphogenesis (GO:0048592),0.6517013298721872,1.5479096947911,0.030555555555555555,0.5859403804599719,1.0,6/19,8.52%,EFEMP1;TENM3;COL5A2;VEGFA;NF1;RARG
prerank,smooth muscle contraction (GO:0006939),-0.5797221933899777,-1.5478854892562754,0.04804804804804805,0.6084831270354044,1.0,6/14,14.58%,ROCK2;ROCK1;PIK3C2A;MYLK;MYH11;ACTA2
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.5660983205955794,1.5473447116057364,0.022388059701492536,0.5842724067411966,1.0,11/41,9.96%,RELN;ERBB3;GPRC5B;FBXW7;NCF1;NTRK2;PRNP;FYN;BTC;PTPN1;GRM5
prerank,modulation of chemical synaptic transmission (GO:0050804),0.508293421834436,1.5467421869445617,0.0031779661016949155,0.5828402661565851,1.0,32/107,15.50%,RELN;CEL;CLSTN2;PTEN;NGF;NRG3;GRIK3;DLGAP1;CACNA1A;GRIK2;GRIK5;SLC12A2;GRID2;SYT1;LRRC4C;NLGN1;GRIK1;SLC8A2;USP46;NMU;SYN1;GRM5;PXK;MCTP1;DGKI;RIMS1;OPHN1;DRD2;CLSTN1;ITGB1;HOMER1;STX1B
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.5996888528349176,-1.5441224835062173,0.036414565826330535,0.6128158694711398,1.0,5/12,10.73%,PARP3;PARP10;PARP1;PARP6;PARP12
prerank,regulation of metal ion transport (GO:0010959),0.6639883167425945,1.5438088198355817,0.034934497816593885,0.5926889264034063,1.0,4/16,1.88%,IL16;BCL2;CACNA2D1;ANK2
prerank,nucleotide biosynthetic process (GO:0009165),-0.5392295232051403,-1.543596692153649,0.04013377926421405,0.6041202702702171,1.0,10/18,22.37%,NMNAT2;ME1;PRPSAP2;RRM1;NMNAT1;RRM2B;PRPS2;GART;PRPS1;PRPS1L1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.49790432928774153,-1.5435815502451973,0.02962962962962963,0.5937425189334236,1.0,10/22,23.97%,SNX9;ROCK1;TIMP3;ADRA2A;TIMP2;NRDC;APOE;TIMP4;SNX33;SH3D19
prerank,ERBB signaling pathway (GO:0038127),0.5372880309974684,1.5426524335953598,0.01740139211136891,0.594057453803251,1.0,17/64,12.57%,EFEMP1;PRKCA;ERBB3;GAREM1;REPS2;SOX9;ERBB2;EGFR;TGFB1;ERBIN;BTC;PIK3R1;ERBB4;CBL;PTPN11;MAPK1;PTPN18
prerank,regulation of stem cell proliferation (GO:0072091),-0.5351428923363645,-1.542592951470596,0.03728813559322034,0.5871262683028622,1.0,9/17,15.31%,GJA1;FBLN1;KDM1A;ACE;ZFP36L1;AGO3;PTPRC;HMGA2;TERT
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.6341438137290467,-1.5419027771511968,0.03783783783783784,0.5702137624812081,1.0,4/10,10.51%,PRKCD;SIRT3;RACK1;TNFRSF1A
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.6341438137290467,-1.5419027771511968,0.03783783783783784,0.5702137624812081,1.0,4/10,10.51%,PRKCD;SIRT3;RACK1;TNFRSF1A
prerank,regulation of cation channel activity (GO:2001257),0.5207593264492821,1.5412959306185694,0.013015184381778741,0.5965191940141847,1.0,18/89,6.64%,RELN;ANK3;CRH;FGF13;ANK2;GRIA1;CACNG7;CAPN1;GRIA3;HPCA;SHISA9;GRIN2B;DLG2;NLGN1;FGF12;CACNB4;JPH3;FGF14
prerank,negative regulation of viral genome replication (GO:0045071),-0.43141589519203805,-1.5411275111500022,0.023121387283236993,0.5640118984063615,1.0,15/40,21.58%,ZC3HAV1;PLSCR1;IFITM3;IFIH1;PARP10;TNIP1;IFITM2;PROX1;OAS2;HMGA2;TASOR;ISG15;IFIT1;BST2;RSAD2
prerank,cardiac conduction system development (GO:0003161),-0.46712404714490224,-1.5410932221523528,0.038461538461538464,0.5552523255752936,1.0,6/24,4.39%,NOTCH2;GJA1;BMP4;GJB6;MAML1;CACNA1G
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.6393921963006284,1.540240287146857,0.052054794520547946,0.5975474029118071,1.0,3/19,4.19%,RAPSN;NQO1;CHRNA4
prerank,regulation of adaptive immune response (GO:0002819),0.6561735887250507,1.5387207090726889,0.05196629213483146,0.6010581167664144,1.0,6/18,12.88%,PYCARD;FADD;SAMSN1;IL4I1;IL6ST;AHR
prerank,divalent inorganic cation homeostasis (GO:0072507),0.6172163946256565,1.5364951247069636,0.03631647211413749,0.6079133845258693,1.0,5/25,4.92%,ANK3;PRKN;KCNA1;TMTC2;MT3
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.5745402931706641,1.5358996809731629,0.02795425667090216,0.6065802919793254,1.0,13/34,14.76%,UBASH3B;PTPN22;DUSP4;PTPRT;PTPN2;DUSP6;PTPN13;PTPN1;PTPRJ;PTPN11;PTPN18;PTPRZ1;PTPRF
prerank,chemokine-mediated signaling pathway (GO:0070098),0.5706939743599316,1.535248807329962,0.015587529976019185,0.605273721776232,1.0,6/42,9.24%,CCL11;CXCL10;CCL4;CCR2;ACKR3;STK39
prerank,negative regulation of cellular component movement (GO:0051271),-0.5543777357052986,-1.5348412312112776,0.04983388704318937,0.5691670243862123,1.0,5/15,9.14%,SP100;FRMD5;FBLN1;ACTN1;CCDC125
prerank,negative regulation of cell development (GO:0010721),0.6136700166856435,1.5346454686042907,0.034255599472990776,0.6040281471975151,1.0,4/25,4.86%,CCL11;PTHLH;FBXW7;PCM1
prerank,extracellular matrix disassembly (GO:0022617),0.538579763276035,1.5344193517805573,0.01652892561983471,0.6008866212537606,1.0,14/53,14.73%,MMP2;A2M;LAMC1;GSN;HTRA1;CAPN1;TLL2;MMP15;CTSK;ADAMTS4;MMP16;SCUBE1;MMP19;WASHC1
prerank,cellular component disassembly (GO:0022411),0.539057841033753,1.5341794608765418,0.0166073546856465,0.597720875969229,1.0,14/53,14.73%,MMP2;A2M;LAMC1;GSN;HTRA1;CAPN1;TLL2;MMP15;CTSK;ADAMTS4;MMP16;SCUBE1;MMP19;WASHC1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.4835627531913629,-1.5339844018358344,0.017857142857142856,0.5636586264157629,1.0,10/26,9.30%,OSBPL8;SORBS1;IGF1;OCLN;CLIP3;CREBL2;INSR;PRKCI;RHOQ;ARPP19
prerank,tight junction assembly (GO:0120192),-0.4058530477691682,-1.5337202871504911,0.0,0.5560562138430023,1.0,12/49,8.69%,AFDN;PARD6G;CDH5;PECAM1;CLDN5;OCLN;ESAM;PARD3;PRKCI;CLDN14;PAK2;MPP7
prerank,regulation of mitochondrial depolarization (GO:0051900),0.7333052636665542,1.533503306980722,0.047021943573667714,0.5967954980439173,1.0,2/10,1.69%,DCN;BCL2
prerank,negative regulation of signaling (GO:0023057),0.6217124645297769,1.5326127642499048,0.04263565891472868,0.5971434673607309,1.0,6/25,9.51%,UBASH3B;ERBB3;ACVR1;SOCS5;HHIP;PTPN1
prerank,estrogen metabolic process (GO:0008210),0.6694997293839229,1.5320772987721654,0.047142857142857146,0.5955382883208558,1.0,3/15,5.48%,HSD17B7;HSD17B11;CYP1B1
prerank,cellular response to chemokine (GO:1990869),0.5598012071510805,1.5297710670951192,0.022727272727272728,0.6033470117090332,1.0,7/46,9.24%,CCL11;CXCL10;CCL4;CCR2;SLC12A2;ACKR3;STK39
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.538408805769095,1.5278838534440031,0.02127659574468085,0.608432777697552,1.0,11/57,5.87%,RELN;CRH;GRIA1;CACNG7;CAPN1;GRIA3;DLGAP1;SHISA9;GRIN2B;DLG2;NLGN1
prerank,extracellular structure organization (GO:0043062),0.48375601778441424,1.5273044984627073,0.0,0.6072934491759931,1.0,37/204,10.26%,LAMA2;VIT;DCN;COL15A1;TGFBI;MMP2;HSPG2;ADAMTS12;VCAN;ADAM19;LUM;ADAMTS20;COL5A3;FGF2;LAMC1;COL28A1;COL5A2;COL27A1;PXDN;COL4A2;RECK;ITGB8;NF1;NID1;POSTN;COL9A2;MMP15;ADAMTS1;COL18A1;BCAN;COL3A1;TNR;ADAMTS4;SPARC;COL1A2;NCAN;MMP16
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.6149019056185057,1.5256353357876786,0.049315068493150684,0.6115263838393337,1.0,11/21,22.54%,SULF1;HS6ST1;EXT1;EXTL3;GLCE;GPC1;HS2ST1;UGDH;SGSH;XYLT1;SULF2
prerank,acyl-CoA metabolic process (GO:0006637),0.5790530906940171,1.5228950710360174,0.031446540880503145,0.6209246396000797,1.0,14/35,21.33%,THEM4;DLST;ACACA;OXSM;ACOT11;ACSF2;SUCLA2;ACSL6;GPAT4;HMGCS2;GLYAT;DBI;ACOT8;ACBD6
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.6180568092164836,-1.5224241040014859,0.060209424083769635,0.5880112724149378,1.0,4/10,11.00%,PLPP1;GAP43;PARD3;DGKH
prerank,serine family amino acid biosynthetic process (GO:0009070),0.6994728981463932,1.5209493832795131,0.0420899854862119,0.6264311197359554,1.0,5/12,7.09%,CTH;CBS;PSPH;PSAT1;PHGDH
prerank,myotube cell development (GO:0014904),-0.6308805353529412,-1.5203502273853677,0.045317220543806644,0.5868576459925687,1.0,2/10,7.25%,IGF1;SIX1
prerank,microtubule anchoring (GO:0034453),0.7073717117516898,1.5202898563099698,0.039816232771822356,0.6255826855721691,1.0,5/12,10.94%,SAXO2;BICD1;PCM1;CLASP1;BICD2
prerank,negative regulation of calcium ion transport (GO:0051926),-0.5526139486994023,-1.519682101193739,0.05572755417956656,0.5807393700919057,1.0,10/15,37.23%,ATP1A2;SLC30A1;ADRA2A;NOS1;PLN;CBARP;TMBIM6;STC1;EPO;LILRB1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.6697649760274307,1.519647149469866,0.05043227665706052,0.6251042508922683,1.0,5/15,10.26%,EDA;GLI2;SCN5A;AMELX;HDAC2
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.6319380764567613,1.5195694379371227,0.04329004329004329,0.6213481245952085,1.0,6/20,8.78%,BMP5;SLC27A1;ERLIN2;FBXW7;ASXL3;BRCA1
prerank,positive regulation of transporter activity (GO:0032411),0.6829444801545448,1.5192600353574002,0.05200594353640416,0.6188108009460263,1.0,5/13,9.56%,SYNGR3;KMT2A;WNK3;STK39;SGK2
prerank,basement membrane organization (GO:0071711),0.675281854914901,1.5184062357198862,0.06666666666666667,0.6191080508377037,1.0,5/14,7.11%,NTN4;PXDN;NID1;NTNG2;NTNG1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.5847288219345053,-1.5182483880458002,0.05105105105105105,0.5776224306439731,1.0,6/13,12.65%,SORBS1;SNX5;IGF2;GKAP1;PRKCZ;ECHDC3
prerank,regulation of myelination (GO:0031641),0.6079008436107383,1.5178557108666735,0.040160642570281124,0.617772528953599,1.0,5/25,9.15%,LGI4;NKX6-2;EIF2AK3;TMEM98;NSUN5
prerank,cell-cell junction maintenance (GO:0045217),-0.6042049492596038,-1.517702844174144,0.03869047619047619,0.5715419136009471,1.0,2/11,3.27%,TJP1;NLGN2
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.6007963039087838,-1.5164967655850714,0.05357142857142857,0.5678409925453152,1.0,5/12,8.93%,SORBS1;SNX5;IGF2;GKAP1;PRKCZ
prerank,Golgi organization (GO:0007030),0.4953632786735653,1.5163613138584455,0.009574468085106383,0.6215018472932465,1.0,37/112,20.05%,SEC16B;TMED6;ATP8B1;GORASP1;HACE1;VAMP4;BLZF1;GOLGB1;OBSL1;YWHAZ;ARL1;GBF1;GAK;TRIP11;BAG5;TMED10;HUWE1;GORASP2;CLASP1;PI4K2A;ARHGAP21;RAB1A;ATL3;USP6NL;CSNK1A1;TBC1D20;TMED2;TMED3;SEC23IP;ARFGEF1;SURF4;STX17;HTT;RAB30;COG1;VMP1;COG4
prerank,T cell differentiation in thymus (GO:0033077),0.6816041760873723,1.5162881769491616,0.04460431654676259,0.617919096250215,1.0,5/14,12.11%,RAG2;FADD;RABL3;ZFP36L2;MR1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.5144939981216153,1.5131768820737925,0.017758046614872364,0.6299025702688467,1.0,11/72,4.62%,ROR2;DCN;ROR1;PDGFRA;ERBB3;NTRK3;FGF2;IRS2;SOX9;NCF1;NTRK2
prerank,negative regulation of fat cell differentiation (GO:0045599),0.5764395178232518,1.5124228940639977,0.031685678073510776,0.6296035624539231,1.0,8/34,13.38%,RORA;TGFB1;WNT5A;ZFP36L2;ZFPM2;WWTR1;TRIO;GATA3
prerank,quinone biosynthetic process (GO:1901663),-0.5450725787758662,-1.5114355086745057,0.06422018348623854,0.5785504024481114,1.0,9/14,26.40%,COQ8B;COQ10B;PDSS1;COQ9;COQ3;FDXR;PDSS2;COQ6;COQ8A
prerank,response to interleukin-1 (GO:0070555),0.5113008630688742,1.5067159148729143,0.01687289088863892,0.6545265742842358,1.0,8/73,4.22%,CCL11;ADAMTS12;PRKCA;HAS2;PYCARD;SOX9;IRAK3;CCL4
prerank,vasculogenesis (GO:0001570),0.5668322095283066,1.5058902822530271,0.04218362282878412,0.6546191058977654,1.0,8/32,6.86%,GLMN;HAS2;VEGFA;TGFB1;ITGB8;RASA1;TGFBR2;SPRED1
prerank,positive regulation of lymphocyte migration (GO:2000403),0.7013342149382544,1.5039684626492271,0.04640718562874251,0.6605804369254134,1.0,2/12,1.42%,CXCL10;PYCARD
prerank,cellular response to estradiol stimulus (GO:0071392),0.6426881186999859,1.5026437827323798,0.04113475177304964,0.6635427556208413,1.0,8/18,19.35%,SSTR1;EGFR;ESR1;NRIP1;LCOR;NCOA3;FAM210B;RUVBL2
prerank,RNA interference (GO:0016246),-0.5148985026120463,-1.5025884125354436,0.05460750853242321,0.6029365695720886,1.0,10/17,30.50%,AGO1;NRDE2;AGO3;TERT;TARBP2;CLP1;MRPL44;AGO2;AGO4;DICER1
prerank,sphingosine biosynthetic process (GO:0046512),-0.6123653220234998,-1.5024855970701292,0.05337078651685393,0.5875061386760203,1.0,6/11,24.97%,ACER2;SPTLC2;ASAH2;SPHK1;SPHK2;SPTLC1
prerank,sphingoid biosynthetic process (GO:0046520),-0.6123653220234998,-1.5024855970701292,0.05337078651685393,0.5875061386760203,1.0,6/11,24.97%,ACER2;SPTLC2;ASAH2;SPHK1;SPHK2;SPTLC1
prerank,positive regulation of nuclear division (GO:0051785),-0.46495887859853907,-1.497916395768106,0.036290322580645164,0.5960113747678094,1.0,7/25,10.82%,IGF1;LRP5;IGF2;INSR;TGFA;RGCC;PDGFRB
prerank,chondroitin sulfate catabolic process (GO:0030207),0.6790758732275629,1.497047957157923,0.0581039755351682,0.6887775818889635,1.0,7/13,18.06%,DCN;VCAN;BCAN;NCAN;IDS;HYAL1;CSPG4
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.5949789415583321,-1.496929817363576,0.03899721448467967,0.5919271512245423,1.0,6/11,16.32%,PARP3;PARP4;PARP10;PARP6;PARP12;PARP14
prerank,regulation of lymphocyte migration (GO:2000401),-0.6227273515382474,-1.496908564313308,0.05994550408719346,0.5845603280104708,1.0,5/10,22.82%,WASL;SLC8B1;STK10;MSN;AKT1
prerank,diol metabolic process (GO:0034311),-0.5043559890906556,-1.4968605334376337,0.05723905723905724,0.5774743931839598,1.0,9/19,24.48%,PLPP1;NOS3;DEGS2;ASAH2;HSP90AA1;SPR;SPHK1;AKT1;SPHK2
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.6859591442424184,1.4963431379261092,0.049924357034795766,0.6881971205638904,1.0,7/13,22.14%,VDAC2;BMF;BNIP3;RHOT2;BCL2L11;RHOT1;BNIP3L
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.6776059711976252,1.4952345923209307,0.07302533532041729,0.6897973348749098,1.0,6/12,20.94%,H6PD;KPNB1;CLCN2;SREBF2;MBTPS1;SEC14L2
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.47546325140583445,1.4941429619641908,0.004145077720207254,0.6915000310214391,1.0,31/159,9.71%,DCHS1;CDH19;MPZ;TENM2;CLDN19;TENM3;IL1RAPL1;PTPRT;ACVR1;DSG2;CDH10;CLDN1;CDH22;PCDHGB4;OBSL1;GRID2;CDH8;LRRC4C;NLGN1;CADM3;TGFBR2;KIRREL3;HMCN1;NTNG1;CNTN6;CNTN2;CADM1;PALLD;DSCAM;CDH20;CDH7
prerank,positive regulation of cation channel activity (GO:2001259),0.5508791840445749,1.493248563821529,0.030599755201958383,0.6920250607383358,1.0,5/40,5.38%,RELN;ANK3;ANK2;EPHB2;CCR2
prerank,positive regulation of vascular permeability (GO:0043117),-0.5769072028597146,-1.4931290279468448,0.0546448087431694,0.5835137123448488,1.0,6/12,7.35%,BMP6;TJP1;OCLN;ANGPT1;TJP2;PDE3A
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.6257311496456255,1.4926561480617053,0.07223796033994334,0.6908552622450312,1.0,3/18,6.23%,APOD;MDFIC;OTUD7B
prerank,cellular lipid catabolic process (GO:0044242),0.5938101304545563,1.4910390215089182,0.050452781371280724,0.6959587175904166,1.0,6/27,7.92%,CEL;PLBD1;MT3;ACBD5;CYP1B1;ACOX1
prerank,axon guidance (GO:0007411),0.46938983329041284,1.4906505519141091,0.0020325203252032522,0.6938405069967395,1.0,52/201,12.74%,LAMA2;RELN;GFRA1;NTN4;PRKCA;LGR6;ENAH;EFNA4;PRKCQ;GLI2;SEMA3E;IRS2;EPHB6;PLXNC1;GFRA4;EFNA5;SEMA6C;VEGFA;EPHB2;MAPK7;SEMA3A;NRXN1;WNT5A;SPTBN1;CHN1;CNTN6;GAB2;FYN;CNTN2;TNR;SMO;DOK6;PALLD;DSCAM;DOK4;PIK3R1;DCC;GDNF;KIF5C;USP33;PTPN11;OPHN1;MAPK1;GPC1;EFNB1;PTPRA;CDK5R1;NRP2;UNC5C;RHOH;EFNB3;SH3KBP1
prerank,embryonic appendage morphogenesis (GO:0035113),0.6837586867331772,1.4905513525079626,0.049475262368815595,0.6902902385405258,1.0,1/12,0.48%,PTCH1
prerank,negative regulation of viral process (GO:0048525),-0.3871393325673268,-1.4888608050325123,0.007246376811594203,0.591346827099452,1.0,20/57,21.58%,ZC3HAV1;CHMP3;PLSCR1;IFITM3;PPIA;IFIH1;PARP10;TRIM5;TNIP1;IFITM2;LARP7;PROX1;OAS2;PML;TRIM21;ISG15;IFIT1;BST2;HEXIM1;RSAD2
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.6075194576952047,-1.4878018920291287,0.07734806629834254,0.5878578238632073,1.0,10/10,39.29%,NAF1;DKC1;RPUSD4;GAR1;TSR3;RPUSD1;NHP2;RPUSD2;RPUSD3;NOP10
prerank,regulation of lamellipodium organization (GO:1902743),-0.5527260082732517,-1.4872954710918818,0.05161290322580645,0.5826622837270933,1.0,6/14,26.83%,CAPZB;PDPN;CDC42;EPHA2;DMTN;TWF2
prerank,embryonic limb morphogenesis (GO:0030326),0.5602655514360159,1.4858705981603129,0.040690505548705305,0.7115022224220425,1.0,4/34,1.92%,OSR2;PTCH1;AFF3;WDPCP
prerank,positive regulation of cartilage development (GO:0061036),0.6334188135092674,1.4858332478266905,0.06789250353606789,0.7076243952039037,1.0,5/17,8.46%,SOX6;PKDCC;SOX9;ZBTB16;SOX5
prerank,negative regulation of myoblast differentiation (GO:0045662),0.6773497377276498,1.483828554036598,0.055636896046852125,0.7144430772922745,1.0,6/13,13.08%,SOSTDC1;SOX8;SOX9;TGFB1;PRICKLE1;EID2B
prerank,wound healing (GO:0042060),0.5156595931355565,1.4826533419574466,0.01873536299765808,0.7170344513482829,1.0,19/62,13.91%,DCBLD2;PDGFRA;ERBB3;EPB41L4B;FGF2;FGF10;ERBB2;CLDN1;NF1;WNT5A;PAK1;PLEC;FZD7;PPP3CA;COL3A1;SYT11;ANXA6;RAB3A;CORO1B
prerank,negative regulation of axonogenesis (GO:0050771),0.5831420877582936,1.4821229291948903,0.04933333333333333,0.7159401911381724,1.0,11/27,16.46%,FGF13;LRP4;PTEN;RNF6;MT3;CDKL3;DCC;NGFR;EFNB3;RTN4;DIP2B
prerank,regulation of Rac protein signal transduction (GO:0035020),0.6378153953518934,1.4817769201449895,0.05673758865248227,0.7136625927780733,1.0,4/16,6.02%,ARHGAP24;CADM4;AUTS2;ALS2
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.5284810231153474,1.4817530558098004,0.03098927294398093,0.7097729289484379,1.0,21/51,16.87%,KIF20B;NGF;GAS7;MAP4K4;TNIK;NYAP1;PAK1;ALS2;CNTNAP2;GPM6A;EPB41L3;DCLK1;BMP7;TAOK3;WASF1;TRIO;SNX1;ANKRD27;UBB;CTTN;SGK1
prerank,positive regulation of signaling receptor activity (GO:2000273),0.5590337975792482,1.481413753672013,0.043758043758043756,0.7077161291311097,1.0,14/36,18.91%,RELN;EPHB2;FBXW7;NCF1;CCR2;BTC;HIF1A;HDAC2;HDAC6;ITGB1;HBEGF;NCOA3;PARK7;TAF1
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.6718345866549629,1.4807322748122524,0.06835066864784546,0.7072213065292926,1.0,1/13,0.13%,SEC16B
prerank,positive regulation of lymphocyte activation (GO:0051251),0.5738283780249451,1.4803932364114496,0.058823529411764705,0.7049938339626697,1.0,10/28,21.38%,PRKCQ;PYCARD;FGF10;CCR2;SH3KBP1;XRCC6;TICAM1;SIRPA;HSPD1;TNIP2
prerank,sphingosine metabolic process (GO:0006670),-0.5211422454043748,-1.4797010856592425,0.07718120805369127,0.6032460314090081,1.0,10/17,36.44%,PLPP1;ACER2;SPTLC2;ASAH2;SPHK1;SPHK2;SPTLC1;PLPP2;SPTLC3;NAAA
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.46935370826548123,1.4779591490806123,0.0020512820512820513,0.7138600237162329,1.0,44/173,15.65%,SEC16B;TMED6;DYNLL1;ANK3;ANK1;ANK2;GORASP1;PGAP1;GRIA1;SEC24D;VAMP4;COG5;COPZ2;GOLGB1;SPTBN1;TRAPPC6B;GBF1;COPB2;COPG2;TRIP11;TMED10;SEC24C;KDELR2;CUL3;VAPA;DYNC1I1;ARF4;RAB1A;BET1L;PROS1;ATL3;DCTN4;KLHL12;TBC1D20;COPA;ARFGAP3;ARFGAP1;TMED2;TMED3;DYNC1I2;COPG1;KDELR3;TRAPPC6A;CNIH4
prerank,chordate embryonic development (GO:0043009),0.5180652631238851,1.47751281410838,0.042067307692307696,0.7122515801882058,1.0,18/55,15.64%,PTCH1;BMP5;SULF1;SOX8;VEGFA;TGFB1;WNT5A;FGFR1;EGFL8;BRCA1;BMP7;KIAA1217;DVL1;COL1A1;GATA3;PKD1;DACT1;TGFB3
prerank,positive regulation of dendritic spine development (GO:0060999),0.603807763104559,1.4768653383627448,0.07192254495159059,0.7118788960420672,1.0,4/20,8.24%,RELN;PSEN1;NLGN1;CPEB3
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.5727482176041009,-1.476650751719903,0.09183673469387756,0.6076063279713221,1.0,4/12,5.11%,CDH5;MAP2;CLIP3;EML2
prerank,epithelium development (GO:0060429),0.4794321845864009,1.4756753926099915,0.013756613756613757,0.7143499357789881,1.0,24/107,12.02%,LGALS3;PTCH1;MEOX1;MEOX2;SOX8;FGF10;TST;CD34;SOX9;VEGFA;CNN3;TGFB1;SOX11;UPK1B;LOXL3;GATA6;CASP6;CTSB;SMO;PPP2R3A;RCN3;PIH1D1;TOLLIP;DVL1
prerank,positive chemotaxis (GO:0050918),0.6190023487330246,1.475406555708681,0.0676056338028169,0.7119835331526589,1.0,7/17,15.14%,LGALS3;FGF10;VEGFA;PTPRJ;FGF7;SCRIB;MET
prerank,positive regulation of protein secretion (GO:0050714),-0.3647720948578131,-1.4743166624395831,0.00909090909090909,0.6092872463054888,1.0,19/69,13.44%,BMP6;WLS;IGF1;MYRIP;RBP4;NLGN2;TLR4;EXOC1;PPIA;NNAT;UNC13B;C1QTNF3;ABCG1;APBB1;SYTL4;AACS;TGFB2;LRRC8A;MYH10
prerank,odontogenesis (GO:0042476),0.5562253634668767,1.473186003740527,0.05309734513274336,0.7198048982152542,1.0,7/35,10.26%,OSR2;EDA;GLI2;SCN5A;COL1A2;AMELX;HDAC2
prerank,regulation of sodium ion transport (GO:0002028),0.5661441718891899,1.4725552570427332,0.04469987228607918,0.7195229783103249,1.0,11/34,15.37%,WNK2;ANK3;NKAIN2;WNK3;CNKSR3;SCN5A;FGF12;DRD2;PER1;AHCYL1;PKP2
prerank,dorsal/ventral pattern formation (GO:0009953),0.6096104038173401,1.4723999590237804,0.07183908045977011,0.7164895502246122,1.0,4/20,5.97%,PTCH1;GLI2;ACVR1;FBXL15
prerank,regulation of cell junction assembly (GO:1901888),-0.4308337067200535,-1.4715251942125835,0.036,0.6123116449103672,1.0,8/27,1.88%,TJP1;ROCK2;PRKCH;PDLIM5;RAP1B;ROCK1;CLDN5;OCLN
prerank,regulation of glucose metabolic process (GO:0010906),0.5564634407945622,1.470211490126918,0.05093167701863354,0.7240429198144804,1.0,6/34,9.62%,RORA;IRS2;PRKN;RORC;PDK3;SELENOS
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.7053935746476931,1.4679408698825254,0.08295625942684766,0.731935797037002,1.0,3/10,5.61%,GCDH;IVD;ETFA
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.655999967790629,1.4679176161778438,0.06466165413533835,0.7282586667262996,1.0,5/15,10.20%,DCN;VCAN;BCAN;CSGALNACT1;NCAN
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.48415475438857136,1.467083583427308,0.019417475728155338,0.728803096677191,1.0,22/100,12.91%,ROR2;DCN;ROR1;PDGFRA;ERBB3;NTRK3;FGF2;PTEN;IRS2;SOX9;EGFR;NCF1;NTRK2;PTPN13;FGFR1;IL18;PIK3R1;CBL;MAPK1;MYDGF;FBXL2;MYOC
prerank,sulfur amino acid metabolic process (GO:0000096),0.5978276020191009,1.4665743317095918,0.07323568575233022,0.7277842193910316,1.0,9/24,15.18%,CTH;TST;DPEP1;CBS;AHCY;SMS;MTRR;ADI1;MTR
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.6067588143958254,-1.466281833132602,0.0728862973760933,0.6239369757368595,1.0,3/10,8.10%,PODXL;WNK1;DPP4
prerank,positive regulation of B cell proliferation (GO:0030890),0.5676282155607478,1.4652951759770647,0.04409857328145266,0.7309660561063844,1.0,6/29,8.26%,BCL2;IRS2;BST1;EPHB2;CD320;VAV3
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.6058099573744284,1.4623005509985656,0.06872370266479663,0.7432639219555242,1.0,8/20,15.44%,GCDH;ACACA;SCD5;FASN;ACLY;PPT2;FAR1;ACSL3
prerank,2-oxoglutarate metabolic process (GO:0006103),0.6749347909922074,1.4621042479432276,0.06906906906906907,0.7405604972553448,1.0,5/13,13.76%,AADAT;IDH2;DLST;GOT2;GPT2
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.6013659322975027,1.4615405778815704,0.060191518467852256,0.7399405242150798,1.0,6/21,10.20%,DCN;VCAN;BCAN;CSGALNACT1;CHSY1;NCAN
prerank,regulation of small molecule metabolic process (GO:0062012),0.5803204600287454,1.4604756157278487,0.06658130601792574,0.7418854603184332,1.0,4/28,7.30%,RORA;PRKN;RORC;PDK3
prerank,copper ion transport (GO:0006825),0.686959239885121,1.4602136612984116,0.08125,0.7396142685163029,1.0,3/11,2.53%,STEAP4;STEAP2;STEAP3
prerank,protein heterooligomerization (GO:0051291),0.6233833147933998,1.460006485032384,0.06569343065693431,0.7370973803273658,1.0,8/17,21.03%,FARSA;CPSF6;GRIN2B;FARSB;TMEM120A;PKD1;MAT2A;PKD2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.5426646696801386,-1.4593994948065623,0.06451612903225806,0.6414447790344268,1.0,8/13,23.72%,PRPF3;SRSF10;PRPF31;DDX20;SRSF12;SART3;AAR2;USP4
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.5985405656074693,1.4585879302855784,0.059639389736477116,0.7410195158726017,1.0,6/22,11.81%,IL2RA;CBFB;SOCS1;SOX12;IL4I1;RUNX1
prerank,response to UV-A (GO:0070141),0.6520039104268893,1.4583753074956156,0.069164265129683,0.7386199974100068,1.0,3/14,8.65%,MMP2;EGFR;PPID
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.5044977900437656,-1.458096206063489,0.08098591549295775,0.6392424539996714,1.0,6/17,11.12%,CACNA1C;ATP1A2;GJA1;ATP1A1;GJC1;GJD3
prerank,embryonic digestive tract development (GO:0048566),0.6201955058971242,1.4576723496295458,0.07344632768361582,0.7388440067068275,1.0,5/18,8.41%,PDGFRA;GLI2;PKDCC;SOX11;RARB
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.5472706298400399,1.4576581370478212,0.04505632040050062,0.7353513053111271,1.0,12/37,20.53%,APOD;PYCARD;CARD9;HIF1A;MAPK14;CHID1;PER1;TICAM1;ABCD2;STAT3;PDCD4;SIRPA
prerank,regulation of epithelial cell proliferation (GO:0050678),0.48571144325309334,1.4573176547071043,0.026373626373626374,0.7336354958754877,1.0,14/85,5.68%,OSR2;BMP5;EPB41L4B;FGF2;MYC;FGF10;CDKN2B;SOX9;LAMC1;ERBB2;EGFR;VEGFA;TGFB1;SCN5A
prerank,tryptophan catabolic process (GO:0006569),0.6892434347938359,1.4571776664156857,0.05967741935483871,0.7309129984963537,1.0,3/11,9.87%,AADAT;KYNU;IL4I1
prerank,endodermal cell fate commitment (GO:0001711),-0.6036692200505486,-1.4571583022445906,0.07605633802816901,0.6357063226359819,1.0,5/10,16.80%,CTR9;LEO1;SOX17;RTF1;PAF1
prerank,glial cell development (GO:0021782),0.574655370282114,1.4559970630066672,0.07152317880794702,0.7337662368605312,1.0,7/25,9.15%,MXRA8;SOX11;MT3;NF1;CDK6;EIF2B5;NSUN5
prerank,blood vessel endothelial cell migration (GO:0043534),-0.4716647517481264,-1.4553839534478785,0.03180212014134275,0.6351344001989113,1.0,9/22,4.45%,ROBO1;CDH5;NRP1;MYH9;PIK3R3;ID1;SLIT2;EPHB4;KDR
prerank,actin filament-based transport (GO:0099515),-0.4776763688473996,-1.4542871087530649,0.0498220640569395,0.6318818344275786,1.0,7/21,13.74%,SYNE2;MYO1D;WASL;FNBP1L;MYO1E;MYO5B;MYO1C
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.647263780736702,1.4542700185556896,0.06446776611694154,0.7395543145833393,1.0,6/14,18.64%,CREB3L1;PRKN;SELENOS;HERPUD1;OPA1;PARK7
prerank,positive regulation of keratinocyte migration (GO:0051549),0.7016335820995159,1.4540075215454529,0.08507223113964688,0.7374247338881026,1.0,4/10,11.39%,EPB41L4B;FGF10;MAP4K4;FGF7
prerank,regulation of leukocyte migration (GO:0002685),0.6289434151237192,1.4531990479855879,0.08563134978229318,0.7383588273742916,1.0,4/16,12.37%,BST1;HOXA7;VEGFA;RHOH
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.5539431272469694,1.4529860477698964,0.06281407035175879,0.7359051466776847,1.0,15/33,20.28%,FGF10;STXBP4;EGFR;UBE2E2;GLI1;PLCB1;ADAMTS1;EIF4G1;CCND2;HYAL1;CDC73;RPTOR;KMT2E;RDX;PHB2
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.5165075894299408,1.4516120828722832,0.037252619324796274,0.7394504303737006,1.0,17/53,15.40%,GLMN;RAD23B;XPO1;PRKN;NUDT15;ARAF;FBXW7;UCHL5;UFL1;OPHN1;TMF1;PRKACA;TMTC3;USP14;PKD1;GABARAPL2;UBB
prerank,kidney development (GO:0001822),0.49693963265452457,1.4512531364432975,0.02558139534883721,0.7379908721963172,1.0,11/65,6.61%,OSR2;SULF1;HAS2;GLI2;LRP4;FGF10;PRKX;VEGFA;ARL3;NF1;ZBTB16
prerank,cellular response to oxygen levels (GO:0071453),-0.6002291325243068,-1.451140911645733,0.07945205479452055,0.636749319374851,1.0,8/10,30.40%,ATP6V0D1;NDUFS2;ATP6AP1;ATP6V0A2;TMEM199;ATP6V1G1;CCDC115;ATP6V1A
prerank,regulation of muscle cell differentiation (GO:0051147),-0.4188009185588841,-1.4495259620621548,0.03286384976525822,0.6359195823972186,1.0,13/31,18.89%,CDH2;BOC;CTNNB1;CDON;IGF2;BNIP2;CAMK1;FGFR2;MAPK12;ID2;CDC42;PTBP1;MYOCD
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.5790850955466654,1.4494138950442044,0.07856191744340879,0.7440599065032412,1.0,6/24,15.00%,GFPT2;MYC;MT3;PID1;COX10;MTLN
prerank,apical junction assembly (GO:0043297),-0.37349659232234367,-1.4474105483576885,0.022727272727272728,0.6372264835476453,1.0,13/53,9.65%,AFDN;PARD6G;CDH5;PECAM1;CLDN5;OCLN;ESAM;PARD3;PRKCI;CLDN14;PAK2;MPP7;RHOA
prerank,sphingoid metabolic process (GO:0046519),-0.5717659646837848,-1.4472974851226879,0.07716049382716049,0.6312430085413692,1.0,9/12,36.44%,PLPP1;KDSR;DEGS2;ASAH2;SPHK1;SPHK2;PLPP2;SPTLC3;NAAA
prerank,establishment of endothelial barrier (GO:0061028),-0.42929311994427943,-1.4471320699456722,0.047619047619047616,0.6254362373921944,1.0,10/29,14.61%,AFDN;TJP1;PECAM1;RAP1B;PPP1R16B;TJP2;ICAM1;PDE2A;ROBO4;MSN
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.5126760911823336,-1.4464367266954405,0.06289308176100629,0.6214920489276003,1.0,8/16,23.25%,NOS3;GUCY1B1;DDAH2;NOS1;NDNF;KCNC2;APOE;AGT
prerank,tryptophan metabolic process (GO:0006568),0.6686098164995832,1.444718429825646,0.08166409861325115,0.7652746272328254,1.0,3/11,9.87%,AADAT;KYNU;IL4I1
prerank,collagen fibril organization (GO:0030199),0.484306974437611,1.4440828647167687,0.03598691384950927,0.7650656964380105,1.0,22/88,9.37%,COL15A1;LUM;COL5A3;COL20A1;COL28A1;COL5A2;P4HA1;COL27A1;PXDN;COL4A2;COL26A1;NF1;TLL2;CYP1B1;COLGALT2;COL9A2;PLEC;COL18A1;LOXL3;COL3A1;PLOD1;COL1A2
prerank,negative regulation of cell junction assembly (GO:1901889),0.5768013780012191,1.4434056681159035,0.07047872340425532,0.7650795357782229,1.0,3/25,1.62%,APOD;DLC1;PTEN
prerank,positive regulation of DNA replication (GO:0045740),0.6230115784473921,1.443102239847671,0.0787518573551263,0.7631804832042601,1.0,4/16,6.27%,GLI2;EGFR;GLI1;STN1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.48703531525516236,-1.442614815727828,0.06752411575562701,0.6288764193079116,1.0,9/19,16.23%,BMP6;AFDN;TJP1;RGCC;NOTCH4;NEXMIF;PTPRU;FLOT1;PPM1F
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.6841716760752686,1.4425750801019261,0.10248447204968944,0.7627168510649914,1.0,5/10,17.73%,KLF15;BRCA1;SNCA;TAF7;CTBP1
prerank,negative regulation of neuron projection development (GO:0010977),0.50885765878148,1.4422046507790138,0.04672897196261682,0.761194153746125,1.0,21/56,20.04%,LRP4;PTEN;LPAR1;SEMA3A;MT3;NLGN1;GAK;BAG5;DCC;HDAC2;NGFR;FKBP4;MYLIP;EFNB3;RTN4;STX1B;EFNB2;RTN4RL1;DENND5A;KANK1;PTPRS
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.3430817729719551,-1.4419890760213705,0.020618556701030927,0.6247591060163712,1.0,24/87,13.34%,PTPRK;GCNT2;SMAD6;CDH5;FMOD;CLDN5;APPL2;ITGB5;ACVRL1;SMAD7;ENG;ID1;USP9X;SMAD9;TGFBR1;PARD3;TWSG1;PRKCZ;RHOA;NLK;LRRC32;MAP3K7;TGFB2;USP15
prerank,cellular response to alcohol (GO:0097306),0.5280607602562272,1.4417661988787274,0.0519159456118665,0.7601232517929991,1.0,14/42,16.10%,PTCH1;PTGFR;GRAMD1A;SMO;BRCA1;GRAMD1C;GNAI1;AHR;GRAMD1B;JUP;KLF9;GPLD1;BLM;SPIDR
prerank,embryonic skeletal system development (GO:0048706),0.542560287022817,1.441517328148448,0.0685785536159601,0.7581938642863959,1.0,6/35,5.73%,OSR2;SULF1;PDGFRA;SOX11;WNT5A;HOXD3
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.524862160729208,1.4411709982401533,0.052121212121212124,0.756608384992881,1.0,17/45,20.99%,EFEMP1;GAREM1;REPS2;SOX9;EGFR;TGFB1;ERBIN;BTC;PIK3R1;CBL;PTPN11;IQGAP1;GAB1;HBEGF;GRB2;AAMP;SOS1
prerank,regulation of leukocyte activation (GO:0002694),-0.5256000663561381,-1.4410174729699743,0.08074534161490683,0.6221919585404881,1.0,4/14,3.82%,CD200;MFHAS1;PLSCR1;LYN
prerank,SNARE complex assembly (GO:0035493),0.6823364392040256,1.440458409960661,0.06605222734254992,0.7569074820398284,1.0,2/10,3.49%,STXBP6;VAMP4
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.5512165992563602,1.4384546180142548,0.06503067484662577,0.7643505935810581,1.0,8/31,12.75%,RELN;SIPA1L1;PTEN;TANC2;NLGN1;PPFIA2;CDK5R1;LZTS3
prerank,positive regulation of behavior (GO:0048520),0.6893238119415914,1.4383564596563971,0.08064516129032258,0.7615327812009354,1.0,3/10,5.87%,SGIP1;CRH;NLGN1
prerank,covalent chromatin modification (GO:0016569),0.6530003875480092,1.4382827507212246,0.07132667617689016,0.7585663802200072,1.0,10/14,27.71%,MT3;HLCS;UFL1;MBD2;HELLS;SETD5;PARK7;CHD1;HDAC1;SIRT1
prerank,dopaminergic neuron differentiation (GO:0071542),0.6129616610876528,1.4381933073931863,0.0700280112044818,0.755667833854549,1.0,3/19,5.53%,CDNF;VEGFA;PHOX2A
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.6781774455670591,1.4380378505105835,0.07570977917981073,0.7532131606003192,1.0,4/10,13.86%,PRKN;MT3;HDAC6;SNCA
prerank,negative regulation of MAPK cascade (GO:0043409),0.48310343938807665,1.4378549784050425,0.026680896478121666,0.750867212525661,1.0,19/87,11.32%,WNK2;MYC;PTEN;DUSP4;PTPN2;EPHB2;IRAK3;CNKSR3;NF1;DUSP6;SPRED2;LMO3;SPRED1;FOXM1;UCHL1;PTPN1;SPRED3;PTPRJ;BMP7
prerank,endomembrane system organization (GO:0010256),0.46049667271526357,1.4373213469972421,0.006109979633401222,0.7504138758413098,1.0,56/178,20.05%,SEC16B;TMED6;USP50;ANK3;DNM1;ATP8B1;GORASP1;SPAG4;HACE1;EIF2AK3;BLZF1;GOLGB1;OBSL1;SPTBN1;ALS2;LAPTM4B;NUP155;ARL1;GBF1;SEC31B;GAK;TRIP11;BAG5;TMED10;VPS11;VAPA;HUWE1;GORASP2;CLASP1;PI4K2A;ARHGAP21;SNX10;RAB22A;PHETA2;RAB1A;ATL3;USP6NL;CSNK1A1;AKTIP;TBC1D20;OTOF;TMED2;TMED3;SEC23IP;BNIP1;ARFGEF1;SURF4;DYSF;STX17;HTT;RAB30;HOOK2;REEP5;COG1;VMP1;COG4
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.5421136555274342,1.4354085990732892,0.047619047619047616,0.7570171633471033,1.0,11/35,13.34%,GCDH;ACACA;ACSS3;HMGCLL1;SCD5;FASN;ACLY;PPT2;FAR1;ALOX5AP;GGTA1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.6318255982894666,1.4353232757279295,0.09221902017291066,0.7542239290341426,1.0,2/16,4.75%,CLDN19;CLDN1
prerank,negative regulation of angiogenesis (GO:0016525),0.4821266381047345,1.4352287811600588,0.03956043956043956,0.7515117529078794,1.0,13/84,6.86%,DCN;HSPG2;SULF1;CXCL10;CREB3L1;SEMA3E;COL4A2;E2F2;CCR2;SLC12A2;PDE3B;ADAMTS1;SPRED1
prerank,myelin maintenance (GO:0043217),0.6850218480451803,1.4351381946065807,0.07975460122699386,0.7487449109968892,1.0,3/10,8.42%,PRX;PTEN;EPB41L3
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.6209699688471859,1.4347177871177166,0.08823529411764706,0.7477084539046622,1.0,4/17,6.79%,CXCL10;ANO6;CCR2;PLA2G7
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.6600715480711785,1.4342902199573457,0.08669656203288491,0.7467535268603757,1.0,5/12,10.36%,SOX8;SOX9;VEGFA;SMO;GDNF
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.36105694247108083,-1.4336985343541526,0.02054794520547945,0.6413134601069346,1.0,10/56,4.30%,BMP6;DAB2;RBPMS;SMAD6;ACVRL1;SMAD7;BMP4;ENG;BMPR2;TGFBR1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.46887027142699367,1.4323316177068068,0.022269353128313893,0.7536987330787559,1.0,19/113,5.68%,CCL11;OSR2;BMP5;PRKCA;FGF2;MYC;FGF10;STXBP4;SOX9;LAMC1;ERBB2;EGFR;TGM1;VEGFA;EGR3;SOX11;CLDN1;WNT5A;SCN5A
prerank,regulation of protein import into nucleus (GO:0042306),0.529667773945913,1.4322982089838376,0.06289308176100629,0.7507278987606925,1.0,6/36,10.11%,APOD;MDFIC;TGFB1;PSEN1;FLNA;PIK3R1
prerank,retinoid metabolic process (GO:0001523),0.48942342578354747,1.431375632330314,0.035509736540664374,0.7521148215040868,1.0,14/71,12.76%,GPC3;CYP2S1;HSPG2;RHO;LRP1;SDC2;CYP1B1;SDC4;AKR1B10;RDH10;DHRS3;GPC1;GPC4;SDC3
prerank,regulation of steroid metabolic process (GO:0019218),0.5900782875987797,1.4313118312096589,0.08859060402684564,0.7493182716088935,1.0,2/23,6.49%,RORA;RORC
prerank,mesonephros development (GO:0001823),0.6665428050738563,1.4309987313675854,0.08527131782945736,0.747809369381371,1.0,5/11,13.38%,OSR2;FGF10;ZBTB16;BMP7;GATA3
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.6261106258526059,1.4306025443377524,0.09274193548387097,0.7468102923594326,1.0,5/17,18.78%,ANK3;AKAP6;SUMO1;KCNRG;NOS1AP
prerank,regulation of protein localization to membrane (GO:1905475),0.5586623834673016,1.4301258617421813,0.071334214002642,0.7460788778065162,1.0,9/28,13.46%,GPC3;GSN;PRKN;SLC5A3;SPTBN1;FYN;GPC1;GPC4;STX8
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.6888216392592326,1.4291397653298177,0.09004739336492891,0.7481732669784493,1.0,3/10,6.42%,PRKCQ;SOCS1;TGFBR2
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.5890639433248144,1.42910680899161,0.09405255878284924,0.7453163683791199,1.0,7/22,12.56%,NTRK3;NGF;NTRK2;RAP1A;MAGI2;ACAP2;WASF1
prerank,myoblast differentiation (GO:0045445),-0.5309554180769592,-1.4280140902608391,0.08734939759036145,0.6562704565113164,1.0,4/14,9.87%,IGF1;DDX5;MAPK12;JAG1
prerank,protein heterotetramerization (GO:0051290),0.6492875385584459,1.4277265347009034,0.10526315789473684,0.7491918877696541,1.0,5/13,14.83%,FARSA;CPSF6;GRIN2B;FARSB;PKD1
prerank,regulation of cellular pH (GO:0030641),-0.4251719110473118,-1.4267753748683842,0.055299539170506916,0.6548551563233752,1.0,13/29,23.25%,SLC4A10;SLC9A6;SLC9A2;SLC4A3;SLC9A8;SLC4A8;SLC9A9;SLC9A7;ATP6AP1;TM9SF4;SLC26A6;SLC9B1;CA2
prerank,embryonic organ morphogenesis (GO:0048562),0.5266865946393009,1.4267604010137476,0.03645200486026731,0.7511829106664168,1.0,7/42,8.52%,OSR2;EFEMP1;PDGFRA;ACVR1;SOX11;HOXD3;RARG
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.569210194855566,1.4261557081914098,0.07372654155495978,0.7512194628321585,1.0,8/24,16.20%,CREB3L1;VEGFA;MAPK7;MT3;HIF1A;NFE2L2;GCN1;TP53
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.45155514796149576,-1.4257055743216989,0.06048387096774194,0.652588231454008,1.0,8/24,8.21%,PHLDB2;TJP1;CGNL1;ARHGAP28;WASF2;RHPN2;ARAP1;PAK2
prerank,positive regulation of T cell migration (GO:2000406),0.5856458218796469,1.4254344266218908,0.08355795148247978,0.7520503551538977,1.0,5/20,9.24%,CXCL10;PYCARD;WNT5A;CCR2;STK39
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.48890347961382963,-1.425339062564119,0.08888888888888889,0.6478967267237777,1.0,8/18,20.79%,ANKRD17;DDX60;BIRC3;NOP53;USP15;UFD1;RNF125;GPATCH3
prerank,nervous system development (GO:0007399),0.4427395872085006,1.4252610528982186,0.0,0.749911373351704,1.0,97/429,15.77%,DCHS1;RELN;MPZ;GFRA1;PRX;PCDHA4;SOX6;CHRM3;VCAN;RBFOX1;ERBB3;FGF13;FGF2;SOX8;LSAMP;PTEN;WDPCP;NGF;GSN;NAB1;PRKN;ADAM23;GFRA4;LPAR1;EFNA5;ATXN10;SCN2A;NRCAM;VEGFA;EPHB2;PCDHA1;CHST8;GPM6B;THOC6;MAB21L2;TGFB1;GBA2;GSS;NRXN1;NF1;NUMBL;ACVR1C;OBSL1;NLGN1;APAF1;NAV1;FGF12;ZBTB16;KIRREL3;BCAN;PAFAH1B3;SCD5;BPNT1;CNTN6;LIMK1;KLK6;DHX30;GRIK1;GPM6A;SMO;LDB2;PMP22;DSCAM;NHEJ1;NCAN;ERBB4;GDNF;DCLK1;OPHN1;ADGRL3;MYLIP;DVL1;APC2;JARID2;PTPRZ1;EFNB3;DRD2;WWTR1;BTBD1;ALDH5A1;ZEB2;TRPC5;NRSN2;MSI1;APBA1;RBM45;PKD1;NES;MET;MTR;GFRA2;DACT1;POU3F1;NAV3;NDUFV2;FZD9;MOBP
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.6579922710784666,1.4250701301664406,0.08978328173374613,0.7477435311246633,1.0,4/12,10.20%,DCN;VCAN;BCAN;NCAN
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.385128684811033,-1.424862568866572,0.031088082901554404,0.6434738389117697,1.0,13/38,18.42%,ROCK2;PTGIS;TLR4;INSR;KLF2;PTGS2;KLF4;DDAH2;HSP90AA1;CAV1;ASS1;EDN1;HSP90AB1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.6525151868323464,1.424476109291569,0.1037037037037037,0.7476981569056522,1.0,3/12,3.30%,PTEN;EPHB6;EPHB2
prerank,serine family amino acid metabolic process (GO:0009069),0.6280402951283147,1.4243211635393025,0.09077809798270893,0.7456087996955447,1.0,4/16,5.74%,CTH;CBS;PSPH;DAO
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.6507486531552615,1.4242844083097856,0.08742331288343558,0.7428619266007945,1.0,3/12,3.60%,WNK2;ANK3;WNK3
prerank,regulation of Wnt signaling pathway (GO:0030111),0.46536602102054075,1.4231464470979374,0.026680896478121666,0.7456256432389309,1.0,27/108,11.81%,GPC3;SOSTDC1;SULF1;MDFIC;LGR6;TAX1BP3;CBFB;VGLL4;LRP1;PRKN;DEPDC1B;FRZB;TLE1;PSEN1;WIF1;SHISA2;DISC1;FZD7;OTULIN;FAM53B;SPIN1;SFRP4;DAAM2;ESR1;EMD;PPP1CA;RUNX1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.5465047539427874,-1.422982047100928,0.09117647058823529,0.6444571270153685,1.0,2/12,0.13%,DAB2;FOXP1
prerank,cellular biogenic amine catabolic process (GO:0042402),0.6859869142034533,1.4213315872303354,0.08823529411764706,0.7519312488045142,1.0,6/10,19.14%,SMOX;COMT;SARDH;LRTOMT;SLC44A1;ALDH7A1
prerank,regulation of cell-substrate adhesion (GO:0010810),0.5108218968193978,1.4212861142986581,0.06181818181818182,0.7493145356206987,1.0,7/42,10.16%,VIT;FBLN2;BST1;NF1;TSC1;FZD7;ARL2
prerank,cell proliferation in forebrain (GO:0021846),0.6838342866687319,1.420996543453377,0.1053484602917342,0.747907635116608,1.0,3/10,5.22%,DOCK7;PCM1;NUMBL
prerank,protein alkylation (GO:0008213),-0.45804223597627214,-1.4201569467347417,0.07581227436823104,0.6484399950588496,1.0,10/22,14.85%,CAMKMT;GSPT1;FAM98A;METTL21A;SNRPD3;PRMT2;LCMT1;PRMT8;PCMT1;SNRPB
prerank,regulation of histone methylation (GO:0031060),0.6379919862574024,1.4200913597856593,0.12223858615611193,0.749454217211111,1.0,4/13,12.13%,FAM47E;AASS;PIH1D1;JARID2
prerank,platelet degranulation (GO:0002576),-0.3152115743406976,-1.4200802591370831,0.0,0.6429859038218543,1.0,34/118,15.61%,IGF1;ABCC4;VWF;PECAM1;VEGFC;VEGFD;STXBP1;VTI1B;LYN;GTPBP2;CYRIB;IGF2;TEX264;THBS1;F8;TIMP3;ACTN1;HABP4;CD109;APP;ACTN2;FN1;SRGN;MANF;TMX3;SOD1;TMSB4X;SERPINE1;SYTL4;TGFB2;LGALS3BP;BRPF3;QSOX1;CYB5R1
prerank,organelle fission (GO:0048285),0.5766672881263065,1.4195966026166003,0.08366533864541832,0.7489660086516814,1.0,3/24,2.42%,SEC16B;DNM1;PRKN
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.4895547092086787,-1.4193269816099467,0.07308970099667775,0.6399270743457207,1.0,6/18,4.20%,ROCK2;CDH5;TEK;RAP1B;ROCK1;CYRIB
prerank,cellular response to estrogen stimulus (GO:0071391),-0.5165987115789504,-1.4179729351911883,0.08852459016393442,0.6390841211769419,1.0,5/14,19.21%,PELP1;SERPINB9;SRA1;ARID5A;RARA
prerank,positive regulation of cell communication (GO:0010647),0.558330601248019,1.4170372253665435,0.07559681697612732,0.7588917831165765,1.0,11/28,15.46%,ANK3;CLSTN2;SOX11;GRIK2;SYT1;NMU;EDN3;RIMS1;GATA3;CLSTN1;HOMER1
prerank,positive regulation of cell projection organization (GO:0031346),0.4585340828854225,1.416942645869747,0.024287222808870117,0.7565646604107226,1.0,16/115,7.56%,ROR2;RELN;ROR1;TENM3;NTRK3;CHODL;NGF;PLXNC1;IL1RAPL1;NTRK2;WNT5A;OBSL1;ALKAL2;CDKL5;CDKL3;RAP1A
prerank,dermatan sulfate metabolic process (GO:0030205),0.6421584951151569,1.4166437207809621,0.0972644376899696,0.7553496971381759,1.0,4/13,10.20%,DCN;VCAN;BCAN;NCAN
prerank,neurotransmitter uptake (GO:0001504),0.6407279209318865,1.4161347706209315,0.10751104565537556,0.7548974459485794,1.0,3/12,5.57%,SLC22A3;SLC1A3;SLC29A1
prerank,negative regulation of lipid storage (GO:0010888),-0.4632285683953523,-1.4153302317976189,0.06716417910447761,0.6425907081677319,1.0,9/19,20.73%,OSBPL8;ABCA1;NFKBIA;PPARD;ABCG1;NR1H2;TTC39B;PNPLA2;NR1H3
prerank,positive regulation of cellular component movement (GO:0051272),-0.442279711094391,-1.4150459472124342,0.04417670682730924,0.6380040178974061,1.0,14/24,27.01%,ETS1;LYN;CCDC25;TGFBR1;RPS19;PDPN;SPOCK2;CAVIN1;TWIST1;ACTN4;CSF1R;TUBB2B;CCL19;STK11
prerank,sodium ion export across plasma membrane (GO:0036376),-0.5334626152725125,-1.4145126834987962,0.07621951219512195,0.634260972382266,1.0,3/13,6.66%,ATP1A2;ATP1B3;ATP1A1
prerank,response to ATP (GO:0033198),0.5976754096973503,1.4144479363640767,0.08879781420765027,0.7601481467837278,1.0,8/18,21.44%,P2RY2;HSP90B1;P2RY12;SSH1;P2RY1;TAF1;RYR3;P2RX7
prerank,cellular response to copper ion (GO:0071280),0.6062838516147563,1.4132599242242019,0.10149253731343283,0.7629323785689909,1.0,12/16,28.53%,PRNP;MT3;AOC1;SNCA;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,positive regulation of telomere capping (GO:1904355),0.609589750140329,1.4129018538230815,0.09246088193456614,0.7617369107284787,1.0,5/17,14.50%,PRKCQ;MAPK1;NEK7;MAP3K4;RTEL1
prerank,androgen metabolic process (GO:0008209),0.595058628032905,1.4125234193538783,0.10453920220082531,0.7608429770738355,1.0,2/18,4.72%,HSD17B7;HSD17B11
prerank,metanephros development (GO:0001656),0.5579853857219418,1.412048322583851,0.07335907335907337,0.7604072956772145,1.0,6/26,11.32%,OSR2;PTCH1;FGF10;NF1;GDNF;BMP7
prerank,secretory granule organization (GO:0033363),-0.5748670858724503,-1.4119457840107095,0.09821428571428571,0.6376537116039508,1.0,3/10,9.06%,ABCA1;DTNBP1;SRGN
prerank,outer dynein arm assembly (GO:0036158),-0.5144535588359056,-1.411553004945575,0.10759493670886076,0.6336049731694808,1.0,11/14,43.22%,LRRC49;ODAD1;DNAH8;DNAAF5;DNAH5;ODAD2;ODAD3;ODAD4;DNAH17;CCDC63;DNAAF4
prerank,regulation of execution phase of apoptosis (GO:1900117),0.663286198727574,1.4108352934610036,0.10182370820668693,0.7635501992844683,1.0,2/11,0.93%,DLC1;FAP
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.6699194219428063,1.4104767107373481,0.09621451104100946,0.7625852934300286,1.0,3/11,7.35%,SOX6;TGFB1;FZD7
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.5686185313304717,1.4101228184124053,0.09302325581395349,0.7615605681882286,1.0,4/23,5.40%,GPC3;PTCH1;PTCH2;HHIP
prerank,response to reactive oxygen species (GO:0000302),0.4937718606346781,1.4098118533237423,0.062206572769953054,0.7602488497213378,1.0,12/54,12.96%,APOD;PDGFRA;EGFR;APTX;NCF1;FYN;MAPK9;HIF1A;MAPK1;ERCC6L2;PRDX3;SOD2
prerank,central nervous system development (GO:0007417),0.4436642995563207,1.4087543078770892,0.005030181086519115,0.7626100583973474,1.0,51/250,15.26%,APOD;RELN;VIT;SOX6;PTCH1;HSPG2;VCAN;SOX8;PTEN;SOX9;GSN;PRKN;ADAM23;NRCAM;CHST8;THOC6;SOX11;GBA2;NF1;GRIN2B;EML1;TGFBR2;ZBTB16;LOXL3;PHGDH;BCAN;PAFAH1B3;CNTN6;EIF2B5;KLK6;DHX30;CNTNAP2;GRIK1;SMO;SOX12;NHEJ1;NCAN;DCLK1;PTPN11;ADGRL3;CDK5R1;JARID2;PHF8;PTPRZ1;ALDH5A1;GRIN2D;GRIN2A;ZFHX2;PKD1;NES;SCYL2
prerank,positive regulation of tissue remodeling (GO:0034105),-0.5738817492236896,-1.4085103694654946,0.10133333333333333,0.6387704549049418,1.0,2/10,1.75%,ROCK2;ROCK1
prerank,V(D)J recombination (GO:0033151),0.6573561537703375,1.4081807731864917,0.08845577211394302,0.7628490193290156,1.0,1/11,0.20%,RAG2
prerank,B cell activation (GO:0042113),0.48298566592812925,1.4079705425830296,0.05875706214689266,0.7611549826571853,1.0,15/68,15.91%,RAG2;FCRL1;BCL2;PTPN2;EPHB2;DNAJB9;CHRNA4;RABL3;LAX1;NHEJ1;PTPRJ;DCAF1;MALT1;ITGB1;LAT2
prerank,lymphocyte migration (GO:0072676),0.533517793484251,1.4078131248176136,0.08270676691729323,0.7591897432876913,1.0,5/32,15.26%,CCL11;CCL4;CKLF;GATA3;CCL14
prerank,carnitine metabolic process (GO:0009437),-0.5337547974953095,-1.4077386682264323,0.1165644171779141,0.6360857269184566,1.0,5/12,12.39%,CPT1C;CPT1A;ACADM;TMLHE;ALDH9A1
prerank,neuron cell-cell adhesion (GO:0007158),0.6392959630042917,1.407280660632341,0.11600587371512482,0.7590802925912932,1.0,5/14,5.87%,CEL;ASTN2;NRXN1;NCAM2;NLGN1
prerank,mesonephric tubule development (GO:0072164),-0.5077614712339384,-1.4071845727663326,0.10377358490566038,0.6328198559530708,1.0,6/15,8.91%,OSR1;BMP4;SLIT2;SIX1;FGFR2;SALL1
prerank,cellular response to cadmium ion (GO:0071276),0.5664345701524828,1.4069493381243623,0.08940852819807428,0.7580213942373626,1.0,16/24,28.53%,EGFR;NCF1;MT3;MAPK9;MAPK1;SUMO1;CHUK;JUN;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,T cell migration (GO:0072678),0.6279919629000807,1.4065774163993414,0.08733624454148471,0.7572742070393146,1.0,2/13,5.46%,CXCL10;SLC12A2
prerank,response to axon injury (GO:0048678),0.597258001670406,1.4055157134206093,0.08057553956834532,0.7598193162336504,1.0,1/18,0.04%,APOD
prerank,positive regulation of synaptic transmission (GO:0050806),0.48187332399244426,1.4040177738896442,0.052868391451068614,0.7645223123463468,1.0,19/72,15.50%,RELN;TSHZ3;CLSTN2;CACNG7;EPHB2;NRXN1;GRIN2B;GRIK2;CCR2;SYT1;MPP2;NLGN1;SLC8A2;NMU;RIMS1;GRIN2D;GRIN2A;CLSTN1;STX1B
prerank,axoneme assembly (GO:0035082),0.5402499183513054,1.403938071660272,0.08091024020227561,0.7622550494191056,1.0,10/30,18.01%,DNAI4;CCDC39;RSPH1;CFAP46;CFAP74;CCDC65;FOXJ1;DNAAF2;RSPH9;DCX
prerank,neuropeptide signaling pathway (GO:0007218),0.49354660994450444,1.4032960744072571,0.052570093457943924,0.7627607762508544,1.0,4/58,2.43%,SSTR1;SORCS2;SORCS1;SORCS3
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.6568638113121675,1.4029639840275236,0.10046367851622875,0.7618085682069697,1.0,6/11,19.08%,ZRANB3;TIPIN;FBH1;BLM;FBXO5;LIG3
prerank,DNA packaging (GO:0006323),0.6129128020916926,1.4029228321469365,0.09272467902995721,0.7593934756295595,1.0,6/16,17.66%,BANF2;HAT1;RBBP4;TP53;NAA10;AIFM1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.42025156368401084,-1.4027565047010881,0.0625,0.6429521240003554,1.0,12/26,22.82%,TLR4;INSR;KLF2;PTGS2;KLF4;DDAH2;HSP90AA1;ASS1;EDN1;HSP90AB1;CLU;AKT1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.5692454843683377,-1.4022656504644915,0.1069364161849711,0.6393180767749437,1.0,6/10,31.23%,KIT;LYN;CD40;BTLA;FGR;BAG6
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.5705153025702642,1.402223249164573,0.10814606741573034,0.7603174749174744,1.0,8/21,14.08%,USP50;PYCARD;NGF;MT3;GRIN2B;FYN;NGFR;TTBK1
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.5498425044685715,1.401614462163978,0.07751937984496124,0.7580218876526729,1.0,11/29,21.33%,THEM4;OXSM;ACOT11;ACLY;ACSF2;ACSL6;GPAT4;GLYAT;DBI;ACOT8;ACBD6
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.5498425044685715,1.401614462163978,0.07751937984496124,0.7580218876526729,1.0,11/29,21.33%,THEM4;OXSM;ACOT11;ACLY;ACSF2;ACSL6;GPAT4;GLYAT;DBI;ACOT8;ACBD6
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.5549650769499683,1.4012054963124871,0.07881136950904392,0.7574289633931595,1.0,7/27,14.43%,FXYD3;UTRN;SCN5A;FGF12;FXYD6;FXYD1;NEDD4L
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.652933631080452,1.4010792109646877,0.11195158850226929,0.7554712685530808,1.0,4/11,6.42%,MYC;SOX9;WNT5A;TGFBR2
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6368972489662418,1.400721473121685,0.10843373493975904,0.7546745804097816,1.0,6/13,17.28%,FGF2;FGFR1;AKT3;SP1;SIRT6;MDK
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.5300693712144315,1.399439339965043,0.09635416666666667,0.7583802662419371,1.0,7/29,14.54%,BMP5;PTEN;SPRED2;SPRED1;SPRED3;GATA3;LDLRAD4
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.42485916467688983,-1.3981845279732013,0.075,0.6484403933818651,1.0,9/27,8.21%,PHLDB2;TJP1;CGNL1;ARHGAP28;SHANK3;WASF2;RHPN2;ARAP1;PAK2
prerank,regulation of cellular metabolic process (GO:0031323),0.5038010212928704,1.398101303968126,0.07064555420219244,0.7624290568275391,1.0,14/45,14.01%,PRKN;PARL;ACACA;CYP1B1;MKLN1;PDK3;FOXM1;FASN;EIF6;ACLY;ARF4;PID1;SSH1;NCOR2
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.6485266801657001,1.3978295159543415,0.11436950146627566,0.7612469707538971,1.0,3/11,15.42%,MLIP;GLRX3;LMNA
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.5839921709594924,1.397716136745739,0.10344827586206896,0.7592542427215978,1.0,4/18,5.87%,RELN;PTEN;NRXN1;NLGN1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.5813647408985335,1.3972131717101082,0.09801136363636363,0.7592966152984693,1.0,6/18,8.06%,GRIK3;GRIK2;GRIK5;GRID2;CDH8;GRIK1
prerank,inositol lipid-mediated signaling (GO:0048017),-0.3641184065906752,-1.3971752332975904,0.051470588235294115,0.6465048090750598,1.0,17/50,10.82%,IGF1;IGF1R;ADAP2;PITPNM2;PLCL1;PI4KA;PIK3C2A;PLCB3;PLCD1;EXOC1;PLCL2;OGT;RPS6KB1;RHOA;PIK3C2B;TNFAIP8L3;PDGFRB
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.5487665122134072,1.39611667990286,0.08819714656290532,0.7620126491818413,1.0,6/27,10.20%,DCN;VCAN;BCAN;CSGALNACT1;CHSY1;NCAN
prerank,ubiquinone metabolic process (GO:0006743),-0.4959364287004314,-1.3958050275105036,0.09967845659163987,0.6465144796469592,1.0,9/15,26.40%,COQ8B;COQ10B;PDSS1;COQ9;COQ3;FDXR;PDSS2;COQ6;COQ8A
prerank,response to cadmium ion (GO:0046686),0.5533057053633372,1.3957502831060584,0.08378378378378379,0.7611679218760902,1.0,16/26,28.53%,EGFR;NCF1;MT3;MAPK9;MAPK1;SUMO1;CHUK;JUN;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,negative regulation of lymphocyte migration (GO:2000402),0.6723959474578364,1.3955975532088765,0.09320695102685624,0.7593007338297826,1.0,1/10,0.04%,APOD
prerank,negative regulation of phosphorylation (GO:0042326),0.4690833871181902,1.3954727868480996,0.04950495049504951,0.7573821867601197,1.0,20/85,13.05%,DYNLL1;NTRK3;PIP5KL1;PTEN;IRS2;CDKN2B;PRKN;NPRL2;EPHB2;CADM4;TGFB1;PRNP;PTPN13;NIBAN1;CBFA2T3;MEN1;PID1;BMP7;PRDX3;WWTR1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.6795930204354053,1.395343889768768,0.1145374449339207,0.7555586851628819,1.0,3/10,14.53%,ANK3;SUMO1;KCNRG
prerank,muscle contraction (GO:0006936),-0.3036219276585657,-1.3950464683295416,0.0196078431372549,0.6441578670469598,1.0,24/126,15.87%,CALD1;MYOF;SORBS1;ROCK2;TMOD3;TPM3;ROCK1;ITGB5;SNTA1;MYL6;TPM1;ACTN2;MYLK;MYL12B;MYL12A;GJC1;MYH11;ITGA1;LMOD1;ACTA2;TPM2;NOS1;TMOD1;DES
prerank,positive regulation of developmental process (GO:0051094),0.4461394517912819,1.3932828880502153,0.023760330578512397,0.7626241989180286,1.0,32/164,14.67%,RELN;DCN;SOX6;BMP5;PHLDB1;SOX8;SPIRE1;SOX9;PRKN;ACVR1;VEGFA;PSEN1;NRXN1;PLCB1;WNT5A;NLGN1;ZBTB16;FGFR1;BNIP3;CPEB3;SOX5;PPP1R13L;EDN3;GDNF;CLASP1;BMP7;DVL1;ANAPC2;CORO1B;COBL;BMPR1A;RTN4
prerank,T cell differentiation (GO:0030217),0.5105885381632932,1.3929577051645359,0.08078335373317014,0.7617786331202712,1.0,10/40,13.38%,RAG2;PTPN22;FADD;PTPN2;RABL3;ZFP36L2;NHEJ1;MR1;RHOH;GATA3
prerank,regulation of AMPA receptor activity (GO:2000311),0.5616574618342076,1.3924445421490816,0.10091743119266056,0.7617049207827238,1.0,4/25,5.87%,RELN;CACNG7;SHISA9;NLGN1
prerank,protein ADP-ribosylation (GO:0006471),-0.41738450741836075,-1.3920191900572363,0.0815450643776824,0.6500036444779588,1.0,10/28,16.67%,ZC3HAV1;PARP3;PARP4;PARP10;PARP1;SIRT3;PARP6;PARP12;PARP14;SIRT4
prerank,positive regulation of cellular component organization (GO:0051130),0.45641290102811116,1.391529793249215,0.036637931034482756,0.7636384427972691,1.0,30/107,17.07%,RELN;GPC3;LGALS3;CLDN19;HRK;LRP4;LRP1;VEGFA;TGFB1;NRXN1;PPP1R15A;NOX1;BMF;BNIP3;BRK1;PIH1D1;SLF2;BMP7;RUNX1;ANAPC2;RHOC;SNCA;NEDD4L;SUMO1;MTLN;TGFB3;BCL2L11;SPIDR;HYAL1;SURF4
prerank,endothelial tube morphogenesis (GO:0061154),-0.5620264277782213,-1.3908638977793877,0.11458333333333333,0.6489063393893411,1.0,4/10,9.65%,CTNNB1;ACVRL1;BMP4;RHOA
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.6449923848536219,1.3907056033927292,0.11616954474097331,0.7650102705765769,1.0,4/12,14.12%,TGFB1;SELENOS;HDAC2;TAF7
prerank,response to tumor necrosis factor (GO:0034612),0.45957479609044416,1.3896990931757047,0.03763440860215054,0.7673002153346966,1.0,17/91,17.31%,CCL11;AFF3;ADAMTS12;HAS2;PYCARD;CCL4;ERBIN;BRCA1;ZFP36L2;NFE2L2;PID1;GATA3;ZFAND6;CCL14;HYAL1;RIPK1;CHUK
prerank,COPII-coated vesicle budding (GO:0090114),0.4775421156336981,1.388848071325408,0.05408388520971302,0.7686329095119089,1.0,24/68,21.70%,SEC16B;GORASP1;GRIA1;ANKRD28;SEC24D;TRAPPC6B;SEC31B;TMED10;SEC24C;CUL3;VAPA;RAB1A;KLHL12;TBC1D20;TMED2;SEC23IP;TRAPPC6A;SEC24A;CNIH3;SEC23B;TRAPPC3;PEF1;TRAPPC2L;LMAN1
prerank,monocyte chemotaxis (GO:0002548),0.5313723357111283,1.3887277509920386,0.08937823834196891,0.7667829822869092,1.0,3/32,4.22%,CCL11;LGALS3;CCL4
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.5659178162280395,1.388020725225161,0.09517241379310344,0.7676590361921078,1.0,11/20,21.24%,HM13;TGFB1;PSEN1;NCSTN;NGFR;APH1A;PSEN2;MBTPS1;SPPL2B;NFKB1;RHBDD1
prerank,cyclooxygenase pathway (GO:0019371),-0.5750766574188849,-1.3870784431210887,0.13043478260869565,0.6571916990241402,1.0,5/10,13.28%,PTGIS;PTGDS;PTGS1;PTGS2;HPGDS
prerank,peptide biosynthetic process (GO:0043043),-0.3065571125775371,-1.386699457059372,0.0,0.6533183203996326,1.0,67/153,26.95%,RPS14;GSPT1;RPL24;RPL18A;RPS16;RPL38;RPL28;RPS19;RPL37;RPS2;SARS1;MRPL10;RPL19;RPL5;RPL34;RPS25;RPS15;TNIP1;RPLP1;RPL31;RPL3;MRPL24;MRPL3;PABPC4;EEF1A1;RPS6;RPS8;EIF4EBP2;RPL11;RPL12;RPS6KB2;RPL13;RPL7A;MRPS7;COPS5;MRPL43;IGF2BP3;RPS21;YARS2;RPL35A;RPL26;RPL32;MRPS17;RPS9;RPS29;RPS23;ASMT;DMD;RPL8;MRPS11;RPLP2;MRPS16;RPL41;PCSK1;RSL24D1;RPS17;DHPS;RPS5;RPS15A;RPL37A;GGT5;RPS10;RPL6;WARS1;MRPL55;RPL9;RPS27
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.38431714210724927,-1.3865558169401895,0.07727272727272727,0.6488715615741734,1.0,14/39,16.23%,BMP6;PODXL;MAP2K5;CDH1;WNK1;RGCC;KLF4;JAG1;NOTCH4;NEXMIF;FXYD5;AKNA;ASS1;PPM1F
prerank,anterograde trans-synaptic signaling (GO:0098916),0.43675908024711146,1.3859863286343024,0.009137055837563452,0.7749357064273806,1.0,42/224,14.73%,MPZ;SLC6A2;CHRM3;RAPSN;CEL;SLC1A3;CRH;CACNA1E;HRH1;PDE7B;GRIA1;KCNA1;GRIA3;DLGAP1;CACNA1A;CHRNA4;PLP1;NRXN1;GRIN2B;PRKAR1B;GRIK2;SYT1;DLG2;NLGN1;CACNB4;KCND2;GRIK1;PMP22;SYN1;SPG11;GRM5;HTR2C;SLC12A4;MAPK1;PRKACA;PENK;APBA1;SNCA;GRIN2A;RPS6KA2;NOVA1;CALM1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5520115695758151,1.3850602345045502,0.1016260162601626,0.7769712679792387,1.0,7/25,13.73%,WNK2;ANK3;ANK2;WNK3;STK39;NDUFA4;TCAF1
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.640744002853707,1.3844729795851618,0.12121212121212122,0.7723420490714445,1.0,8/12,23.82%,CUL3;ANAPC7;CDC23;CDC27;ANAPC4;ANAPC5;CDC16;RB1
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.640744002853707,1.3844729795851618,0.12121212121212122,0.7723420490714445,1.0,8/12,23.82%,CUL3;ANAPC7;CDC23;CDC27;ANAPC4;ANAPC5;CDC16;RB1
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.640744002853707,1.3844729795851618,0.12121212121212122,0.7723420490714445,1.0,8/12,23.82%,CUL3;ANAPC7;CDC23;CDC27;ANAPC4;ANAPC5;CDC16;RB1
prerank,renal absorption (GO:0070293),0.6620581320898493,1.3844568824332557,0.11737089201877934,0.7699889411655731,1.0,2/10,2.28%,HAS2;GSN
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.5349597837793677,-1.3844398456511042,0.11212121212121212,0.6510902550780462,1.0,4/12,5.61%,SORBS1;IGF1;IGF2;INSR
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.5678457655964603,-1.3838854795476705,0.10306406685236769,0.6481832980043961,1.0,3/10,4.45%,NAMPT;TLR4;KDR
prerank,peptidyl-glutamic acid modification (GO:0018200),0.5531208891795593,1.383812718647485,0.1117092866756393,0.7706882356993173,1.0,10/24,17.61%,TTLL10;TTLL5;TTLL11;AGBL4;TTLL4;VKORC1;CFAP20;TPGS1;VKORC1L1;NAA10
prerank,regulation of T cell chemotaxis (GO:0010819),0.6505886908960526,1.3819829697054191,0.11280487804878049,0.7768509639518669,1.0,4/11,9.24%,CXCL10;WNT5A;CCR2;STK39
prerank,cation transmembrane transport (GO:0098655),-0.3706336065752795,-1.3818122257024013,0.045714285714285714,0.6500005572702502,1.0,16/44,23.82%,TRPM3;SLC7A2;ATP1A2;SLC7A5;ABCC9;SLC38A5;SLC25A20;SLC36A4;SFXN3;SLC6A5;ATP1B1;SLC25A19;TRPM2;KCNJ8;SLC25A29;ATP13A2
prerank,glutamate receptor signaling pathway (GO:0007215),0.5167448339473318,1.381799695198185,0.10184049079754601,0.7752664749394401,1.0,12/37,15.46%,GRIK3;GRIA3;PLCB1;GRIN2B;GRIK2;GRID2;GRIK1;GRM5;CDK5R1;HOMER2;GRIN2A;HOMER1
prerank,vesicle coating (GO:0006901),0.48134991119420195,1.3810940212263134,0.06285072951739619,0.7714645233377341,1.0,21/61,21.70%,SEC16B;GORASP1;GRIA1;ANKRD28;SEC24D;TRAPPC6B;TMED10;SEC24C;CUL3;RAB1A;KLHL12;TBC1D20;TMED2;SEC23IP;TRAPPC6A;SEC24A;CNIH3;TRAPPC3;PEF1;TRAPPC2L;LMAN1
prerank,COPII vesicle coating (GO:0048208),0.48134991119420195,1.3810940212263134,0.06285072951739619,0.7714645233377341,1.0,21/61,21.70%,SEC16B;GORASP1;GRIA1;ANKRD28;SEC24D;TRAPPC6B;TMED10;SEC24C;CUL3;RAB1A;KLHL12;TBC1D20;TMED2;SEC23IP;TRAPPC6A;SEC24A;CNIH3;TRAPPC3;PEF1;TRAPPC2L;LMAN1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.48134991119420195,1.3810940212263134,0.06285072951739619,0.7714645233377341,1.0,21/61,21.70%,SEC16B;GORASP1;GRIA1;ANKRD28;SEC24D;TRAPPC6B;TMED10;SEC24C;CUL3;RAB1A;KLHL12;TBC1D20;TMED2;SEC23IP;TRAPPC6A;SEC24A;CNIH3;TRAPPC3;PEF1;TRAPPC2L;LMAN1
prerank,sodium-independent organic anion transport (GO:0043252),-0.569912050902131,-1.3802891122217584,0.11475409836065574,0.6504842352940327,1.0,4/10,8.87%,SLCO3A1;SLCO2A1;SLCO1C1;SLC16A2
prerank,DNA catabolic process (GO:0006308),0.6471293115736911,1.3802518400556085,0.1325115562403698,0.7729748084504422,1.0,4/11,10.34%,SETMAR;XRN2;REXO4;FBH1
prerank,anterior/posterior pattern specification (GO:0009952),-0.3608206805284948,-1.378143786282927,0.019867549668874173,0.6531155279335483,1.0,16/53,19.92%,WLS;LRP5;HOXB9;HOXA3;BMPR2;TGFBR1;HOXC6;HOXC5;TBX1;HOXC4;HOXA9;HEY2;HOXA6;HOXB3;HOXD4;HHEX
prerank,xenobiotic transport (GO:0042908),-0.48135508564388807,-1.3775338787860107,0.09407665505226481,0.6503651274461442,1.0,6/17,3.49%,ABCG2;ABCA3;SLC47A1;GJA1;SLC22A4;SLC7A5
prerank,regulation of mitochondrial fission (GO:0090140),0.5457221729970396,1.3774442767218973,0.1051930758988016,0.7839579385021085,1.0,5/24,10.71%,DCN;SPIRE1;PRKN;BNIP3;MYO19
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.5487378295694072,-1.3769629121755331,0.10876132930513595,0.6478908783302957,1.0,5/11,5.95%,DAB2;WNT5B;RSPO3;MLLT3;NKD1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.6081678841548033,1.3768128545763552,0.12931034482758622,0.7846918612337299,1.0,6/14,16.96%,DNAJB9;UFL1;PTPN1;TMEM33;BCL2L11;FICD
prerank,branched-chain amino acid catabolic process (GO:0009083),0.5759956986640531,1.3760169615402589,0.10335570469798658,0.7837878760751921,1.0,10/20,22.45%,IVD;BCKDHB;MCCC1;MCCC2;HIBADH;HIBCH;DBT;AUH;BCKDK;ALDH6A1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.5759956986640531,1.3760169615402589,0.10335570469798658,0.7837878760751921,1.0,10/20,22.45%,IVD;BCKDHB;MCCC1;MCCC2;HIBADH;HIBCH;DBT;AUH;BCKDK;ALDH6A1
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.46742644848088816,-1.375939281768756,0.11458333333333333,0.6467844120570614,1.0,5/17,10.13%,PRKAG2;PPARD;PRKAA2;ADIPOR2;PANK2
prerank,aromatic amino acid family catabolic process (GO:0009074),0.5999742586627395,1.3754840960657995,0.10534124629080119,0.7838600780336683,1.0,3/15,9.87%,AADAT;KYNU;IL4I1
prerank,oligodendrocyte differentiation (GO:0048709),0.5784800793753304,1.374823552483393,0.11911357340720222,0.7843065955923698,1.0,6/19,12.58%,SOX6;SOX8;SOX9;EIF2B5;NSUN5;PTPRZ1
prerank,DNA alkylation (GO:0006305),0.5712668708298783,1.374659685180157,0.12674094707520892,0.7804673734700612,1.0,6/19,11.17%,GATAD2A;ATF7IP;ATRX;MTRR;TEX15;HELLS
prerank,DNA methylation or demethylation (GO:0044728),0.5712668708298783,1.374659685180157,0.12674094707520892,0.7804673734700612,1.0,6/19,11.17%,GATAD2A;ATF7IP;ATRX;MTRR;TEX15;HELLS
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.5420735771691724,1.3744807803428767,0.10594315245478036,0.7790111615366622,1.0,8/25,14.11%,CHRNA4;GRIN2B;GRID2;MPP2;INSYN1;DRD2;GRIN2D;GRIN2A
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.4873518882866459,1.374465015779851,0.06139315230224321,0.7767914133739662,1.0,5/53,10.08%,SSTR1;CHRM3;HRH1;TSHR;HTR2C
prerank,calcium-mediated signaling (GO:0019722),0.45755237328592513,1.3738960266426206,0.05370569280343716,0.7771978597303992,1.0,24/93,16.82%,CHRM3;ANK2;EGFR;PPP1R9A;EIF2AK3;PTGFR;PRNP;CCR2;PPP3CB;ACKR3;RCAN1;PPP3CA;RCAN3;GRM5;MCTP1;PTPRJ;TPCN2;PRKACA;P2RY12;PPP3CC;ACKR4;LAT2;SLC9A1;STIMATE
prerank,metanephric mesenchyme development (GO:0072075),-0.5575184313935556,-1.3736955411305298,0.1388101983002833,0.6496478675270735,1.0,3/10,7.25%,WNT4;OSR1;SIX1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.5185864415347217,1.3731960754401455,0.09560723514211886,0.778044218715238,1.0,6/33,13.06%,LGALS3;PTPN22;PTPN2;PRNP;PTPRJ;NECTIN2
prerank,cellular response to inorganic substance (GO:0071241),0.5633816241163396,1.3728249912700672,0.12876712328767123,0.777485749199763,1.0,9/21,16.10%,DDX11;DPEP1;NSMCE3;MT3;AOC1;ATRX;MTR;BLM;SPIDR
prerank,negative regulation of transferase activity (GO:0051348),0.5327612555651238,1.3724570734344619,0.10560625814863103,0.7770099877954333,1.0,14/28,20.78%,IRS2;NPRL2;ERCC4;LIMK1;MEN1;BAG5;PRDX3;ABL1;TP53;HNRNPU;EIF4A2;FBXO5;PARK7;ZFP36
prerank,neuron development (GO:0048666),0.4423618872603157,1.3724033081128095,0.029015544041450778,0.7750237158191964,1.0,29/141,12.98%,LGI4;ETV1;TENM2;CDNF;TENM3;DOCK7;GLI2;PPP1R9A;ATXN10;HS6ST1;GPM6B;ARL3;PLP1;NTRK2;GBA2;NLGN1;UNK;CNTNAP2;GPM6A;VAPA;GDNF;OPHN1;PRMT1;STMN4;RUNX1;CDK5R1;ATP8A2;MYOC;CDK16
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.526072365805369,-1.3723391378768937,0.11782477341389729,0.6494335045802806,1.0,7/12,22.14%,IGF1R;INSR;IRGM;UVRAG;SMCR8;JMJD4;ADRB2
prerank,chemical synaptic transmission (GO:0007268),0.42891732525685555,1.3717922635621032,0.005035246727089627,0.7754322112768897,1.0,58/284,15.46%,MPZ;SLC6A2;CHRM3;RAPSN;CEL;SLC1A3;CRH;CACNA1E;PTEN;NQO1;HRH1;PDE7B;GRIA1;GRIK3;KCNA1;GRIA3;DLGAP1;CACNA1A;CHRNA4;PLP1;NRXN1;GRIN2B;PRKAR1B;GRIK2;GRIK5;GRID2;CDH8;SYT1;DLG2;NLGN1;CACNB4;KCND2;GRIK1;PDLIM4;PMP22;SYN1;SPG11;GRM5;HTR2C;SLC12A4;RIMS1;MAPK1;TSPOAP1;DVL1;PRKACA;RAB3A;DRD2;GRIN2D;PENK;APBA1;SNCA;GRIN2A;RPS6KA2;NOVA1;CHAT;CALM1;RIC3;HOMER1
prerank,metal ion homeostasis (GO:0055065),0.5061336315450905,1.3715477756501997,0.094316807738815,0.7743225886149468,1.0,10/40,13.86%,ANK3;SLC12A3;KCNA1;LETM1;TMTC2;MT3;SLC12A2;SLC12A4;SLC7A8;SNCA
prerank,diterpenoid metabolic process (GO:0016101),0.4840794724590539,1.3711389635726132,0.0757396449704142,0.7739792793744042,1.0,12/55,12.76%,GPC3;HSPG2;RHO;LRP1;SDC2;SDC4;AKR1B10;RDH10;DHRS3;GPC1;GPC4;SDC3
prerank,negative regulation of complement activation (GO:0045916),0.6579856511226406,1.3705876914486361,0.12779552715654952,0.7743760680293033,1.0,1/10,0.82%,A2M
prerank,iron ion transmembrane transport (GO:0034755),0.6558293905112251,1.3701015118613458,0.13249211356466878,0.774355183498916,1.0,1/10,0.19%,SCARA5
prerank,negative regulation of cilium assembly (GO:1902018),-0.5258542267958741,-1.368303771127516,0.10703363914373089,0.6583489024499033,1.0,6/12,18.60%,ODF2L;EVI5L;CCP110;TBC1D7;TBC1D30;CDK10
prerank,camera-type eye development (GO:0043010),0.5476149619333885,1.3681372716647626,0.10419485791610285,0.780994858072923,1.0,5/25,5.48%,EFEMP1;TENM3;VEGFA;NF1;CYP1B1
prerank,regulation of interleukin-2 production (GO:0032663),0.5039899951747758,1.367924436431418,0.09610705596107055,0.7797438293725064,1.0,11/43,15.47%,GLMN;CD34;PDE4B;PRNP;CCR2;SPTBN1;RUNX1;PDE4D;MALT1;HOMER2;NAV3
prerank,pinocytosis (GO:0006907),0.6555151218745334,1.3677788492574252,0.13043478260869565,0.7781876251691265,1.0,4/10,7.82%,PYCARD;MAPKAPK3;MAPKAPK2;RAB34
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.4813008049474038,1.3672779557958172,0.0608187134502924,0.7782443133216164,1.0,19/55,19.02%,BST1;PRKN;PARL;MT3;CYP1B1;TGFBR2;PDK3;FOXM1;EIF6;BRCA1;ARF4;MAPK14;PID1;SNCA;TP53;PAX2;RIPK1;AATF;GRB2
prerank,aminoglycan catabolic process (GO:0006026),0.5370187051024309,1.3666808512215198,0.10158311345646438,0.7787568850905642,1.0,9/28,15.22%,GPC3;HSPG2;SDC2;SDC4;GPC1;CTBS;GPC4;SDC3;IDS
prerank,secretion (GO:0046903),-0.5143966730111359,-1.3658801560249623,0.12580645161290321,0.6618051744339477,1.0,4/14,6.24%,SLC22A4;SLC22A6;PRKCI;NPR1
prerank,proteolysis (GO:0006508),0.43020866469206787,1.3650925475241797,0.008105369807497468,0.7837882817599318,1.0,62/252,20.41%,HGFAC;KLK12;MMP2;PTCH1;ADAMTS12;FAP;ADAM19;BACE2;CAPN5;HTRA3;HM13;PARL;HTRA1;CAPN1;MIPEP;NAALAD2;PSEN1;PCSK4;PCSK6;MMP15;CTSK;CTSO;CASP6;TRHDE;CTSB;UFSP2;SPCS3;LNPEP;CAPN6;THOP1;MMP16;NCSTN;RSPRY1;UBA3;FBXL2;APH1A;YME1L1;MALT1;MMP19;NEDD8;CPD;TYSND1;ADAM33;PSEN2;PAPPA2;CASP2;RNPEPL1;USP25;FAM111A;SUFU;ATG4C;MDM2;CASP7;ERMP1;SENP1;CAPN11;MBTPS1;SPPL2B;CPNE1;NPEPPS;PLAT;PCSK7
prerank,embryonic eye morphogenesis (GO:0048048),0.6435320839733886,1.3649898510009046,0.12135176651305683,0.7820606112487842,1.0,5/11,22.58%,EFEMP1;RARG;ALDH1A3;FBN2;TBX2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.6276095352139461,1.3635530442005293,0.12006079027355623,0.7864221551234175,1.0,3/13,9.02%,BMP5;ERLIN2;DKK3
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.6214715340817584,1.363362206547027,0.12272727272727273,0.7850853728984658,1.0,2/13,3.30%,RELN;EPHB2
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.5390886262815723,1.3631431786806154,0.1083223249669749,0.7839782780492545,1.0,9/27,15.37%,FGF13;ANK2;PDE4B;DSG2;SCN5A;CTNNA3;PDE4D;JUP;PKP2
prerank,prostaglandin biosynthetic process (GO:0001516),-0.46193803710868436,-1.3623499768450409,0.10676156583629894,0.6692418006910114,1.0,5/18,8.04%,PLA2G4A;PTGIS;PTGDS;PTGS1;PTGS2
prerank,regulation of platelet activation (GO:0010543),0.5645219706626213,1.3612430781901577,0.1310344827586207,0.7904893738926975,1.0,4/21,3.89%,PRKCA;PDGFRA;PRKCQ;TEC
prerank,regulation of calcium ion import (GO:0090279),0.5676996113891655,1.3610255200215535,0.1310344827586207,0.7892952491991266,1.0,6/21,14.33%,LGALS3;WNK3;PRNP;FYN;PLPP4;PSEN2
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.5327211008022671,1.3608547873123173,0.1273209549071618,0.7879438420495833,1.0,8/24,17.16%,FFAR4;RNF157;PRKAR1B;PDE3B;PDE4D;GNAI1;CGAS;APLNR
prerank,homologous chromosome segregation (GO:0045143),0.5717484799272221,1.360814765880165,0.12429378531073447,0.7859701896473712,1.0,7/20,23.31%,MEIOB;FMN2;PRDM9;SGO1;CENPC;PTTG1;MEI4
prerank,histone lysine methylation (GO:0034968),0.5156870336038951,1.3605073508641348,0.11195928753180662,0.7852660990733058,1.0,14/33,20.30%,SUV39H1;KMT2A;SETD3;CXXC1;SETMAR;MEN1;PRDM9;TRMT112;KDM6A;WDR5B;ASH2L;N6AMT1;SETDB1;KMT2D
prerank,regulation of feeding behavior (GO:0060259),0.6386197310310471,1.360374731819397,0.13056379821958458,0.7836891200431264,1.0,3/11,19.31%,SGIP1;CFAP20;STAT3
prerank,protein localization to chromatin (GO:0071168),0.5863648223561044,1.3594914650606893,0.1274787535410765,0.7856262147734127,1.0,5/18,11.09%,FAM47E;LRWD1;MRNIP;PIH1D1;ESR1
prerank,negative regulation of developmental growth (GO:0048640),0.5130712174819583,1.3589519230474034,0.10539845758354756,0.7858538240801866,1.0,7/30,10.24%,PTCH1;FGF13;PTEN;RNF6;MT3;CDKL3;DCC
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.5328027846421033,-1.3585981212895908,0.11572700296735905,0.6773893395687595,1.0,4/11,14.45%,NBL1;SLIT2;RIN3;PADI2
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.59339052539997,1.3580343382706344,0.13623188405797101,0.7878695708351967,1.0,5/15,10.36%,SOX8;SOX9;VEGFA;SMO;GDNF
prerank,limb development (GO:0060173),0.5272394583098319,1.357613870585637,0.10344827586206896,0.787699713611452,1.0,4/28,2.10%,PTCH1;LRP4;FGF10;KAT2B
prerank,response to interferon-beta (GO:0035456),-0.4342100785806502,-1.3570711525446861,0.1037037037037037,0.6781673396117226,1.0,14/22,28.59%,PLSCR1;IFITM3;AIM2;IRGM;IRF1;IFITM2;UBE2G2;BST2;HTRA2;IFNAR2;CDC34;IKBKE;XAF1;TRIM6
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.5424807236114633,1.356729943457609,0.1193029490616622,0.789715261651018,1.0,5/24,8.15%,ANK3;ERBB2;C2CD5;PRNP;FYN
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.6277942792020639,1.3564953273020963,0.1297134238310709,0.7885896769212754,1.0,2/11,3.76%,GFPT2;NAGK
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.6258599753496219,1.3544139933407509,0.13174603174603175,0.7959386378744903,1.0,3/11,14.12%,TMEM106A;HDAC2;TAF7
prerank,positive regulation of stem cell differentiation (GO:2000738),0.584618573573912,1.354341901934619,0.14655172413793102,0.794087896218327,1.0,3/16,8.46%,SOX6;SOX9;SOX5
prerank,chromatin organization (GO:0006325),0.43966333667122154,1.3538330484630707,0.03966597077244259,0.7943170813018846,1.0,42/132,20.12%,FAM47E;DDX11;PRDM16;MYC;LRWD1;KAT2B;SOX9;HMGN1;SUV39H1;SATB1;BAZ1A;KDM5B;EZH1;PAK1;KDM4B;MTA2;ATRX;MCM3AP;SETD2;PIH1D1;HDAC2;MYSM1;SMARCC2;ESR1;JARID2;SETD5;ZBTB1;SMARCC1;BAZ2B;RBBP4;KDM6A;BAZ1B;PHF19;SMARCE1;PBRM1;NUDT5;RUVBL2;TOP1;HMG20A;SETDB1;HP1BP3;SMARCA4
prerank,cellular response to UV-A (GO:0071492),0.6386831833678969,1.3536139606485713,0.1388888888888889,0.7931990103714638,1.0,2/11,8.65%,MMP2;PPID
prerank,epithelial cell morphogenesis (GO:0003382),0.5738641565284133,1.3533560728945724,0.1332378223495702,0.7921205437975561,1.0,3/17,6.75%,COL15A1;RILPL2;COL18A1
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.6470160720338319,1.351523491050172,0.14696969696969697,0.7986655922687926,1.0,3/10,11.32%,BMP5;SOX11;BMP7
prerank,adherens junction organization (GO:0034332),0.48542382499941045,1.349912976254902,0.09144893111638955,0.8038353934743147,1.0,11/48,9.71%,DCHS1;CDH19;CDH10;CDH22;CDH8;CADM3;CSK;CADM2;CADM1;CDH20;CDH7
prerank,L-serine metabolic process (GO:0006563),0.6518519906988947,1.3498589555392626,0.1435114503816794,0.8019213127398162,1.0,5/10,13.48%,CBS;PSPH;PSAT1;PHGDH;SRR
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.4875809680121116,-1.3493123056633678,0.1262135922330097,0.7004260942070226,1.0,7/14,15.75%,NRP1;VEGFC;VEGFD;KDR;MYO1C;NUS1;FLT4
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.5072481721670655,1.3485233838147839,0.09811320754716982,0.8058855950658885,1.0,9/35,15.21%,ARHGAP24;DLC1;EPHB2;SYNGAP1;MAPKAP1;CUL3;MYOC;MET;ARHGAP44
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.34957867464730197,-1.3480836763401218,0.05612244897959184,0.6999937479900238,1.0,8/45,4.30%,BMP6;DAB2;RBPMS;ACVRL1;BMP4;ENG;BMPR2;TGFBR1
prerank,positive regulation of dendrite extension (GO:1903861),0.5713695761512154,1.3479425877679452,0.14184397163120568,0.8064546278318546,1.0,9/17,23.78%,RNF157;SYT1;RIMS1;NEDD4L;PLAA;SYT2;RIMS2;SYT3;CPNE5
prerank,defense response to tumor cell (GO:0002357),0.642548976905663,1.347452989908928,0.14375,0.8065140661728264,1.0,2/10,1.31%,DLEC1;RBMS3
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.482707761862466,-1.3457671302525038,0.12974683544303797,0.7036517856527169,1.0,7/15,26.36%,DAB2;WASL;SNAP91;HIP1R;TNK2;PIK3CB;BMP2K
prerank,regulation of dendrite extension (GO:1903859),0.5659752876526697,1.3450921582693744,0.14835948644793154,0.8155182463224258,1.0,9/18,23.78%,RNF157;SYT1;RIMS1;NEDD4L;PLAA;SYT2;RIMS2;SYT3;CPNE5
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.5090238683729942,-1.345053060387376,0.13719512195121952,0.7018658556808365,1.0,4/13,5.61%,SORBS1;IGF1;IGF2;INSR
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.540851621312433,1.3442282255107836,0.11397557666214382,0.817511190217376,1.0,5/23,8.15%,UBASH3B;CACNA2D1;ANK2;PRNP;FYN
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.6035450391571558,1.3441461932801084,0.13496932515337423,0.8157555641174461,1.0,5/13,14.58%,FGF2;GLI1;ERBB4;ZFPM2;BMPR1A
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5614945263116622,1.3438977725552141,0.13636363636363635,0.8146010958370796,1.0,5/18,9.87%,PTPN22;FGL1;TNFAIP8L2;LAX1;IL4I1
prerank,nuclear membrane organization (GO:0071763),-0.4491304649208043,-1.3431450367359352,0.11971830985915492,0.7038094325506474,1.0,12/19,31.04%,TOR1B;UBXN2A;VPS4A;DCTN1;TMEM43;UBXN2B;GPER1;CHMP7;TARDBP;NSFL1C;TOR1AIP1;NEMP1
prerank,regulation of protein targeting to membrane (GO:0090313),0.5238263180908453,1.342226717489536,0.1335978835978836,0.8200810346166072,1.0,5/28,8.15%,ANK3;ERBB2;C2CD5;PRNP;FYN
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.5633371505761844,1.3420705851080987,0.1171875,0.8186907758641573,1.0,6/21,8.53%,STK36;EVC;GLI1;UCHL5;RAB34;SMO
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.5198005312842555,1.341588115376983,0.1215323645970938,0.8187975108828784,1.0,7/29,11.60%,RELN;FGF10;IRS2;NGF;ERBIN;SHOC2;MMD2
prerank,ear morphogenesis (GO:0042471),0.5555584292582332,1.3410506030793603,0.1295774647887324,0.8191405532369788,1.0,2/20,3.30%,OSR2;EPHB2
prerank,regulation of cellular component biogenesis (GO:0044087),-0.3680515186397277,-1.340903144670163,0.09302325581395349,0.7069120678425153,1.0,8/39,7.78%,TJP1;SNCAIP;ROCK2;RAP1B;ROCK1;TIE1;PARP10;IRGM
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.5010104156883011,1.3407961410638225,0.11460957178841309,0.8182036024600845,1.0,7/40,6.93%,GLMN;PTEN;RAD23B;XPO1;ARAF;FBXW7;UFL1
prerank,regulation of double-strand break repair (GO:2000779),0.49942138504595507,1.3407660988684165,0.0975609756097561,0.8162321475151638,1.0,12/39,16.30%,DDX11;SPIRE1;FMN2;MRNIP;FOXM1;SETD2;SLF2;SIRT6;RPA2;RTEL1;SPIDR;TERF2IP
prerank,transition metal ion transport (GO:0000041),-0.385738015130849,-1.3403636669305143,0.08585858585858586,0.7042696556178459,1.0,9/35,10.04%,SLC30A10;SLC31A1;ATP7A;SLC31A2;FTH1;SLC39A8;SLC30A1;TRPC6;TFRC
prerank,generation of neurons (GO:0048699),0.42680045438347647,1.340347208175188,0.026530612244897958,0.8160941938289019,1.0,32/190,12.02%,RELN;DOCK7;LHX5;FGF13;ASTN2;ERBB2;IL1RAPL1;OTP;MAP1B;NRCAM;SEMA3A;AUTS2;SOX11;NTRK2;EML1;WNT5A;CEP85L;NAV1;CDKL5;NGRN;DISC1;SDCCAG8;FZD7;CDK6;FGFR1;TAFA1;GPM6A;OPHN1;ADGRL3;POMGNT2;RUNX1;CDK5R1
prerank,regulation of secretion (GO:0051046),0.6125580923029129,1.3400911725557558,0.12575757575757576,0.8152560899764111,1.0,6/13,16.87%,ERBB3;FGF10;ACSL3;GPLD1;OPRK1;SGK1
prerank,regulation of ion transmembrane transport (GO:0034765),0.5158754096780683,1.3393592845124513,0.12891113892365458,0.8165563860341043,1.0,9/33,16.33%,CHRM3;ANO6;WNK3;AKAP6;AHCYL1;KCNJ3;NEDD4L;KCNJ10;KCNH2
prerank,positive regulation of cell adhesion (GO:0045785),0.4479359678812882,1.3392188114244499,0.07349665924276169,0.8151541963156888,1.0,19/74,18.32%,VIT;PRKCA;EPB41L4B;RHOD;FBLN2;ERBB2;VEGFA;PPP3CA;MAGI1;ARL2;PTPRJ;P2RY12;ATM;CITED2;HYAL1;RELL2;MDK;RAC3;MEGF10
prerank,negative regulation of DNA binding (GO:0043392),-0.3957662364051558,-1.3389579501316204,0.13389121338912133,0.7047362507534617,1.0,11/28,18.43%,SP100;LEF1;NFKBIA;KDM1A;HABP4;SUMO3;HMGA2;MDFI;HEY2;SIN3A;TFAP4
prerank,regulation of neurogenesis (GO:0050767),0.47374950803017024,1.3384416401721104,0.1045828437132785,0.8166734794362456,1.0,5/55,5.22%,CCL11;DOCK7;SOX11;PCM1;NUMBL
prerank,energy reserve metabolic process (GO:0006112),0.561616676590391,1.338207030165691,0.13506139154160982,0.8157202350075456,1.0,6/19,11.05%,PYGL;GFPT2;MYC;MT3;PHKB;PID1
prerank,cellular potassium ion homeostasis (GO:0030007),-0.5014551155272698,-1.3377538265526396,0.11254019292604502,0.7046688702974937,1.0,4/13,6.66%,ATP1A2;ATP1B3;KCNJ2;ATP1A1
prerank,amino sugar biosynthetic process (GO:0046349),0.609320210100653,1.3373559369345565,0.14349112426035504,0.8177299651477266,1.0,2/12,3.76%,GFPT2;NAGK
prerank,regulation of macrophage migration (GO:1905521),-0.5468056735524442,-1.3368629684769964,0.15759312320916904,0.7034760088013224,1.0,2/10,1.27%,CD200;MTUS1
prerank,positive regulation of nervous system development (GO:0051962),0.4860922258876204,1.3365765733139805,0.10635696821515893,0.8192167410472997,1.0,13/42,16.67%,CLSTN2;IL1RAPL1;EPHB2;SOX11;NRXN1;NUMBL;GRID2;NLGN1;SYNDIG1;CLSTN1;LRP2;IL1RAP;FAIM
prerank,cAMP-mediated signaling (GO:0019933),0.5384757819897198,1.3356999196871706,0.13161465400271372,0.8211930871722476,1.0,7/24,12.88%,SOX9;PDE7B;MAPK7;KSR1;AKAP6;PDE4D;AHR
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.5962496721817402,1.3354008765156793,0.14327485380116958,0.8204460619998147,1.0,2/13,3.76%,GFPT2;NAGK
prerank,neuron projection morphogenesis (GO:0048812),0.4316912966037933,1.3353752291807715,0.04741833508956796,0.8185086202446612,1.0,43/137,17.16%,ANK3;DOCK7;LRP4;PTEN;KIF20B;NGF;GAS7;MAP4K4;MAP1B;NRCAM;EPHB2;SDC2;CTNNA2;TNIK;NYAP1;PAK1;NLGN1;ALS2;BAIAP2;DOCK10;NTNG2;NTNG1;S100A6;CNTNAP2;GPM6A;EPB41L3;DCC;DCLK1;BMP7;TAOK3;DIP2A;PLPPR4;DVL1;RAB3A;DRD2;TRIO;IQGAP1;ANKRD27;UBB;LRP2;CTTN;SGK1;PAX2
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.5851564629864993,1.3351232872290137,0.14032496307237813,0.8176179792907762,1.0,3/15,8.78%,OSR2;FGFR1;BRCA1
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.48024556727229306,-1.334715463437404,0.1362126245847176,0.7015771566623261,1.0,4/15,13.14%,DTNBP1;BLOC1S5;SNAPIN;AP3D1
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.48024556727229306,-1.334715463437404,0.1362126245847176,0.7015771566623261,1.0,4/15,13.14%,DTNBP1;BLOC1S5;SNAPIN;AP3D1
prerank,negative regulation of response to external stimulus (GO:0032102),0.43180873224054406,1.3338175128182586,0.057608695652173914,0.8217222661333531,1.0,14/105,9.62%,RORA;FFAR4;CLDN19;FGF2;PTEN;PTPN2;IRAK3;MAPK7;TNFAIP8L2;CTNNA2;GRID2;OTULIN;PPM1B;SELENOS
prerank,positive regulation of mitochondrion organization (GO:0010822),0.47127458677305617,1.3330412383678558,0.09474885844748858,0.8231866572494001,1.0,8/57,7.90%,DCN;HRK;PYCARD;SPIRE1;PRKN;FBXO7;BMF;BNIP3
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.4322588610646206,-1.3323373614949543,0.0873015873015873,0.7051217312773582,1.0,6/21,17.19%,FOXP1;PRKCH;PRKCB;PTPRC;IKBKG;SLC39A10
prerank,stabilization of membrane potential (GO:0030322),0.5828863095769208,1.3320784833477604,0.15683453237410072,0.8257067360686628,1.0,2/16,3.04%,KCNK15;KCNK1
prerank,blood circulation (GO:0008015),-0.3612476609397822,-1.3318767700302934,0.07947019867549669,0.7025090250587657,1.0,15/49,11.94%,MYOF;ROCK2;ELN;TBC1D8;ROCK1;ACVRL1;NOS3;COL4A3;NPR1;ACE;AGTR1;GUCY1B1;ADORA2A;SOD1;GPX1
prerank,ion homeostasis (GO:0050801),0.5139194540882378,1.3313375098741227,0.13054499366286437,0.8271755437646833,1.0,4/30,8.05%,P2RY2;WNK2;WNK3;SLC30A4
prerank,endoderm development (GO:0007492),0.6018901990761695,1.3312053819904732,0.14242424242424243,0.8257468900791326,1.0,2/13,2.33%,LAMC1;DUSP4
prerank,positive regulation of protein localization to membrane (GO:1905477),0.44050663277868857,1.3305877012510887,0.07057546145494029,0.82662038648253,1.0,17/98,8.39%,LGALS3;ANK3;BCL2;LRP1;ERBB2;PRKN;EGFR;SLC5A3;C2CD5;EPHB2;WNK3;PRNP;SPTBN1;YWHAZ;DPP10;FYN;ZDHHC8
prerank,positive regulation of cell junction assembly (GO:1901890),0.4645574817147929,1.3300446154272876,0.1048951048951049,0.8270756975907155,1.0,17/56,16.59%,CLDN19;CLSTN2;IL1RAPL1;MAP4K4;VEGFA;EPHB2;NRXN1;GRID2;NLGN1;TSC1;CNTNAP2;PTPRJ;MYOC;SYNDIG1;CLSTN1;ABL1;IL1RAP
prerank,negative regulation of ion transport (GO:0043271),0.5214602043563026,1.329731589038747,0.14749661705006767,0.8265307388131962,1.0,6/24,13.86%,WNK2;GPM6B;WNK3;SYT11;PXK;SNCA
prerank,regulation of sequestering of calcium ion (GO:0051282),0.6065117534982801,1.3295862884081628,0.1590909090909091,0.825188169552177,1.0,4/12,15.00%,UBASH3B;ANK2;ANXA6;MTLN
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.48136063749685665,-1.3290966614808515,0.1254355400696864,0.7073267378587847,1.0,7/15,29.20%,MKNK2;HNRNPA1;PPIF;ZFAND1;GSTO2;VCP;ATF3
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.5115430499886613,-1.328906333505551,0.13924050632911392,0.7036136225472119,1.0,6/13,22.82%,NOS3;FPGS;HSP90AA1;SPR;QDPR;AKT1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.6108289960025054,1.3289048482968853,0.15781487101669195,0.8262963855156595,1.0,3/12,11.96%,PTEN;GORASP1;RAB1A
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.5598188293765792,1.3288899821207172,0.15151515151515152,0.8243425141686302,1.0,7/17,15.36%,CADM4;SPRED2;SPRED1;SPRED3;EIF4G1;CALM1;CALM2
prerank,neuron maturation (GO:0042551),0.565910268791917,1.328655523828636,0.14655172413793102,0.8234402307942775,1.0,4/18,12.42%,LGI4;ADGRB3;FARP2;ANKS1A
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.42854354220899193,1.3275640224783818,0.050261780104712044,0.8263721721630991,1.0,29/140,14.11%,RELN;ARHGAP24;DLC1;ARHGAP32;ARHGAP19;RHOJ;A2M;RHOD;DEPDC1B;AKAP13;FGD4;CHN1;ITSN1;FOXM1;ARHGAP9;RABL3;VAV3;ARHGEF11;RHOT2;ARHGAP11A;MYO9B;MYO9A;OPHN1;ARHGAP21;RHOC;RHOH;TRIO;ARHGAP4;ARHGEF3
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.49539670061066987,1.3274214537046787,0.10683229813664596,0.8250112393769855,1.0,7/38,9.96%,RELN;ERBB3;RAP2B;GPRC5B;PRNP;PTPN1;GRM5
prerank,protein localization to vacuole (GO:0072665),-0.5012832920332295,-1.327232965202569,0.1495601173020528,0.7050301079872187,1.0,8/13,25.99%,LMBRD1;MFSD1;RNF128;KPTN;SH3GLB1;SH3BP4;ATP13A2;SZT2
prerank,negative regulation of histone modification (GO:0031057),0.5890088179799561,1.32686921974778,0.14970930232558138,0.8256287033085123,1.0,6/14,17.73%,AASS;BRCA1;JARID2;SNCA;TAF7;CTBP1
prerank,alpha-amino acid metabolic process (GO:1901605),0.4756470975105801,1.3265773643134944,0.11778563015312132,0.8248962922726552,1.0,18/45,22.17%,AADAT;DPEP1;CBS;NAALAD2;GOT2;MTRR;ASNS;OAT;SRR;GPT2;KYAT3;GLS;GLS2;ASPA;RIMKLB;GLUD1;DDAH1;NAT8L
prerank,regulation of lymphocyte differentiation (GO:0045619),0.5587104280891674,1.3263656334017078,0.14325452016689846,0.824010380656409,1.0,6/18,15.41%,CCR2;METTL3;ZFP36L2;IL4I1;XRCC6;ABL1
prerank,hydrogen peroxide metabolic process (GO:0042743),0.5590571093873378,1.326304657115585,0.13157894736842105,0.8223478770709213,1.0,7/19,18.64%,PXDN;NOX1;ACOX1;GPX3;PRDX3;CAT;PARK7
prerank,negative regulation of transport (GO:0051051),0.472946838639077,1.3257815615136428,0.09747292418772563,0.8227796784225194,1.0,14/51,17.68%,LGALS3;ERBB3;PTEN;PRKN;CRYAB;SYT11;PXK;MCTP1;ARL6IP5;NDFIP1;SNCA;SNX12;DYSF;RAB7A
prerank,receptor clustering (GO:0043113),0.528539496533008,1.32563684149527,0.14150943396226415,0.8215428875339454,1.0,9/27,12.71%,LRP4;SAV1;NRXN1;DLG2;NLGN1;FLNA;MAGI2;DVL1;SCRIB
prerank,positive regulation of kinase activity (GO:0033674),0.43376480837616826,1.3255438647733109,0.052072263549415514,0.8200283636968686,1.0,17/107,7.56%,ROR2;RELN;ROR1;PDGFRA;ERBB3;NTRK3;EPHB6;ERBB2;EGFR;EPHB2;NTRK2;TRAF4;MRNIP;ALS2;VAC14;FGFR1;RAP1A
prerank,cellular response to organic cyclic compound (GO:0071407),0.42799304694947843,1.324775201024212,0.0446521287642783,0.821591946202559,1.0,42/141,21.46%,RORA;P2RY2;SSTR1;HRH1;EGFR;TGFB1;CYP1B1;AOC1;URI1;RORC;CASP6;RAP1A;IL18;BRCA1;AKAP6;ESR1;ARL6IP5;NRIP1;GNAI1;AHR;HSP90B1;P2RY12;SSH1;LCOR;P2RY1;JUP;BLM;GABRG2;SPIDR;NCOA3;CASP7;TAF1;FAM210B;EGR1;RYR3;UBE2L3;RUVBL2;HCN1;ADCY8;PKD2;P2RX7;TIPARP
prerank,regulation of stress fiber assembly (GO:0051492),-0.3278037467691151,-1.323568348738087,0.0673076923076923,0.7129550661372102,1.0,20/74,9.65%,PHLDB2;TJP1;CGNL1;ARHGAP28;ROCK2;NRP1;CCN2;ROCK1;LIMCH1;WASF2;RHPN2;TGFBR1;TPM1;FHOD1;ARAP1;PAK2;RGCC;ARHGEF15;PFN2;RHOA
prerank,morphogenesis of an epithelium (GO:0002009),0.5351763971937651,1.3234158678754624,0.1363040629095675,0.8257202526361742,1.0,4/25,7.02%,SOX8;SOX9;PRKX;TBX18
prerank,histone H4-K16 acetylation (GO:0043984),0.5549224046107055,1.3228030802759443,0.16235632183908047,0.8265069448871539,1.0,11/19,23.61%,KMT2A;JADE1;JADE3;KAT8;PHF20;ING4;KANSL1;MSL3;MCRS1;KANSL2;KAT7
prerank,membrane repolarization (GO:0086009),-0.4759146236807957,-1.3221846957141052,0.1518987341772152,0.713272730609999,1.0,4/15,6.66%,ATP1A2;ATP1B3;KCNJ2;ATP1A1
prerank,gastrulation (GO:0007369),0.575318386154529,1.3219623479643903,0.17385057471264367,0.8282210800770213,1.0,1/15,0.28%,GPC3
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.44686806186868594,1.3218239493607966,0.09312638580931264,0.8268713821645601,1.0,10/75,6.86%,DCN;HSPG2;SULF1;CXCL10;SEMA3E;COL4A2;CCR2;PDE3B;ADAMTS1;SPRED1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5244797739860504,1.3210987731943193,0.14966887417218544,0.8282700025801466,1.0,11/26,19.55%,FGF10;EGFR;UBE2E2;PLCB1;ADAMTS1;EIF4G1;CCND2;HYAL1;RPTOR;KMT2E;RDX
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.4423506208218119,1.3208073340179596,0.08559046587215602,0.8276373774038812,1.0,23/88,18.64%,LGALS3;CLDN19;PRKCA;HRK;VEGFA;TGFB1;SDC4;BMF;LIMK1;BRK1;PIH1D1;SLF2;BMP7;RHOC;SUMO1;PDCD6IP;MTLN;BCL2L11;SPIDR;HYAL1;RAB7A;FNIP1;PARK7
prerank,regulation of intracellular transport (GO:0032386),-0.3721460239213887,-1.3203613360458355,0.09836065573770492,0.7153564834403661,1.0,19/38,27.76%,MAP2;RAB11B;GAS1;LAMP1;ATP9A;SCFD1;ATPSCKMT;WWC1;DYNLT2B;NUMA1;NUP214;NEFH;INPP5F;LCP1;ATP13A2;ANTKMT;DNAJC30;MLC1;RNF139
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.5476622978172452,1.3202202188906147,0.13630229419703105,0.8283072485871914,1.0,7/21,18.78%,CACNA2D1;ANK2;SCN5A;FLNA;KCNH2;KCNA5;NOS1AP
prerank,positive regulation of positive chemotaxis (GO:0050927),0.5792842952447383,1.319322182599126,0.16189111747851004,0.8301966742417752,1.0,3/15,3.17%,IL16;NTRK3;VEGFA
prerank,intestinal lipid absorption (GO:0098856),0.6167247418621365,1.3186211980692706,0.15338345864661654,0.8313222386361664,1.0,1/11,0.92%,CEL
prerank,nerve growth factor signaling pathway (GO:0038180),0.6324243917250454,1.318610280305929,0.16236722306525037,0.829442413236899,1.0,3/10,11.56%,NGF;RAP1A;MAGI2
prerank,central nervous system myelination (GO:0022010),0.622016344401171,1.3183818725832157,0.1586608442503639,0.8285675167588079,1.0,2/11,4.34%,PTEN;PLP1
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.5354908701437886,1.317243882226771,0.15426251691474965,0.8318434814309481,1.0,8/21,14.33%,ADAM19;PRKCQ;BACE2;HM13;PSEN1;NCSTN;APH1A;PSEN2
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.4553882886927107,-1.317079685845775,0.12341772151898735,0.7222163115874448,1.0,4/17,1.81%,ROCK2;CDH5;ROCK1;CLDN5
prerank,amino acid transmembrane transport (GO:0003333),-0.37051320807686,-1.3167112337178928,0.060810810810810814,0.7190798287483717,1.0,14/45,14.94%,SLC7A11;SLC47A1;SLC6A6;SLC22A4;SLC6A13;SLC38A11;SLC7A5;SLC38A7;SLC16A2;SLC38A5;SLC25A12;SLC38A10;SLC36A4;SFXN3
prerank,myelin assembly (GO:0032288),0.6182144786732591,1.3164848603082273,0.1562021439509954,0.8334065644317408,1.0,5/10,20.17%,EPB41L3;PMP22;GPC1;CD9;NCMAP
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.4257306426207895,-1.3160552788730167,0.12167300380228137,0.7174408970488811,1.0,4/22,11.74%,ALDH1A2;RBP1;CUBN;LGMN
prerank,peptidyl-tyrosine modification (GO:0018212),0.4583705137607275,1.3153635738175178,0.12826603325415678,0.8367338240389716,1.0,10/56,8.15%,RELN;EFEMP1;PDGFRA;PKDCC;ERBB2;EGFR;EPHB2;TEC;FGFR1;FYN
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.535759754290934,-1.3146933361721713,0.1495601173020528,0.7178067902978889,1.0,4/11,16.91%,CLK2;SIK1;C1QTNF3;PGP
prerank,organic anion transport (GO:0015711),-0.3174455202322168,-1.314534755167561,0.039603960396039604,0.7142262644970968,1.0,20/76,14.24%,SLCO3A1;ABCC4;ABCG2;SLC26A7;SLCO2A1;SLC4A10;SLCO1C1;SLC22A6;SLC35B4;SLC4A3;SLC39A8;SLC16A2;CYB5R4;ABCC6;CA4;SLC4A8;LRRC8C;SLC2A10;LRRC8A;MGST1
prerank,phagolysosome assembly (GO:0001845),0.6042223717530952,1.3142998606823966,0.15756630265210608,0.8397131832154091,1.0,5/12,17.68%,RAB14;RAB34;RAB39A;RAB7A;RAB7B
prerank,actin filament bundle organization (GO:0061572),-0.3746611309258912,-1.3142409071158694,0.08968609865470852,0.7111252211733187,1.0,12/33,21.36%,PAWR;CALD1;BAIAP2L1;NEDD9;EPS8;FAM107A;SHROOM2;LIMA1;AIF1L;ADD2;RFLNA;LCP1
prerank,glycoprotein catabolic process (GO:0006516),0.5676146986765631,1.3125304536772109,0.17435158501440923,0.8460494256367481,1.0,4/17,11.90%,ADAMTS12;FBXO27;EDEM2;FBXO17
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.5872136074074202,1.3123217545963632,0.15666178623718888,0.8450676118252388,1.0,6/13,19.10%,TRIM44;WNT5A;AGPAT2;TAF9;CD74;AXL
prerank,negative regulation of metabolic process (GO:0009892),-0.3357296661442664,-1.3119108219891646,0.07777777777777778,0.7151275188355455,1.0,21/54,21.17%,ALDH1A1;PLCL1;ID1;NPR3;TLR4;IP6K1;PLCL2;ZNF423;LGR4;FLCN;ZDHHC7;CCDC3;NR1H2;NOVA2;RHEB;PGAM5;NRDC;PCTP;NR1H3;FOXC2;ATF4
prerank,presynaptic endocytosis (GO:0140238),0.520339261942906,1.3118992416186464,0.15272244355909695,0.8449985234681833,1.0,9/24,18.89%,CEL;STON2;SYT1;NLGN1;STON1;OPHN1;SNCA;SYT2;SNCB
prerank,axon development (GO:0061564),0.44254759068675464,1.3115698618839895,0.0918141592920354,0.8445126616764215,1.0,24/78,20.25%,ANK3;DOCK7;MAP1B;NRCAM;EPHB2;PLP1;CTNNA2;BAIAP2;NTNG2;NTNG1;S100A6;DCC;PLPPR4;CDK5R1;RAB3A;DRD2;RTN4;MTR;NREP;PAX2;RTN4RL1;KLF7;CNTN4;SHTN1
prerank,positive regulation of phospholipid transport (GO:2001140),-0.5463663263455907,-1.311103688344523,0.16909620991253643,0.7137083330522177,1.0,5/10,21.48%,ABCA3;ABCB4;ABCA7;APOE;TMEM30A
prerank,regulation of integrin activation (GO:0033623),-0.4641899631228455,-1.310781025904879,0.1270358306188925,0.7109188166352662,1.0,3/15,5.91%,RAP1B;JAM3;RASIP1
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.46490328724013014,-1.3106728369489211,0.15333333333333332,0.7072850597404039,1.0,11/16,28.87%,PARP1;ATPSCKMT;FLCN;TMSB4X;PINK1;AK4;ENO1;ANTKMT;SPHK2;DNAJC30;VCP
prerank,regulation of nuclear division (GO:0051783),0.5547504060254513,1.3104663433097348,0.14565826330532214,0.8475106703960764,1.0,5/20,11.12%,KIF20B;OBSL1;CDK13;RCC1;PKMYT1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.4369573834694778,1.3100147996473728,0.0790899241603467,0.8477017709684027,1.0,20/95,12.76%,DCN;GPC3;HSPG2;VCAN;LUM;HAS2;ST3GAL4;HS6ST1;SDC2;EXT1;SDC4;BCAN;CSGALNACT1;CHSY1;SLC10A7;NCAN;GLCE;GPC1;GPC4;SDC3
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5433173603835986,1.3097541249443823,0.15584415584415584,0.8470526098870953,1.0,7/19,14.58%,FGF2;VGLL4;GLI1;ERBB4;RUNX1;ZFPM2;BMPR1A
prerank,positive regulation of synapse assembly (GO:0051965),0.5108853290637563,1.3088177909592669,0.14417989417989419,0.8493690774655043,1.0,10/27,19.18%,CLSTN2;IL1RAPL1;EPHB2;NRXN1;GRID2;NLGN1;SYNDIG1;CLSTN1;IL1RAP;SEMA4D
prerank,regulation of dendrite development (GO:0050773),0.4822832287509057,1.3085684976901852,0.13442211055276382,0.8486024894061738,1.0,11/37,14.78%,BMP5;CSMD3;SDC2;TNIK;CDKL5;ADGRB3;DCC;BMP7;NEDD4L;COBL;RTN4IP1
prerank,regulation of cytoplasmic transport (GO:1903649),-0.5376758866641095,-1.3084711144996692,0.1588235294117647,0.7106450878973276,1.0,4/11,8.68%,USP7;CHMP3;ATP9A;MAP2K1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.5443537941332047,1.3080938276395826,0.15672676837725383,0.8489402717065055,1.0,7/19,16.56%,HS6ST1;EXT1;EXTL3;CSGALNACT1;GLCE;HS2ST1;UGDH
prerank,regulation of filopodium assembly (GO:0051489),-0.37060899487418175,-1.307887113976459,0.10599078341013825,0.7085024586991271,1.0,10/38,3.42%,CAPZB;NRP1;RAB5A;MYO10;WASL;PPP1R16B;PRKCD;GAP43;AGRN;FNBP1L
prerank,cellular response to metal ion (GO:0071248),0.42415161899677334,1.3075432049965632,0.07240293809024134,0.8495689152644126,1.0,42/123,22.01%,ANK3;CPNE8;DPEP1;PRKN;EGFR;KCNA1;HPCA;NCF1;PRNP;MT3;WNT5A;SLC12A2;SYT1;DLG2;SCN5A;AOC1;NLGN1;BNIP3;MAPK9;SYT11;SYT12;MAPK1;ALOX5AP;SNCA;SUMO1;IQGAP1;GPLD1;SLC25A24;CPNE7;CHUK;SYT2;RYR3;CPNE1;JUN;SYT13;ADCY8;PKD2;CPNE3;CAMK2D;CACNA1H;DLG4;PRKAA1
prerank,response to peptide (GO:1901652),0.5036129030633121,1.3075324585876202,0.1327319587628866,0.8477302145546295,1.0,12/33,23.61%,MMP2;CACNA1A;PRNP;EIF2B5;FYN;ERBIN;GNAI1;EIF2B2;STAT3;STAT5A;STAT6;KAT7
prerank,NAD biosynthetic process (GO:0009435),-0.43728592154656076,-1.3073018012693185,0.13851351351351351,0.7066583148322022,1.0,7/20,9.97%,PTGIS;NAMPT;NMNAT2;NAXD;PARP10;PTGS2;NMNAT1
prerank,regulation of neuroinflammatory response (GO:0150077),-0.4460924886963598,-1.30708151938622,0.12992125984251968,0.7034497166565254,1.0,6/19,17.17%,IGF1;CD200;PTGS2;NUPR1;SPHK1;DAGLA
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.4246531408276938,-1.3067793122208007,0.11372549019607843,0.7005298711792723,1.0,9/23,14.33%,MOSPD2;SLIT2;MPP1;JAM3;DAPK2;CAMK1D;DPP4;NCKAP1L;TIRAP
prerank,muscle tissue development (GO:0060537),0.5946609203594345,1.3067211724972387,0.1628614916286149,0.8495059074142989,1.0,4/13,8.53%,PTCH1;CSRP1;NF1;SMO
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3881177045096421,-1.30661940469886,0.10550458715596331,0.6972512875336935,1.0,13/34,17.34%,FLT1;NRP1;VEGFC;VEGFD;GAS1;MAP2K3;KDR;ERN1;NUS1;FLT4;SPHK1;ANXA1;HSPB1
prerank,regulation of pH (GO:0006885),-0.5130801062432934,-1.306078528909745,0.1844380403458213,0.6951672680108305,1.0,7/11,28.08%,CLCN3;SLC9A7;ATP6V0A4;ATP6AP1;PDK2;LACC1;PDK4
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.4536424668535996,1.305926567556484,0.12114285714285715,0.8510879731344385,1.0,10/63,13.58%,FGF10;BCL2;IRS2;BST1;EPHB2;CD320;IL18;VAV3;IL6ST;NCK1
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.3002329168833034,-1.305597515715767,0.018867924528301886,0.6927847502899481,1.0,53/110,26.95%,RPS14;GSPT1;RPL24;RPL18A;RPS16;UPF3B;RPL38;RPL28;RPS19;RPL37;CTIF;RPS2;RPL19;RPL5;RPL34;RPS25;RPS15;EIF4A3;RPLP1;RPL31;RPL3;HELZ2;RPS6;RPS8;RPL11;RPL12;PNRC2;SMG9;RPL13;RPL7A;RPS21;RPL35A;RPL26;RPL32;RPS9;RPS29;RPS23;RPL8;RPLP2;RPL41;SMG5;RPS17;RPS5;SMG8;RPS15A;RPL37A;UBA52;PPP2CA;RPS10;EIF3E;RPL6;RPL9;RPS27
prerank,hexose metabolic process (GO:0019318),0.47986543335237747,1.3050121532197956,0.15744157441574416,0.8534045822521777,1.0,7/39,15.84%,APOD;IRS2;PGM1;GALM;FUCA2;BRAT1;GALK2
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.4469215875266043,1.3042424107348085,0.08998875140607424,0.8549647470181261,1.0,18/75,13.01%,ANK3;DOCK7;LRP4;MAP1B;NRCAM;SDC2;CTNNA2;BAIAP2;NTNG2;NTNG1;S100A6;UNK;DCC;OPHN1;PLPPR4;DVL1;RAB3A;DRD2
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.471955287415482,-1.3038920533238407,0.13218390804597702,0.6944589772668494,1.0,6/13,18.62%,PLPP1;BMP4;CALCOCO1;NR3C2;ABHD2;GPER1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.44676133126227474,-1.3035320214138522,0.13486842105263158,0.6919291879243858,1.0,8/17,26.83%,MOSPD2;DAPK2;CAMK1D;NCKAP1L;TIRAP;DNM1L;RIPOR2;CCL19
prerank,membrane protein proteolysis (GO:0033619),0.48625368889438825,1.3033184371599447,0.13727959697732997,0.8572223865407951,1.0,11/37,14.33%,ADAM19;PRKCQ;BACE2;HM13;PARL;TGFB1;PSEN1;NCSTN;NGFR;APH1A;PSEN2
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.5275240140947381,-1.303005384706689,0.14824797843665768,0.689993463007269,1.0,4/10,16.02%,ERRFI1;ENG;CAV1;ENPP1
prerank,positive regulation of neutrophil migration (GO:1902624),-0.4387429585283603,-1.3024634787212295,0.15894039735099338,0.6883224538653863,1.0,8/18,26.83%,MOSPD2;DAPK2;CAMK1D;NCKAP1L;TIRAP;DNM1L;RIPOR2;CCL19
prerank,lipid catabolic process (GO:0016042),0.5509386644904737,1.3023512855353732,0.181058495821727,0.859620438348121,1.0,4/18,12.50%,CEL;MT3;LIPC;PLAAT3
prerank,negative regulation of wound healing (GO:0061045),0.5130679548259098,1.3019780742545586,0.15384615384615385,0.8594776331614536,1.0,8/28,11.00%,CLDN19;FGF2;PTEN;CD34;SLC12A2;SERPINE2;CLASP1;AJAP1
prerank,regulation of postsynapse organization (GO:0099175),0.510137154955855,1.300490063334652,0.16261203585147246,0.8643978403177046,1.0,10/28,15.46%,SIPA1L1;IL1RAPL1;TANC2;WNT5A;CDKL5;PPFIA2;CDK5R1;LZTS3;ARHGAP44;HOMER1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.4964976192186942,1.300142215122156,0.13400758533501897,0.8640160443240903,1.0,2/33,1.62%,APOD;PTEN
prerank,vesicle transport along actin filament (GO:0030050),-0.44241903659017073,-1.2997176068625347,0.15845070422535212,0.6939028844010325,1.0,10/19,27.27%,MYO1D;WASL;FNBP1L;MYO1E;MYO5B;MYO1C;ACTN4;MYO5C;MYO1F;MYO15A
prerank,negative regulation of response to stimulus (GO:0048585),0.453947302350821,1.2990834808836385,0.1323529411764706,0.8670458525091799,1.0,13/60,10.16%,UBASH3B;ERBB3;CD34;ACVR1;MAP3K3;MAPK7;SOCS5;HHIP;CDK6;COL3A1;AKT3;PTPN1;MCTP1
prerank,renal filtration (GO:0097205),0.625510953941619,1.2982307106791975,0.18181818181818182,0.8688920616081175,1.0,2/10,1.94%,SULF1;CD34
prerank,cellular response to catecholamine stimulus (GO:0071870),0.5171263998260879,1.2980336713066407,0.17083333333333334,0.8679033849801128,1.0,7/23,16.67%,PRKN;PDE4B;MAPK1;PRKACA;SNCA;ABL1;SLC9A1
prerank,bone morphogenesis (GO:0060349),0.5888877749103885,1.29774146696506,0.17040358744394618,0.8673651303534362,1.0,1/14,0.13%,OSR2
prerank,cellular response to decreased oxygen levels (GO:0036294),0.45306203552100394,1.2976160521452058,0.10183066361556065,0.8660719330599829,1.0,18/65,16.20%,RORA;MYC;SUV39H1;FMN2;SCN2A;VEGFA;MT3;TSC1;GATA6;KCND2;TBL2;BNIP3;HIF1A;BMP7;CPEB1;MDM4;LMNA;TP53
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5771725158726285,1.2975929562162785,0.1824925816023739,0.8643172053023037,1.0,4/13,15.36%,ANK3;PDE4D;CALM1;CALM2
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.425757591855933,1.2973610459675833,0.07781282860147214,0.8634980104898676,1.0,32/113,16.94%,LGALS3;USP50;HRK;VEGFA;GTF2H2;TGFB1;ERCC5;ERCC4;DDB2;RPA3;BMF;BRK1;XPA;PIH1D1;EIF4G1;SLF2;ESR1;RHOC;DDB1;SNCA;RPA2;TTBK1;DHX33;SUMO1;MTLN;ATM;FSCN1;MED25;BCL2L11;SPIDR;TP53;CUL4B
prerank,pharyngeal system development (GO:0060037),0.5580258331477309,1.2964636974917054,0.17467248908296942,0.8656257852418227,1.0,5/15,14.58%,PTCH1;BMP5;BMP7;GATA3;BMPR1A
prerank,mesoderm formation (GO:0001707),-0.4400469045105727,-1.2964273819497742,0.13028169014084506,0.7014977098921191,1.0,4/17,14.46%,ITGA3;BMPR2;KDM6B;HMGA2
prerank,regulation of actin filament-based movement (GO:1903115),0.6313254426433975,1.2961113245133942,0.17884914463452567,0.8653229524754258,1.0,4/10,12.27%,ANK2;PDE4B;SCN5A;PDE4D
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.3675313431573468,-1.2959565912277127,0.10362694300518134,0.6993234384619288,1.0,9/38,13.74%,BMP6;SASH1;ANKRD17;DDX60;PLSCR1;RIOK3;CYBA;USP15;NMI
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.4743311799250045,1.2959497625190446,0.12942612942612944,0.8642763230455129,1.0,13/44,18.78%,WNK2;ANK2;ANO6;WNK3;KCNMB2;KCNMB3;FLNA;AKAP6;KCNJ3;KCNJ10;KCNH2;KCNMA1;NOS1AP
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.4449465013308894,1.295762033951348,0.11731207289293849,0.8632485150393308,1.0,13/70,12.17%,RELN;NTN4;PEAK1;LAMC1;RILPL2;METTL3;MEGF9;NTNG2;NTNG1;UNK;PIK3R1;OPHN1;ANTXR1
prerank,positive regulation of interleukin-2 production (GO:0032743),0.521388482496543,1.2954749455685846,0.17726657645466848,0.862772285417117,1.0,7/25,13.43%,GLMN;PDE4B;CCR2;SPTBN1;RUNX1;PDE4D;MALT1
prerank,negative regulation of immune system process (GO:0002683),0.5631131864839063,1.295050663904332,0.17580872011251758,0.8628829944496558,1.0,4/16,8.09%,SOX9;FADD;HOXA7;COL3A1
prerank,DNA methylation (GO:0006306),0.5222038888793505,1.2946445134991251,0.1636615811373093,0.8628932333554292,1.0,8/23,19.47%,GATAD2A;ATF7IP;ATRX;MTRR;TEX15;HELLS;KMT2E;N6AMT1
prerank,peptidyl-lysine dimethylation (GO:0018027),0.5440666052078725,1.2943321656995828,0.16621253405994552,0.8625327714139104,1.0,6/18,10.06%,SUV39H1;KMT2A;SETD3;SETMAR;SETD2;PRDM9
prerank,regulation of dopamine secretion (GO:0014059),0.5132616733214479,1.2940818190923207,0.15748031496062992,0.8618405264188286,1.0,9/25,13.86%,KCNA2;PRKN;CHRNA4;SYT1;SYT11;SYT12;GDNF;DRD2;SNCA
prerank,regulation of proteolysis (GO:0030162),0.46204521245383096,1.2938550910791804,0.1425206124852768,0.8610376135752161,1.0,11/48,13.83%,TBC1D10A;FADD;PARL;CSTB;SPOP;GSAP;SERPINE2;AURKAIP1;HDAC2;HDAC6;NEDD8
prerank,hydrogen peroxide catabolic process (GO:0042744),0.6064586060824743,1.293432062124414,0.18072289156626506,0.8611649601776225,1.0,4/11,18.53%,PXDN;GPX3;PRDX3;CAT
prerank,neuron apoptotic process (GO:0051402),0.54385534278424,1.292937938693505,0.1774193548387097,0.8614089103550884,1.0,7/19,13.72%,ERBB3;BCL2;SCN2A;NAE1;BNIP3;NGFR;TRPC5
prerank,positive regulation of macrophage differentiation (GO:0045651),0.6227697444350229,1.2927201979538157,0.19186046511627908,0.8605917612510561,1.0,3/11,4.09%,PRKCA;FADD;TGFB1
prerank,chondroitin sulfate metabolic process (GO:0030204),0.5016773546220871,1.292394159948075,0.14058355437665782,0.8602144351853755,1.0,11/30,18.06%,DCN;VCAN;BCAN;CSGALNACT1;CHSY1;NCAN;IDS;CHSY3;UGDH;HYAL1;CSPG4
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.4972481025367937,1.292004111328625,0.14625,0.8601858864913694,1.0,5/31,6.42%,OSR2;PDGFRA;SOX11;HOXD3;TGFBR2
prerank,positive regulation of ossification (GO:0045778),0.4759073048287808,1.2911918496418533,0.1506172839506173,0.8619880597942328,1.0,16/39,15.69%,OSR2;PKDCC;ACVR1;ANO6;GPM6B;TGFB1;SOX11;WNT5A;ZBTB16;PTPN11;BMP7;ATRAID;ATP2B1;BMPR1A;TGFB3;FZD9
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.5031119850846147,1.2907179592421207,0.16129032258064516,0.8623337208711952,1.0,6/26,11.08%,RELN;PTEN;NRXN1;NLGN1;SLC8A2;RIMS1
prerank,substantia nigra development (GO:0021762),0.48410125106690477,1.2901296835218767,0.1569620253164557,0.8632504037590016,1.0,5/37,5.98%,DYNLL1;SYNGR3;NDRG2;PLP1;MAPKAP1
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.6189415771897423,1.2889293031542775,0.2025931928687196,0.8669778608055285,1.0,2/10,4.09%,FAP;TGFB1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.5599212922084947,1.2887979294343481,0.20229555236728838,0.865823334247987,1.0,3/14,12.70%,SLC27A1;SELENOI;ETNK1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.40078867972932336,1.2886076472765617,0.020080321285140562,0.8648578958407744,1.0,78/390,12.82%,ROR2;SIPA1L1;ROR1;MMP2;SHC4;UBASH3B;SULF1;PDGFRA;DNM1;EFNA4;ERBB3;NTRK3;FGF2;FGF10;ARPC1B;IRS2;EPHB6;NGF;ERBB2;EGFR;PTPRT;PTPN2;EFNA5;VEGFA;COL4A2;EPHB2;EIF2AK3;RAB14;MAPKAPK3;ARHGEF28;PSEN1;ATP6V1B2;NCF1;SDC2;NTRK2;MAPKAPK2;PLCB1;GRIN2B;PAK1;POLR2B;RASA1;CHN1;BAIAP2;SPRED2;ITSN1;SPRED1;FGFR1;BRK1;FYN;VAV3;ANKS1B;CEP57;SHOC2;GRB14;POLR2K;DOCK1;SHCBP1;NCBP1;NCF2;PIK3R1;ERBB4;STYK1;PTPRJ;CBL;NCSTN;NGFR;PTPN11;MAPK14;MAPK1;FGF7;EFNB1;CDK5R1;NRP2;ANKS1A;APH1A;EFNB3;COL1A1;PRLR
prerank,regulation of kinase activity (GO:0043549),0.4310971904141175,1.2884248860406888,0.09902067464635474,0.8639221236182029,1.0,14/89,7.52%,ROR2;ROR1;PDGFRA;ERBB3;NTRK3;IRS2;EPHB6;ERBB2;EGFR;NPRL2;EPHB2;NTRK2;VAC14;FGFR1
prerank,toxin transport (GO:1901998),0.6168277234188231,1.288326391451229,0.19484702093397746,0.8625775554137598,1.0,3/10,12.17%,SLC22A3;ANTXR2;ANTXR1
prerank,superoxide anion generation (GO:0042554),0.5941078806657,1.287049145168255,0.1933028919330289,0.8665757786778319,1.0,4/13,10.06%,NCF1;NOX1;TAFA4;NCF2
prerank,skeletal system morphogenesis (GO:0048705),0.47301842396928145,1.2866729473774392,0.14026602176541716,0.8665427455270902,1.0,7/42,9.62%,OSR2;PDGFRA;SOX11;HHIP;HOXD3;FGFR1;SFRP4
prerank,regulation of blood coagulation (GO:0030193),0.5047743090553893,1.2864119333161552,0.1762295081967213,0.8659878950559436,1.0,5/27,7.57%,FAP;ST3GAL4;CD34;EPHB2;SERPINE2
prerank,muscle cell differentiation (GO:0042692),0.4937844841021383,1.285914394318357,0.16020025031289112,0.8663772096405123,1.0,5/32,7.02%,RORA;GLMN;SGCZ;GATA6;TBX18
prerank,negative regulation of protein polymerization (GO:0032272),-0.39694419400014386,-1.285748775099939,0.11659192825112108,0.7289645344382091,1.0,8/27,5.11%,CDH5;MAP2;PRKCD;SLIT2;CLIP3;CYRIB;KANK3;EML2
prerank,positive regulation of neuron migration (GO:2001224),0.6072672629018382,1.2853525833102566,0.1875945537065053,0.8670952270695418,1.0,5/11,20.25%,KIF20B;SEMA3A;PLAA;MDK;SHTN1
prerank,transcription preinitiation complex assembly (GO:0070897),0.5906754186810301,1.2849178836342432,0.1993911719939117,0.8672818031277703,1.0,7/12,27.72%,GTF2B;TAF11;TAF7;TAF1;TBP;DR1;BDP1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.43227316903538493,-1.284388997186504,0.14035087719298245,0.7298063566483944,1.0,8/19,26.83%,MOSPD2;DAPK2;CAMK1D;NCKAP1L;TIRAP;DNM1L;RIPOR2;CCL19
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.4655836237106241,-1.2840649931626642,0.15479876160990713,0.7272784335534387,1.0,3/14,13.34%,ANKRD17;DDX60;USP15
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.5195066244025875,-1.2837050423266645,0.20256410256410257,0.7247256765949146,1.0,5/10,16.23%,BMP6;RGCC;NOTCH4;NEXMIF;PPM1F
prerank,striated muscle cell development (GO:0055002),-0.4651194804989206,-1.2832467703198729,0.16216216216216217,0.7225783189644098,1.0,5/14,20.42%,TMOD3;PGM5;LMOD1;TMOD1;SDC1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.41242459140047383,-1.2826797998497377,0.12015503875968993,0.7207580405575557,1.0,8/23,18.02%,CLK2;SIK1;NUPR1;GSK3A;C1QTNF3;HDAC4;PGP;GIT1
prerank,protein polyglutamylation (GO:0018095),0.5988879994845466,1.2823834460498689,0.19659442724458204,0.8767929769132842,1.0,5/11,14.59%,TTLL5;TTLL11;TTLL4;CFAP20;TPGS1
prerank,cellular response to hormone stimulus (GO:0032870),-0.32222463602732165,-1.2818680716764637,0.09821428571428571,0.7197186539287586,1.0,20/69,19.21%,THRB;ATP1A2;CTSH;TFPI;SLIT2;RAMP1;LMO2;STAT5B;ATP1A1;ZFP36L1;SLC5A5;PELP1;SERPINB9;ADRA2A;SRA1;CAV1;CTSS;ARID5A;GPER1;RARA
prerank,actin cytoskeleton reorganization (GO:0031532),0.44022109908690743,1.281553410054719,0.1319052987598647,0.8788260939258142,1.0,17/63,12.17%,SIPA1L1;CLDN19;FGF10;GSN;GPR65;AUTS2;TNIK;THSD7A;PAK1;MKLN1;PDLIM4;FLNA;THSD7B;FARP2;PTPN1;FGF7;ANTXR1
prerank,detection of calcium ion (GO:0005513),0.5719281516945384,1.2801709940381467,0.19119878603945373,0.8831483377482321,1.0,5/13,15.36%,SYT1;KCNMB2;KCNMB3;CALM1;CALM2
prerank,regulation of cytoplasmic translation (GO:2000765),0.5759426484894824,1.2797610910427817,0.1750358680057389,0.8832239248998672,1.0,7/14,26.12%,UNK;CPEB3;CPEB1;CNBP;YBX3;FMR1;CPEB4
prerank,response to laminar fluid shear stress (GO:0034616),-0.530773308302894,-1.279692030149053,0.19726027397260273,0.7232319781124379,1.0,6/10,8.61%,SMAD6;ABCA1;SMAD7;MAP2K5;KLF2;KLF4
prerank,regulation of cholesterol storage (GO:0010885),-0.4613379874545259,-1.2784219383704223,0.1423841059602649,0.7237939346596599,1.0,7/15,21.36%,ABCA1;PPARD;ABCG1;NR1H2;TTC39B;NR1H3;LPL
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.402793617803884,-1.2782039495764104,0.16,0.721023425472876,1.0,7/24,9.35%,CDH2;BOC;CTNNB1;CDON;BNIP2;CAMK1;MAPK12
prerank,ameboidal-type cell migration (GO:0001667),0.45647134242952886,1.2772251895467308,0.13396004700352526,0.8929787625730818,1.0,16/51,19.18%,GPC3;SOX8;SEMA3E;SEMA6C;SEMA3A;PKN1;ERBB4;GDNF;ANXA6;PDXDC1;SEMA6D;ITGB7;SEMA4B;PKN2;CENPV;SEMA4D
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.49585092304928713,1.2765689201410355,0.1626984126984127,0.8942407954450335,1.0,5/27,7.37%,PDGFRA;MYC;WNT5A;S100A6;CDK6
prerank,T-helper cell differentiation (GO:0042093),-0.4676419132620073,-1.2765133816825789,0.16828478964401294,0.7229940552989357,1.0,3/14,5.21%,FOXP1;LEF1;ATP7A
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.49434852524425504,1.2763414812029106,0.16645807259073842,0.8934361263399175,1.0,9/32,21.10%,CXCL10;AKAP6;SNCA;CALM1;CALM2;APLNR;HTT;PKD2;CEMIP
prerank,neurotransmitter transport (GO:0006836),0.43053210293657773,1.276216480012603,0.12569521690767518,0.8922373352398953,1.0,17/73,17.02%,SLC6A2;SLC22A3;SLC1A3;NRXN1;SLC29A1;SYT1;SYN1;PPFIA2;RIMS1;TSPOAP1;DVL1;RAB3A;APBA1;CHAT;GLS;GLS2;SLC6A15
prerank,brain development (GO:0007420),0.41041994156719314,1.2761905440718748,0.0912863070539419,0.8905950423728378,1.0,24/136,15.74%,APOD;RELN;SOX6;PTCH1;HSPG2;PTEN;NF1;GRIN2B;EML1;CTNNA2;TGFBR2;PHGDH;PAFAH1B3;CNTNAP2;PTPN11;ADGRL3;CDK5R1;PHF8;GRIN2D;GRIN2A;ZFHX2;NES;SCYL2;MEIS3
prerank,positive regulation of immune effector process (GO:0002699),-0.3905098666969906,-1.2757816718253425,0.12280701754385964,0.7215377574943077,1.0,4/27,4.45%,ANKRD17;APPL2;DDX60;RPS19
prerank,protein import into peroxisome matrix (GO:0016558),-0.4838900563986335,-1.2755315383224768,0.18789808917197454,0.7189204972673275,1.0,8/12,27.23%,PEX13;PEX7;PEX14;PEX26;PEX2;PEX10;PEX6;PEX16
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.33018540944658575,-1.2752127292105822,0.07462686567164178,0.7165154188922191,1.0,19/61,17.54%,PRKAG2;PSMD14;AZIN1;OAZ1;PSMB3;PSMD12;PANK2;OAZ2;PSMD6;PSMA1;ODC1;PSMD7;PSMA5;PSMC5;FGFR4;CAV1;PSMC4;PDK2;PSMB6
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.5702679993263203,1.2750734368401635,0.17410714285714285,0.8936661174866855,1.0,5/13,13.58%,DNAJB9;PPP1R15A;UFL1;PTPN1;NCK1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.5870193696040175,1.2749585099491347,0.1893939393939394,0.8923728401071622,1.0,4/13,11.81%,CBFB;SOCS1;TGFBR2;RUNX1
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4702951894566674,1.2748387174927247,0.15233415233415235,0.8911265486053376,1.0,7/40,7.52%,PDGFRA;NTRK3;FGF2;EGFR;LPAR1;NTRK2;FGFR1
prerank,cilium-dependent cell motility (GO:0060285),0.5327625645550135,1.2746274991376232,0.18885869565217392,0.890396399964306,1.0,7/22,17.83%,EFHC1;DNAH2;CCDC39;RFX3;CCDC65;DNAAF2;RSPH9
prerank,protein K11-linked ubiquitination (GO:0070979),0.5053422447256486,1.2742070063500153,0.18592964824120603,0.8904771580999087,1.0,13/27,23.20%,UBE2T;PRKN;UBE2E2;ANAPC7;ANAPC2;CDC23;RNF4;UBE2L3;CDC27;ANAPC4;UBE2D3;ANAPC5;CDC16
prerank,carbohydrate derivative transport (GO:1901264),0.5373116401139166,1.2739274195486188,0.1867043847241867,0.8900010276867798,1.0,3/18,9.60%,SLC28A1;SLC29A1;SLC10A7
prerank,regulation of macrophage differentiation (GO:0045649),0.5787286487625962,1.2735467193232926,0.1793400286944046,0.8899121960169915,1.0,3/15,2.76%,PRKCA;FADD;PTPN2
prerank,synaptic vesicle endocytosis (GO:0048488),0.4786115698080137,1.2733830842951748,0.16455696202531644,0.8888808491104109,1.0,10/33,13.86%,CEL;DNM1;STON2;SYT1;NLGN1;STON1;ITSN1;GAK;OPHN1;SNCA
prerank,positive regulation of calcium ion transport (GO:0051928),0.4807565519775904,1.273277000527155,0.16666666666666666,0.8876295507536699,1.0,4/36,4.22%,LGALS3;ANK2;WNK3;CCL4
prerank,selective autophagy (GO:0061912),0.44596012422724596,1.272919630884634,0.148014440433213,0.8874725837625553,1.0,20/56,22.18%,DYNLL1;PRKN;WDFY3;ACBD5;UFL1;ATG5;DYNC1I1;HDAC6;DYNC1I2;ATM;UBB;RAB7A;NBR1;PARK7;PHB2;PCNT;WDR81;DYNC1H1;UBQLN1;VIM
prerank,serine family amino acid catabolic process (GO:0009071),0.6029503962815966,1.272729668492487,0.21634615384615385,0.8866038165181919,1.0,2/10,5.74%,CBS;DAO
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.46377972898402475,1.2724562724315356,0.15393794749403342,0.886062116151013,1.0,11/48,17.16%,UBASH3B;CXCL10;ANK2;JPH3;AKAP6;PDE4D;PRKACA;SNCA;CALM1;CALM2;APLNR
prerank,negative regulation of secretion (GO:0051048),0.6058316533267969,1.2716864623117616,0.2032,0.8877000369607848,1.0,2/10,3.51%,ERBB3;PTGER3
prerank,microvillus organization (GO:0032528),0.5663606391736761,1.270738342606722,0.1800595238095238,0.8900977182287215,1.0,4/13,7.56%,RAP2B;MAP4K4;TNIK;RAP1A
prerank,response to steroid hormone (GO:0048545),-0.364553457274417,-1.2704308522132222,0.11946902654867257,0.7292575805188476,1.0,11/31,20.73%,ATP1A2;PAQR7;TFPI;THBS1;ATP1A1;PAQR8;TGFB2;CAV1;ABHD2;CATSPER3;NR1H3
prerank,positive regulation of cell killing (GO:0031343),0.5737854086969771,1.2703779479259965,0.19696969696969696,0.8900788997768613,1.0,3/13,7.35%,WNT5A;NOX1;FZD7
prerank,gliogenesis (GO:0042063),0.5461737121564484,1.2701960873362204,0.21408045977011494,0.889141053564709,1.0,3/15,7.37%,RELN;METTL3;CDK6
prerank,positive regulation of interleukin-17 production (GO:0032740),0.5145379853574115,1.269917564757793,0.19642857142857142,0.8887182867726365,1.0,4/22,8.10%,PRKCQ;TGFB1;CARD9;IL18
prerank,sensory perception of pain (GO:0019233),0.5191687041536746,1.2699108908463574,0.18528610354223432,0.8870652583065143,1.0,6/21,16.69%,KCNA2;CHRNA4;CCR2;PTGES;OPRK1;NIPSNAP1
prerank,regulation of response to biotic stimulus (GO:0002831),-0.3826400732079086,-1.2694734461003143,0.12345679012345678,0.7291160813345802,1.0,9/28,10.03%,FOXP1;ERAP1;APPL2;BIRC3;TRIM5;CD55;SAMHD1;CASP8;IRF1
prerank,positive regulation of endocytosis (GO:0045807),0.46091002810530035,1.2691796086458096,0.15956151035322777,0.8885495880168447,1.0,11/45,14.43%,GPC3;SGIP1;BICD1;LRP1;ANO6;NLGN1;RAB21;HIP1;CBL;SNCA;NEDD4L
prerank,anion transport (GO:0006820),0.4831912743068699,1.2682753343444366,0.18879415347137637,0.8908021639055046,1.0,5/33,5.53%,SLC22A3;VDAC2;SLC17A5;LRRC8D;SLCO2B1
prerank,positive regulation of ion transport (GO:0043270),0.4592194096303796,1.2681447321462802,0.16333725029377202,0.889750475780038,1.0,12/48,15.37%,ANK3;ANK2;ANO6;WNK3;CCL4;CNKSR3;SCN5A;GDNF;ATP2B1;DRD2;AHCYL1;PKP2
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5991074013247042,1.267706578581277,0.20916030534351146,0.8899803759736455,1.0,3/10,6.42%,MYC;SOX9;TGFBR2
prerank,digestive tract morphogenesis (GO:0048546),0.5651012851206971,1.2674217841146904,0.21216617210682492,0.889544334360942,1.0,3/14,4.93%,PDGFRA;SOX11;GLI1
prerank,neural tube development (GO:0021915),0.5511190974220221,1.2671225225323512,0.20300751879699247,0.88921783389161,1.0,6/15,15.27%,PTCH1;TGFB1;SOX11;DVL1;PKD1;DACT1
prerank,autonomic nervous system development (GO:0048483),0.5486945919528479,1.2670050314391224,0.19176136363636365,0.8880438299877718,1.0,7/17,13.38%,SOX8;SEMA3A;SOX11;NF1;PHOX2A;GDNF;GATA3
prerank,"base-excision repair, AP site formation (GO:0006285)",0.547275930104797,1.266969780382759,0.20314735336194564,0.8865117096843887,1.0,7/17,16.30%,MBD4;ERCC5;MPG;MUTYH;NEIL1;SMUG1;TERF2IP
prerank,chromatin remodeling (GO:0006338),0.4209071594185907,1.2668729937748873,0.11884368308351177,0.885279926121732,1.0,34/100,20.68%,MYC;KAT2B;SOX9;SATB1;BAZ1A;KDM5B;EZH1;PAK1;KDM4B;MTA2;CHD3;ATRX;MBD2;POLE3;PIH1D1;HDAC2;MYSM1;SMARCC2;ESR1;JARID2;ZBTB1;SMARCC1;BAZ2B;RBBP4;KDM6A;BAZ1B;SMARCE1;PBRM1;NUDT5;RUVBL2;TOP1;SMARCA4;GATAD2B;HNRNPC
prerank,Golgi to plasma membrane transport (GO:0006893),0.4590853931178871,1.2666842285349724,0.15212264150943397,0.8844611315985529,1.0,9/47,7.82%,STXBP6;ANK3;STEAP2;VAMP4;ARL3;BLZF1;OSBPL5;SPTBN1;RAB34
prerank,regulation of endocytosis (GO:0030100),0.43464646088626124,1.2666308065240115,0.13856812933025403,0.883020413635252,1.0,17/61,15.41%,GPC3;LGALS3;LRP1;STON2;PACSIN2;STON1;HIP1;PTPN1;SYT11;MCTP1;OPHN1;RAB4B;SNCA;RAB4A;ARFGAP1;NEDD4L;ABL1
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.5105701079182045,-1.26632260684541,0.17404129793510326,0.7359396118806182,1.0,7/10,29.71%,ATP7A;GIPC1;APPL1;OPN3;CDH3;MFSD12;RAPGEF2
prerank,phasic smooth muscle contraction (GO:0014821),0.62154986408464,1.2661543957065415,0.2021604938271605,0.8834438899194722,1.0,4/10,13.01%,PTGER3;EDN3;GDNF;DRD2
prerank,positive regulation of interleukin-1 production (GO:0032732),0.44831399819594947,1.2650187280725884,0.15550239234449761,0.8867841572002411,1.0,6/51,9.10%,USP50;IL16;PYCARD;WNT5A;TMEM106A;TMED10
prerank,response to estradiol (GO:0032355),0.4895630134096777,1.2649025045603022,0.15943877551020408,0.8856191802019157,1.0,10/31,19.35%,SSTR1;EGFR;TGFB1;ESR1;NRIP1;LCOR;NCOA3;FAM210B;STAT3;RUVBL2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.4915050213913503,1.264762276070656,0.17079530638852672,0.8846257569549696,1.0,4/27,5.38%,PRKCQ;HAS2;PYCARD;CCR2
prerank,regulation of axon regeneration (GO:0048679),-0.492478965886442,-1.2646597009263625,0.17897727272727273,0.7378946605278918,1.0,3/12,7.18%,EPHA4;PTN;SCARF1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.49613902803508925,1.2646411858217739,0.1759379042690815,0.8834942337927792,1.0,8/29,9.70%,GCDH;ACACA;SCD5;FASN;ELOVL6;ACLY;PPT2;ELOVL5
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.5604574863436271,1.2643555638997757,0.21164772727272727,0.8831766309640632,1.0,5/15,15.56%,FAP;LRP1;TGFB1;CLASP1;FSCN1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.38889097564140335,-1.2643107356477628,0.16101694915254236,0.7355610828885236,1.0,4/26,3.13%,DAB2;FOXP1;KANK2;CLOCK
prerank,regulation of focal adhesion assembly (GO:0051893),0.4421469655573325,1.2642582003295095,0.14733178654292342,0.8819357413230178,1.0,14/54,12.91%,APOD;DLC1;PTEN;PEAK1;EFNA5;MAP4K4;VEGFA;GPM6B;TSC1;SLK;PTPRJ;CLASP1;PTPRA;MYOC
prerank,neuron fate commitment (GO:0048663),-0.4577060585824316,-1.2640042877269824,0.18471337579617833,0.7332027120001691,1.0,10/14,45.78%,TGFBR1;ID2;POU3F2;DLL4;DLL1;SHH;POU4F1;PAX6;ASCL1;ISL1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.4357443423729412,1.2638654986481384,0.14675767918088736,0.8819220367587755,1.0,16/69,15.69%,ERBB3;BCL2;CRLF1;NGF;PRKN;NTRK2;MT3;RASA1;HIF1A;SNX6;GDNF;GRN;PTPRZ1;SOD2;TGFB3;FZD9
prerank,regulation of ossification (GO:0030278),0.47726101494236695,1.2633371332850658,0.1643835616438356,0.8825889307685777,1.0,9/36,10.88%,ANKH;LRP4;SOX9;ACVR1;SOX11;WNT5A;ZBTB16;CHSY1;PTPN11
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.5517162187712153,1.2631946801692169,0.18758620689655173,0.8815746911498721,1.0,3/17,5.68%,CACNA2D1;ANK2;SCN5A
prerank,histone H4-K8 acetylation (GO:0043982),0.5553933713749499,1.2630956816266166,0.19584569732937684,0.8787848740357476,1.0,9/15,23.61%,JADE1;JADE3;KAT8;PHF20;ING4;KANSL1;MCRS1;KANSL2;KAT7
prerank,histone H4-K5 acetylation (GO:0043981),0.5553933713749499,1.2630956816266166,0.19584569732937684,0.8787848740357476,1.0,9/15,23.61%,JADE1;JADE3;KAT8;PHF20;ING4;KANSL1;MCRS1;KANSL2;KAT7
prerank,cellular response to cytokine stimulus (GO:0071345),0.39062144122358755,1.2629792452759225,0.025025025025025027,0.8776522815003629,1.0,87/416,17.63%,RORA;CCL11;MMP2;ADAMTS12;IL16;CXCL10;HAS2;IL2RA;FGF2;PYCARD;MYC;BCL2;SOX9;IL20RB;CRLF1;IL1RAPL1;PTPRT;PTPN2;EPRS1;VEGFA;NPR2;IRAK3;SOCS5;TEC;TGFB1;CCL4;ZEB1;IL1RL2;NUMBL;PTPN13;WNT5A;AQP4;CCR2;SLC12A2;SOCS1;YWHAZ;RORC;CSK;CSF3R;GAB2;IL18;FYN;ERBIN;BRCA1;UBE2K;STK39;COL1A2;ZFP36L2;HIF1A;NDN;PIK3R1;PTPRJ;CBL;TYK2;NFE2L2;PTPN11;AKAP6;PID1;IL6ST;UPF1;TBK1;PTPN18;PTPRZ1;PRKACA;PRLR;HSP90B1;GATA3;SHPK;KHSRP;TXLNA;ZFAND6;ITGB1;CCL14;UBB;FSCN1;BCL2L11;TP53;PNPT1;NDUFA13;IL1RAP;HYAL1;HNRNPU;LBP;RIPK1;CHUK;RC3H1;SELPLG
prerank,ganglioside biosynthetic process (GO:0001574),-0.45383890580260977,-1.2611880738066978,0.16943521594684385,0.7392236269312612,1.0,3/15,5.14%,ST6GALNAC3;ST8SIA4;ST3GAL1
prerank,platelet aggregation (GO:0070527),0.47414110152720845,1.2607831624374788,0.18124207858048164,0.885449101441163,1.0,4/33,2.65%,UBASH3B;PDGFRA;CSRP1;RAP2B
prerank,aorta morphogenesis (GO:0035909),-0.4324744565551484,-1.2607529007875844,0.17981072555205047,0.7372763098141337,1.0,9/17,15.09%,ACVRL1;ENG;MYLK;TBX1;EFEMP2;JAG1;PDGFRB;PROX1;HEY2
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.4173371634561351,1.260454915542876,0.11267605633802817,0.8852899685909844,1.0,27/93,21.33%,DOCK7;NTRK3;PTEN;NGF;EGFR;VEGFA;ARAF;TGFB1;CNKSR3;PAK1;MLXIPL;EIF4G1;HDAC6;PDE4D;TBK1;NCK1;SNCA;SH2D3C;RASSF2;TERF2IP;RPTOR;FNIP1;PARK7;INPP5J;BCAR3;PRKD2;NSD1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.5240360706821637,1.2599864208460567,0.1956521739130435,0.8841640703674192,1.0,9/21,16.94%,GTF2H2;ERCC5;ERCC4;DDB2;RPA3;XPA;DDB1;RPA2;CUL4B
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.5240360706821637,1.2599864208460567,0.1956521739130435,0.8841640703674192,1.0,9/21,16.94%,GTF2H2;ERCC5;ERCC4;DDB2;RPA3;XPA;DDB1;RPA2;CUL4B
prerank,ceramide transport (GO:0035627),-0.47975825856819465,-1.2599227074747186,0.1651376146788991,0.7366468288624298,1.0,5/12,25.87%,PLTP;GLTP;ABCB4;CERT1;PLEKHA8
prerank,regulation of interleukin-1 production (GO:0032652),-0.46093814203371897,-1.2598367314938914,0.1737704918032787,0.7335170186425162,1.0,4/15,17.25%,FOXP1;TLR4;CEACAM1;ANXA1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.47080936390796185,1.2596078253586234,0.18686868686868688,0.8842236869242304,1.0,6/35,10.53%,SGIP1;BICD1;MKLN1;RAB21;HIP1;CBL
prerank,regulation of axonogenesis (GO:0050770),0.44433392564205054,1.2592129272266068,0.1736111111111111,0.8844335297005976,1.0,10/51,6.06%,SIPA1L1;CHODL;LRP4;PTEN;NGF;PLXNC1;NTRK2;LRRC4C;PAK1;CHN1
prerank,magnesium ion transport (GO:0015693),0.5750672400810011,1.2587828997422637,0.22565687789799072,0.8846461072537996,1.0,5/12,13.59%,MRS2;NIPA1;NIPAL2;MAGT1;TUSC3
prerank,negative regulation of defense response (GO:0031348),0.42024918744098655,1.258566851377064,0.14942528735632185,0.8839689786907554,1.0,9/77,9.62%,RORA;FFAR4;PTPN2;IRAK3;MAPK7;TNFAIP8L2;OTULIN;PPM1B;SELENOS
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.41333134713558356,-1.257592281499929,0.16541353383458646,0.7377832079330996,1.0,8/20,21.36%,ROCK2;ROCK1;FHOD1;RHOQ;NCKAP1L;IKBKB;LLGL2;LCP1
prerank,regulation of dendrite morphogenesis (GO:0048814),0.47851974988476587,1.2575429712132817,0.19307589880159787,0.8868227722558614,1.0,8/32,9.06%,GORASP1;IL1RAPL1;SDC2;OBSL1;TNIK;CDKL5;CDKL3;ADGRB3
prerank,cognition (GO:0050890),0.45920912904275646,1.2574410018645366,0.15598548972188633,0.8856231388530247,1.0,14/42,14.87%,ST3GAL4;CHRNA4;NF1;RP9;GPR155;SLC8A2;NSUN5;MGAT3;GRM5;MAGT1;SETD5;CBR3;TUSC3;CYFIP1
prerank,spermatid development (GO:0007286),0.4784989402307677,1.2568535286103848,0.18216080402010051,0.8866104688910076,1.0,7/32,15.15%,RSPH1;RFX2;CEP57;CDYL;DDX25;NECTIN2;DPY19L2
prerank,cell-cell junction assembly (GO:0007043),0.43802208043790675,1.2561186211785205,0.16819221967963388,0.8881861136304514,1.0,17/63,16.05%,DCHS1;CDH19;PRKCA;CDH10;CDH22;CDH8;PATJ;EPB41L3;CDH20;CDH7;RHOC;FBF1;CD9;JUP;PKP2;FSCN1;CDH18
prerank,heterochromatin assembly (GO:0031507),0.5189845770880144,1.2557964563883146,0.21709633649932158,0.887980305198509,1.0,6/20,11.17%,SUV39H1;EZH1;ZNFX1;MBD2;POLE3;HELLS
prerank,negative regulation of bone remodeling (GO:0046851),0.5829857251098122,1.2554990773772192,0.20958083832335328,0.8876355558826701,1.0,1/11,0.54%,UBASH3B
prerank,cholesterol homeostasis (GO:0042632),0.4337830163461644,1.2552472000249915,0.15358361774744028,0.887092361526466,1.0,11/64,16.45%,RORA;NPC1;CYP39A1;IL18;MTTP;CYP7B1;ABCA5;LIPC;GRAMD1B;TMEM97;ABCG4
prerank,heart development (GO:0007507),0.4073165661965382,1.2541274991226614,0.08762886597938144,0.8901491168117774,1.0,33/150,15.54%,GPC3;DLC1;BMP5;ERBB3;NTRK3;GLI2;PTEN;KAT2B;SOX9;AKAP13;ACVR1;SGCD;VEGFA;TGFB1;NF1;SGCZ;FGF12;TGFBR2;COL3A1;PDLIM4;ERBB4;SCUBE1;PTPN11;DAND5;BMP7;SMYD4;ZFPM2;KDM6A;LDB3;PKD1;CITED2;PKP2;NDUFV2
prerank,acetyl-CoA metabolic process (GO:0006084),0.5481260260264816,1.2540778187436508,0.21311475409836064,0.8887629412633139,1.0,6/15,17.90%,ACACA;ACSS1;ACLY;DIP2A;PPCS;HMGCS2
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.5092664154792388,1.2539045142089686,0.20713305898491083,0.8879244303702467,1.0,12/22,25.53%,DDX11;ERBB2;EIF2AK3;HEATR1;PIH1D1;PHF8;DHX33;SMARCA4;UBTF;WDR75;MTOR;SMARCB1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.563085967705782,1.2537805186425637,0.2223950233281493,0.8868786576021829,1.0,8/12,24.81%,BICD1;PCM1;BICD2;CCDC120;KIF3A;NIN;HOOK3;BBS4
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5288315116617656,1.253597838097025,0.21288515406162464,0.8861078483669533,1.0,5/18,9.09%,RHOJ;FGF2;VEGFA;MAP3K3;AKT3
prerank,dicarboxylic acid metabolic process (GO:0043648),0.4552544447875346,1.2535051635702408,0.1511216056670602,0.884949737236857,1.0,11/52,15.39%,AADAT;IDH2;DLST;ALDH1L1;GOT2;MTRR;ACLY;MTHFD2L;ALDH5A1;GPT2;ALDH1L2
prerank,negative regulation of leukocyte migration (GO:0002686),0.6079892523029611,1.2531633575246584,0.22776911076443057,0.8848208772946616,1.0,2/10,3.05%,BMP5;HOXA7
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.4744436303567064,1.2526792571929646,0.17797695262483995,0.8853950899264496,1.0,5/32,3.27%,RHOJ;MEOX2;FGF2;VEGFA;MAP3K3
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.49138964223812914,1.252130530791822,0.18613607188703465,0.8861655101974895,1.0,10/29,16.94%,RAD23B;GTF2H2;ERCC5;DDB2;RPA3;XPA;DDB1;RPA2;UBB;CUL4B
prerank,regulation of mononuclear cell migration (GO:0071675),0.5013469723250183,1.2519052702079632,0.20911528150134048,0.8855954842716627,1.0,2/23,0.52%,LGALS3;BMP5
prerank,mononuclear cell differentiation (GO:1903131),-0.399643018849339,-1.251728092133339,0.13409961685823754,0.7536241443214714,1.0,5/24,4.49%,IL31RA;MYH9;BMP4;LYN;RELB
prerank,sterol homeostasis (GO:0055092),0.4315058576625826,1.2512614582406294,0.15209988649262202,0.8868035029555744,1.0,11/65,16.45%,RORA;NPC1;CYP39A1;IL18;MTTP;CYP7B1;ABCA5;LIPC;GRAMD1B;TMEM97;ABCG4
prerank,negative regulation of cellular protein localization (GO:1903828),-0.3658533912343364,-1.2511096917931572,0.13744075829383887,0.7522083006983729,1.0,11/34,9.48%,ROCK2;LZTFL1;MFHAS1;TTBK2;LATS2;COMMD1;LEPROTL1;ACTN2;GSK3B;GOPC;FLCN
prerank,regulation of interleukin-17 production (GO:0032660),0.4780557562687605,1.2510572913286848,0.21188630490956073,0.8861349175828408,1.0,5/31,8.10%,PRKCQ;TGFB1;PRNP;CARD9;IL18
prerank,interstrand cross-link repair (GO:0036297),0.45036009818211953,1.2509404625599074,0.16209773539928488,0.8851405910946605,1.0,13/53,16.74%,UBE2T;POLN;ERCC4;RPA3;XPA;FANCC;MSH6;ERCC6L2;XRCC3;RPA2;UBB;USP1;FANCI
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.4817242703115491,1.2506159636239171,0.1855146124523507,0.8849441074569667,1.0,10/33,11.81%,CBFB;RNF6;PKN1;UFL1;UFSP2;CARM1;NCOA2;ESR1;HDAC6;RUNX1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.28253540583964026,-1.249207493805315,0.03571428571428571,0.7549915819501405,1.0,33/128,14.55%,BMP6;PTPRK;GCNT2;SMAD6;CDH5;CLDN5;APPL2;ITGB5;ACVRL1;SMAD7;BMP4;ENG;ID1;USP9X;SMAD9;BMPR2;TGFBR1;PARD3;DDX5;TWSG1;ACVR1B;STUB1;PRKCZ;RHOA;NLK;LRRC32;MAP3K7;TGFB2;USP15;INHBA;TMEM100;GDF1;HPGD
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.4739643352029393,-1.2491085822553378,0.2054380664652568,0.7518894612300316,1.0,3/13,9.65%,ETS1;NFAT5;RHOA
prerank,endosome organization (GO:0007032),0.46627926290075056,1.2490476724530994,0.17604790419161676,0.8900311500169554,1.0,10/41,13.15%,USP50;DNM1;ALS2;LAPTM4B;VPS11;PI4K2A;SNX10;RAB22A;PHETA2;AKTIP
prerank,pentose-phosphate shunt (GO:0006098),0.5893322609046023,1.2488949926496622,0.22801788375558868,0.8891122319045075,1.0,8/11,26.02%,H6PD;RPE;SHPK;PGLS;TALDO1;RBKS;RPIA;PGM2
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.5000628286327004,-1.2486651343106492,0.2198952879581152,0.750133647125863,1.0,3/11,7.19%,AFDN;TJP1;TJP2
prerank,negative regulation of cell differentiation (GO:0045596),0.3965486522652413,1.2484877196422404,0.08469387755102041,0.8892925132147549,1.0,31/181,13.38%,RORA;PTCH1;SOSTDC1;BMP5;ADAMTS12;EFEMP1;SOX8;PTEN;HOXB8;SOX9;EGFR;COL5A2;PTHLH;TGFB1;WNT5A;SPRED2;ZBTB16;SPRED1;TWIST2;CDK6;MEN1;ZFP36L2;SPRED3;PTPN11;ABCA5;BMP7;ZFPM2;WWTR1;EID2B;TRIO;GATA3
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.5197685204607585,1.2480878356527305,0.2254335260115607,0.8894154646194029,1.0,8/18,18.64%,PRKN;MAPK7;BAG5;HIF1A;NFE2L2;SOD2;TRAP1;PARK7
prerank,embryonic digit morphogenesis (GO:0042733),0.5346895682043694,1.2479385057739008,0.2034139402560455,0.8884890308994812,1.0,2/18,1.92%,OSR2;WDPCP
prerank,regulation of macrophage cytokine production (GO:0010935),0.5584702304945689,1.2476050004908084,0.21190130624092887,0.888468332597975,1.0,4/13,5.26%,IRAK3;GPRC5B;TGFB1;WNT5A
prerank,positive regulation of MAPK cascade (GO:0043410),0.3906087105460664,1.246667692797404,0.06161616161616162,0.8909150947571373,1.0,38/245,11.59%,ROR2;CCL11;FFAR4;ROR1;PRKCA;PDGFRA;GLIPR2;NTRK3;FGF2;PYCARD;FGF10;PTPN22;GAREM1;ERBB2;EGFR;LPAR1;VEGFA;FBXW7;TGFB1;CCL4;NTRK2;MT3;TMEM106A;ALKAL2;KSR1;CARD9;ACKR3;FGFR1;RAP1A;EDN3;HTR2C;ERBB4;PTPRJ;GPR37;PTPN11;MTURN;TAOK3;ARL6IP5
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.30062394088734673,-1.2466464224916134,0.08888888888888889,0.7534711948117955,1.0,25/75,19.73%,GRK5;ROCK2;CAMKMT;ROCK1;ZDHHC3;RGS3;RGS5;MGRN1;GNG7;GRK4;MGLL;ZDHHC7;KCTD8;CAMK2A;RGS4;RGS12;FNTB;RPGRIP1L;FRMPD1;EDN1;GIT1;RGS6;GPER1;NMT1;ADCYAP1
prerank,vesicle organization (GO:0016050),0.45805276560292263,1.2466055355262906,0.16963226571767498,0.889652933255123,1.0,12/46,13.15%,USP50;DNM1;CD34;ALS2;LAPTM4B;EPS15;VPS11;PI4K2A;SNX10;RAB22A;PHETA2;AKTIP
prerank,regulation of B cell proliferation (GO:0030888),0.4538975680630142,1.2465354485431488,0.17454545454545456,0.8884463494928567,1.0,10/44,17.51%,BCL2;IRS2;BST1;EPHB2;CD320;VAV3;AHR;ATM;CD74;RC3H1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.5853278431773503,1.2458595298204072,0.23203592814371257,0.8898554686924603,1.0,3/11,7.97%,PTPRT;SOCS1;NF2
prerank,microvillus assembly (GO:0030033),0.5515586932092383,1.2457805137146203,0.19826338639652677,0.8886460589135818,1.0,4/14,7.56%,RAP2B;MAP4K4;TNIK;RAP1A
prerank,receptor recycling (GO:0001881),-0.5138863776490529,-1.245308969650208,0.2134502923976608,0.7546666356814853,1.0,9/10,32.10%,RAB11B;EHD3;NSG1;PHETA1;ARFGEF2;PLEKHJ1;REP15;LMTK2;SORL1
prerank,amyloid-beta metabolic process (GO:0050435),0.5353829443188856,1.245059340391997,0.2019774011299435,0.890232662439204,1.0,6/16,14.33%,BACE2;PSEN1;MGAT3;NCSTN;APH1A;PSEN2
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5491013990098594,1.2442882889059192,0.22205663189269748,0.8919452708370144,1.0,5/15,12.61%,ERBB2;EGFR;MVB12B;PTPN18;MVB12A
prerank,regulation of sprouting angiogenesis (GO:1903670),0.4738780143721149,1.2436887017860867,0.20306513409961685,0.8929257220027728,1.0,5/33,5.33%,RHOJ;CREB3L1;FGF2;VEGFA;E2F2
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.41394745052311566,1.243228456535274,0.1456736035049288,0.8932972222253942,1.0,17/86,11.39%,RELN;FGF10;BST1;EGFR;RAP2B;ACVR1;EFNA5;VEGFA;CADM4;TEC;TGFB1;PRNP;SAMSN1;FYN;PTPRJ;PTPN11;FGF7
prerank,cell projection organization (GO:0030030),0.4806825149283952,1.2431559499230844,0.20915032679738563,0.8920644339060558,1.0,10/30,20.54%,RHOJ;GSN;PACSIN2;RHOH;P2RY12;CYFIP1;ITGB1;RAC3;NCKAP1;RHOU
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.49214569812388614,1.2431010767000485,0.21693121693121692,0.8907917576031235,1.0,9/26,18.07%,PRKCA;CCDC57;ASNS;CUL3;CDC25B;SMOC2;USP2;MDM2;PKN2
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.5474855899066704,1.2427829285577763,0.22347949080622348,0.8906194001106884,1.0,3/15,3.61%,PIEZO2;LHFPL5;KCNA1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.43005493784756377,1.241660008920956,0.15296803652968036,0.8939285495838808,1.0,20/68,21.33%,ADSS1;THEM4;PTHLH;OXSM;NT5C2;ACOT11;BPNT1;PDE9A;ACLY;BPNT2;ACSF2;HINT1;AK3;OPA1;ACSL6;GPAT4;GLYAT;DBI;ACOT8;ACBD6
prerank,cell-substrate junction assembly (GO:0007044),0.4705595996334087,1.2409025074448032,0.19186785260482847,0.895691128659834,1.0,7/33,9.30%,DLC1;RHOD;PEAK1;LAMC1;TESK2;PLEC;TRIP6
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.47408585263082725,1.2405572000248484,0.20742637644046094,0.8956443030436304,1.0,7/29,10.88%,FADD;PTPN2;WNT5A;METTL3;UBE2K;PTPN1;PTPN11
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.4030037152842179,-1.2403669858124824,0.22743682310469315,0.7679271619542645,1.0,4/20,8.82%,DAB2;LZTFL1;NUMB;RHOQ
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.41433315999507503,1.2400201153713257,0.1657397107897664,0.896388682269384,1.0,15/79,16.32%,SOSTDC1;ADAMTS12;SULF1;CREB3L1;FGF2;HTRA3;CADM4;SHISA2;PTPN1;DAND5;GPC1;BMPER;BMPR1A;VWC2;LRP2
prerank,DNA biosynthetic process (GO:0071897),-0.4337297473217109,-1.2397754183335297,0.19343065693430658,0.7664335374118341,1.0,11/16,34.26%,POLD3;PPIA;POLH;POLA1;TERT;RFC3;POLD2;POLE;POLD4;POLD1;POLL
prerank,isotype switching (GO:0045190),0.6012624047222913,1.2395284646415168,0.23380726698262244,0.8971273461188926,1.0,6/10,27.35%,MSH6;BATF;HSPD1;EXOSC3;LIG4;RNF168
prerank,regulation of smooth muscle contraction (GO:0006940),0.5083894499890103,1.2391529114208557,0.21721854304635763,0.897329878684508,1.0,5/20,16.82%,CHRM3;SETD3;NMU;ATP2B1;CTTN
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.44697417968770725,-1.238902371016072,0.18769230769230769,0.7659323129371274,1.0,6/14,26.19%,MOXD1;ALDH9A1;NOS1;DAGLA;SLC22A2;DAGLB
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.5219274140390012,1.238864934484559,0.21408045977011494,0.897035977205703,1.0,7/18,14.36%,ERBB2;EIF2AK3;FLNA;HEATR1;POLR2K;PHF8;DHX33
prerank,phospholipid transport (GO:0015914),-0.3233418248878087,-1.2385709698728855,0.12056737588652482,0.763567478875062,1.0,22/52,20.17%,OSBPL8;ATP10A;ABCA3;ABCA1;PLTP;PITPNA;ATP9A;ABCA4;OSBPL2;TNFAIP8L3;ABCG1;ATP11A;ATP8B2;ATP11B;MFSD2A;ABCB4;ATP8A1;PRELID2;ATP10B;ABCA7;APOE;PCTP
prerank,zinc ion transmembrane transport (GO:0071577),-0.3998946657152343,-1.2384244644738647,0.1510791366906475,0.760728205648692,1.0,10/22,26.72%,SLC30A10;SLC39A8;SLC30A1;SLC39A6;SLC30A6;SLC39A3;SLC39A10;TRPM2;SLC39A13;SLC39A1
prerank,MAPK cascade (GO:0000165),0.388433074221752,1.2381088176154962,0.05628140703517588,0.8988095728814482,1.0,53/295,11.92%,GFRA1;PDGFRA;ERBB3;PRKCQ;IL2RA;FGF13;FGF2;MYC;FGF10;IRS2;SOX9;ERBB2;EGFR;GFRA4;MAP4K4;MAP3K3;ARAF;TGFB1;MAPKAPK2;MT3;NF1;GRIN2B;DUSP6;TNIK;SPTBN1;DLG2;PAK1;SYNGAP1;RASA1;KSR1;SPRED1;FGFR1;MEN1;RGL1;LYPLA1;IL18;FYN;LAMTOR2;BTC;SHOC2;PSMB7;ZFP36L2;CUL3;PIK3R1;ARL2;MRAS;ERBB4;GDNF;MAPK1;CCM2;FGF7;TAOK3;PTPRA
prerank,positive regulation of interferon-gamma production (GO:0032729),0.44299515299972214,1.2372375714368997,0.1835518474374255,0.9010248778463885,1.0,8/48,12.71%,PYCARD;PTPN22;FADD;PDE4B;CCR2;IL18;PDE4D;SCRIB
prerank,regulation of myotube differentiation (GO:0010830),-0.3871567940664285,-1.2367079921519426,0.15151515151515152,0.7629569567445278,1.0,9/24,23.27%,SIK1;MAML1;HDAC4;ATP11A;TMEM119;DMPK;HDAC3;SMYD1;HDAC5
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.48348621706240047,-1.2364784886461497,0.20496894409937888,0.7604306570124217,1.0,7/12,23.84%,CYP26B1;KLF2;SNW1;CNOT1;TRIM16;CTBP2;CALR
prerank,protein methylation (GO:0006479),-0.33876830082129306,-1.2358375286492984,0.1407035175879397,0.7592496115127789,1.0,15/40,14.85%,CAMKMT;GSPT1;PRMT7;FAM98A;ATPSCKMT;NTMT1;METTL21A;SNRPD3;PRMT2;PRMT5;NSD3;LCMT1;PRMT8;PCMT1;SNRPB
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.48672198542350714,1.2358118575171375,0.21372031662269128,0.905500735375738,1.0,6/26,10.88%,GAREM1;SOX9;ERBB2;EGFR;ZFP36L2;PTPN11
prerank,alcohol catabolic process (GO:0046164),0.5875447139125771,1.2355852707613588,0.25535168195718655,0.9050353746461254,1.0,3/10,14.19%,CEL;MT3;CYP27A1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.4362455977272382,1.235493256149975,0.17951668584579977,0.9039234397941532,1.0,22/56,23.82%,FGF10;EGFR;UBE2E2;PLCB1;ADAMTS1;CUL3;EIF4G1;ANAPC7;CDC25B;CDC23;CCND2;HYAL1;FBXO5;RPTOR;KMT2E;CDC27;RDX;PHB2;ANAPC4;ANAPC5;CDC16;RB1
prerank,inflammatory response (GO:0006954),0.38854044320647946,1.2350257047251911,0.09827760891590678,0.9044885537515935,1.0,21/195,10.77%,CCL11;HSPG2;CXCL10;CRH;IL2RA;TAC1;HRH1;PTGER3;NFX1;TGFB1;CCL4;PTGFR;MAPKAPK2;CCR2;NOX1;LOXL3;IL18;PXK;NFATC3;TLR1;SCUBE1
prerank,myeloid leukocyte differentiation (GO:0002573),-0.3129405792498112,-1.2349808501267603,0.12605042016806722,0.7590328483095268,1.0,16/65,14.52%,FOXP1;LEF1;KIT;IL31RA;MYH9;BMP4;GLO1;TNFRSF11A;PARP1;SBNO2;CASP8;CAMK4;OSTM1;PML;CDC42;CDK2
prerank,postsynaptic membrane organization (GO:0001941),0.5356870280982481,1.2349308502179088,0.23922114047287898,0.9033827670354079,1.0,5/17,8.74%,CEL;LRP4;NRXN1;NLGN1;LHFPL4
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4350901996324431,1.2347105304428392,0.16705607476635514,0.9028222788014314,1.0,12/52,12.61%,LGALS3;LRP1;GPSM2;EGFR;EPHB2;WNK3;SPTBN1;DPP10;ZDHHC8;PIK3R1;EPB41L2;GNAI1
prerank,regulation of myeloid cell differentiation (GO:0045637),0.42416630321038723,1.234630326064483,0.18255813953488373,0.9016990612803083,1.0,11/62,11.81%,LGALS3;PRKCQ;CBFB;HOXB8;KAT2B;KMT2A;ZBTB16;CDK6;EIF6;PRMT1;RUNX1
prerank,histone H3-K4 methylation (GO:0051568),0.49369219640099216,1.2342519081997798,0.2204515272244356,0.9017574708443002,1.0,11/26,20.30%,KMT2A;CXXC1;SETMAR;MEN1;PRDM9;KDM6A;WDR5B;TET3;ASH2L;SETD4;KMT2D
prerank,regulation of lipase activity (GO:0060191),0.5569602062465278,1.2335464290964457,0.23328380386329867,0.9032224944359735,1.0,5/13,13.86%,PCSK6;LMF1;LIPC;RHOC;SNCA
prerank,regulation of endothelial cell migration (GO:0010594),-0.2900718189768992,-1.2331603237158355,0.07368421052631578,0.761738866472216,1.0,16/85,4.45%,FOXP1;ANXA3;PTPRM;SP100;PTN;ROCK2;SASH1;ETS1;TEK;NRP1;ANGPT1;ACVRL1;BMP4;SLIT2;BMPR2;KDR
prerank,regulation of osteoblast differentiation (GO:0045667),-0.29550832133445554,-1.2331573492377308,0.0958904109589041,0.7585158430819443,1.0,17/82,8.75%,BMP6;RANBP3L;CRIM1;SMOC1;IGF1;WNT4;SMAD6;LRP5;TMEM64;BMP4;NOCT;BMPR2;SUCO;ZHX3;DDX5;FGFR2;CCN1
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.3965041357545445,-1.2329448593849737,0.1856060606060606,0.7559683015142311,1.0,4/21,7.34%,MTUS1;IL34;THBS1;AKIRIN1
prerank,protein K48-linked deubiquitination (GO:0071108),0.501746756118135,1.2326722804677221,0.22479564032697547,0.9053029319019539,1.0,8/23,19.36%,USP50;OTUD7B;USP33;USP25;USP37;OTUD4;OTUD7A;USP5
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.4298971952421822,-1.2322850678494086,0.1834862385321101,0.7549655023493418,1.0,2/17,5.85%,PLA2G4A;CRLS1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.5695374434757421,1.231667660044819,0.23401162790697674,0.9080146827046077,1.0,5/12,14.31%,SETMAR;NAE1;STK33;ORC1;TOPBP1
prerank,actin filament organization (GO:0007015),-0.268397147054003,-1.2314822062834265,0.0,0.7544659569907972,1.0,41/151,15.73%,NEBL;CGNL1;RHOBTB1;BAIAP2L1;TMOD3;TPM3;MYO1D;NEDD9;WASL;ARHGAP17;SHROOM4;SHROOM3;TPM1;ACTN1;FHOD1;BCAR1;INPPL1;VILL;EPS8;MYO1E;RHOA;DSTN;ABI2;ARPC4;EVL;EFS;PROX1;CDC42EP2;WHAMM;MYO5B;MYO1C;GAS2;CDC42;SHROOM2;LMOD1;AVIL;TPM2;MPRIP;TMOD1;HIP1R;TRPV4
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5129141732007508,1.2314001447892682,0.2216142270861833,0.9076424603321753,1.0,9/21,18.64%,PRKN;MT3;BRCA1;HDAC6;ABCD2;PAX2;TRAP1;AATF;PARK7
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.4898618790282092,1.231126123711693,0.21944809461235218,0.9073201293550245,1.0,11/25,22.95%,FGF13;ANK2;DSG2;CTNNA3;TBX18;CALM1;JUP;PKP2;NOS1AP;CAMK2D;TRPM4
prerank,cytoskeleton organization (GO:0007010),0.4049716731199556,1.2307555522883722,0.13782051282051283,0.9074394147581164,1.0,24/114,13.89%,CCL11;ANK1;RHOD;WDPCP;RND3;FGD4;RHOBTB3;PAK4;FMNL2;MAST2;PACSIN2;PAK5;OBSL1;TNIK;PDZD8;BIN1;EPB41L3;PALLD;ZMYM6;RHOC;RHOH;SH3KBP1;NECTIN2;ARHGAP4
prerank,signal peptide processing (GO:0006465),0.5808768285289895,1.2302034735726999,0.23868954758190328,0.9082361034293518,1.0,3/11,8.97%,HM13;PARL;SPCS3
prerank,regulation of lipid metabolic process (GO:0019216),0.4082082609541781,1.2284467430074568,0.1739606126914661,0.9142843665738126,1.0,16/88,11.12%,RORA;IRS2;NCOA1;C1QTNF2;SQLE;ACACA;IDI1;RORC;FASN;ELOVL6;CARM1;NCOA2;CHD9;TGS1;SIN3B;SP1
prerank,monocarboxylic acid transport (GO:0015718),-0.32422240126665053,-1.2281512115397204,0.1357142857142857,0.7621132927552398,1.0,10/51,5.09%,SLCO3A1;ABCC4;ABCG2;SLC16A12;SLC16A6;SLC6A12;SLCO2A1;SLCO1C1;SLC6A13;SLC16A11
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.4288362110912218,1.227944798051544,0.17321016166281755,0.9148443244524915,1.0,12/61,8.95%,FGF10;IRS2;NGF;AKAP13;LPAR1;MAP4K4;GPR65;AUTS2;ALS2;COL3A1;ERBIN;SHOC2
prerank,positive regulation of telomere maintenance (GO:0032206),0.4766743159692207,1.2273978856360312,0.22791293213828426,0.9157000132370183,1.0,14/31,26.30%,PRKCQ;ATRX;MAPK1;SIRT6;NEK7;MAP3K4;RTEL1;ATM;RAD50;GNL3;PKIB;SLX4;HNRNPA2B1;NABP2
prerank,ether lipid biosynthetic process (GO:0008611),-0.4971956104570043,-1.226761481550462,0.22865853658536586,0.7636246398769747,1.0,4/10,8.43%,PLA2G4A;PEX7;DHRS7B;GNPAT
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.4823858893906765,1.226542273340605,0.20081967213114754,0.9177318428572832,1.0,8/26,12.96%,PRKN;MAPK7;FBXO7;FYN;BAG5;GPR37;NFE2L2;SOD2
prerank,response to copper ion (GO:0046688),0.49763926973715666,1.2257763105071948,0.21937321937321938,0.9194838621595139,1.0,12/20,28.53%,PRNP;MT3;AOC1;SNCA;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,negative regulation of T cell proliferation (GO:0042130),0.47838001619262827,1.2256059867572906,0.2251655629139073,0.9187343120168645,1.0,5/28,12.71%,GLMN;PRNP;SDC4;IL4I1;SCRIB
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.48585275635915737,1.2254328586298986,0.20794701986754968,0.9179763258239236,1.0,9/29,11.81%,CBFB;PAK1;UFL1;UFSP2;BRCA1;CARM1;VPS11;ESR1;RUNX1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.5126374834301765,1.2250608900508615,0.22349570200573066,0.9180057884486774,1.0,1/19,0.31%,FFAR4
prerank,outflow tract septum morphogenesis (GO:0003148),-0.3875114073929791,-1.2247591899508152,0.21912350597609562,0.7670921092731203,1.0,8/24,8.46%,ROBO1;SMAD6;NRP1;BMP4;ENG;BMPR2;FGFR2;TBX1
prerank,histone mRNA metabolic process (GO:0008334),-0.3795584055102341,-1.2247015233842393,0.20416666666666666,0.7641582403956049,1.0,12/27,15.46%,XRN1;LSM1;MTPAP;ERI1;SLBP;DCP2;CPSF2;SNRPD3;TUT7;SNRPE;SNRPB;EXOSC10
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.46129877288719645,-1.2244586015807306,0.2054380664652568,0.7618192132399566,1.0,4/13,7.80%,ZC3HAV1;MOV10;CNOT1;GTPBP1
prerank,granulocyte differentiation (GO:0030851),-0.42496751692592694,-1.2242152088365132,0.20504731861198738,0.7594180710626164,1.0,7/18,19.21%,LEF1;LBR;PML;CDK2;CDK4;TAL1;RARA
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.4505973312838255,1.2237816717652819,0.21717791411042944,0.9219879756082274,1.0,12/40,19.67%,DDX11;ZRANB3;TIPIN;SETMAR;ATRX;FBH1;EXD2;RTEL1;BLM;FAM111A;WRN;TRAIP
prerank,peptide hormone secretion (GO:0030072),0.4851049300906871,1.2235456880239692,0.23159303882195448,0.9214764349956807,1.0,6/26,18.64%,FFAR4;EDN3;RAB1A;CDK16;RIMS2;PARK7
prerank,positive regulation of actin filament polymerization (GO:0030838),0.44610609402547796,1.2234405658272196,0.20437956204379562,0.9204374631448402,1.0,6/44,7.87%,CCL11;PYCARD;SPIRE1;GSN;BAIAP2;BIN1
prerank,cellular response to misfolded protein (GO:0071218),-0.39992626511436846,-1.2229519383848153,0.19285714285714287,0.7603165432473383,1.0,11/20,25.21%,POMT2;RNF185;DNAJB12;STUB1;UBE2W;AUP1;UFD1;KLHL15;UGGT1;RNF5;RNF126
prerank,regulation of phospholipase C activity (GO:1900274),0.5329040999403056,1.222598260973693,0.2579250720461095,0.9223760868138422,1.0,6/15,11.09%,PDGFRA;NTRK3;FGF2;BICD1;FGFR1;ESR1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.4153458697937844,1.222523319425257,0.1751412429378531,0.9212224679248902,1.0,18/72,14.13%,FGF2;FGF10;RAB14;POLR2B;SPRED2;SPRED1;FGFR1;CEP57;SHOC2;POLR2K;SHCBP1;NCBP1;CBL;PTPN11;MAPK1;FGF7;GALNT3;POLR2G
prerank,gas transport (GO:0015669),0.5879636722377226,1.222337775726877,0.2396825396825397,0.9205806782390624,1.0,2/10,14.57%,MYC;MB
prerank,negative regulation of blood pressure (GO:0045776),-0.4544249354494816,-1.2221958481181845,0.2032258064516129,0.7595967092098528,1.0,3/13,15.24%,NOS3;BMPR2;NOS1
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.33662487227223864,-1.2221540825019201,0.14427860696517414,0.7566809016329876,1.0,5/41,2.49%,AFDN;TJP1;GCNT2;PODXL;SMAD7
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.3802864901767359,-1.222065098587292,0.17374517374517376,0.7539216884585187,1.0,6/24,14.70%,PECAM1;ROCK1;ICAM1;TNIP1;MSN;VCAM1
prerank,endoplasmic reticulum organization (GO:0007029),0.4166016295629865,1.2215657757071618,0.18008948545861297,0.9223692897842304,1.0,27/72,24.85%,SEC16B;EIF2AK3;WDR83OS;PRNP;SEC31B;GAK;VAPA;TMEM33;UBE2J2;EMD;ATL3;OTOF;CCDC47;RTN4;BNIP1;SEC61G;CYB5A;REEP5;SHTN1;SGTA;LMAN1;RAB18;ZBED3;STX18;MIA3;ATL1;REEP3
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.4961777772924381,-1.2213784888252828,0.22015915119363394,0.7531388013682456,1.0,2/10,3.00%,EPHA4;RIC1
prerank,actin filament bundle assembly (GO:0051017),-0.35305687069862984,-1.221016203796167,0.14912280701754385,0.751349285232226,1.0,4/33,2.09%,PAWR;CALD1;BAIAP2L1;NEDD9
prerank,regulation of protein neddylation (GO:2000434),-0.5143259595684095,-1.22100777555042,0.22459893048128343,0.748380899334893,1.0,4/10,13.27%,DCUN1D3;RPL5;DCUN1D1;RPL11
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.504483416965849,1.2207484982584427,0.23529411764705882,0.9242407571378655,1.0,10/19,26.50%,ZMIZ1;RHOH;XRCC6;ZBTB1;GATA3;MDK;AXL;MMP14;PRKDC;SYK
prerank,regulation of fat cell differentiation (GO:0045598),0.4214625682551288,1.2204259465731633,0.17541899441340783,0.9241213051055124,1.0,14/74,13.38%,RORA;FRZB;WDFY2;TGFB1;WNT5A;LMO3;RORC;ZBTB16;CARM1;ZFP36L2;ZFPM2;WWTR1;TRIO;GATA3
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.49827973289375443,1.2202794037813982,0.22636484687083888,0.9232751757073772,1.0,9/23,17.28%,FGF2;SOX8;SOX9;VEGFA;SMO;GDNF;SIRT6;PAX2;MDK
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.44753772494552385,1.2202015786170688,0.20024570024570024,0.9221689775773434,1.0,8/39,6.42%,GLI2;FGF2;MYC;FGF10;SEMA3E;VEGFA;PAK1;TGFBR2
prerank,positive regulation of interferon-beta production (GO:0032728),-0.3568951162996862,-1.2201473999753167,0.16494845360824742,0.7482495878757052,1.0,11/33,19.79%,TOMM70;TLR4;IFIH1;TRIM56;RIOK3;IRF1;OAS2;HSP90AA1;FLOT1;POLR3D;ISG15
prerank,glutamate metabolic process (GO:0006536),0.5155082287286423,1.2195488701655834,0.22612359550561797,0.923416455205434,1.0,6/19,17.01%,AADAT;GOT2;OAT;ALDH5A1;GLS;GLS2
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.5061131010175751,1.2190489503462314,0.24281609195402298,0.9240514444281622,1.0,2/18,7.35%,SOX6;FZD7
prerank,cell junction assembly (GO:0034329),0.4046461786857798,1.2189904402830591,0.16344086021505377,0.9228131814376641,1.0,19/100,11.35%,DCHS1;CDH19;PTEN;NRCAM;CDH10;NRXN1;CDH22;OBSL1;CDH8;NLGN1;KIRREL3;GPM6A;FLNA;DSCAM;CDH20;CDH7;MYO9A;OPHN1;ADGRL3
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.41119766650911493,-1.218988130052892,0.1925925925925926,0.7488460538432534,1.0,6/19,7.34%,IL34;MPP1;JAM3;THBS1;CAMK1D;AKIRIN1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.43019694304445283,1.2189659266455017,0.21264367816091953,0.9214686128011882,1.0,8/56,6.85%,RTKN;ANK3;EFHC1;SPIRE1;ARL3;SPTBN1;RASA1;SON
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.42442979645193935,1.2178094200029392,0.19406392694063926,0.9250720965958836,1.0,17/62,18.64%,CREB3L1;BCL2;PRKN;MAPK7;URI1;ACKR3;BAG5;SELENOS;HERPUD1;NFE2L2;RTKN2;SOD2;OPA1;NDUFA13;MDM2;DNAJA1;PARK7
prerank,neuron differentiation (GO:0030182),0.39042308107192103,1.217746492612599,0.12873326467559218,0.9238741308990633,1.0,16/165,7.35%,TENM2;CDNF;TENM3;GLI2;LHX5;ERBB2;IL1RAPL1;OTP;VEGFA;HS6ST1;SOX11;NTRK2;WNT5A;PHOX2A;NGRN;FZD7
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.3281026759020458,-1.216914448662253,0.16042780748663102,0.7524244441860387,1.0,19/46,21.17%,ALDH1A1;PLCL1;ID1;NPR3;TLR4;IP6K1;PLCL2;ZNF423;LGR4;FLCN;NR1H2;NOVA2;RHEB;PGAM5;NRDC;PCTP;NR1H3;FOXC2;ATF4
prerank,negative regulation of binding (GO:0051100),-0.2894684487479656,-1.2168134615169477,0.08695652173913043,0.7497400339967099,1.0,15/81,9.47%,DAB2;SP100;ARHGAP28;LEF1;ROCK1;WAPL;PRKCD;NFKBIA;IFIT2;KDM1A;HABP4;PEX19;CAMK1;GSK3B;RACK1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.48124996140043896,-1.2165687583996376,0.23391812865497075,0.7475883282361067,1.0,5/11,22.82%,NOS3;HSP90AA1;SPR;QDPR;AKT1
prerank,response to fatty acid (GO:0070542),0.5246710610740748,1.2163888142321746,0.226890756302521,0.9281161178874714,1.0,3/17,11.05%,SOX9;PDK3;PID1
prerank,embryonic axis specification (GO:0000578),0.5442055679738833,1.2161820589469257,0.23795620437956205,0.9274765756682375,1.0,2/15,2.46%,PTCH1;RIPPLY2
prerank,cellular response to BMP stimulus (GO:0071773),0.42504321259643113,1.2156110281546895,0.1956521739130435,0.92843233856585,1.0,8/66,4.79%,BMP5;ADAMTS12;RGMB;SOX9;HIVEP1;ACVR1;TGFB1;GDF9
prerank,artery morphogenesis (GO:0048844),-0.361606884552483,-1.2154760492603052,0.1625,0.7482209525736178,1.0,13/30,15.09%,NRP1;SMAD7;BMP4;ENG;BMPR2;TGFBR1;TBX1;JAG1;STRA6;PDGFRB;TGFB2;HPGD;HEY2
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.43142984008041746,1.2150493060974281,0.2,0.9294389731925987,1.0,11/48,11.12%,PRKCA;RHOJ;FGF2;VEGFA;MAP3K3;TGFB1;FGFR1;AKT3;HIF1A;MAPK14;SP1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.5526116912950911,1.2149263656629599,0.2363367799113737,0.9284928203617433,1.0,7/13,19.50%,CBLB;RANBP2;KPNB1;KPNA6;KPNA1;KPNA3;IPO5
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.3852712161574073,-1.2146913646589181,0.17842323651452283,0.7476451872413254,1.0,7/24,9.68%,SORBS1;IGF1;IGF2;INSR;GSK3B;PPP1R3B;GSK3A
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.25547453080390015,-1.2140142361421173,0.0,0.7468060169454729,1.0,74/168,26.95%,SAMD4A;RPS14;GSPT1;RPL24;RPL18A;RPS16;XRN1;UPF3B;LSM1;RPL38;RPL28;RPS19;RPL37;AGO1;MTPAP;CTIF;ERI1;RPS2;DCP2;ZFP36L1;DDX5;EXOSC7;CNOT1;RPL19;RPL5;RPL34;PATL1;RPS25;RPS15;EIF4A3;RPLP1;RPL31;RPL3;HELZ2;RPS6;TUT7;RPS8;PAN2;RPL11;RPL12;PNRC2;SMG9;EXOSC10;RPL13;RPL7A;CNOT11;CNOT9;RPS21;TENT4B;RPL35A;RPL26;RPL32;RPS9;RPS29;RPS23;RC3H2;RPL8;PDE12;RPLP2;POLR2D;RPL41;SMG5;RPS17;RPS5;SMG8;RPS15A;RPL37A;UBA52;PPP2CA;RPS10;EIF3E;RPL6;RPL9;RPS27
prerank,phosphatidylcholine metabolic process (GO:0046470),0.4117181031124659,1.2139214438545474,0.1951501154734411,0.9310702951461466,1.0,20/70,20.13%,SLC27A1;PLBD1;MBOAT2;SLC44A2;PLA2G7;PLA2G12A;LIPC;PCYT1B;PLAAT3;CHPT1;PNPLA8;CHAT;GPLD1;GPAT4;SLC44A1;CSNK2A2;LPCAT2;PLA2G4E;STARD7;DBI
prerank,hyaluronan metabolic process (GO:0030212),0.5005806704562336,1.2139160889318072,0.24833110814419226,0.9296631799094812,1.0,6/23,16.70%,HAS2;FGF2;TGFB1;SLC9A1;SPAM1;HYAL1
prerank,negative regulation of axon extension (GO:0030517),0.4661321795465986,1.2132942662812813,0.23865110246433205,0.9308355988794341,1.0,12/30,20.04%,SEMA3E;SEMA6C;SEMA3A;RNF6;MT3;CDKL3;RTN4;SEMA6D;DIP2B;SEMA4B;SEMA4D;PTPRS
prerank,positive regulation of response to external stimulus (GO:0032103),-0.2705932220029766,-1.21321536919139,0.07272727272727272,0.7464094865596045,1.0,27/128,13.74%,BMP6;PTN;SASH1;ETS1;ANKRD17;DDX60;THBD;NFKBIA;PLSCR1;GPR4;TLR4;THBS1;APP;SCARF1;AGTR1;RIOK3;TNIP1;CYBA;TNFRSF1A;PDGFRB;OPTN;LRSAM1;SERPINE1;PDE2A;CCN4;USP15;NMI
prerank,regulation of hippo signaling (GO:0035330),-0.41494725500486307,-1.2120895533601794,0.20388349514563106,0.7472394581108378,1.0,8/17,9.59%,WWC2;SCHIP1;MOB3B;MAP2K3;WTIP;CIT;SHANK2;WWC1
prerank,focal adhesion assembly (GO:0048041),0.4956919471026164,1.211892364252055,0.24828532235939643,0.9353308891124941,1.0,5/21,9.30%,DLC1;RHOD;PEAK1;TESK2;TRIP6
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.49443448123720773,1.2115005137119845,0.25444596443228457,0.9355118102930795,1.0,2/22,2.08%,DYNLL1;CDKN2B
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.4128296343726857,1.2112190731512245,0.19540229885057472,0.9352203235631413,1.0,8/67,3.89%,RELN;EFEMP1;PDGFRA;PKDCC;ERBB2;EGFR;EPHB2;TEC
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.45413511030986337,1.2110271385306446,0.22127139364303178,0.9345782223218572,1.0,13/34,22.04%,CHRNA4;GRIN2B;GRID2;MPP2;INSYN1;DRD2;GRIN2D;GRIN2A;GABRG2;GABRA3;RAB3GAP1;GABRA2;ARRB2
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.4759569101216391,1.2106439737288883,0.245136186770428,0.9347388182582568,1.0,6/27,13.78%,SLC27A1;SELENOI;PLAAT5;PLAAT3;ETNK1;PNPLA8
prerank,regulation of viral life cycle (GO:1903900),-0.38943638351975784,-1.210206825858662,0.1718213058419244,0.7502149710969169,1.0,10/21,28.59%,TSG101;TRIM25;PPIA;TRIM5;VPS4A;TRIM21;TRIM68;KPNA2;TYRO3;TRIM6
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.546121906325529,1.2088372597469172,0.2710843373493976,0.9408047776378751,1.0,2/13,8.71%,FAM47E;ZMIZ1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.5172585998592991,1.2086631874144513,0.25177809388335703,0.94006449579506,1.0,4/16,13.32%,PRDX6;TRA2B;NCBP1;DAZAP1
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.5816069792809776,1.2081718383268985,0.25996810207336524,0.9406666947031187,1.0,1/10,1.72%,RHO
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.4481203723103105,1.2080466532778764,0.22384428223844283,0.9397940190092953,1.0,11/41,18.78%,ANK3;ANK2;KCNMB2;KCNMB3;FLNA;AKAP6;KCNJ3;KCNJ10;KCNH2;KCNMA1;NOS1AP
prerank,phagosome-lysosome fusion (GO:0090385),0.5760311982286497,1.2075547927944814,0.26247987117552335,0.940456272182519,1.0,5/10,23.43%,RAB34;RAB39A;RAB7A;RAB7B;ARL8B
prerank,muscle cell development (GO:0055001),-0.37414458669212647,-1.2074041696946305,0.17560975609756097,0.7563248785359311,1.0,6/30,3.93%,NEBL;MYOF;IGF1;CXADR;ENG;KDM1A
prerank,regulation of hemopoiesis (GO:1903706),0.5784542239709762,1.2055269054334692,0.2694805194805195,0.947232035755586,1.0,4/10,11.81%,LGALS3;CBFB;MYSM1;RUNX1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.4766513632485383,1.2054667164121653,0.25166444740346205,0.9460499158482278,1.0,8/26,12.21%,CBLB;SOCS5;FBXW7;NCF1;BTC;SNX6;CBL;ZGPAT
prerank,retinoic acid metabolic process (GO:0042573),0.5403409253670894,1.2051229586046321,0.2691751085383502,0.9459654820636035,1.0,1/14,0.28%,CYP2S1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3831025446195239,1.2051137239110088,0.12271805273833672,0.9445895280014147,1.0,47/208,19.82%,RORA;ROR1;PYCARD;S100A4;PRKN;AKAP13;FADD;LPAR1;ALPK1;MAP3K3;TLE1;GPRC5B;TNFRSF10B;TRAF4;SLC44A2;WNT5A;TMEM106A;OTUD7B;NLRX1;UFL1;CARD9;PELI1;PPM1B;FLNA;VAPA;MID2;ESR1;RHOC;TBK1;RHOH;PER1;MALT1;NDFIP1;GOLT1B;ZFAND6;TICAM1;PIM2;TERF2IP;RIPK1;CD74;CHUK;OTUD7A;ZMYND11;MAPKBP1;TAB3;CPNE1;BCL10
prerank,negative regulation of secretion by cell (GO:1903531),0.44246021761853516,1.2049824614285276,0.23654568210262827,0.9437449694068977,1.0,6/38,13.86%,STXBP6;IL1RAPL1;PNKD;SYT11;DRD2;SNCA
prerank,spliceosomal snRNP assembly (GO:0000387),-0.33331917070355926,-1.2046010158661657,0.1452513966480447,0.7625722026742597,1.0,19/38,31.55%,PRPF3;PRMT7;SRSF10;STRAP;PRPF31;SNRPD3;PRMT5;SNRPE;DDX20;SNRPB;SRSF12;SART3;AAR2;USP4;SNRPD1;SNRPC;PRPF19;LSM4;SNRPG
prerank,entry into host (GO:0044409),-0.449947826697449,-1.2038457782627379,0.239067055393586,0.7621446316795233,1.0,4/13,7.33%,CTNNB1;CDH1;PPIA;CTNND1
prerank,cellular protein catabolic process (GO:0044257),0.4235567375662786,1.2033694751503419,0.19953325554259044,0.9490349755417594,1.0,17/59,20.08%,ADAMTS12;FAP;PRKN;CTSK;CTSO;BNIP3;CTSB;AFG1L;RSPRY1;MYLIP;YME1L1;MALT1;RIPK1;RAB7A;MDM2;MAGEC2;UBE2G1
prerank,regulation of cardiac conduction (GO:1903779),0.42815598521477083,1.203334929813996,0.21504112808460635,0.9477663220989739,1.0,12/54,13.57%,FXYD3;CORIN;ANK2;NPR2;ATP2B3;TMEM65;SLC8A2;FXYD6;ATP2B1;PRKACA;FXYD1;AHCYL1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.5590389128990961,1.2031127898416567,0.2696456086286595,0.9471955427481269,1.0,3/11,7.87%,SESTD1;CACNA2D1;BIN1
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.549177615078946,1.2027271337409715,0.2549618320610687,0.9474422394806998,1.0,7/12,24.46%,FADS2;ACOX1;ELOVL5;ACOT8;SCP2;ELOVL1;HSD17B4
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.36950286620702516,-1.2026225256580627,0.18253968253968253,0.7630615826520293,1.0,20/26,39.10%,APPL2;BIRC3;GPS2;LGR4;GPR108;IRF1;LRRC14;FLOT1;APPL1;CACTIN;NLRP2B;TYRO3;SMPDL3B;TLR3;BIRC2;IRF7;TREM2;NFKBIL1;CD36;TLR5
prerank,inositol phosphate-mediated signaling (GO:0048016),0.5024633471047223,1.20234693834995,0.2430167597765363,0.9475714237748303,1.0,6/19,14.14%,HRH1;PPP3CB;PPP3CA;EDN3;NFATC3;PPP3CC
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.41043355604118226,1.201964034576183,0.20244716351501668,0.9477218168052793,1.0,26/71,22.81%,ADAMTS12;FAP;HM13;PRKN;OTUD7B;CTSK;CTSO;CTSB;RSPRY1;HDAC6;DDB1;YME1L1;MALT1;NEDD8;PDCD6IP;UBB;CHMP4C;CUL4B;MDM2;ZER1;OTUD7A;PSMA8;RHBDD1;FBXO44;ZYG11B;RNF123
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.5487810997374921,1.2013394304757754,0.2844574780058651,0.9488995100215727,1.0,1/12,0.66%,PRKCA
prerank,positive regulation of metabolic process (GO:0009893),0.3931592624804811,1.2003877511712315,0.18162393162393162,0.951447267639841,1.0,17/103,13.86%,EBF2;FFAR4;PRDM16;VEGFA;ACACA;CCR2;PTH2R;PRKAB2;FASN;ELOVL6;IL18;TSHR;ACLY;SIRT6;CNOT3;PRLR;PIGA
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4085278333322403,1.200211660893569,0.19369369369369369,0.9507714887119739,1.0,17/73,18.64%,DOCK7;NTRK3;NGF;EGFR;VEGFA;ARAF;TGFB1;PAK1;EIF4G1;HDAC6;TBK1;SNCA;SH2D3C;TERF2IP;RPTOR;FNIP1;PARK7
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.5346090732312943,1.2001361800624293,0.27382753403933435,0.9496655382131719,1.0,4/14,9.24%,CCL4;WNT5A;CCR2;STK39
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.4308292887864503,1.2000960458952594,0.2099056603773585,0.9484199633495765,1.0,17/54,19.59%,DPP10;BIN1;KCNMB2;KCNMB3;FLNA;STK39;AKAP6;KCNAB2;KCNJ3;KCNIP4;NEDD4L;KCNJ10;KCNH2;KCNMA1;NOS1AP;CD63;CAB39
prerank,positive regulation of ATPase activity (GO:0032781),0.4334664719060216,1.1999105043204576,0.22153465346534654,0.947784456233133,1.0,12/41,21.82%,DYNLL1;FGF10;SETMAR;TNNT3;MSH6;AHSA1;GABARAPL2;HNRNPU;DNAJC10;VMP1;SSBP1;DNAJC9
prerank,regulation of myoblast differentiation (GO:0045661),0.45863226809264046,1.1995692916612415,0.2402088772845953,0.9478304061814545,1.0,6/32,4.99%,SOSTDC1;SOX8;SOX9;XKR8;TGFB1;PLCB1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.4911707851702506,-1.1994436137567452,0.2410958904109589,0.7701830773872694,1.0,4/10,5.43%,VTN;GRB10;PRKCB;ARNT
prerank,limb morphogenesis (GO:0035108),0.49636752026073894,1.1993364884877098,0.24725274725274726,0.947395378226466,1.0,1/20,0.48%,PTCH1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5542217131514859,1.1990204830265225,0.26881720430107525,0.947311076471152,1.0,1/11,1.05%,CREB3L1
prerank,regulation of cell-matrix adhesion (GO:0001952),0.40808670522872137,1.1988885460046064,0.21485714285714286,0.9464326956339011,1.0,18/64,12.91%,UTRN;SEMA3E;PEAK1;BST1;EFNA5;MAP4K4;HOXA7;GPM6B;NF1;RASA1;TSC1;CDK6;NF2;SLK;CLASP1;AJAP1;PTPRA;MYOC
prerank,bone development (GO:0060348),0.44259974218426007,1.1988833197154978,0.23845193508114856,0.9450654089455282,1.0,7/39,12.91%,OSR2;SULF1;AKAP13;SLC10A7;SFRP4;VKORC1;MYOC
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.4618285643842852,-1.1981971777576506,0.26011560693641617,0.7713386375010761,1.0,4/12,10.95%,ABCA1;NFKBIA;ABCG1;NR1H2
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.416571935565423,-1.1973865997720654,0.21035598705501618,0.7709668101230587,1.0,4/17,6.66%,ATP1A2;BMP4;TFPI;ATP1A1
prerank,insulin secretion (GO:0030073),-0.3998701336495446,-1.1970093959059407,0.19875776397515527,0.7692884420461339,1.0,6/19,19.73%,RAB11B;SELENOT;CAMK2G;CYB5R4;ANXA1;ADCYAP1
prerank,carboxylic acid transport (GO:0046942),-0.30752930489988217,-1.196806915997262,0.13178294573643412,0.7671753998356168,1.0,17/55,18.77%,SLC13A3;SLC16A12;SLC16A6;SLC6A12;SLC6A6;SLC6A13;SLC7A5;SLC16A11;SLC16A2;SLC6A11;SLC66A1;SLC38A5;SLC16A9;SLC36A4;SLC6A7;SLC16A7;LLGL2
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.4988885658137251,1.1967477362942684,0.2735166425470333,0.9523901180076974,1.0,2/19,3.54%,DCN;CADM4
prerank,sympathetic nervous system development (GO:0048485),0.5256211188060722,1.1957054592164877,0.2598870056497175,0.9551969081303345,1.0,6/15,13.38%,SEMA3A;SOX11;NF1;GDNF;NRP2;GATA3
prerank,cellular modified amino acid catabolic process (GO:0042219),0.534420071453838,1.19569762445732,0.2796610169491525,0.9538397470382942,1.0,3/15,8.36%,DPEP1;SARDH;GOT2
prerank,placenta development (GO:0001890),0.5538697296539808,1.195291805010246,0.2756598240469208,0.9541650116610436,1.0,1/12,0.98%,ADAM19
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.5374086411724914,1.1946101683028372,0.26627218934911245,0.9556268411414871,1.0,3/12,3.30%,GLI2;EPHB6;EPHB2
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.4904896718307191,-1.194460029185646,0.23529411764705882,0.7721350492149107,1.0,5/10,16.02%,APPL2;GRB10;PRKCB;GSK3A;ENPP1
prerank,motile cilium assembly (GO:0044458),0.54785967560791,1.193563547408288,0.2880354505169867,0.9586962525416576,1.0,3/12,8.20%,CCDC39;SPATA6;BBS5
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.4923963322450491,-1.1932902184477652,0.27011494252873564,0.7730526247172654,1.0,4/10,24.38%,ADGRV1;SOD1;PDZD7;TSKU
prerank,protein localization to organelle (GO:0033365),0.3872288663367205,1.192731922214444,0.18401682439537329,0.9606870455650217,1.0,34/133,15.49%,BICD1;ANK2;ARL3;PACSIN2;WDR83OS;IFT140;PRNP;PPP1R15A;OBSL1;BBS9;FAM83H;ARL1;GBF1;LAMP5;GAK;XPA;WDR35;VAPA;BICD2;UBE2J2;TSPAN17;BMP7;TOLLIP;SNX10;EMD;SYS1;DVL1;COL1A1;OTOF;CCDC47;RPA2;GABARAPL2;LMNA;SEC61G
prerank,aminoglycan biosynthetic process (GO:0006023),0.42127502657302024,1.192380780601741,0.2388758782201405,0.960762523979154,1.0,10/49,12.76%,GPC3;HSPG2;HS6ST1;SDC2;EXT1;B3GNT9;SDC4;GPC1;GPC4;SDC3
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.46550594393580247,-1.1918735295534268,0.2644628099173554,0.774767415210948,1.0,5/12,22.37%,PRPSAP2;PRPS2;GART;PRPS1;PRPS1L1
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.4438017329664558,-1.1912439773087777,0.2361963190184049,0.7739627259676103,1.0,5/13,18.50%,FEZ2;SCFD1;NUPR1;SMCR8;PINK1
prerank,Ras protein signal transduction (GO:0007265),0.3821346602219293,1.190814761070132,0.17287784679089027,0.9659416709941144,1.0,42/137,20.25%,USP50;RTKN;TAX1BP3;FGF2;RHOD;GPSM2;RAP2B;HACE1;CTNNAL1;PLD1;NF1;KSR1;EPS8L1;RALB;RAP1A;LIMK1;BRK1;ARHGEF11;SHOC2;COL1A2;FARP2;MRAS;MYO9B;NGFR;MAPK14;RHOH;WASF1;KPNB1;ARHGAP4;ARHGEF3;CYFIP1;CDC42EP1;ELMO1;TP53;PARK7;NRAS;KRAS;GRB2;NCKAP1;SETDB1;JUN;SHTN1
prerank,regulation of endopeptidase activity (GO:0052548),-0.30689747183886823,-1.190507501488638,0.1885245901639344,0.7735030324635329,1.0,18/59,23.82%,VTN;BIRC3;TIMP3;SPOCK2;SERPIND1;SERPINB9;APH1B;SERPINE1;SERPINI1;TIMP2;NRDC;PSENEN;TIMP4;AKT1;SERPINC1;AGT;PSMB9;ATP13A2
prerank,proteoglycan metabolic process (GO:0006029),0.4669163675821409,1.1903592502933156,0.257516339869281,0.9663904366444965,1.0,4/26,8.01%,ADAMTS12;SULF1;CHST8;CSGALNACT1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.28517795484880587,-1.189947742675758,0.1111111111111111,0.7726132549050863,1.0,21/80,10.68%,EPHA4;ROCK2;SAMD4A;PRKCD;LARP4B;ZCCHC4;YTHDF1;NPM1;UPF3B;THBS1;RBM3;METTL14;RPL5;SIRT3;RPS6KB1;RACK1;GSK3A;EIF4A3;TNFRSF1A;ELAVL1;ABCG1
prerank,regulation of fatty acid oxidation (GO:0046320),-0.42334922527282903,-1.1896834065543316,0.26037735849056604,0.7706799747214443,1.0,3/16,5.36%,PRKAG2;APPL2;LONP2
prerank,inner ear morphogenesis (GO:0042472),0.47795942278436987,1.1896442503189784,0.2476060191518468,0.9679641911191991,1.0,4/22,7.02%,SOX9;EPHB2;TTC39C;TBX18
prerank,mitotic cytokinesis (GO:0000281),0.4287322209730686,1.189116991769541,0.24611708482676226,0.9687525564970665,1.0,7/47,6.85%,RTKN;ANK3;EFHC1;ARL3;SPTBN1;RASA1;SON
prerank,regulation of protein autophosphorylation (GO:0031952),-0.3349854263160018,-1.1889086389046442,0.18779342723004694,0.7703711512469161,1.0,4/36,3.02%,PDGFD;EPHA7;ERRFI1;ENG
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.521832808327528,1.1887528331196564,0.2741477272727273,0.9689340464824138,1.0,3/16,10.17%,MEIOB;ERCC4;HFM1
prerank,mesenchymal cell differentiation (GO:0048762),-0.3084432254468744,-1.1887456055068646,0.16049382716049382,0.7681095181709775,1.0,17/51,15.09%,RANBP3L;ROCK2;LEF1;WNT4;ROCK1;CTNNB1;ENG;TGFBR1;DDX5;FBXL17;GSK3B;FGFR2;NOTCH4;TGFB2;AKNA;HMGA2;HEY2
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.39061550749296176,-1.1887038376802623,0.19217081850533807,0.7654915565885935,1.0,5/22,10.68%,EPHA4;ROCK2;LYN;GSK3A;ABCG1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.4932024709080113,1.1885710791993755,0.26584022038567495,0.9683530509845379,1.0,6/20,13.59%,BCL2;PACS2;PSEN1;THADA;HERPUD1;CCDC47
prerank,response to interferon-gamma (GO:0034341),0.4105155684652648,1.1883013547523793,0.2330316742081448,0.9681077282621151,1.0,6/67,5.28%,CCL11;KYNU;EPRS1;CCL4;WNT5A;AQP4
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.30937226739160223,-1.1874956153607,0.17880794701986755,0.7664659195644278,1.0,22/54,25.91%,NXN;DCUN1D3;CTNNB1;SMAD7;HDAC8;RPL5;OGT;SH3RF2;SQSTM1;RPL11;CAV1;PINX1;TRIM21;ISG15;COPS9;AKT1;U2AF2;USP4;VPS28;SIRT7;TNFAIP3;BAG2
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.4436279456453162,1.1873454082913428,0.24019607843137256,0.9707043418638138,1.0,11/36,19.77%,PRKN;FADD;TRIM44;WNT5A;AGPAT2;UBE2K;HIF1A;RIPK1;CD74;AXL;CPNE1
prerank,negative regulation of interleukin-1 production (GO:0032692),0.47179995332890623,1.1871430678844976,0.273841961852861,0.9701620023916263,1.0,1/23,0.31%,FFAR4
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.44370303674229483,1.1864304768804366,0.25548387096774194,0.9716870616220172,1.0,4/36,4.20%,BCL2L14;PYCARD;BCL2;DEPTOR
prerank,response to light stimulus (GO:0009416),0.4165773687228085,1.1863121821245137,0.24413145539906103,0.9707562633728657,1.0,14/55,17.19%,RHO;ZRANB3;GTF2H2;ERCC5;ERCC4;DDB2;MEN1;GPR88;MSH6;DRD2;CRY1;FECH;USP1;REV1
prerank,lipid transport (GO:0006869),0.39654575677126125,1.186024511182869,0.19281045751633988,0.9705546772192784,1.0,14/97,9.33%,ABCA6;ABCA9;SLC27A1;ATP8B1;NCOA1;PITPNB;SLC27A4;OSBPL5;SLCO2B1;PEX3;GM2A;GOT2;MTTP;NCOA2
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.43226924320965027,-1.1858026170966969,0.23824451410658307,0.7690836562519607,1.0,2/14,0.88%,IGF1;CD200
prerank,synaptic vesicle recycling (GO:0036465),0.45019483110635994,1.1854007970751688,0.24650571791613723,0.9717703748535941,1.0,10/31,18.89%,CEL;STON2;SYT1;NLGN1;STON1;OPHN1;RAB3A;SNCA;SYT2;SNCB
prerank,axonal transport (GO:0098930),-0.3323467597762856,-1.185287948853557,0.19597989949748743,0.7680373190469026,1.0,10/36,13.14%,KIF3B;PAFAH1B1;DTNBP1;KIF1B;BLOC1S5;DCTN1;SOD1;SNAPIN;MAPT;AP3D1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.3995432171743951,1.1852162896836453,0.2222222222222222,0.9711123635116807,1.0,15/67,17.58%,VIT;UTRN;OLFM4;FBLN2;DOCK5;CDK6;FLNA;DOCK1;ARL2;MYOC;JUP;ABL1;RELL2;MDK;RAC3
prerank,regulation of receptor binding (GO:1900120),-0.48331514275260934,-1.1849505844958763,0.2590529247910863,0.7664108420742185,1.0,5/10,24.00%,GREM2;ADAM15;ATP2A3;HFE;ATP2A2
prerank,regulation of ion transport (GO:0043269),0.4037657707729854,1.1849315851704396,0.21948488241881298,0.9710070450287677,1.0,17/76,14.70%,ANK3;KCNA2;NKAIN2;PRKN;CHRNA4;SYT1;SNX6;SYT11;SYT12;PXK;GDNF;DRD2;PER1;SNCA;KCNJ3;NEDD4L;KCNJ10
prerank,phospholipid catabolic process (GO:0009395),0.4727465562301658,1.1848933451800936,0.24406332453825857,0.9697786642744419,1.0,2/24,1.20%,PRDX6;PLBD1
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.293074540359903,-1.1844756114604222,0.1206896551724138,0.7652347568782198,1.0,7/66,1.51%,FLT1;PDGFD;ROBO1;SASH1;MAP3K5;KIT;IL34
prerank,B cell differentiation (GO:0030183),0.42915619090678714,1.1841880915766245,0.2488095238095238,0.9712577606184388,1.0,10/46,18.49%,RAG2;PTPN2;DNAJB9;RABL3;NHEJ1;PTPRJ;DCAF1;ITGB1;MS4A1;FNIP1
prerank,activation of GTPase activity (GO:0090630),0.39764559794980714,1.1835374457449586,0.22448979591836735,0.972489817310106,1.0,11/89,6.50%,ARHGAP24;SIPA1L1;DOCK7;NTRK3;TAX1BP3;TBC1D10A;GPR65;SLC27A4;ARHGEF10;MTSS2;TSC1
prerank,glycine transport (GO:0015816),0.57374148899944,1.1834296628264849,0.2916030534351145,0.9715711012894392,1.0,4/10,19.90%,SLC36A2;SLC25A38;SLC7A8;SLC6A9
prerank,positive regulation of dendrite development (GO:1900006),0.5665018507502718,1.183276894219403,0.2664576802507837,0.9708168791804985,1.0,3/10,14.48%,BMP5;BMP7;COBL
prerank,regulation of isotype switching (GO:0045191),-0.42252166324069795,-1.1831465210521772,0.24281150159744408,0.7669299930745621,1.0,5/14,24.41%,RIF1;PARP3;TFRC;PAXIP1;MAD2L2
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.4792268126427661,1.18272581670883,0.2773224043715847,0.9717712703433422,1.0,5/23,13.78%,PLBD1;MBOAT2;PLA2G12A;PLAAT3;PNPLA8
prerank,zymogen activation (GO:0031638),0.43622761416443173,1.1826425496644106,0.243605359317905,0.9707461726485372,1.0,4/39,7.64%,HGFAC;TBC1D10A;FADD;KLK1
prerank,amino sugar metabolic process (GO:0006040),0.5614481761577537,1.1825167646562855,0.2931547619047619,0.9699082084633945,1.0,3/10,15.27%,GFPT2;CSGALNACT1;GNE
prerank,positive regulation of integrin activation (GO:0033625),-0.4689653583227825,-1.182487847091914,0.2628398791540785,0.766192444760871,1.0,2/11,5.91%,RAP1B;RASIP1
prerank,regulated exocytosis (GO:0045055),-0.24993120376284522,-1.1824062679495106,0.0,0.7637943403567243,1.0,40/173,12.68%,IGF1;ABCC4;VWF;PECAM1;MYH9;VEGFC;RAB11B;SYT9;VEGFD;STXBP1;RAB31;VTI1B;ARHGAP17;LYN;GTPBP2;CYRIB;IGF2;TEX264;THBS1;F8;TIMP3;ACTN1;HABP4;CD109;APP;ACTN2;SDF4;FN1;SRGN;MANF;TMX3;CPLX1;SOD1;TMSB4X;SNAPIN;SYT10;SERPINE1;SYTL4;SYT6;TGFB2
prerank,cellular response to hydroxyurea (GO:0072711),0.5624531384898468,1.1822860480148556,0.28019323671497587,0.9695325991798517,1.0,5/10,16.10%,DDX11;NSMCE3;ATRX;BLM;SPIDR
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.5190285243059718,1.182211247986108,0.2772133526850508,0.9684811461292607,1.0,4/16,15.81%,SOX9;ERLIN2;BRCA1;ERLIN1
prerank,amyloid fibril formation (GO:1990000),0.42504703845327624,1.181621717201372,0.24819277108433735,0.9695049962587108,1.0,4/51,2.42%,TGFBI;HSPG2;GSN;PRKN
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.45202907564723727,-1.1815346398390403,0.26453488372093026,0.7640184483832463,1.0,3/12,4.52%,THRB;CTSH;LMO2
prerank,integrin-mediated signaling pathway (GO:0007229),-0.2912860082277061,-1.1814755092892237,0.11403508771929824,0.7615647204566882,1.0,18/73,15.36%,DAB2;PTN;NRP1;MYH9;FBLN1;NEDD9;ITGB5;SEMA7A;FYB1;BCAR1;ITGA10;FN1;ADAM10;LAMA3;CDC42;ADAM15;CEACAM1;PTK2B
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.41637236384272386,1.181256651117047,0.23577235772357724,0.9695478399160876,1.0,13/57,14.11%,USP50;PYCARD;MYC;TBC1D10A;FADD;GRIN2B;ACVR1C;CARD9;FYN;ARL6IP5;MALT1;TTBK1;GRIN2A
prerank,regulation of signal transduction (GO:0009966),0.37714838789460575,1.1808154497203631,0.15040650406504066,0.96995518037144,1.0,35/190,14.46%,RORA;PTCH1;UBASH3B;SULF1;MDFIC;ERBB3;ZFAND2B;CBFB;BST1;ACVR1;PTPN2;SIK2;SOCS5;TGFB1;PRNP;GLI1;PLCB1;HHIP;RGS11;CSK;FRRS1L;SLC8A2;FYN;DHRS3;CASTOR2;PTPN1;GDNF;USP33;ESR1;RUNX1;WWTR1;GATA3;NCK1;RFNG;SENP2
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.3783237898291614,-1.1807979672418292,0.23255813953488372,0.7610253156666732,1.0,4/24,8.82%,DAB2;LZTFL1;NUMB;RHOQ
prerank,cell differentiation in spinal cord (GO:0021515),0.579785327547718,1.1807848673384898,0.265993265993266,0.9687249116604901,1.0,2/10,6.87%,SOX6;MDGA2
prerank,lung development (GO:0030324),0.4503883997335667,1.1804988646698291,0.28227848101265823,0.9685553264358215,1.0,9/33,11.39%,GLI2;FGF2;FGF10;CCDC39;VEGFA;SOX11;LOXL3;RCN3;FGF7
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.3831490427070294,1.1798349937759334,0.17972831765935215,0.9699042677107483,1.0,14/138,4.62%,ROR2;ROR1;SHC4;PDGFRA;ERBB3;NTRK3;EPHB6;NGF;ERBB2;EGFR;PTPRT;NPR2;EPHB2;NTRK2
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.47665054160690495,1.1797976627589573,0.2567204301075269,0.9687072723247581,1.0,5/25,17.16%,CXCL10;ANK2;AKAP6;SNCA;APLNR
prerank,negative regulation of leukocyte activation (GO:0002695),-0.4240721272143092,-1.1795497828216555,0.2571428571428571,0.7625160486385142,1.0,6/15,20.73%,CD200;IL31RA;CD300A;GPER1;HAVCR2;NR1H3
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.4067921068769227,-1.1794670496378132,0.2315112540192926,0.7601935340525089,1.0,8/17,12.75%,DOCK4;IGF1;NRP1;VTN;IGFBP5;S100A11;PDGFRB;CCN4
prerank,lamellipodium assembly (GO:0030032),-0.35924513910816724,-1.1794308637279003,0.2196078431372549,0.7577560123931539,1.0,9/26,14.28%,ABLIM1;KIT;CDH13;PARVB;ARHGEF6;ABLIM2;WHAMM;PTPRO;S1PR1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5306555763018127,1.1790480140660853,0.2791044776119403,0.9703448952388001,1.0,5/13,12.21%,CBLB;SOCS5;SNX6;CBL;ZGPAT
prerank,polyamine metabolic process (GO:0006595),0.5328392186677167,1.1789895137925774,0.28254437869822485,0.9692613420154211,1.0,5/13,11.38%,SMOX;SMS;AOC1;PAOX;HDAC6
prerank,regulation of actin filament-based process (GO:0032970),0.4040702886445769,1.1786818919398279,0.2276330690826727,0.9691441523254548,1.0,11/70,6.16%,DLC1;RHOD;LRP1;RND3;BST1;EFNA5;RHOBTB3;GPM6B;IQGAP2;PAK1;BAIAP2
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.5544180699850556,1.1778223120667906,0.27341389728096677,0.9712627617985624,1.0,2/11,11.81%,CBFB;RUNX1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.3979683135445575,1.1778191672462741,0.22538293216630198,0.9699379113451543,1.0,18/85,11.60%,DLC1;FGF10;IRS2;NGF;AKAP13;EPHB2;CADM4;ARHGEF28;SYNGAP1;MAPKAP1;EPS8L1;FOXM1;RABL3;ERBIN;SHOC2;MYO9B;OPHN1;MMD2
prerank,apoptotic process (GO:0006915),0.3711117451540123,1.1772958615900129,0.17373737373737375,0.9707743818948489,1.0,60/203,21.18%,DLC1;BCL2L14;FAP;ERBB3;MAGI3;IL2RA;PYCARD;MYC;BCL2;FADD;EFNA5;SCN2A;JADE1;PAK4;TNFRSF10B;PAK5;PPP1R15A;BNIPL;APAF1;TGFBR2;ZBTB16;BMF;CASP6;NAE1;BNIP3;HIP1;DCC;NGFR;CASP12;ING4;YARS1;AHR;RFK;BRAT1;AHCYL1;TRPC5;PAX3;TRAF7;RTN4;IFT57;CASP2;ELMO1;BNIP1;BCL2L11;AKAP1;RIPK1;AIFM1;MDM2;IRF3;CASP7;MRPS30;HK2;NCKAP1;TRAIP;KREMEN1;PDCD4;HSPD1;IER3;AIFM2;DPF2
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.3920950101015319,1.1770817409414023,0.22185792349726777,0.9703854264831242,1.0,13/90,12.82%,EBF2;FFAR4;PRDM16;VEGFA;CCR2;PTH2R;PRKAB2;ELOVL6;IL18;TSHR;SIRT6;CNOT3;PRLR
prerank,regulation of neutrophil migration (GO:1902622),0.5562851464007059,1.1768559065643527,0.30551181102362207,0.9699618045322933,1.0,3/10,12.37%,OLFM4;BST1;RHOH
prerank,regulation of ruffle assembly (GO:1900027),0.48021780438475736,1.176462107154337,0.26308724832214764,0.970202759050909,1.0,3/23,6.45%,ARHGAP24;NLGN1;EPS8L1
prerank,response to thyroid hormone (GO:0097066),-0.4413961457525877,-1.176394904022853,0.26706231454005935,0.7647098797727259,1.0,3/13,4.52%,THRB;CTSH;LMO2
prerank,positive regulation of T cell differentiation (GO:0045582),0.4392329904873509,1.1762084271865703,0.25406758448060074,0.9699560687698797,1.0,10/36,18.34%,GLI2;SOCS1;ZMIZ1;SOX12;IL4I1;RHOH;ZBTB1;GATA3;MDK;SART1
prerank,tRNA wobble uridine modification (GO:0002098),-0.4305095647383014,-1.17601299077422,0.26506024096385544,0.763345525220684,1.0,6/14,16.76%,TRMT9B;URM1;ELP3;ELP1;MTO1;DPH3
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.513483686236177,1.1759621260126198,0.2897473997028232,0.9696428351736199,1.0,1/15,0.51%,USP50
prerank,regulation of T cell proliferation (GO:0042129),0.4120725298115224,1.1757294818785569,0.23976608187134502,0.9692843883917899,1.0,6/61,13.58%,LGALS3;GLMN;SDC4;IL4I1;IL6ST;NCK1
prerank,positive regulation of signaling (GO:0023056),0.4432248839873848,1.175433903993868,0.2569620253164557,0.9691345860327651,1.0,12/37,15.46%,CLSTN2;SOX11;GRIK2;SYT1;NMU;EDN3;RIMS1;SCRIB;GATA3;SNCA;CLSTN1;HOMER1
prerank,regulation of potassium ion transport (GO:0043266),0.4630173847745057,1.175122520759343,0.26169405815423513,0.9691479508700929,1.0,9/31,18.82%,ANK3;ANK2;DPP10;KCNAB2;DRD2;KCNIP4;KCNH2;KCNA5;CD63
prerank,regulation of mitochondrial fusion (GO:0010635),0.550112260006185,1.1748817877773434,0.2904238618524333,0.9688506181029405,1.0,5/11,17.21%,PRKN;BNIP3;HUWE1;PID1;ADCK1
prerank,long-term synaptic potentiation (GO:0060291),0.48042209679455705,1.174472993214601,0.2562747688243065,0.9692125340140387,1.0,6/21,14.11%,TSHZ3;GRIN2B;MPP2;SLC8A2;GRIN2D;GRIN2A
prerank,PERK-mediated unfolded protein response (GO:0036499),0.565784016158731,1.1744686816834713,0.30652503793626706,0.967931547172279,1.0,4/10,16.48%,EIF2AK3;HERPUD1;NFE2L2;QRICH1
prerank,maintenance of blood-brain barrier (GO:0035633),0.4533804762011331,1.174357430108001,0.27860026917900405,0.9671279145100447,1.0,5/30,5.46%,LAMA2;LAMC1;WNK3;CLDN1;SLC12A2
prerank,protein localization to kinetochore (GO:0034501),-0.43842300862494465,-1.1740530171519283,0.24188790560471976,0.7671621348093618,1.0,11/14,47.58%,BUB3;IK;CENPT;KNL1;ZW10;TTK;SPDL1;CDK1;MTBP;AURKB;CHAMP1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.3868092501673531,-1.1739224017676526,0.23622047244094488,0.7650912800952944,1.0,4/21,4.25%,OSBPL8;PLA2G4A;PLA1A;OSBPL10
prerank,epithelial cell-cell adhesion (GO:0090136),-0.4571895718814031,-1.1739139566623273,0.26721763085399447,0.7625751543294519,1.0,2/11,2.33%,KIT;ITGB5
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.39904445802453653,-1.172518286538362,0.25357142857142856,0.7642811319691655,1.0,6/20,12.41%,WTIP;MOV10;AGO1;CNOT1;NRDE2;AGO3
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.5056504441133322,1.1724181922935077,0.292749658002736,0.9735935013414633,1.0,4/17,9.62%,FGF2;SOX9;RFX3;SFRP4
prerank,excitatory postsynaptic potential (GO:0060079),0.4893237763287039,1.172169139984116,0.2719891745602165,0.9733403597235312,1.0,8/19,22.04%,GRIN2B;GRID2;MPP2;DRD2;GRIN2D;GRIN2A;RAB3GAP1;ARRB2
prerank,regulation of synapse assembly (GO:0051963),0.42129504589603356,1.1719576867856674,0.24641148325358853,0.972868158624495,1.0,16/46,19.45%,CLSTN2;IL1RAPL1;EPHB2;NRXN1;GRID2;NLGN1;LHFPL4;EIF4G1;GPC4;SETD5;SYNDIG1;SNCA;CLSTN1;IL1RAP;LRFN5;ROBO2
prerank,protein homooligomerization (GO:0051260),0.38341592363443305,1.1715736059101443,0.2157279489904357,0.973145156122699,1.0,32/114,21.28%,SCARA5;STEAP4;CTH;PYCARD;SLC1A5;ACACA;LETM1;AQP4;MPP2;ALS2;CARD9;PRMT1;ALOX5AP;ATL3;TMEM120A;ZBTB1;SOD2;NACC2;PDCD6IP;BLM;PNPT1;ALDH1A3;GLS;FUS;MLKL;RYR3;BCL10;HCN1;ADCY8;DISP1;PKD2;SSBP1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.39283802964662057,1.1714105433949535,0.23799126637554585,0.972481266803575,1.0,13/87,6.16%,DLC1;PDGFRA;SEMA3E;RHOD;LRP1;RND3;BST1;EFNA5;RHOBTB3;GPM6B;IQGAP2;PAK1;BAIAP2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.501946487369421,1.171389496731586,0.27436281859070466,0.9712545285691104,1.0,5/15,15.14%,FGF2;VEGFA;FGFR1;SMOC2;MET
prerank,digestive tract development (GO:0048565),0.44957777461361825,1.171388288050506,0.25485122897800777,0.9699612330815025,1.0,7/32,8.53%,GLI2;PKDCC;CCDC39;GLI1;GATA6;RARB;SMO
prerank,myeloid dendritic cell activation (GO:0001773),0.5427804970518476,1.1713813244974296,0.28810975609756095,0.9686933474500882,1.0,2/12,6.42%,PYCARD;TGFBR2
prerank,membrane lipid catabolic process (GO:0046466),0.5471706677654893,1.1711206607889078,0.31100478468899523,0.968431044341199,1.0,3/10,12.11%,CYP1B1;NAGA;PDXDC1
prerank,regulation of DNA recombination (GO:0000018),0.4486479456749124,1.1705386083067106,0.26515151515151514,0.9695812161430551,1.0,10/32,16.30%,ZRANB3;SETD2;MSH6;SIRT6;RPA2;RTEL1;KPNA1;BLM;SPIDR;TERF2IP
prerank,protein K48-linked ubiquitination (GO:0070936),0.40789547894298905,1.1704677854096643,0.24284077892325315,0.9685877523858362,1.0,9/54,9.93%,UBE2T;PRKN;UBE2E2;HACE1;RNF6;FBXO38;PELI1;UBE2K;CUL3
prerank,Rac protein signal transduction (GO:0016601),0.49513490572778657,1.1701661212761194,0.2759103641456583,0.9686195451908727,1.0,8/18,19.30%,HACE1;BRK1;FARP2;RHOH;WASF1;CYFIP1;ELMO1;NCKAP1
prerank,inhibitory synapse assembly (GO:1904862),0.5433246472070951,1.1697971361035486,0.3010752688172043,0.968874494270929,1.0,5/11,21.13%,FGF13;WNT5A;GABRG2;CBLN4;GABRA2
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.43259178954404204,1.1697392342374866,0.24939172749391728,0.9678154430108812,1.0,3/39,2.01%,FFAR4;CRH;IRS2
prerank,glycerol metabolic process (GO:0006071),-0.48428516031159674,-1.1694336210086005,0.2916666666666667,0.771506228878712,1.0,5/10,27.22%,COQ3;PGP;GOT1;ANGPTL3;TKFC
prerank,macrophage differentiation (GO:0030225),-0.4396937122952672,-1.1691540057900691,0.27113702623906705,0.7698519293345326,1.0,5/13,14.11%,IL31RA;BMP4;PARP1;CASP8;CDC42
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.49347600028979244,1.1688355545602156,0.2967651195499297,0.9702025912348001,1.0,8/19,18.64%,PRKN;FBXW7;FBXO7;HDAC6;SREBF2;CSNK2A2;HTT;PARK7
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.4402882672652442,1.1687621928709542,0.28061224489795916,0.9692225359312829,1.0,4/34,5.26%,PTPN22;EPHB2;DNAJB9;WNT5A
prerank,negative regulation of cell population proliferation (GO:0008285),0.3619193346522303,1.1678718474062242,0.11457286432160804,0.9714688022433685,1.0,63/351,15.91%,ROR2;APOD;DLC1;SSTR1;BMP5;WNK2;CLDN19;GLMN;FAP;MYC;PTEN;CDKN2B;KAT2B;SOX9;NGF;VGLL4;FRZB;PTPN2;PTHLH;TGFB1;SOX11;NUPR2;NF1;ACVR1C;WNT5A;CYP1B1;PAK1;BNIPL;PODN;TSC1;ADAMTS1;COL18A1;GATA6;CDK6;CBFA2T3;MEN1;NF2;RARG;SFRP4;ERBB4;PTPRJ;ATRAID;EMD;MAGI2;ING4;ATP8A2;STRN;SOD2;DRD2;ADARB1;ATF5;RBBP4;GATA3;NACC2;PDS5B;RPS6KA2;MDM4;CD164;LMNA;PIM2;TGFB3;MED25;GPLD1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3895640349885788,1.1676358259332718,0.2265193370165746,0.9710988913513146,1.0,27/87,21.05%,FGF2;FGF10;EGR3;RAB14;POLR2B;SPRED2;SPRED1;FGFR1;CEP57;SHOC2;POLR2K;ZFP36L2;SHCBP1;NCBP1;CBL;PTPN11;MAPK1;FGF7;GALNT3;POLR2G;HYAL1;GRB2;POLR2A;FGF9;ZFP36;FLRT1;RBFOX2
prerank,lipid oxidation (GO:0034440),0.538985961840817,1.1673015022851438,0.29742033383915023,0.9711601816383898,1.0,2/12,7.92%,PLA2G7;ACOX1
prerank,protein processing (GO:0016485),0.38453229341050604,1.16668871142651,0.24167561761546724,0.9722751277598375,1.0,20/102,15.32%,HGFAC;PTCH1;ADAM19;HM13;PARL;PSEN1;PCSK4;PCSK6;ATP23;KLK1;KLK6;SPCS3;MMP16;NCSTN;APH1A;YME1L1;CPD;TYSND1;PSEN2;CASP2
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.4571186066730931,1.1665648547312275,0.29078947368421054,0.9715082545735526,1.0,7/25,13.86%,GLMN;EGFR;PSEN1;FZD7;DSCAM;KCTD20;SNCA
prerank,sodium ion transport (GO:0006814),0.3971007295210866,1.166496325970165,0.23177366702937977,0.9705088377356837,1.0,11/85,8.12%,SLC6A2;FGF13;SCN7A;SLC12A3;SCN2A;KCNK1;ANO6;SLC12A2;SCN5A;SCN3A;SLC8A2
prerank,positive regulation of neuron differentiation (GO:0045666),0.43052308207431,1.1662681259497594,0.26119402985074625,0.9701919859815791,1.0,12/40,20.59%,NGF;NRCAM;GPRC5B;SOX11;ZEB1;HOXD3;FGFR1;MMD2;VWC2;HEYL;CPNE1;PCP4
prerank,negative regulation of anoikis (GO:2000811),0.5094154044428446,1.165731984929551,0.29910714285714285,0.9710734855180313,1.0,2/14,3.71%,BCL2;TLE1
prerank,negative regulation of hippo signaling (GO:0035331),-0.4544358651272799,-1.1653275113273371,0.28160919540229884,0.7795844850315091,1.0,6/12,9.59%,WWC2;MAP2K3;WTIP;CIT;SHANK2;WWC1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.44344927977763393,1.165207532081027,0.27417218543046357,0.9718832243797413,1.0,9/32,19.92%,SLC27A1;SLC44A2;PCYT1B;CHPT1;CHAT;GPAT4;SLC44A1;CSNK2A2;STARD7
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.43123014363307766,1.1651304958154705,0.2665847665847666,0.9709553768031575,1.0,11/38,16.33%,CACNA2D1;ANK2;DSG2;SCN5A;CTNNA3;KCND3;BIN1;KCNJ3;JUP;PKP2;KCNH2
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.46718304481926487,-1.1649130090094821,0.2737430167597765,0.7783119451063706,1.0,3/10,6.85%,SHANK3;RAB5A;APP
prerank,adipose tissue development (GO:0060612),0.5386530723871837,1.164590589443101,0.31297709923664124,0.9718853423563717,1.0,4/11,7.22%,SOX8;PGRMC2;RORC;DYRK1B
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.3754018598510765,-1.1645813423600087,0.25,0.7767812600627007,1.0,6/21,8.85%,FOXP1;PRKCH;LYN;PRKCB;GPS2;ELF1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.5044906260976525,1.1645381580117558,0.2859195402298851,0.9708227868442575,1.0,3/17,3.69%,MAML3;KAT2B;MAML2
prerank,manganese ion transport (GO:0006828),-0.4305035472077483,-1.1642731157295227,0.27102803738317754,0.7753358790573992,1.0,5/14,17.61%,SLC30A10;SLC39A8;TRPC6;TRPC3;TRPC7
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.3975514378236513,1.16372862904241,0.24507658643326038,0.9727819580100785,1.0,12/69,7.84%,PDGFRA;ERBB3;PTEN;IRS2;NGF;ERBB2;NF1;PLCB1;NYAP1;PI4KB;FGFR1;GAB2
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.42237292332580856,1.163294775533034,0.2762364294330519,0.9731463384065344,1.0,11/43,12.74%,CBLB;EGFR;PTPN2;SOCS5;EPS15;BTC;SNX6;PTPRJ;CBL;ZGPAT;SH3KBP1
prerank,organelle transport along microtubule (GO:0072384),0.4478751174156052,1.1632304216592646,0.28914141414141414,0.9721125932126046,1.0,13/31,18.55%,BICD1;NDE1;COPG2;RHOT2;DYNC1I1;BICD2;ARHGAP21;RAB1A;COPG1;UBB;TRAK2;HTT;RHOT1
prerank,carnitine shuttle (GO:0006853),-0.4474241272233906,-1.1628404506916148,0.2692307692307692,0.7771371945735884,1.0,5/11,12.80%,PRKAG2;CPT1A;PRKAA2;ACACB;SLC25A20
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.3397710852433267,-1.162697819644869,0.225,0.7751080952792391,1.0,6/31,3.32%,RANBP3L;CRIM1;SMAD6;LRP5;TMEM64;NOCT
prerank,actin nucleation (GO:0045010),0.48741801730478596,1.1626498680038313,0.28314917127071826,0.9731113852721086,1.0,3/21,4.97%,SPIRE1;ARPC1B;IQGAP2
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.4605273941869496,-1.1624726663076115,0.2591549295774648,0.7683146066543834,1.0,5/11,18.59%,PANK1;PANK2;PANK3;PPCDC;PANK4
prerank,coenzyme A biosynthetic process (GO:0015937),-0.4605273941869496,-1.1624726663076115,0.2591549295774648,0.7683146066543834,1.0,5/11,18.59%,PANK1;PANK2;PANK3;PPCDC;PANK4
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.4605273941869496,-1.1624726663076115,0.2591549295774648,0.7683146066543834,1.0,5/11,18.59%,PANK1;PANK2;PANK3;PPCDC;PANK4
prerank,positive regulation of axon extension (GO:0045773),-0.3746980119344166,-1.1622359256985308,0.2158273381294964,0.7666351509269673,1.0,4/22,2.92%,MACF1;NRP1;GOLGA4;SEMA7A
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.43842881084603225,1.1615265243726323,0.2692307692307692,0.9763160632961388,1.0,9/35,12.88%,SOX9;PDE7B;MAPK7;KSR1;PDE9A;HTR2C;AKAP6;PDE4D;AHR
prerank,epithelial cell differentiation (GO:0030855),0.379784176012727,1.1614657765101792,0.24295010845986983,0.9752997049075339,1.0,18/88,14.18%,LGALS3;TST;VEGFA;CNN3;GLI1;UPK1B;GATA6;CASP6;FZD7;CTSB;PIH1D1;HDAC2;ERBB4;SCUBE1;TOLLIP;SCRIB;GATA3;PTER
prerank,mitochondrion disassembly (GO:0061726),0.4329337101612606,1.161389474376757,0.26590330788804073,0.9743283510284713,1.0,8/34,15.07%,PRKN;WIPI1;FBXO7;CTSK;BNIP3;ATG5;ATG3;GABARAPL2
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.560569038976414,1.1608197349107445,0.30495356037151705,0.9753104345194149,1.0,3/10,7.97%,PTPN2;SOCS1;NF2
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.4772253443288108,1.1605698855134843,0.3020833333333333,0.9750378756474701,1.0,8/22,21.03%,ANK2;AKAP6;CALM1;CALM2;SLC9A1;HTT;VMP1;PKD2
prerank,cell-cell junction organization (GO:0045216),0.39242084943980243,1.1605590954600034,0.2505567928730512,0.9738284442058525,1.0,14/79,9.71%,DCHS1;CDH19;TGFB1;DSG2;CDH10;CLDN1;CDH22;CDH8;CADM3;CSK;CADM2;CADM1;CDH20;CDH7
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.27475956373123134,-1.160086547905819,0.13725490196078433,0.7707773221742417,1.0,21/84,11.82%,FOXP1;ANXA3;ROCK2;SASH1;ETS1;TEK;NRP1;ANGPT1;NOS3;BMP4;MAP2K3;BMPR2;KDR;THBS1;BCAR1;GPI;ATOH8;TMSB4X;PROX1;LGMN;GATA2
prerank,regulation of cell-cell adhesion (GO:0022407),-0.3191338523435183,-1.15941253486158,0.22885572139303484,0.7704334144284104,1.0,6/39,3.09%,AFDN;EPHA7;PTPRG;PODXL;SMAD7;CDH1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.45893938866875866,1.1593751918288777,0.26639344262295084,0.9772605575743524,1.0,7/24,18.64%,CREB3L1;PRKN;SELENOS;HERPUD1;OPA1;USP25;PARK7
prerank,renal system development (GO:0072001),0.4079676540425975,1.1583698456577662,0.2532855436081243,0.9800571312984107,1.0,7/52,7.02%,SULF1;HAS2;GLI2;LRP4;VEGFA;ARL3;TBX18
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.30981373135580004,-1.157949757406624,0.21052631578947367,0.7724767140367486,1.0,14/46,12.75%,FOXP1;IGF1;ELN;CDH13;CTNNB1;BMP4;IGFBP3;IGFBP5;THBS1;OGN;IL6R;PDGFRB;ID2;CCN4
prerank,negative regulation of endothelial cell migration (GO:0010596),0.4342478227316402,1.1576203616749146,0.27351485148514854,0.9817492860664101,1.0,3/36,4.09%,DCN;FGF2;TGFB1
prerank,snRNA 3'-end processing (GO:0034472),0.4808751704077999,1.1571032373555477,0.3008720930232558,0.9825537548565426,1.0,6/19,13.76%,USB1;INTS6;EXOSC8;EXOSC2;INTS2;INTS8
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.5584660426901581,1.1567912527969633,0.32334384858044163,0.9825171208531455,1.0,6/10,22.01%,KLF15;DIP2A;SETD5;DIP2B;PARK7;PRKAA1
prerank,regulation of lipid storage (GO:0010883),0.48027101704558245,1.155668667008422,0.2845849802371542,0.9858756384889605,1.0,3/22,4.77%,PTPN2;FBXW7;MEST
prerank,ribosomal small subunit assembly (GO:0000028),-0.3975796061946705,-1.1556394832803714,0.2777777777777778,0.7773817584476074,1.0,8/16,26.95%,RPS14;RPS19;RPS15;MRPS7;MRPS11;RPS5;PWP2;RPS27
prerank,monocyte differentiation (GO:0030224),-0.4704580679302218,-1.1555482298008444,0.2934472934472934,0.7753155838486702,1.0,3/10,2.62%,IL31RA;MYH9;BMP4
prerank,amyloid precursor protein catabolic process (GO:0042987),0.510089359992782,1.1554583081224992,0.2857142857142857,0.9854927206020998,1.0,5/14,14.33%,ADAM19;PSEN1;NCSTN;APH1A;PSEN2
prerank,nuclear transport (GO:0051169),0.5020699620244645,1.1548699563735423,0.2813411078717201,0.9864973070586116,1.0,6/16,16.86%,XPO1;RSRC1;PSIP1;NUP205;NXT1;AAAS
prerank,cellular response to calcium ion (GO:0071277),0.39694065903565995,1.1544058218469888,0.26101694915254237,0.9871433298080102,1.0,26/67,24.33%,CPNE8;DPEP1;HPCA;WNT5A;SYT1;SCN5A;NLGN1;SYT11;SYT12;ALOX5AP;IQGAP1;GPLD1;SLC25A24;CPNE7;SYT2;RYR3;CPNE1;SYT13;ADCY8;PKD2;CPNE3;CAMK2D;PRKAA1;SYT3;CPNE5;MEF2A
prerank,neurogenesis (GO:0022008),0.4210115167850038,1.1541477246023513,0.27439024390243905,0.9869221035422047,1.0,4/43,7.37%,DCHS1;LPAR1;METTL3;CDK6
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.2817684606147081,-1.1538567109870865,0.16,0.7782467441196248,1.0,18/75,12.92%,ATP1A2;ATP1B3;SLC8A3;SLC12A7;SLC9A6;SLC9A2;KCNJ2;ABCC9;ATP1A1;SLC12A9;SLC39A8;SLC39A6;SLC9A9;SLC9A7;SLC6A1;KCNK9;TRPV2;SLC12A8
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.47521256205874723,1.1537579008274765,0.292749658002736,0.9872304328043623,1.0,8/23,20.34%,RAD23B;DDB2;XPA;DDB1;UBB;CUL4B;COPS6;COPS7A
prerank,cellular response to heat (GO:0034605),-0.323827971797446,-1.1536202664879953,0.19786096256684493,0.7765213190997013,1.0,23/35,40.16%,ANO1;THBS1;STUB1;MAPT;HSP90AA1;TRPV4;HSP90AB1;HTRA2;TCIM;PDCD6;IER5;POLR2D;ZFAND1;VCP;SLU7;FGF1;HSPA1B;HMOX1;ATXN3;BAG3;HSF1;HSBP1L1;IL1A
prerank,global genome nucleotide-excision repair (GO:0070911),0.4636077940115844,1.1532807206385398,0.28683181225554105,0.9878388351734025,1.0,9/26,16.94%,RAD23B;GTF2H2;ERCC4;DDB2;XPA;DDB1;UBB;RNF111;CUL4B
prerank,Golgi inheritance (GO:0048313),0.5391765086373892,1.153232990682149,0.3073248407643312,0.9867784433636166,1.0,2/11,7.26%,YWHAZ;GBF1
prerank,protein insertion into membrane (GO:0051205),0.44027856997592973,1.152594405177075,0.28607594936708863,0.9880726816090417,1.0,10/32,15.49%,EGFR;WDR83OS;PRNP;COX18;VAPA;UBE2J2;EMD;OTOF;CCDC47;SEC61G
prerank,aorta development (GO:0035904),-0.4237238747846646,-1.152392902019143,0.2870662460567823,0.7777004215280626,1.0,7/14,12.23%,ROBO1;TBX1;EFEMP2;JAG1;HECTD1;PDGFRB;PDE2A
prerank,histone H4 acetylation (GO:0043967),0.41972872866021577,1.1520918982349584,0.27075812274368233,0.988872661682904,1.0,15/47,15.72%,KMT2A;JADE1;HAT1;JADE3;KAT8;BRD8;MORF4L2;ATF2;PHF20;ING4;EPC1;PER1;KANSL1;TRRAP;MSL3
prerank,cell-matrix adhesion (GO:0007160),0.3824226023921495,1.1519487102083488,0.24615384615384617,0.988212872750751,1.0,21/95,17.60%,DLC1;ADAMTS12;RHOD;CD34;PEAK1;ITGB8;TESK2;HOXD3;TSC1;MKLN1;COL3A1;TRIP6;SGCE;PPFIA2;TMEM8B;PKD1;ITGB1;CTTN;ZYX;ITGB7;PIP5K1A
prerank,L-glutamate transmembrane transport (GO:0015813),0.564446178351424,1.151792296239429,0.31921331316187596,0.9876167216977505,1.0,3/10,13.27%,SLC1A3;ARL6IP5;PRAF2
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.4564505331022667,1.1516636997582044,0.2967032967032967,0.9868861242139192,1.0,4/26,7.37%,MYC;PTPN2;HOXA7;CDK6
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.496346445580096,1.1514217045247668,0.2867332382310984,0.9865925557582507,1.0,6/18,17.10%,MYC;NF1;EMD;MED25;TP53;CDC73
prerank,homotypic cell-cell adhesion (GO:0034109),0.4270115565657837,1.1511750399522447,0.2825,0.9862851933418763,1.0,4/39,2.65%,UBASH3B;PDGFRA;CSRP1;RAP2B
prerank,regulation of interleukin-6 production (GO:0032675),0.3850097697383008,1.1505697600244547,0.2531914893617021,0.9874659398694704,1.0,22/96,20.62%,IL16;PYCARD;PTPN22;IRAK3;MAPKAPK2;WNT5A;TMEM106A;CARD9;SELENOS;SYT11;TLR1;PTPN11;IL33;FOXJ1;LBP;CD74;RAB7B;SETD4;STAT3;BCL10;SIRPA;HSPD1
prerank,positive regulation of transferase activity (GO:0051347),0.3719788088447385,1.1504411572336009,0.21897810218978103,0.9867524638679355,1.0,15/142,4.62%,ROR2;ROR1;PDGFRA;ERBB3;NTRK3;PRKCQ;MYC;EPHB6;ERBB2;EGFR;EPHB2;FBXW7;CHTF18;TGFB1;NTRK2
prerank,positive regulation of neurogenesis (GO:0050769),0.39470027779108857,1.1504185277654184,0.26042841037204056,0.9855848218305698,1.0,13/68,6.40%,CHODL;SOX8;NGF;PLXNC1;IL1RAPL1;VEGFA;SOX11;NTRK2;NUMBL;OBSL1;CDKL5;CDKL3;DISC1
prerank,snRNA metabolic process (GO:0016073),0.48771197738490574,1.1500090950776143,0.29411764705882354,0.9859922245147348,1.0,7/17,15.92%,INTS11;INTS6;INTS4;INTS2;INTS8;RBM7;MEPCE
prerank,lymphocyte mediated immunity (GO:0002449),-0.4413147903793206,-1.1498285028929365,0.28023598820059,0.7834407598590741,1.0,4/12,29.10%,CD55;JAG1;GNL1;MSH2
prerank,positive regulation of bone mineralization (GO:0030501),0.43365437606035806,1.1498257111768546,0.30472636815920395,0.9854781627530247,1.0,12/35,15.69%,OSR2;PKDCC;ACVR1;ANO6;GPM6B;TGFB1;BMP7;ATRAID;ATP2B1;BMPR1A;TGFB3;FZD9
prerank,RNA biosynthetic process (GO:0032774),-0.3392007199193751,-1.1495839960650245,0.2168141592920354,0.7817528072754761,1.0,13/31,24.55%,NCOA6;BRF1;PRIM2;POLA1;TAF13;PRMT5;HELB;POLA2;TERT;SMARCA5;BRF2;TAF10;TBPL1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.43969326195685693,1.1491893440846193,0.30066225165562915,0.9867811608652537,1.0,8/29,20.13%,PLBD1;MBOAT2;PLA2G12A;PLAAT3;PNPLA8;LPCAT2;PLA2G4E;DBI
prerank,negative regulation of neuron death (GO:1901215),0.3858725965962596,1.1490901239162312,0.2631004366812227,0.9859193325512863,1.0,19/93,15.69%,ERBB3;BCL2;CD34;CRLF1;NGF;PRKN;NTRK2;MT3;FBXO7;RASA1;SNX6;EIF4G1;GDNF;GRN;PTPRZ1;SOD2;SNCA;TGFB3;FZD9
prerank,negative regulation of RNA metabolic process (GO:0051253),0.48214747021902116,1.1490323850400408,0.2923728813559322,0.9849241835101692,1.0,5/18,14.01%,KAT2B;TGFB1;SHQ1;ESR1;NCOR2
prerank,response to histamine (GO:0034776),0.5412907854121712,1.1489887022705467,0.3119266055045872,0.9838405069011689,1.0,4/10,16.01%,HRH1;AOC1;DRD2;GABRG2
prerank,response to muramyl dipeptide (GO:0032495),0.5289265112234521,1.148547807066094,0.3228346456692913,0.984416843188661,1.0,3/12,11.40%,PTPN22;ERBIN;TRIM41
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.46366742092055513,1.1480002451577838,0.297554347826087,0.9852915235419452,1.0,4/25,8.01%,HAS2;EXT1;B3GNT9;CSGALNACT1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.4936194372695807,1.1479840469637825,0.31142857142857144,0.9841386407137808,1.0,3/18,6.22%,CCDC39;AQP4;RFX3
prerank,regulation of neuron apoptotic process (GO:0043523),0.38398892199586504,1.1479333876407434,0.253475935828877,0.9831303681132666,1.0,19/96,12.96%,ERBB3;BCL2;CRLF1;NGF;PRKN;NTRK2;PRNP;MT3;NF1;GRID2;RASA1;TRIM2;NAE1;SNX6;GDNF;CDK5R1;GRN;PTPRZ1;SOD2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.4805509161522119,1.147166362998802,0.32123655913978494,0.9849588803602738,1.0,5/20,15.14%,RNF157;BICD1;SNCA;CRY1;MET
prerank,carboxylic acid catabolic process (GO:0046395),0.530569994128261,1.1470286819641309,0.3176470588235294,0.9842884010056187,1.0,5/12,21.31%,NAGK;IL4I1;GNPDA1;BCKDK;ACOT8
prerank,positive regulation of endopeptidase activity (GO:0010950),0.44323552064329563,1.1468409617645516,0.28936742934051146,0.9837987986185871,1.0,7/26,14.08%,USP50;PYCARD;GRIN2B;FYN;NCSTN;APH1A;TTBK1
prerank,response to calcium ion (GO:0051592),0.3740049919081175,1.1467263651576611,0.25026624068157616,0.9830187608378125,1.0,33/102,22.01%,CPNE8;DPEP1;HPCA;WNT5A;SYT1;SCN5A;NLGN1;PPP3CA;KCNMB2;KCNMB3;ANXA11;SYT11;SYT12;ALOX5AP;AHCYL1;CALM1;IQGAP1;CALM2;HOMER1;GPLD1;SLC25A24;CPNE7;KCNMA1;SYT2;RYR3;CPNE1;SYT13;ADCY8;PEF1;PKD2;CPNE3;CAMK2D;PRKAA1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.5015620051310653,1.1465569964632363,0.30505952380952384,0.9824513950232253,1.0,2/15,5.38%,HSPH1;CCR2
prerank,positive regulation of B cell activation (GO:0050871),0.40488508606587487,1.146415160022595,0.27726218097447797,0.9817730683473481,1.0,6/50,8.26%,BCL2;IRS2;BST1;EPHB2;CD320;VAV3
prerank,negative regulation of protein modification process (GO:0031400),0.3859038568340386,1.146292886594264,0.2599118942731278,0.9810243469459692,1.0,18/79,13.05%,NTRK3;PIP5KL1;PTEN;PRKN;EPHB2;CADM4;TGFB1;PRNP;PPP1R15A;PTPN13;NIBAN1;MEN1;ENSA;PPP1R8;CDYL;PID1;FXYD1;WWTR1
prerank,T cell mediated immunity (GO:0002456),-0.43813004479135864,-1.1454985854865163,0.2874617737003058,0.7924959342040824,1.0,3/13,9.87%,CTSH;CD55;JAG1
prerank,peptidyl-arginine modification (GO:0018195),-0.41566211103385386,-1.1454679778545476,0.26,0.7901531215395623,1.0,5/15,14.45%,PRMT7;PRMT5;KRTCAP2;PRMT8;PADI2
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.5139758807335074,1.145461089693165,0.3093841642228739,0.9830686852559106,1.0,4/12,16.03%,PTPN1;PIK3R1;TMEM33;BCL2L11
prerank,positive regulation of glucose metabolic process (GO:0010907),0.512338331298557,1.1453713384645121,0.3204172876304024,0.982190597801347,1.0,4/14,15.91%,IRS2;PTPN2;DDB1;GPLD1
prerank,negative regulation of blood coagulation (GO:0030195),0.42291341497087503,1.1449016546093238,0.2806573957016435,0.9827998395876099,1.0,4/38,7.57%,PDGFRA;A2M;CD34;SERPINE2
prerank,atrioventricular valve development (GO:0003171),0.5044952956506841,1.1447644956114058,0.31846153846153846,0.982127561442394,1.0,6/14,17.26%,ACVR1;TGFBR2;MDM4;BMPR1A;APLNR;HEYL
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.48882840237209374,1.1431691095741547,0.30831099195710454,0.9872294727993391,1.0,3/18,7.90%,BCL2;THEM4;BNIP3
prerank,neuron projection regeneration (GO:0031102),-0.47913184452516394,-1.142756064476508,0.3258426966292135,0.7965321983843796,1.0,2/10,2.84%,PTN;GAP43
prerank,positive regulation of phospholipase activity (GO:0010518),0.46608392131388054,1.142648592368211,0.3129346314325452,0.9881587129714674,1.0,7/22,11.09%,PDGFRA;NTRK3;FGF2;ARL1;FGFR1;ARF4;ESR1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.5232682033198932,1.1410008363807786,0.3153846153846154,0.9933393466121484,1.0,5/12,24.35%,SNAP23;SNAP29;STX1B;STX2;SNAP47
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.501198147587728,1.140841640719962,0.33709449929478136,0.9927336090267053,1.0,5/17,16.33%,ANK2;SCN5A;NEDD4L;PKP2;KCNH2
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5057144280275389,1.140634481553155,0.2865671641791045,0.9923162671281116,1.0,5/13,19.10%,AP1G1;IL18;ZBTB1;TICAM1;AXL
prerank,response to hydroxyurea (GO:0072710),0.5357928225541801,1.140554011503908,0.32315112540192925,0.9913748184767609,1.0,5/11,16.10%,DDX11;NSMCE3;ATRX;BLM;SPIDR
prerank,positive regulation of double-strand break repair (GO:2000781),0.4257193045052048,1.140392975231874,0.3054187192118227,0.990810933628185,1.0,7/39,10.38%,DDX11;SPIRE1;FMN2;MRNIP;SETMAR;FOXM1;SLF2
prerank,protein localization to plasma membrane (GO:0072659),0.3693568401548175,1.140092591172561,0.24581589958158995,0.9908048507993433,1.0,30/129,15.37%,PTCH1;ANK3;ANK1;FGF13;ANK2;GORASP1;C2CD5;WNK3;PACS2;TSPAN32;TNIK;SPTBN1;DPP10;RAP1A;RAB34;GAK;EPB41L3;FLNA;RAB3D;GORASP2;TSPAN17;RAB3A;MAP7;TMED2;P2RY1;TTC7A;KCNIP4;EHD2;JUP;PKP2
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.4355230906917014,-1.140003708802116,0.2883435582822086,0.8027409500400337,1.0,4/12,18.46%,NOTCH2;PTK2B;LFNG;MFNG
prerank,chloride transport (GO:0006821),0.38642205251922385,1.139186839661299,0.28013392857142855,0.9931590869172593,1.0,14/74,16.01%,FXYD3;ANO2;SLC1A3;SLC12A3;ANO6;SLC12A2;TTYH3;TTYH1;SLC12A4;FXYD1;ANO10;CLIC1;CLCN2;GABRG2
prerank,tRNA aminoacylation (GO:0043039),0.423376225069748,1.138856073892863,0.30357142857142855,0.9932465889827967,1.0,9/37,14.00%,IARS2;EPRS1;FARSA;SARS2;GATB;FARSB;FARS2;YARS1;HARS1
prerank,response to interferon-alpha (GO:0035455),-0.4097573361244495,-1.138851692870893,0.2764505119453925,0.8040605294803475,1.0,7/16,22.29%,IFITM3;KLHL20;IFITM2;BST2;IFNAR1;IFNAR2;PDE12
prerank,metal ion transport (GO:0030001),0.383467566287951,1.1387564339518075,0.2891566265060241,0.9924268212586939,1.0,17/86,14.33%,CACNA1E;CACNA2D1;MRS2;CACNG7;NIPA1;CACNA1A;CHRNA4;PSEN1;MT3;NIPAL2;SLC8A2;FYN;MAGT1;NDFIP1;TUSC3;TRPC5;PSEN2
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.458826671002806,1.1385561725941151,0.3035019455252918,0.9920770648197861,1.0,8/27,13.58%,PRKCQ;PTPN2;SLC27A4;SOCS1;GRB14;PTPN1;PID1;NCK1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.24317508475253924,-1.1385200507078708,0.10526315789473684,0.8025451043947323,1.0,45/182,13.07%,FOXP1;NOTCH2;IGF1;ROBO1;ROCK2;WNT4;CLDN5;OCLN;ACVRL1;BMP4;ENG;NOCT;SLC7A5;REL;ANXA7;MOV10;KDR;SETDB2;AGO1;ERP29;TERF2;APP;PARP10;RIN3;MTMR2;KLF4;TET1;MAP2K1;ADAM10;RACK1;FLCN;PRKAA2;SLC24A3;XDH;CCDC3;ATOH8;OPTN;LGMN;GATA2;AGO3;MAPT;ID2;TGFB2;SLC2A10;VHL
prerank,histone H3-K36 demethylation (GO:0070544),0.5555435354651106,1.1383587460895732,0.3261205564142195,0.9916205303290029,1.0,4/10,19.97%,KDM8;KDM4B;PHF8;RIOX2
prerank,response to amyloid-beta (GO:1904645),0.4092201632130716,1.1372900988544918,0.29156626506024097,0.9945757515441263,1.0,10/44,10.82%,MMP2;CACNA2D1;LRP1;CACNA1A;PSEN1;PRNP;FYN;SNX6;GRM5;NGFR
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.4210966188402342,1.1372690683752738,0.2952261306532663,0.9934743315792913,1.0,12/33,20.14%,FGF2;TGFB1;HIF1A;KLF5;NGFR;GATA3;TP53;EGR1;PPARG;STAT3;SMARCA4;JUN
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.4053968082412217,-1.1363641365388908,0.3059210526315789,0.8068293815823971,1.0,6/15,23.97%,SNX9;ADRA2A;NRDC;APOE;SNX33;SH3D19
prerank,fat cell differentiation (GO:0045444),0.39940103968242135,1.1362927897263737,0.2909090909090909,0.9959429522092338,1.0,10/57,14.46%,FFAR4;STEAP4;SOX8;PRDM16;BBS9;FAM120B;PID1;TMEM120A;ATF5;SENP2
prerank,muscle filament sliding (GO:0030049),-0.3205828384917585,-1.135954221456662,0.2205128205128205,0.8032747899128053,1.0,20/38,41.57%,TPM3;MYL6;TPM1;ACTN2;TPM2;TMOD1;DES;MYBPC1;DMD;MYL4;TNNI1;TTN;MYL1;NEB;TNNC1;TNNI3;TCAP;MYBPC2;MYL3;ACTA1
prerank,actin-myosin filament sliding (GO:0033275),-0.3205828384917585,-1.135954221456662,0.2205128205128205,0.8032747899128053,1.0,20/38,41.57%,TPM3;MYL6;TPM1;ACTN2;TPM2;TMOD1;DES;MYBPC1;DMD;MYL4;TNNI1;TTN;MYL1;NEB;TNNC1;TNNI3;TCAP;MYBPC2;MYL3;ACTA1
prerank,regulation of acrosome reaction (GO:0060046),0.5486653060332107,1.1358226735383914,0.3386327503974563,0.9965423448106792,1.0,1/10,4.99%,PLCB1
prerank,positive regulation of biomineral tissue development (GO:0070169),0.4192547753000322,1.1355455295964818,0.3148371531966224,0.9964455497012824,1.0,13/40,15.69%,OSR2;PKDCC;ACVR1;ANO6;GPM6B;TGFB1;AMELX;BMP7;ATRAID;ATP2B1;BMPR1A;TGFB3;FZD9
prerank,peptidyl-lysine trimethylation (GO:0018023),0.45346235407910146,1.1355168119652594,0.3118421052631579,0.9953563326929548,1.0,13/26,26.87%,SUV39H1;KMT2A;SETD3;SETD2;PRDM9;SETD5;TET3;SETD4;KMT2D;TET2;KMT5B;VCPKMT;KMT5C
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.3955544959106305,-1.135222432996794,0.28040540540540543,0.8031698226550696,1.0,9/16,28.87%,ATP7A;SLC25A33;NUPR1;PINK1;AK4;PDE12;COX7A2;PPIF;VCP
prerank,organic substance transport (GO:0071702),0.36833666990005687,1.1352071756348863,0.2707240293809024,0.9953105183292289,1.0,24/121,18.45%,ABCA6;SLC6A2;ABCA9;SLC22A3;RAB38;CD320;SLCO2B1;SCAMP2;PEX3;GM2A;RCN3;SLC50A1;NDC1;ABCA5;ARL6IP5;HSP90B1;ABCB9;LRP2;ABCG4;ABCD2;DENND10;RAB7A;KIF3A;SLC6A4
prerank,activation of phospholipase C activity (GO:0007202),0.4396117859837726,1.134640879938094,0.30179028132992325,0.9962654277113354,1.0,3/29,4.62%,EGFR;LPAR1;NTRK2
prerank,leukotriene metabolic process (GO:0006691),0.47162436415151865,1.1345379152942716,0.31353591160220995,0.9954756554019416,1.0,5/19,11.78%,DPEP1;MAPKAPK2;LTA4H;DPEP2;ALOX5AP
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.33129192969743926,-1.1343241651060973,0.27522935779816515,0.8036791967674295,1.0,16/31,29.08%,TOMM70;TIMM23;PEX7;DNAJC15;PEX14;PEX26;TIMM17A;PEX2;ROMO1;PEX10;GRPEL1;PEX6;PEX16;DNLZ;TOMM40;TOMM40L
prerank,chromosome organization (GO:0051276),0.37444931107364976,1.134323713777533,0.2713833157338965,0.9951016864518905,1.0,24/99,20.34%,MYC;RAD23B;LRWD1;HMGN1;SUV39H1;SATB1;EZH1;DDB2;NUP155;XPA;POLE3;HDAC2;MSH6;DDB1;UBB;ABL1;PHF19;CUL4B;CENPV;NUF2;COPS6;HMG20A;SMARCA4;COPS7A
prerank,regulation of dephosphorylation (GO:0035303),-0.41267980064430326,-1.134061354631661,0.2981366459627329,0.8022215752548486,1.0,6/15,25.35%,PPP1R16B;MTMR2;IGBP1;MTMR9;SMG5;MTMR3
prerank,protein localization to membrane (GO:0072657),0.36049619659186954,1.1339600301579713,0.2286302780638517,0.9953316401046537,1.0,42/187,15.37%,PTCH1;ANK3;ANK1;HPS6;FGF13;ANK2;RAB38;C2CD5;SAV1;WNK3;ARL3;PACS2;NPC1;NRXN1;TSPAN32;TNIK;SPTBN1;DLG2;NLGN1;NUP155;DPP10;RAP1A;RAB34;GAK;EPB41L3;FLNA;RAB3D;ARL5C;NDC1;TSPAN17;MAGI2;DVL1;SCRIB;RAB3A;MAP7;TMED2;P2RY1;TTC7A;KCNIP4;EHD2;JUP;PKP2
prerank,regulation of interleukin-1 beta production (GO:0032651),0.38823334012230837,1.1338887160209743,0.28255813953488373,0.9944168555559875,1.0,5/66,5.27%,FFAR4;USP50;PYCARD;WNT5A;TMEM106A
prerank,mRNA splice site selection (GO:0006376),0.43797468054502303,1.13362278755934,0.29908972691807545,0.9942665045598394,1.0,11/30,20.76%,CELF5;LUC7L2;PSIP1;CELF6;SRSF6;YTHDC1;LUC7L;PRPF39;SF3A1;SF1;CELF4
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.55058825739113,1.133471989776926,0.338006230529595,0.9936282669934706,1.0,3/10,9.95%,KMT2A;BRCA1;PIH1D1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.39188868041450414,1.1329047476136895,0.27335640138408307,0.9946000334905638,1.0,7/63,4.20%,LGALS3;BCL2L14;PYCARD;ACVR1;FADD;TNFRSF10B;DEPTOR
prerank,positive regulation of cellular respiration (GO:1901857),-0.4362355491599769,-1.1328361030219856,0.33630952380952384,0.8038393664935977,1.0,7/11,36.17%,NUPR1;IL10RB;PINK1;IFNAR1;VCP;ISCU;IFNLR1
prerank,hippo signaling (GO:0035329),0.44679221620544896,1.1327699174242423,0.3289817232375979,0.9939390588949107,1.0,2/26,3.20%,DCHS1;SAV1
prerank,P-body assembly (GO:0033962),0.5176505977486412,1.13148068715193,0.33124018838304553,0.997700304041134,1.0,7/12,22.06%,ATXN2;LSM3;EIF4ENIF1;RC3H1;LIMD1;DDX6;DYNC1H1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.3788925178347646,1.131127934668103,0.2830396475770925,0.9979264627088869,1.0,28/80,20.05%,PITPNB;ATP9B;COPZ2;GBF1;COPB2;COPG2;TMED10;KDELR2;ARF4;NBAS;BICD2;RAB1A;COPA;ARFGAP3;ARFGAP1;TMED2;TMED3;KIF22;COPG1;KDELR3;BNIP1;SURF4;KIF3A;HTT;KIF2A;ERGIC3;RINT1;COG4
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.38808487995804647,1.1307898542770343,0.2916666666666667,0.9980480004343923,1.0,19/72,16.94%,RNASE6;GTF2H2;DXO;ERCC5;ERCC4;DDB2;SETMAR;RPA3;XRN2;XPA;DCP1B;REXO4;EDC4;FBH1;DDB1;EXD2;RPA2;UBB;CUL4B
prerank,positive regulation of multicellular organismal process (GO:0051240),0.35489220265624627,1.1306363027409314,0.19254032258064516,0.997491186931828,1.0,34/308,8.53%,EBF2;FFAR4;SOX6;ETV4;GLMN;GLIPR2;CRH;SLC27A1;FGF2;SOX8;PRDM16;SOX9;LRP1;ACVR1;VEGFA;TGFB1;SOX11;PLCB1;WNT5A;CCR2;NLGN1;AGPAT2;RFX3;PTH2R;TGFBR2;ZBTB16;PRKAB2;CARD9;ELOVL6;IL18;TSHR;CADM1;SOX5;SMO
prerank,positive regulation of viral process (GO:0048524),0.39235715900911633,1.130542535054437,0.2916666666666667,0.9966828231516077,1.0,16/60,19.11%,MDFIC;FKBP6;PABPC1;POLR2B;PPID;POLR2K;DDB1;ADARB1;TBC1D20;KPNA6;POLR2G;PPIH;RAB7A;PKN2;AXL;POLR2A
prerank,cranial nerve development (GO:0021545),0.5225348563136579,1.130170246459137,0.33037037037037037,0.9970207336447936,1.0,1/11,1.05%,ERBB3
prerank,inner dynein arm assembly (GO:0036159),0.5538487899525008,1.1299782257276867,0.33695652173913043,0.9965796771890978,1.0,1/10,3.01%,CCDC39
prerank,mitochondrion transport along microtubule (GO:0047497),0.5080674970096143,1.129771938232396,0.3204334365325077,0.9962217609170815,1.0,6/13,22.98%,HIF1A;RHOT2;OPA1;UBB;RHOT1;SYBU
prerank,C-terminal protein amino acid modification (GO:0018410),0.5139608682428148,1.1296656147518878,0.3230769230769231,0.9955062638104807,1.0,4/11,15.91%,ATG5;AGBL4;AGBL1;GPLD1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.40125368844985304,1.1293040941941903,0.30742049469964666,0.9957586805037092,1.0,9/52,10.11%,LGALS3;LRP1;EGFR;EPHB2;WNK3;SPTBN1;DPP10;ZDHHC8;PIK3R1
prerank,transport along microtubule (GO:0010970),0.5146337038563209,1.1292125511415496,0.32488822652757077,0.9949590653504515,1.0,7/13,14.65%,COPG2;SPG11;DYNC1I1;ARHGAP21;APBA1;DYNC1I2;COPG1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.3248138446852794,-1.129195389286572,0.25,0.8129430106708272,1.0,6/30,6.73%,FLT1;KIT;MLLT3;BMP4;KDR;ACE
prerank,linoleic acid metabolic process (GO:0043651),0.4868436790968207,1.128737314510777,0.32271468144044324,0.9956638689103042,1.0,3/17,13.78%,FADS2;ELOVL5;PNPLA8
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.45561313267829673,1.1286639194014894,0.3190348525469169,0.9948125312088821,1.0,5/28,7.18%,BCL2;NGF;FADD;TNFRSF10B;DEDD
prerank,regulation of establishment of cell polarity (GO:2000114),-0.39777254633344766,-1.1284275505122034,0.296969696969697,0.812977362824017,1.0,5/16,4.20%,ROCK2;CDH5;RAP1B;ROCK1;CYRIB
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.3578843488466762,-1.1284209461652503,0.2765957446808511,0.8106057590457365,1.0,8/21,11.89%,MACF1;ROCK2;ROCK1;LIMCH1;EPHA3;DUSP3;RHOA;ACTG1
prerank,regulation of platelet aggregation (GO:0090330),0.4846691809562086,1.1282681542336253,0.33476394849785407,0.9951673528144829,1.0,3/17,7.57%,PRKCA;PRKCQ;SERPINE2
prerank,copper ion homeostasis (GO:0055070),-0.3901863981632131,-1.1282464016158322,0.28802588996763756,0.8087602195892044,1.0,5/17,7.14%,SLC31A1;ATP7A;COMMD1;APP;SLC31A2
prerank,T cell homeostasis (GO:0043029),0.5392816677136352,1.1278884305309977,0.32861635220125784,0.9954722618647955,1.0,2/10,7.75%,FADD;ZC3H8
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.5093467134495074,1.1276163976769737,0.3277439024390244,0.9953652221280076,1.0,3/13,13.06%,FADD;MR1;NECTIN2
prerank,regulation of protein kinase activity (GO:0045859),0.36683482394389777,1.127577682205761,0.267515923566879,0.9943478262859237,1.0,24/106,18.70%,RELN;UBASH3B;RAP2B;DEPTOR;TRAF4;NF1;MRNIP;ALS2;SPRED1;RAP1A;MMD2;DVL1;XRCC6;WWTR1;SNCA;TAF7;IQGAP1;RASSF2;PYDC1;JTB;DBNDD2;PARK7;MAPRE3;PPM1E
prerank,histone acetylation (GO:0016573),0.387015606670863,1.1274810414807388,0.2907239819004525,0.9935551545629315,1.0,18/69,15.72%,KAT2B;JADE1;HAT1;TADA1;TAF5L;JADE3;KAT8;POLE3;BRD8;MORF4L2;ATF2;PHF20;TAF9;ING4;EPC1;PER1;TRRAP;MSL3
prerank,intracellular sterol transport (GO:0032366),-0.42523607402295827,-1.1273460911301496,0.31750741839762614,0.8092751417950154,1.0,6/13,12.08%,ABCA1;OSBP;OSBPL2;VPS4A;ABCG1;STARD4
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.47935895701349085,1.1272004388522892,0.32673267326732675,0.9934962211876327,1.0,5/17,13.10%,HM13;DERL2;SELENOS;HERPUD1;HSP90B1
prerank,"wound healing, spreading of cells (GO:0044319)",0.44396508064311824,1.1271244486373915,0.30492676431424764,0.9926286878033682,1.0,1/24,0.14%,ARHGAP24
prerank,hyaluronan catabolic process (GO:0030214),0.48019258125239817,1.1270285337563541,0.34119278779472956,0.9918528984276925,1.0,8/18,25.35%,FGF2;TGFB1;SLC9A1;SPAM1;HYAL1;CEMIP;HEXB;CEMIP2
prerank,protein localization to condensed chromosome (GO:1903083),-0.4523670327346698,-1.1266064848864124,0.31547619047619047,0.8090652026863487,1.0,10/12,47.58%,BUB3;IK;KNL1;ZW10;TTK;SPDL1;CDK1;MTBP;AURKB;CHAMP1
prerank,Rho protein signal transduction (GO:0007266),0.3964422225709794,1.1265686829623682,0.30221703617269546,0.992419264504947,1.0,14/53,15.02%,RTKN;RHOJ;TAX1BP3;RHOD;CTNNAL1;EPS8L1;LIMK1;ARHGEF11;COL1A2;MYO9B;NGFR;ARHGAP4;ARHGEF3;CDC42EP1
prerank,GTP metabolic process (GO:0046039),-0.41399834367637056,-1.1264932738717315,0.31683168316831684,0.8070860020352244,1.0,7/15,19.89%,GTPBP1;RHOQ;ENTPD7;GNAI3;IMPDH1;AK4;IMPDH2
prerank,positive regulation of chromosome organization (GO:2001252),0.4947384550422067,1.1260306788166605,0.33480176211453744,0.9934144037435052,1.0,4/15,14.50%,DDX11;ATRX;SIRT6;RTEL1
prerank,regulation of DNA repair (GO:0006282),-0.30349064951904897,-1.1259703598931363,0.26143790849673204,0.8063549813823279,1.0,13/44,14.95%,EYA1;EYA2;PARG;EYA4;ERCC8;NPAS2;BABAM1;POLH;ABRAXAS1;WRAP53;PML;UBE2N;PCNA
prerank,lymphocyte differentiation (GO:0030098),0.38805852862431467,1.125693676720232,0.2987598647125141,0.9934862760542016,1.0,11/68,15.04%,RAG2;PTPN22;PTPN2;DNAJB9;RABL3;NHEJ1;PTPRJ;DCAF1;RHOH;GATA3;ITGB1
prerank,steroid hormone biosynthetic process (GO:0120178),0.4334266593621026,1.1256474725924344,0.32567049808429116,0.9925376620396107,1.0,3/29,11.75%,HSD17B7;HSD17B11;TSPOAP1
prerank,protein localization to cell periphery (GO:1990778),0.3639912854202064,1.1252526013951518,0.26332288401253917,0.9929353987069959,1.0,29/133,15.37%,PTCH1;ANK3;ANK1;FGF13;ANK2;C2CD5;WNK3;ARL3;PACS2;TSPAN32;TNIK;SPTBN1;DPP10;RAP1A;RAB34;GAK;EPB41L3;FLNA;RAB3D;TSPAN17;RAB3A;MAP7;TMED2;P2RY1;TTC7A;KCNIP4;EHD2;JUP;PKP2
prerank,smooth muscle tissue development (GO:0048745),0.5251399705802876,1.1249211535037584,0.33384615384615385,0.9929899619992061,1.0,3/10,8.53%,PTCH1;NF1;SMO
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.5434269461603453,1.1248775721456143,0.36288998357963875,0.9920440465984094,1.0,4/10,17.43%,FBXW7;NCF1;BTC;HBEGF
prerank,positive regulation of interleukin-10 production (GO:0032733),0.4425684644430311,1.1246014835605223,0.32611464968152865,0.9919644384746035,1.0,2/30,1.94%,PYCARD;CD34
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.4887825506161163,1.124462961366599,0.3342776203966006,0.9913980324938508,1.0,2/16,1.37%,BMP5;ZFAND2B
prerank,regulation of neuron migration (GO:2001222),0.4509196220517655,1.1241146654931347,0.31752305665349145,0.9915581675065691,1.0,6/26,8.09%,KIF20B;SEMA3A;CTNNA2;NTNG2;NTNG1;COL3A1
prerank,regulation of monocyte chemotaxis (GO:0090025),0.450707940553949,1.1237917312219337,0.324254215304799,0.9915920938027913,1.0,4/24,6.79%,CXCL10;ANO6;CCR2;PLA2G7
prerank,regulation of B cell activation (GO:0050864),0.44389355067837705,1.1237683302241503,0.3149100257069409,0.9905569110130155,1.0,7/25,21.38%,SAMSN1;ZFP36L2;IL4I1;SH3KBP1;AHR;FOXJ1;TNIP2
prerank,positive regulation of gene expression (GO:0010628),0.3491741715126484,1.1235322057738395,0.1579476861167002,0.9903385824348215,1.0,64/442,11.39%,OSR2;SEC16B;CLDN19;ANK3;GLMN;ADAM19;NTRK3;EPB41L4B;FGF2;RBMS3;MYC;FGF10;PTPN22;ANK2;CD34;KAT2B;SOX9;NGF;GSN;ERBB2;PRKN;EGFR;VEGFA;EPHB2;EIF2AK3;ELAVL4;TLE1;PLD1;UPF3A;TGFB1;ITGB8;PSEN1;SOX11;NTRK2;MT3;WNT5A;TAF1A;NIBAN1;HOXD3;AGPAT2;METTL3;CARD9;EIF3C;CPEB3;CADM1;SMO;EIF6;BRCA1;POLR2K;MAPK9;NSUN5;PASK;HIF1A;SFRP4;PIK3R1;ATF2;NFE2L2;MAPK14;PID1;RIMS1;SP1;BMP7;MAPK1;FGF7
prerank,second-messenger-mediated signaling (GO:0019932),0.37788198493675607,1.1232963503542983,0.283205268935236,0.990076030906021,1.0,14/82,15.91%,CHRM3;HRH1;PPP1R9A;EIF2AK3;CCR2;ACKR3;RCAN1;RCAN3;EDN3;MCTP1;TPCN2;P2RY12;ACKR4;LAT2
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.31985637781024395,-1.1231883412252885,0.2474747474747475,0.8131004555163978,1.0,12/36,15.68%,WASL;NOS3;NPR3;NOSTRIN;TERF2;DNM2;DDAH2;HSP90AA1;NUS1;CAV1;TERT;SPR
prerank,regulation of protein-containing complex assembly (GO:0043254),0.3719934884666817,1.1230972967691462,0.280982905982906,0.9897192940107452,1.0,24/110,16.10%,LGALS3;HRK;GSN;VEGFA;TGFB1;ATF7IP;RALB;BMF;BRK1;ANKRA2;CRYAB;FARP2;PIH1D1;SLF2;PTPN11;HDAC6;RHOC;HJURP;SUMO1;GFAP;MTLN;STX1B;BCL2L11;SPIDR
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.2840538691828338,-1.1230476133110476,0.1951219512195122,0.8112445982795183,1.0,26/65,29.73%,PSMD14;USP47;FBXL7;PSMB3;PSMD12;VPS4A;PSMD6;PSMA1;NABP1;PSMD7;PSMA5;PSMC5;PINX1;PSMC4;PSMB6;PSMA4;AVEN;PSMB9;PSMB1;CHFR;ZFYVE19;PSMD3;PSMC6;PSMD10;PSME3;CHEK1
prerank,amino acid import across plasma membrane (GO:0089718),-0.3535966355639015,-1.1228227063719993,0.2901960784313726,0.8095709261528433,1.0,6/24,3.49%,SLC7A2;SLC47A1;SLC6A6;SLC22A4;SLC6A13;SLC7A5
prerank,cellular response to dsRNA (GO:0071359),-0.40894750129080937,-1.1228069313644344,0.3063973063973064,0.8073145823167664,1.0,9/15,23.00%,NPM1;IFIH1;RIOK3;CAV1;FLOT1;IFIT1;COLEC12;PDE12;MUL1
prerank,ERK1 and ERK2 cascade (GO:0070371),0.460857232268561,1.1226370638981573,0.34444444444444444,0.9903644686527563,1.0,6/21,11.33%,MYC;FGF10;SOX9;MT3;ZFP36L2;MAPK1
prerank,positive regulation of catabolic process (GO:0009896),0.3901776848989701,1.1223136492550203,0.296,0.9903788556207128,1.0,13/65,17.68%,GPC3;PRKN;HACE1;WNT5A;ASB5;HUWE1;APC2;DDB1;NEDD4L;AREL1;DACT1;NDUFA13;RAB7A
prerank,negative regulation of cell migration (GO:0030336),0.362932518520646,1.1216579274693979,0.28186528497409324,0.9916732734331872,1.0,31/137,15.47%,DLC1;CLDN19;SULF1;FGF2;PIP5KL1;PTEN;DPEP1;LRP1;PTPRT;RAP2B;HOXA7;RECK;NF1;ACVR1C;CYP1B1;PODN;NF2;COL3A1;MCTP1;PTPRJ;CLASP1;NGFR;MAGI2;DRD2;ADARB1;TCAF1;ARHGAP4;LDLRAD4;BMPR1A;CITED2;NAV3
prerank,positive regulation of histone methylation (GO:0031062),0.4519687703259873,1.121310596677099,0.34185733512786004,0.9918640192337254,1.0,5/24,12.13%,FAM47E;KMT2A;AUTS2;BRCA1;JARID2
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.478868040897324,1.1211034063350183,0.33238636363636365,0.9915311098493794,1.0,3/18,12.02%,CHRM3;PLCB1;CDK5R1
prerank,positive regulation of leukocyte migration (GO:0002687),0.4421490187041386,1.1207425008766896,0.3372395833333333,0.9917551323017421,1.0,3/27,9.69%,LGALS3;VEGFA;EDN3
prerank,regulation of bone mineralization (GO:0030500),0.4009344901284789,1.1207016666236491,0.30011723329425555,0.9908102369247611,1.0,7/55,4.09%,OSR2;ANKH;PKDCC;ACVR1;ANO6;GPM6B;TGFB1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.4425388190478784,1.1205879369558518,0.33553500660501984,0.9900887811264384,1.0,10/27,24.07%,KAT2B;KAT8;BRD8;MORF4L2;PHF20;TRRAP;MSL3;RUVBL2;KAT7;ATAT1
prerank,positive regulation of axonogenesis (GO:0050772),-0.3036114188652159,-1.1203301526518414,0.26256983240223464,0.8128464540404979,1.0,12/43,12.93%,MACF1;PLXNA2;ROBO1;GOLGA4;SEMA7A;SLIT2;RHOA;PLXNB1;ZFYVE27;PLXNA4;MAPT;PLXNA1
prerank,pre-miRNA processing (GO:0031054),-0.41907536565429226,-1.1202915395624233,0.29153605015673983,0.8106755123849199,1.0,9/14,30.50%,AGO1;TUT7;AGO3;TARBP2;LIN28B;MRPL44;AGO2;AGO4;DICER1
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.508010510032555,1.1200427817172567,0.33043478260869563,0.9909941686756695,1.0,2/12,4.99%,BMP5;PLCB1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.517918447003757,1.119726945926795,0.3515625,0.991115451857653,1.0,2/12,8.10%,CCR2;IL18
prerank,response to organonitrogen compound (GO:0010243),0.41462334729056244,1.119641459540468,0.32777115613825986,0.9903368809032486,1.0,14/38,25.73%,KYNU;PRKN;IRAK3;HLCS;RCN3;DRD2;CCDC47;GLRB;RHBDD1;UBXN6;KAT7;MTOR;ERLEC1;IRF5
prerank,organelle organization (GO:0006996),0.3501384571800835,1.1187057555983468,0.193,0.9927932255360323,1.0,113/388,22.28%,CCL11;SEC16B;TMED6;ANK1;HPS6;MYC;ATP8B1;WDPCP;GORASP1;PRKN;RAB38;FGD4;PAK4;PITPNB;HACE1;FMNL2;EIF2AK3;RAB14;MAST2;PACSIN2;BLZF1;PAK5;GOLGB1;OBSL1;TNIK;PEX3;ARL1;PDZD8;GBF1;EPS15;RAB34;BIN1;SEC31B;GAK;TRIP11;BAG5;PPID;TFAM;TMED10;PALLD;VPS11;RHOT2;VAPA;HUWE1;KIF5C;GORASP2;AFG1L;CLASP1;PI4K2A;ARHGAP21;HPS3;ZMYM6;RAB1A;MREG;PLAAT3;ATL3;USP6NL;SH3KBP1;CSNK1A1;PRDX3;NECTIN2;YME1L1;TBC1D20;POLRMT;ARHGAP4;TMED2;TMED3;PDCD6IP;SEC23IP;POLG2;OPA1;CHMP4C;BNIP1;CFAP61;DIAPH3;ARFGEF1;ABCD2;GABPB1;SURF4;ADCK1;MDK;RAB7A;STX17;CLUH;KIF3A;PEX1;HTT;RHOT1;CAMSAP1;RAB30;PEX11A;PARK7;ATXN7;REEP5;COG1;VMP1;CHMP1B;COG4;PHB2;CEP78;RAB3GAP1;RHOU;PKD2;TANGO2;SSBP1;LIMD1;WDR81;MTFR1;LMAN1;CDC42BPB;DYNC2H1;BRWD1;IQCG
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.46771781795792144,1.1186083606512132,0.3149717514124294,0.9920617621404004,1.0,2/19,3.76%,GFPT2;NAGK
prerank,pyruvate metabolic process (GO:0006090),-0.28831547107868616,-1.1185705673925486,0.26666666666666666,0.8136228522004806,1.0,10/52,10.36%,BSG;ME1;GLO1;HAGH;PDHX;PGK1;GPI;PGAM1;PGAM4;PDHA1
prerank,negative regulation of immune effector process (GO:0002698),0.5046751384233149,1.118440428889604,0.34970238095238093,0.9916161275209244,1.0,1/13,0.38%,LGALS3
prerank,regulation of cellular component organization (GO:0051128),0.3636690430002469,1.1181176577901675,0.28936170212765955,0.9917456919973503,1.0,37/135,16.97%,PTCH2;PRKCQ;STON2;ANGPTL7;NRG3;PAK4;IRAK3;PACSIN2;PAK5;WNT5A;URI1;STON1;RAP1A;LAMTOR2;ARHGEF11;BAG5;HIP1;ANKRA2;PTPN1;SGK3;SGK2;PTPN11;OPHN1;HJURP;RAB4B;SETD5;CHPT1;ATF5;RAB4A;ARFGAP1;PAPPA2;GFAP;ABL1;TMEM97;HNRNPU;SGK1;SNX12
prerank,regulation of catecholamine secretion (GO:0050433),0.42946895749294095,1.117626260406415,0.31069182389937106,0.9924795798014721,1.0,8/29,13.86%,KCNA2;PRKN;CHRNA4;SYT1;SYT11;SYT12;DRD2;SNCA
prerank,ESCRT III complex disassembly (GO:1904903),-0.4543216501811239,-1.1170924461082856,0.3058103975535168,0.8136192330001227,1.0,5/10,24.37%,VPS4A;CHMP1A;VPS4B;CHMP7;CHMP2B
prerank,ESCRT complex disassembly (GO:1904896),-0.4543216501811239,-1.1170924461082856,0.3058103975535168,0.8136192330001227,1.0,5/10,24.37%,VPS4A;CHMP1A;VPS4B;CHMP7;CHMP2B
prerank,positive regulation of embryonic development (GO:0040019),-0.378927064864846,-1.1159844504459764,0.2947761194029851,0.8147928422246146,1.0,4/19,14.45%,WNT4;OSR1;RACK1;RBM19
prerank,anterior/posterior axis specification (GO:0009948),-0.4122370678934195,-1.1155431415020876,0.30745341614906835,0.813805053702168,1.0,2/15,3.85%,WLS;TBX3
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.36232062889046673,-1.1155408719598363,0.3127147766323024,0.8115254877254113,1.0,4/22,8.61%,GCNT2;MAP2K5;WNK1;KLF4
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.4600634141316381,1.1152820649015291,0.33467202141900937,0.9999856153189127,1.0,7/22,16.94%,RAD23B;GTF2H2;DDB2;XPA;DDB1;UBB;CUL4B
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.5227035073906915,1.1150198885612,0.356120826709062,0.9998513898840599,1.0,3/11,9.52%,PRKN;FBXO7;HIF1A
prerank,potassium ion export across plasma membrane (GO:0097623),0.5083990277815235,1.1149103531435256,0.35789473684210527,0.9991415144301006,1.0,4/13,18.68%,KCND3;KCNT2;KCNH2;KCNA5
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.4174704563702523,1.1148775600492329,0.340153452685422,0.9981508736915671,1.0,14/38,21.85%,PRKN;PARL;FBXW7;VPS11;HUWE1;UBE2J2;SREBF2;CSNK2A2;UBE2L3;MICALL2;NPEPPS;RHOU;LMAN1;UBE2D3
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3638139954007298,1.1148683819711718,0.29610115911485774,0.9970879171821899,1.0,30/118,15.69%,SIPA1L1;PHLDB1;FGF2;ERBB2;EFNA5;FMNL2;TGFB1;SDC2;NF1;TANC2;TNIK;LRRC4C;PAK1;CHN1;PDZD8;SPARC;ADGRB3;BCL9L;GDNF;PPFIA2;MYO19;CLASP1;PID1;ZMYM6;CDK5R1;LZTS3;BMPER;NEDD4L;ARHGAP44;HTATIP2
prerank,neural tube closure (GO:0001843),0.4262628156792955,1.114814580904317,0.3155893536121673,0.996198447972284,1.0,10/34,21.67%,DLC1;TGFB1;PRICKLE1;DVL1;SCRIB;COBL;LRP2;PAX2;BCL10;DVL3
prerank,regulation of wound healing (GO:0061041),0.4086785290293521,1.114533876084955,0.3258426966292135,0.9961423863527277,1.0,10/42,17.43%,CLDN19;FGF2;EPHB2;CADM4;CLDN1;AJAP1;SRSF6;ITGB1;ARFGEF1;HBEGF
prerank,sphingolipid biosynthetic process (GO:0030148),-0.27439605645054427,-1.1139806216047543,0.25196850393700787,0.8142697661268079,1.0,24/71,21.71%,SGMS1;ELOVL7;PLPP1;CERS5;KDSR;ACER2;HACD4;SPTLC2;DEGS2;CERS4;SPNS2;ALDH3A2;SGPL1;VAPB;ASAH2;CERS1;SPHK1;A4GALT;CERT1;SPTSSB;ST6GALNAC5;CLN8;LARGE1;ALDH3B1
prerank,defense response to fungus (GO:0050832),0.47559267261423516,1.1138874743567786,0.32994186046511625,0.9973921930769664,1.0,5/17,25.47%,CARD9;BCL10;FAM3A;RARRES2;RNASE7
prerank,cochlea morphogenesis (GO:0090103),0.5282726325752777,1.113524043296863,0.3595679012345679,0.9977004940907136,1.0,3/10,17.16%,SOX9;TBX18;PAX2
prerank,protein destabilization (GO:0031648),0.4285719441694573,1.1134957007226782,0.34394904458598724,0.9967306338513988,1.0,10/32,18.45%,GSN;PRKN;KDM8;PRNP;CUL3;SNCA;SENP2;CDC73;MDM2;HTT
prerank,positive regulation of cell migration (GO:0030335),0.3463543342391159,1.1132169782668295,0.24316109422492402,0.9966974949987397,1.0,47/253,15.29%,ROR2;CCL11;PRKCA;PDGFRA;LGR6;GLIPR2;NTRK3;HAS2;FGF10;SEMA3E;KIF20B;RHOD;SOX9;EGFR;ACVR1;SEMA6C;MAP4K4;VEGFA;EPHB2;SEMA3A;TGFB1;CLDN1;DOCK5;CCR2;PAK1;FAM83H;TWIST2;PPP3CA;SMO;TRIP6;DOCK1;HIF1A;CLASP1;HDAC6;RHOC;GRN;COL1A1;MYOC;SOD2;SPAG9;RTN4;WASHC1;ELP5;ITGB1;ATM;PLAA;SEMA6D
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.5301154987909489,1.1128341911087776,0.3353846153846154,0.9970847512439378,1.0,1/10,0.85%,GFPT2
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.4116709283218215,1.1125745674445058,0.33496332518337407,0.9969848375546986,1.0,20/42,27.10%,MTA2;CHD3;VPS72;MBD2;HDAC2;SMARCC2;ANP32E;SMARCC1;RBBP4;SMARCE1;PBRM1;NASP;SMARCA4;GATAD2B;HNRNPC;ACTR5;SMARCB1;HDAC1;SPTY2D1;SMARCA1
prerank,cellular biogenic amine metabolic process (GO:0006576),0.5105963979416241,1.1124362508029026,0.34894259818731116,0.9963993459896318,1.0,2/12,5.08%,SLC22A3;SMS
prerank,regulation of extracellular matrix organization (GO:1903053),0.49811036846413126,1.1120688475141096,0.34384384384384387,0.9967435569050023,1.0,3/15,3.04%,FAP;LRP1;ANGPTL7
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.46786138205699396,1.1117857989782995,0.3224932249322493,0.9967747253401114,1.0,11/21,27.36%,H6PD;RPE;SHPK;PGLS;HK2;TALDO1;HK1;RBKS;RPIA;PGM2;GCK
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.4578459054048063,1.1116983641042892,0.3342503438789546,0.9960275138371595,1.0,2/20,4.99%,CHRM3;PLCB1
prerank,skeletal muscle tissue development (GO:0007519),-0.3202726592847296,-1.1111040065802893,0.2849462365591398,0.8210999297803095,1.0,16/32,41.57%,MYL6;SIX1;LEMD2;CAV1;CFLAR;MYH14;SIX4;FOXL2;KLHL41;MSC;MEF2C;MYORG;POPDC3;RYR1;POPDC2;ACTA1
prerank,negative regulation of protein phosphorylation (GO:0001933),0.35384158416602307,1.1100608880600114,0.29595015576323985,1.0,1.0,40/150,19.26%,UBASH3B;NTRK3;PIP5KL1;PTEN;PRKN;EPHB2;CADM4;TGFB1;DEPTOR;PRNP;CNKSR3;NF1;PTPN13;NIBAN1;SPRED2;MLXIPL;SPRED1;SAMSN1;MEN1;SPRED3;EIF4G1;PID1;DVL1;PDE4D;WWTR1;NCK1;SNCA;TAF7;LDLRAD4;CALM1;RASSF2;CALM2;PYDC1;TERF2IP;DBNDD2;PARK7;PPM1E;DNAJC10;SEMA4D;TESK1
prerank,cellular response to growth factor stimulus (GO:0071363),0.3525090712769587,1.1097420328124832,0.29718456725756,1.0,1.0,29/151,12.28%,SOX6;ADAMTS12;NTRK3;HAS2;GAREM1;SOX9;ERBB2;EGFR;ACVR1;VEGFA;EGR3;MAPK7;TGFB1;NTRK2;MAPKAPK2;ACVR1C;WNT5A;URI1;MTSS2;TGFBR2;RAP1A;SOX5;ZFP36L2;PTPN11;MAPK14;BMP7;EMD;MAGI2;ACAP2
prerank,vasodilation (GO:0042311),-0.41712930969320566,-1.1095897066594347,0.31671554252199413,0.8234676922012047,1.0,6/13,22.14%,NOS3;KLF2;SOD1;NOS1;GPER1;ADRB2
prerank,regulation of microtubule depolymerization (GO:0031114),0.44504457443426504,1.109533664140123,0.33598937583001326,1.0,1.0,8/25,18.84%,FGF13;MAP1B;CLASP1;APC2;KATNB1;NAV3;CAMSAP1;ATXN7
prerank,negative regulation of signaling receptor activity (GO:2000272),0.4426777333525715,1.1091754541018628,0.328,1.0,1.0,6/25,12.21%,CBLB;EPHB2;SOCS5;SNX6;CBL;ZGPAT
prerank,regulation of angiogenesis (GO:0045765),0.3503236086025607,1.1091488879639135,0.26774847870182555,1.0,1.0,31/192,12.41%,DCN;HSPG2;SULF1;PRKCA;CXCL10;RHOJ;FGF2;SEMA3E;CD34;ERBB2;VEGFA;COL4A2;PAK4;ITGB8;NF1;WNT5A;HSPB6;CCR2;PDE3B;CYP1B1;ADAMTS1;SPRED1;GATA6;BRCA1;SPARC;HIF1A;ATF2;SP1;RUNX1;MYDGF;GRN
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.5066092495838463,1.1087024547149418,0.36065573770491804,1.0,1.0,4/12,17.51%,PTPN22;CBFB;RUNX1;RC3H1
prerank,positive regulation of cytokine production (GO:0001819),0.34625934253952023,1.1086208170791376,0.23641851106639838,0.9997830542754326,1.0,57/292,19.31%,RORA;SULF1;IL16;GLMN;PRKCQ;PYCARD;PTPN22;CD34;FADD;EIF2AK3;TGFB1;PDE4B;PLCB1;WNT5A;TMEM106A;CCR2;CYP1B1;SPTBN1;NOX1;AGPAT2;CARD9;LRRFIP1;IL18;CADM1;BRCA1;POLR2K;TMED10;HIF1A;TLR1;PTPN11;MAPK14;IL6ST;RUNX1;RAB1A;PDE4D;TBK1;SCRIB;XRCC6;DRD2;GATA3;MALT1;DHX33;IL33;CGAS;TICAM1;LBP;RIPK1;CD74;MDK;RAB7B;POLR1C;BATF;IRF3;PARK7;SETD4;EGR1;STAT3
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.48076440972177775,1.1084901988669142,0.3357452966714906,0.9991556656686772,1.0,5/15,17.91%,BCL2;PRKN;TAF9;CD74;MDM2
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.4138302850928918,1.1084690220095044,0.3316831683168317,0.9981655600633667,1.0,4/38,3.99%,LGALS3;BMP5;FADD;TNFRSF10B
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.4600621421034438,1.1080928846784557,0.3328840970350404,0.9985179842100761,1.0,8/20,24.52%,PTPN22;TGFB1;IL18;TICAM1;LBP;BCL10;PRKCE;HCK
prerank,protein acetylation (GO:0006473),0.42576744503006714,1.1075148124421312,0.3539253539253539,0.9995391343714493,1.0,8/30,18.54%,KAT2B;HAT1;NAA35;NAA16;GTF2B;ING4;NAA10;NAA15
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.43601491594188263,1.1071545244604943,0.3363286264441592,0.9998385254585411,1.0,9/28,18.65%,MAP1B;GBA2;ARL2;CLASP1;FKBP4;STMN4;ABL1;CAMSAP1;MAPRE3
prerank,microtubule polymerization (GO:0046785),0.43691072315807467,1.1071436564507477,0.3463541666666667,0.9988104996436439,1.0,7/28,13.04%,FGF13;CCDC57;NDE1;TUBGCP5;CLASP1;SLAIN2;CKAP5
prerank,tube closure (GO:0060606),0.4296650726291761,1.1068445921458714,0.3350582147477361,0.9988017108554251,1.0,8/31,19.82%,DLC1;TGFB1;PRICKLE1;SCRIB;COBL;LRP2;PAX2;BCL10
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.39474734665108985,-1.1067783971177996,0.323943661971831,0.8301457414556586,1.0,6/16,26.88%,KIF5B;TUBB4B;PLEKHM2;CEBPG;VAMP7;ULBP1
prerank,regulation of response to cytokine stimulus (GO:0060759),0.467815742256245,1.10615124248081,0.3606102635228849,1.0,1.0,5/19,11.81%,CBFB;MAPK7;WNT5A;TAF9;RUNX1
prerank,rRNA modification (GO:0000154),-0.36666318839206136,-1.106055358118002,0.30656934306569344,0.8300998552276627,1.0,11/21,30.61%,ZCCHC4;NSUN3;DKC1;BUD23;DIMT1;GAR1;METTL5;TFB2M;TSR3;MRM2;NHP2
prerank,negative regulation of DNA replication (GO:0008156),-0.4223788609791128,-1.1057829623426216,0.31213872832369943,0.828763128537909,1.0,2/13,6.24%,WAPL;S100A11
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3476732464515285,1.1056901516893676,0.2419678714859438,1.0,1.0,87/336,19.02%,UBE2T;DDX11;MYC;BCL2;STXBP4;SUV39H1;UBE2E2;ZRANB3;FMN2;APTX;MBD4;WAC;POLE2;CHRNA4;PSEN1;NUPR2;NSMCE3;MAPKAPK2;PPP1R15A;MRNIP;ERCC4;PAK1;DDB2;METTL3;NUDT1;UFL1;MUTYH;MEN1;VAV3;XPA;BRCA1;POLE3;TLK2;TDP1;REXO4;ZBTB38;FBXO45;ENDOV;FBH1;ATF2;SLF2;ASF1A;MAPK14;FANCC;MSH6;TAF9;TAOK3;UPF1;STK33;XRCC3;ZBTB1;DDB1;AKTIP;BRAT1;HPF1;PDS5B;TOPBP1;SUMO1;CRY1;RTEL1;BAZ1B;CGAS;ATM;RAD52;CASP2;ABL1;TRRAP;BLM;BCL2L11;CSNK1E;SPIDR;XIAP;TP53;FAM111A;CUL4B;CEP63;FBXO31;UBA1;WRN;NSMCE4A;BATF;IRF3;ASH2L;AATF;PARK7;TAF1;GRB2
prerank,retinol metabolic process (GO:0042572),0.4989673479765809,1.1053872150689539,0.34678624813153963,1.0,1.0,3/14,8.23%,CYP1B1;RDH10;DHRS3
prerank,primary neural tube formation (GO:0014020),0.43351416562868383,1.10538562715469,0.3333333333333333,0.9998690775902664,1.0,8/30,19.82%,DLC1;TGFB1;PRICKLE1;SCRIB;COBL;LRP2;PAX2;BCL10
prerank,glucose metabolic process (GO:0006006),0.38853153456378325,1.1052100657877644,0.33716915995397007,0.9994403561961178,1.0,9/58,16.23%,APOD;IRS2;PGM1;GOT2;GALM;SLC25A10;BRAT1;CRY1;SLC25A11
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.49531456935361196,1.1050779657743461,0.3533950617283951,0.9988737619945708,1.0,7/12,25.03%,WAC;RPA2;RPS27L;TP53;FBXO31;PLK5;PRKDC
prerank,regulation of phospholipase activity (GO:0010517),0.5337587237942446,1.1048502197884704,0.3570274636510501,0.9985948865628111,1.0,3/10,13.86%,LRP1;FGFR1;SNCA
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.5123513888866754,1.104834846830768,0.36153846153846153,0.9975892753892563,1.0,2/11,5.33%,CREB3L1;E2F2
prerank,regulation of exocytosis (GO:0017157),0.39967966995925597,1.1047413019781664,0.3305489260143198,0.9968563320924905,1.0,12/46,18.98%,STXBP6;IL1RAPL1;SYT1;RAB21;RAB3D;CLASP1;STXBP5;RAB3A;SNCA;UNC13D;RIMS2;RAB3B
prerank,regulation of innate immune response (GO:0045088),-0.2841494331036004,-1.1046022590416078,0.2709677419354839,0.8303185790544024,1.0,25/57,27.50%,ERAP1;APPL2;BIRC3;PLSCR1;ABCE1;SAMHD1;RIOK3;CASP8;IRF1;NMI;TIRAP;APPL1;USP18;TRIM21;IFI35;HSP90AB1;POLR3D;IFNAR2;CACTIN;MUL1;TNFAIP3;TYRO3;TKFC;PTPN6;LYAR
prerank,prostanoid metabolic process (GO:0006692),0.5018908028602024,1.1044781597329942,0.341534008683068,0.9967749756962088,1.0,4/13,16.49%,CYP2S1;ACOX1;PLAA;PTGES
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.5272970212798967,1.104264941589899,0.3610698365527489,0.9965710797625456,1.0,4/10,17.10%,CPEB3;NCBP1;CPEB1;CDC73
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.5027614135126957,1.1040314918667984,0.345565749235474,0.9964319699717796,1.0,3/11,6.42%,ACVR1;TGFB1;TGFBR2
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.4278407097838882,1.1039899008971408,0.3198482932996207,0.995531906334705,1.0,6/31,17.51%,GLMN;SOX11;SDC4;IL4I1;ATM;RC3H1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3446344204907562,1.1038778172162487,0.24120603015075376,0.9948743093506822,1.0,48/348,11.56%,OSR2;SEC16B;CLDN19;ANK3;ADAM19;NTRK3;EPB41L4B;FGF2;RBMS3;MYC;FGF10;PTPN22;ANK2;CD34;SOX9;NGF;GSN;PRKN;VEGFA;EPHB2;MAPK7;EIF2AK3;TLE1;TGFB1;ITGB8;PSEN1;SOX11;NTRK2;MT3;ATF7IP;WNT5A;HOXD3;SMO;BRCA1;MAPK9;PTPN1;HIF1A;SFRP4;ATF2;NFE2L2;MAPK14;PID1;RIMS1;SP1;BMP7;MAPK1;FGF7;MAGI2
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.396410036993413,1.1035071424365985,0.33577533577533575,0.9951640886408304,1.0,4/45,5.27%,USP50;PYCARD;WNT5A;TMEM106A
prerank,negative regulation of interleukin-2 production (GO:0032703),0.4741205457190818,1.1032845925055024,0.36363636363636365,0.9949415969885251,1.0,5/18,20.78%,CD34;PRNP;HOMER2;NAV3;ZFP36
prerank,epiboly involved in wound healing (GO:0090505),-0.3888506385693493,-1.1031322109016364,0.2826086956521739,0.8327770387647723,1.0,6/16,14.72%,PDPN;ARHGAP35;CCN1;RHOA;DDR1;CEACAM1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.3364721259234941,-1.1027165907559047,0.32677165354330706,0.8319090452368203,1.0,6/27,10.95%,PRKCH;ABCA1;NFKBIA;AGTR1;ABCG1;NR1H2
prerank,regulation of urine volume (GO:0035809),0.5176862333561857,1.1023945926942795,0.37422360248447206,0.9971085442694025,1.0,1/10,1.09%,HAS2
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.521385639986131,1.102351214554771,0.37003058103975534,0.9962053873607332,1.0,5/11,18.04%,HAT1;ATRX;ASF1A;RBBP4;NASP
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.2584443105203397,-1.1022353625469021,0.20634920634920634,0.8310879477203379,1.0,28/112,13.34%,PTPRK;GCNT2;WNT4;SMAD6;CDH5;CLDN5;APPL2;ITGB5;ACVRL1;SMAD7;ENG;ID1;USP9X;SMAD9;TGFBR1;PDCD5;PARD3;ZFP36L1;TWSG1;PDE3A;PRKCZ;RHOA;NLK;LRRC32;MAP3K7;PDE2A;TGFB2;USP15
prerank,nuclear membrane disassembly (GO:0051081),0.4919225183099047,1.1019268163102443,0.358187134502924,0.9966781222121406,1.0,1/14,0.66%,PRKCA
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.42326973688584335,-1.1015510578967733,0.3423728813559322,0.8307909456297091,1.0,7/13,21.70%,USP19;NUPR1;MANF;NR1H2;AQP11;NR1H3;CLU
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.3609975447828436,-1.1010980798464225,0.3150684931506849,0.829851516804771,1.0,10/22,20.73%,APPL2;MFHAS1;LYN;WDFY1;TIRAP;FLOT1;APPL1;IFI35;NINJ1;NR1H3
prerank,regulation of telomere capping (GO:1904353),0.4527377824987618,1.1006573557330195,0.35570469798657717,1.0,1.0,7/23,15.98%,PRKCQ;MAPK1;NEK7;MAP3K4;RTEL1;ATM;SMG6
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.5077727955255863,1.1004900718957802,0.3669172932330827,0.9997233522026104,1.0,3/12,15.81%,ERLIN2;BRCA1;ERLIN1
prerank,regulation of protein localization (GO:0032880),-0.28469421725380656,-1.0999500875804915,0.248,0.8313608776737661,1.0,21/58,19.73%,AFDN;MAP2;KDM1A;TRIM25;RABGAP1L;PARP1;TRIM5;CAMK1;RACK1;ZDHHC7;VPS4A;RAB9A;HSP90AA1;ATCAY;PPM1F;TRIM21;PLEKHM2;HSP90AB1;TRIM17;TRIM68;ADCYAP1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.40878101160533903,1.0997174073873053,0.3472906403940887,1.0,1.0,14/36,23.57%,MYC;PTPN22;PRKN;FOXM1;MEN1;TAOK3;PER1;DACT1;FKTN;ZMYND11;DUSP1;SIRPA;AIDA;CYLD
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.34368169162899603,-1.099635688539204,0.29277566539923955,0.8301270399237495,1.0,8/26,14.30%,ROCK2;SHANK3;ROCK1;FHOD1;PFN2;ACTG1;CDC42;SYNPO2
prerank,cellular response to interleukin-1 (GO:0071347),0.35401775811957,1.0994150809832468,0.3096976016684046,1.0,1.0,32/143,21.38%,CCL11;ADAMTS12;HAS2;PYCARD;SOX9;MAP3K3;IRAK3;RPS6KA4;CCL4;PLCB1;PELI1;PSMB7;HIF1A;TOLLIP;UPF1;PSMD2;CCL14;UBB;PSMC1;IL1RAP;HYAL1;CHUK;PSMB2;RC3H1;PSMD9;EGR1;TAB3;PSME4;SIRPA;PSMA8;NFKB1;TNIP2
prerank,cellular response to glucose starvation (GO:0042149),-0.2958262762370454,-1.0992614508170142,0.2786885245901639,0.8290513751314563,1.0,17/41,25.99%,PRKAG2;NUAK1;SIK1;NIM1K;BECN1;PRKAA2;SESN2;PRKAG3;ATG14;KPTN;ATF4;NUAK2;HNRNPA1;SH3GLB1;BRSK2;MTMR3;SZT2
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.4806838810156713,1.0989139854295231,0.3760932944606414,1.0,1.0,6/16,14.58%,FGF2;GLI1;ERBB4;AKAP6;ZFPM2;BMPR1A
prerank,regulation of protein catabolic process (GO:0042176),0.36479663427003456,1.0988965661188197,0.3159041394335512,1.0,1.0,26/99,21.51%,GPC3;PRKN;EGFR;FMN2;HACE1;IRAK3;WNT5A;ASB5;FLNA;HUWE1;APC2;DDB1;MDM4;NEDD4L;GFAP;AREL1;DACT1;NDUFA13;SNX12;RAB7A;MDM2;AZIN2;SF3B3;FURIN;TIPARP;AGAP2
prerank,regulation of cellular component movement (GO:0051270),-0.2943689590899847,-1.0987326589747666,0.2891566265060241,0.8285889739719915,1.0,16/49,9.65%,SP100;ROCK2;ETS1;ROCK1;DIAPH1;LYN;YTHDF1;ABL2;TGFBR1;RPS19;PDPN;ZSWIM6;ACTN1;ARAP1;ZSWIM4;RHOA
prerank,snRNA processing (GO:0016180),0.46541495352841045,1.0985539737922998,0.3609467455621302,1.0,1.0,5/16,13.76%,INTS11;INTS6;INTS4;INTS2;INTS8
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.35459777242118046,1.097955151719385,0.31125131440588855,1.0,1.0,25/128,14.89%,DYNLL1;CDKN2B;HAUS3;CNTRL;KDM8;CCDC57;PCM1;PLCB1;FBXL15;NDE1;SDCCAG8;PHLDA1;FOXM1;ENSA;CEP57;PPP2R2A;CLASP1;PKMYT1;TAF2;CDC25B;PRKACA;CKAP5;CEP76;DYNC1I2;NES
prerank,sulfur compound biosynthetic process (GO:0044272),0.36385218566031907,1.0977636976456049,0.32914046121593293,1.0,1.0,17/104,13.34%,DCN;VCAN;LUM;CTH;ST3GAL4;CBS;PAPSS2;GSS;BCAN;CSGALNACT1;CHSY1;SLC10A7;NCAN;GLCE;GGCT;SLC35B3;GGTA1
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.4103784444790835,-1.097677483807506,0.32831325301204817,0.8298757292453226,1.0,2/12,3.82%,IL34;LYN
prerank,anterograde axonal transport (GO:0008089),-0.3156742143098458,-1.0972465292824285,0.32019704433497537,0.8290274616164819,1.0,10/37,13.14%,KIF3B;KIF1C;TRAK1;DTNBP1;KIF1B;KIF5B;BLOC1S5;SOD1;SNAPIN;AP3D1
prerank,positive regulation of protein kinase activity (GO:0045860),0.3515665619217924,1.0969958891085714,0.3053830227743271,1.0,1.0,30/148,15.36%,RELN;ERBB3;SLC27A1;MAP4K4;VEGFA;PAK4;GPRC5B;PAK5;TRAF4;PRNP;MRNIP;TNIK;PAK1;ALS2;TGFBR2;RALB;RAP1A;SLC8A2;PTPN1;PIH1D1;GRM5;TAOK3;MMD2;XRCC6;SNCA;TTBK1;CALM1;IQGAP1;RASSF2;CALM2
prerank,negative regulation of response to wounding (GO:1903035),0.4546254690445652,1.0963200574786383,0.34676258992805753,1.0,1.0,7/19,20.12%,CLDN19;FGF2;AJAP1;MDK;RTN4RL1;PTPRS;CERS2
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.43619442968234357,1.0960335411411868,0.35968379446640314,1.0,1.0,8/24,19.18%,SEMA3E;SEMA6C;VEGFA;SEMA3A;DSCAM;SEMA6D;SEMA4B;SEMA4D
prerank,establishment of apical/basal cell polarity (GO:0035089),0.4784526828280464,1.0958885497471642,0.36363636363636365,1.0,1.0,7/14,21.92%,PATJ;MYO9A;OPHN1;SCRIB;FSCN1;FOXJ1;RAP2A
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.36486280657705883,1.0958339752440045,0.3268398268398268,1.0,1.0,37/100,23.12%,GLMN;RAD23B;XPO1;PRKN;ARAF;WAC;SOCS5;UCHL5;UFL1;CBFA2T3;BAG5;TLK2;HERPUD1;TAF9;PRICKLE1;DVL1;CSNK1A1;DET1;SUMO1;DDA1;RNF19A;RCHY1;CSNK1E;N4BP1;MDM2;FBXO22;NKD2;ZER1;PARK7;TAF1;USP5;BBS7;UBQLN4;ZYG11B;COP1;ELOB;CAMLG
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.47265791239811045,1.0957202780246331,0.3649425287356322,1.0,1.0,2/16,7.65%,PRKCA;KLK6
prerank,response to endoplasmic reticulum stress (GO:0034976),0.36225092873430925,1.095704776416509,0.3411016949152542,1.0,1.0,34/107,22.16%,CREB3L1;BCL2;PRKN;EIF2AK3;DNAJB9;TNFRSF10B;PPP1R15A;NIBAN1;CREB3L2;UFL1;EIF2B5;RCN3;SELENOS;HERPUD1;PIK3R1;GORASP2;TMEM33;HSP90B1;NCK1;CCDC47;TMTC3;TMEM117;BCL2L11;TP53;QRICH1;FICD;AIFM1;DNAJC10;MBTPS1;JUN;RHBDD1;UBXN6;ERO1A;UBQLN1
prerank,peroxisome organization (GO:0007031),0.442003712935584,1.0956061635898464,0.3391655450874832,1.0,1.0,6/25,18.64%,SEC16B;PEX3;PLAAT3;ABCD2;PEX1;PEX11A
prerank,regulation of defense response to virus (GO:0050688),0.4832376116023561,1.0955683205765447,0.3683409436834094,1.0,1.0,2/14,8.39%,ELMOD2;PPM1B
prerank,cell cycle G2/M phase transition (GO:0044839),0.35360886112199164,1.09543494824905,0.3126967471143757,1.0,1.0,25/129,14.89%,DYNLL1;CDKN2B;HAUS3;CNTRL;KDM8;CCDC57;PCM1;PLCB1;FBXL15;NDE1;SDCCAG8;PHLDA1;FOXM1;ENSA;CEP57;PPP2R2A;CLASP1;PKMYT1;TAF2;CDC25B;PRKACA;CKAP5;CEP76;DYNC1I2;NES
prerank,development of primary male sexual characteristics (GO:0046546),0.4164848224391563,1.094956196920576,0.3464373464373464,1.0,1.0,12/34,21.39%,SOX8;SOX9;WNT5A;MAMLD1;GATA6;GATA3;LRP2;LHFPL2;NR5A1;CSDE1;FGF9;MEA1
prerank,regulation of keratinocyte proliferation (GO:0010837),0.4455501589868614,1.0947389394228244,0.3524590163934426,1.0,1.0,4/22,2.80%,EPB41L4B;FGF10;STXBP4;TGM1
prerank,regulation of tumor necrosis factor production (GO:0032680),0.35789536509220277,1.094529350462355,0.337953091684435,1.0,1.0,16/112,10.88%,PYCARD;PTPN22;CD34;FADD;EPHB2;IRAK3;PSEN1;MAPKAPK2;WNT5A;TMEM106A;CCR2;SELENOS;SYT11;PTPRJ;TLR1;PTPN11
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.38350827599514103,-1.0945155602441843,0.3161512027491409,0.8352332288971096,1.0,6/17,4.45%,ROBO1;NRP1;PIK3R3;SLIT2;EPHB4;KDR
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.36851140019972395,-1.0942865881001325,0.30985915492957744,0.8337155610104003,1.0,7/17,16.97%,COX7B;COX6B1;COX6A1;COX4I1;COX7C;COX5A;COX5B
prerank,protein localization to chromosome (GO:0034502),0.4121838345545479,1.093949498194044,0.3730964467005076,1.0,1.0,7/34,16.30%,FAM47E;MRNIP;ATRX;SLF2;ESR1;RPA2;TERF2IP
prerank,potassium ion transport (GO:0006813),0.3580461732370021,1.09393332384853,0.3200419727177335,1.0,1.0,33/120,23.28%,KCNK15;SLC1A3;KCNA2;KCNH8;KCNK1;KCNA1;KCNA6;KCND1;KCND2;KCND3;KCNMB2;KCNMB3;KCNAB2;KCNJ3;KCNJ10;KCNH2;SLC9A5;SLC9A1;KCNMA1;KCNA5;SLC24A4;SLC24A2;KCNS3;HCN1;KCNH7;PKD2;KCNK10;LRRC55;KCNQ3;KCNK6;KCNC1;KCNA4;KCNJ13
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.44767612403728263,1.0938655533321668,0.3678474114441417,0.9998270259099612,1.0,3/21,6.60%,MMP2;FGF2;ADAMTS1
prerank,protein localization to phagophore assembly site (GO:0034497),0.508865052608074,1.0936458423178543,0.3703125,0.9995737851902886,1.0,2/11,5.34%,PACS2;WIPI1
prerank,cell projection assembly (GO:0030031),0.45110383226782,1.0934206503587582,0.36995827538247567,0.9993437413396383,1.0,7/22,20.54%,RHOJ;GSN;RHOH;CYFIP1;RAC3;NCKAP1;RHOU
prerank,neuromuscular process controlling balance (GO:0050885),0.5046558589299869,1.0929456882505981,0.3726993865030675,1.0,1.0,2/12,4.86%,PCDH15;NRXN1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.46018634461926444,1.0926112103713497,0.3723252496433666,1.0,1.0,6/19,16.82%,PTGFR;PRNP;GRM5;PTPRJ;PRKACA;STIMATE
prerank,skin development (GO:0043588),0.3786723596499074,1.092494169753873,0.338302752293578,0.9995913486736772,1.0,13/65,15.14%,COL5A3;CERS3;TGM1;COL5A2;CLDN1;WNT5A;GATA6;COL3A1;HRNR;COL1A2;COL1A1;PKD1;MET
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.4568851549448516,1.09207706584817,0.35825105782792666,1.0,1.0,9/20,27.49%,VEGFA;MT3;HIF1A;NFE2L2;CHD6;BMP2;RUNX2;SMAD5;RELA
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.39792480770496164,-1.091887007802596,0.33663366336633666,0.8389432724037823,1.0,8/14,22.88%,RBMX;SRSF10;SRSF4;SAP18;PTBP1;SRSF7;SRSF12;U2AF2
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.29750712416611413,-1.0911831532785146,0.3212121212121212,0.8388820648767471,1.0,9/44,7.80%,ROCK2;ZC3HAV1;ROCK1;YTHDF1;MOV10;METTL14;ZFP36L1;CNOT1;GTPBP1
prerank,regulation of developmental growth (GO:0048638),-0.322562628000899,-1.091142429379723,0.32751091703056767,0.8368024679696934,1.0,9/29,11.95%,IGF1;LATS2;INSR;STAT5B;APP;SIX1;GSK3B;SOD1;DNM2
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.30230294096700117,-1.0908704550138184,0.2777777777777778,0.8355113015625474,1.0,11/39,14.23%,CDH5;TEK;ANGPT1;KDR;PRKCI;THBS1;ICAM1;RGCC;GATA2;SERPINE1;ECSCR
prerank,negative regulation of innate immune response (GO:0045824),0.41321736367296646,1.0908405965696444,0.35398230088495575,1.0,1.0,4/34,6.31%,A2M;PTPN2;IRAK3;METTL3
prerank,amyloid precursor protein metabolic process (GO:0042982),0.4577392504377637,1.09049306981988,0.3595505617977528,1.0,1.0,6/18,14.33%,ADAM19;PSEN1;KLK6;NCSTN;APH1A;PSEN2
prerank,phosphatidylinositol metabolic process (GO:0046488),0.3572087966963184,1.0904832520075618,0.33650793650793653,1.0,1.0,18/109,12.50%,PLEKHA4;SLC27A1;INPP4B;PLBD1;FGF2;PTEN;PGAP1;RAB14;MTMR14;PLCB1;PTPN13;PI4KB;VAC14;PLA2G12A;PIK3R1;PI4K2A;MTMR12;PLAAT3
prerank,epithelial tube morphogenesis (GO:0060562),0.4131777420951103,1.090241380851819,0.3575197889182058,1.0,1.0,10/32,15.14%,GLI2;FGF10;ACVR1;PRKX;PAK1;CCM2;SCRIB;GATA3;PKD1;MET
prerank,response to retinoic acid (GO:0032526),-0.28415359430821524,-1.0897337323436627,0.24,0.8368629437264822,1.0,11/59,8.46%,WNT5B;CTSH;RBP4;EPHA3;ACER2;LYN;ABL2;WNT6;SNW1;WNT9A;TBX1
prerank,mitochondrial protein processing (GO:0034982),0.5112936148017473,1.0896214334335206,0.37183544303797467,1.0,1.0,6/11,23.45%,MIPEP;ATP23;PMPCB;YME1L1;PMPCA;IMMP2L
prerank,negative regulation of epithelial cell migration (GO:0010633),0.4133567060570305,1.089575337721186,0.37055837563451777,1.0,1.0,2/33,1.62%,DCN;PTEN
prerank,clathrin coat assembly (GO:0048268),0.4732404187730256,1.0892750796549053,0.38115942028985506,1.0,1.0,3/15,8.90%,SGIP1;EPS15;HIP1
prerank,negative regulation of vascular permeability (GO:0043116),-0.4239712351328727,-1.089244751920372,0.31215469613259667,0.8363344995269067,1.0,6/12,14.72%,CLDN5;ANGPT1;SLIT2;PDE3A;PDE2A;CEACAM1
prerank,bile acid and bile salt transport (GO:0015721),0.43741899294768744,1.0891431496320059,0.37027379400260757,1.0,1.0,5/24,14.07%,ATP8B1;NCOA1;SLCO2B1;NCOA2;SLC10A1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.48852773199411875,1.0890246583856251,0.37622377622377623,1.0,1.0,2/13,2.73%,TBC1D10A;FADD
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.4046701571171283,1.0889735723030338,0.35447761194029853,1.0,1.0,16/37,21.10%,CADM4;WNK3;TGFB1;SPRED2;SPRED1;UBE2K;SPRED3;EIF4G1;BMP7;MAPK1;CALM1;CALM2;S1PR2;RPTOR;CAB39;CEMIP
prerank,ureteric bud morphogenesis (GO:0060675),0.4719233678015049,1.0889000569456204,0.39067055393586003,1.0,1.0,7/16,23.40%,FGF2;MYC;GDNF;GATA3;PAX2;PKD2;BMP2
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.3035603022558391,-1.0886669541316363,0.325,0.8358836488012109,1.0,10/36,12.41%,LEF1;CTNNB1;PLCB3;MOV10;AGO1;FZD6;NLK;MAP3K7;CAMK2A;AGO3
prerank,regulation of collagen biosynthetic process (GO:0032965),0.45297668907001987,1.0884137580105884,0.3728813559322034,1.0,1.0,6/19,15.64%,CREB3L1;TGFB1;AMELX;HDAC2;RUNX1;TGFB3
prerank,cellular response to oxygen-containing compound (GO:1901701),0.3412611977950198,1.0883799036325983,0.27364185110663986,1.0,1.0,73/291,21.63%,RORA;P2RY2;SSTR1;CXCL10;PDGFRA;PYCARD;DPEP1;SOX9;EGFR;NCF1;PDE4B;MT3;WNT5A;AOC1;RORC;PDK3;FZD7;RAP1A;CPEB3;LAMTOR2;TSHR;MAPK9;SELENOS;MAPK14;AKAP6;PID1;ESR1;MAPK1;TRIM41;UPF1;NRIP1;ERCC6L2;CPEB1;AHR;PRDX3;HSP90B1;SHPK;P2RY12;SSH1;LCOR;P2RY1;ATM;TICAM1;MTR;PLAA;GPLD1;NDUFA13;CDC73;LBP;PAX2;CHUK;NCOA3;RPTOR;SPAAR;TAF1;FAM210B;AXL;EGR1;RYR3;RUVBL2;IPO5;RRAGA;BCL10;PDCD4;HCN1;JUN;SIRPA;ZFP36;NFKB1;PKD2;TNIP2;P2RX7;PXN
prerank,snRNA transcription (GO:0009301),0.3650159593458839,1.0880091274000656,0.34988713318284426,1.0,1.0,19/70,15.93%,INTS11;SNAPC2;RPRD1A;POLR2B;INTS6;ZC3H8;GTF2B;POLR2K;NCBP1;INTS4;SP1;TAF9;TAF11;INTS2;INTS8;POLR2G;ELL;GTF2E1;GTF2E2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.3012204954157608,-1.0875074048031579,0.31176470588235294,0.8372725990548266,1.0,13/39,17.11%,PI4KA;PIK3R3;PIK3C2A;TTC7B;IP6K1;SOCS4;SOCS7;PIK3C2B;EFR3B;TMEM150A;ITPKC;PIP4K2B;ITPKB
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3658125320099703,1.0869941256187392,0.35334088335220837,1.0,1.0,19/69,15.93%,INTS11;SNAPC2;RPRD1A;POLR2B;INTS6;ZC3H8;GTF2B;POLR2K;NCBP1;INTS4;SP1;TAF9;TAF11;INTS2;INTS8;POLR2G;ELL;GTF2E1;GTF2E2
prerank,cardiac muscle cell development (GO:0055013),0.45712370460382334,1.0868657389813874,0.3770491803278688,1.0,1.0,3/20,5.34%,PDGFRA;VEGFA;OBSL1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.33807329872851904,1.0867107568921766,0.28542713567839195,1.0,1.0,53/259,15.56%,DYNLL1;PTPDC1;RHOD;RHO;STK36;WDPCP;GSN;RAP2B;FGD4;CC2D2A;MAP4K4;ANO6;ARL3;NEK1;CCDC57;RFX2;EMP1;TTC39C;IFT140;PCM1;TNIK;RILPL2;SNAP29;RFX3;BBS9;DISC1;GBF1;RAP1A;CPLANE1;BBS5;FLNA;PMP22;WDR35;SPATA13;ARF4;OPHN1;HDAC6;SNX10;RAB1A;CEP89;CFAP20;P2RY12;TRAPPC14;FBF1;CCDC28B;RAB11FIP3;EHD2;PKD1;CYFIP1;ITGB1;CCDC65;CDC14A;FSCN1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.36944957541492274,1.086513928390439,0.34417040358744394,1.0,1.0,13/75,12.29%,CCL11;PRKCA;FGF2;VEGFA;EGR3;WNT5A;FGFR1;AKT3;HIF1A;SP1;SIRT6;MYDGF;NRP2
prerank,icosanoid metabolic process (GO:0006690),0.40332187756468585,1.0865027591120118,0.37753882915173237,1.0,1.0,8/40,13.78%,CYP2S1;DPEP1;MAPKAPK2;LTA4H;CYP1B1;DPEP2;ALOX5AP;PNPLA8
prerank,organophosphate ester transport (GO:0015748),-0.34702249418703063,-1.086424666341225,0.3549618320610687,0.8383794478787929,1.0,6/24,10.37%,OSBPL8;ABCA3;PLTP;PITPNA;OSBPL2;TNFAIP8L3
prerank,regulation of fibroblast proliferation (GO:0048145),0.39234800499016875,1.0861591111777944,0.35697115384615385,1.0,1.0,11/45,17.26%,PDGFRA;MYC;NF1;WNT5A;S100A6;CDK6;EMD;MED25;TP53;CDC73;CD74
prerank,N-terminal protein amino acid modification (GO:0031365),0.4855407914519496,1.0861417760911043,0.3813813813813814,0.9999763371460938,1.0,8/14,27.32%,NAA35;NAA16;NAA10;NAA15;METAP1;METAP1D;NAA50;NAA40
prerank,positive regulation of blood coagulation (GO:0030194),0.465331240416362,1.0855618242456382,0.3762962962962963,1.0,1.0,2/17,3.49%,ST3GAL4;ANO6
prerank,positive regulation of T cell activation (GO:0050870),0.3759690090199067,1.0852008209857094,0.3523375142531357,1.0,1.0,14/62,22.84%,PRKCQ;PYCARD;CCR2;ZMIZ1;IL6ST;RHOH;ZBTB1;GATA3;NCK1;MDK;SIRPA;HSPD1;FLOT2;NCK2
prerank,negative regulation of myotube differentiation (GO:0010832),-0.4237287433639901,-1.085169530023478,0.3835227272727273,0.8401317883675621,1.0,4/12,23.27%,HDAC4;TMEM119;HDAC3;HDAC5
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.26307502907716857,-1.08494739031906,0.3,0.8386188825168589,1.0,24/67,20.02%,CAPZB;PODXL;TBC1D8;RAB5A;MYO10;TBC1D14;PPP1R16B;TBC1D1;GAP43;TBC1D15;DCDC2;TBC1D13;DYNC2LI1;DYNLT2B;RABEP2;CDC42;CAV1;TBC1D10B;TBC1D2;FXR2;ABITRAM;TBC1D22B;EPHA2;TBC1D16
prerank,establishment of protein localization to extracellular region (GO:0035592),0.40075048980848854,1.084836208108422,0.36,1.0,1.0,19/39,28.97%,STEAP3;COPG2;MTTP;RCN3;RAB3D;RAB3A;ARFGAP3;COPG1;TANGO6;RAB3B;TANGO2;TVP23A;MIA3;MON1A;SEL1L;SCG2;LTBP2;RAB13;PREB
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.43518925365639316,-1.084673671429439,0.3159420289855073,0.8372984530816516,1.0,10/11,56.51%,RTP4;PKD2L1;PKD1L3;LPO;RTP3;TAS1R2;GNAT3;GNAT2;PIGR;TAS1R3
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.4018466548357359,1.0844567010730013,0.35128518971848227,1.0,1.0,12/37,20.75%,MMP2;FGF2;PTEN;ADAMTS1;SOD2;BMPR1A;TGFB3;TAFA5;PPARG;PDCD4;JUN;FGF9
prerank,regulation of MAPK cascade (GO:0043408),0.3485250875543335,1.0844335500017588,0.3495850622406639,1.0,1.0,30/157,14.85%,ROR2;ROR1;NTRK3;FGF2;FGF10;ERBB2;EGFR;LPAR1;MAP4K4;PAK4;PAK5;NTRK2;NF1;TMEM106A;TNIK;PAK1;YWHAZ;KSR1;SPRED1;FGFR1;PTPRJ;GPR37;MAPK1;TAOK3;MYDGF;MYOC;PRDM11;DHX33;TRAF7;IQGAP1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.41165424094909253,1.0841736283918149,0.365792759051186,1.0,1.0,8/34,16.67%,ANK2;PDE4B;SCN5A;PDE4D;PRKACA;CALM1;CALM2;SLC9A1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.4740428917621536,1.0840828665818447,0.37257824143070045,1.0,1.0,4/14,10.11%,ZEB1;SPRED2;SPRED1;SPRED3
prerank,regulation of gastrulation (GO:0010470),-0.39226362227827866,-1.083926111857389,0.335423197492163,0.8376003013097447,1.0,2/14,1.37%,PHLDB2;OSR1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.426047672687229,1.0839098823540785,0.3540856031128405,0.9997878243738529,1.0,4/30,8.79%,HSD17B7;SQLE;IDI1;ACLY
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.3839325823446925,-1.083899920125073,0.34121621621621623,0.8355344293164684,1.0,4/17,7.50%,BMP6;SASH1;TRIM5;CD55
prerank,regulation of cellular component size (GO:0032535),0.4165367618088509,1.0838587060024023,0.3619550858652576,0.9989877092130587,1.0,12/30,21.27%,PTEN;PPP1R15A;VAV3;RARG;RAB22A;PPP1CA;RPTOR;PEX11A;RAB3B;RDX;HP1BP3;VAV2
prerank,potassium ion homeostasis (GO:0055075),-0.3478525775636025,-1.0837606023493145,0.3134920634920635,0.8338315676293118,1.0,6/23,7.79%,ATP1A2;ATP1B3;SLC12A7;KCNJ2;ATP1A1;SLC12A9
prerank,positive regulation of intracellular protein transport (GO:0090316),0.3461421168413673,1.0836327202286387,0.3298429319371728,0.9987861619233358,1.0,19/144,11.55%,SEC16B;ANK3;KIF20B;BCL2;ERBB2;C2CD5;FBXW7;TGFB1;PSEN1;PRNP;PCM1;YWHAZ;FYN;FLNA;VPS11;PIK3R1;HUWE1;UBE2J2;EMD
prerank,regulation of endothelial cell proliferation (GO:0001936),0.36000744764974996,1.0835716857224746,0.3519736842105263,0.9980352142303822,1.0,11/88,9.52%,CCL11;SULF1;PRKCA;FGF2;VEGFA;EGR3;NF1;WNT5A;SPARC;AKT3;HIF1A
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.46941115210053713,1.08353610909592,0.37155297532656023,0.9971707590760053,1.0,6/16,15.64%,CREB3L1;TGFB1;AMELX;HDAC2;RUNX1;TGFB3
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.2951952579264237,-1.0832410032408313,0.3314285714285714,0.8333945979266714,1.0,8/40,9.87%,DAB2;GCNT2;LEF1;CTNNB1;TGFBR1;PDPN;RGCC;JAG1
prerank,positive regulation of response to wounding (GO:1903036),-0.34448978634185534,-1.083150204218161,0.3137254901960784,0.8315346789458855,1.0,7/24,11.89%,PTN;OCLN;VTN;SCARF1;MYLK;ADRA2A;ACTG1
prerank,metal ion export (GO:0070839),-0.3159487880089552,-1.0825000297384193,0.3157894736842105,0.8313519910368689,1.0,5/31,7.15%,ATP1A2;ATP1B3;ATP7A;ATP1A1;SLC40A1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.4000161467620425,1.0823920155273294,0.36295369211514394,1.0,1.0,9/39,12.91%,SEMA3E;EFNA5;MAP4K4;HOXA7;RASA1;FZD7;NF2;AJAP1;MYOC
prerank,autophagy of mitochondrion (GO:0000422),0.39565601776556764,1.0823284612177562,0.36755386565272496,0.9994511115441878,1.0,8/38,15.07%,PRKN;WIPI1;FBXO7;CTSK;BNIP3;ATG5;ATG3;GABARAPL2
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.4046135164402768,1.0821400499124676,0.37402597402597404,0.9991401898399698,1.0,9/37,12.54%,NUDT15;RNASE6;ENTPD2;NUDT1;XRN2;PPP1R8;NCBP1;RNASEH2C;NUDT9
prerank,negative regulation by host of viral process (GO:0044793),0.5231198111003534,1.0817430105938735,0.3787878787878788,0.9995946904633329,1.0,2/10,10.27%,PRKN;VAPA
prerank,replication fork processing (GO:0031297),0.3972661991673182,1.0816238931847568,0.38166047087980176,0.9990440471273884,1.0,11/38,19.67%,DDX11;ZRANB3;SETMAR;ATRX;FBH1;EXD2;RTEL1;BLM;FAM111A;WRN;TRAIP
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5221839103644893,1.0814218632935506,0.3894899536321484,0.9987873372232375,1.0,3/10,11.81%,CBFB;SOCS1;RUNX1
prerank,photoreceptor cell development (GO:0042461),0.47986497152022434,1.0804803239733216,0.39642324888226527,1.0,1.0,2/14,3.74%,VEGFA;ARL3
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.3769290321691793,-1.0802746927033944,0.3310344827586207,0.836473655337971,1.0,7/18,21.70%,EPHA4;ROCK2;GSK3A;ABCG1;CASP3;CHRNA7;CLU
prerank,negative regulation of locomotion (GO:0040013),-0.417064479130118,-1.0797609100789936,0.35384615384615387,0.8360010222466269,1.0,4/12,9.14%,FRMD5;FBLN1;DUSP3;CCDC125
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.46564544052795925,1.0793843660686724,0.3753623188405797,1.0,1.0,5/15,16.10%,GPC3;SFRP4;DAAM2;DACT1;CSNK1E
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.5056575965523586,1.0793581430221768,0.37808641975308643,1.0,1.0,5/11,19.59%,BIN1;STK39;NEDD4L;KCNH2;CAB39
prerank,small GTPase mediated signal transduction (GO:0007264),0.3561485978960568,1.0788772459430904,0.3365695792880259,1.0,1.0,14/103,10.90%,ARHGAP32;USP50;FGF2;RAB38;ARL3;PLD1;NUCB1;NF1;KSR1;RALB;RGL1;SHOC2;MRAS;MAPK14
prerank,regulation of cell migration (GO:0030334),0.3342257209465831,1.078852557358206,0.281,1.0,1.0,78/382,15.47%,ROR2;CCL11;DLC1;CLDN19;SULF1;PRKCA;PDGFRA;LGR6;NTRK3;HAS2;FGF2;PIP5KL1;FGF10;PTEN;SEMA3E;RHOD;DPEP1;PLXNC1;EGFR;PTPRT;RAP2B;ACVR1;SEMA6C;MAP4K4;PRKX;VEGFA;EPHB2;HACE1;RECK;SEMA3A;TGFB1;CLDN1;NF1;CTNNA2;CYP1B1;PAK1;PODN;FAM83H;DOCK10;TWIST2;NTNG2;NTNG1;SERPINE2;NF2;PPP3CA;SMO;FLNA;TRIP6;MGAT3;LDB2;SGK3;SPATA13;MCTP1;ERBB4;SLK;PTPRJ;NGFR;FGF7;MAGI2;RHOC;GRN;COL1A1;MYOC;SOD2;DRD2;ADARB1;TCAF1;ARHGAP4;SPAG9;LDLRAD4;WASHC1;ELP5;ITGB1;ATM;CITED2;SEMA6D;LMNA;NAV3
prerank,organonitrogen compound catabolic process (GO:1901565),0.3802548374875736,1.0784249787779725,0.3758620689655172,1.0,1.0,21/57,24.09%,CTH;TST;NAGK;LTA4H;PLA2G7;TRHDE;IL4I1;LNPEP;UCHL3;LIPC;PDXDC1;PNPLA8;GNPDA1;TXN2;BCKDK;NPEPPS;RIDA;CLN6;SIAH1;TPP1;MTOR
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.34851705362483354,-1.078142171530438,0.3103448275862069,0.8390467654572844,1.0,8/21,16.02%,ROCK2;ROCK1;NOS3;ASPN;SRGN;HEY2;PTK2B;ENPP1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.4619845468147282,1.0780736874058527,0.38472418670438474,1.0,1.0,5/16,18.54%,KAT2B;NAA35;NAA16;NAA10;NAA15
prerank,hemopoiesis (GO:0030097),-0.2588948899112034,-1.0776081403846938,0.3291139240506329,0.8386614721810046,1.0,21/87,14.39%,FLT1;NOTCH2;MECOM;TEK;KIT;NCOA6;BMP4;ETV6;KDR;KITLG;FLT3LG;MKNK2;FGFR2;FLCN;JAG1;NOTCH4;TGFB2;INHBA;PTPRC;TIRAP;BMI1
prerank,regulation of interferon-gamma production (GO:0032649),0.3666412631556918,1.0773021664128515,0.358659217877095,1.0,1.0,9/71,12.71%,PYCARD;PTPN22;FADD;PDE4B;PRNP;CCR2;IL18;PDE4D;SCRIB
prerank,regulation of dendritic spine development (GO:0060998),0.45032570593693494,1.0768038500275707,0.37482319660537483,1.0,1.0,5/19,10.59%,PSEN1;TANC2;NLGN1;CPEB3;PPFIA2
prerank,presynapse organization (GO:0099172),0.5196795927420105,1.0767178979577545,0.3940809968847352,1.0,1.0,4/10,16.48%,WNT5A;NLGN1;DVL1;LRRTM3
prerank,negative regulation of cell motility (GO:2000146),0.35721808599342963,1.0761454617445356,0.34371643394199786,1.0,1.0,25/108,15.47%,DLC1;CLDN19;SULF1;PIP5KL1;PTEN;DPEP1;PTPRT;RAP2B;RECK;NF1;CYP1B1;PODN;NF2;MCTP1;PTPRJ;NGFR;MAGI2;DRD2;ADARB1;GATA3;TCAF1;ARHGAP4;LDLRAD4;CITED2;NAV3
prerank,negative regulation of double-strand break repair (GO:2000780),-0.3177408159354581,-1.0758241778907804,0.33649289099526064,0.8423347265420312,1.0,16/30,28.95%,RIF1;HELB;HMGA2;POLQ;KLHL15;TWIST1;TRIP12;OGG1;ERCC6;FANCB;MAD2L2;RNF169;RMI2;NUDT16L1;PARPBP;UBR5
prerank,regulation of cation transmembrane transport (GO:1904062),0.4236588620607794,1.0756395158291652,0.3732484076433121,1.0,1.0,9/29,18.82%,WNK3;SCN5A;FGF12;DPP10;KCNAB2;KCNIP4;HOMER1;KCNH2;CD63
prerank,regulation of DNA binding (GO:0051101),-0.29022490892760755,-1.0754075326788795,0.2994011976047904,0.8415159019400966,1.0,20/44,24.36%,IGF1;SP100;LEF1;NFKBIA;KDM1A;HABP4;DOT1L;SUMO3;HMGA2;MDFI;NME1;CEBPG;TFAP4;TXN;HMGB2;CSNK2B;EGF;PLAUR;MAPK8;E2F1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.3471629583608191,1.075116725150846,0.3597497393117831,1.0,1.0,20/122,9.25%,GLI2;FGF2;MYC;HSPH1;IRS2;ERBB2;EGFR;PLD1;UPF3A;GLI1;TMEM106A;NIBAN1;NOX1;STN1;METTL3;EIF3C;CPEB3;EIF6;NSUN5;PASK
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.3515660587577662,-1.0749491457558589,0.316,0.8387549265605907,1.0,5/21,6.54%,EYA1;EYA2;MAP2K5;EYA4;MCL1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.3515660587577662,-1.0749491457558589,0.316,0.8387549265605907,1.0,5/21,6.54%,EYA1;EYA2;MAP2K5;EYA4;MCL1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.4054372787813918,1.0746443207051608,0.3593556381660471,1.0,1.0,5/33,5.67%,ERBB3;PTEN;ERBB2;NF1;NYAP1
prerank,erythrocyte development (GO:0048821),-0.44003679913138366,-1.0746095591150393,0.3805309734513274,0.8377814108669855,1.0,5/10,31.35%,ALAS1;NCKAP1L;DMTN;LYAR;ALAS2
prerank,positive regulation of GTPase activity (GO:0043547),0.34311984620650393,1.074467203181963,0.3292307692307692,1.0,1.0,22/188,8.63%,CCL11;ARHGAP24;SIPA1L1;DOCK7;NTRK3;TAX1BP3;TBC1D10A;ERBB2;MAP4K4;GPR65;SLC27A4;CCL4;NF1;ARHGEF10;ALS2;MTSS2;CDKL5;TSC1;DOCK10;RAP1A;ZC3H15;TBCK
prerank,protein-DNA complex disassembly (GO:0032986),0.46477229244310175,1.074342810013102,0.37749287749287747,1.0,1.0,5/16,20.12%,MYC;SMARCC2;SMARCC1;SMARCE1;SMARCA4
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.3480910848165211,1.0742773902205083,0.3492063492063492,1.0,1.0,19/121,11.39%,RELN;ERBB3;FGF10;CRLF1;ACVR1;EFNA5;VEGFA;GPRC5B;TEC;TGFB1;PRNP;IL18;PTPN1;GRM5;ERBB4;PTPRJ;PTPN11;IL6ST;FGF7
prerank,regulation of transmembrane transport (GO:0034762),0.41223665576658486,1.0740370767641558,0.38618925831202044,1.0,1.0,6/31,14.70%,FFAR4;BCL2;SNCA;KCNJ3;NEDD4L;KCNJ10
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.40182563192720455,-1.0737305052378705,0.38557993730407525,0.8384202310800416,1.0,4/12,11.25%,PTPN14;BMP4;IFI27;NUP214
prerank,positive regulation of phosphorylation (GO:0042327),0.33649229326136276,1.0736500467455696,0.3293172690763052,1.0,1.0,30/240,7.52%,ROR2;ROR1;CLDN19;PDGFRA;GLMN;ERBB3;NTRK3;FGF2;FGF10;ZBTB20;SOX9;EPHB6;ERBB2;EGFR;EFNA5;WDFY2;VEGFA;EPHB2;TGFB1;PSEN1;NTRK2;MT3;TNIK;NIBAN1;PAK1;VAC14;RALB;MLXIPL;FZD7;FGFR1
prerank,ceramide metabolic process (GO:0006672),-0.2855118318725135,-1.0736466188449365,0.3315508021390374,0.8366056291952757,1.0,13/49,16.57%,SGMS1;ST6GALNAC3;PLPP1;CERS5;ACER2;SPTLC2;DEGS2;CERS4;SGPL1;ASAH2;CERS1;ORMDL3;PLA2G15
prerank,cobalamin metabolic process (GO:0009235),0.45390499497398795,1.0736398992029246,0.37787356321839083,1.0,1.0,5/17,16.94%,MMAB;CD320;MTRR;MTR;ABCC1
prerank,membrane lipid biosynthetic process (GO:0046467),-0.27698899194292104,-1.0735430792496932,0.2925170068027211,0.8348922827903256,1.0,14/58,9.50%,SGMS1;ELOVL7;PLPP1;CERS5;KDSR;ACER2;HACD4;SPTLC2;DEGS2;CERS4;SPNS2;ALDH3A2;SGPL1;VAPB
prerank,regulation of lymphocyte activation (GO:0051249),-0.4178113547699968,-1.073347516025808,0.37349397590361444,0.8334176156356164,1.0,7/12,44.06%,KAT2A;LAT;IKZF3;THEMIS2;CCL5;CRTAM;LCK
prerank,intracellular cholesterol transport (GO:0032367),-0.3927832894665727,-1.0731785349615546,0.35668789808917195,0.8318852981666652,1.0,6/15,12.08%,ABCA1;OSBP;OSBPL2;VPS4A;ABCG1;STARD4
prerank,protein localization to Golgi apparatus (GO:0034067),0.4305602695613582,1.0731481440124322,0.37904269081500647,1.0,1.0,8/27,11.83%,OBSL1;ARL1;GBF1;GAK;TMED10;ARL5C;BICD2;SYS1
prerank,oligodendrocyte development (GO:0014003),0.47079201880466115,1.0730162247088664,0.40660919540229884,1.0,1.0,5/15,21.16%,PLP1;EIF2B5;NSUN5;EIF2B2;B4GALT6
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.4413979021966642,1.0729454822039208,0.3878378378378378,1.0,1.0,3/20,3.81%,SEMA3E;SEMA6C;SEMA3A
prerank,chloride transmembrane transport (GO:1902476),0.38649702676158704,1.0729436949339939,0.368547418967587,1.0,1.0,5/48,5.46%,ANO2;SLC1A3;SLC12A3;ANO6;SLC12A2
prerank,regulation of membrane repolarization (GO:0060306),0.48607366263154606,1.0725710150788648,0.4190751445086705,1.0,1.0,4/13,16.33%,CACNA2D1;AKAP6;NEDD4L;KCNH2
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.43630058366299385,1.0724512641560608,0.405777166437414,1.0,1.0,6/21,15.04%,PTEN;CNKSR3;MLXIPL;PDE4D;NCK1;RASSF2
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.4160189800127916,-1.0724383778711588,0.3644067796610169,0.832239544242844,1.0,8/11,31.23%,POMT2;RNF185;AUP1;UFD1;UGGT1;RNF5;VCP;BAG6
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.48346299544044735,1.072249774091948,0.38235294117647056,1.0,1.0,3/13,11.06%,CRLF1;TYK2;IL6ST
prerank,mitochondrial gene expression (GO:0140053),0.3981309689703409,1.0719923883675462,0.379436964504284,1.0,1.0,10/42,15.09%,MRPL47;IARS2;MRPS18A;MRPL16;GATB;MRPS28;TFAM;POLRMT;HARS1;MRPL51
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.42818975629329326,1.0719256819058782,0.3963963963963964,1.0,1.0,8/28,13.58%,PRKCQ;PTPN2;SLC27A4;SOCS1;GRB14;PTPN1;PID1;NCK1
prerank,regulation of intracellular signal transduction (GO:1902531),0.3328660005618465,1.0716944609614028,0.30220883534136544,1.0,1.0,101/420,18.55%,ARHGAP24;DLC1;ARHGAP32;ARHGAP19;RHOJ;A2M;NTRK3;PYCARD;PTEN;RHOD;PTPN22;BST1;EGFR;DEPDC1B;AKAP13;FGD4;MAP4K4;VEGFA;PAK4;ARAF;PAK5;NTRK2;TRAF4;PRKAR1B;PTPN13;WNT5A;NOP2;TNIK;PAK1;NLGN1;MAPKAP1;CHN1;MTA2;RPA3;ITSN1;PRKAB2;SPRED1;UFL1;ARHGAP9;NF2;CHD3;VAV3;CASTOR2;ARHGEF11;TBCK;PPP1R13L;BRCA1;RCN3;RHOT2;ARHGAP11A;HDAC2;MYO9B;PHF20;MAPK14;MYO9A;AKAP6;OPHN1;TAF2;TAF9;ARHGAP21;MAPK1;TAOK3;TAF11;CDK5R1;RHOC;RHOH;FBXL2;GNAI1;MYOC;TRIO;RBBP4;PRDM11;ARHGAP4;RPA2;ARHGEF3;TAF7;TOPBP1;MDM4;ZFAND6;RASSF2;ATM;ARHGAP44;TAF4;GPAT3;TTI1;TAF4B;BLM;XIAP;TP53;SGK1;USP2;ARHGEF4;PLEKHG2;WRN;RAC3;PIP5K1A;MDM2;TP53RK;BOP1;CSNK2A2;RHOT1
prerank,natural killer cell mediated immunity (GO:0002228),-0.39874730531600233,-1.0716107743003258,0.3710247349823322,0.8328690754376645,1.0,5/15,26.88%,KIF5B;TUBB4B;PLEKHM2;CEBPG;ULBP1
prerank,regulation of macrophage activation (GO:0043030),-0.3126227930338659,-1.0712339812127476,0.33185840707964603,0.8320119182733867,1.0,5/30,5.72%,CD200;IL31RA;MFHAS1;TLR4;THBS1
prerank,negative regulation of endocytosis (GO:0045806),0.4149027323755518,1.070929278954644,0.3665768194070081,1.0,1.0,3/24,10.16%,LGALS3;SYT11;MCTP1
prerank,sodium ion transmembrane transport (GO:0035725),0.359696391961725,1.0709069934891255,0.3545945945945946,1.0,1.0,10/84,8.12%,SLC6A2;SCN7A;SLC12A3;SCN2A;KCNK1;ANO6;SLC12A2;SCN5A;SCN3A;SLC8A2
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.38718483886200084,1.0707800242616594,0.3905683192261185,1.0,1.0,8/46,12.17%,NTN4;PEAK1;LAMC1;MEGF9;NTNG2;NTNG1;PIK3R1;ANTXR1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.41438739531401203,-1.0701640834692,0.3937677053824363,0.8332491674718551,1.0,3/12,19.82%,GCNT2;FLOT1;SKAP1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.35871494631106016,1.0700632773279228,0.3580931263858093,1.0,1.0,30/84,26.00%,PRDX6;RBFOX1;CELF5;QKI;TRA2B;SON;KHDRBS3;NCBP1;PCBP4;DAZAP1;CELF6;SRSF6;RBM7;NOVA1;YTHDC1;HNRNPU;RNPS1;SF1;RBFOX3;CELF4;RBFOX2;HNRNPL;SRSF3;RBM25;FMR1;NSRP1;CIRBP;RBM15;RBM4;TRA2A
prerank,atrial septum morphogenesis (GO:0060413),-0.438308803005907,-1.0699458031605247,0.3821138211382114,0.8318532395577467,1.0,5/10,19.16%,NOTCH2;BMPR2;TGFB2;HEY2;ZFPM1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.38225456677834424,1.0693775752363415,0.3737864077669903,1.0,1.0,8/49,11.81%,PRKCQ;CBFB;KAT2B;KMT2A;EIF6;MTURN;PRMT1;RUNX1
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.43409662272512434,-1.0693616956813032,0.34972677595628415,0.8317611563113314,1.0,4/10,16.77%,ABCA3;MTMR2;MFSD2A;MTMR9
prerank,regulation of axon guidance (GO:1902667),-0.4461479823664233,-1.0687017997468233,0.37047353760445684,0.831751885333916,1.0,4/10,8.54%,NRP1;YTHDF1;ZSWIM6;ZSWIM4
prerank,synapse organization (GO:0050808),0.3444222789650051,1.0681954627590335,0.37725823591923485,1.0,1.0,29/125,14.87%,ANK3;PDZRN3;LRP4;PTEN;SEMA3E;NRCAM;PSEN1;NRXN1;OBSL1;LRRC4C;NLGN1;APBB2;CACNB4;KIRREL3;NTNG1;SLC8A2;GPM6A;CNTN2;DSCAM;GRM5;PPFIA2;ADGRL3;DVL1;GPC4;DRD2;SNCA;GPHN;PTPRF;CYFIP1
prerank,neuron projection development (GO:0031175),0.34011070128353066,1.0680039193935063,0.3545734840698869,1.0,1.0,34/168,13.14%,CDNF;DOCK7;PTEN;KIF20B;NGF;PPP1R9A;GAS7;MAP4K4;ATXN10;EPHB2;GPM6B;PLP1;TNIK;NYAP1;PAK1;NLGN1;ALS2;DOCK10;CNTNAP2;GPM6A;EPB41L3;VAPA;GDNF;DCLK1;OPHN1;PRMT1;STMN4;BMP7;TAOK3;DIP2A;CDK5R1;MYOC;CDK16;TRIO
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.3557937251639335,-1.0674197661457914,0.33098591549295775,0.8336803283541877,1.0,9/20,19.95%,BIRC3;STUB1;OGT;NUPR1;CASP8;HSP90AA1;FLOT1;SPATA2;CFLAR
prerank,regulation of calcium ion transport (GO:0051924),0.37855078370854434,1.0673910725846636,0.37834691501746215,1.0,1.0,6/54,4.22%,IL16;BCL2;CACNA2D1;ANK2;WNK3;CCL4
prerank,regulation of macromolecule metabolic process (GO:0060255),0.33980370672483934,1.0672895995815608,0.3513238289205703,1.0,1.0,42/170,20.53%,AFF3;MYC;DHH;C1D;HNRNPDL;PTHLH;TRIM44;PSEN1;RFXANK;HNRNPAB;RASA1;UBAP2;MKLN1;TRIM11;CDK6;SLC8A2;ZNF462;ANKRA2;HIF1A;ZFP64;EDN3;PRDM9;GDNF;PCBP4;POGZ;ATRAID;AHR;PRDM11;KDM6A;KHSRP;NOVA1;STX1B;FUBP1;ZUP1;APLNR;CGGBP1;MARF1;PRDM2;AFF1;HMG20A;FUBP3;SIRPA
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.3950414747820216,1.0672022586130137,0.39125,1.0,1.0,9/39,12.74%,ERBB2;EGFR;PTPN2;EPS15;BTC;PTPRJ;CBL;PTPN18;SH3KBP1
prerank,positive regulation of transport (GO:0051050),0.35929541199929105,1.0664754322256045,0.37790055248618787,1.0,1.0,6/85,2.75%,GPC3;SYNGR3;PYCARD;LRP1;C2CD5;KMT2A
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.4314260419068999,-1.0663110920851264,0.40524781341107874,0.8352425545186365,1.0,4/10,12.02%,ATP5MC3;ATP5PD;VPS9D1;ATP5F1D
prerank,cellular response to organonitrogen compound (GO:0071417),0.3533337332085563,1.0661831084924394,0.3783494105037513,1.0,1.0,28/99,21.44%,P2RY2;SOX9;HRH1;AOC1;RAP1A;CPEB3;LAMTOR2;TSHR;BRCA1;AKAP6;CPEB1;AHR;HSP90B1;P2RY12;SSH1;P2RY1;JUP;GABRG2;RPTOR;SPAAR;TAF1;EGR1;RYR3;IPO5;RRAGA;HCN1;PKD2;P2RX7
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.39155168807062807,1.0660003037200763,0.38316582914572866,1.0,1.0,5/37,9.74%,DYNLL1;IFT140;PCM1;TRIP11;WDR35
prerank,protein complex oligomerization (GO:0051259),0.35980142863397996,1.065611760598794,0.39106753812636164,1.0,1.0,35/85,25.13%,PYCARD;LETM1;LRRC8D;CLDN1;CPSF6;MPP2;ALS2;CARD9;PRMT1;ATL3;TMEM120A;ZBTB1;YME1L1;NACC2;SNCA;PDCD6IP;OPA1;HOMER1;BLM;PNPT1;UGDH;SLC9A1;MS4A1;FUS;BCL10;ADCY8;MAT2A;PKD2;CARD11;KCNC1;G3BP2;ALAD;ATL1;CPSF7;TRMT61B
prerank,protein dephosphorylation (GO:0006470),0.34214059690917703,1.065579549828458,0.375,1.0,1.0,30/135,14.76%,PTPRH;UBASH3B;PTEN;PTPN22;DUSP4;PTPRT;PTPN2;PPP1R15A;DUSP6;PTPN13;RPRD1A;PPP3CB;PPP3CA;PPM1B;PPM1J;PPP2R3A;PPP2R2A;PTPN1;PTPRJ;DUSP11;PTPN11;PPP1CA;PTPRA;PTPN18;PTPRZ1;NCK1;SSH1;PTPN21;PPP3CC;PTPRF
prerank,tricarboxylic acid metabolic process (GO:0072350),0.49463850449194696,1.0653971915742826,0.40092879256965946,1.0,1.0,4/12,14.50%,IDH2;IDH3B;ACLY;IDH3A
prerank,positive regulation of mRNA processing (GO:0050685),0.44016834241675834,1.0652766167640293,0.39339752407152684,1.0,1.0,5/21,17.10%,PRDX6;TRA2B;NCBP1;DAZAP1;CDC73
prerank,plasma membrane repair (GO:0001778),-0.39931768284010727,-1.0652161577227577,0.38372093023255816,0.836472842602882,1.0,4/13,12.24%,MYOF;MYH9;AHNAK2;SYTL4
prerank,melanocyte differentiation (GO:0030318),0.49085662233976757,1.0650200426111385,0.40888208269525267,1.0,1.0,5/11,20.72%,HPS6;SLC24A5;MREG;MITF;USP13
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.491902227572085,1.0647119864668433,0.40540540540540543,1.0,1.0,3/11,18.64%,GSN;PIH1D1;PARK7
prerank,cation transport (GO:0006812),0.3431180072640031,1.0646254182053883,0.355464759959142,1.0,1.0,26/167,14.70%,SLC22A3;PIEZO2;FGF13;KCNA2;SCN7A;SLC12A3;SCN2A;KCNK1;ANO6;KCNA1;KCNA6;SLC36A2;SLC12A2;SCN5A;SCN3A;KCND3;SLC8A2;KCNMB2;KCNMB3;SLC7A8;ANO10;NDFIP1;KCNJ3;TAF7;NEDD4L;KCNJ10
prerank,RNA transport (GO:0050658),0.36391314607350467,1.064064772319632,0.39096045197740115,1.0,1.0,26/71,26.01%,RBFOX1;TST;THOC6;ATXN2;NUP155;TGFBR2;SRSF11;CASC3;NCBP1;KIF5C;CKAP5;SRSF6;PNPT1;POM121;NXF1;RNPS1;THOC7;SRRM1;ZFP36;SRSF3;XPO5;THOC5;FMR1;MAGOHB;RAE1;HNRNPA2B1
prerank,positive regulation of collagen metabolic process (GO:0010714),0.4569944495585957,1.06379257601257,0.40086206896551724,1.0,1.0,6/17,15.64%,CREB3L1;TGFB1;AMELX;HDAC2;RUNX1;TGFB3
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.3798343761628534,-1.063689345119772,0.3776223776223776,0.8391473813363045,1.0,7/16,22.22%,SOX13;SIX1;PTGS2;FLCN;RREB1;VSTM2A;ZBTB7B
prerank,lipoprotein transport (GO:0042953),0.5105091530576849,1.0635215445606965,0.39228295819935693,1.0,1.0,6/10,25.66%,LRP1;PPARG;VMP1;UNC119B;MIA3;ZDHHC17
prerank,skeletal muscle organ development (GO:0060538),-0.3267296724695009,-1.063424081430044,0.3432203389830508,0.8379811977843211,1.0,12/26,36.02%,MYL6;SIX1;STRA6;CAV1;CFLAR;LARGE1;MYH14;SIX4;FOXL2;MSC;MEF2C;FXR1
prerank,translation (GO:0006412),-0.2230869657374194,-1.0633444037377595,0.11764705882352941,0.836260010071984,1.0,90/208,27.14%,RPS14;GSPT1;RPL24;RPL18A;DRG1;RPS16;GTPBP2;RPL38;RPL28;RPS19;RPL37;ABCE1;RARS2;RPS2;FTSJ1;SARS1;MRPL10;RPL19;RPL5;GTPBP1;RPL34;MRPS24;RPS25;RPS15;TNIP1;EEF1G;RPLP1;RPL31;RPL3;QRSL1;MRPL24;MRPL3;PABPC4;EEF1A1;DRG2;FASTKD2;RPS6;LARS1;RPS8;GFM2;EIF4EBP2;AARS1;RARS1;RPL11;KARS1;RPL12;TSFM;RPS6KB2;RPL13;RPL7A;EEF1B2;MRPS7;COPS5;MRPL43;IGF2BP3;RPS21;NOA1;YARS2;RPL35A;RPL26;RPL32;MRPS17;RPS9;RPS29;RPS23;ASMT;RPL8;MRPS11;MRPL2;EEF1E1;RPLP2;MRPS16;RPL41;RSL24D1;RPS17;VARS1;GATC;DHPS;RPS5;RPS15A;RPL37A;UBA52;RPS10;RPL6;MRPL57;WARS1;MRPL55;RPL9;RPS27;MRPS34
prerank,cilium organization (GO:0044782),0.3335169855557847,1.062936932480728,0.37044534412955465,1.0,1.0,39/209,15.75%,DYNLL1;PTPDC1;RHO;STK36;WDPCP;GSN;CC2D2A;ARL3;NEK1;CCDC57;RFX2;TTC39C;IFT140;PCM1;RILPL2;SNAP29;RFX3;BBS9;DISC1;GBF1;CPLANE1;BBS5;FLNA;WDR35;ARF4;HDAC6;SNX10;RAB1A;CEP89;CFAP20;TRAPPC14;FBF1;CCDC28B;RAB11FIP3;EHD2;PKD1;CCDC65;CDC14A;CFAP61
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.38167092501630073,-1.0628273881255406,0.3527397260273973,0.8358430639057509,1.0,8/17,34.37%,BUB3;IK;BOD1;KNL1;ZW10;TTK;SPDL1;CENPA
prerank,protein import into mitochondrial matrix (GO:0030150),-0.358056613236338,-1.062253457505178,0.38782051282051283,0.8355506110688412,1.0,9/18,29.08%,TOMM70;TIMM23;DNAJC15;TIMM17A;ROMO1;GRPEL1;DNLZ;TOMM40;TOMM40L
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.5094715248871728,1.062210599254801,0.4034003091190108,1.0,1.0,3/10,9.24%,WNT5A;CCR2;STK39
prerank,negative regulation of kinase activity (GO:0033673),0.3675735015384727,1.0619442155279317,0.3825581395348837,1.0,1.0,16/62,18.70%,UBASH3B;IRS2;NPRL2;DEPTOR;NF1;SPRED1;DVL1;PRDX3;WWTR1;SNCA;TAF7;PYDC1;HNRNPU;DBNDD2;PARK7;PPM1E
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.40295860346286083,-1.0618796291389363,0.3611111111111111,0.8347887869685147,1.0,3/13,4.45%,NAMPT;TLR4;KDR
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.35440332915322065,-1.0618494184371758,0.33948339483394835,0.832912219590136,1.0,4/20,6.66%,ATP1A2;ATP1B3;KCNJ2;ATP1A1
prerank,protein kinase B signaling (GO:0043491),0.4297206433578394,1.0618447422365305,0.4191852825229961,1.0,1.0,4/23,4.92%,PTEN;THEM4;TGFB1;MT3
prerank,negative regulation of synaptic transmission (GO:0050805),0.4227037912235033,1.0618351819128518,0.3967168262653899,1.0,1.0,5/23,13.01%,PTEN;GRIK3;PNKD;SYT11;DRD2
prerank,positive regulation of interleukin-6 production (GO:0032755),0.37005133672499757,1.0616562319240732,0.3925759280089989,1.0,1.0,15/68,20.62%,IL16;PYCARD;WNT5A;TMEM106A;CARD9;TLR1;PTPN11;IL33;LBP;CD74;RAB7B;SETD4;STAT3;BCL10;HSPD1
prerank,ribosome assembly (GO:0042255),-0.2887568716553119,-1.061632262123189,0.3312883435582822,0.8316165296874171,1.0,24/47,26.95%,RPS14;RPL24;NPM1;RPS19;RPL5;EIF2A;RPS15;RPL3;MRPL20;NOP53;RPL11;MRPS7;MRPL22;DHX37;MRPS11;RSL24D1;NLE1;MPV17L2;RPS5;PPAN;RPF2;PWP2;RPL6;RPS27
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.36136116223260795,1.061568431108401,0.3766519823788546,1.0,1.0,12/88,7.48%,STXBP6;STEAP2;SNAP23;SORCS1;RAB14;ARL3;GOLGB1;OSBPL5;SCAMP2;AP1G1;GBF1;EPS15
prerank,sphingolipid catabolic process (GO:0030149),-0.38625738171294993,-1.0614714319039733,0.36555891238670696,0.8301202876126362,1.0,7/15,29.96%,ACER2;SGPL1;ASAH2;SPHK1;SMPDL3A;PPT1;GLA
prerank,regulation of fibrinolysis (GO:0051917),0.4731384716151539,1.0614180932343025,0.4050632911392405,1.0,1.0,1/13,0.93%,FAP
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.3112580485697124,-1.0612957684357187,0.3119266055045872,0.828765002403335,1.0,15/31,24.36%,PPP1R13B;YWHAQ;GSK3B;CASP8;GSK3A;TFDP2;BID;HIP1R;BOK;NMT1;BAK1;MAPK8;BBC3;PPP3R1;E2F1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.41766239552938206,-1.060980921641332,0.363395225464191,0.8277759010590395,1.0,9/11,26.43%,UQCRB;UQCR11;CYC1;UQCR10;UQCRH;UQCRFS1;CYCS;UQCRC1;UQCC3
prerank,cellular response to lipopolysaccharide (GO:0071222),0.34697076941888577,1.0606812126237546,0.3916309012875536,1.0,1.0,25/101,22.99%,CXCL10;PYCARD;PTPN22;TGFB1;PDE4B;WNT5A;IL18;SELENOS;MAPK14;TRIM41;UPF1;SHPK;TICAM1;PLAA;CDC73;LBP;AXL;BCL10;PDCD4;SIRPA;ZFP36;NFKB1;TNIP2;VIM;CARD16
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.40286084925250376,1.0604568009020137,0.3731155778894472,1.0,1.0,8/31,15.53%,ANK1;DLG2;ERBIN;MYO9A;OPHN1;SCRIB;PDCD6IP;PARD3B
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.250942276913052,-1.0603794303396752,0.3048780487804878,0.8276505334409666,1.0,30/91,20.94%,BMP6;ABCG2;SLC30A10;SLC31A1;FLVCR1;ATP7A;FBXL5;ATP6V0D1;APP;SLC31A2;SLC40A1;FTH1;SLC39A8;FTL;SLC30A1;SLC39A6;TFRC;SOD1;CYB561A3;FRRS1;ATP6AP1;ATP6V0A2;FXN;SLC39A10;SLC22A17;ACO1;HFE;ABCB7;TMEM199;MT2A
prerank,positive regulation of vasoconstriction (GO:0045907),-0.38703793576843076,-1.0600666679589212,0.39570552147239263,0.8266839430917163,1.0,3/13,17.24%,ADRA1B;CAV1;TBXA2R
prerank,regulation of autophagosome maturation (GO:1901096),-0.39199219028933274,-1.0599114867695667,0.37579617834394907,0.8252061592421023,1.0,6/13,22.14%,IRGM;TBC1D25;UVRAG;SMCR8;RUBCN;ADRB2
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.37228341861038716,-1.0595952507089414,0.36303630363036304,0.824257296067971,1.0,4/16,7.34%,RANBP3L;BOC;IGFBP3;AKIRIN1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.46047978323349575,1.0595383830720106,0.4050073637702504,1.0,1.0,7/17,22.01%,ERLIN2;KPNB1;ERLIN1;SREBF2;MBTPS1;SEC14L2;PRKAA1
prerank,cellular response to lipid (GO:0071396),0.3352290019437056,1.059525097728346,0.35030549898167007,1.0,1.0,42/191,20.84%,RORA;SSTR1;CXCL10;PYCARD;SOX9;EGFR;PDE4B;WNT5A;URI1;RORC;PDK3;FZD7;SELENOS;MAPK14;PID1;ESR1;TRIM41;UPF1;NRIP1;GNAI1;AHR;SHPK;LCOR;ATM;TICAM1;PLAA;GPLD1;NDUFA13;CDC73;LBP;PAX2;NCOA3;FAM210B;AXL;UBE2L3;RUVBL2;BCL10;PDCD4;ADCY8;SIRPA;ZFP36;NFKB1
prerank,negative regulation of protein secretion (GO:0050709),-0.2947004361003824,-1.0594828546350565,0.3385416666666667,0.8226673748452216,1.0,13/38,21.58%,CD200;MIDN;ERP29;OPRM1;ADRA2A;KCNB1;RHBDF2;SIRT4;DPH3;APOE;NR1H3;RAB11FIP1;RSAD2
prerank,protein-containing complex assembly (GO:0065003),0.33168156305704566,1.0592204715440847,0.36189516129032256,1.0,1.0,74/259,21.99%,SEC16B;MYC;REPS2;SOX9;GORASP1;LAMC1;FADD;KMT2A;WIPF1;GRIA1;EPRS1;ANKRD28;SEC24D;ANO6;TLE1;CLDN1;TRAPPC6B;MEN1;PPID;TMED10;MAGI1;FARP2;SEC24C;CUL3;BCL9L;FANCC;RIMS1;RAB1A;BCL9;WASF1;CSNK1A1;KLHL12;TBC1D20;DET1;TMED2;MDM4;SEC23IP;OPA1;TRAPPC6A;TRRAP;PYGO1;NIFK;BLM;LPXN;PPIH;TP53;IL1RAP;SLC9A1;TLE3;CDC73;RIPK1;CD74;SEC24A;CNIH3;TLE4;RSPH9;MDM2;SKAP2;ASH2L;KPNA3;TRAPPC3;SMARCA4;KMT2D;NAPG;ADCY8;MITF;PEF1;SH3PXD2B;TRAPPC2L;PYGO2;P2RX7;LMAN1;DLG4;LLGL1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.420506363908479,-1.0591998703634282,0.38738738738738737,0.8216196736364961,1.0,4/11,14.33%,MFHAS1;LYN;CYBA;TIRAP
prerank,glycolipid metabolic process (GO:0006664),0.3798079122378405,1.058984955872597,0.39950980392156865,1.0,1.0,8/47,9.72%,ST3GAL4;PGAP1;GBA2;NAGA;GM2A;ST6GALNAC6;SCCPDH;GALC
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.4637260422199381,1.058646633807499,0.4152671755725191,1.0,1.0,3/14,8.66%,BST1;LOXL3;FLNA
prerank,negative regulation of histone methylation (GO:0031061),0.4967965733126407,1.0586208670846644,0.4028662420382166,1.0,1.0,3/10,12.13%,AASS;BRCA1;JARID2
prerank,cilium assembly (GO:0060271),0.3292334651646446,1.0584106428379438,0.37037037037037035,1.0,1.0,55/296,15.34%,DYNLL1;PTPDC1;RHO;STK36;WDPCP;GSN;CC2D2A;CCDC39;HAUS3;RSPH1;CNTRL;ARL3;NEK1;CCDC57;RFX2;TTC39C;IFT140;PCM1;RILPL2;SNAP29;RFX3;NDE1;BBS9;DISC1;SDCCAG8;GBF1;SPATA6;CPLANE1;BBS5;TRIP11;FLNA;CEP57;CFAP46;WDR35;CFAP74;ARF4;CLASP1;HDAC6;SNX10;RAB1A;CEP89;PRKACA;CKAP5;CFAP20;TRAPPC14;CEP76;FBF1;CCDC28B;DYNC1I2;RAB11FIP3;EHD2;PKD1;IFT57;CCDC65;CDC14A
prerank,positive regulation of cell motility (GO:2000147),0.3318583132492927,1.057704744929459,0.3693877551020408,1.0,1.0,21/205,6.88%,ROR2;CCL11;PRKCA;PDGFRA;LGR6;NTRK3;HAS2;SEMA3E;RHOD;EGFR;ACVR1;SEMA6C;MAP4K4;VEGFA;EPHB2;SEMA3A;TGFB1;CLDN1;PAK1;FAM83H;TWIST2
prerank,detection of mechanical stimulus (GO:0050982),0.44349714776454074,1.0576119843084417,0.39183673469387753,1.0,1.0,4/19,15.37%,PIEZO2;LHFPL5;PKD1;JUP
prerank,DNA geometric change (GO:0032392),0.42407605994106845,1.057412742274056,0.38821954484605087,1.0,1.0,10/24,26.49%,DDX11;ZRANB3;RTEL1;BLM;WRN;RAD50;SUPV3L1;RECQL;HNRNPA2B1;DDX1
prerank,positive regulation of cell population proliferation (GO:0008284),0.3295560045333572,1.0572559762952038,0.3153153153153153,1.0,1.0,70/423,13.05%,OSR2;BMP5;PDGFRA;ERBB3;NTRK3;HAS2;FGF2;SOX8;MYC;FGF10;PTEN;KIF20B;BCL2;GAREM1;IRS2;SOX9;LAMC1;CRLF1;ERBB2;BST1;EGFR;VEGFA;MAP3K3;PTHLH;CAPN1;SAAL1;TGFB1;PTGFR;SOX11;TIPIN;NTRK2;GDF9;GLI1;WNT5A;NOP2;NOX1;SCN5A;PAK1;CDK13;TGFBR2;MLXIPL;UFL1;S100A6;CDK6;FOXM1;FGFR1;GAB2;IL18;TSHR;BTC;DERL2;EDN3;CUL3;HDAC2;ERBB4;GDNF;PID1;IL6ST;S1PR3;PRMT1;FGF7;CDC25B;SIRT6;GLP2R;ZFPM2;GRN;RTKN2;PRLR;PRDX3;WWTR1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.38281743113063266,-1.0572289577914997,0.38175675675675674,0.8258758535343744,1.0,3/15,6.66%,ATP1A2;ATP1B3;ATP1A1
prerank,positive regulation of chemotaxis (GO:0050921),0.38281496015407224,1.0563722479495843,0.39603960396039606,1.0,1.0,10/43,15.14%,NTRK3;FGF2;VEGFA;TGFB1;CCR2;DSCAM;EDN3;P2RY12;SMOC2;MET
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.481029156243555,1.0561108904875465,0.40236686390532544,1.0,1.0,5/12,15.37%,DSG2;CTNNA3;BIN1;JUP;PKP2
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.4190006731531536,-1.0560738902548261,0.38482384823848237,0.8273012840855436,1.0,6/11,23.02%,TOMM70;TIMM9;TIMM22;TIMM8B;TIMM10B;ROMO1
prerank,DNA double-strand break processing (GO:0000729),0.45032017125248475,1.0559679722453532,0.4126984126984127,1.0,1.0,10/18,25.79%,SETMAR;BRCA1;EXD2;ATM;RAD52;BLM;RAD50;BARD1;SLX4;RBBP8
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.4363078602902909,-1.055895991343439,0.3963254593175853,0.8240357174181449,1.0,3/10,8.61%,MAP2K5;WNK1;KLF4
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.4363078602902909,-1.055895991343439,0.3963254593175853,0.8240357174181449,1.0,3/10,8.61%,MAP2K5;WNK1;KLF4
prerank,positive regulation of bone resorption (GO:0045780),0.5031072084476352,1.055768602693112,0.40217391304347827,1.0,1.0,1/11,0.66%,PRKCA
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.41297413897662744,1.0556242115829884,0.3895424836601307,1.0,1.0,14/29,21.42%,MYC;TLE1;MEN1;BCL9L;BCL9;TRRAP;PYGO1;TLE3;CDC73;TLE4;ASH2L;SMARCA4;KMT2D;PYGO2
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.45274906564347467,1.0553657875802835,0.4011627906976744,1.0,1.0,3/17,9.62%,SULF1;PCSK6;SFRP4
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.3299326319389471,-1.055068136401736,0.3486590038314176,0.8246936616848707,1.0,4/24,5.85%,PLA2G4A;ABCA3;GPAM;CRLS1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.35640636479377835,-1.0548871686158614,0.38095238095238093,0.8233104901630569,1.0,6/19,8.61%,MAP2K5;SLCO1C1;MTPN;KLF2;APP;KLF4
prerank,cellular response to chemical stress (GO:0062197),0.34756889824969195,1.0547591406008836,0.3762057877813505,1.0,1.0,25/96,18.94%,PRDX6;SRXN1;LRRC8D;NCF1;MT3;NOX1;GPX3;MGAT3;SELENOS;NCF2;NFE2L2;FANCC;PRDX3;SOD2;SNCA;ATM;RAD52;ABL1;VKORC1L1;PNPT1;SLC25A24;TXNRD1;CAT;PARK7;ERMP1
prerank,cholesterol metabolic process (GO:0008203),0.3670521970184773,1.054568964017475,0.4111731843575419,1.0,1.0,9/68,11.01%,CEL;HSD17B7;SQLE;GBA2;MT3;OSBPL5;IDI1;ACLY;ABCA5
prerank,organic hydroxy compound transport (GO:0015850),0.3930261001837748,1.0543138948491364,0.4176904176904177,1.0,1.0,7/36,14.07%,ATP8B1;NCOA1;SLC5A3;SLCO2B1;NCOA2;SLC16A1;SLC10A1
prerank,tetrapyrrole metabolic process (GO:0033013),0.44098773337011277,1.0541174541413074,0.40714285714285714,1.0,1.0,5/18,16.94%,MMAB;CD320;MTRR;MTR;ABCC1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3658447551814032,1.05399529956777,0.4045714285714286,1.0,1.0,12/65,11.11%,PRDM16;HTRA3;TGFB1;SPRED2;TGFBR2;SPRED1;PEG10;SNX6;BCL9L;SPRED3;LTBP1;DAND5
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.28949714182667613,-1.0538778786186995,0.3575757575757576,0.8244910801995853,1.0,8/43,5.87%,BMP6;IGF1;WNT4;LRP5;BMP4;BMPR2;SUCO;ZHX3
prerank,peptidyl-serine modification (GO:0018209),0.33285234238754957,1.053526170540888,0.38461538461538464,1.0,1.0,49/166,19.89%,PRKCA;STK32B;PRKCQ;PRKX;EIF2AK3;RPS6KA4;MAST2;MAPKAPK3;MAPKAPK2;DYRK4;PKN1;TGFBR2;DYRK1B;PDK3;GALNT1;AKT3;MAPK9;TLK2;STK39;SGK3;SGK2;MAPK14;STK32A;MAPK1;CDK5R1;TBK1;CSNK1G1;PRKACA;CSNK1A1;GALNT13;HPF1;GALNT3;TTBK1;RPS6KA2;PKD1;ATM;CSNK1G2;CSNK1E;SGK1;CHUK;NAA10;POGLUT2;PKN2;VRK3;CSNK2A2;TAF1;TOP1;CAB39;CSNK1G3
prerank,cellular response to interleukin-2 (GO:0071352),0.4888024639055572,1.053513051768188,0.42201834862385323,1.0,1.0,1/11,1.14%,IL2RA
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.4888024639055572,1.053513051768188,0.42201834862385323,1.0,1.0,1/11,1.14%,IL2RA
prerank,cellular response to drug (GO:0035690),0.42408177722991464,1.0529278637722093,0.4206989247311828,1.0,1.0,7/25,18.70%,MYC;DPEP1;PDE4B;GPLD1;TP53;KCNH2;PPM1E
prerank,Notch signaling involved in heart development (GO:0061314),-0.41220102198573255,-1.0521835612604469,0.3830409356725146,0.8278272546222337,1.0,3/11,15.09%,NOTCH2;JAG1;HEY2
prerank,female gamete generation (GO:0007292),0.4098612895068497,1.051787804280886,0.3900255754475703,1.0,1.0,11/29,23.59%,FMN2;GDF9;METTL3;DIAPH2;PRDM9;MDK;MARF1;KMT2D;SPO11;MEI4;TOB2
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.4094866267535322,-1.0517712030551905,0.3872832369942196,0.8271393809843027,1.0,5/11,35.40%,LYN;ANXA1;PIK3CB;RAPGEF2;MEF2C
prerank,secondary alcohol metabolic process (GO:1902652),0.3867128232742989,1.0517380935639686,0.40047961630695444,1.0,1.0,8/42,14.50%,IDH2;SQLE;GBA2;OSBPL5;IDH3B;ABCA5;CYP27A1;IDH3A
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.31488820012040575,-1.0516446172108114,0.37448559670781895,0.8256639967092688,1.0,9/32,12.33%,SNCAIP;RAB5A;DTNBP1;GSK3B;SLC30A1;CPLX1;CAMK2A;SNAPIN;MCTP2
prerank,response to nitric oxide (GO:0071731),0.4694357375610996,1.051083772036906,0.41363636363636364,1.0,1.0,2/13,4.92%,DPEP1;MT3
prerank,cellular response to reactive oxygen species (GO:0034614),0.3653149495424633,1.0501968082173236,0.4214780600461894,1.0,1.0,21/59,21.63%,PDGFRA;EGFR;MAPK7;NCF1;CYP1B1;MAPK9;NFE2L2;MAPK1;HDAC6;ERCC6L2;PRDX3;ABL1;PAX2;RIPK1;CHUK;PARK7;OSER1;JUN;SIRPA;PKD2;PXN
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.4470042718082138,1.0500831590213275,0.3987915407854985,1.0,1.0,6/16,21.97%,RSRC1;CDK13;SFPQ;SRSF6;CELF4;RBM17
prerank,circulatory system development (GO:0072359),0.34514229552901393,1.049784359196122,0.38396624472573837,1.0,1.0,25/118,15.37%,HSPG2;ERBB3;NTRK3;GLI2;PTEN;KAT2B;SOX9;AKAP13;ACVR1;FBXW7;TGFB1;NF1;FGF12;TGFBR2;COL3A1;PDLIM4;ERBB4;PTPN11;SMYD4;ZFPM2;KDM6A;LDB3;PKD1;CITED2;PKP2
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.4524775010885659,1.0494498544304165,0.41509433962264153,1.0,1.0,2/16,1.50%,FGF2;MYC
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.3732068423038255,-1.0491230345786342,0.3633633633633634,0.8312526153494607,1.0,8/16,28.05%,NPR3;TERF2;NUS1;TERT;APOE;AKT1;PIK3CB;HTR2B
prerank,glycosaminoglycan metabolic process (GO:0030203),0.37065997664700906,1.0489510633360155,0.4023391812865497,1.0,1.0,12/54,16.56%,GPC3;HSPG2;HS6ST1;SDC2;EXT1;SDC4;GPC1;GPC4;SDC3;IDS;HS2ST1;UGDH
prerank,endoderm formation (GO:0001706),0.3984089340935714,1.0486424897812547,0.4154228855721393,1.0,1.0,5/35,9.84%,MMP2;DUSP4;COL4A2;MMP15;SETD2
prerank,GPI anchor metabolic process (GO:0006505),0.4156105704284183,1.0480349106986244,0.41397849462365593,1.0,1.0,9/26,20.22%,PGAP1;PIGC;PIGP;PIGN;PIGA;GPLD1;PIGU;DPM1;PIGO
prerank,respiratory tube development (GO:0030323),0.4156730860196379,1.047768005409427,0.39438502673796794,1.0,1.0,5/28,6.77%,GLI2;FGF2;CCDC39;VEGFA;LOXL3
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.3363027819719095,-1.0475891191441076,0.3607843137254902,0.831998396321525,1.0,7/22,15.21%,ZDHHC14;ZDHHC3;CLIP3;ZDHHC18;ZDHHC7;ZDHHC20;ZDHHC4
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.3363027819719095,-1.0475891191441076,0.3607843137254902,0.831998396321525,1.0,7/22,15.21%,ZDHHC14;ZDHHC3;CLIP3;ZDHHC18;ZDHHC7;ZDHHC20;ZDHHC4
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.4392143827200158,1.0474442417204248,0.43115438108484005,1.0,1.0,6/18,17.17%,EGFR;TGFB1;ESR1;NCOR2;TP53;RIPK1
prerank,protein monoubiquitination (GO:0006513),0.38881519518408686,1.0472982578831833,0.4059040590405904,1.0,1.0,9/36,17.10%,UBE2T;PRKN;WAC;CUL3;HUWE1;KLHL12;KLHL22;UBE2O;CDC73
prerank,apoptotic mitochondrial changes (GO:0008637),0.39645605737856016,1.0471789134097105,0.41366459627329194,1.0,1.0,11/32,21.09%,BCL2;THEM4;BNIP3;ERBB4;ATG3;GGCT;SOD2;FZD9;HK2;HSPD1;AIFM2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3242305284073842,1.0471304802387293,0.357,1.0,1.0,116/476,20.95%,RORA;OSR2;MDFIC;GLI2;FGF2;SOX8;CRLF3;PRDM16;MYC;RGMB;SOX9;NCOA1;EGFR;ACVR1;KMT2A;WAC;TRIM44;KDM8;TGFB1;PSEN1;SOX11;FANK1;NCF1;SETD3;BICRAL;RNF6;MT3;GLI1;PLCB1;RAI1;ATF7IP;WNT5A;CXXC1;HNRNPAB;RFX3;CREB3L2;RORC;MLXIPL;ZBTB16;GATA6;PPP3CB;NAA16;DYRK1B;FZD7;FOXM1;KAT8;BICRA;SPIN1;ATMIN;ARHGEF11;TFAM;ZMIZ1;BRCA1;HIF1A;MED13;HDAC2;ERBB4;SMARCC2;ESR1;SP1;BMP7;FGF7;RUNX1;EPC1;PHF8;COL1A1;XRCC6;AHR;SMARCC1;ATF5;GATA3;PRDM11;PAX3;HIVEP3;PCBD2;MED12;CITED2;POU3F1;PIM2;TGFB3;RNF111;SP3;BLM;TP53;KCNH2;USP21;QRICH1;ING1;PAX2;CD74;RNF10;CHUK;PCID2;ZNF496;MED30;NAA15;MAPRE3;PSMD9;RNF4;KMT2E;EGR1;PPARG;STAT3;CNBP;BCL10;SMARCA4;JUN;NR1D2;FUBP3;TFE3;MITF;SNAI1;BCL3;NFKB1;SEC14L2;CD38
prerank,cGMP-mediated signaling (GO:0019934),-0.3930336673075332,-1.0471149087212284,0.39039039039039036,0.8315422474201712,1.0,6/13,20.10%,IRAG1;PDE3A;GUCY1B1;PDE2A;KCNC2;APOE
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.2882681816551179,-1.0470536871878227,0.34234234234234234,0.8298553292830054,1.0,13/35,20.35%,ETS1;LYN;ARNT;STAT5B;ZFP36L1;ACVR1B;NCKAP1L;INHBA;TAL1;MAFB;ANKRD54;ZFPM1;HMGB2
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.3564326936827056,-1.0470222322416325,0.3701067615658363,0.8281294117106193,1.0,9/19,21.70%,XRN1;TERF2;DCP2;EXOSC10;PINX1;TEN1;TINF2;TENT4B;HNRNPA1
prerank,regulation of multicellular organism growth (GO:0040014),0.4541091711915693,1.046926078127436,0.4133522727272727,1.0,1.0,1/15,0.48%,PTCH1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.3194963490501058,-1.046814043340472,0.3524229074889868,0.8269528070054801,1.0,13/30,21.70%,ACVRL1;DACH1;BMPR2;XRN1;TERF2;DCP2;CERS1;EXOSC10;PINX1;TEN1;TINF2;TENT4B;HNRNPA1
prerank,myotube differentiation (GO:0014902),-0.36544401493968154,-1.0462982568062091,0.3835616438356164,0.8267382162476391,1.0,4/17,15.24%,IGF1;MYEF2;SORT1;NOS1
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.485971745634922,1.0461105736793173,0.4008941877794337,1.0,1.0,3/12,14.82%,IL18;TTBK1;IL33
prerank,ncRNA transcription (GO:0098781),0.4699820347943121,1.0457215576452858,0.4180451127819549,1.0,1.0,6/13,22.55%,SNAPC2;SPIN1;GTF3C1;NIFK;POLR1G;SNAPC3
prerank,regulation of protein kinase B signaling (GO:0051896),0.33119235274643416,1.0455276767568071,0.4065372829417773,1.0,1.0,37/193,16.32%,PDGFRA;ERBB3;NTRK3;FGF2;FGF10;PTEN;IRS2;ERBB2;EGFR;THEM4;TGFB1;NTRK2;FGFR1;GAB2;IL18;FYN;BTC;RCN3;HIP1;PIK3R1;ERBB4;PTPRJ;PTPN11;ESR1;FGF7;MAGI2;MYDGF;STRN;MYOC;DRD2;GATA3;P2RY12;RTN4;ITGB1;MET;GAB1;LRP2
prerank,inositol phosphate metabolic process (GO:0043647),0.3816359455146508,1.0453546678520846,0.4376470588235294,1.0,1.0,5/46,4.99%,ITPK1;INPP4B;FGF2;PTEN;PLCB1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.47492012559339264,1.0451268068636923,0.4289985052316891,1.0,1.0,2/13,9.51%,CADM4;PTPN1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.4094146556923973,1.044768129768511,0.4300385109114249,1.0,1.0,3/28,3.91%,PTEN;PRKN;FBXW7
prerank,neural crest cell development (GO:0014032),0.38177844029820057,1.0447643137977227,0.4195470798569726,1.0,1.0,13/44,20.66%,SOX8;SEMA3E;SEMA6C;SEMA3A;SOX11;ERBB4;GDNF;ANXA6;KLHL12;SEMA6D;SEMA4B;SEMA4D;PEF1
prerank,dicarboxylic acid transport (GO:0006835),-0.31154299908177796,-1.044403299245877,0.35377358490566035,0.8305548316572545,1.0,6/28,6.72%,SLC13A3;SLC26A7;GJA1;SLC22A6;PDPN;GIPC1
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3334367704500706,1.044295558057209,0.4194214876033058,1.0,1.0,31/150,16.32%,PDGFRA;ERBB3;FGF2;FGF10;IRS2;ERBB2;EGFR;THEM4;TGFB1;FGFR1;GAB2;IL18;FYN;BTC;HIP1;PIK3R1;ERBB4;PTPRJ;PTPN11;ESR1;FGF7;MYDGF;STRN;MYOC;GATA3;P2RY12;RTN4;ITGB1;MET;GAB1;LRP2
prerank,DNA duplex unwinding (GO:0032508),0.3771580220542429,1.0440629517722575,0.42105263157894735,1.0,1.0,12/50,17.46%,DDX11;RAD23B;GTF2H2;DDB2;XPA;MCM4;DDB1;RTEL1;UBB;BLM;CUL4B;WRN
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.34646207851131583,-1.0436928373130043,0.4175824175824176,0.8308544440266179,1.0,5/20,4.30%,ACVRL1;BMP4;ENG;TBX3;TGFBR1
prerank,angiogenesis involved in wound healing (GO:0060055),0.48602293840408123,1.0436771677389725,0.4175491679273828,1.0,1.0,2/11,3.17%,CD34;VEGFA
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.37889614724187975,-1.0435426563665755,0.37910447761194027,0.8295588212071057,1.0,6/14,12.18%,SLIT2;IGFBP3;IGFBP5;TPM1;PRKG1;SERPINE1
prerank,gland development (GO:0048732),0.35883993625477284,1.0431516168553185,0.4180327868852459,1.0,1.0,14/59,15.64%,GLI2;FGF10;SOX9;FADD;PRKCSH;NF1;HOXD3;DKK3;IGSF3;ZBTB1;COBL;CITED2;MET;TGFB3
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.4700236596610302,1.0431177685831803,0.4281524926686217,1.0,1.0,5/13,22.25%,MBD4;NEIL1;SMUG1;NT5C;TDG
prerank,response to organophosphorus (GO:0046683),-0.36617167229649594,-1.042947051628527,0.40836012861736337,0.8295093540182529,1.0,5/16,25.36%,ABCC9;TRIM16;TRPC3;RFC3;VGF
prerank,positive regulation of protein polymerization (GO:0032273),0.3578764378443057,1.0428459351082258,0.4153498871331828,1.0,1.0,15/65,16.82%,CCL11;PYCARD;PAK1;BAIAP2;BIN1;ARL2;CLASP1;SLAIN2;CDK5R1;NCK1;TTBK1;CDC42EP1;MET;NAV3;CTTN
prerank,fatty acid transport (GO:0015908),0.4450972369638514,1.0426751037907729,0.42436974789915966,1.0,1.0,3/17,8.36%,SLC27A1;SLC27A4;GOT2
prerank,cholesterol biosynthetic process (GO:0006695),0.40669027940406377,1.0425277090566196,0.39768339768339767,1.0,1.0,4/31,8.79%,HSD17B7;SQLE;IDI1;ACLY
prerank,nucleotide-sugar metabolic process (GO:0009225),0.47921567581119107,1.042302995501204,0.4277198211624441,1.0,1.0,2/12,8.01%,GFPT2;CSGALNACT1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.31952683601034304,1.041694803282964,0.256,1.0,1.0,361/1646,20.74%,RORA;EBF2;OSR2;FAM47E;ETV1;MLF2;SOX6;NKX6-2;EFEMP1;KLF15;MDFIC;MEOX1;EBF4;ETV4;TSHZ3;MEOX2;CREB3L1;PRKCQ;GLI2;SCML4;LHX5;TLX3;FGF2;RCOR2;IFRD1;SOX8;CRLF3;PRDM16;MYC;TGIF2;ATP8B1;DMRT2;RGMB;CBFB;EBF1;ZNF25;HOXB8;ZBTB20;SOX9;SSBP2;VGLL4;NAB1;ERBB2;NCOA1;EGFR;SUV39H1;HIVEP1;ACVR1;KMT2A;ZBTB37;HOXA7;SATB1;VEGFA;EGR3;CCNC;TFCP2;WAC;TLE1;RPS6KA4;TRIM44;KDM8;NFX1;ZNF326;BAZ1A;FOXP2;KDM5B;GTF2H2;TGFB1;PSEN1;GATAD2A;RFX2;SOX11;FANK1;ZNF276;NCF1;NUPR2;SETD3;MED31;BICRAL;RFXANK;MBD1;ZEB1;RNF6;MT3;GLI1;PLCB1;RAI1;ATF7IP;WNT5A;NOP2;E2F2;PGBD1;CXXC1;PHOX2A;HOXD3;TRPS1;PKN1;URI1;EED;CIPC;HNRNPAB;APBB2;MAMLD1;RFX3;ZFP14;CREB3L2;RORC;MLXIPL;MLX;ZBTB16;TADA1;DRAP1;LOXL3;TAF5L;TWIST2;GATA6;PPP3CB;TBX18;NAA16;E2F6;DYRK1B;FZD7;CBFA2T3;FOXM1;LRRFIP1;KAT8;CBX4;ZSCAN20;BICRA;ZC3H8;MEN1;SPIN1;CHD3;ATMIN;MKX;ATRX;ZBTB41;CDK15;ARHGEF11;SOX5;MBD2;KCTD1;TFAM;ZMIZ1;PPP1R13L;BRCA1;CARM1;SOX12;POLR2K;DKK3;BBX;CRYAB;ZNF569;NCOA2;LANCL2;PIAS2;HIF1A;ARID4B;CHD2;KLF5;SNX6;ZBTB6;REXO4;DBX2;ZBTB38;MED13;ZNF260;HDAC2;ERBB4;HINT1;MBTD1;ZSCAN26;ATF2;ELP2;NFATC3;PSIP1;ZKSCAN8;PHF20;NFE2L2;LIN9;SMARCC2;MAPK14;ESR1;SP1;MYT1;ZNF112;RBAK;BMP7;PRICKLE1;HDAC6;FGF7;SFPQ;NSD2;ING4;CREBZF;RUNX1;ZFHX4;DVL1;CDK5R1;MIDEAS;JARID2;ZGPAT;PATZ1;FOXP4;ZFPM2;L3MBTL4;ZNF250;EPC1;RHOH;PHF8;KLF13;SIX5;NR6A1;COL1A1;SETD5;XRCC6;AHR;ZBTB1;SOD2;CDK16;WWTR1;EID2B;SMARCC1;ATF5;BAZ2B;PER1;SCML2;GATA3;ZNF83;ZEB2;SALL2;ELP4;ZBTB39;PRDM11;NACC2;LCOR;TGFBRAP1;NCOR2;ORC1;TAF7;PAX3;HIVEP3;ZFHX2;MDM4;PCBD2;SUMO1;CRY1;CREM;BAZ1B;MED12;CITED2;SLTM;IRX5;HOXB7;ZNF235;ABL1;POU3F1;PIM2;MED21;TRRAP;TGFB3;HTATIP2;MSL3;MEIS3;KLF9;ZFX;PURG;RNF111;SP3;LCORL;MTA3;BLM;TP53;PHF19;TERF2IP;KCNH2;USP21;ZXDB;QRICH1;NDUFA13;NFIX;NFIA;SREBF2;ING1;ZKSCAN1;SUFU;FOXJ1;PAX2;HEYL;CD74;RNF10;CHUK;SMARCE1;FBXO5;SFMBT2;PCID2;CCDC85B;CTBP1;NR5A1;ZNF496;FUS;CSRNP3;BATF;MDM2;APBB3;IRF3;EPC2;TCEA2;MLF1;KLF16;ZNF697;MED30;PHC2;EID2;NAA15;AATF;PRRX1;MAPRE3;ZMYND11;ELOC;PSMD9;RFX7;RNF4;KLF7;KMT2E;POLR2A;EGR1;PPARG;UBE2L3;STAT3;PRDM2;RUVBL2;FOXJ3;CNBP;MED8;HMG20A;YEATS2;BCL10;PDCD4;BCOR;HP1BP3;SMARCA4;JUN;BBS7;MEIS1;NR1D2;PHB2;ONECUT2;KMT2D;CTDSP1;FUBP3;TFE3;MITF;POLR3G;HSPD1;SNAI1;BCL3;ZSCAN21;JDP2;USP13;PBX1
prerank,modulation by host of viral genome replication (GO:0044827),0.47730976737076936,1.0416138433583766,0.44040697674418605,1.0,1.0,4/13,13.25%,PRKN;VAPA;FBXL2;TBC1D20
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.32456643682015235,1.0416041085228755,0.36736736736736736,1.0,1.0,79/417,14.48%,NKX6-2;MDFIC;TSHZ3;CREB3L1;SCML4;RCOR2;SOX8;PRDM16;ATP8B1;SOX9;VGLL4;NAB1;SUV39H1;HOXA7;TLE1;KDM8;FOXP2;TGFB1;GATAD2A;MBD1;ZEB1;MT3;PLCB1;ATF7IP;WNT5A;EED;CIPC;RFX3;MLXIPL;MLX;ZBTB16;LOXL3;TWIST2;GATA6;CBFA2T3;FOXM1;KAT8;CBX4;ZC3H8;MEN1;MBD2;KCTD1;BRCA1;DKK3;CRYAB;LANCL2;SNX6;ZBTB38;HDAC2;MBTD1;SMARCC2;RBAK;BMP7;PRICKLE1;HDAC6;SFPQ;ING4;CREBZF;CDK5R1;MIDEAS;JARID2;ZGPAT;PATZ1;ZFPM2;L3MBTL4;EPC1;XRCC6;AHR;EID2B;ATF5;PER1;SCML2;GATA3;PRDM11;NACC2;NCOR2;TAF7;SUMO1;CRY1
prerank,peptidyl-threonine modification (GO:0018210),0.35510045417937985,1.0413829757687667,0.40660592255125283,1.0,1.0,15/66,14.08%,PRKCA;GALNTL6;ACVR1;WNK3;DYRK4;TGFBR2;DYRK1B;GALNT1;STK39;MAPK1;CDK5R1;TBK1;GALNT13;GALNT3;TTBK1
prerank,positive regulation of DNA repair (GO:0045739),0.37306045923966685,1.041188075123031,0.4085510688836104,1.0,1.0,8/46,10.38%,DDX11;FGF10;SPIRE1;EGFR;FMN2;FOXM1;BRCA1;SLF2
prerank,response to growth factor (GO:0070848),0.38769631571718527,1.0411359691398352,0.42105263157894735,1.0,1.0,10/41,11.55%,MYC;ERBB2;ACVR1;MAPK7;ACVR1C;URI1;TGFBR2;GATA6;HDAC6;EMD
prerank,cellular response to peptide (GO:1901653),0.3627767859722951,1.040953308214996,0.43919716646989376,1.0,1.0,12/56,11.40%,DDX11;PTPN22;CACNA2D1;LRP1;CACNA1A;PSEN1;PRNP;FYN;SNX6;GRM5;NGFR;TRIM41
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.3735377841022443,1.040774170735182,0.4138755980861244,1.0,1.0,12/47,17.98%,MYC;EGFR;MAP4K4;CARD9;FOXM1;MAPK1;TAOK3;ARL6IP5;PER1;KLHDC10;MID1;NBR1
prerank,mRNA catabolic process (GO:0006402),0.3765295783197419,1.0404047568654389,0.43272727272727274,1.0,1.0,9/44,11.77%,DHX34;DXO;METTL3;XRN2;TUT4;MRTO4;ZFP36L2;NBAS;UPF1
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.3599545498845406,-1.040359385432292,0.39869281045751637,0.8353119360861746,1.0,6/17,14.60%,ATP5MC3;ATP5PD;VPS9D1;STOML2;ATP5F1D;ATP5MF
prerank,regulation of cell death (GO:0010941),0.3486038554739912,1.0403147449517716,0.4133042529989095,1.0,1.0,20/94,16.33%,FGF2;OLFM4;LRP1;PRKN;SOX11;MT3;TSC1;BNIP3;ATG5;PACRG;CRYAB;DCC;EIF4G1;BMP7;TBK1;NCK1;SNCA;SRSF6;UBB;SLC25A24
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.40640982464490516,1.0401514900451574,0.4442953020134228,1.0,1.0,3/27,8.14%,CSTF3;RNASE6;ZC3H12B
prerank,regulation of microtubule-based movement (GO:0060632),-0.4157260426323905,-1.0401241287640495,0.42342342342342343,0.8341376220518189,1.0,5/11,15.51%,MAP2;LAMP1;DYNLT2B;NEFH;IGBP1
prerank,cardiac muscle cell contraction (GO:0086003),0.440220135153055,1.0400990956568534,0.41517241379310343,1.0,1.0,4/19,6.25%,CACNA2D1;GSN;SCN5A;FGF12
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.4153687838100443,1.0400840607848651,0.4258312020460358,1.0,1.0,4/25,7.90%,HRK;PYCARD;BMF;BNIP3
prerank,regulation of cellular response to heat (GO:1900034),0.3516622164567934,1.0399888844739775,0.42745535714285715,1.0,1.0,19/77,17.75%,CD34;HSPH1;RANBP2;MAPKAPK2;NUP155;RPA3;BAG5;CRYAB;NDC1;NUP205;FKBP4;DNAJB6;MAPK1;NUP160;RPA2;ATM;POM121;AAAS;RPTOR
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.38317828984524127,-1.0397113251506804,0.39322033898305087,0.8335246724111026,1.0,11/14,51.99%,ATP6AP1;TYROBP;CSF1;POU4F1;CCR1;OCSTAMP;IL23A;TNF;TNFSF11;IL12B;IL23R
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.4020046338985914,-1.0396353024117495,0.42011834319526625,0.8319573663895241,1.0,3/12,2.81%,WAPL;CTNNB1;HDAC8
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.48685619191732016,1.0389915741138347,0.43605546995377503,1.0,1.0,4/10,14.14%,PPP3CB;PPP3CA;NFATC3;PPP3CC
prerank,calcineurin-mediated signaling (GO:0097720),0.48685619191732016,1.0389915741138347,0.43605546995377503,1.0,1.0,4/10,14.14%,PPP3CB;PPP3CA;NFATC3;PPP3CC
prerank,regulation of microtubule-based process (GO:0032886),-0.3039357842482911,-1.0389168171663075,0.38349514563106796,0.8323711749650545,1.0,12/36,12.55%,PHLDB2;MACF1;ROCK1;DIAPH1;EPHA3;TRIM36;KLHL42;GSK3B;PRKAA2;MARK2;FAM107A;MAPT
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.33682459220349276,-1.038425187204601,0.3858267716535433,0.8320280386788639,1.0,7/24,12.18%,CDH5;TEK;ANGPT1;KDR;ICAM1;GATA2;SERPINE1
prerank,sulfate transport (GO:0008272),-0.3722978654331737,-1.0383718009979939,0.42105263157894735,0.8304336523638215,1.0,7/14,26.13%,SLC26A7;SLC26A2;SLC25A30;SLC13A4;SLC26A6;RACGAP1;SLC26A8
prerank,response to lipid (GO:0033993),-0.23583345704166372,-1.0382069069522484,0.3230769230769231,0.8291853031802562,1.0,16/105,7.30%,FOXP1;SMAD6;CTSH;RBP4;CTNNB1;PAQR7;NOS3;ACER2;NOCT;TLR4;PPARD;OTUD5;STAT5B;ALPL;LIAS;TNFRSF11A
prerank,cellular copper ion homeostasis (GO:0006878),-0.38709477270205916,-1.0381761640929865,0.41389728096676737,0.827535191947556,1.0,4/14,7.14%,SLC31A1;ATP7A;APP;SLC31A2
prerank,neuromuscular junction development (GO:0007528),0.4123362738919857,1.03806814977855,0.42567567567567566,1.0,1.0,4/24,6.56%,ANK3;PDZRN3;LRP4;CACNB4
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.4195092932058485,-1.0378672979008885,0.4265129682997118,0.8267069711410518,1.0,2/10,1.37%,ATP1A2;OSR1
prerank,positive regulation of protein catabolic process (GO:0045732),0.3444580463260579,1.0377996828916243,0.4091403699673558,1.0,1.0,16/84,17.68%,GPC3;VGLL4;PRKN;HACE1;WNT5A;ASB5;VPS11;HUWE1;APC2;DDB1;NEDD4L;AREL1;DACT1;GPLD1;NDUFA13;RAB7A
prerank,"phagocytosis, engulfment (GO:0006911)",0.3999564439245001,1.0375314046315833,0.441025641025641,1.0,1.0,4/36,2.83%,XKR7;GULP1;GSN;XKR8
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.37547885829016536,-1.0371800511022122,0.375,0.8269782012999618,1.0,3/14,7.34%,IL34;THBS1;AKIRIN1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.476557726967489,1.0369808108430294,0.4485842026825633,1.0,1.0,8/12,25.89%,METTL3;BRCA1;CDYL;YTHDC1;HNRNPU;LRIF1;SMCHD1;RBM15
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.325937873205245,1.0368305495687578,0.41372351160444,1.0,1.0,61/248,19.89%,GPC3;WNK2;TPBGL;LGR6;PLEKHA4;RBMS3;LRP4;FGF10;SOX9;PRKN;EGFR;FRZB;JADE1;TLE1;GPRC5B;TGFB1;PSEN1;GLI1;WNT5A;LGR5;FZD7;OTULIN;FAM53B;PPM1B;DKK3;PSMB7;SFRP4;CUL3;DAAM2;TMEM131L;PRICKLE1;EMD;PPP1CA;DVL1;APC2;CSNK1G1;COL1A1;CSNK1A1;KLHL12;WWTR1;ZEB2;PSMD2;SCYL2;DACT1;JUP;CSNK1G2;PSMC1;FZD9;CSNK1E;XIAP;TLE3;MDK;PSMB2;TLE4;NKD2;PSMD9;RUVBL2;KANK1;PSME4;KREMEN1;CSNK1G3
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.44407207165600926,1.036502646314718,0.42589928057553955,1.0,1.0,3/16,13.06%,AP1G1;CADM1;NECTIN2
prerank,negative regulation of protein depolymerization (GO:1901880),0.41930230329766954,1.0364250001269573,0.42625169147496617,1.0,1.0,12/24,27.39%,FGF13;CLASP1;PLEKHH2;APC2;KATNB1;NAV3;CAMSAP1;ATXN7;TAOK1;CIB1;APC;PIK3CA
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3368248040255591,1.036315790652405,0.42573221757322177,1.0,1.0,25/129,16.18%,GPC3;WNK2;LGR6;PLEKHA4;FGF10;EGFR;GPRC5B;TGFB1;LGR5;FAM53B;PPM1B;PSMB7;SFRP4;DAAM2;CSNK1G1;COL1A1;ZEB2;PSMD2;DACT1;JUP;CSNK1G2;PSMC1;FZD9;CSNK1E;XIAP
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.4820081762903713,1.036175160564708,0.4309063893016345,1.0,1.0,5/12,25.52%,TIPIN;BLM;WRNIP1;KAT7;WDR18
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.36881373708436554,1.0359675030910465,0.4379391100702576,1.0,1.0,15/56,23.69%,ALPK1;MAPKAPK3;MAPKAPK2;CTSK;CTSB;TLR1;HSP90B1;UNC93B1;UBB;LBP;TAB3;BCL10;RPS6KA3;TAB2;IRAK2
prerank,positive regulation of epithelial cell migration (GO:0010634),0.34488854433822175,1.0357961970748333,0.42251950947603123,1.0,1.0,24/92,16.70%,PRKCA;GLIPR2;EPB41L4B;FGF2;FGF10;SOX9;MAP4K4;VEGFA;DOCK5;WNT5A;SPARC;DOCK1;HIF1A;CLASP1;HDAC6;FGF7;NRP2;GRN;GATA3;SMOC2;RTN4;ABL1;GPLD1;HYAL1
prerank,response to gamma radiation (GO:0010332),0.40941463063621764,1.0357056206067785,0.4418300653594771,1.0,1.0,9/24,17.91%,MYC;MEN1;CRYAB;TLK2;XRCC6;ATM;TP53;WRN;MDM2
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.3311418202190761,-1.0353801858955594,0.373015873015873,0.828859580389755,1.0,10/23,21.07%,DAB2;THBS1;SNW1;GIPC1;ING2;FLCN;SLC2A10;CREBBP;HSP90AB1;TGFB1I1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.3311418202190761,-1.0353801858955594,0.373015873015873,0.828859580389755,1.0,10/23,21.07%,DAB2;THBS1;SNW1;GIPC1;ING2;FLCN;SLC2A10;CREBBP;HSP90AB1;TGFB1I1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.3919470126237036,1.0353589767321658,0.42985842985842987,1.0,1.0,4/33,4.93%,PTEN;STXBP4;FBXW7;GLI1
prerank,regulation of cellular catabolic process (GO:0031329),-0.2662086189201104,-1.034905100651817,0.41935483870967744,0.8285905875155037,1.0,21/62,20.04%,DAPK1;ITPR1;ROCK1;ACER2;RRAGC;ABL2;LONP2;DAPK2;NUPR1;KEAP1;RAB8A;MAPT;RMC1;DRAM2;BOK;PIP4K2B;OSBPL7;HSPB1;SMCR8;RRAGB;GPR137
prerank,negative regulation of cellular process (GO:0048523),0.3204145426975739,1.0343163136780222,0.39039039039039036,1.0,1.0,100/521,17.86%,ROR2;TGFBI;DLC1;DCBLD2;SSTR1;BMP5;WNK2;CLDN19;GLMN;ERBB3;FGF2;CRLF3;MYC;PTEN;BCL2;CD34;CDKN2B;KAT2B;NGF;VGLL4;PRKN;PLXNC1;FRZB;PTPN2;JADE1;EPHB2;PTHLH;EIF2AK3;TGFB1;SOX11;NUPR2;MT3;PDE3B;CYP1B1;RASA1;BNIPL;APBB2;PODN;TSC1;ADAMTS1;TMEM98;COL18A1;CDK6;CBFA2T3;FOXM1;MEN1;BNIP3;NF2;ATG5;RARG;PACRG;CRYAB;TEX15;DSCAM;SFRP4;SYT11;ERBB4;PTPRJ;ANXA6;BMP7;MAGI2;ING4;ATP8A2;STRN;SOD2;DRD2;ADARB1;ATF5;RBBP4;GATA3;NCK1;PRDM11;NACC2;PDS5B;CD9;RPS6KA2;MDM4;SRSF6;RTN4;CD164;LMNA;PIM2;TGFB3;GPLD1;BLM;LPXN;TP53;NDUFA13;HYAL1;ING1;CDC73;MDK;RNF167;FBXO5;DYSF;FKTN;CCDC85B;CTBP1;NUDT6;PBRM1
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.4080149160320715,-1.0341827241684394,0.4092219020172911,0.8291242834150507,1.0,4/12,14.99%,ZDHHC7;LAMA3;ACTG1;FUZ
prerank,protein insertion into ER membrane (GO:0045048),0.3856404222761535,1.0341703903395278,0.42105263157894735,1.0,1.0,17/37,23.36%,WDR83OS;PRNP;VAPA;UBE2J2;EMD;OTOF;CCDC47;SEC61G;EMC10;EMC1;CYB5A;SGTA;EMC8;EMC3;CAMLG;EMC2;EMC6
prerank,regulation of T cell mediated immunity (GO:0002709),0.5060637375885216,1.033620949730982,0.4521604938271605,1.0,1.0,3/10,22.95%,CCR2;ZBTB1;TRPM4
prerank,glycoprotein biosynthetic process (GO:0009101),-0.25962164936362486,-1.0334812395498771,0.391304347826087,0.8293805568183219,1.0,18/79,16.28%,IGF1;GCNT2;ST3GAL6;ST8SIA4;FAM20B;BMPR2;ATP7A;MGAT1;CHST11;ST6GALNAC2;TNIP1;SERP1;FOXL1;CHST12;B4GALT7;NUS1;B3GALT2;B3GALT1
prerank,regulation of transforming growth factor beta production (GO:0071634),0.436219316749907,1.033436646724691,0.44096728307254623,1.0,1.0,4/18,10.84%,CD34;ITGB8;HIF1A;LTBP1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.35629155018909586,1.033336027068855,0.4342403628117914,1.0,1.0,12/60,15.05%,PRKCQ;FGF2;MYC;CCT7;CHTF18;PARM1;MAPK1;NEK7;SMOC2;MAP3K4;POLG2;ATM
prerank,cytoplasmic translational initiation (GO:0002183),0.43481762875461805,1.033314625898811,0.4227994227994228,1.0,1.0,10/17,29.88%,EIF3M;EIF4G1;EIF4A2;DHX29;DENR;RBM4;MCTS1;EIF3I;EIF2S2;EIF2D
prerank,modulation by symbiont of entry into host (GO:0052372),-0.35807649185080603,-1.0331364321822294,0.4090909090909091,0.8286607193267714,1.0,6/16,19.64%,TRIM25;TRIM5;EXOC2;CAV1;TRIM21;TRIM68
prerank,proteoglycan biosynthetic process (GO:0030166),-0.30747628733383325,-1.033014928910447,0.40930232558139534,0.8272913804603201,1.0,11/31,15.61%,IGF1;FAM20B;BMPR2;NDST3;PXYLP1;CHST11;FOXL1;CHST12;B4GALT7;HS3ST3B1;B3GAT1
prerank,regulation of cell communication (GO:0010646),-0.29088552120926814,-1.032913781904042,0.3557692307692308,0.8258721681450186,1.0,8/35,12.04%,GRK5;CXADR;IGFBP7;SCG5;GRK4;GRK2;MGLL;UGCG
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.21681303351763825,-1.03279690192112,0.2222222222222222,0.8244357695555532,1.0,124/306,27.82%,THRB;RPS14;POLD3;GSPT1;RPL24;RPL18A;RRAGC;DRG1;RECQL5;RPS16;ALAS1;GTPBP2;RPL38;RPL28;RPS19;CREBL2;RPL37;MMS19;RPS2;SARS1;MRPL10;RPL19;RPL5;GTPBP1;RPL34;PTMS;RPS25;PWP1;RPS15;POLA1;TNIP1;EEF1G;MCM6;RPLP1;RPL31;RPL3;MRPL24;MRPL3;RMI1;PABPC4;EEF1A1;RPS6;HELB;HUS1;RPS8;EIF4EBP2;MED20;RPL11;RPL12;INHBA;ORC6;TSFM;RPS6KB2;CDK2;POLA2;TERT;RPL13;RPL7A;EEF1B2;POLR2C;BAZ2A;MRPS7;CLSPN;DTX1;KAT5;COPS5;CDC7;MRPL43;IGF2BP3;NT5M;RPS21;YARS2;DONSON;RPL35A;POLR2E;APOE;RPL26;RPL32;MRPS17;RPS9;RPS29;RPS23;ASMT;LARGE1;RNASEH2A;PTMA;RPL8;MRPS11;POLR2J;XAB2;RPLP2;MRPS16;DNA2;GAL3ST2;POLR2D;RFC3;NBN;RPL41;RSL24D1;TIMELESS;ING5;RPS17;TOP1MT;RAD9B;E2F1;DHPS;RPS5;RPS15A;RPL37A;THAP1;RPS10;INHA;POLD2;TBRG1;RPL6;WARS1;MRPL55;MCM8;RPL9;RPS27;MRE11;RMI2;CDC45;RAD9A
prerank,monosaccharide transmembrane transport (GO:0015749),0.44454513112576066,1.0325337294438257,0.43982808022922637,1.0,1.0,3/16,10.80%,SLC5A3;SLC50A1;SLC2A2
prerank,regulation of steroid biosynthetic process (GO:0050810),0.4885729008606799,1.0325036104384662,0.45068285280728376,1.0,1.0,1/11,0.52%,BMP5
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.39262717108085277,1.0324226481927075,0.44374209860935526,1.0,1.0,6/32,21.44%,CXCL10;AKAP6;SNCA;APLNR;CEMIP;P2RX7
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.35370758709236366,1.0319795629325668,0.43847874720357943,1.0,1.0,15/69,19.31%,PYCARD;FADD;EPHB2;PSEN1;WNT5A;TMEM106A;CCR2;PTPRJ;TLR1;PTPN11;IL33;LBP;RIPK1;SETD4;STAT3
prerank,insulin receptor signaling pathway (GO:0008286),-0.2536811464162128,-1.0318909589951828,0.38461538461538464,0.8254560528869658,1.0,14/69,9.68%,SORBS1;IGF1R;PIK3R3;PIK3C2A;GRB10;NAMPT;IGF2;INSR;ATP6V0C;ATP6V0D1;BCAR1;GSK3B;RHOQ;GSK3A
prerank,negative regulation of RNA splicing (GO:0033119),-0.3429521381612541,-1.0316816366033006,0.4035714285714286,0.8243281736447043,1.0,9/19,22.88%,RBMX;SRSF10;SRSF4;SAP18;PTBP1;PTBP3;SRSF7;SRSF12;U2AF2
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3593274994792828,1.03165831977606,0.43507972665148065,1.0,1.0,18/66,19.55%,FGF10;PTEN;CDKN2B;EGFR;UBE2E2;JADE1;PLCB1;ADAMTS1;CDK6;EIF4G1;PKD1;DACT1;CCND2;HYAL1;CDC73;RPTOR;KMT2E;RDX
prerank,autophagy of nucleus (GO:0044804),0.44012038920523755,1.031561176812562,0.4419642857142857,1.0,1.0,3/16,12.19%,WIPI1;ATG5;ATG3
prerank,protein localization to lysosome (GO:0061462),-0.31271654222691625,-1.0311539184797534,0.3972602739726027,0.824211515749038,1.0,14/28,32.39%,LMBRD1;M6PR;MFSD1;VPS4A;RNF128;KPTN;LAPTM5;SH3BP4;ATP13A2;SZT2;NAGPA;LAMTOR4;SORL1;NEDD4
prerank,cAMP biosynthetic process (GO:0006171),-0.4407208119088113,-1.0311438099495638,0.4265927977839335,0.8225244658484818,1.0,3/10,18.13%,ADCY9;ADCY4;ADCY3
prerank,establishment of protein localization to membrane (GO:0090150),-0.2542352792775404,-1.031094759592633,0.3779527559055118,0.8209405187372865,1.0,21/66,17.60%,AFDN;RAB11B;ZDHHC14;ZDHHC3;RFTN1;PARD3;PRKCI;SYNE3;NECTIN3;VPS37C;ZDHHC18;ZDHHC7;AQP11;OXA1L;ZDHHC20;MYO1C;BID;ZDHHC4;MICALL1;FRMPD1;TAOK2
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.297207436616074,-1.03094455239439,0.3798076923076923,0.8196303183601615,1.0,6/35,8.41%,PLPP1;PPARGC1B;CALCOCO1;DDX5;NR3C2;EGLN2
prerank,dopamine metabolic process (GO:0042417),0.4430333251775703,1.0308681087085345,0.43365253077975374,1.0,1.0,6/18,14.16%,PRKN;COMT;DAO;DRD2;SNCA;LRTOMT
prerank,cellular response to organic substance (GO:0071310),0.33428508860251227,1.0308174551835159,0.4270386266094421,1.0,1.0,25/116,14.58%,ERBB2;NCOA1;IL1RAPL1;ACVR1;PTPN2;MAPK7;TGFB1;IL1RL2;PTPN13;ACVR1C;CYP1B1;URI1;TGFBR2;IL18;NCOA2;PTPN11;AKAP6;PID1;HDAC6;EMD;ARL6IP5;TBK1;PTPN18;KHSRP;BMPR1A
prerank,regulation of cell morphogenesis (GO:0022604),0.3990303442315979,1.0306004547232166,0.44260204081632654,1.0,1.0,9/30,11.93%,EFNA5;FMNL2;PDZD8;NTNG2;NTNG1;SPARC;BCL9L;MYO9A;ZMYM6
prerank,neurotrophin signaling pathway (GO:0038179),0.42984503063489443,1.0305267957447852,0.4469798657718121,1.0,1.0,5/21,11.56%,NGF;NTRK2;RAP1A;NGFR;MAGI2
prerank,intracellular lipid transport (GO:0032365),-0.34165202408667744,-1.0304226607000748,0.3837638376383764,0.8194308672392893,1.0,7/21,18.72%,PRKAG2;CPT1A;PRKAA2;ACACB;SLC25A20;MID1IP1;CERT1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.47417498701729166,1.0304094701740782,0.44561933534743203,1.0,1.0,2/12,8.10%,CARD9;IL18
prerank,apoptotic cell clearance (GO:0043277),0.39397230624693264,1.0304017698559162,0.4428754813863928,1.0,1.0,3/30,2.83%,XKR7;LRP1;XKR8
prerank,amino acid transport (GO:0006865),-0.27883865897777427,-1.030339411772421,0.41333333333333333,0.8180040742737008,1.0,8/49,6.87%,SLC7A11;SLC7A2;SLC6A12;SLC6A6;SLC38A11;SLC7A5;PDPN;SLC38A7
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.35054396623802264,1.030196753384489,0.4446902654867257,1.0,1.0,19/73,19.29%,DLC1;PYCARD;NGF;FADD;EIF2AK3;TNFRSF10B;APAF1;HIP1;NGFR;CASP12;SNCA;IFT57;CASP2;CRADD;RPS27L;RIPK1;AIFM1;PPARG;SENP1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.32290903651760944,1.030133152784822,0.4154929577464789,1.0,1.0,73/327,20.72%,RORA;MLF2;SOX6;NKX6-2;EFEMP1;PRKCQ;TGIF2;SSBP2;NAB1;RPS6KA4;NFX1;SOX11;RNF6;CXXC1;APBB2;RFX3;MLXIPL;MLX;DRAP1;TAF5L;FZD7;SPIN1;CHD3;ATRX;ZMIZ1;CARM1;SOX12;NCOA2;HIF1A;REXO4;ZBTB38;HINT1;ZSCAN26;ATF2;ESR1;SP1;MYT1;RBAK;SFPQ;NSD2;DVL1;PATZ1;RHOH;AHR;WWTR1;ATF5;TGFBRAP1;CREM;HOXB7;ABL1;TRRAP;MSL3;SP3;TP53;PHF19;TERF2IP;NFIA;SUFU;FUS;APBB3;MLF1;POLR2A;UBE2L3;STAT3;PRDM2;CNBP;HMG20A;HP1BP3;NR1D2;KMT2D;MITF;ZSCAN21;USP13
prerank,mRNA stabilization (GO:0048255),0.3812655134120413,1.0300191671001995,0.4438964241676942,1.0,1.0,15/40,22.46%,ELAVL4;PABPC1;MAPKAPK2;GDNF;MAPK14;EIF4ENIF1;HNRNPU;FUS;SYNCRIP;TENT5A;TENT5D;HNRNPC;ZFP36;YBX3;TENT5C
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.4045276724415024,1.0297650473204518,0.4453125,1.0,1.0,8/27,15.36%,ANK2;HPCA;CACNB4;JPH3;PDE4D;PRKACA;CALM1;CALM2
prerank,regulation of peptide hormone secretion (GO:0090276),0.3524829178198457,1.0297339115002362,0.44013683010262256,1.0,1.0,10/67,10.80%,PRKCA;CACNA1E;CACNA1A;RFX3;PPP3CB;RAP1A;ENSA;PASK;HTR2C;SLC2A2
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.43114604032293374,1.0296735574714708,0.4562841530054645,1.0,1.0,7/21,17.28%,VEGFA;DISC1;DRD2;NES;FZD9;LRP2;MDK
prerank,positive regulation of catalytic activity (GO:0043085),0.3812211045846646,1.0296475296141139,0.44165621079046424,1.0,1.0,12/37,18.11%,SLC5A3;PSEN1;MT3;NHEJ1;NCSTN;MAPK14;MSH6;APH1A;PSEN2;ABL1;WRN;AZIN2
prerank,iron ion homeostasis (GO:0055072),-0.2552670781257001,-1.0294434447596037,0.43661971830985913,0.8189050491120076,1.0,21/58,20.24%,BMP6;ABCG2;FLVCR1;FBXL5;ATP6V0D1;SLC40A1;FTH1;FTL;TFRC;BDH2;SOD1;CYB561A3;FRRS1;ATP6AP1;ATP6V0A2;FXN;SLC22A17;ACO1;HFE;ABCB7;TMEM199
prerank,RNA processing (GO:0006396),0.327445084427804,1.0293598612892414,0.42636457260556127,1.0,1.0,48/176,21.26%,CSTF3;BICD1;DHX8;USB1;ELAVL4;CPSF6;RNGTT;RSRC1;RP9;METTL3;XRN2;SON;RNPC3;IVNS1ABP;TUT4;DDX54;SRSF11;APOBEC1;AURKAIP1;ALKBH5;NCBP1;ADARB2;DUSP11;SFPQ;SNRNP40;LSM3;PRKACA;PRPF18;PRPF6;ADARB1;TSEN2;KHSRP;NOVA1;SF3A1;HNRNPU;RNPS1;FUS;SYNCRIP;DDX23;TENT2;HNRNPUL1;SRRM1;PRMT9;SF3B3;RBMS1;HNRNPC;TSEN34;HNRNPL
prerank,glucose import (GO:0046323),0.46974164914020483,1.0292266051283012,0.43831640058055155,1.0,1.0,3/13,12.68%,SLC27A1;SLC27A4;RAB4B
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.3972866828279137,1.0289431045509492,0.4225721784776903,1.0,1.0,12/29,23.48%,COG5;COPZ2;COPB2;COPG2;COPA;COPG1;GABARAPL2;COG1;TRAPPC3;NAPG;RAB6A;TRAPPC10
prerank,erythrocyte differentiation (GO:0030218),-0.2794409540119837,-1.0288780750203776,0.37714285714285717,0.8187468162511116,1.0,16/44,20.82%,KIT;RPS14;MFHAS1;FLVCR1;LYN;ALAS1;RPS19;ACIN1;ID2;NCKAP1L;INHBA;TAL1;CEBPG;UBA5;ZFPM1;CASP3
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.46171420074911507,1.0288656612608305,0.44879518072289154,1.0,1.0,3/13,10.12%,CPSF6;NCBP1;FIP1L1
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.2951811960481687,-1.0287357423200956,0.4205607476635514,0.8174025089985377,1.0,7/34,10.82%,IGF1;LRP5;IGF2;INSR;TGFA;RGCC;PDGFRB
prerank,mitotic cell cycle phase transition (GO:0044772),0.32490139684812663,1.028149575133775,0.44354018311291965,1.0,1.0,46/203,19.55%,DYNLL1;CRLF3;MYC;CDKN2B;ACVR1;HAUS3;CCNJ;CNTRL;KDM8;CCDC57;PCM1;PLCB1;FBXL15;NDE1;SDCCAG8;PHLDA1;CDK6;FOXM1;ENSA;CEP57;PPP2R2A;CUL3;RCC1;ANAPC7;CLASP1;PKMYT1;TAF2;CDC25B;PHF8;PRKACA;CKAP5;CEP76;DYNC1I2;NES;PIM2;CDC23;CSNK1E;CCND2;CUL4B;CEP63;NASP;USP37;TUBA1A;DBF4;FBXL12;CDC27
prerank,maturation of SSU-rRNA (GO:0030490),-0.2906573980835993,-1.028069217212756,0.38860103626943004,0.8175953829672796,1.0,16/34,26.64%,RPS14;RPS16;RPS19;NGDN;WDR3;RIOK3;HELB;RPS8;RIOK1;DHX37;MRPS11;SNU13;DDX52;TSR3;RIOK2;PWP2
prerank,regulation of response to interferon-gamma (GO:0060330),0.45806211614619574,1.0276679837414833,0.46607669616519176,1.0,1.0,3/14,14.47%,PTPN2;SOCS1;SUMO1
prerank,positive regulation of apoptotic process (GO:0043065),0.32489701673511723,1.027622956294085,0.42799597180261834,1.0,1.0,72/293,18.45%,DLC1;HRK;FAP;PIP5KL1;PYCARD;NGF;AKAP13;FRZB;FADD;FGD4;ANO6;TNFRSF10B;SLC27A4;PSEN1;FANK1;PRNP;NF1;DUSP6;ACVR1C;CYP1B1;APAF1;ITSN1;BMF;SHQ1;PHLDA1;BIN1;BNIP3;VAV3;ARHGEF11;RARG;PPID;SFRP4;UBE2Z;NCSTN;NGFR;ARL6IP5;ING4;CDK5R1;GRN;APH1A;SCRIB;TRIO;PRDM11;SNCA;ARHGEF3;RPS6KA2;PSEN2;TRAF7;ITGB3BP;RASSF2;ITGB1;ATM;CASP2;UBB;ABL1;CRADD;TGFB3;FZD9;GPLD1;BCL2L11;TP53;QRICH1;KCNMA1;ARHGEF4;RIPK1;PLEKHG2;RNPS1;AIFM1;CSRNP3;ADAMTSL4;DNAJA1;HTT
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.40335458035699867,-1.0264925742667725,0.4068767908309456,0.8203763680875019,1.0,4/11,11.46%,MAP3K5;PRKCD;DIABLO;GSKIP
prerank,intraciliary retrograde transport (GO:0035721),-0.3842071873606503,-1.0256633932539827,0.4310850439882698,0.8210566741577793,1.0,6/12,13.15%,WDR19;IFT43;DYNC2LI1;DYNLT2B;IFT122;DYNC2I2
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.47792579972646965,1.025195950588953,0.4716981132075472,1.0,1.0,2/11,3.57%,TAX1BP3;GPM6B
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.41982321268317435,1.0247312425052681,0.43706777316735823,1.0,1.0,2/21,2.18%,PTEN;GORASP1
prerank,negative regulation of mRNA processing (GO:0050686),-0.3684828126859301,-1.0246821525152008,0.4117647058823529,0.822149005513975,1.0,8/15,22.88%,RBMX;SRSF10;SRSF4;SAP18;PTBP1;SRSF7;SRSF12;U2AF2
prerank,regulation of telomerase activity (GO:0051972),0.3763122956536731,1.0246204966322963,0.4344660194174757,1.0,1.0,11/45,16.20%,PRKCQ;MYC;ERCC4;MEN1;PARM1;MAPK1;NEK7;MAP3K4;ATM;SMG6;TP53
prerank,potassium ion transmembrane transport (GO:0071805),0.33462427812319795,1.0244078880703504,0.4397905759162304,1.0,1.0,34/135,23.28%,KCNK15;SLC1A3;KCNA2;KCNH8;SLC12A3;KCNK1;KCNA1;KCNA6;SLC12A2;KCND1;KCND2;KCND3;KCNT2;SLC12A4;KCNAB2;KCNJ3;KCNJ10;KCNH2;SLC9A5;SLC9A1;KCNA5;SLC24A4;SLC24A2;KCNS3;HCN1;KCNH7;PKD2;KCNK10;LRRC55;KCNQ3;KCNK6;KCNC1;KCNA4;KCNJ13
prerank,peptidyl-serine phosphorylation (GO:0018105),0.3245304282938984,1.0242218333260895,0.42679127725856697,1.0,1.0,44/153,19.89%,PRKCA;STK32B;PRKCQ;PRKX;EIF2AK3;RPS6KA4;MAST2;MAPKAPK3;MAPKAPK2;DYRK4;PKN1;TGFBR2;DYRK1B;PDK3;AKT3;MAPK9;TLK2;STK39;SGK3;SGK2;MAPK14;STK32A;MAPK1;CDK5R1;TBK1;CSNK1G1;PRKACA;CSNK1A1;TTBK1;RPS6KA2;PKD1;ATM;CSNK1G2;CSNK1E;SGK1;RIPK1;CHUK;PKN2;VRK3;CSNK2A2;TAF1;TOP1;CAB39;CSNK1G3
prerank,positive regulation of secretion by cell (GO:1903532),-0.2545030361002372,-1.024204007606882,0.39823008849557523,0.8219234765851775,1.0,22/70,19.48%,BMP6;IGF1;RAB5A;DTNBP1;EXOC1;PPIA;RGCC;GRK2;UNC13B;ABCG1;KCNB1;RAB9A;APBB1;SYTL4;TGFB2;MYH10;ATP6AP1;STX1A;EDN1;GPER1;DNM1L;BAIAP3
prerank,regulation of synapse organization (GO:0050807),0.4098705004019946,1.023998422122108,0.4497354497354497,1.0,1.0,7/26,15.41%,IL1RAPL1;CTNNA2;WNT5A;YWHAZ;CDKL5;SETD5;ABL1
prerank,epithelial cell migration (GO:0010631),-0.2932735283624978,-1.023538376619861,0.42011834319526625,0.8222258523043172,1.0,10/37,9.65%,KANK2;NRP1;KIT;ROCK1;CDH13;NOS3;GIPC1;DPP4;TNFSF12;RHOA
prerank,nucleosome organization (GO:0034728),0.36209377383976626,1.0232977317184353,0.43398392652123996,1.0,1.0,11/55,13.17%,SOX9;VPS72;ATRX;MCM3AP;POLE3;SETD2;PRDM9;ASF1A;SMARCC2;ANP32E;SMARCC1
prerank,nuclear body organization (GO:0030575),0.4599678343773497,1.0232737262310103,0.43859649122807015,1.0,1.0,1/12,0.51%,USP50
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.38219518900187244,-1.0231704179542582,0.40672782874617736,0.8216244578006376,1.0,6/13,22.22%,SOX13;SIX1;PTGS2;RREB1;VSTM2A;ZBTB7B
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.29713087033524654,-1.023120211970644,0.3767441860465116,0.8201180763167218,1.0,8/33,12.18%,CDH5;TEK;ANGPT1;KDR;ICAM1;NUPR1;GATA2;SERPINE1
prerank,regulation of protein dephosphorylation (GO:0035304),0.38489958132183366,1.0229024575218575,0.45153374233128835,1.0,1.0,11/37,18.45%,DLC1;TGFB1;PPP1R15A;TSC1;ENSA;PPP1R8;HSP90B1;CALM1;CALM2;TIPRL;HTT
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.42785198101316557,1.022791937214439,0.4259776536312849,1.0,1.0,8/21,21.84%,FGF13;CLASP1;APC2;KATNB1;NAV3;CAMSAP1;ATXN7;TAOK1
prerank,apical protein localization (GO:0045176),0.49516797541423974,1.0225352978319682,0.44648318042813456,1.0,1.0,2/10,3.48%,ATP8B1;INSC
prerank,cellular response to mechanical stimulus (GO:0071260),0.3662180715511156,1.0225343698136058,0.4359281437125748,1.0,1.0,9/46,16.67%,PIEZO2;SOX9;FADD;TNFRSF10B;BNIP3;MAP2K4;CASP2;CRADD;SLC9A1
prerank,glycolipid biosynthetic process (GO:0009247),0.3789064775969922,1.021921701037095,0.44704433497536944,1.0,1.0,11/38,21.16%,ST3GAL4;PIGC;SCCPDH;PIGP;ST8SIA1;PIGN;PIGA;PIGU;DPM1;PIGO;B4GALT6
prerank,mitochondrial fission (GO:0000266),0.4392273813236248,1.021548803768384,0.44733044733044736,1.0,1.0,2/16,2.42%,DNM1;PRKN
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.4344137395731774,1.0214999593040281,0.434971098265896,1.0,1.0,3/17,13.06%,AP1G1;CADM1;NECTIN2
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3151771486792095,1.0210798547567024,0.4559118236472946,1.0,1.0,85/509,16.32%,ROR2;RELN;DCN;FFAR4;ROR1;PDGFRA;ERBB3;NTRK3;FGF2;S100A4;FGF10;BCL2;IRS2;SOX9;ERBB2;PRKN;EGFR;AKAP13;FADD;LPAR1;ALPK1;MIOS;VEGFA;MAP3K3;THEM4;GPRC5B;TRIM44;TNFRSF10B;TGFB1;CCL4;SOX11;NCF1;NTRK2;SLC44A2;WNT5A;TMEM106A;NLGN1;KSR1;CARD9;BMF;FGFR1;GAB2;PELI1;IL18;FYN;LAMTOR2;FLNA;BTC;HIP1;TRIP6;PIK3R1;VAPA;ERBB4;PTPRJ;CBL;GPR37;MID2;PTPN11;ESR1;FGF7;MYDGF;RHOC;TBK1;RTKN2;STRN;MYOC;GATA3;MALT1;NDFIP1;P2RY12;DHX33;TRAF7;GOLT1B;RTN4;IQGAP1;CGAS;ITGB1;TICAM1;MET;PIM2;BCL2L11;TP53;TERF2IP;GAB1;LRP2
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.3583224375923016,-1.0210569424731983,0.4174757281553398,0.8242110635287468,1.0,6/17,21.85%,TLR4;CD55;BACH2;JAG1;IL18BP;GNL1
prerank,regulation of cell size (GO:0008361),0.4076698429586439,1.020990458079346,0.4458161865569273,1.0,1.0,8/23,21.27%,PTEN;DEPTOR;VAV3;RARG;PRR16;RPTOR;RDX;VAV2
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.2636107831505078,-1.0208313845494514,0.4503311258278146,0.8231884328774673,1.0,21/55,29.15%,PSMD14;USP47;FBXL7;PSMB3;PSMD12;PSMD6;PSMA1;PSMD7;PSMA5;PSMC5;PINX1;PSMC4;PSMB6;PSMA4;AVEN;PSMB9;PSMB1;PSMD3;PSMC6;PSMD10;PSME3
prerank,chemical homeostasis (GO:0048878),0.35622771040137996,1.0207153995573697,0.45039908779931587,1.0,1.0,12/61,17.21%,WNK2;IRS2;ZBTB20;WNK3;FBXW7;AQP4;ACOX1;THADA;PNPLA8;NEDD4L;SLC4A7;ADCK1
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.37667808713416084,1.0205538364830837,0.42857142857142855,1.0,1.0,8/40,15.41%,PIP5KL1;BCL2;PID1;ARL6IP5;PRDX3;MTLN;UBB;ABL1
prerank,peptidyl-asparagine modification (GO:0018196),0.3993842491943871,1.0204528198600762,0.4479578392621871,1.0,1.0,13/31,27.22%,UGGT2;STT3A;MAGT1;ALG5;TUSC3;ALG8;DPM1;RPN1;LMAN1;MGAT5;ST6GAL1;UBE2J1;HIF1AN
prerank,respiratory system development (GO:0060541),0.3941369283268665,1.0203158749429193,0.4375,1.0,1.0,5/32,6.77%,GLI2;FGF2;CCDC39;VEGFA;LOXL3
prerank,regulation of glucose transmembrane transport (GO:0010827),0.431835249244897,1.0201036003120474,0.4556786703601108,1.0,1.0,2/18,2.62%,FFAR4;C2CD5
prerank,cellular component assembly (GO:0022607),0.32002058016679613,1.020017924995499,0.45096056622851366,1.0,1.0,61/253,20.78%,ANK3;RHOJ;HAS2;RHOD;REPS2;SOX9;LAMC1;GSN;KMT2A;WIPF1;EPRS1;RSPH1;GPM6B;TGFB1;WNT5A;SPTBN1;NLGN1;YWHAZ;BAIAP2;PPID;FLNA;TEX11;CFAP46;MAGI1;GORASP2;CFAP74;FANCC;MYO9A;RIMS1;OPHN1;DVL1;RHOH;WASF1;RBBP4;DET1;CORO1B;MDM4;RTN4;CYFIP1;PKP2;FSCN1;NIFK;LPXN;PPIH;TP53;LRRTM3;IL1RAP;FOXJ1;CD74;RAC3;RSPH9;MDM2;DCX;SKAP2;KPNA3;NCKAP1;VMP1;NAPG;MITF;RHOU;SYCE2
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.43030121238942276,1.0199668573686351,0.4449213161659514,1.0,1.0,7/18,20.78%,ZFP36L2;KLF9;BCL2L11;HNRNPU;PCK2;UBE2L3;ZFP36
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.3567667539612933,1.019932486072534,0.44224037339556593,1.0,1.0,10/54,11.12%,PRKCA;FGF2;VEGFA;TGFB1;NF1;FGFR1;AKT3;HIF1A;MAPK14;SP1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.4829367494236264,1.0198065235905955,0.45794392523364486,1.0,1.0,2/10,3.58%,IRAK3;MAPK7
prerank,amino acid import (GO:0043090),-0.3332505264571392,-1.0195918744294505,0.42214532871972316,0.8251034820097288,1.0,8/21,14.94%,SLC47A1;SLC6A6;SLC22A4;SLC6A13;SLC7A5;SLC16A2;SLC6A1;SFXN3
prerank,protein phosphorylation (GO:0006468),0.3153139821012937,1.0195864308003402,0.443,1.0,1.0,93/478,15.69%,CCL11;RELN;WNK2;EFEMP1;PRKCA;PDGFRA;STK32B;PRKCQ;PKDCC;STK36;PEAK1;ERBB2;EGFR;ACVR1;MAP4K4;PRKX;PAK4;MAP3K3;EPHB2;IRAK3;WNK3;EIF2AK3;SIK2;RPS6KA4;TEC;MAST2;MAPKAPK3;TGFB1;NEK1;PAK5;NTRK2;MAPKAPK2;DYRK4;PRKAR1B;TESK2;ACVR1C;TNIK;EEF2K;PKN1;PAK1;YWHAZ;CDK13;CDKL5;CDK8;CDKL3;TGFBR2;CSK;PPP3CB;DYRK1B;PDK3;CDK6;FGFR1;LIMK1;FYN;CDK15;TBCK;CDK19;AKT3;MAPK9;TLK2;STK39;PASK;SGK3;SGK2;PXK;ERBB4;SLK;TYK2;DCLK1;MAPK14;STK32A;MAPK1;CDC25B;TAOK3;CDK5R1;STK33;TBK1;CSNK1G1;PRKACA;CSNK1A1;CDK16;NEK7;TTBK1;RPS6KA2;CRY1;BMPR1A;BAZ1B;PKD1;ATM;ABL1;PIM2;CSNK1G2;HTATIP2
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.3464268947266167,1.0195064677961692,0.4643652561247216,1.0,1.0,16/74,15.64%,BMP5;GLIPR2;PHLDB1;PTEN;TGFB1;SPRED2;TGFBR2;SPRED1;BCL9L;SPRED3;CLASP1;COL1A1;WWTR1;GATA3;LDLRAD4;TGFB3
prerank,neural crest cell migration (GO:0001755),0.37995748999727863,1.0193815065683702,0.4544334975369458,1.0,1.0,7/36,11.29%,SOX8;SEMA3E;SEMA6C;SEMA3A;ERBB4;GDNF;ANXA6
prerank,heart morphogenesis (GO:0003007),0.366884007274777,1.0192929399381239,0.45892018779342725,1.0,1.0,4/50,3.17%,DLC1;SOX9;ACVR1;VEGFA
prerank,response to interleukin-4 (GO:0070670),-0.41787198952411364,-1.019265355971996,0.41397849462365593,0.8243523186233789,1.0,1/10,0.61%,LEF1
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.23513237277263668,-1.0188446126961577,0.4225352112676056,0.8239388344695464,1.0,18/102,10.32%,SORBS1;TBC1D4;ADCY9;SLC30A10;PRKCD;RAB31;PRKAR1A;INSR;PRKCI;LPIN2;ZFP36L1;PARP1;SLC25A33;RHOQ;RPS6KB1;ADCY4;GSK3A;INSIG2
prerank,negative regulation of JNK cascade (GO:0046329),0.3844687245103973,1.0185773079386895,0.44836272040302266,1.0,1.0,13/31,23.57%,PTPN22;PRKN;MEN1;TAOK3;PER1;DACT1;FKTN;DNAJA1;ZMYND11;PDCD4;SIRPA;AIDA;CYLD
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.3318018386720232,-1.0180083262251132,0.4065934065934066,0.8246257482329254,1.0,8/18,23.94%,GSK3B;GSK3A;BID;HIP1R;BOK;SLC35F6;MUL1;BAK1
prerank,defense response to bacterium (GO:0042742),-0.23527767438384795,-1.017877672533086,0.35,0.8233755800038631,1.0,23/105,21.53%,ANXA3;ANKRD17;PRKCD;TLR4;RPS19;DEFA6;IRGM;PGLYRP1;IL6R;PPP1R11;OPTN;STAB1;OAS2;SERPINE1;TIRAP;CFP;GSDMD;MPEG1;ISG15;HMGB2;FCER1G;NOD1;COLEC12
prerank,positive regulation of lyase activity (GO:0051349),-0.3774413615780175,-1.0177926508380264,0.40192926045016075,0.8219640137797168,1.0,5/14,16.33%,CACNA1C;NOS3;STIM1;NOS1;FXN
prerank,regulation of muscle contraction (GO:0006937),0.39786753583202933,1.0177558614553812,0.4524421593830334,1.0,1.0,4/26,11.29%,MYBPH;KCNA1;TNNT3;ANXA6
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.3201070146854088,-1.0177545123158143,0.4099099099099099,0.8204728321881641,1.0,6/26,6.81%,EYA1;EYA2;MAP2K5;EYA4;MCL1;PPP2R1B
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.40221998009711113,1.0176042560990972,0.4568733153638814,1.0,1.0,11/30,24.16%,UGGT2;STT3A;MAGT1;ALG5;TUSC3;ALG8;DPM1;RPN1;LMAN1;MGAT5;ST6GAL1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.44644188756003084,1.0173966871602287,0.442572741194487,1.0,1.0,4/14,12.54%,NUDT15;ENTPD2;NUDT1;NUDT9
prerank,regulation of amyloid-beta formation (GO:1902003),-0.29302037056873276,-1.0172039276481515,0.4306930693069307,0.8203610402910607,1.0,4/34,1.75%,EPHA4;IGF1;ROCK2;ROCK1
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.34894908999979,1.0170181617193093,0.4765625,1.0,1.0,17/72,17.31%,PYCARD;CBFB;FADD;PTPN2;IRAK3;TRIM44;SOCS1;AGPAT2;OTULIN;PTPN1;PTPN11;RUNX1;TAX1BP1;SUMO1;RIPK1;CD74;CHUK
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.37052822869988206,1.0163857690043696,0.42927429274292744,1.0,1.0,8/40,11.56%,SGIP1;BICD1;VEGFA;RAB21;HIP1;SFRP4;CBL;MAGI2
prerank,protein O-linked glycosylation via serine (GO:0018242),0.48610214259583173,1.0163767750929893,0.4667697063369397,1.0,1.0,4/10,18.00%,GALNT1;GALNT13;GALNT3;POGLUT2
prerank,positive regulation of coagulation (GO:0050820),0.48104395317939885,1.0163567162334317,0.46899841017488075,1.0,1.0,1/10,1.66%,ST3GAL4
prerank,positive regulation of hemostasis (GO:1900048),0.48104395317939885,1.0163567162334317,0.46899841017488075,1.0,1.0,1/10,1.66%,ST3GAL4
prerank,negative regulation of macrophage activation (GO:0043031),-0.35593401243838585,-1.0161543867682037,0.4024390243902439,0.8216857684465947,1.0,2/16,1.50%,CD200;IL31RA
prerank,epidermis development (GO:0008544),0.3570023018757094,1.0161217222140881,0.43565525383707204,1.0,1.0,8/56,11.39%,CERS3;PTHLH;EMP1;GLI1;GATA6;PLOD1;HDAC2;FGF7
prerank,folic acid-containing compound metabolic process (GO:0006760),0.42362978016263453,1.016044515702109,0.45892351274787535,1.0,1.0,5/19,21.01%,ALDH1L1;MTRR;MTHFD2L;ALDH1L2;SLC25A32
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.46240280311856863,1.0155036165958635,0.46646795827123694,1.0,1.0,4/14,10.06%,KMT2A;AUTS2;BRCA1;PRDM9
prerank,cardiac muscle cell differentiation (GO:0055007),0.4213487995599463,1.0150380412249354,0.47275204359673023,1.0,1.0,3/21,3.17%,AKAP13;ACVR1;VEGFA
prerank,synapse assembly (GO:0007416),0.3530601928188724,1.0148981464612066,0.45342312008978675,1.0,1.0,17/67,16.48%,FGF13;PTEN;NRCAM;NRXN1;WNT5A;OBSL1;GRID2;NLGN1;KIRREL3;GPM6A;DSCAM;ADGRL3;DVL1;DRD2;GABRG2;CBLN4;LRRTM3
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.46089282753552313,1.0148713846194262,0.47577092511013214,1.0,1.0,4/12,19.24%,TGFB1;ESR1;NCOR2;PPARG
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.4360455902023538,1.0147506288695118,0.4663805436337625,1.0,1.0,3/17,12.50%,PLBD1;PLA2G12A;PLAAT3
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.41740605007346976,1.0147308609143906,0.4578313253012048,1.0,1.0,2/20,1.69%,ERBB3;BCL2
prerank,negative regulation of cation channel activity (GO:2001258),0.39810318304300374,1.0143402681024305,0.4520367936925099,1.0,1.0,8/26,24.56%,EPHB2;DRD2;CALM1;CALM2;SLC6A9;PKD2;UBQLN1;FMR1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.3690856180914248,1.0141998376356305,0.45690672963400236,1.0,1.0,11/48,16.20%,PYCARD;BCL2;BRCA1;MSH6;ATM;CASP2;ABL1;AEN;RPS27L;BCL2L11;TP53
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.3139650316332275,-1.0140388159598512,0.4098360655737705,0.8262084070866781,1.0,9/25,21.54%,RECQL5;WDR43;EAF2;EAF1;LEO1;LARP7;NELFCD;CDK12;HEXIM1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.3261783955619641,1.0138227742332742,0.4779033915724563,1.0,1.0,31/152,17.33%,GPC3;WNK2;SULF1;LGR6;PLEKHA4;FGF10;EGFR;DEPDC1B;GPRC5B;TGFB1;DISC1;LGR5;FAM53B;SPIN1;PPM1B;PSMB7;SFRP4;DAAM2;CSNK1G1;COL1A1;ZEB2;PSMD2;DACT1;JUP;CSNK1G2;PSMC1;FZD9;CSNK1E;XIAP;CDC73;PSMB2
prerank,tRNA 5'-leader removal (GO:0001682),0.45692493998773653,1.0138083602061636,0.44052863436123346,1.0,1.0,7/13,27.45%,RPP38;PRORP;POP1;RPP21;SSB;RPP30;RPP14
prerank,folic acid metabolic process (GO:0046655),0.4300881279468922,1.0137484880855911,0.45689655172413796,1.0,1.0,5/18,21.01%,ALDH1L1;MTRR;MTHFD2L;ALDH1L2;SLC25A32
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.34106349551783444,1.0133238916856258,0.4649610678531702,1.0,1.0,20/80,17.68%,TBC1D10A;DENND2A;RHOBTB3;VPS29;ARL1;GBF1;HEATR5A;SNX6;VPS26B;PHETA2;BET1L;SPAG9;SNX1;WASHC1;UBE2O;SNX12;RBSN;SURF4;RAB7A;RAB7B
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.39497302260332595,1.013186472153095,0.46578947368421053,1.0,1.0,6/29,23.31%,MEIOB;TEX11;PRDM9;SYCE2;SYCP2;MEI4
prerank,epidermal cell differentiation (GO:0009913),0.3676395687806789,1.0131433521871456,0.43266832917705733,1.0,1.0,6/41,10.26%,CERS3;TGM1;GLI1;WNT5A;GATA6;HDAC2
prerank,regulation of cell adhesion (GO:0030155),0.32392929946086135,1.0131042032835207,0.45705196182396607,1.0,1.0,18/129,10.88%,TGFBI;PRKCA;ERBB3;EPB41L4B;RHOD;ERBB2;PLXNC1;EFNA5;PRKX;VEGFA;EPHB2;PDE3B;RASA1;PPP3CA;IL18;DSCAM;PTPRJ;PTPN11
prerank,regulation of interleukin-12 production (GO:0032655),0.36518450603168073,1.0130921388152094,0.46107784431137727,1.0,1.0,4/47,4.99%,IL16;IRAK3;MAST2;PLCB1
prerank,sulfur compound transport (GO:0072348),-0.3153803664366769,-1.0130875267905748,0.3942307692307692,0.8274579564676134,1.0,9/27,14.24%,ABCG2;SLC26A7;SLC6A6;SLC6A13;SLC25A26;SLC25A30;SLC13A4;SLC5A6;MGST1
prerank,water-soluble vitamin metabolic process (GO:0006767),0.3455184000761554,1.012891334120386,0.47416762342135477,1.0,1.0,15/68,16.94%,ACP5;MMAB;PDXK;CD320;ALDH1L1;MCCC1;HLCS;PNPO;MTRR;MCCC2;MTHFD2L;RFK;MTR;ALDH1L2;ABCC1
prerank,regulation of cell motility (GO:2000145),0.33040325302276785,1.0128521479392794,0.46178343949044587,1.0,1.0,23/121,11.39%,ERBB3;FGF2;FGF10;ERBB2;PLXNC1;EGFR;PRKX;HACE1;CADM4;TGFB1;PKN1;DOCK10;CDK6;SERPINE2;FLNA;BTC;MGAT3;LDB2;SGK3;SPATA13;ERBB4;SLK;FGF7
prerank,cellular component maintenance (GO:0043954),-0.3887050692203821,-1.0127335137375675,0.4438356164383562,0.8268877706203739,1.0,4/12,8.45%,IGF1R;ITGA3;INSR;MTMR2
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3268898699900043,1.0124120922072177,0.48037190082644626,1.0,1.0,22/142,15.69%,PDGFRA;TAC1;LPAR1;PTGER3;ATP2B3;CACNA1A;PTGFR;WNT5A;CCR2;ACKR3;CD52;SLC8A2;ESR1;S1PR3;ATP2B1;PRKACA;DRD2;TRPC5;P2RY1;ACKR4;ABL1;FZD9
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.3456760691868213,1.0124101547648723,0.45982142857142855,1.0,1.0,16/73,19.82%,PYCARD;FADD;EPHB2;PSEN1;WNT5A;TMEM106A;CCR2;PTPRJ;TLR1;PTPN11;IL33;LBP;RIPK1;SETD4;STAT3;BCL10
prerank,negative regulation of catabolic process (GO:0009895),0.36284488086280786,1.011862331874197,0.4467065868263473,1.0,1.0,15/47,24.18%,EGFR;FMN2;IRAK3;PDE3B;CBFA2T3;FLNA;MDM4;SNX12;AZIN2;SF3B3;PFKFB1;AGAP2;PRKAA1;PRKCG;HMGCR
prerank,positive regulation of protein deacetylation (GO:0090312),-0.37854839877556584,-1.0113387872924204,0.4341317365269461,0.8292364584352377,1.0,7/14,30.71%,SAP30BP;ING2;ZBTB7B;FNTA;BRMS1;NIPBL;NNMT
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.31569415837573667,1.0108127144338517,0.46593186372745493,1.0,1.0,82/366,20.76%,RORA;MLF2;SOX6;NKX6-2;EFEMP1;PRKCQ;TGIF2;SSBP2;NAB1;RPS6KA4;NFX1;SOX11;RNF6;CXXC1;ATXN2;APBB2;RFX3;TSC1;MLXIPL;MLX;DRAP1;TAF5L;FZD7;SPIN1;CHD3;RABL3;ATRX;CARM1;SOX12;NCOA2;HIF1A;REXO4;GRM5;ZBTB38;HINT1;ZSCAN26;ATF2;ESR1;SP1;MYT1;RBAK;SFPQ;NSD2;DVL1;PATZ1;DDX25;RHOH;AHR;WWTR1;ATF5;RBM4B;TGFBRAP1;CREM;CYFIP1;HOXB7;ABL1;TRRAP;MSL3;SP3;TP53;PHF19;TERF2IP;NFIA;SUFU;FBXO5;FUS;APBB3;USP37;MLF1;POLR2A;UBE2L3;STAT3;PRDM2;CNBP;HMG20A;HP1BP3;NR1D2;KMT2D;MITF;ZSCAN21;USP13;CCDC88A
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.4660873884266848,1.0107881813009205,0.4626865671641791,1.0,1.0,3/12,6.60%,DOCK7;DOCK5;ADAMTS1
prerank,spliceosomal complex assembly (GO:0000245),0.3668769755017061,1.0107761157365127,0.4491525423728814,1.0,1.0,22/46,29.82%,CELF5;LUC7L2;TXNL4A;NCBP1;PRPF6;CELF6;SRSF6;YTHDC1;LUC7L;SF3A1;SF1;DDX23;CELF4;SNRNP200;SCAF11;DDX1;SRSF5;RBM5;CELF1;CELF2;USP39;SRSF9
prerank,respiratory chain complex IV assembly (GO:0008535),0.41362325090166485,1.0107178605387048,0.4426450742240216,1.0,1.0,5/21,13.64%,COX20;COX18;SCO1;COX19;COX10
prerank,dendritic spine morphogenesis (GO:0060997),0.44155578188263195,1.010648733272831,0.48175182481751827,1.0,1.0,4/15,11.49%,PTEN;EPHB2;DOCK10;DIP2A
prerank,negative regulation of ATPase activity (GO:0032780),0.4390671713044399,1.0103912859320612,0.4630404463040446,1.0,1.0,5/16,17.73%,TSC1;THADA;PXK;TP53;PAM16
prerank,regulation of response to oxidative stress (GO:1902882),0.47037918927999267,1.0103869745422345,0.46841294298921415,1.0,1.0,2/11,10.16%,PRKN;MCTP1
prerank,response to alcohol (GO:0097305),0.39481374656341983,1.0102165481633345,0.46164021164021163,1.0,1.0,5/27,14.11%,TGFB1;GRIN2B;TGFBR2;GOT2;GRIN2A
prerank,ventricular septum morphogenesis (GO:0060412),-0.3055410703282363,-1.0102138546186883,0.3911290322580645,0.8307852252116565,1.0,6/27,4.30%,ROBO1;SMAD7;BMP4;SLIT2;BMPR2;TGFBR1
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.390134627439922,1.0101527524326446,0.4295125164690382,1.0,1.0,12/29,25.68%,DHX34;PABPC1;GDNF;NBAS;EIF4ENIF1;HNRNPU;FUS;TENT5A;TENT5D;TENT5C;FMR1;CIRBP
prerank,cellular calcium ion homeostasis (GO:0006874),0.3276892630096908,1.0097665049317892,0.49109947643979057,1.0,1.0,21/133,13.72%,CCL11;BCL2;ANK2;LETM1;ATP2B3;PACS2;PSEN1;CCR2;PDZD8;SLC8A2;SLC24A5;SLC10A7;EDN3;HERPUD1;HTR2C;ANXA6;ATP2B1;TPCN2;PRKACA;CCDC47;TRPC5
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.4727364556145412,1.0093357475822151,0.46533127889060094,1.0,1.0,3/12,16.58%,IRS2;MTLN;ABCD2
prerank,regulation of hormone secretion (GO:0046883),0.4576267667359455,1.0092982070763132,0.45750708215297453,1.0,1.0,3/15,9.75%,SOX11;EDN3;SNX6
prerank,peptide metabolic process (GO:0006518),0.3476026478375508,1.0090323947096835,0.4569832402234637,1.0,1.0,12/75,10.17%,BACE2;DPEP1;HM13;PARL;MIPEP;PSEN1;LTA4H;TRHDE;SPCS3;MGAT3;LNPEP;THOP1
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.35389960646302504,-1.0089548529687893,0.3987341772151899,0.8328311778180023,1.0,4/16,9.68%,PLCB3;BMPR2;ACE;GSK3A
prerank,lamellipodium organization (GO:0097581),-0.2999566407551403,-1.008844264597107,0.39330543933054396,0.8314951956750956,1.0,9/29,14.28%,ABLIM1;KIT;CDH13;PARVB;ARHGEF6;ABLIM2;WHAMM;PTPRO;S1PR1
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.3668384499156571,1.008795952926308,0.45510455104551045,1.0,1.0,8/42,14.00%,IARS2;EPRS1;FARSA;SARS2;FARSB;FARS2;YARS1;HARS1
prerank,histone mRNA catabolic process (GO:0071044),-0.36382905535126103,-1.0084999100326069,0.45481049562682213,0.830854162165549,1.0,8/15,19.43%,XRN1;LSM1;MTPAP;ERI1;DCP2;TUT7;EXOSC10;TENT4B
prerank,regulation of gene expression (GO:0010468),0.31159767410817635,1.0079118783191758,0.46,1.0,1.0,141/903,15.72%,RORA;OSR2;SEC16B;RAG2;PRX;MLF2;SOX6;NKX6-2;AFF3;CLDN19;ANK3;EFEMP1;GLMN;ADAM19;CREB3L1;NTRK3;PRKCQ;EPB41L4B;FGF2;RBMS3;MYC;TGIF2;FGF10;DHH;PTPN22;ANK2;CD34;SOX9;SSBP2;NGF;GSN;NAB1;C1D;PRKN;HNRNPDL;VEGFA;EPHB2;PTHLH;EIF2AK3;TRA2B;TLE1;RPS6KA4;TRIM44;NFX1;ZNF326;FBXW7;TGFB1;ITGB8;PSEN1;SOX11;NTRK2;RFXANK;RNF6;MT3;WNT5A;CXXC1;HOXD3;HNRNPAB;APBB2;UBAP2;RFX3;MLXIPL;MLX;DRAP1;TAF5L;SON;TRIM11;FZD7;CDK6;SPIN1;CHD3;SLC8A2;ATRX;ZNF462;SMO;BRCA1;CARM1;SOX12;ANKRA2;MAPK9;NCOA2;HIF1A;SFRP4;ZFP64;EDN3;REXO4;ZBTB38;PRDM9;HINT1;ZSCAN26;GDNF;ATF2;PCBP4;NFE2L2;MAPK14;PID1;RIMS1;ESR1;SP1;MYT1;RBAK;BMP7;MAPK1;HDAC6;FGF7;POGZ;ATRAID;DIP2A;SFPQ;NSD2;RUNX1;DVL1;PATZ1;RHOH;AHR;WWTR1;ATF5;PER1;GATA3;NDFIP1;SPOUT1;PRDM11;TGFBRAP1;KDM6A;TTBK1;PDCL3;KHSRP;NOVA1;BMPR1A;YTHDC1;CREM;IL33;ATM;TICAM1;CITED2;HOXB7;ABL1;POU3F1;STX1B;TRRAP;MSL3
prerank,male gonad development (GO:0008584),0.3848620435539873,1.0077728957173004,0.4642409033877039,1.0,1.0,11/34,21.39%,SOX8;SOX9;WNT5A;MAMLD1;GATA6;GATA3;LRP2;NR5A1;CSDE1;FGF9;MEA1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.46020073247157844,1.0074310855842576,0.4587706146926537,1.0,1.0,4/12,19.31%,TGFB1;ESR1;NCOR2;STAT3
prerank,RNA destabilization (GO:0050779),-0.34203651080352515,-1.0070973699158297,0.44912280701754387,0.8333050195049827,1.0,4/18,6.68%,ROCK2;ROCK1;YTHDF1;METTL14
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.48068462545323026,1.0070757088514644,0.47730829420970267,1.0,1.0,5/10,19.87%,RNF157;PDE3B;PDE4D;APLNR;PDE11A
prerank,substrate-dependent cell migration (GO:0006929),-0.371196397770184,-1.0070067645649619,0.459214501510574,0.8319118437591778,1.0,5/14,16.63%,NRP1;VEGFC;EPHA8;PTPRC;ITGA11
prerank,O-glycan processing (GO:0016266),0.3578593516217139,1.0068154385700034,0.4591715976331361,1.0,1.0,16/54,24.16%,ST3GAL4;GALNT9;GALNT1;C1GALT1;GALNT15;GALNT7;GALNT13;GALNT6;GALNT3;MUC3B;MUC3A;GALNT11;GXYLT1;ST6GALNAC4;XXYLT1;ST6GAL1
prerank,lysosome organization (GO:0007040),0.3750514744609627,1.0061875247219534,0.4539800995024876,1.0,1.0,16/36,24.09%,GNPTAB;VPS33A;ACP2;GRN;TPCN2;AKTIP;CLVS1;HPS1;HOOK2;MBTPS1;CLN6;CLVS2;HOOK3;HOOK1;TPP1;MTOR
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.36787573169477455,1.0059159045431747,0.48696682464454977,1.0,1.0,12/41,21.95%,FGF2;CACNA2D1;GRIN2B;SLC8A2;HTR2C;DRD2;GRIN2D;GRIN2A;SLC24A2;RYR3;PKD2;ERO1A
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.37760960025738766,-1.0057973298583986,0.4171779141104294,0.8336867329615796,1.0,2/13,3.95%,IGF1;RAMP1
prerank,regulation of neuroblast proliferation (GO:1902692),0.43966015861490076,1.0053808825319255,0.4815361890694239,1.0,1.0,5/15,13.01%,VEGFA;NF1;DISC1;TAFA1;DRD2
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.4446347547478228,1.005260782447745,0.4756277695716396,1.0,1.0,4/15,15.46%,GRIK3;GRM5;HOMER2;HOMER1
prerank,lipoxygenase pathway (GO:0019372),-0.3693469315828879,-1.0052242938363398,0.4758842443729904,0.833758514125235,1.0,5/14,22.19%,PTGS2;GPX1;HPGD;GPX4;ALOX12
prerank,polyol metabolic process (GO:0019751),0.3676382791363756,1.0050383585094653,0.4887307236061684,1.0,1.0,5/46,4.99%,ITPK1;INPP4B;PTEN;SLC5A3;PLCB1
prerank,regulation of cell population proliferation (GO:0042127),0.31035260990307245,1.0047056054388404,0.484,1.0,1.0,120/691,16.22%,ROR2;OSR2;DLC1;SSTR1;BMP5;WNK2;CLDN19;CXCL10;PDGFRA;GLMN;ERBB3;NTRK3;HAS2;FGF2;MYC;FGF10;PTEN;KIF20B;BCL2;GAREM1;IRS2;CDKN2B;KAT2B;SOX9;CRLF1;NGF;ERBB2;BST1;EGFR;FRZB;PTPN2;SQLE;VEGFA;CADM4;PTHLH;CAPN1;TGFB1;PTGFR;SOX11;TIPIN;NUPR2;NTRK2;GDF9;GLI1;NOP2;CYP1B1;NOX1;PAK1;BNIPL;KSR1;CDK13;PODN;TGFBR2;TSC1;MLXIPL;ADAMTS1;COL18A1;UFL1;CDK6;CBFA2T3;FOXM1;FGFR1;MEN1;GAB2;NF2;TSHR;RARG;BTC;DERL2;SGK3;SGK2;SFRP4;EDN3;SHCBP1;AMELX;CUL3;HDAC2;ERBB4;GDNF;PTPRJ;IL6ST;S1PR3;PRMT1;FGF7;CDC25B;MAGI2;ING4;RUNX1;GLP2R;RTKN2;ATP8A2;PRLR;XRCC6;STRN;PRDX3;SOD2;DRD2;WWTR1;ADARB1;ATF5;RBBP4;GATA3;TRAPPC14;NACC2;PDS5B;RPS6KA2;MDM4;BMPR1A;CD164;CCL14;JUP;LMNA;PIM2;TGFB3;MEIS3;GPLD1;TRNP1;XIAP;TP53;CCND2
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.3669236374243649,1.0040811361216424,0.459727385377943,1.0,1.0,5/41,9.88%,PTPN22;CD34;IRAK3;SELENOS;SYT11
prerank,cellular response to hypoxia (GO:0071456),0.32837115094873137,1.0039612282170791,0.49575371549893843,1.0,1.0,35/126,23.05%,RORA;MYC;SUV39H1;FMN2;SCN2A;VEGFA;MT3;GATA6;KCND2;TBL2;BNIP3;PSMB7;HIF1A;BMP7;CPEB1;MDM4;PSMD2;UBB;LMNA;PSMC1;TP53;PSMB2;MDM2;ELOC;PSMD9;ACAA2;PSME4;HP1BP3;NPEPPS;PSMA8;LIMD1;BNIP3L;UBQLN1;CARD16;ELOB
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.318402333119101,1.0031764326735266,0.4857142857142857,1.0,1.0,49/190,22.09%,RORA;PYCARD;PTEN;RNF157;BCL2;VGLL4;NPRL2;THEM4;TLE1;DEPTOR;NF1;PDE3B;URI1;OTUD7B;NLRX1;TSC1;SPRED1;PPM1B;HERPUD1;PTPRJ;MAPK14;ESR1;BMP7;MAGI2;PDE4D;RHOH;RTKN2;DRD2;PER1;NDUFA13;APLNR;RIPK1;MDM2;PIK3IP1;OTUD7A;FNIP1;ZMYND11;MAPKBP1;CPNE1;PDE11A;DUSP1;LIMD1;ARHGAP12;P2RX7;PDE10A;PRKAA1;DEPDC5;ARRB2;PPM1A
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.34520811890541614,-1.003111198012279,0.4652567975830816,0.8382768642432266,1.0,3/15,8.14%,XPO4;CAMK1;GSK3B
prerank,regulation of gluconeogenesis (GO:0006111),-0.3081859997397366,-1.0027304939271275,0.4262948207171315,0.8377212606691539,1.0,8/27,16.98%,USP7;CLK2;SIK1;OGT;ARPP19;C1QTNF3;PGP;PDK2
prerank,microtubule nucleation (GO:0007020),0.4250435773528524,1.002329771239792,0.47455295735900965,1.0,1.0,5/19,11.76%,CCDC57;NDE1;TUBGCP5;CLASP1;SLAIN2
prerank,positive regulation of cholesterol efflux (GO:0010875),0.41316991208051057,1.0022281055109319,0.47183098591549294,1.0,1.0,3/21,8.39%,PTCH1;LRP1;ZDHHC8
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.30815212474303777,1.0020427527293647,0.494,1.0,1.0,253/1082,21.48%,RORA;DCN;OSR2;ETV1;BMP5;MLIP;CXCL10;KLF15;MDFIC;ETV4;MEOX2;GLI2;MAML3;MACC1;FGF2;SOX8;CRLF3;PRDM16;MYC;RGMB;CDKN2B;KAT2B;SOX9;SSBP2;HMGN1;ERBB2;NCOA1;PRKN;EGFR;HIVEP1;ACVR1;FADD;KMT2A;HOXA7;VEGFA;CCNC;TFCP2;MAPK7;WAC;EIF2AK3;CRTC1;MAML2;RPS6KA4;TRIM44;KDM8;AUTS2;TGFB1;PSEN1;SOX11;FANK1;NCF1;SETD3;BICRAL;RFXANK;RNF6;MT3;GLI1;PLCB1;RAI1;ATF7IP;WNT5A;E2F2;CXXC1;PHOX2A;HOXD3;HNRNPAB;CDK8;RFX3;CREB3L2;RORC;MLXIPL;MLX;ZBTB16;DRAP1;GATA6;PPP3CB;NAA16;DYRK1B;FZD7;FOXM1;KAT8;BICRA;ZC3H8;MEN1;SPIN1;PPP3CA;IL18;ATMIN;ASXL3;ATRX;RARB;ARHGEF11;ZNF462;RARG;TFAM;HEATR1;ZMIZ1;BRCA1;SOX12;NCOA2;BRD8;LDB2;HIF1A;ZFP64;KLF5;IL4I1;BCL9L;ZBTB38;MED13;PIK3R1;HDAC2;ERBB4;MYSM1;GDNF;ATF2;NFATC3;NFE2L2;ASF1A;ARF4;SMARCC2;PID1;ESR1;SP1;TAF9;BMP7;FGF7;POGZ;SFPQ;RUNX1;NRIP1;DVL1;MYDGF;BCL9;TMF1;TBK1;ZFPM2;EPC1;PHF8;COL1A1;XRCC6;AHR;PRPF6;WWTR1;SMARCC1;ATF5;PER1;GATA3;ZEB2;SALL2;NCK1;PRDM11;TAF7;PAX3;HIVEP3;DHX33;PCBD2;BMPR1A;IL33;PKD1;MED12;ATM;CITED2;MET;ELL;HOXB7;JUP;UBB;ABL1;POU3F1;PIM2;MED21;TGFB3;MED25;HTATIP2;MEIS3;RNF111;SP3;BLM;ASXL2;TP53;KCNH2;USP21;TET3;QRICH1;NFIX;SLC9A1;NFIA;HNRNPU;SREBF2;ING1;WWOX;GABPB1;GABPB2;FOXJ1;PAX2;RIPK1;HEYL;CD74;RNF10;CHUK;PCID2;NCOA3;NR5A1;RPTOR;ZNF496;CSRNP3;IRF3;MED30;NAA15;AATF;PARK7;MAPRE3;PSMD9;RNF4;KLF7;KMT2E;EGR1;PPARG;SENP1;STAT3;PRDM2;RUVBL2;FOXJ3;CNBP;BCL10;MCRS1;SMARCA4;JUN;UBTF;MEIS1;NR1D2;ONECUT2;KMT2D;FUBP3;TFE3;MITF;SNAI1;BCL3;ZSCAN21;PBX1;NFKB1;ZBED4;SEC14L2;CD38;PRKD2;PKD2;DPF2;NSD1;RPS6KA3;TNIP2;ZXDC;DCAF6;THRA
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.30898055645195777,1.001822205495146,0.507,1.0,1.0,153/834,17.31%,RORA;DCN;OSR2;ETV1;BMP5;MLIP;CXCL10;KLF15;ETV4;MEOX2;GLI2;MAML3;MACC1;FGF2;SOX8;CRLF3;MYC;CDKN2B;KAT2B;SOX9;SSBP2;NCOA1;PRKN;EGFR;HIVEP1;ACVR1;FADD;KMT2A;HOXA7;VEGFA;CCNC;TFCP2;MAPK7;CRTC1;MAML2;RPS6KA4;AUTS2;TGFB1;SOX11;SETD3;RFXANK;GLI1;WNT5A;E2F2;PHOX2A;HOXD3;CDK13;CDK8;RFX3;MLXIPL;MLX;DRAP1;GATA6;PPP3CB;FOXM1;KAT8;MEN1;PPP3CA;IL18;ATMIN;ASXL3;ATRX;RARB;ZNF462;RARG;ZMIZ1;BRCA1;SOX12;NCOA2;BRD8;LDB2;HIF1A;ZFP64;KLF5;IL4I1;BCL9L;ZBTB38;MED13;PIK3R1;HDAC2;MYSM1;GDNF;ATF2;NFATC3;NFE2L2;ARF4;NGFR;PID1;ESR1;SP1;TAF9;POGZ;SFPQ;RUNX1;NRIP1;DVL1;MYDGF;BCL9;TMF1;TBK1;ZFPM2;EPC1;XRCC6;AHR;PRPF6;WWTR1;ATF5;PER1;GATA3;ZEB2;SALL2;NCK1;TAF7;PAX3;BMPR1A;IL33;PKD1;MED12;ATM;CITED2;MET;ELL;HOXB7;JUP;UBB;ABL1;GCN1;MED21;TGFB3;MED25;HTATIP2;MEIS3;RNF111;SP3;MEPCE;ASXL2;TP53;TET3;NFIX;SLC9A1;NFIA;HNRNPU;SREBF2;WWOX;GABPB1;GABPB2;FOXJ1;CDC73;PAX2;RIPK1;HEYL;RNF10;CHUK
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.3584775935549515,1.001546935982792,0.4820574162679426,1.0,1.0,14/43,20.14%,FGF2;SOX9;TGFB1;HIF1A;KLF5;NFATC3;NGFR;GATA3;TP53;EGR1;PPARG;STAT3;SMARCA4;JUN
prerank,hematopoietic stem cell differentiation (GO:0060218),0.4774963909085942,1.0015143765476422,0.47770700636942676,1.0,1.0,4/10,17.89%,MEOX1;UFL1;TP53;BATF
prerank,potassium ion import across plasma membrane (GO:1990573),-0.2777182880371835,-1.0014658544068922,0.46551724137931033,0.8397842613223381,1.0,9/41,12.92%,ATP1A2;ATP1B3;SLC12A7;KCNJ2;ABCC9;ATP1A1;SLC12A9;KCNK9;SLC12A8
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.4769434397592303,1.0014128566333522,0.4637223974763407,1.0,1.0,3/10,17.51%,PRNP;SCRIB;RC3H1
prerank,inorganic anion transport (GO:0015698),0.3636348760727352,1.0011772322947616,0.4887839433293979,1.0,1.0,11/53,16.23%,FXYD3;ANO6;TTYH3;TTYH1;FXYD1;SLC25A10;ANO10;CLIC1;XPR1;CLCN2;SLC25A11
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.2971257767692356,-1.0011358431456499,0.43243243243243246,0.8390907880844154,1.0,12/29,18.97%,TERF2;PPIA;RFC1;DKC1;WRAP53;HSP90AA1;CDK2;TERT;PINX1;HSP90AB1;GAR1;TINF2
prerank,endothelial cell development (GO:0001885),0.398612390435129,1.0010868077596944,0.45209176788124156,1.0,1.0,3/25,7.56%,COL15A1;COL18A1;RAP1A
prerank,dephosphorylation (GO:0016311),0.318404411116399,1.0009265096046114,0.5092592592592593,1.0,1.0,51/147,24.66%,PTPRH;PTEN;PTPN22;DUSP4;PSPH;PTPRT;DUSP6;PTPN13;ACP2;PPP3CB;PPP3CA;PPM1B;PPM1J;PPP2R3A;PPP2R2A;PTPN1;PTPRJ;DUSP11;PLPP4;PPP1CA;PLPPR4;PTPRA;PTPN18;PTPRZ1;HDHD2;SSH1;PTPN21;PPP3CC;PTPRF;DUSP16;PPM1E;NT5C;DAPP1;PLPPR2;PTPRS;PPP4R1;DUSP12;DUSP1;CTDSP1;PTPRN2;SSH2;PPM1A;PLPPR1;CTDSP2;MTMR7;PPP2R1A;MTM1;PPP2R5A;PPEF2;PPM1M;EPHX2
prerank,hemidesmosome assembly (GO:0031581),0.4717123853229048,1.000739829230123,0.4806201550387597,1.0,1.0,2/11,6.46%,LAMC1;PLEC
prerank,negative chemotaxis (GO:0050919),0.3784134097308699,1.0005993891795784,0.4622166246851385,1.0,1.0,4/33,3.81%,LGR6;SEMA3E;SEMA6C;SEMA3A
prerank,regulation of cell growth (GO:0001558),0.3144450867657537,1.0005834113324354,0.48778004073319753,1.0,1.0,41/204,17.75%,DCBLD2;PTCH2;PRKCQ;CRLF3;BCL2;VGLL4;ERBB2;EGFR;FRZB;NRG3;JADE1;PAK4;TGFB1;PAK5;MT3;URI1;APBB2;LAMTOR2;ARHGEF11;DERL2;SGK3;SGK2;NCBP1;EXOSC2;EIF4G1;PTPRJ;AKAP6;CHPT1;BRAT1;PRDM11;KLHL22;RTN4;PAPPA2;TMEM97;TP53;NDUFA13;HYAL1;ING1;SGK1;CCDC85B;RPTOR
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.34575968482139285,-1.0005500609169118,0.4725274725274725,0.8392947608520511,1.0,5/16,10.82%,PDGFD;NRP1;PIK3C2A;BCAR1;PDGFRB
prerank,histone deacetylation (GO:0016575),0.36742895804766834,1.0004177732597421,0.4689403166869671,1.0,1.0,12/43,15.95%,RCOR2;MTA2;MORF4L2;HDAC2;SIN3B;HDAC6;SFPQ;SIRT6;MIDEAS;PER1;MSL3;MTA3
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.36604011005239545,-1.0003533149888888,0.4740061162079511,0.8382371066873768,1.0,5/13,12.93%,PLXNA2;NRP1;PLXNB1;PLXNA4;PLXNA1
prerank,positive regulation of potassium ion transport (GO:0043268),0.3816131874097624,1.0003014285617324,0.48675914249684743,1.0,1.0,10/38,18.78%,ANK2;KCNMB2;KCNMB3;FLNA;AKAP6;KCNJ3;KCNJ10;KCNH2;KCNMA1;NOS1AP
prerank,regulation of lamellipodium assembly (GO:0010591),-0.2913887527828685,-1.000139292063568,0.4305555555555556,0.8372505841965331,1.0,9/34,16.60%,CAPZB;OCLN;SLIT2;WASF2;AKIRIN1;ABI2;CDC42;AVIL;ABI3
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.37498773619781023,-1.0000430662123991,0.4380952380952381,0.8359328450884274,1.0,5/13,19.16%,NOS3;TMSB4X;NOS1;PINK1;ENO1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.3289892317730024,0.9997322691458422,0.48814655172413796,1.0,1.0,20/104,16.32%,SOSTDC1;PRDM16;HTRA3;ACVR1;TGFB1;SPRED2;TGFBR2;SPRED1;PEG10;SNX6;BCL9L;SPRED3;DAND5;MAGI2;BMPER;LDLRAD4;BMPR1A;UBB;VWC2;LRP2
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.3337921412773068,-0.9996544493095956,0.4460431654676259,0.8354997681715998,1.0,11/19,34.26%,POLD3;AMPD3;TERT;DCK;APRT;CDA;POLD2;POLD1;PNP;ADA;POLL
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.32363128616349446,0.9995648966578178,0.49117341640706125,1.0,1.0,18/140,14.22%,PDGFRA;TAC1;CACNA2D1;LPAR1;PTGER3;GPR65;CACNA1A;PTGFR;CCR2;JPH3;ACKR3;CD52;HTR2C;ESR1;S1PR3;DRD2;P2RY1;ACKR4
prerank,regulation of cytoskeleton organization (GO:0051493),0.32749176672949465,0.9990681031629752,0.49575371549893843,1.0,1.0,24/108,15.56%,DLC1;PHLDB1;RHOD;BICD1;LRP1;RND3;BST1;EFNA5;RHOBTB3;GPM6B;IQGAP2;PAK1;BAIAP2;CAPN6;CLASP1;BICD2;MAPK1;RHOC;RHOH;IQGAP1;ARHGAP44;ABL1;MAP6D1;FSCN1
prerank,actin crosslink formation (GO:0051764),0.4514713396382535,0.9989136377544355,0.4605263157894737,1.0,1.0,3/12,8.66%,GAS2L3;BAIAP2;FLNA
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.32878704764785177,0.9988333433353346,0.4870967741935484,1.0,1.0,43/109,28.14%,PRKCQ;TEC;PAK1;PPP3CB;GAB2;PPP3CA;VAV3;PSMB7;MAPK9;PIK3R1;NFATC3;MAP2K4;MAPK1;MALT1;CALM1;PSMD2;PSMC1;LAT2;CHUK;PSMB2;PSMD9;GRB2;TAB3;PSME4;BCL10;JUN;PSMA8;NFKB1;SOS1;VAV2;CARD11;TAB2;CUL1;NFATC1;PSMD8;PSMD13;SYK;PIK3CA;RELA;LCP2;TRAF6;TAB1;PSMD4
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.34220922676862997,-0.9988083365550418,0.4201388888888889,0.8362320675325704,1.0,8/18,15.46%,DCP2;NAF1;DKC1;RUVBL1;CCT4;CCT6A;CCT8;EXOSC10
prerank,sphingolipid metabolic process (GO:0006665),-0.2360946720374097,-0.9985653223678749,0.4576271186440678,0.8353316911780162,1.0,28/108,17.07%,SGMS1;ST6GALNAC3;ELOVL7;PLPP1;CERS5;KDSR;ACER2;HACD4;SPTLC2;ESYT2;DEGS2;CERS4;SPNS2;ESYT1;GLTP;ALDH3A2;SGPL1;SUMF2;VAPB;GAL3ST1;UGCG;ASAH2;CERS1;ORMDL3;ESYT3;PLA2G15;SPHK1;SERINC1
prerank,peptidyl-proline modification (GO:0018208),-0.31817705367790206,-0.9985574332647638,0.4308300395256917,0.8337926846072332,1.0,6/25,8.49%,PPIC;PPIL2;OGFOD1;CWC27;PPIA;NTMT1
prerank,catecholamine metabolic process (GO:0006584),0.4479449644940342,0.9983657396594878,0.4694167852062589,1.0,1.0,4/14,14.16%,PRKN;COMT;DRD2;LRTOMT
prerank,cytosolic transport (GO:0016482),0.32804855803529914,0.9977654109745934,0.5005336179295624,1.0,1.0,30/108,19.56%,TBC1D10A;DENND2A;RHOBTB3;RAB14;VPS29;CCDC91;ARL1;AP1G1;GBF1;EPS15;GAK;HEATR5A;SNX6;VPS26B;PHETA2;SYS1;BET1L;AKTIP;STX8;SPAG9;SNX1;WASHC1;ANKRD27;UBE2O;AP4M1;RBSN;RAB7A;HOOK2;SNX16;DENND5A
prerank,activin receptor signaling pathway (GO:0032924),0.44936960904189194,0.997687677991404,0.5007451564828614,1.0,1.0,2/15,5.25%,ACVR1;ACVR1C
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.30589451913397186,0.997006006180852,0.528,1.0,1.0,292/1668,17.35%,RORA;EBF2;DCN;OSR2;ETV1;SOX6;NKX6-2;PTCH1;TENM2;BMP5;MLIP;CXCL10;KLF15;MEOX1;EBF4;ETV4;TSHZ3;MEOX2;CREB3L1;GLI2;MAML3;LHX5;MACC1;TLX3;FGF2;RCOR2;IFRD1;AASS;SOX8;CRLF3;PRDM16;MYC;TGIF2;DMRT2;PTEN;CBFB;EBF1;ZNF25;HOXB8;ZBTB20;CDKN2B;KAT2B;SOX9;SSBP2;ERBB2;NCOA1;PRKN;RIPPLY2;EGFR;SUV39H1;HIVEP1;ACVR1;FADD;KMT2A;OTP;ZBTB37;HOXA7;SATB1;VEGFA;EGR3;CCNC;TFCP2;MAPK7;CRTC1;MAML2;RPS6KA4;NFX1;BAZ1A;FOXP2;KDM5B;AUTS2;GTF2H2;TGFB1;PSEN1;GATAD2A;RFX2;EZH1;SOX11;ZNF276;NUPR2;SETD3;MED31;RFXANK;ZEB1;GLI1;RAI1;WNT5A;NOP2;E2F2;PGBD1;PHOX2A;RPRD1A;HOXD3;TRPS1;PKN1;URI1;EED;MTA2;CDK13;MAMLD1;CDK8;RFX3;OTUD7B;ZFP14;CREB3L2;RORC;MLXIPL;MLX;ZBTB16;TADA1;DRAP1;TWIST2;GATA6;PPP3CB;TBX18;E2F6;FOXM1;LRRFIP1;KAT8;CBX4;ZSCAN20;MEN1;CHD3;PPP3CA;IL18;ATMIN;VPS72;MKX;CPEB3;ASXL3;ATRX;ZBTB41;RARB;SOX5;MBD2;ZNF462;RARG;KCTD1;PPID;ZMIZ1;PPP1R13L;BRCA1;SOX12;BBX;ZNF569;NCOA2;PIAS2;BRD8;LDB2;HIF1A;ARID4B;CHD2;ZFP64;KLF5;ZBTB6;DBX2;IL4I1;BCL9L;ZBTB38;MED13;ZNF260;PIK3R1;HDAC2;MYSM1;ZSCAN26;GDNF;ATF2;ELP2;NFATC3;PSIP1;ZKSCAN8;PHF20;NFE2L2;ARF4;LIN9;SMARCC2;MAPK14;SIN3B;PID1;ESR1;SP1;MYT1;ZNF112;TAF9;RBAK;POGZ;SFPQ;SIRT6;CREBZF;DCAF1;RUNX1;NRIP1;ZFHX4;DVL1;MIDEAS;MYDGF;BCL9;ZGPAT;TMF1;PATZ1;PER3;FOXP4;TBK1;ZFPM2;ZNF250;EPC1;PHF8;KLF13;SIX5;NR6A1;XRCC6;AHR;ZBTB1;SOD2;PRPF6;WWTR1;SMARCC1;ATF5;BAZ2B;PER1;GATA3;ZNF83;ZEB2;SALL2;NCK1;ELP4;ZBTB39;NACC2;SNCA;LCOR;NCOR2;TAF7;PAX3;HIVEP3;ZFHX2;MDM4;NEDD4L;SUMO1;CRY1;BMPR1A;CREM;BAZ1B;IL33;PKD1;MED12;ATM;CITED2;SLTM;MET;IRX5;HOXB7;DACT1;JUP;ZNF235;UBB;ABL1;POU3F1;MED21;TGFB3;MED25;HTATIP2;MEIS3;KLF9;ZFX;PURG;RNF111;SP3;LCORL;MTA3;ASXL2;TP53;ZXDB;TET3;NFIX;SLC9A1;NFIA;HNRNPU;SREBF2;WWOX;GABPB1;GABPB2;ZKSCAN1;USP2;SUFU;FOXJ1;CDC73;PAX2;RIPK1;HEYL;RNF10;CHUK;SMARCE1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.3601949022754923,0.9969397934139661,0.47671568627450983,1.0,1.0,5/43,9.88%,PTPN22;CD34;IRAK3;SELENOS;SYT11
prerank,regulation of cell projection organization (GO:0031344),-0.375620316373856,-0.996266439835004,0.44571428571428573,0.8387401422267924,1.0,2/13,4.06%,MACF1;MOV10
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.32152331683858576,0.9961850299285496,0.49214659685863876,1.0,1.0,33/138,20.27%,RORA;MAML3;KAT2B;MAML2;GTF2H2;E2F2;POLR2B;RORC;GTF2B;RARB;RARG;POLR2K;ESR1;TAF2;TAF9;TAF11;NR6A1;WWTR1;NR2C2AP;NCOR2;TAF7;POLR2G;TAF4;GTF2E1;TAF4B;GTF2E2;NR5A1;NRBF2;TAF1;POLR2A;PPARG;TAF8;NR1D2
prerank,regulation of telomere maintenance (GO:0032204),0.3950051223307557,0.9961475807203374,0.47651006711409394,1.0,1.0,8/26,16.30%,MYC;ERCC4;ATRX;SIRT6;UPF1;RTEL1;SMG6;TERF2IP
prerank,gene silencing by miRNA (GO:0035195),-0.28872402942554737,-0.9960776787649422,0.45982142857142855,0.8376869520578749,1.0,7/32,12.41%,WTIP;MOV10;AGO1;ZC3H7B;CNOT1;NOTCH4;AGO3
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.32949780171821647,-0.9957198881283414,0.45348837209302323,0.8371128946833513,1.0,5/21,6.76%,ROCK2;ROCK1;ERRFI1;BMP4;ZFP36L1
prerank,cellular response to retinoic acid (GO:0071300),-0.27026329665338766,-0.995572683054259,0.4530386740331492,0.8360109904770133,1.0,8/42,8.46%,WNT5B;EPHA3;LYN;ABL2;WNT6;SNW1;WNT9A;TBX1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.4405272085935823,0.9954629035649326,0.47919655667144906,1.0,1.0,6/14,22.44%,ELAVL4;MAPKAPK2;MAPK14;HNRNPC;ZFP36;YBX3
prerank,positive regulation of programmed cell death (GO:0043068),0.3151130294712963,0.9954144241516558,0.5186680121089808,1.0,1.0,67/272,18.45%,HRK;PIP5KL1;PYCARD;NGF;AKAP13;FRZB;FADD;FGD4;ANO6;TNFRSF10B;SLC27A4;PSEN1;FANK1;NF1;DUSP6;ACVR1C;CYP1B1;APAF1;ITSN1;BMF;SHQ1;PHLDA1;BIN1;BNIP3;VAV3;ARHGEF11;RARG;PPID;SFRP4;UBE2Z;NCSTN;NGFR;HDAC6;ARL6IP5;ING4;APH1A;SCRIB;TRIO;SNCA;ARHGEF3;RPS6KA2;PSEN2;ITGB3BP;RASSF2;ITGB1;ATM;CASP2;UBB;ABL1;CRADD;TGFB3;FZD9;HTATIP2;GPLD1;BCL2L11;TP53;QRICH1;KCNMA1;ARHGEF4;RIPK1;PLEKHG2;RNPS1;AIFM1;CSRNP3;ADAMTSL4;DNAJA1;HTT
prerank,monocarboxylic acid catabolic process (GO:0072329),0.4200272151399964,0.9949616912829363,0.483739837398374,1.0,1.0,3/21,7.92%,CEL;ACBD5;ACOX1
prerank,regulation of cellular respiration (GO:0043457),0.4231357653635657,0.9946991574726728,0.47579529737206083,1.0,1.0,4/17,17.34%,PRDM16;CBFA2T3;PNPT1;TRAP1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.47767200662188325,0.9944248900257442,0.4885844748858447,1.0,1.0,4/10,21.48%,ATF7IP;ESR1;TP53;THRA
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.3453966798609779,-0.9941047919195056,0.45454545454545453,0.8385462187624968,1.0,4/18,8.68%,DAB2;CHMP3;MTMR2;MAP2K1
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.3954358884644379,-0.9937777508419321,0.4733893557422969,0.8378196742649464,1.0,5/10,30.50%,TERT;TARBP2;MRPL44;AGO2;DICER1
prerank,tRNA wobble base modification (GO:0002097),-0.3703719453509474,-0.9935680711745937,0.4648318042813456,0.8368579403616361,1.0,5/14,16.76%,TRMT9B;URM1;ELP3;MTO1;DPH3
prerank,determination of left/right symmetry (GO:0007368),0.3745407295786444,0.992957052285601,0.48595848595848595,1.0,1.0,10/36,21.03%,CCDC39;RFX3;SMO;DAND5;ENKUR;CITED2;FOXJ1;GALNT11;BBS7;PKD2
prerank,regulation of cilium assembly (GO:1902017),-0.24774410110262743,-0.9928826456566464,0.456,0.8373940329703986,1.0,21/62,18.64%,TBC1D8;ODF2L;TBC1D14;TBC1D1;TBC1D15;DCDC2;ARHGAP35;EVI5L;CCP110;TBC1D13;DYNC2LI1;DYNLT2B;RABEP2;TBC1D7;FUZ;TBC1D30;TBC1D10B;CROCC;TBC1D2;CDK10;TBC1D22B
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.25795796334718996,-0.9928407091504043,0.47019867549668876,0.8359830610178889,1.0,16/53,19.65%,PSMD14;AZIN1;OAZ1;PSMB3;PSMD12;OAZ2;PSMD6;PSMA1;ODC1;PSMD7;PSMA5;PSMC5;PSMC4;PSMB6;PPM1K;PSMA4
prerank,protein deacetylation (GO:0006476),0.36770219642308544,0.9925022983136289,0.49818181818181817,1.0,1.0,11/41,15.95%,RCOR2;MTA2;FLNA;MORF4L2;HDAC2;SIN3B;HDAC6;SIRT6;MIDEAS;MSL3;MTA3
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.3247788174482096,0.9924572538705753,0.4962080173347779,1.0,1.0,18/101,10.27%,TBC1D10A;VGLL4;ERBB2;FADD;PLD1;UPF3A;TGFB1;NIBAN1;METTL3;EIF3C;CPEB3;EIF6;NSUN5;PASK;AURKAIP1;VPS11;HDAC2;EIF4G1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.33759024986596464,0.992456917935798,0.5022271714922049,1.0,1.0,13/76,16.65%,GNA14;HRH1;LPAR1;PTGER3;GPR65;GRM5;HTR2C;ESR1;DRD2;P2RY12;P2RY1;HOMER1;OPRK1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3143154188395383,0.9924202494759303,0.49948717948717947,1.0,1.0,41/166,20.27%,RORA;MAML3;KAT2B;MAML2;GTF2H2;E2F2;TAF1A;POLR2B;RORC;GTF2B;RARB;RARG;TFAM;POLR2K;ESR1;TAF2;TAF9;TAF11;NR6A1;WWTR1;POLRMT;NR2C2AP;NCOR2;POLR1B;TAF7;POLR2G;GTF3C1;TAF4;GTF2E1;TAF4B;GTF2E2;NR5A1;POLR1C;POLR1G;NRBF2;TAF1;POLR2A;PPARG;TAF8;UBTF;NR1D2
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.26292352813977166,-0.9924053292990805,0.5034965034965035,0.8356234998232023,1.0,10/47,8.04%,SOX13;LRP5;TMEM64;NOCT;CREBL2;PPARD;CDS1;ZFP36L1;SIX1;PTGS2
prerank,positive regulation of protein transport (GO:0051222),-0.24619680404489175,-0.9923771474576237,0.4930555555555556,0.8341456672103473,1.0,15/67,14.84%,BMP6;IGF1;OAZ1;EXOC1;PPIA;RACK1;UNC13B;CNST;ABCG1;OAZ2;APBB1;SYTL4;TGFB2;MYH10;ARHGEF5
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.40434545732069793,-0.9923657972228896,0.4659400544959128,0.8326570127119792,1.0,5/10,12.27%,ACER2;WNK1;JAM3;SERPINE1;NEXMIF
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.3343838985508007,0.9918563584884371,0.4866666666666667,1.0,1.0,24/82,23.83%,DYNLL1;HAUS3;CNTRL;PCM1;NDE1;SDCCAG8;CEP57;CLASP1;PRKACA;CKAP5;ATF5;CEP76;DYNC1I2;CSNK1E;TP53;CEP63;TUBA1A;SSNA1;CEP78;PCNT;DYNC1H1;CDK5RAP2;PPP2R1A;ALMS1
prerank,endocytic recycling (GO:0032456),0.34884399898313184,0.9916905283797258,0.4892086330935252,1.0,1.0,24/50,29.01%,RAB14;VPS29;EPS15;VPS39;DENND1C;ACAP2;RAB11FIP3;EHD2;WASHC1;ANKRD27;SNX12;RAB7A;MICALL2;SNX4;EIPR1;DENND1A;ENTR1;VPS35;STX6;DENND1B;VPS53;RAB13;VPS26C;SNF8
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.3814818777457069,0.9914657316034851,0.4897172236503856,1.0,1.0,2/32,4.00%,CXCL10;RNASE6
prerank,nitrogen compound transport (GO:0071705),0.32057211650064926,0.9909081083450545,0.5124740124740125,1.0,1.0,28/141,18.45%,SLC6A2;SLC22A3;SLC1A5;RAB38;SLC38A4;SLC16A10;CD320;LRRC8D;SLC44A2;SLC36A2;SLC12A2;SCAMP2;SLC43A1;SEC14L1;RCN3;SLC7A7;NDC1;ARL6IP5;SLC7A8;HSP90B1;LRP2;ABCC1;SLC6A15;DENND10;RAB7A;SLC44A1;KIF3A;SLC6A4
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.4332074207676244,0.9909014562507615,0.5023328149300156,1.0,1.0,2/15,3.91%,SLC27A1;FBXW7
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.4258767692975468,0.990759858014047,0.4697406340057637,1.0,1.0,6/16,11.77%,IRAK3;ETF1;BNIP3;CLEC16A;HDAC6;UPF1
prerank,muscle cell migration (GO:0014812),-0.40519244773108803,-0.9906086565681411,0.5040431266846361,0.8360819646719553,1.0,3/10,14.17%,ROCK1;SIX1;DDR1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.3237996773297682,0.9905026782841329,0.5111111111111111,1.0,1.0,20/125,14.60%,DYNLL1;EFHC1;XPO1;GPSM2;TBCE;RANBP2;EML1;NDE1;SETD2;RCC1;DYNC1I1;CLASP1;NUP160;SGO1;ZWINT;KPNB1;CKAP5;BUB1B;DYNC1I2;ITGB3BP
prerank,thymus development (GO:0048538),0.4519604030985723,0.9899435489515374,0.48757763975155277,1.0,1.0,2/13,2.73%,FGF10;FADD
prerank,regulation of programmed cell death (GO:0043067),0.31978726495786536,0.9896281100331382,0.5291113381001021,1.0,1.0,36/161,17.46%,BCL2L14;RTKN;CXCL10;OLFM4;SOX9;PRKN;STEAP3;TNFRSF10B;FANK1;APAF1;CASP6;NAE1;BNIP3;NF2;CTSB;RARG;HIP1;SLK;ANP32E;MALT1;TM7SF3;DDX42;RTN4;ATM;IFT57;CASP2;ABL1;CRADD;HTATIP2;BCL2L11;TP53;SGK1;GLS2;PAX2;RIPK1;WRN
prerank,regulation of immunoglobulin production (GO:0002637),0.3975495745283684,0.9893508940175177,0.49463806970509383,1.0,1.0,2/23,3.77%,EPHB2;DNAJB9
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.42078175309985894,-0.9892934394155063,0.47674418604651164,0.8368037814525806,1.0,4/10,14.11%,CDC42EP4;CDC42EP3;CDC42EP2;CDC42
prerank,regulation of pseudopodium assembly (GO:0031272),-0.42078175309985894,-0.9892934394155063,0.47674418604651164,0.8368037814525806,1.0,4/10,14.11%,CDC42EP4;CDC42EP3;CDC42EP2;CDC42
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3253322664366489,0.9892068842446616,0.5105708245243129,1.0,1.0,27/108,19.82%,DLC1;PYCARD;MYC;NGF;GSN;FADD;EIF2AK3;TNFRSF10B;ACVR1C;APAF1;CARD9;HIP1;NGFR;CASP12;ARL6IP5;MALT1;SNCA;IFT57;CASP2;CRADD;RPS27L;NDUFA13;RIPK1;AIFM1;PPARG;SENP1;BCL10
prerank,regulation of neurotransmitter transport (GO:0051588),-0.34715264848066013,-0.989176784766262,0.4676923076923077,0.8355994961194481,1.0,5/16,15.42%,SNCAIP;CPLX1;CAMK2A;MCTP2;FLOT1
prerank,regulation of nervous system process (GO:0031644),-0.3320104207035357,-0.9891726862478668,0.4826388888888889,0.8340834971084915,1.0,4/18,6.85%,ROCK2;SLC8A3;NOS3;APP
prerank,vasoconstriction (GO:0042310),-0.3870909646265075,-0.9890633728732598,0.4608695652173913,0.8328965758489638,1.0,4/11,17.83%,PIK3C2A;ACTA2;EDNRB;EDN1
prerank,negative regulation of protein metabolic process (GO:0051248),0.36152993936509203,0.9887354259504654,0.4817961165048544,1.0,1.0,24/48,28.35%,EGFR;FMN2;IRAK3;PRNP;FLNA;CRYAB;MDM4;SNX12;AZIN2;SF3B3;NFKB1;CD84;AGAP2;FLOT2;INHBB;PRKCG;HMGCR;PFDN2;PIN1;PFDN1;ITGAV;CYP51A1;IAPP;SIRT2
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.3553861923676022,-0.9880044433045126,0.4583333333333333,0.8342777244641191,1.0,5/15,7.38%,IGF1;ROCK2;ROCK1;MTPN;PARP1
prerank,response to ketone (GO:1901654),-0.3099182117832435,-0.987818077229237,0.45977011494252873,0.8333090127635588,1.0,8/24,20.73%,SLIT2;THBS1;TGFB2;CAV1;ABHD2;ABCB4;CATSPER3;NR1H3
prerank,actin filament polymerization (GO:0030041),0.38160613570840807,0.9876217872439439,0.4986979166666667,1.0,1.0,10/29,22.95%,SPIRE1;GSN;GAS7;WASF1;COBL;DIAPH3;MICALL2;WASHC3;CORO7;WASF3
prerank,regulation of supramolecular fiber organization (GO:1902903),0.39963274679365723,0.9873831029071852,0.48010610079575594,1.0,1.0,8/22,18.65%,AKAP13;MAP1B;GBA2;ARL2;ABL1;CAMSAP1;PARK7;MAPRE3
prerank,cellular protein localization (GO:0034613),0.3093851811556331,0.9873791451100681,0.5336683417085427,1.0,1.0,64/285,17.26%,TMED6;HPS6;FGF10;TBC1D10A;BICD1;ANK2;ARMCX3;EGFR;RAB38;RAB14;PACS2;COPZ2;SNX15;VPS33A;WNT5A;WIPI1;VPS29;GRID2;ITSN1;ARL1;RAB21;COPB2;SEC31B;CNTNAP2;RABL3;LAMTOR2;CNTN2;EPB41L3;TBCK;FLNA;TMED10;SNX6;VPS26B;ARL5C;COX18;ARF4;NGFR;BICD2;HDAC6;FGF7;RAB22A;RAB1A;USP6NL;RAB3GAP2;STX8;COPA;SYNDIG1;CORO1B;ARFGAP3;TMED2;TMED3;TRIM23;SNX1;SEC23IP;UNC93B1;SGSM1;RIC3;STX1B;AP4M1;PIGU;TM9SF2;CTTN;FOXJ1;CD74
prerank,plasma membrane organization (GO:0007009),0.3447508753012733,0.9871796021143324,0.4920091324200913,1.0,1.0,15/61,17.51%,ANK3;ANK2;PLSCR4;ANO6;PACSIN2;SPTBN1;BIN1;EPB41L3;SYT11;ANXA6;RAB3A;OTOF;EHD2;ABCD2;DYSF
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.37718703161764444,0.9867681786009992,0.4758269720101781,1.0,1.0,9/30,18.51%,TGFB1;SOX11;PCSK6;DKK3;SFRP4;BCL9;XIAP;NREP;EID2
prerank,methylguanosine-cap decapping (GO:0110156),-0.3936564506353406,-0.9867098569527948,0.46216216216216216,0.8348663128892966,1.0,5/10,18.79%,LSM1;DCP2;PATL1;PNRC2;EDC3
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.2582064666020356,-0.986202745456471,0.5031055900621118,0.8347779283312269,1.0,18/48,24.01%,ROBO1;SLIT2;GPS2;SAMHD1;CCDC3;NR1H2;PTPRC;PADI2;STAT2;PARP14;USP18;PELI3;ISG15;NR1H3;RFFL;CACTIN;MUL1;NLRP2B
prerank,protein polymerization (GO:0051258),0.34772909852289013,0.9861173274782532,0.4858156028368794,1.0,1.0,5/55,2.74%,FGF13;SPIRE1;GSN;PRKN;GAS7
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.46124371531654546,0.9854650078018604,0.49375,1.0,1.0,6/11,21.38%,FADD;UNC93B1;TICAM1;RIPK1;SCARA3;TNIP2
prerank,positive regulation of cholesterol transport (GO:0032376),0.37859018358713836,0.9852698054031793,0.488031914893617,1.0,1.0,4/27,11.01%,PTCH1;LRP1;ZDHHC8;ABCA5
prerank,regulation of heart contraction (GO:0008016),0.32990822736621667,0.9849664415364278,0.4923413566739606,1.0,1.0,17/90,17.36%,FXYD3;CORIN;ANK2;NPR2;ATP2B3;TMEM65;SLC8A2;FXYD6;PDE4D;ATP2B1;PRKACA;FXYD1;AHCYL1;CALM1;CALM2;NPPC;MYH6
prerank,purine nucleotide catabolic process (GO:0006195),0.44749466041115166,0.9847741301011242,0.4883720930232558,1.0,1.0,3/13,10.31%,NUDT15;NT5C2;HINT1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.33316878199225153,0.9846379150193532,0.5106382978723404,1.0,1.0,7/74,3.99%,LGALS3;BMP5;BCL2;ACVR1;FADD;MAPK7;TNFRSF10B
prerank,nucleic acid metabolic process (GO:0090304),0.3389887884040266,0.984047993452434,0.49193548387096775,1.0,1.0,23/69,21.26%,DXO;ATXN2;POLR2B;METTL3;SETMAR;XRN2;DDX54;DDX24;POLR2K;NCBP1;DUSP11;HNRNPA3;EXD2;POLR2G;TOPBP1;POLG;HNRNPU;WRN;POLR2A;HNRNPH2;HNRNPC;RBFOX2;HNRNPL
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3408117850728516,0.9838684376373248,0.5257270693512305,1.0,1.0,25/70,24.62%,ARPC1B;WIPF1;PAK1;BAIAP2;LIMK1;BRK1;FYN;VAV3;DOCK1;PIK3R1;MAPK1;PLPP4;NCK1;CYFIP1;ELMO1;ABL1;GRB2;NCKAP1;YES1;VAV2;NCKIPSD;PRKCE;HCK;ACTR2;CRK
prerank,heart process (GO:0003015),0.43596590699092286,0.9837611109824858,0.4808259587020649,1.0,1.0,3/14,8.15%,SGCD;SGCZ;FYN
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.3801979484827448,0.9835364292741932,0.49288486416558863,1.0,1.0,4/30,8.09%,AKAP13;LPAR1;GPR65;COL3A1
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.38569353671144435,0.9834615808071753,0.5039473684210526,1.0,1.0,2/28,3.30%,RELN;EPHB2
prerank,supramolecular fiber organization (GO:0097435),0.30651892217098725,0.9833176406082665,0.5523138832997988,1.0,1.0,51/333,13.04%,COL15A1;TGFBI;HSPG2;LUM;COL5A3;FGF13;RHOD;COL20A1;GSN;RND3;COL28A1;PRKN;PPP1R9A;COL5A2;P4HA1;RHOBTB3;COL27A1;PXDN;COL4A2;COL26A1;PCM1;NF1;TLL2;CYP1B1;COLGALT2;TNXB;COL9A2;PLEC;COL18A1;LOXL3;COL3A1;HIP1;PLOD1;COL1A2;KATNAL1;BFSP1;TUBGCP5;SLK;NCSTN;MYO19;COL14A1;STMN4;DNAJB6;FIGN;SLAIN2;RHOC;KATNB1;RHOH;APH1A;COL1A1;CKAP5
prerank,positive regulation of biosynthetic process (GO:0009891),0.3628597557573842,0.9832726979410934,0.49879227053140096,1.0,1.0,8/40,11.81%,CREB3L1;ZBTB20;SLC5A3;TGFB1;MLXIPL;AMELX;HDAC2;RUNX1
prerank,positive regulation of interleukin-12 production (GO:0032735),0.37660941774025547,0.9832084459548979,0.49744245524296676,1.0,1.0,3/31,10.90%,IL16;PLCB1;MAPK14
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.41326805753141665,0.9827598186564909,0.4915492957746479,1.0,1.0,3/18,8.10%,PYCARD;FADD;IL18
prerank,extracellular transport (GO:0006858),-0.3799801163982419,-0.9826564575371171,0.49538461538461537,0.8430426959117614,1.0,10/12,43.22%,TSG101;ARRDC1;CABYR;WWP2;ROPN1L;ADCY10;SPAG17;SPA17;CCDC40;DNAAF4
prerank,import into cell (GO:0098657),0.36072472232410885,0.9825145589709694,0.4897466827503016,1.0,1.0,8/41,11.65%,SLC1A3;SLC27A1;SLC5A3;LRRC8D;SLC29A1;NEURL1B;SLC12A4;SLC7A8
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.45150012475163537,0.9822914128688245,0.5068285280728376,1.0,1.0,2/13,4.42%,PSEN1;SOX11
prerank,cellular response to amino acid stimulus (GO:0071230),0.37359082878670974,0.9822254402513327,0.49687108886107634,1.0,1.0,14/33,26.12%,FYN;CPEB3;LAMTOR2;CASTOR2;CPEB1;KLHL22;RPTOR;SPAAR;IPO5;RRAGA;MTOR;SESN1;SLC38A9;CPEB4
prerank,regulation of mRNA processing (GO:0050684),0.37453980895495126,0.9820301464433463,0.47341772151898737,1.0,1.0,9/32,17.75%,QKI;SON;KHDRBS3;NCBP1;AHCYL1;YTHDC1;SLTM;PAPOLA;SF1
prerank,engulfment of apoptotic cell (GO:0043652),0.43148795655368066,0.9820184731058305,0.4868421052631579,1.0,1.0,2/15,2.83%,XKR7;XKR8
prerank,gonad development (GO:0008406),0.3617944044631021,0.9818385558104371,0.49522673031026254,1.0,1.0,13/41,22.59%,SOX8;SOX9;WNT5A;MAMLD1;GATA6;GATA3;IRX5;LRP2;NR5A1;CSDE1;FGF9;MEA1;NR2F2
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.2919606591677363,-0.9816487842497115,0.4870689655172414,0.8443713073449242,1.0,5/28,9.33%,ARHGAP28;FCHSD2;ESAM;ARHGAP35;PFN2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.3499923519270851,0.9813663995212447,0.5006016847172082,1.0,1.0,20/52,25.93%,RBFOX1;CELF5;TRA2B;KHDRBS3;CELF6;SRSF6;RBM7;NOVA1;YTHDC1;HNRNPU;RNPS1;RBFOX3;CELF4;RBFOX2;HNRNPL;RBM25;FMR1;NSRP1;RBM15;RBM4
prerank,regulation of mast cell activation (GO:0033003),-0.40258322885975983,-0.9812973863784437,0.4714285714285714,0.8438575346493142,1.0,2/10,3.82%,PLSCR1;LYN
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3033374213573063,0.9810664388819466,0.576,1.0,1.0,191/807,21.58%,OSR2;NKX6-2;PTCH1;TENM2;MLIP;MDFIC;TSHZ3;CREB3L1;GLI2;SCML4;RCOR2;AASS;SOX8;PRDM16;MYC;TGIF2;ATP8B1;CBFB;ZNF25;SOX9;VGLL4;NAB1;PRKN;RIPPLY2;SUV39H1;HIVEP1;OTP;HOXA7;SATB1;VEGFA;TLE1;KDM8;NFX1;FOXP2;TGFB1;PSEN1;GATAD2A;EZH1;SOX11;NUPR2;MBD1;ZEB1;MT3;PLCB1;ATF7IP;WNT5A;TRPS1;URI1;EED;CIPC;MTA2;RFX3;OTUD7B;RORC;MLXIPL;MLX;ZBTB16;DRAP1;LOXL3;TWIST2;GATA6;E2F6;CBFA2T3;FOXM1;LRRFIP1;KAT8;CBX4;ZC3H8;MEN1;CHD3;VPS72;CPEB3;RARB;MBD2;RARG;KCTD1;PPID;FLNA;BRCA1;DKK3;CRYAB;LANCL2;LDB2;SNX6;ZBTB38;HDAC2;MBTD1;SMARCC2;SIN3B;ESR1;RBAK;BMP7;PRICKLE1;HDAC6;SFPQ;ING4;SIRT6;CREBZF;DCAF1;RUNX1;NRIP1;CDK5R1;MIDEAS;JARID2;ZGPAT;PATZ1;PER3;FOXP4;ZFPM2;L3MBTL4;EPC1;NR6A1;XRCC6;AHR;ZBTB1;EID2B;ATF5;PER1;SCML2;GATA3;ZEB2;PRDM11;NACC2;SNCA;LCOR;NCOR2;TAF7;MDM4;NEDD4L;SUMO1;CRY1;CREM;IL33;CITED2;DACT1;UBB;MED25;SP3;MTA3;TP53;NDUFA13;NFIX;HNRNPU;SREBF2;WWOX;USP2;SUFU;FOXJ1;CDC73;PAX2;HEYL;SMARCE1;SFMBT2;CCDC85B;CTBP1;MDM2;CGGBP1;FNIP1;PHC2;EID2;ZMYND11;KLF7;TAF1;SEMA4D;PPARG;STAT3;PRDM2;CNBP;YEATS2;PDCD4;BCOR;SMARCA4;JUN;ORC2;NR1D2;PHB2;MITF;GATAD2B;SNAI1;BCL3;JDP2;ZFP36;NFKB1;CD38;RBFOX2;DPF2;LIMD1;NSD1;THRA;ZMYM5;ZNF8
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.28530178762429304,-0.9809094415589218,0.4840182648401826,0.8434089924719309,1.0,7/35,11.08%,FLT1;PTPRM;COL4A3;THBS1;RGCC;XDH;ATOH8
prerank,nuclear migration (GO:0007097),0.43877563109497913,0.9804586116408346,0.48746081504702193,1.0,1.0,2/13,4.86%,DOCK7;PCM1
prerank,negative regulation of cytokine production (GO:0001818),0.3139255981049557,0.9804503378372105,0.5373443983402489,1.0,1.0,30/163,20.91%,APOD;FFAR4;PYCARD;PTPN22;CD34;IRAK3;RPS6KA4;PRNP;OTUD7B;NLRX1;SELENOS;SYT11;CHID1;TAX1BP1;TBK1;ATP2B1;HOMER2;NAV3;SSC5D;ABCD2;FOXJ1;N4BP1;IRF3;MAPKBP1;AXL;PDCD4;SIRPA;BCL3;ZFP36;CD84
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.38957762862571393,-0.9803356710113323,0.48534201954397393,0.8435611963301269,1.0,5/12,26.29%,RECQL5;LARP7;NELFCD;HEXIM1;EAPP
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.2972623884949116,-0.980189238817144,0.5093457943925234,0.8424653942734031,1.0,6/30,11.47%,DAB2;FOXP1;KDM1A;DDX5;KDM4C;PRMT2
prerank,positive regulation of cellular protein localization (GO:1903829),0.3394154606489499,0.9800799045963468,0.5159817351598174,1.0,1.0,24/69,26.82%,BICD1;PRKN;SLC5A3;EIF2AK3;TGFB1;FYN;SYT11;NGFR;WWTR1;RTN4;RIC3;PARK7;TESK1;CCDC88A;PRKAA1;LIMK2;KAT7;GNL3L;GNL3;GPR137B;ENTR1;CARD10;CDK5RAP3;APC
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.40083848124532007,0.9798188093770858,0.49463806970509383,1.0,1.0,4/22,13.43%,FADD;FBXO38;ZBTB1;MALT1
prerank,synaptic vesicle transport (GO:0048489),-0.3930399022475081,-0.9793789544561381,0.47645429362880887,0.8432945553414747,1.0,5/11,15.12%,SYNJ1;KIF5B;DNM2;SNAPIN;TMEM230
prerank,retinal metabolic process (GO:0042574),0.452482316752742,0.9786228879407987,0.5,1.0,1.0,3/12,16.50%,CYP1B1;RDH10;ALDH1A3
prerank,negative regulation of JUN kinase activity (GO:0043508),0.46355692328740034,0.978615886321023,0.5078369905956113,1.0,1.0,4/10,23.18%,PTPN22;DNAJA1;PDCD4;AIDA
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.3699718312401306,0.978431778105827,0.5181476846057572,1.0,1.0,9/36,11.83%,ANK3;GORASP1;VAMP4;BLZF1;SPTBN1;RILPL2;RAB34;GORASP2;SYS1
prerank,regulation of phosphorylation (GO:0042325),0.31808746359516993,0.9782142463189705,0.544689800210305,1.0,1.0,19/120,11.48%,DYNLL1;GLMN;CDKN2B;EGFR;CADM4;PSEN1;RANBP2;SOCS1;NUP155;FZD7;EIF6;LDB2;HIF1A;DSCAM;GRM5;NDC1;NUP205;BMP7;NUP160
prerank,cellular response to nitrogen compound (GO:1901699),0.4035458755154732,0.9781420412494146,0.4856361149110807,1.0,1.0,6/20,16.10%,DDX11;NSMCE3;AOC1;ATRX;BLM;SPIDR
prerank,negative regulation of viral entry into host cell (GO:0046597),0.44227555099585913,0.9778931824541007,0.49775112443778113,1.0,1.0,3/12,10.58%,GSN;TRIM11;MID2
prerank,negative regulation of histone acetylation (GO:0035067),0.45847683520812543,0.977877489684281,0.4992389649923896,1.0,1.0,4/11,17.73%,BRCA1;SNCA;TAF7;CTBP1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.37431147166985346,-0.9776629209239001,0.4694533762057878,0.846553707753324,1.0,5/13,26.29%,RECQL5;LARP7;NELFCD;HEXIM1;EAPP
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.34535956875597834,0.9771817184934789,0.4921212121212121,1.0,1.0,20/48,25.99%,OLFM4;IL1RAPL1;DOCK5;OBSL1;CDKL5;CDKL3;FLNA;DOCK1;MYOC;ABL1;MDK;RAC3;TESK1;TRIOBP;CRK;CIB1;PRKDC;FBXW8;ARHGEF7;LIMS1
prerank,regulation of osteoclast differentiation (GO:0045670),0.3763713866815291,0.976765251259724,0.49805950840879687,1.0,1.0,1/33,0.54%,UBASH3B
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.40103092793250045,0.9765540897933124,0.48817802503477054,1.0,1.0,8/20,20.78%,HOXB8;ZBTB16;CDK6;PRMT1;CDC73;HSPA9;MEIS1;ZFP36
prerank,transcription by RNA polymerase II (GO:0006366),0.3027541863150841,0.9765072749619083,0.5725806451612904,1.0,1.0,68/305,19.24%,RORA;CSTF3;MAML3;CBFB;KAT2B;INTS11;TFCP2;MAML2;NFX1;GTF2H2;SNAPC2;MBD1;RNGTT;E2F2;TAF1A;RPRD1A;POLR2B;CDK13;RORC;DRAP1;TAF5L;INTS6;ZC3H8;GTF2B;RARB;SOX5;TRIP11;RARG;POLR2K;SETD2;NCBP1;FIP1L1;ELP2;INTS4;ESR1;SP1;TAF2;TAF9;TAF11;KLF13;NR6A1;ZBTB1;WWTR1;NR2C2AP;INTS2;ELP4;INTS8;NCOR2;TAF7;POLR2G;RNMT;ELL;TAF4;PAPOLA;GTF2E1;TAF4B;GTF2E2;NFIX;CDC73;PCID2;NR5A1;NRBF2;PRRX1;ELOC;TAF1;POLR2A;MLLT1;PPARG
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.3312138142575457,0.9762819662091189,0.5254424778761062,1.0,1.0,7/76,7.87%,CCL11;NTRK3;PYCARD;GPSM2;BAIAP2;LIMK1;BIN1
prerank,regulation of endocytic recycling (GO:2001135),-0.3945641170698223,-0.9762158483620207,0.4780058651026393,0.848935460425998,1.0,3/11,7.72%,RAB11B;ATP9A;ACTN2
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.4389525336816214,0.9761004960852764,0.496996996996997,1.0,1.0,5/15,20.28%,STXBP4;GLI1;CUL3;CDC73;PHB2
prerank,negative regulation of heart contraction (GO:0045822),-0.38822834500539716,-0.9760349713864733,0.47129909365558914,0.8479731297230504,1.0,6/11,33.35%,ATP1A2;GRK2;SRI;PLN;SPX;PIK3CG
prerank,amide transport (GO:0042886),-0.2973034562061835,-0.9758967586108671,0.4603174603174603,0.8468635653759651,1.0,7/26,12.30%,ABCG2;PLTP;PDPN;GLTP;AQP11;SLC38A5;SLC5A6
prerank,growth hormone receptor signaling pathway (GO:0060396),0.43682397412714075,0.9755276872159252,0.5045045045045045,1.0,1.0,8/14,22.42%,PTPN1;PIK3R1;PRLR;STAT3;STAT5A;GHR;PXN;STAT6
prerank,ceramide biosynthetic process (GO:0046513),-0.27530003950083226,-0.9753980199588125,0.5027932960893855,0.8467460935924003,1.0,7/40,7.67%,SGMS1;ST6GALNAC3;ST8SIA4;CERS5;SPTLC2;DEGS2;CERS4
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.46872827445502585,0.9750762702545932,0.5167682926829268,1.0,1.0,2/10,7.87%,SESTD1;BIN1
prerank,positive regulation of interleukin-8 production (GO:0032757),0.35624072342028645,0.9749836316186643,0.51985559566787,1.0,1.0,11/49,21.03%,PYCARD;FADD;TLR1;RAB1A;LBP;RIPK1;CD74;PARK7;STAT3;BCL10;PRKD2
prerank,regulation of intracellular pH (GO:0051453),-0.28162648667878626,-0.9748895710938691,0.4631578947368421,0.8466192888489175,1.0,8/34,11.69%,SLC4A10;SLC9A6;SLC9A2;SLC4A3;SLC9A8;SLC4A8;SLC9A9;SLC9A7
prerank,regulation of inflammatory response (GO:0050727),0.30618421698815823,0.9747600806117729,0.5593047034764826,1.0,1.0,30/190,17.28%,RORA;FFAR4;ADAMTS12;IL16;BST1;PTPN2;MAPK7;GPRC5B;TNFAIP8L2;IL1RL2;WNT5A;CCR2;PLA2G7;UFL1;OTULIN;IL18;SELENOS;SNX6;CASP12;GRN;GATA3;SHPK;SNCA;IL33;AREL1;XIAP;PTGES;ABCC1;RIPK1;MDK
prerank,protein import into nucleus (GO:0006606),0.33929379298495976,0.9747058024786281,0.5121107266435986,1.0,1.0,20/66,20.96%,CBLB;RANBP2;NUP155;FAM53B;IPO9;PRICKLE1;KPNB1;NXT1;IPO13;KPNA6;EIF4ENIF1;KPNA1;POM121;TNPO3;KPNA3;STAT3;IPO5;CSE1L;PHB2;HEATR3
prerank,blood vessel morphogenesis (GO:0048514),0.33806105649049883,0.9746935889478114,0.5105140186915887,1.0,1.0,9/54,6.42%,GLMN;HAS2;VEGFA;TGFB1;ITGB8;NF1;CYP1B1;RASA1;TGFBR2
prerank,macrophage activation (GO:0042116),-0.2786506714592701,-0.9746163100338496,0.48044692737430167,0.8458410097677123,1.0,10/34,21.70%,FOXP1;TLR4;APP;CD93;SBNO2;MAPT;NMI;IFI35;C1QA;CLU
prerank,negative regulation of organelle assembly (GO:1902116),-0.28055352254039495,-0.9741655999501971,0.45454545454545453,0.8456288238410087,1.0,14/35,22.38%,ODF2L;FEZ2;SCFD1;EVI5L;CCP110;NUPR1;RBM14;TBC1D7;TBC1D30;SMCR8;PINK1;CDK10;KAT2A;STYXL1
prerank,regulation of viral genome replication (GO:0045069),-0.24463440120583155,-0.974142807404152,0.48031496062992124,0.8442189542588099,1.0,18/56,22.29%,ZC3HAV1;PLSCR1;IFITM3;PPIA;IFIH1;PARP10;TNIP1;VAPB;IFITM2;PROX1;OAS2;PPIE;ISG15;TARBP2;IFIT1;BST2;RSAD2;PDE12
prerank,histone H3 acetylation (GO:0043966),0.3587940277646968,0.9740714392728924,0.5225,1.0,1.0,9/40,13.30%,KAT2B;JADE1;TADA1;TAF5L;JADE3;POLE3;TAF9;ING4;PER1
prerank,negative regulation of MAP kinase activity (GO:0043407),0.3565287213501612,0.9739296868325789,0.5229681978798587,1.0,1.0,7/44,11.32%,PTPN22;IRAK3;NF1;UCHL1;PTPN1;PTPRJ;BMP7
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.4303652504897698,0.973929426669004,0.5014367816091954,1.0,1.0,3/16,7.97%,PTPN2;SOCS1;NF2
prerank,positive regulation of protein metabolic process (GO:0051247),0.3177070869442973,0.9737127683872506,0.5337620578778135,1.0,1.0,19/110,15.27%,GPC3;PRKN;HACE1;MAPK7;TGFB1;PSEN1;WNT5A;ASB5;CARD9;IL18;EIF4G1;HUWE1;PRMT1;RAB1A;APC2;DDB1;NEDD4L;AREL1;DACT1
prerank,JNK cascade (GO:0007254),-0.273068048293173,-0.9733365515032758,0.4734042553191489,0.8450285872760337,1.0,15/40,24.90%,MAP3K5;TNFRSF19;ARHGEF6;GPS2;MAP3K7;UBE2N;IKBKG;MINK1;MAPK10;CRKL;NOD1;MAP3K13;GPS1;MAPK8;UBA52
prerank,recombinational repair (GO:0000725),0.3318916786541091,0.9732617166202523,0.5499438832772167,1.0,1.0,18/77,17.46%,POLN;MEIOB;AP5S1;ERCC5;ERCC4;REV3L;RPA3;BRCA1;FBH1;SFPQ;XRCC3;HELQ;EXD2;RPA2;RAD52;BLM;SPIDR;WRN
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3280362863435692,0.9731662761375638,0.5347298787210585,1.0,1.0,18/77,18.77%,LGALS3;BCL2;PRKN;ACVR1;URI1;PIH1D1;HERPUD1;RTKN2;OPA1;FZD9;NDUFA13;MPV17L;RIPK1;CSNK2A2;HTT;PARK7;ZMYND11;ACAA2
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.34776791062384343,0.9729440037607981,0.4911452184179457,1.0,1.0,12/44,18.49%,DPEP1;NGF;VEGFA;MT3;NGFR;DNAJB6;SNCA;XIAP;PAX2;PCID2;CAST;FNIP1
prerank,cortical cytoskeleton organization (GO:0030865),0.3584725251674063,0.9728030645761782,0.5197604790419161,1.0,1.0,8/41,12.37%,RHOD;RND3;RHOBTB3;FMNL2;NLGN1;EPB41L3;RHOC;RHOH
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.3237327516269015,0.9724132902671976,0.5433589462129528,1.0,1.0,26/94,23.83%,DYNLL1;CC2D2A;HAUS3;CNTRL;PCM1;NDE1;SDCCAG8;CEP57;CLASP1;CEP89;PRKACA;CKAP5;CEP76;FBF1;DYNC1I2;CSNK1E;CEP63;TUBA1A;SSNA1;CEP78;PCNT;DYNC1H1;CDK5RAP2;CEP97;PPP2R1A;ALMS1
prerank,regulation of neuron differentiation (GO:0045664),0.3353128994103947,0.9724132768677802,0.5328054298642534,1.0,1.0,19/76,20.59%,NGF;NRCAM;GPRC5B;SOX11;ZEB1;HOXD3;NLGN1;FGFR1;BIN1;BMP7;MMD2;CDK5R1;ZFHX2;VWC2;NREP;HEYL;CNTN4;CPNE1;PCP4
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.4592682134994353,0.9721352985482244,0.49846625766871167,1.0,1.0,3/10,15.91%,IRS2;SNCA;GPLD1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.406638645877861,0.9720276275479276,0.49299719887955185,1.0,1.0,4/18,12.38%,COX20;COX18;SCO1;COX19
prerank,microtubule anchoring at centrosome (GO:0034454),0.4577970333932865,0.9717052546766601,0.5041736227045075,1.0,1.0,7/10,28.28%,PCM1;CCDC120;KIF3A;NIN;HOOK3;BBS4;CEP19
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.42421385422419206,0.9715370920782344,0.4963820549927641,1.0,1.0,5/15,20.43%,ZFAND2B;SPCS3;RAB3GAP2;SEC61G;RAB3GAP1
prerank,mRNA destabilization (GO:0061157),-0.2752081015304187,-0.9714985134364291,0.5072463768115942,0.8488113219380803,1.0,7/38,7.56%,ROCK2;ROCK1;YTHDF1;MOV10;METTL14;ZFP36L1;CNOT1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.37708325842031104,0.9709786759537528,0.4986842105263158,1.0,1.0,16/27,30.81%,EGFR;TGFB1;EIF4G1;EIF4ENIF1;TP53;RIPK1;STAT3;ZFP36;LIMD1;DDX6;FMR1;AJUBA;PUM2;TNRC6B;EIF4E2;PUM1
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.25773349347589225,-0.9708483624476913,0.5375,0.849206942695886,1.0,14/50,17.54%,PSMD14;AZIN1;OAZ1;PSMB3;PSMD12;OAZ2;PSMD6;PSMA1;ODC1;PSMD7;PSMA5;PSMC5;PSMC4;PSMB6
prerank,Golgi to endosome transport (GO:0006895),0.4334346995224356,0.9707472588128323,0.5211864406779662,1.0,1.0,7/16,17.50%,RAB14;WIPI1;GBF1;EPS15;SYS1;AP4M1;AP1AR
prerank,negative regulation of ossification (GO:0030279),0.39236554807696256,0.970634419465238,0.4844559585492228,1.0,1.0,3/23,8.43%,LRP4;SOX9;CHSY1
prerank,positive regulation of viral genome replication (GO:0045070),0.3764405053997655,0.9700756929794144,0.5044929396662388,1.0,1.0,7/29,18.07%,FKBP6;PABPC1;PPID;DDB1;ADARB1;PPIH;PKN2
prerank,Golgi to lysosome transport (GO:0090160),0.4585207222982395,0.9700394985014121,0.5015290519877675,1.0,1.0,5/11,17.03%,CCDC91;AP1G1;GAK;AP4M1;RBSN
prerank,mRNA transport (GO:0051028),0.32000148600288425,0.9699983918755977,0.5363735070575462,1.0,1.0,37/101,26.01%,THOC6;RANBP2;NUP155;SRSF11;MCM3AP;CASC3;ALKBH5;NCBP1;FIP1L1;KIF5C;NDC1;NUP205;NUP160;UPF1;DDX25;NXT1;SRSF6;YTHDC1;SMG6;POM121;AAAS;NXF1;RNPS1;THOC7;SRRM1;ZFP36;FYTTD1;SRSF3;GLE1;NUP42;SYMPK;THOC5;FMR1;MAGOHB;NUP35;RAE1;HNRNPA2B1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.3840618228114845,-0.9699574606156532,0.5114285714285715,0.8500479451886804,1.0,2/10,4.94%,DSE;PXYLP1
prerank,protein tetramerization (GO:0051262),0.33358433237366325,0.9698686162617504,0.5234285714285715,1.0,1.0,20/67,22.95%,CTH;ACACA;FARSA;CPSF6;GRIN2B;AQP4;FARSB;SOD2;SNCA;PKD1;HOMER1;ALDH1A3;GLS;MS4A1;RYR3;HCN1;PKD2;SSBP1;KCNC1;TRPM4
prerank,negative regulation of cell adhesion (GO:0007162),0.33081384796847124,0.9695906996508461,0.5333333333333333,1.0,1.0,11/72,9.58%,TGFBI;ERBB3;PLXNC1;EPHB2;TGFB1;PDE3B;CYP1B1;RASA1;FZD7;NF2;DSCAM
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.3957982966672526,0.969568520112535,0.5217965653896962,1.0,1.0,6/22,16.67%,MLIP;PRKCA;PDE9A;IL6ST;GLRX3;SLC9A1
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.28478741968565346,-0.9692495589856184,0.4889867841409692,0.8505303892761114,1.0,11/32,20.10%,PRKAG2;SORBS1;CREBL2;PRKAA2;ADIPOR2;AVIL;CEACAM1;SIRT4;MID1IP1;GPER1;APOE
prerank,regulation of embryonic development (GO:0045995),0.37067810103223914,0.9691666624025534,0.49165596919127086,1.0,1.0,4/34,4.99%,PHLDB1;WDPCP;RAB14;PLCB1
prerank,glycerophospholipid catabolic process (GO:0046475),0.37868351392714117,0.9682608021874484,0.49744897959183676,1.0,1.0,8/27,21.01%,PRDX6;PLA2G7;LIPC;ENPP6;PNPLA8;GDPD3;PLA2G4E;ABHD16A
prerank,ketone body metabolic process (GO:1902224),0.45892242843736003,0.968256509845952,0.5264,1.0,1.0,2/10,6.42%,ACSS3;HMGCLL1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.3391243417170173,0.9682529575078296,0.5214368482039398,1.0,1.0,7/57,13.60%,CHRM3;LPAR1;FLNA;GPR37;GNAI1;DRD2;P2RY12
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.3593024482013502,-0.9676163863934946,0.53,0.8518465768616178,1.0,2/14,6.96%,ABCG2;BLVRA
prerank,heme catabolic process (GO:0042167),-0.3593024482013502,-0.9676163863934946,0.53,0.8518465768616178,1.0,2/14,6.96%,ABCG2;BLVRA
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.3860314798598589,0.9675357966567038,0.5167525773195877,1.0,1.0,11/26,23.82%,CUL3;ANAPC7;CDC23;FBXO5;CDC27;DUSP1;ANAPC4;CDK5RAP2;ANAPC5;CDC16;RB1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.3344396796944773,0.9672629891959327,0.5403587443946188,1.0,1.0,25/71,24.62%,ARPC1B;WIPF1;PAK1;BAIAP2;LIMK1;BRK1;FYN;VAV3;DOCK1;PIK3R1;MAPK1;PLPP4;NCK1;CYFIP1;ELMO1;ABL1;GRB2;NCKAP1;YES1;VAV2;NCKIPSD;PRKCE;HCK;ACTR2;CRK
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.4427049916291207,0.9671195667384183,0.5224312590448625,1.0,1.0,2/13,7.75%,GLI2;ZC3H8
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.4312812503119428,0.9669169126190897,0.5192307692307693,1.0,1.0,2/15,3.17%,FGF2;VEGFA
prerank,cardiac myofibril assembly (GO:0055003),0.4283076276761668,0.966891285214189,0.5251076040172167,1.0,1.0,2/15,5.34%,PDGFRA;OBSL1
prerank,positive regulation of cell cycle process (GO:0090068),-0.22916403063025423,-0.9667081326789304,0.4444444444444444,0.8528741659145804,1.0,17/91,11.07%,IGF1;PKP4;LRP5;MAP3K20;PLSCR1;USP19;CIT;IGF2;INSR;GIPC1;TGFA;RGCC;DYNC1LI1;RHOA;NUMA1;PDGFRB;WIZ
prerank,positive regulation of viral transcription (GO:0050434),0.38489649946648374,0.9666836086756854,0.512022630834512,1.0,1.0,4/25,14.13%,MDFIC;POLR2B;POLR2K;POLR2G
prerank,stem cell differentiation (GO:0048863),-0.26201497687213604,-0.9665589787315803,0.5025380710659898,0.8517600570221591,1.0,11/39,14.46%,KIT;OSR1;MLLT3;MTF2;ACE;FBXL17;FGFR2;TGFB2;EEF1AKMT4-ECE2;PTPRC;HMGA2
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.4014566042861242,0.9663914846561152,0.5138121546961326,1.0,1.0,4/20,12.65%,SLC27A1;GSS;PTDSS1;GGCT
prerank,negative regulation of translation (GO:0017148),-0.2347641802850718,-0.9661488644672647,0.5824175824175825,0.8513873227198059,1.0,13/87,10.91%,DAPK1;ROCK2;SAMD4A;ROCK1;YBX1;YTHDF1;CAPRIN1;IGFBP5;METTL14;CNOT1;RACK1;EIF4A3;BTG2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.4329476496552082,0.9657162925093346,0.5197657393850659,1.0,1.0,3/13,6.42%,SEMA3E;VEGFA;TGFBR2
prerank,endocrine system development (GO:0035270),0.387273776210925,0.965451157866887,0.5146036161335188,1.0,1.0,4/21,9.02%,GLI2;NF1;HOXD3;DKK3
prerank,inner mitochondrial membrane organization (GO:0007007),-0.26209995175981393,-0.9651771503284579,0.5060240963855421,0.852423713685952,1.0,17/47,23.02%,MTX2;TOMM70;MICOS10;DNAJC11;ATP5MC3;SPG7;IMMT;TMEM11;ATP5PD;ATP5F1D;ATP5MF;TIMM9;TIMM22;MTX1;TIMM8B;TIMM10B;ROMO1
prerank,response to molecule of bacterial origin (GO:0002237),-0.23377331860911404,-0.9651328756776351,0.5370370370370371,0.8510882151281254,1.0,9/69,7.30%,FOXP1;SMAD6;NOS3;NOCT;CYRIB;TLR4;OTUD5;LIAS;TNFRSF11A
prerank,positive regulation of cell death (GO:0010942),0.3366543890333721,0.9643216588468158,0.5355504587155964,1.0,1.0,13/59,17.17%,LRP1;PRNP;MT3;GRIN2B;WNT5A;BNIP3;FYN;RARG;EIF4G1;SNCA;HTATIP2;EFNB2;RIPK1
prerank,regulation of interleukin-10 production (GO:0032653),0.35661689453465806,0.9641726417122586,0.5241545893719807,1.0,1.0,2/44,1.94%,PYCARD;CD34
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.363144968088978,-0.9639819226278332,0.4662576687116564,0.8525728029403556,1.0,3/13,1.40%,CACNA1C;GJA1;CACNB2
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.24398448513022467,-0.9639631600657541,0.5413533834586466,0.8511659140625585,1.0,7/59,4.49%,ROCK2;ROCK1;BIRC3;NFKBIA;REL;TLR4;RELB
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.39785499908636196,-0.9638653248562272,0.4970588235294118,0.8499660095251753,1.0,4/10,17.29%,APPL2;RAB31;NCKAP1L;CD300A
prerank,regulation of aerobic respiration (GO:1903715),-0.3423390817844971,-0.9636969668974332,0.4645161290322581,0.8489324182927945,1.0,7/15,28.87%,ATP7A;SLC25A33;NOP53;PINK1;AK4;COX7A2;VCP
prerank,negative regulation of cellular metabolic process (GO:0031324),0.36182535259639464,0.9636241997977818,0.5173267326732673,1.0,1.0,10/37,21.98%,PRKN;MT3;ATXN2;BRCA1;PAX2;TRAP1;AP1AR;AATF;NFKB1;DLG4
prerank,regulation of anoikis (GO:2000209),0.4023000303087504,0.9635868575614556,0.5244755244755245,1.0,1.0,2/19,3.71%,BCL2;TLE1
prerank,respiratory electron transport chain (GO:0022904),-0.344708540442637,-0.963581726648762,0.4886731391585761,0.8477987812890665,1.0,7/14,22.94%,SDHB;SLC25A12;ETFRF1;ETFB;SDHA;UQCRFS1;SLC25A18
prerank,regulation of interferon-beta production (GO:0032648),-0.2596361175477179,-0.9635809067203059,0.5153374233128835,0.8463569466270103,1.0,12/46,15.42%,TOMM70;REL;TLR4;RELB;IFIH1;TRIM56;RIOK3;IRF1;OAS2;HSP90AA1;TIRAP;FLOT1
prerank,BMP signaling pathway (GO:0030509),0.33848827539972365,0.9629852207085283,0.5320886814469078,1.0,1.0,6/62,4.79%,BMP5;RGMB;HIVEP1;ACVR1;TGFB1;GDF9
prerank,membrane fusion (GO:0061025),0.3655117409641846,0.9629284070482399,0.5057471264367817,1.0,1.0,9/33,14.99%,DNM1;SNAP23;HACE1;SNAP29;VAPA;HUWE1;RIMS1;OTOF;OPA1
prerank,positive regulation of acute inflammatory response (GO:0002675),0.4370987395559182,0.9628979542241131,0.5252225519287834,1.0,1.0,3/14,18.64%,PTGER3;IL6ST;PARK7
prerank,positive regulation of lipid localization (GO:1905954),0.4619212549198751,0.9628894493856418,0.5269461077844312,1.0,1.0,1/11,2.34%,LRP1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.39350098674505696,0.9627708549408301,0.5261744966442953,1.0,1.0,8/22,22.09%,DUSP4;DUSP6;PPM1B;PPP1CA;DUSP16;PPM1E;DUSP1;PPM1A
prerank,regulation of B cell apoptotic process (GO:0002902),-0.379556646447903,-0.9624817202940895,0.5379939209726444,0.847890743493011,1.0,2/12,3.82%,FOXP1;LYN
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.4505782709997783,0.9624735513828002,0.5338461538461539,1.0,1.0,4/11,17.17%,EGFR;TGFB1;TP53;RIPK1
prerank,Fc receptor signaling pathway (GO:0038093),0.31567396873752385,0.9624252061775354,0.5635005336179295,1.0,1.0,43/110,28.14%,PRKCQ;TEC;PAK1;PPP3CB;GAB2;PPP3CA;VAV3;PSMB7;MAPK9;PIK3R1;NFATC3;MAP2K4;MAPK1;MALT1;CALM1;PSMD2;PSMC1;LAT2;CHUK;PSMB2;PSMD9;GRB2;TAB3;PSME4;BCL10;JUN;PSMA8;NFKB1;SOS1;VAV2;CARD11;TAB2;CUL1;NFATC1;PSMD8;PSMD13;SYK;PIK3CA;RELA;LCP2;TRAF6;TAB1;PSMD4
prerank,glutamine family amino acid metabolic process (GO:0009064),0.3698466617737086,0.9623427875586856,0.52,1.0,1.0,15/33,28.67%,AADAT;GOT2;OAT;ALDH5A1;GLS;GLS2;RIMKLB;GLUD1;DDAH1;DGLUCY;GCLM;NIT2;CAD;RIMKLA;PYCR2
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.3224482965842387,0.9623165301051968,0.5539803707742639,1.0,1.0,16/86,15.47%,CCL11;PYCARD;PSEN1;PAK1;BAIAP2;LIMK1;BIN1;ARL2;CLASP1;SLAIN2;CDK5R1;KATNB1;NCK1;CDC42EP1;MET;NAV3
prerank,icosanoid secretion (GO:0032309),-0.3771706011659982,-0.9622589115696403,0.5176470588235295,0.8470962402061721,1.0,2/12,6.73%,ABCC4;ACE
prerank,regulation of centriole replication (GO:0046599),0.41193606240640734,0.9622350999786355,0.5197657393850659,1.0,1.0,5/17,13.75%,KAT2B;BRCA1;CEP295NL;CEP76;MDM1
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.23610429622215484,-0.9621797850170128,0.5922330097087378,0.8458667757627149,1.0,22/80,14.99%,NRP1;OCLN;WASL;AGRN;FNBP1L;PLEKHM1;CDC42EP4;WASF2;ARHGAP35;ARAP1;FAM98A;AKIRIN1;CCP110;RHOQ;CDC42EP3;EPS8;ABI2;EPS8L2;CDC42EP2;CDC42;AVIL;FUZ
prerank,regulation of cell development (GO:0060284),-0.26925803205792065,-0.9619172416567235,0.5,0.8451735995689115,1.0,8/36,16.23%,NOTCH2;CTNNB1;CLOCK;RPS19;RHEB;PRUNE1;HEY2;ADGRA2
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.38736232062672277,-0.9618731807950367,0.5013550135501355,0.8438713723525975,1.0,3/10,13.85%,CTNNB1;RYK;FZD1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.2924034214848654,-0.9617708434033299,0.5317460317460317,0.8427354239047296,1.0,9/25,20.35%,ETS1;ARNT;STAT5B;ACVR1B;NCKAP1L;INHBA;TAL1;ANKRD54;HMGB2
prerank,regulation of actomyosin structure organization (GO:0110020),-0.35821086953950654,-0.9617476793004605,0.48476454293628807,0.8413896553973061,1.0,5/13,14.11%,ROCK2;ROCK1;FHOD1;ACTG1;CDC42
prerank,regulation of activated T cell proliferation (GO:0046006),0.3696981780380738,0.9616603075473114,0.5491480996068152,1.0,1.0,5/30,12.71%,PYCARD;FADD;PRNP;IL18;SCRIB
prerank,histone H2A acetylation (GO:0043968),0.4224365424495471,0.9615530293252591,0.5090152565880721,1.0,1.0,6/16,19.35%,BRD8;MORF4L2;EPC1;TRRAP;MSL3;RUVBL2
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.28961935549620976,-0.9615464591479146,0.5146443514644351,0.8405287463636288,1.0,8/27,17.60%,MAP3K5;MAP3K20;MAP3K8;MAP3K7;IKBKB;CCDC88C;IKBKG;TAOK2
prerank,negative regulation of cellular component organization (GO:0051129),0.3246264525687363,0.9615439587536704,0.5498320268756999,1.0,1.0,9/74,11.38%,LGALS3;FAP;VEGFA;IRAK3;CRYAB;SYT11;MCTP1;DNAJB6;HDAC6
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.35717471949981455,0.9610541110811764,0.5285714285714286,1.0,1.0,10/43,13.58%,PRKCQ;PTPN2;SIK2;SLC27A4;SOCS1;GRB14;PTPN1;PTPN11;PID1;NCK1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.32053315100886803,0.961050894794126,0.5527747551686616,1.0,1.0,22/95,16.64%,PRDM16;HTRA3;CDKN2B;TGFB1;SOX11;SPRED2;TGFBR2;SPRED1;MEN1;PEG10;DKK3;SNX6;BCL9L;SPRED3;DAND5;BCL9;ZEB2;LDLRAD4;CITED2;UBB;RNF111;NREP
prerank,chromatin assembly (GO:0031497),0.35801746103163035,0.9608940371589543,0.5259975816203144,1.0,1.0,8/38,16.20%,SOX9;EZH1;ATRX;POLE3;PRDM9;ASF1A;RBBP4;TP53
prerank,organelle disassembly (GO:1903008),-0.2748410915078511,-0.9605943005378861,0.5405405405405406,0.8415055593883332,1.0,10/33,21.35%,MTIF2;TEX264;KIF5B;KLC1;UFM1;GFM2;MTIF3;UFC1;UBA5;ULK1
prerank,RNA metabolic process (GO:0016070),0.3092429249606529,0.9604593194370081,0.5721868365180467,1.0,1.0,36/127,21.26%,BICD1;DHX8;ELAVL4;RNASE6;RNGTT;ATXN2;POLR2B;METTL3;XRN2;DDX54;DDX24;PPP1R8;APOBEC1;POLR2K;NCBP1;ADARB2;DUSP11;SNRNP40;HNRNPA3;RNASEH2C;ADARB1;POLR2G;NOVA1;PAPOLA;PNPT1;HNRNPU;TP53RK;SYNCRIP;TENT2;POLR2A;HNRNPUL1;RBMS1;HNRNPH2;HNRNPC;RBFOX2;HNRNPL
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.30831165828883567,-0.9602178932987551,0.5113636363636364,0.8411704345289841,1.0,6/21,11.07%,MFHAS1;PPP1R16B;PTPA;GSK3B;ARPP19;PPP1R11
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.30831313113303516,0.960010862320614,0.5807453416149069,1.0,1.0,28/158,17.31%,ROR1;S100A4;PRKN;AKAP13;FADD;LPAR1;ALPK1;MAP3K3;GPRC5B;TNFRSF10B;SLC44A2;TMEM106A;CARD9;PELI1;FLNA;VAPA;MID2;RHOC;TBK1;MALT1;NDFIP1;GOLT1B;TICAM1;PIM2;TERF2IP;RIPK1;CD74;CHUK
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.4162007889615338,0.9598627679131321,0.5195936139332366,1.0,1.0,6/17,22.27%,IRS2;SOCS1;STAT3;SMARCA4;STAT5A;BRWD1
prerank,cellular response to interleukin-7 (GO:0098761),0.4162007889615338,0.9598627679131321,0.5195936139332366,1.0,1.0,6/17,22.27%,IRS2;SOCS1;STAT3;SMARCA4;STAT5A;BRWD1
prerank,response to unfolded protein (GO:0006986),0.34985596516767836,0.9597966152161549,0.5368171021377672,1.0,1.0,13/48,21.24%,HSPH1;PRKN;DNAJB4;PACRG;PTPN1;HERPUD1;HSPA4;TM7SF3;DNAJC4;DNAJA1;HSPA9;HSPD1;RHBDD1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.41345017199684136,0.9597813433097637,0.5203938115330521,1.0,1.0,6/17,19.85%,PTEN;SOD2;TGFB3;TAFA5;PPARG;PDCD4
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.37571208576646975,-0.9596798831425755,0.5056497175141242,0.8411870393184794,1.0,3/11,13.85%,CTNNB1;RYK;FZD1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3051840286447072,0.9594889451694218,0.565843621399177,1.0,1.0,30/166,13.96%,GLI2;SLC27A1;FGF2;MYC;IRS2;ERBB2;EGFR;PTPN2;PLD1;UPF3A;GLI1;NIBAN1;STN1;METTL3;MLXIPL;EIF3C;CPEB3;EIF6;NSUN5;PASK;HIF1A;ELOVL5;PAOX;SP1;PRMT1;DDB1;PRR16;ZEB2;SNCA;SMOC2
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.3577648952759138,0.9594299958360453,0.5129151291512916,1.0,1.0,15/38,23.72%,NDUFS5;NDUFA4;NDUFB2;NDUFA8;NDUFS8;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1;NDUFA5;NDUFV1;NDUFAF1
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.23210630122925371,-0.9591547929431741,0.5846153846153846,0.8411943775389421,1.0,32/72,34.00%,PSMD14;BIRC3;REL;RELB;PSMB3;PSMD12;ZFP91;MAP3K7;PSMD6;PSMA1;PSMD7;TIRAP;PSMA5;PSMC5;PSMC4;PSMB6;PSMA4;NFKB2;AKT1;PSMB9;PSMB1;PSMD3;PSMC6;PSMD10;PSME3;DICER1;TLR3;BTRC;BIRC2;FBXW11;PSME2;PSMA6
prerank,inorganic cation transmembrane transport (GO:0098662),0.3047094766566459,0.9588865060834096,0.6072507552870091,1.0,1.0,23/268,8.12%,SCARA5;KCNK15;SLC6A2;SLC1A3;KCNA2;SCN7A;KCNH8;SLC12A3;SCN2A;KCNK1;ANO6;KCNA1;CACNA1A;KCNA6;SLC36A2;SLC12A2;SCN5A;KCND1;KCND2;SCN3A;KCND3;SLC30A4;SLC8A2
prerank,keratinocyte differentiation (GO:0030216),0.36978634093281415,0.9584725431480797,0.524966261808367,1.0,1.0,3/29,5.26%,CERS3;TGM1;WNT5A
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.41949332341254353,0.9580010533384921,0.5314787701317716,1.0,1.0,2/15,4.09%,IRAK3;TGFB1
prerank,long-chain fatty acid import into cell (GO:0044539),0.45657522160620795,0.9579743542043613,0.5288611544461779,1.0,1.0,2/10,4.13%,SLC27A1;SLC27A4
prerank,regulation of protein polymerization (GO:0032271),-0.2727340596091841,-0.9578232588998357,0.5235849056603774,0.8433792788598854,1.0,9/35,15.05%,ARHGAP28;FCHSD2;MAP2;ESAM;PFN2;MAPT;HAX1;HSP90AA1;PRUNE1
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.41584966399706363,0.957590768019632,0.5305832147937412,1.0,1.0,4/16,9.95%,KMT2A;AUTS2;BRCA1;PIH1D1
prerank,lytic vacuole organization (GO:0080171),0.365306841853147,0.9574147536765398,0.5348542458808618,1.0,1.0,15/32,24.09%,GNPTAB;ACP2;GRN;TPCN2;AKTIP;CLVS1;HPS1;HOOK2;MBTPS1;CLN6;CLVS2;HOOK3;HOOK1;TPP1;MTOR
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.37908674763022854,-0.9573911785424761,0.5128205128205128,0.8430524488706467,1.0,2/11,0.38%,IGF1;IGF1R
prerank,RNA polyadenylation (GO:0043631),0.37540266791465415,0.957029761753096,0.5414438502673797,1.0,1.0,10/26,23.80%,CSTF3;PABPC1;FIP1L1;AHCYL1;PAPOLA;PNPT1;CDC73;TENT2;SYMPK;TUT1
prerank,mRNA polyadenylation (GO:0006378),0.37540266791465415,0.957029761753096,0.5414438502673797,1.0,1.0,10/26,23.80%,CSTF3;PABPC1;FIP1L1;AHCYL1;PAPOLA;PNPT1;CDC73;TENT2;SYMPK;TUT1
prerank,positive regulation of RNA splicing (GO:0033120),0.37287258379903904,0.9570206821416674,0.5218543046357615,1.0,1.0,5/29,13.32%,PRDX6;TRA2B;NCBP1;PIK3R1;DAZAP1
prerank,response to hydrogen peroxide (GO:0042542),0.3434271087331891,0.9568270759585153,0.5322966507177034,1.0,1.0,14/45,20.53%,APTX;MAPK7;CYP1B1;FYN;NFE2L2;HDAC6;PRDX3;ABL1;PAX2;RIPK1;CAT;PARK7;OSER1;SIRPA
prerank,cellular response to oxidative stress (GO:0034599),0.30946362561052165,0.9565168775048004,0.560796645702306,1.0,1.0,30/118,18.94%,PRDX6;PDGFRA;SRXN1;EGFR;NCF1;MT3;MAPK9;GPX3;MGAT3;HIF1A;SELENOS;NCF2;NFE2L2;FANCC;MAPK1;ERCC6L2;PRDX3;SOD2;SNCA;RAD52;ABL1;VKORC1L1;TP53;PNPT1;SLC25A24;CHUK;TXNRD1;CAT;PARK7;ERMP1
prerank,regulation of DNA recombination at telomere (GO:0072695),0.39416006993346975,0.9564737397171591,0.5146198830409356,1.0,1.0,8/19,24.51%,POLR2B;ATRX;POLR2K;POLR2G;TERF2IP;POLR2A;ACD;POLR2F
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.39416006993346975,0.9564737397171591,0.5146198830409356,1.0,1.0,8/19,24.51%,POLR2B;ATRX;POLR2K;POLR2G;TERF2IP;POLR2A;ACD;POLR2F
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.27218028813790107,-0.9559387606996712,0.5284974093264249,0.8455313130823542,1.0,11/39,14.08%,ROBO1;TSPAN5;NOS3;MAML1;PRKCI;SNW1;JAG1;JAG2;NOTCH4;TGFB2;NEPRO
prerank,central nervous system neuron development (GO:0021954),0.4233250057048825,0.9558878219815,0.5189873417721519,1.0,1.0,3/15,4.67%,PTEN;NTRK2;GBA2
prerank,neutrophil mediated immunity (GO:0002446),0.2967987614668704,0.9556626629830737,0.6412825651302605,1.0,1.0,59/432,12.97%,DYNLL1;PRDX6;LGALS3;PYGL;CRISPLD2;PYCARD;OLFM4;SNAP23;GSN;BST1;RAP2B;TMEM63A;ANO6;PDXK;CAPN1;RAB14;PLD1;PSEN1;SLC44A2;PGM1;IQGAP2;CSTB;LTA4H;AOC1;SNAP29;AGPAT2;APAF1;GM2A;CDK13;CARD9;GALNS;PTGES2;RAP1A;ARHGAP9;CTSB;GDI2;LAMTOR2;ACLY;HRNR;PSMB7;CKAP4;RAB3D;MAGT1;VAPA;PTPRJ;HUWE1;NCSTN;MAPK14;COMMD3;MAPK1;TOLLIP;FUCA2;GRN;KCNAB2;RAB4B;ARL8A;XRCC6;RAB3A;KPNB1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.4295262916354243,0.9556563293661935,0.5316642120765832,1.0,1.0,4/14,16.58%,IRS2;TYSND1;MTLN;ABCD2
prerank,neutrophil degranulation (GO:0043312),0.29689383739714736,0.9554344916583901,0.6452905811623246,1.0,1.0,58/425,12.97%,DYNLL1;PRDX6;LGALS3;PYGL;CRISPLD2;PYCARD;OLFM4;SNAP23;GSN;BST1;RAP2B;TMEM63A;ANO6;PDXK;CAPN1;RAB14;PLD1;PSEN1;SLC44A2;PGM1;IQGAP2;CSTB;LTA4H;AOC1;SNAP29;AGPAT2;APAF1;GM2A;CDK13;GALNS;PTGES2;RAP1A;ARHGAP9;CTSB;GDI2;LAMTOR2;ACLY;HRNR;PSMB7;CKAP4;RAB3D;MAGT1;VAPA;PTPRJ;HUWE1;NCSTN;MAPK14;COMMD3;MAPK1;TOLLIP;FUCA2;GRN;KCNAB2;RAB4B;ARL8A;XRCC6;RAB3A;KPNB1
prerank,histone monoubiquitination (GO:0010390),0.38679861754525674,0.9553804436102135,0.52832674571805,1.0,1.0,12/24,28.60%,WAC;DDB2;DDB1;CUL4B;CDC73;BCOR;UBE2E1;RNF2;PCGF1;RNF20;RNF168;TRIM37
prerank,protein maturation (GO:0051604),0.31628680445791607,0.9553449778547085,0.5412647374062165,1.0,1.0,24/95,21.06%,PTCH1;ADAM19;PSEN1;TSPAN32;PCSK4;PCSK6;NAA35;NAA16;LMF1;MMP16;NCSTN;TSPAN17;APH1A;CPD;TYSND1;PSEN2;GLRX3;CASP2;CIAO2B;NAA10;NAA15;PCSK7;HSPD1;FURIN
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.2992971440217796,-0.9553436002821999,0.5122950819672131,0.8456869639098412,1.0,8/23,23.49%,SASH1;MAP3K5;TNFRSF11A;MAP3K7;ARHGEF5;EDN1;DVL2;DUSP19
prerank,positive regulation of cellular catabolic process (GO:0031331),0.30658453604984637,0.9550702132892327,0.5873180873180873,1.0,1.0,26/132,16.58%,DCN;IRS2;ZBTB20;VGLL4;NPRL2;PSEN1;DXO;MLXIPL;UFL1;BNIP3;VPS11;PTPN1;HIF1A;MID2;UPF1;ZC3H18;SNCA;KHSRP;MTLN;TICAM1;DACT1;PIM2;GPLD1;ZSWIM8;PNPT1;ABCD2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.406456335182578,0.9550344311688447,0.5338028169014084,1.0,1.0,9/17,26.34%,CARD9;TAOK3;ARL6IP5;KLHDC10;MID1;RNF13;TAOK1;EIF2AK2;SEMA4C
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.3749948903141733,-0.9549340545722689,0.5214723926380368,0.8453323619466593,1.0,3/12,8.37%,RBP4;TLR4;STRAP
prerank,DNA modification (GO:0006304),0.3932952218989885,0.9547686663616397,0.5226960110041265,1.0,1.0,9/22,23.75%,MBD4;MPG;MUTYH;NEIL1;SMUG1;TERF2IP;TDG;EXOSC3;ACD
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.3723463341278616,0.9547430309146422,0.5407124681933843,1.0,1.0,5/30,7.82%,ANK3;VAMP4;BLZF1;SPTBN1;RAB34
prerank,nucleic acid-templated transcription (GO:0097659),-0.27047238620725905,-0.9545335188921138,0.521978021978022,0.8450318264003113,1.0,18/42,24.93%,THRB;RRAGC;DRG1;CREBL2;MMS19;PWP1;MED20;TERT;POLR2C;BAZ2A;DTX1;POLR2E;PTMA;POLR2J;XAB2;POLR2D;E2F1;THAP1
prerank,negative regulation of DNA metabolic process (GO:0051053),0.3826362982917099,0.9538951411690624,0.5299479166666666,1.0,1.0,7/24,16.30%,KMT2A;ZRANB3;ERCC4;MSH6;RTEL1;BLM;TERF2IP
prerank,response to metal ion (GO:0010038),0.32347984516250095,0.9536495980332493,0.5413363533408834,1.0,1.0,18/67,21.66%,BCL2;MT3;SLC30A4;PPP3CA;ANXA11;HIF1A;PPP1CA;AHCYL1;SNCA;GPHN;NEDD4L;CALM1;CALM2;HOMER1;KCNMA1;SNCB;PEF1;SLC11A2
prerank,neutrophil activation involved in immune response (GO:0002283),0.296227712316199,0.9534157211655933,0.6472945891783567,1.0,1.0,58/428,12.97%,DYNLL1;PRDX6;LGALS3;PYGL;CRISPLD2;PYCARD;OLFM4;SNAP23;GSN;BST1;RAP2B;TMEM63A;ANO6;PDXK;CAPN1;RAB14;PLD1;PSEN1;SLC44A2;PGM1;IQGAP2;CSTB;LTA4H;AOC1;SNAP29;AGPAT2;APAF1;GM2A;CDK13;GALNS;PTGES2;RAP1A;ARHGAP9;CTSB;GDI2;LAMTOR2;ACLY;HRNR;PSMB7;CKAP4;RAB3D;MAGT1;VAPA;PTPRJ;HUWE1;NCSTN;MAPK14;COMMD3;MAPK1;TOLLIP;FUCA2;GRN;KCNAB2;RAB4B;ARL8A;XRCC6;RAB3A;KPNB1
prerank,necroptotic process (GO:0070266),0.41822385971728343,0.9532182647545351,0.5339105339105339,1.0,1.0,4/16,19.05%,ITPK1;TICAM1;RIPK1;MLKL
prerank,regulation of interleukin-8 production (GO:0032677),0.3299792632343499,0.9527247067255811,0.5580608793686584,1.0,1.0,16/69,21.03%,PYCARD;PTPN22;FADD;OTUD7B;TLR1;RAB1A;SSC5D;LBP;RIPK1;CD74;PARK7;MAPKBP1;STAT3;BCL10;BCL3;PRKD2
prerank,positive regulation of signal transduction (GO:0009967),0.301313938385224,0.9526336425082611,0.6026422764227642,1.0,1.0,35/238,11.08%,RELN;SULF1;PRKCA;LGR6;NTRK3;MAML3;PTEN;STK36;KAT2B;DEPDC1B;MAML2;TRIM44;EVC;NRXN1;MT3;GLI1;NLGN1;AGPAT2;DISC1;LMO3;UCHL5;LOXL3;KLK6;RAB34;SPIN1;SMO;FLNA;ZMIZ1;LANCL2;HIF1A;PIH1D1;PIK3R1;PTPN11;IL6ST;RIMS1
prerank,regulation of coagulation (GO:0050818),0.4487231789929867,0.9525877226330566,0.5300632911392406,1.0,1.0,1/11,3.30%,EPHB2
prerank,regulation of apoptotic process (GO:0042981),0.29487693425746564,0.9523398847683107,0.685,1.0,1.0,154/676,19.18%,FFAR4;BCL2L14;RTKN;CXCL10;HRK;PIP5KL1;SOX8;PYCARD;MYC;OLFM4;RNF157;BCL2;DPEP1;SOX9;NGF;PRKN;EGFR;AKAP13;STEAP3;FRZB;FADD;FGD4;MAP4K4;FMN2;VEGFA;EGR3;ARAF;ANO6;THOC6;WNK3;TNFRSF10B;SLC27A4;PSEN1;ERCC5;FANK1;MT3;NF1;DUSP6;ACVR1C;WNT5A;CYP1B1;GRID2;YWHAZ;RASA1;APAF1;NAA35;ITSN1;SON;GATA6;BMF;NAA16;CASP6;TRIM2;SHQ1;PHLDA1;CBX4;NAE1;BIN1;BNIP3;NF2;CTSB;VAV3;ARHGEF11;RARG;PPID;FLNA;HIP1;CRYAB;SFRP4;ASNS;UBE2Z;PRDM9;PIK3R1;HDAC2;SLK;GDNF;CBL;NCSTN;ARF4;NGFR;IL6ST;TAF9;ARL6IP5;ING4;ANP32E;MYDGF;TAX1BP1;APH1A;SCRIB;PRLR;PRDX3;HSP90B1;TRIO;ATF5;YME1L1;MALT1;DDX42;SNCA;ARHGEF3;RPS6KA2;PSEN2;ITGB3BP;RTN4;AREL1;OPA1;ZFAND6;RASSF2;ITGB1;ATM;CITED2;IFT57;CASP2;UBB;ABL1;BNIP1;PIM2;UBE2O;CRADD;TGFB3;FZD9;HTATIP2;GPLD1;BCL2L11;XIAP;TP53;CCND2;LRP2;QRICH1;SGK1;GLS2;KCNMA1;ARHGEF4;PAX2;RIPK1;CD74;PLEKHG2;RNPS1;WRN;PCID2;AIFM1;CSRNP3;ADAMTSL4;IRF3;DNAJA1;HSPA9;HTT;CAT;NAA15;AATF;PARK7;CHM;MAP3K11;AXL;SEMA4D
prerank,cellular glucose homeostasis (GO:0001678),0.35318589254601773,0.9521975324735804,0.5442092154420921,1.0,1.0,16/41,25.44%,ZBTB20;TRA2B;LRRC8D;PDK3;HIF1A;PIK3R1;NGFR;PRKACA;PAX2;PCK2;HK2;ADCY8;PRKAA1;HK1;SLC39A14;SOX4
prerank,regulation of actin filament polymerization (GO:0030833),0.3254311138679797,0.9520082185445372,0.5678733031674208,1.0,1.0,8/69,7.87%,CCL11;PYCARD;KANK4;GBA2;RASA1;BAIAP2;SSH3;BIN1
prerank,cellular response to interleukin-4 (GO:0071353),-0.38701213328525413,-0.951901446938788,0.5052631578947369,0.8505940767353549,1.0,1/10,0.61%,LEF1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.3277932756938949,0.9516901576848326,0.5549389567147613,1.0,1.0,25/73,24.62%,ARPC1B;WIPF1;PAK1;BAIAP2;LIMK1;BRK1;FYN;VAV3;DOCK1;PIK3R1;MAPK1;PLPP4;NCK1;CYFIP1;ELMO1;ABL1;GRB2;NCKAP1;YES1;VAV2;NCKIPSD;PRKCE;HCK;ACTR2;CRK
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.2966046521978164,-0.951580589006385,0.5532786885245902,0.8500386271269056,1.0,11/26,24.97%,NOS3;ACER2;SPTLC2;DDAH2;ASAH2;NOS1;SPR;SPHK1;AKT1;SPHK2;SPTLC1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.36300317346915745,-0.9515427471136312,0.5095367847411444,0.8487444740390347,1.0,2/12,1.75%,ROCK2;ROCK1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.32017407603125225,0.9512516618927804,0.5689084895259096,1.0,1.0,11/78,11.05%,LGALS3;LRP1;EGFR;EPHB2;WNK3;TGFB1;SPTBN1;DPP10;ZDHHC8;PIK3R1;PID1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.30145310441142825,0.9509223596689997,0.6148373983739838,1.0,1.0,21/199,10.11%,FFAR4;PTCH1;SOSTDC1;BMP5;DOCK7;LRP4;PTEN;SOX9;EGFR;HOXA7;RPS6KA4;TGFB1;ACVR1C;SPRED2;ACOT11;SPRED1;TBX18;CHSY1;SYT11;LNPEP;SPRED3
prerank,negative regulation of reproductive process (GO:2000242),0.4142225417553128,0.9507878236494917,0.5421195652173914,1.0,1.0,2/17,5.25%,SULF1;ACVR1C
prerank,carbohydrate homeostasis (GO:0033500),-0.2331652341161451,-0.9507478076629634,0.5739130434782609,0.8494749922734699,1.0,14/67,12.53%,IGF1R;RBP4;APPL2;SLC8B1;SELENOT;INSR;CYB5R4;PRKAA2;ADIPOR2;ADRA2A;RPS6;HECTD4;KCNB1;CRTC2
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3586136641504191,0.9504571066296411,0.5242346938775511,1.0,1.0,3/33,4.09%,MEOX2;FGF2;TGFB1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.36888877139863674,0.9504299519584742,0.5391527599486521,1.0,1.0,5/30,7.97%,PTPN2;CADM4;SOCS1;SAMSN1;NF2
prerank,endocardial cushion development (GO:0003197),-0.3059963504698801,-0.9502601223992493,0.5179856115107914,0.8494396885704142,1.0,5/21,3.86%,ACVRL1;NOS3;BMP4;ENG;BMPR2
prerank,regulation of cytokine production (GO:0001817),0.3128711132352831,0.9500017961115172,0.5866388308977035,1.0,1.0,21/126,18.08%,FFAR4;GLMN;DTX4;RPS6KA4;MAST2;MAPKAPK2;CCR2;AGPAT2;CARD9;CADM1;SYT11;MAPK14;TBK1;ATP2B1;PER1;GATA3;IL33;N4BP1;TRIL;BATF;IRF3
prerank,regulation of G0 to G1 transition (GO:0070316),0.35353641224089355,0.9498892853655011,0.5305867665418227,1.0,1.0,15/38,26.81%,CDKN2B;EED;APAF1;E2F6;BRCA1;EPC1;RBBP4;RBBP7;CBX5;RNF2;CBX3;EHMT2;RHNO1;RBBP8;EZH2
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.3864502075532801,-0.9497562089396964,0.5415549597855228,0.8492997451909801,1.0,2/10,14.72%,PTPRC;CEACAM1
prerank,mammary gland development (GO:0030879),0.3886313541167149,0.9496183601876381,0.5347885402455662,1.0,1.0,6/21,17.76%,GLI2;VEGFA;ERBB4;PRLR;TGFB3;GPAT4
prerank,protein K63-linked ubiquitination (GO:0070534),0.34686200818850965,0.9493726181431635,0.5315533980582524,1.0,1.0,4/41,7.97%,UBE2T;PRKN;UBE2E2;PELI1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.294454065970587,0.9492963151136491,0.6766766766766766,1.0,1.0,86/497,14.48%,NKX6-2;MDFIC;TSHZ3;CREB3L1;SCML4;RCOR2;SOX8;PRDM16;ATP8B1;SOX9;VGLL4;NAB1;SUV39H1;EPRS1;HOXA7;EIF2AK3;TLE1;KDM8;FOXP2;TGFB1;GATAD2A;MBD1;ZEB1;MT3;PLCB1;ATF7IP;WNT5A;EED;CIPC;RFX3;TSC1;MLXIPL;MLX;ZBTB16;LOXL3;TWIST2;GATA6;CBFA2T3;FOXM1;KAT8;CBX4;ZC3H8;MEN1;CPEB3;MBD2;KCTD1;BRCA1;DKK3;CRYAB;PASK;LANCL2;SELENOS;SNX6;ZBTB38;HDAC2;MBTD1;SMARCC2;RBAK;BMP7;PRICKLE1;HDAC6;SFPQ;ING4;CREBZF;CDK5R1;MIDEAS;JARID2;ZGPAT;PATZ1;ZFPM2;L3MBTL4;EPC1;XRCC6;AHR;EID2B;ATF5;PER1;SCML2;GATA3;PRDM11;NACC2;PUS7;NCOR2;TAF7;SUMO1;CRY1
prerank,cellular protein modification process (GO:0006464),0.29253325939880265,0.9492732224368734,0.726,1.0,1.0,166/982,14.85%,CCL11;PTPRH;GPC3;CHRM3;WNK2;VCAN;PRKCA;CEL;CTH;PTEN;ST3GAL4;PTPN22;STK36;MXRA8;PEAK1;FBXW9;CHRDL1;LAMC1;DUSP4;ERBB2;PGAP1;RAB38;PTPRT;ACVR1;TGM1;UBE2E2;MAP4K4;PAK4;IRAK3;ARAF;WNK3;EIF2AK3;SIK2;RPS6KA4;SOCS5;TEC;MAST2;FBXW7;PRKCSH;TGFB1;SPSB4;NEK1;ASB8;NUCB1;NPC1;PAK5;SETD3;SDC2;MAPKAPK2;KLHL13;MT3;PRKAR1B;DUSP6;TESK2;PTPN13;ACVR1C;OBSL1;WIPI1;TNIK;HLCS;FBXO7;PKN1;PAK1;YWHAZ;FBXL15;ASB5;DDB2;CDK13;CDKL5;CDK8;FBXO32;MMP15;EVA1A;B3GNT9;CDKL3;TGFBR2;MAN2A2;ZBTB16;CSK;UFL1;PPP3CB;DYRK1B;RCN1;PDK3;CDK6;FGFR1;LIMK1;MEN1;NAE1;STT3A;PPP3CA;COL3A1;FYN;ATG5;VWA1;CDK15;PPM1B;PPM1J;TBCK;PPP2R3A;FBXL16;PPP2R2A;PSMB7;CDK19;AKT3;MAPK9;TLK2;CKAP4;STK39;PASK;FBXO27;PTPN1;HIF1A;SGK3;SGK2;AMELX;CUL3;PXK;PTPRJ;TYK2;DUSP11;ST8SIA1;ARF4;DCLK1;LTBP1;UCHL3;CALU;MAPK1;CDC25B;TAOK3;UBA3;ALG5;SIRT6;SLC35A1;PPP1CA;FBXO17;PTPRA;RAB1A;ATG3;TBK1;FBXL2;FUCA2;DCAF8;PTPN18;PTPRZ1;PRKACA;CSNK1A1;RAB3A;DDB1;CDK16;HSP90B1;BTBD1;NEK7;SSH1;PENK;PTPN21;NEDD8;SUMF1;TTBK1;PPP3CC;DDA1;KLHL22;BMPR1A;ALG1;PTPRF;PSMD2
prerank,DNA replication initiation (GO:0006270),0.3539778380624744,0.9487664701348186,0.5374233128834356,1.0,1.0,11/37,20.27%,LRWD1;POLE2;RPA3;POLE3;MCM4;RPA2;ORC1;TOPBP1;ORC4;DBF4;ORC2
prerank,plasma membrane invagination (GO:0099024),0.3776720262967985,0.9484382050694643,0.534640522875817,1.0,1.0,3/29,2.28%,SPIRE1;GULP1;GSN
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.32790241142456905,-0.948426038425863,0.5101351351351351,0.8514484876645265,1.0,3/17,1.12%,BAIAP2L1;TEK;NRP1
prerank,glycerolipid metabolic process (GO:0046486),-0.3827863570086315,-0.9484189957093352,0.5491329479768786,0.8500761656503248,1.0,6/11,27.24%,GAL3ST1;PLA2G15;PGP;DGKG;PNPLA3;DGKB
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.4214512572500847,0.9477601808581605,0.5508100147275405,1.0,1.0,2/15,4.97%,ARPC1B;IQGAP2
prerank,regulation of cell killing (GO:0031341),0.4129823177236312,0.9476894911251275,0.5398496240601504,1.0,1.0,3/16,7.35%,WNT5A;NOX1;FZD7
prerank,osteoclast differentiation (GO:0030316),-0.30617906995364363,-0.9473132911493793,0.5263157894736842,0.8516451129198681,1.0,5/22,12.44%,FOXP1;GLO1;TNFRSF11A;SBNO2;OSTM1
prerank,regulation of epithelial cell migration (GO:0010632),0.3374006646499217,0.9471910063252755,0.5555555555555556,1.0,1.0,11/51,14.67%,RHOJ;GLIPR2;FGF10;SOX9;DOCK5;DOCK1;HIF1A;CLASP1;HDAC6;BMPER;RTN4
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.35883477145720144,-0.9471045670167654,0.5309734513274337,0.8507667967129136,1.0,5/13,19.08%,GTPBP1;RHOQ;ENTPD7;GNAI3;AK4
prerank,organic acid transport (GO:0015849),0.3194482998632166,0.946846823716728,0.5882990249187432,1.0,1.0,18/94,14.07%,SLC27A1;ATP8B1;SLC1A5;NCOA1;SLC38A4;SLC16A10;SLC27A4;LRRC8D;SLC36A2;SLCO2B1;SLC43A1;GOT2;NCOA2;SLC7A7;SLC7A8;SLC25A10;SLC16A1;SLC10A1
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.3005122420556194,-0.9468422375606366,0.5110294117647058,0.8486967460967132,1.0,7/20,23.69%,GSTA4;GSTM1;HPGDS;MGST1;ESD;MGST3;GSTM5
prerank,glutathione derivative metabolic process (GO:1901685),-0.3005122420556194,-0.9468422375606366,0.5110294117647058,0.8486967460967132,1.0,7/20,23.69%,GSTA4;GSTM1;HPGDS;MGST1;ESD;MGST3;GSTM5
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.31434796944256943,0.9468323066132592,0.5747001090512541,1.0,1.0,34/96,26.01%,THOC6;RANBP2;NUP155;SRSF11;MCM3AP;CASC3;ALKBH5;NCBP1;FIP1L1;NDC1;NUP205;NUP160;UPF1;DDX25;NXT1;SRSF6;YTHDC1;SMG6;POM121;AAAS;NXF1;RNPS1;THOC7;SRRM1;FYTTD1;SRSF3;GLE1;NUP42;SYMPK;THOC5;MAGOHB;NUP35;RAE1;HNRNPA2B1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.3075477101696781,-0.9468091388847315,0.5567375886524822,0.8474167395032987,1.0,9/20,30.50%,AGO1;ZC3H7B;AGO3;TERT;TARBP2;MRPL44;AGO2;AGO4;DICER1
prerank,regulation of epithelial cell differentiation (GO:0030856),0.3931464357200263,0.9465525239276971,0.5290780141843971,1.0,1.0,4/17,13.38%,SOX9;PRKX;AJAP1;GATA3
prerank,positive regulation of cellular process (GO:0048522),0.29251897438003216,0.9465011397505354,0.677,1.0,1.0,71/565,11.43%,OSR2;BMP5;PRKCA;PDGFRA;ERBB3;NTRK3;HAS2;EPB41L4B;FGF2;PYCARD;MYC;FGF10;PTEN;KIF20B;BCL2;RHOD;GAREM1;IRS2;SOX9;CRLF1;LRP1;ERBB2;BST1;EGFR;TGM1;VEGFA;ACACA;PTHLH;CAPN1;TGFB1;PTGFR;SOX11;TIPIN;NTRK2;GDF9;MT3;GLI1;WNT5A;NOP2;NOX1;PAK1;CDK13;TGFBR2;MLXIPL;UFL1;FZD7;FOXM1;FGFR1;GAB2;FASN;PPP3CA;TSHR;PPP1R13L;ACLY;BTC;DERL2;EDN3;CUL3;NCBP1;EXOSC2;HDAC2;EIF4G1;ERBB4;GDNF;PTPRJ;AKAP6;IL6ST;S1PR3;PRMT1;FGF7;CDC25B
prerank,RNA splicing (GO:0008380),0.3165329117467267,0.9464064683466755,0.5902702702702702,1.0,1.0,32/95,25.72%,DHX8;USB1;TRA2B;RSRC1;RP9;RNPC3;IVNS1ABP;SRSF11;TXNL4A;NCBP1;SFPQ;SNRNP40;PRPF18;PRPF6;KHSRP;NOVA1;RNPS1;FUS;SYNCRIP;DDX23;SRRM1;SF3B3;DBR1;HNRNPC;SNRPN;SF3B2;WBP4;PPP2R1A;MAGOHB;NONO;SCAF11;SNRPA1
prerank,phosphorylation (GO:0016310),0.2946418531766128,0.9460179760116904,0.6536536536536537,1.0,1.0,66/384,13.40%,CCL11;WNK2;PRKCA;STK36;PEAK1;ERBB2;ACVR1;MAP4K4;PAK4;EPHB2;IRAK3;GNPTAB;WNK3;EIF2AK3;SIK2;RPS6KA4;TEC;MAST2;TGFB1;NEK1;PAK5;MAPKAPK2;PRKAR1B;TESK2;ACVR1C;TNIK;PKN1;PAK1;YWHAZ;CDK13;CDKL5;CDK8;CDKL3;TGFBR2;CSK;PPP3CB;DYRK1B;PDK3;CDK6;FGFR1;LIMK1;FYN;CDK15;TBCK;CDK19;AKT3;MAPK9;TLK2;STK39;PASK;SGK3;SGK2;PXK;TYK2;DCLK1;DGKI;MAPK1;TOLLIP;CDC25B;TAOK3;TBK1;PRKACA;CSNK1A1;CDK16;NEK7;SHPK
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.3705971206989372,0.9454391997108503,0.5371352785145889,1.0,1.0,6/26,9.70%,ERLIN2;MLXIPL;PRKAB2;EIF6;BRCA1;ELOVL5
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.376780233912681,-0.9452935697528143,0.4782608695652174,0.8501593308564694,1.0,5/11,14.30%,DKC1;WRAP53;CCT4;CCT6A;CCT8
prerank,mesenchymal cell development (GO:0014031),0.40062954747321466,0.9452101406242681,0.5424657534246575,1.0,1.0,6/18,22.43%,SOX8;SOX11;KLHL12;HEYL;PEF1;NRG1
prerank,vasculature development (GO:0001944),-0.33576296489143176,-0.9451214913489644,0.5414012738853503,0.8492797993272762,1.0,7/16,12.13%,CDH5;ERRFI1;ACVRL1;BMPR2;STRA6;PDGFRB;NOTCH4
prerank,telomere maintenance via recombination (GO:0000722),0.44050302415351467,0.9449819483719194,0.5397553516819572,1.0,1.0,4/11,22.82%,ERCC4;XRCC3;TPRKB;RAD50
prerank,iron ion transport (GO:0006826),0.34503731616355804,0.9449348945259972,0.5580568720379147,1.0,1.0,4/47,7.86%,SCARA5;STEAP3;ATP6V1B2;TTYH1
prerank,Notch signaling pathway (GO:0007219),0.33034013966931136,0.9444331334725065,0.5637426900584795,1.0,1.0,15/59,18.27%,MAML3;MYC;KAT2B;DTX4;MAML2;PSEN1;HOXD3;NCSTN;APH1A;PSEN2;TRAF7;MIB1;HEYL;MDK;GALNT11
prerank,negative regulation of interferon-beta production (GO:0032688),0.44618423612437863,0.9442418066528331,0.5357142857142857,1.0,1.0,4/10,20.53%,PYCARD;PPM1B;PTPRS;SIRPA
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.44546698705453674,0.9441123852018697,0.5372424722662441,1.0,1.0,4/10,19.35%,SHQ1;PIH1D1;TAF9;RUVBL2
prerank,synaptic vesicle exocytosis (GO:0016079),0.3442536032440336,0.9440983811077998,0.5470297029702971,1.0,1.0,11/40,18.60%,SNAP23;SYT1;SNAP29;RIMS1;RAB3A;OTOF;DOC2B;SNCA;STX1B;SYT2;RIMS2
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.3771448426607357,0.9437889183743233,0.5443213296398892,1.0,1.0,4/23,12.82%,CRLF3;CYP1B1;ERBB4;PRLR
prerank,vesicle transport along microtubule (GO:0047496),-0.3029950859264352,-0.9437676316249879,0.5476190476190477,0.8513583868868412,1.0,6/23,8.55%,KIF3B;KIF1C;TRAK1;PAFAH1B1;KIF5B;BICDL1
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.25899786168046807,-0.9434465199920177,0.532967032967033,0.8508700852260425,1.0,18/40,24.97%,PARG;PRKCD;NPAS2;MCL1;POLH;ARMT1;ING2;ETAA1;SMYD2;MAPT;HMGA2;UBE2N;BCLAF1;FXR2;NSMCE1;CASP9;SIRT7;WDR76
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.3279387548678734,-0.9433474246135963,0.5072992700729927,0.8497775337983072,1.0,5/17,20.96%,PODXL;TGFB2;NCKAP1L;SKAP1;FOXC2
prerank,protein autoubiquitination (GO:0051865),0.32756459449672026,0.9433385275688987,0.5638418079096045,1.0,1.0,9/61,10.14%,UBE2T;RNF157;PRKN;NFX1;DDB2;BRCA1;RNFT1;CUL3;UHRF2
prerank,cellular response to tumor necrosis factor (GO:0071356),0.29863383565485124,0.9429403535859546,0.6196319018404908,1.0,1.0,23/175,17.33%,CCL11;ADAMTS12;EDA;HAS2;PYCARD;CCL4;ERBIN;BRCA1;PSMB7;ZFP36L2;NFE2L2;PID1;GATA3;PSMD2;ZFAND6;CCL14;PSMC1;PYDC1;TP53;HYAL1;RIPK1;CHUK;PSMB2
prerank,regulation of water loss via skin (GO:0033561),0.42267098224175287,0.9429036706752298,0.5421511627906976,1.0,1.0,3/15,15.14%,CLDN1;HRNR;MET
prerank,establishment of skin barrier (GO:0061436),0.42267098224175287,0.9429036706752298,0.5421511627906976,1.0,1.0,3/15,15.14%,CLDN1;HRNR;MET
prerank,lipid translocation (GO:0034204),-0.3144787657050894,-0.9426921262690782,0.5546558704453441,0.8501263130907644,1.0,12/21,21.48%,ATP10A;ABCA1;ATP9A;ABCA4;ATP11A;ATP8B2;ATP11B;ABCB4;ATP8A1;ATP10B;ABCA7;TMEM30A
prerank,negative regulation of B cell activation (GO:0050869),-0.3039100895142163,-0.9422507920902851,0.5483870967741935,0.8499018818690857,1.0,10/21,25.89%,LYN;PARP3;ID2;INHBA;CD300A;LAPTM5;TNFAIP3;TYROBP;TNFRSF21;INHA
prerank,regulation of biomineral tissue development (GO:0070167),0.3765995826528151,0.9419324840350931,0.5464052287581699,1.0,1.0,3/26,4.09%,ANKH;SOX9;TGFB1
prerank,cell chemotaxis (GO:0060326),0.328949030712742,0.9417809814295958,0.5785876993166287,1.0,1.0,7/60,7.16%,PDGFRA;PRKCQ;LPAR1;VEGFA;EGR3;CCR2;ACKR3
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.42236201753712954,0.9417327781552943,0.5481049562682215,1.0,1.0,4/13,17.45%,UBA2;NAE1;UBA3;UBA1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.3117846322968711,0.9417275716045566,0.5625668449197861,1.0,1.0,40/104,29.12%,SLC27A1;PYCARD;CDKN2B;CCNJ;KSR1;RALB;SLC8A2;PIH1D1;PKMYT1;CDK5R1;SNCA;CALM1;CDK5R2;CALM2;ABL1;BLM;CCND2;RPTOR;HTT;TESK1;CAB39;BCCIP;RB1;PPEF2;CCNH;CCNT2;CIB1;CDC37;CCND3;CDK5RAP3;CDKN1A;EZH2;CCNI;SIRT1;CDKN2D;TELO2;GTPBP4;CCNE1;SNF8;CDKN1B
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.37845898407130435,0.9415869853514683,0.5588235294117647,1.0,1.0,6/22,18.41%,EDEM3;UGGT2;DERL2;EDEM2;UBB;MAN1A2
prerank,negative regulation of autophagy (GO:0010507),0.3332769110765437,0.9415292008921579,0.5566150178784267,1.0,1.0,24/54,28.78%,BCL2;PTPN22;MT3;TSC1;BMF;TLK2;EIF4G1;SNCA;KLHL22;WASHC1;MET;TAB3;STAT3;RRAGA;EIF4G3;NRBP2;TAB2;MTOR;CPTP;SMG1;PIK3CA;DAP;SIRT2;EIF4E
prerank,inositol phosphate biosynthetic process (GO:0032958),0.442354343842904,0.9414827483686037,0.5332326283987915,1.0,1.0,1/11,1.25%,FGF2
prerank,regulation of RNA export from nucleus (GO:0046831),0.43242370435552324,0.9413824100856863,0.5398773006134969,1.0,1.0,2/11,9.84%,CPSF6;SETD2
prerank,negative regulation of interleukin-6 production (GO:0032715),0.3703675860101618,0.9411018011732407,0.5402597402597402,1.0,1.0,4/27,9.88%,PTPN22;IRAK3;SELENOS;SYT11
prerank,microtubule-based transport (GO:0099111),0.4301807110547525,0.9407953141918239,0.5287187039764359,1.0,1.0,4/12,18.45%,DYNC1I1;DYNC1I2;DNAAF2;HTT
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.4186458837124353,0.94067984263222,0.56752655538695,1.0,1.0,3/14,10.12%,CPSF6;NCBP1;FIP1L1
prerank,cellular response to gamma radiation (GO:0071480),0.4019776567518292,0.9400141497285751,0.5651558073654391,1.0,1.0,7/17,17.91%,CRYAB;TLK2;XRCC6;ATM;TP53;WRN;MDM2
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.33151960209103226,0.9399445473167461,0.5601415094339622,1.0,1.0,9/52,15.42%,DDX11;DNAJB9;WIPI1;CXXC1;EXTL3;MYDGF;ARFGAP1;KDELR3;LMNA
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.42968477630011315,0.9399436116190449,0.5417322834645669,1.0,1.0,1/11,1.29%,BACE2
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.384955897087375,-0.9394720111690945,0.5194444444444445,0.8556826477641374,1.0,5/10,14.30%,DKC1;WRAP53;CCT4;CCT6A;CCT8
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.32622170193450284,-0.9392702890741815,0.5373134328358209,0.8549062109692536,1.0,5/17,15.31%,GJA1;KDM1A;PTPRC;HMGA2;TERT
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.4069919376661225,0.9391553291067913,0.5446685878962536,1.0,1.0,6/16,20.78%,CPEB3;ZFP36L2;UPF1;KHSRP;RC3H1;ZFP36
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.28571548540666825,-0.9390760536949749,0.5560165975103735,0.8540777664417445,1.0,5/28,15.26%,PRKAG2;PRKAA2;ADIPOR2;AVIL;FGFR4
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.38160640259380196,0.9388610242565305,0.5425101214574899,1.0,1.0,5/23,12.21%,CBLB;SOCS5;SNX6;CBL;ZGPAT
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.33693785048156766,0.9385597098187078,0.5587878787878788,1.0,1.0,13/47,20.84%,SLC27A1;CD34;ERLIN2;FBXW7;FYN;BRCA1;KHSRP;CRY1;ERLIN1;MPV17L;SIRPA;SNAI1;NFKB1
prerank,lipid droplet formation (GO:0140042),-0.3883243260203789,-0.9376288382737913,0.5504322766570605,0.8564714925087077,1.0,4/10,12.20%,ZFYVE1;CDS1;BSCL2;AUP1
prerank,myofibril assembly (GO:0030239),0.34141996017396026,0.9374250803590534,0.5424133811230586,1.0,1.0,4/42,8.62%,PDGFRA;CSRP1;OBSL1;TNNT3
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.35381879561185026,0.9373553491472674,0.5677339901477833,1.0,1.0,10/37,16.94%,GTF2H2;ERCC5;ERCC4;DDB2;RPA3;XPA;DDB1;RPA2;UBB;CUL4B
prerank,regulation of mRNA polyadenylation (GO:1900363),0.40496962910864165,0.9373198314599474,0.5530085959885387,1.0,1.0,9/17,27.04%,CPSF6;CPEB3;NCBP1;CPEB1;VIRMA;CDK9;CPSF7;RNF20;NELFE
prerank,regulation of macroautophagy (GO:0016241),0.3059830988917357,0.9372414736297695,0.6086021505376344,1.0,1.0,16/105,12.70%,DCN;WAC;CAPN1;ATP6V1B2;TSC1;PRKAB2;BNIP3;LAMTOR2;UCHL1;SNX6;VPS26B;CLEC16A;HDAC6;CDK5R1;TBK1;PRKACA
prerank,membrane organization (GO:0061024),0.29774159487384233,0.9372312105293996,0.6454545454545455,1.0,1.0,45/227,17.51%,ANK3;SGIP1;DNM1;ANK2;REPS2;SNAP23;EGFR;STON2;SPAG4;HACE1;VAMP4;PACSIN2;NPC1;WNT5A;SPTBN1;SYT1;SNAP29;SGCZ;NUP155;ITSN1;EPS15;BIN1;GAK;CNTN2;BTC;HIP1;COX18;VAPA;CBL;HUWE1;TMEM33;RIMS1;EMD;SH3KBP1;OTOF;PDCD6IP;OPA1;UBB;CHMP4C;LRP2;IGF2R;CTTN;SYT2;HBEGF;DYSF
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.361282213378718,0.9371000827663661,0.5509677419354839,1.0,1.0,4/29,13.06%,FADD;AP1G1;CADM1;NECTIN2
prerank,protein targeting (GO:0006605),-0.21072185865708684,-0.9368295491377674,0.6415094339622641,0.8572758125177823,1.0,33/118,17.60%,KIF13B;TOMM70;ZDHHC14;ZDHHC3;TIMM23;SPCS2;LONP2;TRAK1;PARD3;PRKCI;GABARAP;VPS37C;GIPC1;PEX19;AP4E1;ZDHHC18;ZDHHC7;AQP11;MFF;SRPRA;SRP14;RASSF9;ZDHHC20;RPL11;MYO1C;ZDHHC4;ZFAND2A;TOMM7;TIMM9;MICALL1;TIMM17A;TIMM22;TAOK2
prerank,positive regulation of heart contraction (GO:0045823),-0.3127000180608279,-0.9367678930098445,0.5387323943661971,0.856068025537989,1.0,6/19,25.13%,ATP1A2;GSK3A;TGFB2;EDN1;ATP2A2;SCN3B
prerank,cellular response to superoxide (GO:0071451),-0.3778222954102211,-0.9364608144825685,0.5208333333333334,0.8555031648531151,1.0,4/10,11.26%,NOS3;ATP7A;ADPRS;SOD1
prerank,cardiac muscle tissue development (GO:0048738),0.33700522569683766,0.9359456919365711,0.5669383003492433,1.0,1.0,7/50,7.02%,BMP5;AKAP13;SGCD;SCN5A;SGCZ;GATA6;TBX18
prerank,positive regulation of protein phosphorylation (GO:0001934),0.2906792267305984,0.935890720751507,0.6676676676676677,1.0,1.0,74/348,19.26%,RELN;BMP5;CLDN19;DOCK7;NTRK3;FGF2;FGF10;SOX9;NGF;ERBB2;EGFR;ACVR1;EFNA5;WDFY2;VEGFA;ARAF;WNK3;RPS6KA4;TEC;TGFB1;NTRK2;TRAF4;PRNP;GDF9;MT3;MRNIP;TNIK;NIBAN1;PAK1;ALS2;RALB;RAP1A;UBE2K;EIF4G1;ERBB4;FBH1;PTPRJ;PTPN11;BMP7;MAPK1;HDAC6;FGF7;MMD2;MYDGF;TBK1;XRCC6;AKTIP;BRAT1;SNCA;P2RY1;SH2D3C;BMPR1A;CALM1;IQGAP1;RASSF2;CALM2;ABL1;TGFB3;TP53;CCND2;TERF2IP;JTB;APLNR;RIPK1;CD74;S1PR2;RPTOR;CSPG4;FNIP1;PARK7;MAPRE3;KRAS;SEMA4D;TESK1
prerank,regulation of insulin secretion (GO:0050796),0.30974735536407494,0.9358258070093975,0.585945945945946,1.0,1.0,15/101,13.84%,PRKCA;CACNA1E;IRS2;STXBP4;PRKN;EFNA5;CACNA1A;RFX3;PPP3CB;RAP1A;ENSA;SLC2A2;CDK16;TM7SF3;DOC2B
prerank,negative regulation of immune response (GO:0050777),0.2985359171889742,0.9357727660191972,0.6195426195426196,1.0,1.0,13/154,8.39%,LGALS3;CRH;DPEP1;IRAK3;PTHLH;PRKAR1B;CCR2;PTH2R;SAMSN1;COL3A1;FYN;TSHR;PPM1B
prerank,RNA export from nucleus (GO:0006405),0.3104795525476578,0.9357059308474298,0.593681917211329,1.0,1.0,35/100,26.01%,THOC6;RANBP2;NUP155;SRSF11;MCM3AP;CASC3;ALKBH5;NCBP1;FIP1L1;NDC1;NUP205;NUP160;UPF1;DDX25;NXT1;SRSF6;YTHDC1;SMG6;POM121;AAAS;NXF1;RNPS1;THOC7;SRRM1;FYTTD1;SRSF3;GLE1;NUP42;SYMPK;XPO5;THOC5;MAGOHB;NUP35;RAE1;HNRNPA2B1
prerank,sodium ion import across plasma membrane (GO:0098719),-0.3267941829672524,-0.9356908542665687,0.5547703180212014,0.8561221441665714,1.0,5/17,11.85%,SLC9A6;SLC9A2;SLC9A9;SLC9A7;SLC6A1
prerank,positive regulation of vacuole organization (GO:0044090),0.4460427225905491,0.9356591567165419,0.5765765765765766,1.0,1.0,4/10,20.43%,RALB;GRN;RAB3GAP2;RAB3GAP1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.3069200702171363,0.9356222844601115,0.6189473684210526,1.0,1.0,21/119,14.25%,PLEKHA4;SLC27A1;INPP4B;FGF2;PTEN;RAB14;SOCS5;MTMR14;PTPN13;SOCS1;PI4KB;VAC14;PIGC;PIK3R1;PIGP;PI4K2A;MTMR12;PIGN;PIGA;RAB4A;TTC7A
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.43841449647992525,0.9349313199072177,0.5482388973966309,1.0,1.0,3/11,14.44%,RASA1;PCBP4;NOVA1
prerank,translational termination (GO:0006415),0.3093650108961881,0.9347516041978878,0.6078431372549019,1.0,1.0,28/95,22.77%,MRPL47;MRPS18A;ETF1;MRPL14;MRPL32;MRPL16;MRPL58;MRPS35;MRPS28;AURKAIP1;MRPL35;GSPT2;MRPL28;MRPL30;TRMT112;MRPL46;MRPL51;MRPS30;N6AMT1;MRPS14;MRPL1;DAP3;MRPS9;MRPS31;MRPS6;PTCD3;MRPL52;MRPL18
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.4128291110078338,0.9346333414251486,0.5525568181818182,1.0,1.0,5/15,20.99%,NGF;NTRK2;NGFR;GRB2;SOS1
prerank,proteasome assembly (GO:0043248),-0.3700183544657364,-0.9343466664493489,0.5083798882681564,0.8582657704189192,1.0,5/11,28.94%,OTUD6B;PSMG2;PSMG1;ADRM1;PSMD10
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.29221081208260624,-0.9343168070863677,0.5564516129032258,0.8569892905086068,1.0,10/25,31.44%,KIT;SLC7A5;CD55;MAP3K7;LAPTM5;SPHK2;NOD2;LACC1;TRIM6;FZD5
prerank,regulation of striated muscle contraction (GO:0006942),0.36594678203927833,0.9341288063615129,0.5587096774193548,1.0,1.0,6/27,15.36%,MYBPH;ANK2;TNNT3;PRKACA;CALM1;CALM2
prerank,response to cytokine (GO:0034097),0.29955527438064955,0.9340699749186954,0.5981112277019937,1.0,1.0,22/141,14.38%,AFF3;PRKCA;BCL2;KYNU;IL1RAPL1;PTPN2;IRAK3;MAPKAPK3;MAPKAPK2;IL1RL2;PTPN13;COL3A1;SETD2;PTPN11;AKAP6;PID1;IL6ST;TAF9;TBK1;PTPN18;SNCA;KHSRP
prerank,calcium import into the mitochondrion (GO:0036444),-0.38285948839770717,-0.9339961853417046,0.5512465373961218,0.856480322940185,1.0,3/10,16.53%,MICU1;MCUB;MICU3
prerank,protein prenylation (GO:0018342),-0.3734158548152772,-0.9337520654969682,0.5316091954022989,0.8557581186719081,1.0,6/10,30.22%,PGGT1B;CHML;FNTB;RCE1;FNTA;RABGGTA
prerank,regulation of organelle assembly (GO:1902115),0.31810533596671353,0.9334501069083235,0.5870307167235495,1.0,1.0,16/72,14.66%,TBC1D10A;GSN;NPRL2;IFT140;ATXN2;CDKL5;SDCCAG8;ATG5;TBC1D19;VPS11;CEP295NL;ATG3;USP6NL;TBC1D20;CEP76;PDCD6IP
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.3224811916994484,0.9332571195066821,0.5838150289017341,1.0,1.0,17/67,15.32%,SULF1;VEGFA;MAPKAPK3;NCF1;MAPKAPK2;BAIAP2;BRK1;FYN;VAV3;DOCK1;NCF2;PIK3R1;MAPK14;NRP2;NCK1;CYFIP1;ELMO1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.3790850058000337,-0.9330469783171004,0.5214899713467048,0.856243849970301,1.0,7/11,29.73%,SERTAD2;SMARCD1;PADI2;SERTAD1;ELOF1;CDCA4;CHEK1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.4213417659984895,0.9323748470754961,0.5368421052631579,1.0,1.0,4/13,15.05%,SPRED2;SPRED1;SPRED3;ATM
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.3781861973505396,0.9321013464934108,0.5460893854748603,1.0,1.0,3/22,10.30%,CRLF3;CYP1B1;ERBB4
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.3856820898586295,0.9320505298826466,0.5416666666666666,1.0,1.0,4/20,11.05%,PKDCC;TGFB1;CSK;PID1
prerank,RNA 3'-end processing (GO:0031123),0.31794659435461614,0.9319267822383978,0.5863228699551569,1.0,1.0,22/69,24.99%,CSTF3;THOC6;RPRD1A;TUT4;SRSF11;CASC3;NCBP1;FIP1L1;SRSF6;PAPOLA;PNPT1;RNPS1;THOC7;TENT2;SRRM1;SRSF3;SYMPK;TUT1;THOC5;SUPV3L1;CPSF7;MAGOHB
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.45340126249367707,0.9319147806372423,0.5641838351822503,1.0,1.0,4/10,18.78%,CACNA2D1;PDE4B;CALM1;NOS1AP
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.27300779441571726,-0.9314456441357007,0.6329113924050633,0.8589767523759886,1.0,7/31,12.68%,SMAD7;ENG;TGFBR1;TPM1;FGFR2;PROX1;TGFB2
prerank,stress-activated MAPK cascade (GO:0051403),-0.23601344882451938,-0.931198610989465,0.5606060606060606,0.8582488603452544,1.0,21/61,24.90%,MAP3K5;TNFRSF19;MAP3K20;MAP2K3;MAP3K8;ZFP36L1;ARHGEF6;GPS2;MAP3K7;UBE2N;IKBKB;IKBKG;TAOK2;MINK1;MAPK10;CRKL;NOD1;MAP3K13;GPS1;MAPK8;UBA52
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.3603801770041024,0.9310674997320042,0.5683544303797469,1.0,1.0,4/30,8.78%,BMP5;FADD;TNFRSF10B;BRCA1
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.4470421414267307,0.9307927227213068,0.5514018691588785,1.0,1.0,3/10,13.01%,VEGFA;DISC1;DRD2
prerank,cellular response to osmotic stress (GO:0071470),0.3844282297535354,0.9305634065227408,0.5743243243243243,1.0,1.0,4/21,9.24%,SCN2A;WNK3;LRRC8D;STK39
prerank,regulation of exit from mitosis (GO:0007096),0.34463293995610594,0.930184270593639,0.5770653514180024,1.0,1.0,14/38,23.20%,ANAPC7;ANAPC2;BUB1B;CDC14A;UBB;CDC23;ANAPC16;ANLN;CDC27;UBE2E1;PHB2;ANAPC4;ANAPC5;CDC16
prerank,myoblast fusion (GO:0007520),0.42499608133098343,0.9301772587087465,0.5263975155279503,1.0,1.0,4/12,21.93%,ADGRB3;CD9;ADAM12;CACNA1H
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.4344003627464226,0.9300364643332953,0.5740131578947368,1.0,1.0,1/11,1.12%,SLC27A1
prerank,L-amino acid transport (GO:0015807),0.36932211181603125,0.929947843720153,0.5823899371069182,1.0,1.0,5/28,13.27%,SLC1A3;SLC36A2;ARL6IP5;SLC7A8;PRAF2
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.41444945104094466,0.9297911496183052,0.5636896046852123,1.0,1.0,2/14,8.10%,CARD9;IL18
prerank,regulation of interleukin-4 production (GO:0032673),-0.3097173247437217,-0.9297659912900961,0.5769230769230769,0.8605173127353712,1.0,8/21,20.51%,LEF1;SLC7A5;PRKCZ;CD86;ZFPM1;HAVCR2;RARA;FCER1G
prerank,regulation of ATP metabolic process (GO:1903578),-0.238555396374785,-0.9292331982238882,0.5897435897435898,0.860550826093082,1.0,15/54,19.08%,PRKAG2;NUP93;NUP107;ATP7A;OGT;SLC25A33;PGAM1;NUP214;NUP43;NUP210;NUP88;PINK1;BEND3;NUP98;AK4
prerank,phagosome acidification (GO:0090383),0.3720504747416219,0.9291427224861882,0.5647668393782384,1.0,1.0,11/26,27.11%,RAB38;ATP6V1B2;RAB39A;RAB7A;ATP6V1C1;ATP6V0E2;ATP6V0E1;ATP6V1G2;ATP6V1H;TCIRG1;ATP6V1D
prerank,positive regulation of DNA recombination (GO:0045911),-0.28821963781897103,-0.9288430937390142,0.5367965367965368,0.8601620067904387,1.0,11/27,24.41%,RIF1;MMS19;PARP1;TFRC;WRAP53;ERCC2;PAXIP1;ERCC6;FANCB;TIMELESS;MAD2L2
prerank,error-prone translesion synthesis (GO:0042276),0.3767355905811148,0.9287305172450743,0.56,1.0,1.0,6/21,17.19%,POLE2;REV3L;RPA3;RPA2;UBB;REV1
prerank,negative regulation of receptor binding (GO:1900121),-0.36982215220173126,-0.9283437588570241,0.5522788203753352,0.8600520150075437,1.0,4/10,24.00%,ADAM15;ATP2A3;HFE;ATP2A2
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.42446354312944584,0.928029483255381,0.559375,1.0,1.0,6/13,24.63%,PABPC1;CPEB3;POLR2G;EIF4ENIF1;ZFP36;TNRC6A
prerank,cellular response to amyloid-beta (GO:1904646),0.34909787707504925,0.9276828986730887,0.5871794871794872,1.0,1.0,9/35,10.82%,CACNA2D1;LRP1;CACNA1A;PSEN1;PRNP;FYN;SNX6;GRM5;NGFR
prerank,organic cation transport (GO:0015695),0.3812382680937111,0.9273780148399487,0.5740479548660085,1.0,1.0,3/20,8.83%,SLC22A3;SLC44A2;SEC14L1
prerank,brain morphogenesis (GO:0048854),0.4184941320809068,0.9271932062063161,0.5357142857142857,1.0,1.0,4/12,18.45%,PTEN;CTNNA2;PAX2;SLC6A4
prerank,regulation of protein binding (GO:0043393),-0.2057725764303823,-0.926964496981228,0.7301587301587301,0.8621924109299371,1.0,34/114,20.69%,DAB2;ROCK1;CLDN5;VTN;PRKCD;BMP4;EPB41;IFIT2;KDM1A;PRMT7;NVL;APP;CAMK1;GSK3B;RACK1;MARK2;HDAC4;SNAPIN;PRMT8;RPL11;STK3;PEX14;CAV1;TERT;FLOT1;HIP1R;GTF2F1;TRIM21;ZFPM1;HFE;CFHR2;MARK3;IFIT1;ADD2
prerank,transepithelial transport (GO:0070633),0.40996225926282537,0.9267429214595408,0.5530085959885387,1.0,1.0,4/15,16.94%,SLC1A3;SLC12A2;GPLD1;ABCC1
prerank,regulation of protein phosphorylation (GO:0001932),0.2914832167862396,0.9267202283646834,0.6743718592964824,1.0,1.0,42/256,14.21%,CLDN19;NTRK3;FGF2;PIP5KL1;FGF10;PTEN;SOX9;ERBB2;BST1;PRKN;EGFR;EFNA5;WDFY2;VEGFA;EPHB2;CADM4;EIF2AK3;TGFB1;NTRK2;PRNP;MT3;PTPN13;TNIK;NIBAN1;PAK1;SOCS1;RALB;MEN1;FYN;GRM5;ERBB4;FBH1;PID1;BMP7;FGF7;MYDGF;WWTR1;AKTIP;BRAT1;BMPER;PDCL3;P2RY1
prerank,cellular amide metabolic process (GO:0043603),0.30653487507460747,0.9266404321325982,0.6133190118152524,1.0,1.0,26/102,21.33%,THEM4;MIPEP;OXSM;ALDH1L1;MCCC1;HLCS;ACOT11;MTRR;ACSF2;MCCC2;THOP1;PLAAT5;MTHFD2L;PLAAT3;CPD;GNE;ALDH1L2;ABCB9;ACSL6;GPAT4;GLYAT;PLA2G4E;DBI;SLC25A32;ACOT8;ACBD6
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.372801187417369,0.9265944881625333,0.5824607329842932,1.0,1.0,11/23,21.10%,WNK3;TGFB1;UBE2K;BMP7;MAPK1;CALM1;CALM2;S1PR2;RPTOR;CAB39;CEMIP
prerank,regulation of response to external stimulus (GO:0032101),0.297052713018215,0.9264397385733205,0.610062893081761,1.0,1.0,25/121,18.64%,ADAMTS12;PDGFRA;RHO;PTPN22;BST1;EPHB2;ELMOD2;IL1RL2;WNT5A;CCR2;GATA6;UFL1;CASP12;GRN;SHPK;P2RY12;USP14;CALM1;AREL1;XIAP;PTGES;EFNB2;N4BP1;SPAAR;PARK7
prerank,DNA strand elongation (GO:0022616),-0.3181183689769529,-0.9263896988756016,0.5759717314487632,0.8623239247267398,1.0,11/18,30.62%,POLD3;POLA1;TERT;DCLRE1B;RFC3;NBN;GINS4;POLD2;MRE11;GINS1;MCM3
prerank,regulation of phosphatase activity (GO:0010921),0.3746381631906353,0.9262786261147985,0.5419440745672437,1.0,1.0,12/24,28.32%,URI1;TSC1;HSP90B1;TIPRL;HTT;ZCCHC9;BMP2;PPP6R2;PPP6R1;CDK5RAP3;GPATCH2;CHP1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.3367980969405248,-0.9259163171279621,0.5314465408805031,0.8622162232162469,1.0,7/14,20.69%,NOS3;ACE;ENPEP;AGTR1;ECE1;EDN1;ACE2
prerank,negative regulation of apoptotic process (GO:0043066),0.2854941021764573,0.9258096037900845,0.714,1.0,1.0,95/444,18.64%,FFAR4;PRKCA;ERBB3;SOX8;MYC;RNF157;BCL2;DPEP1;SOX9;CRLF1;NGF;PRKN;EGFR;MAP4K4;FMN2;VEGFA;EGR3;ARAF;THOC6;WNK3;TLE1;PSEN1;ERCC5;FANK1;NTRK2;MT3;WNT5A;YWHAZ;RASA1;NAA35;SON;GATA6;NAA16;CBX4;BNIP3;FLNA;CRYAB;ASNS;SNX6;UBE2Z;PRDM9;PIK3R1;HDAC2;GDNF;CBL;ARF4;NGFR;IL6ST;TAF9;DNAJB6;MAPK1;SFPQ;MYDGF;TAX1BP1;GRN;PTPRZ1;PRLR;PRDX3;SOD2;HSP90B1;ATF5;YME1L1;MALT1;SNCA;PSEN2;AREL1;OPA1;ZFAND6;ITGB1;CITED2;CASP2;UBB;BNIP1;PIM2;UBE2O;TGFB3;FZD9;HTATIP2;XIAP;TP53;CCND2;LRP2;PAX2;RIPK1;CD74;MDK;PCID2;DNAJA1;HSPA9;CSNK2A2;FNIP1;CAT;NAA15;AATF;PARK7
prerank,regulation of microtubule polymerization (GO:0031113),-0.26254182636372997,-0.9254136745436883,0.6107784431137725,0.8622195585577529,1.0,12/40,16.65%,CDH5;MAP2;OCLN;DRG1;CLIP1;CLIP3;EML2;DCTN1;NUMA1;MAPT;PRUNE1;TBCD
prerank,regulation of viral transcription (GO:0046782),0.34113633654297504,0.9252617450036815,0.583969465648855,1.0,1.0,12/39,24.53%,MDFIC;POLR2B;TRIM11;POLR2K;MID2;POLR2G;POLR2A;ZFP36;CDK9;UBP1;POLR2F;TRIM14
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.3337775917441326,-0.9251566497148633,0.5326460481099656,0.8615681784801803,1.0,3/15,3.27%,ZDHHC3;STXBP1;NLGN2
prerank,regulation of viral release from host cell (GO:1902186),-0.30991697653974815,-0.9250770309507259,0.5571428571428572,0.860424704649978,1.0,7/21,17.93%,CHMP3;TSG101;TRIM25;TRIM5;VPS4A;PML;TRIM21
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.26806180263357227,-0.9250087951987895,0.5960591133004927,0.8592796524586657,1.0,9/33,13.05%,ACER2;LYN;JAM3;DPP4;EPHA8;SERPINE1;NEXMIF;TGFB2;NCKAP1L
prerank,vascular transport (GO:0010232),0.310598199688711,0.9246228897783695,0.6,1.0,1.0,10/81,5.57%,SLC22A3;SLC1A3;SLC27A1;SLC1A5;LRP1;SLC5A3;SLC27A4;SLC12A2;SLCO2B1;SLC29A1
prerank,pore complex assembly (GO:0046931),-0.31002239055962094,-0.9244348554683978,0.5598591549295775,0.859341631465058,1.0,7/19,19.06%,AFDN;NUP93;NUP107;ADAM10;PDZD11;GSDMD;NUP98
prerank,cytokine-mediated signaling pathway (GO:0019221),0.2861250059709967,0.9243848633410054,0.751,1.0,1.0,80/532,18.26%,RORA;CCL11;MMP2;EDA;IL16;CXCL10;SLC27A1;IL2RA;FGF2;PYCARD;MYC;BCL2;IRS2;IL20RB;CRLF1;HNRNPDL;VEGFA;MAP3K3;IRAK3;RPS6KA4;SOCS5;TEC;TGFB1;CCL4;ZEB1;MT3;PLCB1;IL1RL2;NUMBL;CCR2;SOCS1;YWHAZ;RORC;CSK;CSF3R;ACKR3;GAB2;PELI1;IL18;FYN;PSMB7;COL1A2;AIP;HIF1A;NDN;PIK3R1;PTPRJ;CBL;TYK2;PTPN11;IL6ST;TOLLIP;PTPRZ1;PRKACA;PRLR;SOD2;HSP90B1;GATA3;TXLNA;IL33;PSMD2;ITGB1;CCL14;UBB;FSCN1;PSMC1;BCL2L11;PYDC1;TP53;IL1RAP;LBP;RIPK1;CHUK;PSMB2;MTAP;MID1;BATF;IRF3;PTAFR;HSPA9
prerank,mRNA export from nucleus (GO:0006406),0.30387852814250305,0.924213577010494,0.6075268817204301,1.0,1.0,36/102,26.01%,THOC6;RANBP2;NUP155;SRSF11;MCM3AP;CASC3;ALKBH5;NCBP1;FIP1L1;NDC1;NUP205;NUP160;UPF1;DDX25;NXT1;SRSF6;YTHDC1;SMG6;POM121;AAAS;NXF1;RNPS1;PCID2;THOC7;SRRM1;FYTTD1;SRSF3;GLE1;NUP42;SYMPK;THOC5;MAGOHB;ENY2;NUP35;RAE1;HNRNPA2B1
prerank,regulation of mRNA metabolic process (GO:1903311),0.4232566751093728,0.924068639100818,0.5446009389671361,1.0,1.0,3/11,24.12%,NCBP1;SLTM;SAFB2
prerank,positive regulation of cell differentiation (GO:0045597),0.2910834838743669,0.9240008428404144,0.6622851365015167,1.0,1.0,38/237,11.60%,FFAR4;SOX6;GLIPR2;PKDCC;CD34;SOX9;NGF;FRZB;ACVR1;XKR8;WDFY2;NRCAM;GPRC5B;TGFB1;SOX11;ZEB1;PLCB1;CTNNA2;HOXD3;TGFBR2;LMO3;ZBTB16;FGFR1;RAP1A;IL18;SOX5;PPP1R13L;CARM1;MAPK9;EDN3;BCL9L;GDNF;MAPK14;IL6ST;BMP7;GPC1;ATRAID;MMD2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.3072720171188863,-0.9239893569774692,0.5466666666666666,0.8591465208598851,1.0,5/21,8.90%,MICU1;SLC8A3;SLC8B1;TGM2;MCUB
prerank,DNA repair (GO:0006281),0.29137504110890483,0.9239625152615234,0.6878147029204431,1.0,1.0,59/284,16.94%,UBE2T;RAD23B;POLN;ZRANB3;APTX;MBD4;POLE2;GTF2H2;CHRNA4;ERCC5;NSMCE3;MPG;ERCC4;KDM4B;DDB2;RPA3;NUDT1;MUTYH;MEN1;XPA;BRCA1;TDP1;ALKBH5;REXO4;SETD2;ENDOV;FBH1;NEIL1;HUWE1;ASF1A;FANCC;MSH6;NSD2;UPF1;ERCC6L2;XRCC3;ZBTB1;DDB1;MDC1;HPF1;EXD2;PDS5B;RPA2;TOPBP1;SUMO1;BAZ1B;SMUG1;ATM;RAD52;UBB;ABL1;TRRAP;BLM;CSNK1E;TP53;USP1;FANCI;FAM111A;CUL4B
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.32967787883315275,-0.9234627147775247,0.6111111111111112,0.8591747628376118,1.0,12/16,51.99%,TYROBP;TNFRSF21;DLL1;VSIR;AGER;LILRB1;PDCD1LG2;IL23A;FOXP3;TRIB2;IL12B;IL23R
prerank,glycolytic process (GO:0006096),-0.27514344247360656,-0.9231675329081009,0.5805084745762712,0.8585373519199808,1.0,12/28,30.18%,PGK1;GPI;PGAM1;PGAM4;PFKM;PFKL;ENO1;GAPDHS;ENO3;PKM;PFKFB2;LDHA
prerank,intestinal absorption (GO:0050892),-0.3514597637365523,-0.923120299670589,0.5614035087719298,0.8573567790519252,1.0,4/13,20.71%,TJP2;ADRA2A;UGCG;SLC26A6
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.32769984443181344,-0.9230930483378533,0.5277777777777778,0.8561478772549066,1.0,2/16,2.05%,ST6GALNAC3;ST8SIA4
prerank,zinc ion transport (GO:0006829),-0.304034980258165,-0.9229103724781145,0.5745454545454546,0.8553334572596498,1.0,9/21,26.72%,SLC30A10;SLC39A8;SLC30A1;SLC39A6;SLC30A6;SLC39A3;TRPM2;SLC39A13;SLC39A1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.4135921604864667,0.9228339423905967,0.5593471810089021,1.0,1.0,3/13,11.11%,CHRDL1;LTBP1;DAND5
prerank,steroid metabolic process (GO:0008202),0.3171280286909121,0.9225113999950427,0.6117381489841986,1.0,1.0,16/72,25.24%,HSD17B7;NPC1;GBA2;CYP39A1;CYP1B1;CYP7B1;PRLR;CYP27A1;LRP2;TSPO;SCP2;GC;HSD17B4;SULT1A1;STARD3;AMACR
prerank,integrated stress response signaling (GO:0140467),0.4135645052761777,0.922401452331536,0.5607613469985359,1.0,1.0,4/14,16.48%,EIF2AK3;HERPUD1;NFE2L2;QRICH1
prerank,cellular senescence (GO:0090398),-0.27297326706460756,-0.9223732981853201,0.5596707818930041,0.8553354420748276,1.0,12/27,26.15%,PRKCD;TBX3;TERF2;MAP2K1;ID2;PML;HMGA2;ECRG4;ULK3;CALR;HRAS;SRF
prerank,regulation of neuron death (GO:1901214),0.311543226352846,0.9220830417222342,0.6087912087912087,1.0,1.0,20/82,19.78%,CD34;PRKN;PRNP;GRIN2B;WNT5A;GRID2;TSC1;TRIM2;NAE1;FYN;DCC;EIF4G1;TBK1;SNCA;UBB;EFNB2;PARK7;SNCB;EGR1;BTBD10
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.42797644888080044,0.9219033485616374,0.5718701700154559,1.0,1.0,5/11,25.53%,DDX11;PIH1D1;SMARCA4;MTOR;SMARCB1
prerank,RNA catabolic process (GO:0006401),0.33076014807233556,0.9218487496057893,0.5983213429256595,1.0,1.0,8/46,12.49%,RNASE6;DXO;METTL3;XRN2;PPP1R8;ZFP36L2;NCBP1;RNASEH2C
prerank,meiosis I (GO:0007127),0.3684452755057271,0.9212592526321193,0.563013698630137,1.0,1.0,7/23,22.56%,MEIOB;SGO1;BCL2L11;FOXJ3;ZSCAN21;PTTG1;DDX4
prerank,positive regulation of ERAD pathway (GO:1904294),0.41791478596837583,0.9212062825798493,0.5541125541125541,1.0,1.0,7/13,23.35%,RNFT1;HERPUD1;NFE2L2;USP13;SGTA;UBQLN1;UBQLN2
prerank,negative regulation of protein transport (GO:0051224),0.3688815286882887,0.9211845172701161,0.5885558583106267,1.0,1.0,5/25,16.97%,PKDCC;CSK;DRD2;NDFIP1;SNX12
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.36777556013903917,0.9211080456262517,0.568,1.0,1.0,14/24,31.19%,EED;CREBZF;JARID2;EPC1;RBBP4;PHF19;RBBP7;MPHOSPH8;AEBP2;EZH2;DNMT1;SMYD5;DNMT3B;PPHLN1
prerank,calcium ion homeostasis (GO:0055074),0.3072982403579472,0.9211074296624244,0.6229685807150596,1.0,1.0,13/95,13.86%,CCL11;ANK2;TMTC2;ATP2B3;CCR2;SLC8A2;SLC24A5;SLC10A7;EDN3;HTR2C;ATP2B1;TPCN2;SNCA
prerank,glucan biosynthetic process (GO:0009250),0.43215784604098084,0.920340360193431,0.6,1.0,1.0,7/12,31.30%,PGM1;GYS1;PGM2;GYG1;PER2;NR1D1;UGP2
prerank,glycogen biosynthetic process (GO:0005978),0.43215784604098084,0.920340360193431,0.6,1.0,1.0,7/12,31.30%,PGM1;GYS1;PGM2;GYG1;PER2;NR1D1;UGP2
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.322176601278497,0.9202016473598499,0.5832376578645235,1.0,1.0,15/57,17.44%,WAC;TIPIN;MRNIP;BRCA1;ATF2;TAOK3;STK33;MDC1;RPA2;TOPBP1;ATM;RPS27L;BLM;TP53;FBXO31
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.3280880691596056,-0.9199177924980542,0.5584795321637427,0.8601802092082896,1.0,3/13,4.68%,NFIB;BMP4;PPARD
prerank,cellular response to UV (GO:0034644),0.3154592305466395,0.9196619368381281,0.5978021978021978,1.0,1.0,24/76,24.86%,MMP2;MYC;NSMCE3;ERCC4;DDB2;METTL3;BMF;PPID;XPA;ZBTB1;DDB1;TP53;HYAL1;CUL4B;N4BP1;TAF1;RUVBL2;RHBDD1;ACTR5;CARD16;ATR;FMR1;USP28;RHNO1
prerank,DNA replication checkpoint signaling (GO:0000076),0.4048232246562684,0.919628409146865,0.5811001410437235,1.0,1.0,4/16,14.31%,TIPIN;NAE1;ORC1;TOPBP1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.3281804292872511,0.9189688596280764,0.6048951048951049,1.0,1.0,7/51,11.33%,CXCL10;VEGFA;ANO6;CCR2;PLA2G7;EDN3;MAPK1
prerank,regulation of chemotaxis (GO:0050920),0.35554689284966534,0.9189590454888515,0.5869281045751634,1.0,1.0,7/30,16.79%,PDGFRA;PTPN2;TGFB1;P2RY12;USP14;ZSWIM8;EFNB2
prerank,ureteric bud development (GO:0001657),0.39220945805978313,0.9188129255317207,0.5747126436781609,1.0,1.0,1/17,0.28%,GPC3
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.4009359544494686,0.9185619729605123,0.5703918722786647,1.0,1.0,2/15,6.31%,PTPN2;METTL3
prerank,cytoplasmic microtubule organization (GO:0031122),-0.2403768277561192,-0.9184899808466269,0.6158536585365854,0.8624556871008766,1.0,16/54,16.74%,CLIP4;CLIP1;CLIP3;FIGNL2;TUBGCP4;TUBGCP3;TUBGCP6;WDR73;RHOA;DCTN1;NUMA1;MAPT;TRPV4;CCDC88C;VPS4B;TUBGCP2
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.26897399680412065,-0.9184385979314857,0.5982905982905983,0.8612998944114706,1.0,15/34,30.69%,MFHAS1;LYN;TLR4;GPS2;LGR4;GPR108;LRRC14;CD300A;GRAMD4;CACTIN;NLRP2B;TNFAIP3;TYRO3;SMPDL3B;TLR3
prerank,mRNA metabolic process (GO:0016071),0.30476003645968,0.9182510523732476,0.6063249727371864,1.0,1.0,18/90,17.56%,CSTF3;DXO;CPSF6;METTL3;SON;SRSF11;AURKAIP1;ZFP36L2;ALKBH5;NCBP1;SFPQ;LSM3;PRKACA;PRPF18;TP53;PNPT1;SF3A1;SSB
prerank,negative regulation of hormone secretion (GO:0046888),-0.37599547507206954,-0.9181857515448375,0.5936599423631124,0.8605987108352177,1.0,1/10,1.39%,GJA1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.32882279196539344,0.9178801158586154,0.6019300361881785,1.0,1.0,23/50,30.22%,CDKN2B;CCNJ;PKMYT1;CDK5R1;TTBK1;CDK5R2;BLM;CCND2;BCCIP;CCNH;CCNT2;CDC37;CCND3;CDK5RAP3;CDKN1A;CCNI;CDKN2D;GTPBP4;CCNE1;CDKN1B;CDKN1C;CAMK2N1;CDC25A
prerank,proton transmembrane transport (GO:1902600),-0.256719087747349,-0.9176852331860913,0.6182795698924731,0.8605545330276623,1.0,7/36,15.36%,ATP1A2;ATP6V0C;ATP6V0D1;ATP1A1;ATP6V0A4;ATP5MF;NNT
prerank,regulation of rRNA processing (GO:2000232),0.3971553155644791,0.9175729668078698,0.5741279069767442,1.0,1.0,4/16,12.92%,KAT2B;SHQ1;HEATR1;TRMT112
prerank,transport across blood-brain barrier (GO:0150104),0.30880085060380685,0.917540736508696,0.6091205211726385,1.0,1.0,10/83,5.57%,SLC22A3;SLC1A3;SLC27A1;SLC1A5;LRP1;SLC5A3;SLC27A4;SLC12A2;SLCO2B1;SLC29A1
prerank,cellular response to interferon-beta (GO:0035458),-0.3347122813387494,-0.9172253844388762,0.5439093484419264,0.8603594570761398,1.0,7/14,23.30%,AIM2;IRGM;IRF1;IFITM2;UBE2G2;HTRA2;CDC34
prerank,activation of protein kinase activity (GO:0032147),0.30002979700725346,0.9170447958913569,0.6247288503253796,1.0,1.0,15/106,8.10%,NTRK3;MAP4K4;VEGFA;PAK4;TNFRSF10B;PAK5;MT3;PRKAR1B;WNT5A;TNIK;PAK1;MAPKAP1;TGFBR2;PRRC1;IL18
prerank,retina homeostasis (GO:0001895),-0.2953494455211506,-0.9162216794707951,0.5563636363636364,0.8615984362375246,1.0,9/23,39.03%,POC1B;SOD1;ACTG1;HSPB1;TULP1;CDH3;CNGB1;JCHAIN;CRB2
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.28030716086494567,-0.9157804717982273,0.5826086956521739,0.8613444667617651,1.0,6/29,14.28%,SMAD7;ENG;TPM1;FGFR2;PROX1;S1PR1
prerank,nitric oxide metabolic process (GO:0046209),0.4116739021856976,0.9157531478772137,0.5788690476190477,1.0,1.0,2/14,5.48%,NQO1;CYP1B1
prerank,motor neuron axon guidance (GO:0008045),-0.3328188266776414,-0.9154019346646609,0.5736196319018405,0.8610152536477681,1.0,3/15,6.20%,EPHA4;SLIT2;TMEFF1
prerank,establishment of spindle localization (GO:0051293),0.4040438665627858,0.9153601402475764,0.5537065052950075,1.0,1.0,5/14,23.30%,CLASP1;KPNB1;LLGL1;DYNC1H1;ZBED3
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.2901733927790391,0.9151938870160609,0.6649590163934426,1.0,1.0,42/186,19.85%,SOSTDC1;TPBGL;TAX1BP3;RBMS3;LRP4;SOX9;VGLL4;LRP1;PRKN;FRZB;JADE1;TLE1;WIF1;GLI1;WNT5A;SHISA2;DKK3;PSMB7;SFRP4;CUL3;TMEM131L;PRICKLE1;EMD;DVL1;APC2;CSNK1A1;KLHL12;WWTR1;PSMD2;SCYL2;DACT1;PSMC1;WWOX;TLE3;MDK;PSMB2;TLE4;NKD2;PSMD9;RUVBL2;PSME4;KREMEN1
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.289728957136816,0.9151142981723229,0.6666666666666666,1.0,1.0,38/172,20.65%,PLEKHA4;SLC27A1;INPP4B;FGF2;PTEN;RAB14;PLD1;MTMR14;SLC44A2;PTPN13;AGPAT2;PI4KB;VAC14;PLA2G12A;PTDSS1;PIK3R1;PI4K2A;SELENOI;FAR1;MTMR12;PCYT1B;ETNK1;CHPT1;AGPAT5;RAB4A;CHAT;GPAT3;CPNE7;PIP5K1A;GPAT4;AGK;SLC44A1;CSNK2A2;LPCAT2;CPNE1;STARD7;INPP5J;DDHD1
prerank,ERAD pathway (GO:0036503),0.3077575408124757,0.9151104460461796,0.613882863340564,1.0,1.0,32/83,26.52%,PRKN;ERLIN2;DNAJB9;RHBDD2;UGGT2;RCN3;DERL2;FBXO27;SELENOS;HERPUD1;UBE2J2;RNF121;FBXO17;TMUB2;HSP90B1;CCDC47;JKAMP;ERLIN1;DNAJC10;USP13;SGTA;RHBDD1;UBXN6;UBQLN1;FBXO44;UBQLN2;ERLEC1;MAN1B1;UBXN8;TMEM67;UBE2J1;SGTB
prerank,aspartate family amino acid metabolic process (GO:0009066),0.3970737993879944,0.9149655904429623,0.5822603719599427,1.0,1.0,5/18,13.16%,NAALAD2;SMS;GOT2;ASNS;ADI1
prerank,protein autophosphorylation (GO:0046777),0.29407159878236344,0.9143852067026076,0.6771488469601677,1.0,1.0,23/157,10.36%,WNK2;PDGFRA;PEAK1;ERBB2;EGFR;PRKX;MAP3K3;WNK3;EIF2AK3;SIK2;TEC;MAPKAPK3;NTRK2;MAPKAPK2;TNIK;EEF2K;PAK1;CDKL5;FGFR1;STK39;PASK;ERBB4;SLK
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.3871036524844411,0.9141388775569828,0.5534407027818448,1.0,1.0,5/17,12.96%,MAPK7;BAG5;NFE2L2;SFPQ;SOD2
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.3314536236255709,0.9136770385690256,0.608433734939759,1.0,1.0,19/47,26.19%,OLFM4;EFNA5;DOCK5;FLNA;DOCK1;MYOC;ABL1;MDK;AP1AR;RAC3;TESK1;KANK1;TRIOBP;SPRY4;CRK;CIB1;ARHGEF7;LIMS1;CORO1C
prerank,positive regulation of dephosphorylation (GO:0035306),0.35904885495211425,0.9134631881143638,0.5721784776902887,1.0,1.0,2/27,4.09%,DLC1;TGFB1
prerank,actin polymerization or depolymerization (GO:0008154),0.3268226912565623,0.9133367692409534,0.6068075117370892,1.0,1.0,4/50,2.74%,ENAH;SPIRE1;GSN;GAS7
prerank,double-strand break repair via homologous recombination (GO:0000724),0.3067610467250035,0.9131403377704129,0.6497797356828194,1.0,1.0,19/95,16.10%,POLN;MEIOB;AP5S1;ERCC5;ERCC4;REV3L;RPA3;BRCA1;GINS2;FBH1;MCM4;SFPQ;XRCC3;HELQ;EXD2;RPA2;RAD52;BLM;SPIDR
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.39667380880250297,0.9128560003999483,0.5786435786435786,1.0,1.0,4/15,13.10%,DERL2;SELENOS;HERPUD1;HSP90B1
prerank,mitochondrial translational elongation (GO:0070125),0.3034508550418415,0.9126657728269427,0.6315217391304347,1.0,1.0,25/88,22.77%,MRPL47;MRPS18A;MRPL14;MRPL32;TUFM;MRPL16;MRPL58;MRPS35;MRPS28;AURKAIP1;MRPL35;MRPL28;MRPL30;MRPL46;MRPL51;MRPS30;MRPS14;MRPL1;DAP3;MRPS9;MRPS31;MRPS6;PTCD3;MRPL52;MRPL18
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.3573942857100163,0.9124455841304075,0.6099744245524297,1.0,1.0,8/29,15.73%,EPHB2;SHISA9;GRIK2;SLC8A2;MCTP1;RAB3A;DRD2;NETO1
prerank,nitric oxide biosynthetic process (GO:0006809),0.4157162728313877,0.9123000589939715,0.5712166172106825,1.0,1.0,2/13,5.48%,NQO1;CYP1B1
prerank,B cell activation involved in immune response (GO:0002312),0.42110664856243185,0.9122310378271968,0.5876436781609196,1.0,1.0,5/13,27.35%,MSH6;BATF;EXOSC3;LIG4;RNF168
prerank,reticulophagy (GO:0061709),-0.3569573154313648,-0.9122113250689043,0.5734870317002881,0.8675286223468104,1.0,5/12,21.35%,TEX264;UFM1;UFC1;UBA5;ULK1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.3502802781268891,0.9117266491453593,0.6002587322121604,1.0,1.0,3/31,3.91%,PTEN;GORASP1;FBXW7
prerank,embryonic hemopoiesis (GO:0035162),-0.3499404005089598,-0.911249369581406,0.5657492354740061,0.8685535012105497,1.0,7/12,21.17%,KIT;KDR;KITLG;FLT3LG;TAL1;ZFPM1;ATF4
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.33703433228450724,0.9107714222771628,0.594059405940594,1.0,1.0,9/37,16.20%,BCL2;BMF;FBH1;SFPQ;NCK1;NACC2;UBB;BCL2L11;TP53
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.34405905020335886,0.910509863629775,0.5796019900497512,1.0,1.0,7/35,15.05%,PRKCQ;CCT7;MAPK1;NEK7;MAP3K4;RTEL1;ATM
prerank,negative regulation of inflammatory response (GO:0050728),0.2865301642378128,0.9103589109786827,0.6901554404145078,1.0,1.0,19/182,13.38%,RORA;FFAR4;CRH;DPEP1;PTPN2;MAPK7;PTHLH;TNFAIP8L2;PRKAR1B;PTH2R;OTULIN;FYN;TSHR;SELENOS;MAPK14;GLP2R;GRN;PRKACA;GATA3
prerank,regulation of osteoblast proliferation (GO:0033688),-0.3183851881473093,-0.9103457393604805,0.570957095709571,0.8694075540515606,1.0,6/17,10.92%,NPR3;MN1;FGFR2;CCN1;RHOA;PLXNB1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.37278725360611686,0.9102825514007462,0.5749656121045392,1.0,1.0,2/22,5.09%,LGALS3;PPP1R15A
prerank,positive regulation of cell growth (GO:0030307),0.29780270553773586,0.9102810749347922,0.6493506493506493,1.0,1.0,25/96,20.25%,RNF157;BCL2;NGF;ERBB2;EGFR;SYT1;CDKL5;LIMK1;DERL2;NCBP1;EXOSC2;EIF4G1;AKAP6;RIMS1;BRAT1;NEDD4L;KLHL22;PLAA;HYAL1;SYT2;RPTOR;RIMS2;SEMA4D;N6AMT1;SHTN1
prerank,regulation of cell cycle (GO:0051726),0.28732363254587473,0.9101574305794566,0.704225352112676,1.0,1.0,62/271,18.42%,FAP;CRLF3;MYC;FGF10;KIF20B;CDKN2B;KAT2B;SOX9;TGM1;TGFB1;NUPR2;PPP1R15A;CKS1B;APBB2;METTL3;SETMAR;TSC1;MLXIPL;SON;GATA6;GBF1;CDK6;FOXM1;MEN1;BIN1;NF2;BRCA1;UHRF2;LIN9;BMP7;MAGI2;ING4;TMEM8B;PRKACA;ADARB1;NEK7;RBBP4;GATA3;PRDM11;RPS6KA2;PKD1;IQGAP1;ATM;CITED2;CDC14A;ABL1;PIM2;MED25;FZD9;TRNP1;XIAP;TP53;PNPT1;HNRNPU;RNF167;FBXO5;CTBP1;NUDT6;MDM2;MLF1;BOP1;CSNK2A2
prerank,cell part morphogenesis (GO:0032990),0.40850354758418256,0.9095694146109323,0.5688073394495413,1.0,1.0,6/13,24.78%,PACSIN2;PID1;WASF1;PNPT1;MTM1;SUPV3L1
prerank,glycogen metabolic process (GO:0005977),-0.27904861614611537,-0.9093254447548145,0.6171171171171171,0.8705776976648287,1.0,6/27,10.19%,PRKAG2;PYGB;GSK3B;AGL;PYGM;GAA
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.29422156267466765,-0.9092825125584195,0.5875,0.8693745982675181,1.0,3/22,4.68%,SORBS1;CREBL2;PPARD
prerank,regulation of Rho protein signal transduction (GO:0035023),0.3111398725900379,0.9089388775266646,0.6183465458663646,1.0,1.0,14/72,15.41%,DLC1;AKAP13;LPAR1;GPR65;ARHGEF28;EPS8L1;COL3A1;CUL3;MYO9B;OPHN1;MYOC;ARHGEF3;MET;ABL1
prerank,post-translational protein modification (GO:0043687),0.28391412547699,0.908691480304776,0.7294589178356713,1.0,1.0,79/332,21.57%,GPC3;VCAN;MXRA8;FBXW9;CHRDL1;LAMC1;RAB38;SOCS5;FBXW7;PRKCSH;SPSB4;ASB8;NUCB1;SDC2;KLHL13;OBSL1;FBXO7;FBXL15;ASB5;DDB2;FBXO32;EVA1A;ZBTB16;RCN1;MEN1;NAE1;STT3A;ATG5;VWA1;FBXL16;PSMB7;CKAP4;FBXO27;HIF1A;AMELX;CUL3;LTBP1;UCHL3;CALU;UBA3;FBXO17;RAB1A;FUCA2;DCAF8;RAB3A;DDB1;HSP90B1;BTBD1;PENK;NEDD8;SUMF1;DDA1;KLHL22;PSMD2;PSMC1;FBXL4;CUL4B;PSMB2;FBXO31;FBXO22;ELOC;PSMD9;CHM;FAM20C;FBXL12;COPS6;MBTPS1;PSME4;FBXO11;DCAF7;DCAF11;RBBP7;LAMB1;COPS7A;PSMA8;PDIA6;RHBDD1;DCAF6;IGFBP4
prerank,regulation of p38MAPK cascade (GO:1900744),0.3423978918645388,0.908626494631032,0.5916870415647921,1.0,1.0,12/35,23.57%,PTPN22;VEGFA;NCF1;PRMT1;PER1;MAP3K4;RELL2;EMC10;DUSP1;PJA2;BMP2;CYLD
prerank,response to glucose (GO:0009749),0.32387211782399794,0.9086089376816726,0.592326139088729,1.0,1.0,11/46,18.05%,IRS2;ZBTB20;TRA2B;PDK3;EIF2B5;SELENOS;PRKACA;GPLD1;PAX2;EIF2B2;PCK2
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.37795862539095465,0.9078556649602466,0.6039325842696629,1.0,1.0,3/20,9.62%,GSN;ANO6;SFRP4
prerank,Golgi ribbon formation (GO:0090161),0.4082855788585492,0.9077180009202417,0.5783132530120482,1.0,1.0,2/13,8.46%,VAMP4;TRIP11
prerank,replicative senescence (GO:0090399),-0.34915803245750643,-0.9075235067748644,0.5681159420289855,0.8722804018977924,1.0,8/12,29.73%,SERPINE1;TERT;PLA2R1;WNT16;ROMO1;MME;CHEK2;CHEK1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.3089694353066915,0.9073506299382365,0.6132404181184669,1.0,1.0,23/62,25.47%,TGFB1;RANBP2;POLR2B;NUP155;POLR2K;EIF4G1;NDC1;NUP205;NUP160;POLR2G;POM121;AAAS;POLR2A;PPARG;STAT3;ZFP36;LIMD1;NUP42;POLR2F;FMR1;TNRC6A;NUP35;RAE1
prerank,regulation of cholesterol efflux (GO:0010874),0.34781549559652736,0.9072650782151265,0.602287166454892,1.0,1.0,4/30,11.01%,PTCH1;LRP1;ZDHHC8;ABCA5
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.41561477178692835,0.9070658971482484,0.5914454277286135,1.0,1.0,1/12,2.55%,SLC5A3
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.305295653138821,0.9069544501903829,0.6255411255411255,1.0,1.0,20/94,16.48%,PYCARD;BCL2;SCN2A;TNFRSF10B;PPP1R15A;CYP1B1;APAF1;BNIP3;BRCA1;CUL3;HINT1;MSH6;ARL6IP5;TMEM117;ATM;CASP2;ABL1;BCL2L11;TP53;QRICH1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.36133991364754253,0.9069029412322547,0.5810635538261998,1.0,1.0,6/24,14.39%,ETV4;CBFB;HOXA7;CTSK;RUNX1;SRSF6
prerank,regulation of monooxygenase activity (GO:0032768),0.3702141637303295,0.9068795189050232,0.5780189959294437,1.0,1.0,9/23,22.17%,POR;EGFR;LYPLA1;GDNF;SNCA;CALM1;NOS1AP;ZDHHC21;DDAH1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.35416493735370846,0.9068593810096128,0.5959731543624162,1.0,1.0,11/30,21.85%,FBXW7;VPS11;HUWE1;UBE2J2;SREBF2;CSNK2A2;UBE2L3;MICALL2;NPEPPS;RHOU;UBE2D3
prerank,response to lipopolysaccharide (GO:0032496),0.2915091634673984,0.9068128035530466,0.6549586776859504,1.0,1.0,33/138,22.99%,CXCL10;PYCARD;PTPN22;IRAK3;MAPKAPK3;PDE4B;MAPKAPK2;WNT5A;PELI1;ERBIN;SELENOS;MAPK14;TRIM41;UPF1;PRDX3;SHPK;SRR;SNCA;TICAM1;PLAA;CDC73;LBP;AXL;BCL10;PDCD4;SIRPA;ZFP36;NFKB1;RPS6KA3;TNIP2;VIM;TAB2;CARD16
prerank,protein targeting to mitochondrion (GO:0006626),0.31998675132091925,0.906733232713476,0.6028537455410226,1.0,1.0,16/52,20.62%,MIPEP;FBXO7;TOMM22;AIP;TOMM20;PMPCB;HSPA4;GDAP1;NDUFA13;DNAJC19;AIFM1;PAM16;AGK;PMPCA;TSPO;HSPD1
prerank,striated muscle contraction (GO:0006941),-0.23127999369635152,-0.9064770341862354,0.697841726618705,0.8734214812579494,1.0,15/53,25.73%,ATP1A2;RCSD1;TPM1;GRK2;GAA;NOS1;ATP1B1;STAC;SCN4B;DMD;MYH14;STAC3;SCN3B;MYL4;CASQ2
prerank,negative regulation of chemotaxis (GO:0050922),0.3412311366151975,0.9062194257020155,0.5955334987593052,1.0,1.0,4/31,3.81%,SEMA3E;PTPN2;SEMA6C;SEMA3A
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.40766281780358327,0.9061030633875228,0.5818713450292398,1.0,1.0,3/15,9.46%,PABPC1;CPEB3;ZFP36L2
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.40766281780358327,0.9061030633875228,0.5818713450292398,1.0,1.0,3/15,9.46%,PABPC1;CPEB3;ZFP36L2
prerank,regulation of MAP kinase activity (GO:0043405),0.3038990188496761,0.9060953148521148,0.6368477103301384,1.0,1.0,14/92,11.32%,FGF2;ERBB2;EGFR;VEGFA;IRAK3;TGFB1;NF1;KSR1;FGFR1;UCHL1;PTPN1;EDN3;PTPRJ;BMP7
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.3148674287945629,0.9060952105713623,0.6180790960451977,1.0,1.0,7/60,6.20%,PTEN;CBFB;SOX9;CCNC;MED31;ATF7IP;CDK8
prerank,phospholipid metabolic process (GO:0006644),-0.22506716426333545,-0.9059525874500668,0.6785714285714286,0.8733085318490007,1.0,20/71,23.18%,PLA2G4A;PLPP1;GPAM;PLCD1;GNPAT;MBOAT1;TNFAIP8L3;ACP6;PIP4P1;AGPAT4;GPX4;PIP4K2B;PLA2G15;PGP;ABHD12;PLPPR5;CLN8;LPL;PNPLA3;PLA2G4C
prerank,regulation of cellular protein localization (GO:1903827),0.326573490106884,0.9056337630529907,0.6166868198307134,1.0,1.0,11/45,16.10%,GPC3;RALB;GBF1;PTPN1;SETD2;GPC1;DVL1;KCNAB2;GPC4;CSNK1E;SPIDR
prerank,mitochondrial genome maintenance (GO:0000002),0.4236564192725262,0.9056096283767646,0.5870570107858244,1.0,1.0,8/11,27.90%,AKT3;OPA1;TOP3A;MGME1;SLC25A36;MEF2A;LONP1;MPV17
prerank,sensory perception (GO:0007600),0.32687288711087037,0.9054708885362395,0.6129807692307693,1.0,1.0,8/45,16.69%,KCNA2;CHRNA4;PCDH15;CCR2;PENK;PTGES;OPRK1;NIPSNAP1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.4229758711782993,0.9053951545749617,0.5718701700154559,1.0,1.0,7/10,26.99%,EMC10;EMC1;EMC8;EMC3;EMC2;EMC6;EMC7
prerank,ncRNA export from nucleus (GO:0097064),0.3423748684692678,0.9050521738299028,0.5933503836317136,1.0,1.0,10/36,17.56%,RANBP2;NUP155;TSC1;NDC1;NUP205;NUP160;XPOT;POM121;AAAS;SSB
prerank,regulation of histone modification (GO:0031056),-0.33500965244975683,-0.9050340480606311,0.6121212121212121,0.8742442013390282,1.0,5/13,18.89%,PARG;IGF2;FLCN;UBE2N;MYOCD
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.4101910681583978,0.9048556526981254,0.6033434650455927,1.0,1.0,4/13,12.89%,SHISA9;GRIK2;SLC8A2;RAB3A
prerank,fatty acid oxidation (GO:0019395),-0.24239171464399684,-0.904472672782947,0.6962962962962963,0.8743599073301367,1.0,20/57,27.35%,ACAD10;ECHDC1;PEX13;PPARD;PHYH;ACADM;ALDH3A2;ADIPOR2;BDH2;ECHDC2;ECI1;PECR;ECHS1;PEX2;ALOX12;CROT;SLC27A2;ECI2;CPT2;MCAT
prerank,positive regulation of telomerase activity (GO:0051973),0.34890650625684294,0.9044299696185789,0.6154822335025381,1.0,1.0,6/33,14.35%,PRKCQ;MYC;PARM1;MAPK1;NEK7;MAP3K4
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.3727574411099872,0.9044151292898868,0.5896032831737346,1.0,1.0,3/20,8.10%,PYCARD;ANO6;IL18
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.3761158354797623,0.904354412092546,0.5762237762237762,1.0,1.0,5/19,20.69%,PYCARD;AEN;RPS27L;TP53;BCL3
prerank,phospholipid homeostasis (GO:0055091),-0.35654052302701883,-0.9041902581648426,0.5619335347432024,0.8737389172672289,1.0,5/11,26.62%,ABCA1;ABCG1;TLCD1;ANGPTL3;TLCD2
prerank,Rap protein signal transduction (GO:0032486),0.4321862009363763,0.9036784069097706,0.603125,1.0,1.0,2/10,7.56%,RAP2B;RAP1A
prerank,response to ethanol (GO:0045471),0.39622306100955695,0.903547944176403,0.5849858356940509,1.0,1.0,3/14,14.11%,GRIN2B;GOT2;GRIN2A
prerank,cellular metal ion homeostasis (GO:0006875),0.29827465541167986,0.9034278611707642,0.6599362380446334,1.0,1.0,20/102,18.72%,CCL11;ANK2;LETM1;ATP2B3;MT3;CCR2;SLC12A2;SLC8A2;SLC24A5;SLC10A7;EDN3;HTR2C;ATP2B1;TPCN2;NEDD4L;CCL14;SLC9A1;KCNMA1;SLC24A4;SLC24A2
prerank,regulation of fibroblast migration (GO:0010762),0.36980476071928237,0.9033147422080225,0.5980528511821975,1.0,1.0,2/20,4.09%,FGF2;TGFB1
prerank,histone H2A ubiquitination (GO:0033522),0.392123176047532,0.9029676680558752,0.5909732016925247,1.0,1.0,8/17,28.60%,DDB2;DDB1;CUL4B;BCOR;RNF2;PCGF1;RNF168;TRIM37
prerank,positive regulation of reproductive process (GO:2000243),0.3470627705630227,0.9029523221365395,0.5902688860435339,1.0,1.0,8/31,23.10%,VEGFA;PLCB1;PRDM9;LHFPL2;CFAP69;CACNA1H;INHBB;TAC4
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.300270024777073,-0.9028124127537525,0.5858585858585859,0.8759050290366033,1.0,4/20,11.39%,IL1R1;CD55;PRKCZ;MAP3K7
prerank,response to hexose (GO:0009746),0.3545442572216021,0.9026011428930423,0.6142668428005285,1.0,1.0,5/25,17.53%,IRS2;EIF2B5;SELENOS;GPLD1;EIF2B2
prerank,membrane depolarization during action potential (GO:0086010),0.3568267729081058,0.9025033530700262,0.5883870967741935,1.0,1.0,4/26,7.11%,SCN7A;SCN2A;SCN5A;SCN3A
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.35851250280658525,-0.9024535491205651,0.5734870317002881,0.8755720866451632,1.0,4/11,8.41%,P4HB;OGFOD1;P4HA2;EGLN2
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.34110718080913993,0.9023977547117953,0.6141935483870967,1.0,1.0,14/34,25.99%,OLFM4;DOCK5;FLNA;DOCK1;MYOC;ABL1;MDK;RAC3;TESK1;TRIOBP;CRK;CIB1;ARHGEF7;LIMS1
prerank,synaptic vesicle membrane organization (GO:0048499),0.38764983355031796,0.902217218398702,0.6020114942528736,1.0,1.0,2/17,5.75%,SNAP23;SNAP29
prerank,regulation of stem cell differentiation (GO:2000736),0.30097635004934764,0.9020630065159849,0.6268980477223427,1.0,1.0,20/89,20.59%,PDGFRA;CBFB;KMT2A;METTL3;PSMB7;ZFP36L2;GDNF;RUNX1;GATA3;PUS7;BMPR1A;PSMD2;ABL1;PSMC1;HNRNPU;PSMB2;PSMD9;PSME4;NSUN2;PSMA8
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.3539688045225088,-0.9019602244745465,0.5777777777777777,0.8754828746197519,1.0,2/11,6.75%,NRP1;BCAR1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.28002122100558235,0.9019001061939338,0.796,1.0,1.0,121/572,20.84%,OSR2;PTCH1;TENM2;MLIP;GLI2;AASS;SOX8;PRDM16;MYC;TGIF2;CBFB;ZNF25;SOX9;PRKN;RIPPLY2;SUV39H1;HIVEP1;OTP;HOXA7;SATB1;VEGFA;NFX1;FOXP2;PSEN1;GATAD2A;EZH1;SOX11;NUPR2;ZEB1;TRPS1;URI1;EED;MTA2;OTUD7B;RORC;MLX;ZBTB16;DRAP1;GATA6;E2F6;FOXM1;LRRFIP1;CBX4;MEN1;CHD3;VPS72;CPEB3;ATRX;RARB;MBD2;RARG;KCTD1;PPID;LDB2;HDAC2;NFATC3;SIN3B;ESR1;SFPQ;SIRT6;DCAF1;RUNX1;NRIP1;ZGPAT;PER3;FOXP4;ZFPM2;EPC1;NR6A1;ZBTB1;PER1;GATA3;ZEB2;NACC2;SNCA;LCOR;NCOR2;TAF7;MDM4;NEDD4L;SUMO1;CRY1;CREM;IL33;CITED2;DACT1;UBB;MED25;MTA3;TP53;NFIX;HNRNPU;SREBF2;WWOX;USP2;SUFU;FOXJ1;CDC73;CTBP1;MDM2;CGGBP1;FNIP1;KLF7;TAF1;SEMA4D;PPARG;STAT3;PRDM2;CNBP;YEATS2;BCOR;SMARCA4;JUN;ORC2;NR1D2;MITF;GATAD2B;SNAI1;JDP2;ZFP36;NFKB1
prerank,retrograde axonal transport (GO:0008090),-0.31977361758279205,-0.9018109025238866,0.5943396226415094,0.874556833654831,1.0,4/16,11.26%,KIF1C;PAFAH1B1;KIF5B;SOD1
prerank,endothelial cell migration (GO:0043542),0.33573920444730054,0.9018049809594199,0.6319702602230484,1.0,1.0,5/37,5.48%,FAP;PRKX;VEGFA;EGR3;CYP1B1
prerank,lung epithelium development (GO:0060428),0.43412858707953406,0.9017147604463299,0.5920245398773006,1.0,1.0,4/10,17.06%,FGF10;RCN3;PKD1;FOXJ1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.41057146142374845,0.9016588786570011,0.583203732503888,1.0,1.0,7/12,26.52%,SEC61G;SEC63;SGTA;SEC61A2;CHMP4A;CHMP4B;SGTB
prerank,cholesterol transport (GO:0030301),0.32460785417348775,0.9015548886773417,0.6204033214709371,1.0,1.0,6/45,11.36%,CEL;NPC1;OSBPL5;RELCH;ABCA5;LIPC
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.22931775884220815,-0.9015020351454259,0.6766917293233082,0.8740498166970624,1.0,28/57,29.62%,NPM1;RPS16;RPL38;RPS19;NVL;RPL5;RPS25;RPS15;NAF1;RPS6;RPL11;EMG1;SURF6;BYSL;RIOK1;RPL35A;RPL26;PES1;DHX37;CUL4A;RPS17;RPF2;NOC2L;RIOK2;URB2;PAK1IP1;MRPL36;GLUL
prerank,negative regulation of DNA recombination (GO:0045910),0.32685999179529646,0.9014290797537124,0.6176836861768369,1.0,1.0,11/43,16.30%,ZRANB3;POLR2B;ATRX;POLR2K;FBH1;MSH6;POLR2G;RTEL1;CGAS;BLM;TERF2IP
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.312510177643765,0.9012991877589515,0.6218302094818081,1.0,1.0,7/70,7.18%,ERBB3;BCL2;NGF;FADD;TNFRSF10B;TGFB1;DEDD
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.4065227119881891,0.9011092552411709,0.5964391691394659,1.0,1.0,8/13,31.86%,UNC93B1;TNIP2;IRAK2;IRAK1;PIK3C3;TRAF6;IRAK4;EPG5
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.33858426778889306,0.9010641324942513,0.6171003717472119,1.0,1.0,10/39,16.94%,GTF2H2;ERCC5;ERCC4;DDB2;RPA3;XPA;DDB1;RPA2;UBB;CUL4B
prerank,positive regulation of macroautophagy (GO:0016239),0.3274375233957397,0.9010255065722852,0.6242568370986921,1.0,1.0,4/48,7.90%,DCN;WAC;RALB;BNIP3
prerank,aerobic respiration (GO:0009060),-0.3066599660558457,-0.9009394210594889,0.6309963099630996,0.8741275656564478,1.0,10/20,28.16%,SDHB;SIRT3;UQCRB;OXA1L;ATP5F1D;UQCR10;UQCRH;UQCRC1;SURF1;MTFR2
prerank,"phototransduction, visible light (GO:0007603)",0.4047162942016334,0.9009078071077002,0.592814371257485,1.0,1.0,1/14,1.72%,RHO
prerank,DNA metabolic process (GO:0006259),0.2840685533952097,0.9005583998869091,0.7454728370221329,1.0,1.0,63/270,19.66%,UBE2T;LRWD1;CBS;NUDT15;ZRANB3;MBD4;POLE2;CHRNA4;ERCC5;NSMCE3;MPG;ERCC4;DDB2;STN1;SETMAR;RPA3;NUDT1;MUTYH;MEN1;XPA;BRCA1;POLE3;TDP1;REXO4;UHRF2;ENDOV;NEIL1;ASF1A;FANCC;MCM4;MSH6;HELLS;UPF1;XRCC3;XRCC6;ZBTB1;DDB1;EXD2;PDS5B;RPA2;ORC1;TOPBP1;SUMO1;RTEL1;SMUG1;ATM;RAD52;UBB;TRRAP;BLM;POLG;CSNK1E;TERF2IP;WRN;NSMCE4A;ORC4;PARK7;DDX23;DBF4;LIG3;CNBP;TOP1;PSME4
prerank,positive regulation of protein maturation (GO:1903319),-0.3534923151539678,-0.8999578417862147,0.6094182825484764,0.8752090709997856,1.0,1/11,1.32%,CCBE1
prerank,organelle assembly (GO:0070925),0.27833887781561206,0.8996209946152501,0.769,1.0,1.0,83/384,20.17%,DYNLL1;PTPDC1;RHO;BICD1;STK36;WDPCP;CD34;GSN;RAB38;CC2D2A;SQLE;HAUS3;ARL3;PACS2;NEK1;CCDC57;RFX2;STARD9;TTC39C;IFT140;PCM1;WIPI1;RILPL2;ATXN2;SNAP29;RFX3;BBS9;DISC1;GBF1;CPLANE1;ATG5;BBS5;FLNA;FARP2;WDR35;RCC1;TUBGCP5;VPS37B;GORASP2;ARF4;HDAC6;SNX10;POGZ;VPS36;RAB1A;ATG3;LSM3;CEP89;MVB12A;CFAP20;NEK7;TRAPPC14;FBF1;CCDC28B;RAB11FIP3;EHD2;PDCD6IP;PKD1;GABARAPL2;CCDC65;CDC14A;CHMP4C;EIF4ENIF1;TRAPPC6A;ANLN;FOXJ1;HPS1;MYH6;CEP63;RC3H1;RAB7A;GALNT11;KIF3A;MAPRE3;FLII;IFT81;UBAP2L;VMP1;CENPC;CCDC66;CHMP1B;CSDE1;BBS7
prerank,phagosome maturation (GO:0090382),0.34566109222171115,0.8995415333462408,0.6110414052697616,1.0,1.0,14/35,27.11%,RAB38;RAB14;ATP6V1B2;RAB34;RAB39A;MREG;RAB7A;ATP6V1C1;ATP6V0E2;ATP6V0E1;ATP6V1G2;ATP6V1H;TCIRG1;ATP6V1D
prerank,protein-containing complex subunit organization (GO:0043933),0.29187001071656454,0.8995387580815515,0.645367412140575,1.0,1.0,33/109,23.72%,REPS2;SOX9;LAMC1;KMT2A;WIPF1;EPRS1;PPID;MAGI1;NDC1;FANCC;NUP205;RIMS1;WASF1;DET1;MDM4;NIFK;LPXN;PPIH;TP53;IL1RAP;CD74;MDM2;SKAP2;KPNA3;NAPG;MITF;DLG4;LLGL1;KIFAP3;WASF3;ELOB;PPP2R1A;NDUFAF1
prerank,immunoglobulin mediated immune response (GO:0016064),0.440737478918647,0.8993254300992897,0.6046511627906976,1.0,1.0,2/10,17.26%,CARD9;CD74
prerank,keratan sulfate catabolic process (GO:0042340),0.4178420407460338,0.8990688331447242,0.6052631578947368,1.0,1.0,2/11,7.06%,LUM;GALNS
prerank,calcium ion transport into cytosol (GO:0060402),0.37177420365782227,0.8987583570336599,0.5945205479452055,1.0,1.0,6/21,17.78%,CACNA2D1;GRIN2B;JPH3;GRIN2D;GRIN2A;MS4A1
prerank,hematopoietic stem cell proliferation (GO:0071425),0.42274862884956504,0.8987480910936996,0.6140089418777943,1.0,1.0,3/11,11.81%,CD34;WNT5A;RUNX1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.2859877016839567,-0.8986684623019522,0.5826771653543307,0.8770939496950119,1.0,10/24,21.70%,XRN1;TERF2;DCP2;PARP1;EXOSC10;PINX1;TEN1;TINF2;TENT4B;HNRNPA1
prerank,telomere maintenance via telomerase (GO:0007004),-0.2674908092535563,-0.898587686405488,0.6398305084745762,0.8760182801065957,1.0,11/28,18.97%,TERF2;RFC1;DKC1;WRAP53;HSP90AA1;CDK2;TERT;PINX1;HSP90AB1;GAR1;TINF2
prerank,regulation of tissue remodeling (GO:0034103),0.3759519621277706,0.8982913907600661,0.5935672514619883,1.0,1.0,4/18,17.28%,TGFB1;IL18;RUNX1;MDK
prerank,positive regulation of filopodium assembly (GO:0051491),0.3525850703786511,0.8981512776050106,0.6055944055944056,1.0,1.0,6/24,15.64%,TENM2;NLGN1;GPM6A;PIK3R1;FSCN1;TGFB3
prerank,toll-like receptor signaling pathway (GO:0002224),0.30476126353103217,0.8981050095285262,0.6558089033659066,1.0,1.0,24/84,23.69%,FADD;IRAK3;MAPKAPK3;MAPKAPK2;CTSK;CTSB;TLR1;HSP90B1;UNC93B1;TICAM1;UBB;LBP;RIPK1;CHUK;TRIL;TAB3;BCL10;SCARA3;HSPD1;RPS6KA3;TNIP2;UBE2D3;TAB2;IRAK2
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.3629076765184322,-0.8979860086126212,0.5970588235294118,0.8762465128226339,1.0,4/10,21.70%,HSP90AA1;NAB2;HSP90AB1;CLU
prerank,regulation of histone deacetylation (GO:0031063),-0.3400428279211557,-0.8972903290601965,0.5900621118012422,0.8767140298943636,1.0,6/13,27.79%,SAP30BP;ING2;ZBTB7B;SPHK2;PRMT6;NIPBL
prerank,regulation of cellular protein catabolic process (GO:1903362),0.37848923098902487,0.8970567953867692,0.5950292397660819,1.0,1.0,8/18,26.69%,VGLL4;VPS11;ATRAID;DACT1;RDX;CDK5RAP3;VPS35;PTTG1IP
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.33416479322051273,0.8969666999354472,0.6376638855780691,1.0,1.0,5/40,7.90%,HRK;PYCARD;PRKN;BMF;BNIP3
prerank,diacylglycerol metabolic process (GO:0046339),-0.2842699675472299,-0.896808585871767,0.6245059288537549,0.8764805690132452,1.0,10/23,29.86%,GPAM;DGKH;PLA2G15;DAGLA;PNPLA2;DGKG;LIPE;DGKB;ANG;DGAT1
prerank,positive regulation of autophagy (GO:0010508),0.3029326192853224,0.8965429395666829,0.6548672566371682,1.0,1.0,7/81,7.90%,DCN;PRKN;NPRL2;WAC;FBXO7;UFL1;BNIP3
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.3830860288536669,0.8965345472751153,0.6090651558073654,1.0,1.0,8/17,22.95%,CTNNA2;BRK1;WASF1;CORO1B;CYFIP1;ARFIP1;NCKAP1;WASF3
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.2006174304034808,-0.8964908021857193,0.7924528301886793,0.8760053394074675,1.0,38/114,27.56%,PSMD14;BIRC3;NFKBIA;TNFRSF11B;PSMB3;AIM2;PSMD12;TNFRSF11A;TNFSF12;TNFRSF1A;TMSB4X;PSMD6;COMMD7;PSMA1;CDIP1;EIF5A;PSMD7;PSMA5;PSMC5;PTK2B;IKBKB;PSMC4;BAG4;PSMB6;PSMA4;EDA2R;TRADD;CD40;PSMB9;ACTN4;PSMB1;TRAF1;ILK;TNFSF13;PSMD3;EDAR;PSMC6;CD27
prerank,oogenesis (GO:0048477),0.387760315310915,0.8960245607109456,0.603042876901798,1.0,1.0,6/15,23.31%,FMN2;METTL3;MDK;MARF1;KMT2D;MEI4
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3123135448524901,0.8959300404574819,0.6287964004499438,1.0,1.0,12/64,17.29%,FADS2;SLC27A4;LTA4H;CYP1B1;AIG1;ACOX1;ELOVL6;ELOVL5;PNPLA8;ACAD9;ACSL3;ACSL6
prerank,mitotic spindle organization (GO:0007052),0.2883618489156972,0.895500698740298,0.6980351602895554,1.0,1.0,22/153,14.60%,DYNLL1;EFHC1;XPO1;GPSM2;TBCE;RANBP2;ARHGEF10;EML1;NDE1;STAG2;FLNA;RCC1;DYNC1I1;CLASP1;NUP160;SGO1;ZWINT;KPNB1;CKAP5;BUB1B;DYNC1I2;ITGB3BP
prerank,tRNA transport (GO:0051031),0.3360797318256377,0.8952116628658584,0.5962025316455696,1.0,1.0,10/35,17.56%,RANBP2;NUP155;TOMM20;NDC1;NUP205;NUP160;XPOT;POM121;AAAS;SSB
prerank,cardiac muscle cell action potential (GO:0086001),0.34856928938579695,0.8952018177758517,0.6063291139240506,1.0,1.0,5/30,7.85%,CACNA2D1;ANK2;SCN5A;FGF12;KCND3
prerank,striated muscle tissue development (GO:0014706),0.3534646913038591,0.8950297572077159,0.6020942408376964,1.0,1.0,3/29,6.02%,BMP5;SGCD;SGCZ
prerank,regulation of sensory perception of pain (GO:0051930),-0.3573279489867871,-0.8948055153796913,0.5809248554913294,0.8788156640815638,1.0,6/11,33.79%,ATPSCKMT;MGLL;TMEM100;ACP3;SPX;F2R
prerank,carboxylic acid transmembrane transport (GO:1905039),0.3332621563978409,0.8947998341008909,0.5948905109489051,1.0,1.0,10/40,16.94%,SLC27A1;SLC38A4;SLC25A21;SLC36A2;SLC7A7;SLC7A8;SLC25A10;SLC16A1;SLC25A11;ABCC1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.32096949600378016,-0.8946771779640638,0.5714285714285714,0.8778756281031618,1.0,4/16,13.07%,RIF1;PARP3;WRAP53;KDM4D
prerank,protein modification by small protein conjugation (GO:0032446),0.2785050110987569,0.8945281098818492,0.785,1.0,1.0,84/361,20.20%,UBE2T;PDZRN3;RNF157;PRKN;DTX4;HACE1;WAC;TRIM44;NFX1;FBXW7;SPSB4;RANBP2;KLHL13;RNF6;UBA2;FBXO7;FBXL15;ASB5;FBXO32;NUP155;UFL1;TRIM11;OTULIN;NAE1;BRCA1;UBE2K;PIAS2;VPS11;HIF1A;SELENOS;CUL3;UBE2Z;UHRF2;FBXO45;ANAPC7;FBH1;CBL;HUWE1;NFE2L2;NDC1;NUP205;UBE2J2;UCHL3;TSPAN17;TRIM41;NUP160;UBA3;MYLIP;ATG3;FBXL2;DDB1;NEDD8;DET1;TRIM23;NEDD4L;TRAF7;SUMO1;AREL1;UBB;RNF111;CDC23;RCHY1;ZSWIM8;POM121;ANAPC16;MIB1;AAAS;RNF182;CUL4B;CDC73;UBA1;MDM2;ELOC;PCNP;UBE2L3;USP5;CDC27;TRIM35;TRAIP;FBXO11;RRAGA;BCL10;UBE2G1;UBE2E1
prerank,DNA damage checkpoint signaling (GO:0000077),-0.26774040543140804,-0.8942503702684024,0.6510638297872341,0.8775989601722975,1.0,15/28,34.46%,MAP3K20;CLOCK;DOT1L;HUS1;CLSPN;DONSON;ERCC6;NBN;E2F1;RAD9A;CHEK2;CHEK1;PRPF19;ATRIP;FBXO6
prerank,positive regulation of TOR signaling (GO:0032008),-0.24658213725267875,-0.8942074500098844,0.6521739130434783,0.8764587909003251,1.0,14/40,21.78%,SIK3;WDR59;RICTOR;RRAGC;FLCN;LARS1;PIP4P1;NCKAP1L;RHEB;SMCR8;RRAGB;LAMTOR1;GPR137;HDAC3
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.3705306554589938,-0.89373204292824,0.5882352941176471,0.8762799610140891,1.0,4/10,24.79%,USP7;OGT;PDK2;SIRT7
prerank,steroid catabolic process (GO:0006706),0.426151526680948,0.8936835504516416,0.6291793313069909,1.0,1.0,1/10,4.72%,HSD17B11
prerank,stem cell development (GO:0048864),0.38996805359617903,0.8933675074349138,0.6208333333333333,1.0,1.0,2/16,4.42%,SOX8;SOX11
prerank,positive regulation of developmental growth (GO:0048639),0.31598617593652384,0.893112410058067,0.6291079812206573,1.0,1.0,14/49,21.11%,RNF157;NGF;PLCB1;SYT1;CDKL5;LIMK1;RIMS1;NEDD4L;PLAA;SYT2;RIMS2;SEMA4D;SHTN1;GHR
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.41432041595664715,0.8929975741522028,0.6146645865834633,1.0,1.0,5/11,18.64%,FYN;ABCD2;MPV17L;TRAP1;PARK7
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.34276511316708846,0.8928760739821892,0.6083009079118028,1.0,1.0,9/32,17.56%,RANBP2;NUP155;NDC1;NUP205;NUP160;XPOT;POM121;AAAS;SSB
prerank,tRNA export from nucleus (GO:0006409),0.34276511316708846,0.8928760739821892,0.6083009079118028,1.0,1.0,9/32,17.56%,RANBP2;NUP155;NDC1;NUP205;NUP160;XPOT;POM121;AAAS;SSB
prerank,calcium ion import (GO:0070509),-0.26614689177946244,-0.8926737034877453,0.636734693877551,0.8775074409719346,1.0,4/28,4.39%,CACNA1C;MICU1;CACNB2;CACNA1G
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.3142101572548922,-0.8926229605733402,0.5923566878980892,0.8763454447553315,1.0,5/16,14.60%,ATP5MC3;ATP5PD;STOML2;ATP5F1D;ATP5MF
prerank,cellular zinc ion homeostasis (GO:0006882),-0.2755714049711036,-0.8924016992785256,0.6446886446886447,0.8756125034771307,1.0,8/26,23.82%,SLC30A10;SLC39A8;SLC30A1;SLC39A6;SLC39A10;MT2A;SLC39A13;ATP13A2
prerank,regulation of cell differentiation (GO:0045595),0.28800355081140916,0.8922433962997199,0.7033985581874357,1.0,1.0,24/148,13.38%,LGALS3;PHLDB1;CBFB;NGF;MBOAT2;PTHLH;TGFB1;NF1;TRPS1;NLGN1;RORC;CDK6;FGFR1;KLK6;BIN1;PPP1R13L;EDN3;GDNF;CLASP1;RUNX1;CDK5R1;APC2;PRKACA;GATA3
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.2933284653523141,0.8922168566770812,0.646551724137931,1.0,1.0,22/95,22.99%,CXCL10;PYCARD;PDE4B;WNT5A;SELENOS;MAPK14;TRIM41;UPF1;SHPK;TICAM1;PLAA;CDC73;LBP;AXL;BCL10;PDCD4;SIRPA;ZFP36;NFKB1;TNIP2;VIM;CARD16
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.3097928853165665,0.8920708105364422,0.6340621403912543,1.0,1.0,8/57,11.06%,CRLF1;PTPN2;VEGFA;SOCS1;NF2;IL18;ERBB4;IL6ST
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.28955492489891044,-0.8911855275267095,0.6346863468634686,0.8771301327063409,1.0,8/20,26.26%,OSR1;ACTN2;GOPC;ADRA2A;HECW2;TCAF2;CASQ2;PLN
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.3551724947117654,0.8910724829105179,0.609375,1.0,1.0,1/25,0.14%,ARHGAP24
prerank,protein localization to cilium (GO:0061512),0.3383051516129556,0.8904803179395382,0.6248447204968944,1.0,1.0,5/32,11.39%,ARL3;IFT140;BBS9;WDR35;SNX10
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.3478816218882186,0.8903305443913677,0.6172506738544474,1.0,1.0,3/27,4.09%,PDGFRA;FGF2;TGFB1
prerank,protein modification by small protein removal (GO:0070646),0.2831028655179244,0.8903049952218761,0.7472081218274111,1.0,1.0,66/252,22.22%,USP50;MYC;PTEN;RAD23B;USP35;KAT2B;USP11;PRKN;SENP3;DDB2;OTUD7B;UCHL5;INO80E;BRCA1;UCHL1;PSMB7;HIF1A;USP46;TOMM20;MYSM1;USP33;UCHL3;ESR1;NFRKB;USP32;USP48;GATA3;USP40;NEDD8;MDM4;SENP2;USP14;IL33;PSMD2;UBB;TRRAP;PSMC1;ASXL2;TP53;USP25;USP21;USP1;USP2;RIPK1;PSMB2;MDM2;USP37;OTUD4;OTUD7A;RHOT1;PSMD9;ATXN7;SENP1;USP5;COPS6;PSME4;MCRS1;COPS7A;MBD6;PSMA8;USP13;JOSD1;TNIP2;USP31;ARRB2;ACTR5
prerank,purine ribonucleotide catabolic process (GO:0009154),0.362409052508734,0.8902114127350012,0.614406779661017,1.0,1.0,6/21,12.73%,NT5C2;PDE9A;HINT1;PDE4D;NUDT10;NUDT3
prerank,regulation of DNA replication (GO:0006275),0.31879930334441736,0.8900106775548325,0.6274509803921569,1.0,1.0,16/49,24.63%,GLI2;EGFR;GLI1;STN1;ZBTB38;BLM;FBXO5;USP37;CCDC88A;BCAR3;CTC1;KAT7;PPP2R1A;ATR;ORC3;EHMT2
prerank,photoperiodism (GO:0009648),-0.26895792808216956,-0.8898936214309275,0.6363636363636364,0.8788588532498771,1.0,8/28,13.95%,SIK1;PPP1CB;CLOCK;MTA1;PPP1CC;FBXL17;ID2;PML
prerank,mitotic sister chromatid cohesion (GO:0007064),0.3839655955766213,0.8897919410290032,0.6011396011396012,1.0,1.0,6/16,26.46%,POGZ;SGO1;PDS5B;SMC1A;RB1;NAA50
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.3481694050697423,0.8896271745677448,0.5931758530183727,1.0,1.0,3/25,5.97%,SULF1;SOX11;FBXL15
prerank,early endosome to late endosome transport (GO:0045022),0.3668411282712793,0.889042434591828,0.6082036775106082,1.0,1.0,13/20,29.56%,AKTIP;STX8;ANKRD27;RAB7A;HOOK2;SNX16;WDR81;HOOK3;HOOK1;PIK3C3;EEA1;SNF8;EMP2
prerank,regulation of receptor recycling (GO:0001919),-0.31247703586594566,-0.8889628184360066,0.6179401993355482,0.8797662136336138,1.0,6/16,20.33%,NSF;OPTN;ECE1;LAMTOR1;TBC1D16;INPP5F
prerank,sensory perception of mechanical stimulus (GO:0050954),0.30075749618610326,0.8889110796019546,0.6499454743729552,1.0,1.0,13/85,16.32%,ROR1;PIEZO2;LHFPL5;PCDH15;LHFPL3;LHFPL4;COL1A1;HOMER2;LRTOMT;PAX3;CCDC50;CDC14A;LRP2
prerank,negative regulation of programmed cell death (GO:0043069),0.27542689758999644,0.8886502679493338,0.7875125881168177,1.0,1.0,79/355,18.64%,FFAR4;SOX8;MYC;RNF157;BCL2;DPEP1;SOX9;NGF;EGFR;MAP4K4;FMN2;VEGFA;EGR3;ARAF;THOC6;WNK3;PSEN1;ERCC5;FANK1;MT3;WNT5A;YWHAZ;RASA1;NAA35;SON;GATA6;NAA16;CBX4;BNIP3;FLNA;CRYAB;ASNS;UBE2Z;PRDM9;PIK3R1;HDAC2;GDNF;CBL;ARF4;NGFR;IL6ST;TAF9;MYDGF;TAX1BP1;PRLR;PRDX3;HSP90B1;ATF5;YME1L1;MALT1;TM7SF3;SNCA;PSEN2;AREL1;OPA1;ZFAND6;CITED2;MET;CASP2;UBB;BNIP1;PIM2;UBE2O;HTATIP2;XIAP;TP53;CCND2;LRP2;PAX2;RIPK1;CD74;PCID2;RAB7A;DNAJA1;HSPA9;CAT;NAA15;AATF;PARK7
prerank,regulation of vasculature development (GO:1901342),0.35450026374515137,0.8884882056501013,0.6258234519104084,1.0,1.0,3/26,4.96%,FGF2;ERBB2;NF1
prerank,relaxation of cardiac muscle (GO:0055119),-0.32960575431081623,-0.8880999242881688,0.593167701863354,0.8805502741718029,1.0,3/13,6.66%,ATP1A2;KCNJ2;ATP1A1
prerank,regulation of monocyte differentiation (GO:0045655),0.38751857517117905,0.8877470600339772,0.6080691642651297,1.0,1.0,3/14,7.37%,MYC;HOXA7;CDK6
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.38097110896242353,0.8870736299284018,0.6020864381520119,1.0,1.0,1/16,1.12%,SLC27A1
prerank,negative regulation of interleukin-12 production (GO:0032695),0.39765728307692827,0.8868383586403312,0.6147058823529412,1.0,1.0,1/14,3.41%,IRAK3
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.36120086664802314,0.8867416915181578,0.608876560332871,1.0,1.0,8/22,27.06%,HMGN1;CDK13;ELL;CDC73;KAT7;THOC5;CCNT2;TCERG1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.37594376059486434,0.8867106711468029,0.6246575342465753,1.0,1.0,4/19,13.25%,PAPSS2;BPNT1;BPNT2;SLC35B3
prerank,tRNA 5'-end processing (GO:0099116),0.3897237570184092,0.8866906079715862,0.6242857142857143,1.0,1.0,5/15,17.56%,RPP38;PRORP;POP1;RPP21;SSB
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.28641695522398797,-0.8865459159430974,0.6446886446886447,0.882839831071753,1.0,6/21,19.67%,NPM1;VPS4B;CDK4;CDC7;RAD51C;MECP2
prerank,7-methylguanosine RNA capping (GO:0009452),0.33595328920047574,0.8864413862164371,0.6257901390644753,1.0,1.0,9/31,19.46%,GTF2H2;RNGTT;POLR2B;POLR2K;NCBP1;POLR2G;RNMT;POLR2A;CMTR2
prerank,7-methylguanosine mRNA capping (GO:0006370),0.33595328920047574,0.8864413862164371,0.6257901390644753,1.0,1.0,9/31,19.46%,GTF2H2;RNGTT;POLR2B;POLR2K;NCBP1;POLR2G;RNMT;POLR2A;CMTR2
prerank,receptor-mediated endocytosis (GO:0006898),0.2876613454501142,0.8863010227291054,0.702928870292887,1.0,1.0,23/132,16.82%,HSPG2;SGIP1;DNM1;HSPH1;LRP1;PI4KB;ACKR3;AP1G1;EPS15;GAK;SPARC;AP1S1;GPR107;WASF1;TPCN2;HSP90B1;SNCA;CD9;SNX1;ITGB1;LRP2;IGF2R;CTTN
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.3647284158333578,-0.8862321979826443,0.5860058309037901,0.8823102971230318,1.0,5/10,31.20%,CDC42;RACGAP1;ECT2;KNSTRN;SPAG5
prerank,peptidyl-lysine acetylation (GO:0018394),0.4242960271617776,0.8862047816884454,0.6259541984732825,1.0,1.0,1/10,2.10%,KAT2B
prerank,superoxide metabolic process (GO:0006801),0.34916391576753425,0.8859630968408744,0.6085271317829457,1.0,1.0,6/29,12.96%,NCF1;MT3;NOX1;TAFA4;NCF2;SOD2
prerank,hexose biosynthetic process (GO:0019319),-0.24319292030441678,-0.8858393784166914,0.6844919786096256,0.8820148813618022,1.0,13/42,23.71%,RBP4;CHST15;PGK1;GPI;PGAM1;SORD;CRTC2;SLC25A12;ENO1;GOT1;ATF4;GAPDHS;ENO3
prerank,regulation of protein modification process (GO:0031399),0.31735752653378935,0.8856410627088412,0.636144578313253,1.0,1.0,9/50,10.11%,KAT2B;CADM4;MT3;SOCS1;SPRED2;SPRED1;RABL3;GRM5;SPRED3
prerank,positive regulation of lipid kinase activity (GO:0090218),0.34500460316289694,0.8856068143963114,0.6318607764390897,1.0,1.0,3/29,4.09%,PDGFRA;FGF2;TGFB1
prerank,negative regulation of protein binding (GO:0032091),-0.21519550023763576,-0.8851515971534264,0.6984126984126984,0.8822877828213214,1.0,23/71,24.04%,DAB2;MAP2;ROCK1;PRKCD;IFIT2;TTBK2;KDM1A;CAMK1;GSK3B;RACK1;ADAM15;PEX14;ATP2A3;CAV1;GTF2F1;ZFPM1;HFE;CFHR2;IFIT1;ADRB2;AKT1;ATP2A2;MAPK8
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.262056604513994,-0.885100428327798,0.6681818181818182,0.8811681132160515,1.0,10/29,22.19%,RPS14;RPS16;RPS19;NGDN;HELB;RPS8;NOP9;RPS21;DHX37;MRPS11
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.4260249318473227,0.8846670928922946,0.5971563981042654,1.0,1.0,1/10,0.91%,ETV4
prerank,mRNA 3'-end processing (GO:0031124),0.2966985860561333,0.8846116286135716,0.6475770925110133,1.0,1.0,23/78,24.99%,CSTF3;THOC6;PABPC1;CPSF6;RPRD1A;SRSF11;CASC3;NCBP1;FIP1L1;AHCYL1;SRSF6;PAPOLA;CDC73;RNPS1;THOC7;TENT2;SRRM1;SRSF3;SYMPK;TUT1;THOC5;CPSF7;MAGOHB
prerank,relaxation of muscle (GO:0090075),-0.32991753557287123,-0.8845591617470839,0.5875,0.8811693766317018,1.0,3/13,6.66%,ATP1A2;KCNJ2;ATP1A1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.3669420507164917,0.8841597668730464,0.6145552560646901,1.0,1.0,6/21,15.36%,ANK2;AKAP6;PDE4D;PRKACA;CALM1;CALM2
prerank,positive regulation of rRNA processing (GO:2000234),-0.3539503844267806,-0.8830677657138893,0.5931758530183727,0.8833037065964213,1.0,7/10,26.55%,WDR43;UTP15;BUD23;DIMT1;RIOK1;SIRT7;RIOK2
prerank,histone H3-K4 trimethylation (GO:0080182),0.41825870145926514,0.8829641364630546,0.6144578313253012,1.0,1.0,5/11,23.57%,KMT2A;PRDM9;TET3;KMT2D;TET2
prerank,calcium ion transmembrane transport (GO:0070588),0.2951154349990495,0.8827127412669625,0.673469387755102,1.0,1.0,25/86,21.44%,CACNA2D1;PARL;ANO6;LETM1;ATP2B3;CACNA1A;GRIN2B;SLC8A2;SLC24A5;PMPCB;SLC25A23;ATP2B1;YME1L1;TRPC5;GRIN2D;GRIN2A;PKD1;CACNA2D4;PMPCA;SLC24A4;SLC24A2;RYR3;PHB2;PKD2;P2RX7
prerank,intermediate filament organization (GO:0045109),0.3817282874723663,0.882335503446438,0.632183908045977,1.0,1.0,6/17,23.74%,BFSP1;DNAJB6;GFAP;PKP2;VIM;MTM1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.3490914524685561,0.8822955420386518,0.6153846153846154,1.0,1.0,8/26,15.47%,PAK1;ARL2;CLASP1;SLAIN2;CDK5R1;KATNB1;MET;NAV3
prerank,response to muscle stretch (GO:0035994),-0.3204577637600702,-0.8818734959805798,0.6177474402730375,0.88480108756851,1.0,2/15,2.37%,CDH2;CTNNB1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.29739883586853866,-0.8812092607087288,0.6146788990825688,0.8850248287873971,1.0,6/18,12.06%,RAP1B;RAB5A;DTNBP1;GSK3B;SLC4A8;SNAPIN
prerank,regulation of necroptotic process (GO:0060544),-0.28215550284220914,-0.8808730783275496,0.6411290322580645,0.884595557908696,1.0,9/23,19.95%,BIRC3;STUB1;OGT;CASP8;HSP90AA1;FLOT1;SPATA2;ARHGEF2;CFLAR
prerank,bile acid metabolic process (GO:0008206),0.3417970431732729,0.8806641785859097,0.6222222222222222,1.0,1.0,10/27,25.24%,NPC1;GBA2;CYP39A1;CYP7B1;CYP27A1;OSBPL1A;ACOT8;SCP2;HSD17B4;AMACR
prerank,nucleocytoplasmic transport (GO:0006913),0.3278223511642084,0.880617021229275,0.6506765067650676,1.0,1.0,9/40,17.94%,XPO1;RSRC1;NCBP1;NUP205;NXT1;MALT1;HTATIP2;AAAS;GEMIN7
prerank,cellular respiration (GO:0045333),-0.24679670271327114,-0.8806166446811022,0.6373626373626373,0.8839776011898846,1.0,18/41,28.16%,COQ10B;SDHB;SIRT3;UQCRB;OXA1L;ATP5F1D;ETFRF1;ETFB;SDHA;SDHAF4;UQCR10;UQCRH;UQCRFS1;CYCS;UQCRC1;SURF1;NR4A3;MTFR2
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.35771226111497323,0.8801611416936801,0.6223118279569892,1.0,1.0,7/23,18.15%,BMF;TOMM22;COX18;HSPA4;BCL2L11;NDUFA13;AGK
prerank,regulation of mitotic cell cycle (GO:0007346),0.28223740748459214,0.8800769426476921,0.7316821465428277,1.0,1.0,53/171,26.36%,PRKCA;KIF20B;TGFB1;CCDC57;CKS1B;OBSL1;CDK13;GBF1;PSMB7;ASNS;RCC1;ANAPC7;PKMYT1;CDC25B;ANAPC2;TMEM8B;SCRIB;DDB1;NEK7;SMOC2;BUB1B;PSMD2;IQGAP1;PIM2;PSMC1;CDC23;ANAPC16;HNRNPU;USP2;PSMB2;FBXO5;MDM2;PKN2;PSMD9;CDC27;TRIM35;PSME4;UBE2E1;PSMA8;HECA;ANAPC4;CDK9;ANAPC5;CDC16;CYLD;RB1;CUL1;BTG3;RNF20;DAPK3;PSMD8;PSMD13;CDK5RAP3
prerank,negative regulation of coagulation (GO:0050819),-0.32706453034357047,-0.8800418772228253,0.6217008797653959,0.8840551002299051,1.0,3/14,2.75%,VTN;THBD;TFPI
prerank,body fluid secretion (GO:0007589),0.3876906423121169,0.879876720123193,0.5979827089337176,1.0,1.0,4/15,17.76%,VEGFA;ERBB4;PRLR;GPAT4
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.34944025246826027,0.8798391976708734,0.6264744429882044,1.0,1.0,6/26,19.59%,ANK2;STK39;NEDD4L;ITGB1;NETO1;CAB39
prerank,regulation of BMP signaling pathway (GO:0030510),0.2969920185323746,0.879731703686729,0.6741321388577828,1.0,1.0,14/73,16.32%,SOSTDC1;SULF1;HTRA3;SOX11;PCSK6;FBXL15;SFRP4;DAND5;BMPER;BMPR1A;UBE2O;XIAP;VWC2;LRP2
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.3690610857517702,0.8797278571783729,0.6100981767180925,1.0,1.0,6/19,15.41%,MAP4K4;VEGFA;TSC1;PTPRJ;MYOC;ABL1
prerank,negative regulation of potassium ion transport (GO:0043267),0.3963698587831025,0.8796279589710553,0.608955223880597,1.0,1.0,5/13,19.59%,BIN1;STK39;NEDD4L;KCNH2;CAB39
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.32607421331171005,-0.87918224992785,0.6265060240963856,0.8847420173252003,1.0,5/13,14.52%,NFKBIA;GOPC;KEAP1;GET4;MDFI
prerank,negative regulation of protein catabolic process (GO:0042177),0.3202283263165037,0.8791243159392992,0.6402439024390244,1.0,1.0,17/40,28.35%,EGFR;FMN2;IRAK3;FLNA;ATRAID;SNCA;MDM4;SNX12;AZIN2;SF3B3;AGAP2;PRKCG;HMGCR;CDK5RAP3;PIN1;CYP51A1;SIRT2
prerank,detection of visible light (GO:0009584),0.38064087156213683,0.8790024032720154,0.6244604316546762,1.0,1.0,1/16,1.72%,RHO
prerank,axonemal dynein complex assembly (GO:0070286),0.34751136549872474,0.8787881539963038,0.6314432989690721,1.0,1.0,2/27,3.01%,DNAI4;CCDC39
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.32835461776663194,0.8787611357424757,0.6242274412855378,1.0,1.0,5/35,10.30%,CRLF3;CYP1B1;SOCS1;NF2;ERBB4
prerank,programmed necrotic cell death (GO:0097300),0.3804035761212279,0.8786150730204493,0.6103151862464183,1.0,1.0,4/18,19.05%,ITPK1;TICAM1;RIPK1;MLKL
prerank,monocarboxylic acid metabolic process (GO:0032787),0.28693495341433883,0.8785680454442497,0.7032734952481521,1.0,1.0,13/117,9.85%,CYP2S1;KYNU;THEM4;SLC27A4;NPC1;GBA2;MCCC1;HLCS;ACOT11;FASN;GOT2;ACSF2;MCCC2
prerank,response to organic cyclic compound (GO:0014070),0.31191169163446875,0.8785089265716329,0.657010428736964,1.0,1.0,8/52,13.01%,KYNU;TGFB1;HLCS;CYP1B1;IL18;ESR1;ARL6IP5;DRD2
prerank,regulation of vesicle-mediated transport (GO:0060627),0.29431426847774705,0.8783540102879084,0.6969365426695843,1.0,1.0,25/91,19.65%,OLFM4;STON2;PLD1;PACSIN2;SYT1;STON1;RAB21;HIP1;PTPN1;RAB3D;OPHN1;MAPK1;BET1L;STXBP5;RAB4B;RAB3A;RAB4A;ARFGAP1;ABL1;SNX12;DENND10;RIMS2;RAB3B;RINT1;MBTPS1
prerank,mitochondrial translational termination (GO:0070126),0.29210908127538804,0.8776780853746285,0.6943231441048034,1.0,1.0,24/88,22.77%,MRPL47;MRPS18A;MRPL14;MRPL32;MRPL16;MRPL58;MRPS35;MRPS28;AURKAIP1;MRPL35;MRPL28;MRPL30;MRPL46;MRPL51;MRPS30;MRPS14;MRPL1;DAP3;MRPS9;MRPS31;MRPS6;PTCD3;MRPL52;MRPL18
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.294271484377053,0.8773485697250745,0.6865342163355408,1.0,1.0,16/85,22.04%,ROR2;WNT5A;FZD7;PRICKLE2;PSMB7;PRICKLE1;MAGI2;DVL1;PSMD2;PSMC1;PSMB2;PSMD9;PSME4;PSMA8;DVL3;ARRB2
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.28477603776152616,0.8771761258198442,0.7142857142857143,1.0,1.0,30/124,21.03%,CDNF;DOCK7;WDPCP;PPP1R9A;ATXN10;GPM6B;PLP1;NLGN1;CNTNAP2;GPM6A;VAPA;GDNF;OPHN1;PRMT1;STMN4;CDK5R1;MYOC;CDK16;CORO1B;CYFIP1;CFAP61;CTTN;LRP12;CAMSAP1;CNTN4;MICALL2;NPY;LAMB1;CEP78;PKD2
prerank,positive regulation of histone modification (GO:0031058),0.3341451521638119,0.8768327541043204,0.6386138613861386,1.0,1.0,3/33,8.78%,FAM47E;RPS6KA4;BRCA1
prerank,negative regulation of hemostasis (GO:1900047),-0.3407619688967696,-0.8764685347544235,0.6038251366120219,0.8896593165028144,1.0,3/12,2.75%,VTN;THBD;TFPI
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.3827147003995803,0.8758842592913046,0.6337817638266069,1.0,1.0,3/14,13.43%,SOCS5;IL18;MALT1
prerank,protein ubiquitination (GO:0016567),0.2715112228785183,0.87579962791426,0.833,1.0,1.0,111/471,20.30%,UBE2T;PDZRN3;RNF157;BCL2;CBFB;FBXW9;PRKN;DTX4;UBE2E2;HACE1;WAC;TRIM44;NFX1;FBXW7;SPSB4;KLHL13;RNF6;FBXO7;SPOP;ZNRF2;FBXL15;ASB5;DDB2;FBXO32;TRIM2;TRIM11;OTULIN;PELI1;HECTD2;BRCA1;UBE2K;FBXL16;PSMB7;RNFT1;FBXO27;VPS11;HIF1A;SELENOS;LNPEP;CUL3;UBE2Z;UHRF2;THOP1;FBXO45;ANAPC7;FBH1;CBL;HUWE1;NFE2L2;UBE2J2;UCHL3;TSPAN17;TRIM41;MYLIP;FBXO17;ATG3;FBXL2;DDB1;KLHL12;AKTIP;NEDD8;DET1;TRIM23;NEDD4L;TRAF7;DDA1;KLHL22;PSMD2;AREL1;UBB;UBE2O;RNF19A;PSMC1;RNF111;CDC23;RCHY1;UBOX5;ZSWIM8;UBE2Q1;ANAPC16;FBXL4;MIB1;RNF182;CUL4B;CDC73;RNF10;PSMB2;RNF167;FBXO31;UBA1;RC3H1;MDM2;FBXO22;ELOC;PSMD9;RNF4;TAF1;PCNP;UBE2L3;USP5;FBXL12;CDC27;TRIM35;PSME4;TRAIP;FBXO11;RRAGA;BCL10;UBE2G1;UBE2E1;NPEPPS
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.26360405953151966,-0.8757241139119594,0.6974789915966386,0.8900264307969714,1.0,2/26,0.63%,IGF1;FHL2
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.41008054272136074,0.8755154772083016,0.6290571870170015,1.0,1.0,3/11,14.58%,CD34;GATA6;BMPR1A
prerank,epithelial to mesenchymal transition (GO:0001837),0.3130393049900295,0.8753198323111553,0.6299879081015719,1.0,1.0,10/47,11.32%,S100A4;SOX9;TGFB1;WNT5A;HNRNPAB;LOXL3;FGFR1;HIF1A;AMELX;BMP7
prerank,regulation of inclusion body assembly (GO:0090083),-0.3415669407252844,-0.8752553237746795,0.5929203539823009,0.8898850792430989,1.0,1/11,0.32%,SNCAIP
prerank,regulation of RNA metabolic process (GO:0051252),0.3092674001232022,0.8751051575388423,0.6706021251475797,1.0,1.0,15/59,22.54%,PRX;TRA2B;ZNF326;RASA1;SON;PCBP4;NOVA1;RC3H1;FUS;HNRNPH2;MITF;HNRNPL;AFF2;AHNAK;PTBP2
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.2089367390888226,-0.8750348192176094,0.7857142857142857,0.8891363318373875,1.0,23/87,18.47%,KANK2;DCUN1D3;PSMD14;BRD7;USP47;FBXL7;PSMB3;ZFP36L1;PSMD12;RGCC;KLF4;PRMT2;PSMD6;PSMA1;FAM107A;PSMD7;PSMA5;PSMC5;PINX1;PSMC4;CDK4;PSMB6;RBL1
prerank,regulation of hydrolase activity (GO:0051336),0.29795929024661433,0.8749866033068139,0.6603351955307263,1.0,1.0,9/71,8.26%,SIPA1L1;PLXNC1;FGD4;EFNA5;NTRK2;NF1;CHN1;ARHGAP9;VAV3
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.3297125385081994,0.8748972763292906,0.6534526854219949,1.0,1.0,5/35,6.16%,PDGFRA;NTRK3;SEMA3E;IQGAP2;BAIAP2
prerank,in utero embryonic development (GO:0001701),0.34695686197453224,0.8747034418743119,0.6229729729729729,1.0,1.0,6/25,17.36%,SOX8;VEGFA;EGFL8;PKD1;TGFB3;MYH6
prerank,regulation of catabolic process (GO:0009894),0.36919349445773825,0.8742691775971044,0.6320224719101124,1.0,1.0,6/18,21.71%,FAP;NEDD4L;ITGB1;MDM2;FURIN;RARRES2
prerank,aromatic amino acid family metabolic process (GO:0009072),0.40957721798689684,0.8740517002361776,0.5920245398773006,1.0,1.0,2/10,9.87%,KYNU;IL4I1
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.34346989612413487,0.8740023949588215,0.6458072590738423,1.0,1.0,3/28,6.31%,EGFR;FBXW7;METTL3
prerank,endocardial cushion morphogenesis (GO:0003203),0.37033936660540573,0.8739382764700165,0.6248216833095578,1.0,1.0,6/18,17.26%,SOX9;ACVR1;TGFBR2;MDM4;BMPR1A;HEYL
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.36739313644517685,0.8736795035353369,0.6320224719101124,1.0,1.0,7/18,21.84%,SLC43A1;BIN1;STK39;NEDD4L;KCNH2;CAB39;CAMK2D
prerank,regulation of protein kinase C signaling (GO:0090036),0.38654721082993926,0.8735839506016022,0.6329305135951662,1.0,1.0,2/14,5.26%,VEGFA;WNT5A
prerank,positive regulation of defense response to virus by host (GO:0002230),0.35010498596142237,0.8734040413583827,0.642570281124498,1.0,1.0,2/24,3.78%,PTPN22;TRIM44
prerank,carbohydrate transport (GO:0008643),0.3989291072879455,0.8730312133854756,0.636085626911315,1.0,1.0,2/11,10.80%,SLC50A1;SLC2A2
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.2964667986680861,0.8726365466971906,0.6805708013172338,1.0,1.0,28/78,23.35%,PRKN;SOCS5;CBFA2T3;HERPUD1;NFE2L2;PRICKLE1;SIRT6;DVL1;CSNK1A1;DET1;SUMO1;DDA1;RNF19A;RCHY1;CSNK1E;MDM2;FBXO22;NKD2;ZER1;TAF1;USP5;BBS7;SGTA;UBQLN1;ZYG11B;COP1;ELOB;UBQLN2
prerank,protein modification process (GO:0036211),0.29548435092836317,0.8724965664620297,0.6608122941822173,1.0,1.0,23/76,21.95%,CHRM3;TGM1;ARAF;MMP15;CDKL3;UBA3;SLC35A1;ATG3;FBXL2;NEDD8;ABL1;USP25;FBXO22;UBE2L3;RPN1;FBXO11;CSNK1G3;MCRS1;DUSP12;PLAT;YES1;UBE2D3;ERO1A
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.3863762573778165,0.8722571744873376,0.6528803545051699,1.0,1.0,2/15,6.42%,PDGFRA;TGFBR2
prerank,sterol transport (GO:0015918),0.36104280975379055,0.8715794675641402,0.6411682892906815,1.0,1.0,2/19,5.37%,NPC1;OSBPL5
prerank,acute-phase response (GO:0006953),-0.33876008793172663,-0.8714270429763392,0.5880503144654088,0.8960460520751802,1.0,2/12,10.15%,PLSCR1;IL6R
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.29865093250752495,0.8713349267765544,0.674496644295302,1.0,1.0,24/76,23.05%,PTEN;PRKN;SOCS5;FBXW7;CBFA2T3;PRICKLE1;DVL1;CSNK1A1;DET1;SUMO1;DDA1;RNF19A;RCHY1;CSNK1E;MDM2;FBXO22;NKD2;ZER1;TAF1;USP5;BBS7;ZYG11B;COP1;ELOB
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.34185925071690354,0.8712301600949427,0.6384915474642393,1.0,1.0,4/27,13.01%,LPAR1;GPR65;HTR2C;DRD2
prerank,regulation of cellular senescence (GO:2000772),-0.2665733641164416,-0.8709014444225721,0.6496062992125984,0.8960313233303907,1.0,12/28,22.51%,NUAK1;SLC30A10;YBX1;TERF2;ING2;HMGA2;TERT;ABI3;RBL1;TWIST1;VASH1;EEF1E1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.22856708167869116,-0.870746851377926,0.7183908045977011,0.8951384565848624,1.0,11/47,12.55%,PRKCD;TLR4;THBS1;AGTR1;DHRS4;RNF41;XDH;CYBA;PDGFRB;SOD1;MAPT
prerank,purine-containing compound catabolic process (GO:0072523),0.3942967695736783,0.8707249969756161,0.6299694189602446,1.0,1.0,2/13,6.51%,NUDT15;NT5C2
prerank,histone H3-K9 demethylation (GO:0033169),-0.33961858343835494,-0.8704442849924116,0.64375,0.8946271559263146,1.0,5/11,19.60%,KDM1A;KDM4C;KDM4D;KDM3B;HR
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.27158610505664726,-0.8703881774008293,0.6743295019157088,0.8935182158348725,1.0,14/25,37.46%,AMPD3;PRPSAP2;PRPS2;DCK;GART;PRPS1;PRPS1L1;APRT;GMPS;PNP;ADA;SHMT2;SHMT1;PRPSAP1
prerank,neuron projection fasciculation (GO:0106030),0.418754728126807,0.8702330042434308,0.6434231378763867,1.0,1.0,5/10,19.33%,NRCAM;EPHB2;CDK5R1;RTN4;CNTN4
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.2822797189212335,-0.8694644933038191,0.6602316602316602,0.8942813901106191,1.0,4/23,7.35%,ACSL1;ELOVL7;FAR2;ACSL5
prerank,protein deubiquitination (GO:0016579),0.2769172640360655,0.8692402598561287,0.7890466531440162,1.0,1.0,62/242,22.22%,USP50;MYC;PTEN;RAD23B;USP35;KAT2B;USP11;PRKN;DDB2;OTUD7B;UCHL5;OTULIN;INO80E;BRCA1;UCHL1;PSMB7;HIF1A;USP46;TOMM20;MYSM1;USP33;UCHL3;ESR1;NFRKB;USP32;USP48;GATA3;USP40;NEDD8;MDM4;USP14;IL33;PSMD2;UBB;TRRAP;PSMC1;ASXL2;TP53;USP25;USP21;USP1;USP2;RIPK1;PSMB2;MDM2;USP37;OTUD4;OTUD7A;RHOT1;PSMD9;ATXN7;USP5;PSME4;MCRS1;MBD6;PSMA8;USP13;JOSD1;TNIP2;USP31;ARRB2;ACTR5
prerank,negative regulation of developmental process (GO:0051093),-0.2134980794135433,-0.8689835827871665,0.7547169811320755,0.894044778023182,1.0,25/69,23.00%,ROCK2;NFIB;ROCK1;NOS3;BMP4;PARP3;TBX1;ARHGEF15;TFRC;IL17D;NOTCH4;VAT1;MAPT;SINHCAF;ARPIN;FUZ;HEY2;RPS6KA6;SUZ12;PINK1;GRIN3A;WNT11;VASH1;HOPX;MUL1
prerank,mRNA processing (GO:0006397),0.27020752891253674,0.8688515830742388,0.7977867203219315,1.0,1.0,92/287,26.01%,CSTF3;DHX8;THOC6;TRA2B;GTF2H2;PABPC1;CPSF6;RNGTT;RSRC1;RPRD1A;POLR2B;METTL3;DHX35;SON;RNPC3;SRSF11;CWF19L2;RBM10;TXNL4A;POLR2K;AURKAIP1;CASC3;ALKBH5;SNRPB2;NCBP1;FIP1L1;SFPQ;SNRNP40;HNRNPA3;LSM3;PRKACA;PRPF18;PRPF6;RBM4B;DDX42;POLR2G;SRSF6;NOVA1;YTHDC1;RNMT;PAPOLA;PPIH;RAVER2;SNRPA;SF3A1;HNRNPU;RNPS1;SF1;FUS;GEMIN7;SART1;SYNCRIP;DDX23;THOC7;POLR2A;CMTR2;HNRNPUL1;SRRM1;PRMT9;SF3B3;DBR1;HNRNPH2;HNRNPC;HNRNPL;SRSF3;RBM17;SNIP1;SNRPN;DNAJC8;SYMPK;SNRNP200;PLRG1;RBMX2;SF3B2;WBP4;CTNNBL1;PCBP2;THOC5;CCNH;POLR2F;TFIP11;CPSF7;MAGOHB;NONO;SCAF11;U2SURP;SNRPA1;RBM15;SPEN;RBM4;TRA2A;HNRNPA2B1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.3052806324932435,0.8688119143663711,0.660092807424594,1.0,1.0,12/50,18.64%,DPEP1;NGF;VEGFA;MT3;PIH1D1;NGFR;DNAJB6;SNCA;XIAP;PAX2;FNIP1;PARK7
prerank,modulation by symbiont of host process (GO:0044003),-0.35094106929460644,-0.8687261095193187,0.6260869565217392,0.8933560764290505,1.0,4/10,24.90%,PGK1;ENO1;MRC1;UBA52
prerank,negative regulation of cell growth (GO:0030308),0.2801484915689254,0.8683648569871494,0.7007376185458377,1.0,1.0,11/121,6.39%,DCBLD2;FGF13;CRLF3;VGLL4;FRZB;JADE1;TGFB1;RNF6;MT3;APBB2;CDKL3
prerank,mitotic DNA replication (GO:1902969),-0.3536150888059622,-0.8683560749680685,0.6347826086956522,0.892964118945682,1.0,7/10,33.99%,POLA1;MCM6;LIG1;CDC45;GINS1;MCM3;MCM2
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.3014783543250033,0.8681414918496726,0.6816091954022988,1.0,1.0,12/59,9.58%,TENM3;PTPRT;DSG2;OBSL1;CADM3;KIRREL3;HMCN1;CNTN6;CNTN2;CADM1;PALLD;DSCAM
prerank,positive regulation of cyclase activity (GO:0031281),-0.31920589887422207,-0.8680630777177462,0.6537216828478964,0.8923618273413199,1.0,6/14,24.04%,CACNA1C;NOS3;STIM1;NOS1;CACNA1D;MAPK8
prerank,synaptic membrane adhesion (GO:0099560),0.3804605749265345,0.8679121737205151,0.6333853354134166,1.0,1.0,6/14,20.04%,LRRC4C;NTNG1;GPC4;PTPRF;LRFN5;PTPRS
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.36542237328038285,0.8676982110892536,0.632088520055325,1.0,1.0,7/19,17.06%,DLG2;PATJ;ERBIN;SCRIB;PARD3B;FSCN1;FOXJ1
prerank,regulation of establishment of planar polarity (GO:0090175),0.2901898679998317,0.8674659074045428,0.7092511013215859,1.0,1.0,16/88,22.04%,ROR2;WNT5A;FZD7;PRICKLE2;PSMB7;PRICKLE1;DVL1;PSMD2;DACT1;PSMC1;PSMB2;PSMD9;PSME4;PSMA8;DVL3;ARRB2
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.3650219527343591,0.8674065159670108,0.6414285714285715,1.0,1.0,6/18,17.28%,NF1;TMEM98;DAAM2;PTPRZ1;OPALIN;MDK
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.2934321147751414,-0.8674018695974728,0.6534653465346535,0.8925438186131548,1.0,7/17,18.42%,PTPA;PPP1R15B;PDGFRB;ITGA1;PTPRC;CD300A;HSP90AB1
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.41432583452179395,0.8672482879278125,0.6188271604938271,1.0,1.0,3/10,12.13%,ATRX;BRCA1;JARID2
prerank,cilium movement (GO:0003341),0.31682882530960543,0.8670627021211215,0.6591981132075472,1.0,1.0,7/47,17.83%,DNAI4;CCDC39;DNHD1;CFAP91;CFAP61;DNAAF2;RSPH9
prerank,purine ribonucleotide transport (GO:0015868),-0.3103070234156121,-0.8669960262578416,0.662020905923345,0.8921937237126698,1.0,4/16,13.39%,ABCC4;ABCC6;LRRC8C;LRRC8A
prerank,positive regulation of nervous system process (GO:0031646),-0.3006487258299675,-0.8666895883597806,0.6296296296296297,0.8916791554643073,1.0,4/18,10.24%,NLGN2;PARD3;ATPSCKMT;UNC13B
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.3274350197573414,0.8666797734318922,0.6683608640406608,1.0,1.0,14/36,25.77%,WAC;UCHL5;BAG5;TLK2;OPHN1;TAF9;GABARAPL2;USP25;N4BP1;PARK7;CAMLG;PRKCG;ALAD;FHIT
prerank,activation of protein kinase B activity (GO:0032148),0.3342052836008467,0.8666181349140034,0.6466753585397653,1.0,1.0,5/29,8.10%,NTRK3;MT3;WNT5A;MAPKAP1;IL18
prerank,glucan catabolic process (GO:0009251),0.37922810962387066,0.8665738694022389,0.6534653465346535,1.0,1.0,3/15,14.73%,PYGL;PHKB;CALM1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.31767682946700293,-0.8665641722122944,0.6037037037037037,0.8907319568302329,1.0,5/16,7.38%,IGF1;ROCK2;ROCK1;MTPN;PARP1
prerank,regulation of GTPase activity (GO:0043087),0.2744202596785353,0.8665126343111058,0.7535787321063395,1.0,1.0,18/177,8.26%,CCL11;SIPA1L1;ERBB2;PLXNC1;FGD4;EFNA5;MAP4K4;CCL4;NTRK2;NF1;ALS2;CHN1;CDKL5;DOCK10;RAP1A;ARHGAP9;ZC3H15;VAV3
prerank,DNA conformation change (GO:0071103),0.3739957740351587,0.8661619180513445,0.6192528735632183,1.0,1.0,5/17,21.77%,HAT1;ABL1;NAA10;TOP1;TOP3A
prerank,positive regulation of proteolysis (GO:0045862),-0.222482385951504,-0.8660414870833933,0.7555555555555555,0.8906152135454923,1.0,11/55,12.11%,CTSH;CCBE1;SNX9;CTSC;STUB1;OGT;TNIP1;CASP8;MAPK12;ADRA2A;PERP
prerank,positive regulation of vasculature development (GO:1904018),0.2866036679458267,0.8657675193367924,0.7166123778501629,1.0,1.0,25/94,18.67%,PRKCA;FGF2;CD34;VEGFA;PAK4;ITGB8;WNT5A;HSPB6;CYP1B1;GATA6;BRCA1;HIF1A;SP1;RUNX1;MYDGF;GRN;SMOC2;PDCL3;ITGB1;JUP;GAB1;HYAL1;APLNR;EMC10;HK2
prerank,response to interleukin-6 (GO:0070741),-0.35020345117659546,-0.8653123433428259,0.6388888888888888,0.8909645897824974,1.0,3/10,9.21%,PTGIS;ST3GAL6;SBNO2
prerank,regulation of histone acetylation (GO:0035065),0.3321847707298808,0.8652853555822712,0.6484771573604061,1.0,1.0,9/33,19.35%,KMT2A;RPS6KA4;BRCA1;SETD5;SNCA;TAF7;CTBP1;PARK7;RUVBL2
prerank,lysosome localization (GO:0032418),-0.24592399809707258,-0.8650572771764169,0.7193877551020408,0.890301905265363,1.0,14/37,19.80%,KIT;MYH9;PLEKHM1;FAM98A;KIF5B;FLCN;BORCS5;SNAPIN;SYTL4;PIP4P1;TMEM106B;PLEKHM2;TFEB;LAMTOR1
prerank,cellular response to nutrient levels (GO:0031669),0.2996692102435995,0.8648352832324884,0.6885617214043035,1.0,1.0,20/62,24.63%,CDKN2B;NUPR2;WIPI1;TSC1;RALB;EIF4G1;USP33;CLEC16A;VPS41;SREBF2;WRN;RPTOR;FNIP1;RRAGA;LAMP2;PRKAA1;INHBB;MTOR;WDR45B;EHMT2
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3011164487695291,0.864702957857237,0.6863425925925926,1.0,1.0,17/59,22.33%,PTEN;CBFB;SOX9;CCNC;MED31;CDK8;MED13;MED12;MED25;TP53;MED30;MED8;JUN;MITF;NFKB1;THRA;MED24
prerank,regulation of protein processing (GO:0070613),0.3535567550378316,0.864396560943621,0.636986301369863,1.0,1.0,6/21,21.24%,PRNP;SERPINE2;RUNX1;SNX12;NKD2;RHBDD1
prerank,inositol phosphate dephosphorylation (GO:0046855),0.4065517004409971,0.8643406867382137,0.6352395672333848,1.0,1.0,1/11,1.62%,PTEN
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.4065517004409971,0.8643406867382137,0.6352395672333848,1.0,1.0,1/11,1.62%,PTEN
prerank,regulation of axon extension (GO:0030516),0.31677619476159896,0.8643217625954134,0.6481012658227848,1.0,1.0,13/37,20.25%,NRCAM;SEMA3A;RNF6;MT3;CDKL5;CDKL3;LIMK1;RTN4;ABL1;DIP2B;CTTN;PTPRS;SHTN1
prerank,response to UV (GO:0009411),0.2859058089980447,0.8642375540865364,0.7041036717062635,1.0,1.0,26/95,21.24%,MYC;EGFR;ZRANB3;GTF2H2;ERCC5;NSMCE3;ERCC4;DDB2;METTL3;BMF;MEN1;XPA;MSH6;ZBTB1;MAP3K4;TP53;USP1;N4BP1;REV1;WRN;CAT;TAF1;RUVBL2;SCARA3;BCL3;RHBDD1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.33177155404607267,0.864099648395621,0.6475095785440613,1.0,1.0,6/32,15.05%,PRKCQ;CCT7;MAPK1;NEK7;MAP3K4;ATM
prerank,myeloid cell differentiation (GO:0030099),0.310471307392425,0.8639200585884119,0.6772228989037758,1.0,1.0,9/47,12.92%,CDKN2B;PTPN2;PRKX;SLC25A38;ZBTB16;UFL1;KAT8;RUNX1;PRDX3
prerank,negative regulation of cholesterol transport (GO:0032375),0.41814744270681914,0.8636799662283062,0.6446540880503144,1.0,1.0,2/10,20.84%,SREBF2;NFKB1
prerank,positive regulation of vasculogenesis (GO:2001214),0.42031419398709613,0.8632092735316249,0.6422893481717011,1.0,1.0,2/10,7.56%,CD34;RAP1A
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.3307339459170282,0.8630680447483071,0.6573957016434893,1.0,1.0,3/32,5.09%,DLC1;TGFB1;PPP1R15A
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.2940016294085127,0.8630231365662558,0.7018909899888766,1.0,1.0,22/73,24.58%,GLMN;KAT2B;TAF1A;EED;POLR2K;HDAC6;CREBZF;JARID2;EPC1;RBBP4;POLR1B;BAZ1B;PHF19;POLR1C;POLR1G;CGGBP1;RBBP7;TDG;MPHOSPH8;AEBP2;POLR2F;TBP
prerank,neural crest cell differentiation (GO:0014033),0.3754673907706808,0.8630158432861839,0.6690042075736325,1.0,1.0,2/18,4.42%,SOX8;SOX11
prerank,protein O-linked glycosylation (GO:0006493),0.286657189643626,0.8629124804753988,0.7003293084522503,1.0,1.0,23/96,18.76%,GALNTL6;ST3GAL4;TMTC2;GALNT9;GALNT1;PLOD1;RXYLT1;POMGNT2;C1GALT1;GALNT15;GALNT7;GALNT13;GALNT6;GALNT3;TMTC3;MUC3B;MUC3A;TET3;DPM1;FKTN;POGLUT2;GALNT11;FKRP
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.3820207355164485,0.8629087027484671,0.6340740740740741,1.0,1.0,1/14,0.97%,MEOX2
prerank,cellular response to zinc ion (GO:0071294),0.3808098350138241,0.8627502625150287,0.6319018404907976,1.0,1.0,9/15,28.53%,MT3;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,fatty acid beta-oxidation (GO:0006635),0.3107908089371664,0.8626826409501355,0.6837806301050176,1.0,1.0,15/51,22.52%,GCDH;IVD;ETFA;HADHA;ACOX1;MTLN;ABCD2;EHHADH;AUH;CRAT;ACAA2;DECR1;ACOT8;ACADS;SCP2
prerank,regulation of calcium-mediated signaling (GO:0050848),0.35192811999587936,0.8624469096379241,0.6537949400798935,1.0,1.0,3/25,8.12%,BST1;CCL4;SLC8A2
prerank,glycerolipid catabolic process (GO:0046503),0.35679189191226385,0.8623599417133385,0.6347469220246238,1.0,1.0,6/19,19.70%,PRDX6;ENPP6;LYPLA2;ABHD6;GDPD3;PLA2G4E
prerank,double-strand break repair (GO:0006302),0.27680429654754934,0.8622753103473432,0.7403545359749739,1.0,1.0,30/158,16.10%,POLN;MEIOB;APTX;AP5S1;ERCC5;ERCC4;REV3L;KDM4B;SETMAR;RPA3;ATP23;BRCA1;TDP1;NHEJ1;FBH1;SFPQ;NSD2;XRCC3;XRCC6;MDC1;HELQ;HPF1;EXD2;RPA2;SUMO1;BAZ1B;ATM;RAD52;BLM;SPIDR
prerank,ganglioside metabolic process (GO:0001573),-0.2885840300122026,-0.8617463893246673,0.651685393258427,0.8964478542191251,1.0,2/20,2.05%,ST6GALNAC3;ST8SIA4
prerank,protein import (GO:0017038),0.2897137600627214,0.8615548760151067,0.6978021978021978,1.0,1.0,23/84,20.96%,ACBD5;PEX3;PXMP2;NUP155;FAM53B;TOMM22;HSPA4;IPO9;PRICKLE1;KPNB1;NXT1;IPO13;EIF4ENIF1;GDAP1;POM121;ABCD2;TNPO3;STAT3;IPO5;CSE1L;PHB2;LAMP2;HEATR3
prerank,dendritic spine organization (GO:0097061),0.33954213126175803,0.8613898473812742,0.6648351648351648,1.0,1.0,6/26,11.49%,PTEN;EPHB2;PRNP;DOCK10;FYN;DIP2A
prerank,response to nutrient levels (GO:0031667),-0.2980843651706918,-0.8611753824666003,0.6306620209059234,0.8964627550477223,1.0,6/17,21.35%,RPS6KB1;PRKAA2;KCNB1;FAM107A;ATF4;ULK1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.325503655405139,-0.8607168676202626,0.6209912536443148,0.8962839566451738,1.0,4/12,22.82%,WNK1;ASS1;SKAP1;AKT1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.40231037702248884,0.860657519822297,0.6293494704992436,1.0,1.0,4/10,18.64%,GPR37;NFE2L2;RIPK1;PARK7
prerank,regulation of chromatin binding (GO:0035561),0.4059569678517593,0.860601836115154,0.6257668711656442,1.0,1.0,1/10,1.32%,DDX11
prerank,cellular protein-containing complex assembly (GO:0034622),0.27691272134284484,0.8605939238804201,0.7605344295991778,1.0,1.0,23/159,15.31%,STXBP6;SGIP1;DNAI4;CCDC39;VAMP4;TBCE;TGFB1;SHQ1;EPS15;BIN1;GTF2B;HIP1;ARL2;HSPA4;NDC1;NUP205;POGZ;TBCC;PRLR;NCK1;SNCA;RTN4;CCDC65
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.284795592009968,0.8604568464552673,0.6925566343042071,1.0,1.0,16/86,15.84%,BMP5;SULF1;CDKN2B;ACVR1;TGFB1;SOX11;GDF9;FBXL15;MEN1;BMP7;ZEB2;BMPR1A;CITED2;UBE2O;TGFB3;RNF111
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.39022301956895983,0.8602462472509683,0.6400580551523948,1.0,1.0,7/13,31.11%,PLCB1;GRB2;STAT3;STAT5A;JAK3;SHC1;IL15RA
prerank,cellular response to interleukin-15 (GO:0071350),0.39022301956895983,0.8602462472509683,0.6400580551523948,1.0,1.0,7/13,31.11%,PLCB1;GRB2;STAT3;STAT5A;JAK3;SHC1;IL15RA
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.39453968197481154,0.8600969979702119,0.6519083969465649,1.0,1.0,3/11,17.26%,BCL2;TAF9;CD74
prerank,regulation of stem cell population maintenance (GO:2000036),-0.2959597853930367,-0.8600950304432784,0.6445993031358885,0.896508800857107,1.0,6/18,14.46%,PTN;WDR43;CNOT1;ELAVL1;TAF6L;HMGA2
prerank,actin filament capping (GO:0051693),0.3670733233427904,0.8600619697905624,0.6531468531468532,1.0,1.0,2/18,2.28%,ADD3;GSN
prerank,barbed-end actin filament capping (GO:0051016),0.3670733233427904,0.8600619697905624,0.6531468531468532,1.0,1.0,2/18,2.28%,ADD3;GSN
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.2067798741751132,-0.859979945152246,0.8165137614678899,0.8955489532090956,1.0,14/76,12.84%,PTGIS;CD200;USP7;MAP2K5;NFKBIA;COMMD1;AIM2;PARP10;ANXA4;KLF4;TMSB4X;PRMT2;COMMD7;LRRC14
prerank,receptor internalization (GO:0031623),0.3097641343448711,0.8599147530776016,0.665871121718377,1.0,1.0,9/44,15.26%,DNM1;LRP1;GTF2H2;ACKR3;SNCA;CD9;SNX1;ITGB1;SCYL2
prerank,mesenchyme morphogenesis (GO:0072132),0.369925402899497,0.8594281620007627,0.6446991404011462,1.0,1.0,7/17,23.40%,SOX9;ACVR1;MDM4;BMPR1A;HEYL;TBX2;BMP2
prerank,histone lysine demethylation (GO:0070076),0.34885762633299516,0.8591183465642122,0.6644993498049415,1.0,1.0,5/25,14.04%,KDM8;KDM5B;KDM4B;PHF8;KDM6A
prerank,regulation of protein localization to centrosome (GO:1904779),0.4081754587940746,0.8590408443061364,0.6413690476190477,1.0,1.0,1/10,1.83%,BICD1
prerank,protein localization to synapse (GO:0035418),0.39709993817503153,0.8589574004490773,0.6381381381381381,1.0,1.0,2/12,5.87%,NRXN1;NLGN1
prerank,response to insulin (GO:0032868),0.29182980892480537,0.8588725738043042,0.7031763417305587,1.0,1.0,10/80,10.11%,SLC27A1;IRS2;KAT2B;C2CD5;EPRS1;PDE3B;TSC1;EIF6;SELENOS;PIK3R1
prerank,calcium-ion regulated exocytosis (GO:0017156),0.33102915502526575,0.8588186014746413,0.665359477124183,1.0,1.0,11/27,23.43%,SYT1;PPP3CB;SYT11;SYT12;RIMS1;DOC2B;SYT2;RIMS2;SYT13;SYT3;ARL8B
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.40606142480955176,0.8585830223067492,0.608214849921011,1.0,1.0,6/10,22.42%,PTPN1;PRLR;STAT3;STAT5A;GHR;STAT6
prerank,phosphate-containing compound metabolic process (GO:0006796),0.2718647871571384,0.8584467652604216,0.7838939857288482,1.0,1.0,48/198,22.34%,ITPK1;GFPT2;INPP4B;PLBD1;PTEN;DUSP4;PSPH;EPHB2;TGFB1;PLCB1;ACP2;PAK1;AGPAT2;PPP3CB;PPP3CA;TOLLIP;PPP1CA;PLPPR4;ACYP2;PLAAT3;NUDT10;NUDT3;HDHD2;SHPK;CALM1;PLAA;MINPP1;AGK;DUSP16;NUDT5;HK2;NT5C;STAT3;TOP1;PLA2G4E;BCKDK;PLPPR2;CERKL;DUSP12;INPP5J;PFKFB1;LIMD1;NUDT11;TAOK1;LIMK2;PPM1A;PLPPR1;SLC20A1
prerank,neutral amino acid transport (GO:0015804),0.3304994840642929,0.8583644761288869,0.6394472361809045,1.0,1.0,4/28,11.65%,SLC1A5;SLC36A2;SLC43A1;SLC7A8
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.41492058454386205,0.8583480979635035,0.6525157232704403,0.9997633963682316,1.0,3/10,15.40%,TUT4;NEDD8;UBB
prerank,apoptotic DNA fragmentation (GO:0006309),-0.30207667647750835,-0.8581425464987668,0.6838487972508591,0.898389919517635,1.0,8/16,30.50%,DFFA;H1-0;DNASE2;HMGB2;CASP3;FOXL2;CECR2;DICER1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.4098970323808575,0.8580625705882323,0.6342592592592593,0.9997833127938612,1.0,3/10,21.14%,DLGAP1;BEGAIN;DLGAP3
prerank,eye development (GO:0001654),0.304781996902551,0.8578783011840592,0.6847058823529412,0.999624408752139,1.0,4/54,3.87%,EFEMP1;CHRDL1;COL5A2;MAB21L2
prerank,phosphatidylserine metabolic process (GO:0006658),0.33178271962206274,0.857640528255152,0.6614785992217899,0.9995586416462505,1.0,6/32,12.50%,SLC27A1;MBOAT2;OSBPL5;PLA2G12A;PTDSS1;PLAAT3
prerank,neuromuscular process (GO:0050905),0.3792557935789268,0.8574872899911032,0.6425406203840472,0.9993153687794758,1.0,2/16,4.86%,KCNA1;NRXN1
prerank,mitochondrial translation (GO:0032543),0.2808907797128358,0.8574717784425453,0.7345415778251599,0.9988154203488822,1.0,27/104,22.00%,MRPL47;IARS2;MRPS18A;MRPL14;MRPL32;TUFM;MRPL16;GATB;MRPL58;MRPS35;MRPS28;AURKAIP1;MRPL35;MRPL28;MRPL30;HARS1;MRPL46;MRPL51;MRPS30;MRPS14;MRPL1;DAP3;MRPS9;MRPS31;MRPS6;PTCD3;MRPL52
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.34235526747407913,0.8572523855509895,0.667574931880109,0.9987166718210027,1.0,9/26,24.61%,STXBP4;EFNA5;PPP3CB;CDK16;GPLD1;KLF7;ADCY8;TRPM4;ADCY5
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.3928382879353228,0.8571587311489893,0.6006144393241167,0.9983634287662184,1.0,8/11,30.81%,STAT3;ZFP36;LIMD1;XPO5;FMR1;AJUBA;PUM2;PUM1
prerank,protein targeting to membrane (GO:0006612),-0.19955454692474073,-0.857134493709997,0.8736842105263158,0.8995104269332254,1.0,21/83,17.60%,ZDHHC14;ZDHHC3;PEX13;PARD3;PRKCI;VPS37C;PEX19;ALDH3A2;ZDHHC18;ZDHHC7;AQP11;SRPRA;SRP14;ZDHHC20;MYO1C;PEX14;SSR2;ZDHHC4;PEX26;MICALL1;TAOK2
prerank,signal release from synapse (GO:0099643),0.30700662352362584,0.8569060336682782,0.6773809523809524,0.9983330205553301,1.0,8/43,13.86%,NRXN1;SYT1;SYN1;RIMS1;DVL1;RAB3A;OTOF;SNCA
prerank,early endosome to Golgi transport (GO:0034498),0.40283712336943955,0.8565748346848308,0.6666666666666666,0.9984565805340908,1.0,6/11,23.48%,SNX1;RBSN;SURF4;LMAN1;RAB6A;TRAPPC10
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.36683503958329616,0.85652282726982,0.6492957746478873,0.9980227387659183,1.0,7/18,19.24%,FGF2;FGFR1;AKT3;SP1;SIRT6;MDK;PPARG
prerank,regulation of plasminogen activation (GO:0010755),0.39839359805022934,0.8564817216933663,0.6731927710843374,0.9975708439137423,1.0,3/12,11.81%,SERPINE2;PLGRKT;RUNX1
prerank,cellular response to fluid shear stress (GO:0071498),0.3898990549352235,0.8564654823648832,0.6329704510108864,0.9970747099973883,1.0,3/12,10.66%,HAS2;MAPK7;NFE2L2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.2736692088599411,0.8563034954842392,0.7494866529774127,0.9968544686897401,1.0,40/161,21.67%,TPBGL;RBMS3;LRP4;SOX9;PRKN;FRZB;JADE1;TLE1;GLI1;WNT5A;TBX18;DKK3;PSMB7;SFRP4;CUL3;TMEM131L;PRICKLE1;EMD;DVL1;APC2;CSNK1A1;KLHL12;WWTR1;PSMD2;SCYL2;DACT1;PSMC1;TLE3;MDK;PSMB2;TLE4;NKD2;PSMD9;RUVBL2;PSME4;KREMEN1;PSMA8;LIMD1;IGFBP4;DVL3
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.3654475601006943,0.8561343032815801,0.6352112676056338,0.996639082406642,1.0,7/18,25.06%,TGFB1;CLASP1;RUNX1;FSCN1;BMP2;RB1;COLGALT1
prerank,positive regulation of cell cycle (GO:0045787),0.29632658859203975,0.8560782456715401,0.7009132420091324,0.9962206987190629,1.0,14/62,18.65%,PRKCA;EGFR;TGM1;CCDC57;ASNS;CDC25B;SMOC2;PKD1;CITED2;CCND2;USP2;MDM2;PKN2;MAPRE3
prerank,calcium ion import into cytosol (GO:1902656),0.37688897398132815,0.8557515592748195,0.65379113018598,0.9963408167011681,1.0,4/15,18.72%,CACNA2D1;SLC8A2;MS4A1;SLC24A2
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.30446897481812146,-0.8557224292022363,0.6656151419558359,0.9013396767694645,1.0,2/16,1.85%,ETS1;NFAT5
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.29305006823850344,0.8556713214865326,0.6942528735632184,0.9959784010245697,1.0,8/66,8.94%,SULF1;CDKN2B;SOX9;FBXW7;TGFB1;NF1;CDK6;SPARC
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.3803634901777774,0.8553448272600828,0.6475770925110133,0.9960898096160057,1.0,7/14,25.24%,ACOX1;EHHADH;CRAT;ACOT8;SCP2;HSD17B4;AMACR
prerank,negative regulation of bone mineralization (GO:0030502),-0.31950123635161287,-0.8552619261288036,0.6441717791411042,0.9011218047067922,1.0,8/13,39.69%,SRGN;PTK2B;ENPP1;RFLNA;GREM1;ECM1;AHSG;RFLNB
prerank,neuron projection extension (GO:1990138),0.32421099726994407,0.8552097655300254,0.6811779769526248,0.9958252114464309,1.0,9/32,14.87%,MAP1B;SEMA3A;AUTS2;CDKL3;PPP3CB;SPG11;NRP2;IQGAP1;CYFIP1
prerank,regulation of interleukin-13 production (GO:0032656),-0.32211433608935347,-0.8549818749576149,0.676829268292683,0.900503106919156,1.0,5/13,25.64%,LEF1;PRKCZ;RARA;SPHK2;TNFRSF21
prerank,negative regulation of T cell differentiation (GO:0045581),-0.34231373304344337,-0.8544858747669727,0.6403508771929824,0.9003842017555104,1.0,3/10,10.03%,BMP4;GLI3;IRF1
prerank,ion transport (GO:0006811),0.27989566378892783,0.8544284954837889,0.7417640807651434,0.9968082452397937,1.0,11/111,8.93%,PIEZO2;SLC1A3;VDAC2;SLC12A3;SLC17A5;ANO6;CHRNA4;SLC36A2;SLC12A2;SLC8A2;SLC24A5
prerank,cellular response to fatty acid (GO:0071398),0.3941737565313183,0.8540428187804506,0.6432748538011696,0.9970443725198176,1.0,2/12,11.05%,PDK3;PID1
prerank,glycogen catabolic process (GO:0005980),0.37434059506615736,0.8536602136433173,0.6694444444444444,0.997281784088065,1.0,3/15,14.73%,PYGL;PHKB;CALM1
prerank,nucleoside phosphate catabolic process (GO:1901292),0.3762386887296494,0.8534659347639035,0.6464339908952959,0.997114721695825,1.0,2/13,5.29%,NUDT15;ENTPD2
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.3112709028180021,-0.8529221141953593,0.6795252225519288,0.9027117992205048,1.0,6/14,23.22%,PRKCI;THBS1;RGCC;ECSCR;GPER1;CD40
prerank,endodermal cell differentiation (GO:0035987),0.32868262638119977,0.8527482621483737,0.6482412060301508,0.9979249160805401,1.0,4/31,9.84%,MMP2;COL4A2;MMP15;SETD2
prerank,negative regulation of dephosphorylation (GO:0035305),0.3577502029350872,0.8526118086565557,0.6449375866851595,0.9976714180448252,1.0,4/18,8.82%,PPP1R15A;URI1;ENSA;PPP1R8
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.2935520306674006,0.8525977451303695,0.6869965477560415,0.9971727718864788,1.0,11/59,14.08%,PRKCA;ACVR1;WNK3;DYRK4;TGFBR2;DYRK1B;STK39;MAPK1;CDK5R1;TBK1;TTBK1
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.3245620154246532,-0.8525564439547529,0.6436781609195402,0.902283069225866,1.0,5/13,25.37%,TM9SF4;HSP90AB1;ABCA7;SNX33;TYROBP
prerank,histone H4 deacetylation (GO:0070933),-0.34613007371147986,-0.8520573852629302,0.6744791666666666,0.9021285117205445,1.0,4/10,21.78%,HDAC8;HDAC4;SMARCAD1;HDAC3
prerank,adenine nucleotide transport (GO:0051503),-0.29786386345030774,-0.8519856588128061,0.6964285714285714,0.9010889143063086,1.0,4/17,13.39%,ABCC4;ABCC6;LRRC8C;LRRC8A
prerank,protein stabilization (GO:0050821),0.27286407302355414,0.8517587198762171,0.757201646090535,0.9982748758881899,1.0,45/168,23.30%,PTEN;ANK2;STXBP4;PRKN;CCT7;TRIM44;FBXW7;MT3;ATF7IP;TSC1;NAA16;RAB21;RABL3;BAG5;FLNA;HIP1;CRYAB;PIK3R1;USP33;TAF9;DVL1;PER3;GRN;PDCL3;MDM4;SUMO1;RTN4;RASSF2;PIM2;USP2;NAA15;PARK7;TAF1;PHB2;NAPG;LAMP2;HSPD1;USP13;TNIP2;WDR81;DVL3;P3H1;FLOT2;CAMLG;ZBED3
prerank,sensory organ development (GO:0007423),-0.22575539964774166,-0.8517088561512687,0.7548387096774194,0.9004942093397474,1.0,12/51,18.60%,SMOC1;RBP4;SIPA1L3;PBX3;STRA6;ECE1;TGFB2;PBX4;SHROOM2;SMG9;PBX2;MAFB
prerank,regulation of transport (GO:0051049),0.320927548864609,0.8516669093112157,0.6759142496847415,0.9979201674827878,1.0,2/36,2.42%,CLDN19;PRKN
prerank,electron transport chain (GO:0022900),0.3754728922975686,0.8514917670213177,0.6366197183098592,0.9977589003125147,1.0,2/15,5.61%,POR;ETFA
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.363719412377777,0.8513973080900884,0.6558073654390935,0.9974084008671671,1.0,3/17,5.68%,CACNA2D1;ANK2;SCN5A
prerank,RNA stabilization (GO:0043489),-0.25407124346706905,-0.8508706879504899,0.7285714285714285,0.9010283555104056,1.0,7/33,10.75%,YBX1;NOCT;ZCCHC17;NAF1;ELAVL1;DKC1;TAF15
prerank,establishment of mitotic spindle localization (GO:0040001),0.3317960942032716,0.8508151293145622,0.6732542819499341,0.9980388769468558,1.0,7/28,18.45%,GPSM2;INSC;NDE1;CLASP1;KPNB1;ITGB1;HTT
prerank,mitotic cytokinetic process (GO:1902410),-0.27784960152849125,-0.8508131467552681,0.6897810218978102,0.8999782695075355,1.0,7/20,24.37%,CHMP3;RHOA;VPS4A;CHMP1A;VPS4B;CHMP7;CHMP2B
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.3236707002812878,-0.8504589778518472,0.6666666666666666,0.8995594558749244,1.0,5/12,14.30%,DKC1;WRAP53;CCT4;CCT6A;CCT8
prerank,positive regulation of growth (GO:0045927),0.29053617270302223,0.850458287272854,0.7009132420091324,0.9981783901573327,1.0,13/64,17.75%,BCL2;ERBB2;EGFR;PLCB1;DERL2;NCBP1;EXOSC2;EIF4G1;AKAP6;BRAT1;KLHL22;HYAL1;RPTOR
prerank,triglyceride biosynthetic process (GO:0019432),0.36067667655832814,0.8503169956020531,0.6618705035971223,0.997913624379725,1.0,5/18,18.05%,AGMO;MOGAT3;GPAT3;GPAT4;PCK2
prerank,nucleotide metabolic process (GO:0009117),-0.2702310065245146,-0.8499292040542246,0.667910447761194,0.8995233014988447,1.0,10/23,24.72%,RNASEH2B;NMNAT2;ME1;NMNAT1;GUK1;DCK;AK4;AK1;NME2;ENPP3
prerank,positive regulation of macrophage migration (GO:1905523),-0.290129813445111,-0.8498740914744035,0.6897810218978102,0.8984531616504406,1.0,3/19,7.34%,IL34;THBS1;AKIRIN1
prerank,sensory perception of light stimulus (GO:0050953),0.285719020605862,0.8496571716092101,0.7337662337662337,0.9986774817501436,1.0,15/87,19.98%,EFEMP1;CRYBG3;PCDH15;COL18A1;RDH10;DHRS3;OAT;MYO9A;COL1A1;OPA1;DNAJC19;PAX2;RGS16;ATXN7;COL11A1
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.402111306931909,0.8487952343591394,0.6567164179104478,0.9998351046879586,1.0,6/11,28.62%,ATF7IP;SIRT6;SETDB1;MPHOSPH8;RESF1;DNMT1
prerank,positive regulation of DNA binding (GO:0043388),0.32896824798792257,0.8485116516647623,0.6841448189762797,0.9998327934380997,1.0,3/31,4.09%,NGF;PRKN;TGFB1
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.3855985644327877,0.8483201288972696,0.6517985611510791,0.9996686634632166,1.0,2/13,7.84%,AP1G1;GAB2
prerank,calcium ion import across plasma membrane (GO:0098703),0.3800138233549045,0.8482219840521539,0.6671511627906976,0.9993221817663646,1.0,2/14,8.12%,CACNA2D1;SLC8A2
prerank,autophagy of peroxisome (GO:0030242),0.3899861907062768,0.8479555455866152,0.6621621621621622,0.9993247035391919,1.0,3/12,17.98%,ACBD5;ATM;NBR1
prerank,dendrite morphogenesis (GO:0048813),0.3172584246582431,0.8473069816227813,0.6604010025062657,1.0,1.0,8/35,12.02%,LRP4;PTEN;EPHB2;SDC2;CTNNA2;DOCK10;DIP2A;DVL1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.34222805611252005,0.8472888909373116,0.6788511749347258,0.9995413368391571,1.0,8/24,21.84%,JPH3;AKAP6;PDE4D;PRKACA;CALM1;CALM2;PKD2;CAMK2D
prerank,fatty acid biosynthetic process (GO:0006633),0.2921737969652295,0.8471341472852107,0.7150964812712827,0.9993347827794963,1.0,8/63,11.36%,ACACA;OXSM;LTA4H;SCD5;ELOVL6;ACLY;ELOVL5;LIPC
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.34422882194785465,0.8471245467844797,0.6711051930758988,0.998834641514177,1.0,11/24,25.12%,SLC25A38;UROS;RSAD1;SUCLA2;COX10;FECH;PGRMC1;TSPO;CPOX;ALAD;UROD
prerank,positive regulation of microtubule polymerization (GO:0031116),0.3265553111573071,0.846896701062447,0.652230971128609,0.9987413814160842,1.0,8/28,15.47%,PAK1;ARL2;CLASP1;SLAIN2;CDK5R1;CKAP5;MET;NAV3
prerank,keratan sulfate biosynthetic process (GO:0018146),0.3354417076452224,0.8464492962425656,0.6684073107049608,0.9990634579023308,1.0,2/26,1.66%,LUM;ST3GAL4
prerank,cellular polysaccharide catabolic process (GO:0044247),0.3630237187318134,0.8462995308972394,0.6633941093969145,0.9988237566119185,1.0,3/16,14.73%,PYGL;PHKB;CALM1
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.2942127764029705,-0.8460338038936566,0.6582278481012658,0.9050332043352042,1.0,6/16,20.04%,SIK3;FLCN;LARS1;PIP4P1;RRAGB;GPR137
prerank,piRNA metabolic process (GO:0034587),0.35050728154272215,0.8460259753247901,0.6538461538461539,0.9988224908225627,1.0,2/19,9.47%,FKBP6;TEX15
prerank,mismatch repair (GO:0006298),0.3347762390659877,0.845910185330852,0.6967320261437908,0.9985100318968607,1.0,7/27,15.51%,RPA3;MUTYH;SETD2;MSH6;RPA2;ABL1;MSH5
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.24251729419894846,-0.8458919135431276,0.7589743589743589,0.9041399656323025,1.0,14/35,22.38%,NUAK1;PTPA;PPP1R15B;GSK3B;PDGFRB;PPP1R11;ITGA1;CD300A;HSP90AB1;MASTL;CSNK2B;PPP1R2;BOD1;STYXL1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.36278971480971767,0.8458470504554562,0.6638655462184874,0.9980995982998322,1.0,4/17,15.69%,BCL2;GGCT;SOD2;FZD9
prerank,negative regulation of cell aging (GO:0090344),0.3711194818105876,0.8454711698288354,0.6642547033285094,0.998285636904592,1.0,4/16,9.09%,MAP3K3;CDK6;FOXM1;AKT3
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.328414425295354,-0.8453584361695488,0.6925287356321839,0.9028422837406284,1.0,5/11,14.30%,DKC1;LARP7;CCT4;CCT6A;CCT8
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.328414425295354,-0.8453584361695488,0.6925287356321839,0.9028422837406284,1.0,5/11,14.30%,DKC1;LARP7;CCT4;CCT6A;CCT8
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.29568851200163687,0.8445241205493396,0.6981818181818182,0.9990814298801561,1.0,18/50,25.47%,RANBP2;POLR2B;NUP155;POLR2K;EIF4G1;NDC1;NUP205;NUP160;POLR2G;POM121;AAAS;POLR2A;NUP42;POLR2F;FMR1;TNRC6A;NUP35;RAE1
prerank,regulation of gene silencing by RNA (GO:0060966),0.29568851200163687,0.8445241205493396,0.6981818181818182,0.9990814298801561,1.0,18/50,25.47%,RANBP2;POLR2B;NUP155;POLR2K;EIF4G1;NDC1;NUP205;NUP160;POLR2G;POM121;AAAS;POLR2A;NUP42;POLR2F;FMR1;TNRC6A;NUP35;RAE1
prerank,protein transport (GO:0015031),0.2635471044335708,0.8444863699412561,0.8514056224899599,0.9986267809300322,1.0,93/332,23.79%,TMED6;ANK3;TBC1D10A;LRP1;RAB38;STEAP3;VAMP4;RAB14;ATP6V1B2;BLZF1;COPZ2;SNX15;VPS33A;SPTBN1;VPS29;SCAMP2;ARL1;RAB21;COPB2;RAB34;SEC31B;COPG2;RABL3;MTTP;TBCK;RCN3;TMED10;SLC10A7;NEURL1B;RAB3D;SNX6;VPS26B;ARL5C;ARF4;NGFR;NDC1;HDAC6;ARL6IP5;RAB22A;SYS1;RAB1A;USP6NL;RAB3A;HSP90B1;RAB3GAP2;STX8;COPA;SYNDIG1;ARFGAP3;TMED2;TMED3;TRIM23;SNX1;COPG1;SEC23IP;UNC93B1;SGSM1;STX1B;AP4M1;LRP2;TANGO6;CTTN;CD74;DENND10;RAB7A;ATP6V1C1;STX17;KIF3A;RAB3B;PPARG;ARFIP1;VMP1;TBC1D12;CHMP1B;NAPG;LAMP2;ATP6V0E2;TBC1D8B;TANGO2;TBC1D9B;ATP6V0E1;SNX4;RAB6A;FAM91A1;UNC119B;RAB18;KIF13A;SCFD2;TVP23A;STX2;ATP6V1G2;ACD;STX7
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.38935816476613105,0.8444260670173019,0.6586102719033232,0.9976998038647119,1.0,3/12,13.91%,PRNP;RCAN1;HOMER2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.38935816476613105,0.8444260670173019,0.6586102719033232,0.9976998038647119,1.0,3/12,13.91%,PRNP;RCAN1;HOMER2
prerank,regulation of autophagy (GO:0010506),0.26618748859690733,0.8442753596482293,0.8034623217922607,0.9974680824177353,1.0,37/216,15.58%,DCN;BCL2;PTPN22;PRKN;NPRL2;CAPN1;FBXW7;ATP6V1B2;MT3;VPS29;PRKAB2;UFL1;BMF;KAT8;BNIP3;LAMTOR2;UCHL1;TLK2;SNX6;VPS26B;EIF4G1;MID2;USP33;HDAC6;CDK5R1;FBXL2;DRAM1;TPCN2;PRKACA;KLHL22;WASHC1;GFAP;ATM;TICAM1;MET;ABL1;PIM2
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.404012157026031,0.8442308480567011,0.6605504587155964,0.9970327848437661,1.0,1/10,1.73%,PTPN22
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.24172441744802195,-0.8440165846235227,0.7388888888888889,0.9044536391647165,1.0,10/39,13.74%,MYO1D;WASL;FNBP1L;TRAK1;PAFAH1B1;KIF5B;BICDL1;MYO1E;MYO5B;MYO1C
prerank,regulation of chromatin organization (GO:1902275),-0.30832351797037355,-0.8438736702759714,0.6656626506024096,0.9035701505389512,1.0,3/14,4.91%,MLLT3;PARG;IGF2
prerank,negative regulation of viral life cycle (GO:1903901),0.37197368277415965,0.843748829021084,0.659606656580938,0.9974152912290197,1.0,3/15,10.58%,GSN;TRIM11;MID2
prerank,regulation of cilium movement (GO:0003352),0.4046129605672052,0.8435058391224587,0.6661585365853658,0.9973535815764085,1.0,2/10,15.31%,CCDC39;CCDC65
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.3617588473372691,0.8434809567314993,0.660458452722063,0.9968864399382876,1.0,3/17,11.36%,PCSK6;LMF1;LIPC
prerank,lipid homeostasis (GO:0055088),0.29726911458060223,0.8431595592049806,0.6986143187066974,0.9969999071269536,1.0,7/57,9.78%,IRS2;ZBTB20;FBXW7;MLXIPL;ACOX1;RCN3;THADA
prerank,striated muscle cell differentiation (GO:0051146),-0.2934474074405893,-0.8431041389643504,0.6948529411764706,0.9038260168827843,1.0,7/16,20.42%,SIK1;KDM6B;MYEF2;SORT1;CBY1;MYOCD;SDC1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.26667342288504026,0.8427852362251431,0.8282828282828283,0.9971928700936753,1.0,43/234,21.03%,RELN;ROR1;EDA;PRKCQ;PYCARD;PTEN;STK36;VEGFA;IRAK3;CRTC1;RPS6KA4;FANK1;WNT5A;CARD9;IL18;SMO;ATF2;MID2;ESR1;TRIM41;RTKN2;PRDX3;MALT1;DHX33;TICAM1;JUP;UBB;TERF2IP;IL1RAP;RIPK1;CHUK;RAB7B;PARK7;TAF1;TAB3;PPARG;STAT3;BCL10;SMARCA4;PHB2;ADCY8;NFKB1;PRKD2
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.36039621362355645,0.8427717142264864,0.6468885672937771,0.9967055175637245,1.0,3/16,10.82%,FGF2;VEGFA;NGFR
prerank,regulation of microglial cell activation (GO:1903978),0.36830195619454664,0.84253711471263,0.6764275256222547,0.9966368315318653,1.0,3/15,14.08%,SYT11;GRN;TTBK1
prerank,sarcomere organization (GO:0045214),0.33407252485479155,0.8424028640152343,0.6751677852348993,0.9963587433527084,1.0,2/27,8.62%,CSRP1;TNNT3
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.30744622055447385,0.8420378352420789,0.6896969696969697,0.9965181604116885,1.0,5/43,8.10%,MMP2;FGF2;NOX1;ADAMTS1;IL18
prerank,ribosomal subunit export from nucleus (GO:0000054),0.38765192312096264,0.8416941124400488,0.6671732522796353,0.9966449505881213,1.0,3/13,13.09%,XPO1;EIF6;SDAD1
prerank,sensory perception of smell (GO:0007608),0.389664715324581,0.8416571276768837,0.6752655538694993,0.9961910845099619,1.0,4/11,24.81%,DRD2;SLC24A4;UBR3;BBS4
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.3008283036158681,0.8415427877836011,0.7089639115250291,0.9953740139480977,1.0,26/51,30.20%,NUP155;PPP2R2A;RCC1;NDC1;NUP205;NUP160;EMD;KPNB1;SUMO1;LMNA;CHMP4C;POM121;AHCTF1;PPP2R1A;IST1;REEP3;NUP35;CHMP4A;CHMP4B;UBE2I;SIRT2;SPAST;CC2D1B;VRK1;SEC13;ANKLE2
prerank,mitotic nuclear membrane organization (GO:0101024),0.3008283036158681,0.8415427877836011,0.7089639115250291,0.9953740139480977,1.0,26/51,30.20%,NUP155;PPP2R2A;RCC1;NDC1;NUP205;NUP160;EMD;KPNB1;SUMO1;LMNA;CHMP4C;POM121;AHCTF1;PPP2R1A;IST1;REEP3;NUP35;CHMP4A;CHMP4B;UBE2I;SIRT2;SPAST;CC2D1B;VRK1;SEC13;ANKLE2
prerank,genitalia development (GO:0048806),0.38696662530399345,0.8415162145839599,0.6615620214395099,0.9949115363375743,1.0,4/12,17.02%,WNT5A;PTPN11;PKD1;DNAJC19
prerank,positive regulation of protein modification process (GO:0031401),0.2669444773021585,0.8413655315618442,0.8028455284552846,0.9946781784596412,1.0,18/203,6.54%,DLC1;CLDN19;NTRK3;FGF2;FGF10;SOX9;ERBB2;EGFR;EFNA5;WDFY2;VEGFA;TGFB1;NTRK2;MT3;TNIK;NIBAN1;PAK1;RALB
prerank,positive regulation of macrophage activation (GO:0043032),0.3576745433399715,0.8410001386137156,0.6671289875173371,0.9948418691435092,1.0,6/17,21.38%,WNT5A;TTBK1;IL33;LBP;HSPD1;TNIP2
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.28106546246126113,0.8409288178866743,0.7196969696969697,0.9944749270319395,1.0,21/87,18.56%,NDUFAF4;COX20;NDUFS5;NDUFAF6;COX18;SCO1;NDUFB2;NDUFA8;COX19;NDUFS8;ACAD9;NDUFV3;NDUFS6;NDUFV2;SDHAF1;NDUFA13;NDUFA6;AIFM1;NDUFA12;UQCC1;NDUFC1
prerank,fatty acid metabolic process (GO:0006631),0.2774140140270859,0.8408194428736612,0.7648305084745762,0.994170532930229,1.0,20/115,19.24%,CEL;THEM4;ACACA;SLC27A4;OXSM;ACBD5;ACOT11;ACOX1;FASN;ACLY;ACSF2;LIPC;ALOX5AP;PNPLA8;ACAD9;ACSL3;ABCD2;ACSL6;CRAT;PPARG
prerank,cellular macromolecule catabolic process (GO:0044265),0.30515303999396104,0.8406660918159014,0.6996381182147166,0.9939464863710178,1.0,17/49,26.22%,PRKN;RNASE6;XRN2;PPP1R8;FBXO27;NCBP1;FBXO17;RNASEH2C;PNPT1;RIPK1;MAGEC2;UBE2G1;FBXO44;OGA;SUPV3L1;RNASE3;SND1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.2890706420714842,-0.8402432993527827,0.7133333333333334,0.9084148079423204,1.0,3/18,7.35%,ACSL1;ELOVL7;ACSL5
prerank,embryonic heart tube morphogenesis (GO:0003143),0.3079543650401115,0.8402236833426779,0.7096385542168675,0.9942259836948173,1.0,5/43,8.53%,ACVR1;CCDC39;TGFBR2;BBS5;SMO
prerank,axon extension (GO:0048675),0.3364602298172181,0.83924471219492,0.6725304465493911,0.9955351415656497,1.0,7/23,14.87%,MAP1B;SEMA3A;AUTS2;PPP3CB;SPG11;NRP2;CYFIP1
prerank,macroautophagy (GO:0016236),0.2719549815145185,0.8392040482046811,0.767416934619507,0.9951166689062988,1.0,25/118,18.66%,DYNLL1;PRKN;MTMR14;LIX1;VPS33A;ACBD5;WIPI1;SNAP29;PRKAB2;VPS39;ATG5;TOMM22;TOMM20;VPS37B;VPS36;ATG3;MVB12A;VPS41;GABARAPL2;PLAA;CHMP4C;NBR1;STX17;CSNK2A2;SNX14
prerank,anion transmembrane transport (GO:0098656),0.2946181558955245,0.8391446027896728,0.7269700332963374,0.994717972968868,1.0,11/67,13.27%,SLC1A3;SLC27A1;SLC25A21;LRRC8D;SLC35C2;SLC25A38;ARL6IP5;SLC7A8;SLC35A1;SLC25A10;PRAF2
prerank,cellular response to acid chemical (GO:0071229),0.3312507697622529,0.8391161022042414,0.6793193717277487,0.9942770438481194,1.0,11/27,26.12%,VEGFA;CPEB3;LAMTOR2;CPEB1;RPTOR;SPAAR;IPO5;RRAGA;MTOR;SLC38A9;CPEB4
prerank,base-excision repair (GO:0006284),0.3010642392962266,0.8388471349655723,0.6962616822429907,0.994249386260471,1.0,13/48,19.08%,MBD4;ERCC5;MPG;RPA3;MUTYH;XPA;NEIL1;HUWE1;RPA2;SMUG1;POLG;WRN;LIG3
prerank,regulation of trophoblast cell migration (GO:1901163),0.38180484858614616,0.8384178831168515,0.6455882352941177,0.9945437203210219,1.0,2/14,5.25%,VEGFA;ACVR1C
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.2880997473553488,0.8383385299654198,0.7352614015572859,0.9941872249654664,1.0,15/69,15.81%,ERLIN2;DNAJB9;RHBDD2;DERL2;FBXO27;SELENOS;HERPUD1;EDEM2;UBE2J2;RNF121;FBXO17;TMUB2;HSP90B1;JKAMP;ERLIN1
prerank,exit from mitosis (GO:0010458),-0.33055332567434065,-0.8381407200760987,0.6528189910979229,0.9113889842001007,1.0,5/12,24.79%,PPP2R2D;EPS8;CTDP1;CHMP7;SIRT7
prerank,positive regulation of glycolytic process (GO:0045821),0.3439756903158369,0.8381244937235773,0.6573426573426573,0.9935920459612086,1.0,9/20,22.53%,ZBTB20;PSEN1;MLXIPL;HIF1A;PFKFB1;P2RX7;PRXL2C;PRKAA1;SLC4A4
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.3439756903158369,0.8381244937235773,0.6573426573426573,0.9935920459612086,1.0,9/20,22.53%,ZBTB20;PSEN1;MLXIPL;HIF1A;PFKFB1;P2RX7;PRXL2C;PRKAA1;SLC4A4
prerank,nuclear export (GO:0051168),0.2854215867612225,0.8380710146688246,0.7261640798226164,0.9931846802350172,1.0,17/80,19.79%,CCHCR1;XPO1;THOC6;TGFB1;NUP155;SRSF11;CASC3;NCBP1;MALT1;SRSF6;PKD1;POM121;NXF1;RNPS1;THOC7;SRRM1;CSE1L
prerank,negative regulation of transmembrane transport (GO:0034763),0.39735131493215464,0.838005187555957,0.661993769470405,0.9928073744112925,1.0,1/10,2.01%,IRS2
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.3351769358214041,0.8378616587791698,0.6918767507002801,0.9925647704112872,1.0,9/25,24.57%,HMGN1;ZNF326;SETD5;ELL;TCEA2;ZMYND11;KAT7;THOC5;CCNT2
prerank,regulation of protein metabolic process (GO:0051246),-0.2251215452834383,-0.8371902052889308,0.7383720930232558,0.9121260808966164,1.0,17/44,24.33%,ROCK2;MAP2K5;MTPN;KLF2;ACE;APP;KLF4;CENATAC;ODC1;TMEM9;HSP90AB1;ABCA7;APOE;CHRNA7;PLAUR;MAPK8;ZDHHC2
prerank,inorganic anion transmembrane transport (GO:0098661),0.2893838627346718,0.8369904805109531,0.7097505668934241,0.9936209681244356,1.0,10/63,16.23%,ANO2;SLC1A3;SLC12A3;ANO6;SLC12A2;SLC12A4;SLC25A10;XPR1;GABRG2;SLC25A11
prerank,transferrin transport (GO:0033572),-0.24095668692830952,-0.8361487362252559,0.7272727272727273,0.9129071424315056,1.0,16/33,30.40%,RAB11B;ATP6V0C;ATP6V0D1;MCOLN1;TFRC;DNM2;ATP6V0A4;ATP6AP1;ATP6V0A2;HFE;REP15;ATP6V1G1;ATP6V0B;ATP6V1E1;LMTK2;ATP6V1A
prerank,negative regulation of centrosome duplication (GO:0010826),0.395134888470712,0.8361362005424183,0.6787974683544303,0.9947490981407959,1.0,3/11,13.75%,KAT2B;BRCA1;MDM1
prerank,cellular response to interferon-gamma (GO:0071346),0.27962846947579095,0.8358904164150689,0.7475083056478405,0.9947085214637656,1.0,5/88,5.28%,CCL11;EPRS1;CCL4;WNT5A;AQP4
prerank,negative regulation of cell activation (GO:0050866),0.36956228050147916,0.8352227956114312,0.6811377245508982,0.9954387329447655,1.0,1/14,0.81%,PDGFRA
prerank,protein export from nucleus (GO:0006611),0.33275343948232894,0.8349874214474741,0.6992084432717678,0.9953604123500258,1.0,3/27,4.09%,CCHCR1;XPO1;TGFB1
prerank,cytosolic calcium ion transport (GO:0060401),0.3271186754338845,0.8349796999122154,0.6861499364675985,0.9948686367095367,1.0,6/28,12.51%,CACNA2D1;ATP2B3;JPH3;SLC8A2;SLC25A23;ATP2B1
prerank,regulation of vasoconstriction (GO:0019229),0.324338189330004,0.8345707253686163,0.6626826029216467,0.9951183929848566,1.0,3/27,12.51%,CHRM3;KCNMB2;ATP2B1
prerank,cellular response to unfolded protein (GO:0034620),0.3283009241274305,0.8344483353602118,0.6895213454075032,0.9948347811601321,1.0,7/26,21.24%,PRKN;PACRG;PTPN1;TM7SF3;HSPA9;HSPD1;RHBDD1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.2956174924697364,0.8343363681735354,0.6947743467933492,0.9945362194212314,1.0,15/52,21.85%,BCL2;FBXW7;YWHAZ;VPS11;HUWE1;UBE2J2;PPP3CC;TP53;SREBF2;CSNK2A2;UBE2L3;MICALL2;NPEPPS;RHOU;UBE2D3
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.3350627530640706,0.8342420412451758,0.6835781041388518,0.9942178175142924,1.0,7/24,15.41%,MAP4K4;VEGFA;TSC1;PIK3R1;PTPRJ;MYOC;ABL1
prerank,histone deubiquitination (GO:0016578),-0.27899304076373044,-0.8339164227862201,0.7024221453287197,0.9162791627093463,1.0,6/18,28.47%,USP7;USP3;USP15;KAT2A;TAF10;UIMC1
prerank,cellular response to glucagon stimulus (GO:0071377),-0.29245272370046105,-0.8338545888202292,0.7003257328990228,0.9152511018267868,1.0,7/17,25.04%,ADCY9;PRKAR1A;ADCY4;ADCY3;CYSLTR2;PRKAR2A;PRKACB
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.2988980937000569,0.8338102713816193,0.7054631828978623,0.9945292698124586,1.0,10/49,16.57%,PYCARD;BCL2;EIF2AK3;URI1;BMF;HERPUD1;RTKN2;BCL2L11;TP53;NDUFA13
prerank,visual perception (GO:0007601),0.27958004199964825,0.8332935844604211,0.7454545454545455,0.9949734141352127,1.0,15/84,19.98%,EFEMP1;CRYBG3;COL18A1;RDH10;DHRS3;OAT;MYO9A;COL1A1;OPA1;DNAJC19;PAX2;CACNA2D4;RGS16;ATXN7;COL11A1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.32742725562057107,0.8328980314903983,0.6864516129032258,0.9952091123648998,1.0,4/31,7.37%,PTEN;CDKN2B;JADE1;CDK6
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.3330343367080091,0.8327777378170619,0.6856763925729443,0.9949459293237302,1.0,6/23,18.51%,TGFB1;SOX11;DKK3;BCL9;NREP;EID2
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.345271363885647,0.832668327272959,0.680939226519337,0.9946315567639796,1.0,4/18,15.40%,UGGT2;DERL2;EDEM2;UBB
prerank,cellular response to radiation (GO:0071478),0.30599593012539744,0.8325490523072344,0.705237515225335,0.9943439523292615,1.0,8/40,19.02%,RHO;NSMCE3;MAPK14;GPR88;BLM;SPIDR;TP53;GRB2
prerank,positive regulation of chemokine production (GO:0032722),0.30517051961518377,0.8325357298946956,0.6990521327014217,0.9938681573400965,1.0,7/44,19.13%,PYCARD;WNT5A;IL18;HIF1A;IL33;CD74;EGR1
prerank,protein oxidation (GO:0018158),-0.32510267010775934,-0.8324494782546539,0.66,0.9168519661285944,1.0,3/11,10.07%,LOXL1;LOX;TMX3
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.33760476341995693,0.8323677977585426,0.6941340782122905,0.9936697960298022,1.0,10/23,22.53%,ZBTB20;PSEN1;MLXIPL;HIF1A;PFKFB1;NFKB1;P2RX7;PRXL2C;PRKAA1;SLC4A4
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.21458097144491228,-0.8323638625157715,0.7972972972972973,0.9158386554855947,1.0,25/54,27.84%,NSA2;RPL24;NPM1;NVL;RPL5;RPL3;MRPL20;NOP53;MAK16;LAS1L;RPL11;RPL7A;SURF6;RPL35A;RPL26;PES1;RSL24D1;NLE1;SNU13;PPAN;RPF2;NOC2L;RPL6;RPF1;PAK1IP1
prerank,androgen receptor signaling pathway (GO:0030521),-0.3346602667063591,-0.8319653311674637,0.6933701657458563,0.915374931990322,1.0,2/11,6.87%,PLPP1;DDX5
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.39919533108987926,0.8319378916221932,0.653968253968254,0.9939714625017935,1.0,2/10,6.91%,LAPTM4B;GATA6
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.3891850197847597,0.8316760826298455,0.6800618238021638,0.9939409149214696,1.0,3/10,16.58%,MLXIPL;ELOVL5;ABCD2
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.3716687156465257,0.8313753354187707,0.6784615384615384,0.9939700041907595,1.0,5/14,21.76%,ADSS1;ADK;RFK;ADSL;PFAS
prerank,postreplication repair (GO:0006301),-0.22406820876769337,-0.8312621667656697,0.7904191616766467,0.9155952415757165,1.0,23/45,31.36%,POLD3;TRIM25;PRIMPOL;PARP10;RFC1;POLH;UBE2A;UBE2N;PCNA;RAD18;POLK;ISG15;FAAP20;NSMCE1;RFC3;UBA52;USP43;POLD2;PCLAF;VCP;MSH2;POLD4;POLD1
prerank,histone modification (GO:0016570),0.27538473685738557,0.8311639829505515,0.7724358974358975,0.9938725873762119,1.0,22/109,16.37%,RCOR2;RPS6KA4;MT3;HLCS;MTA2;UFL1;KAT8;CARM1;BRD8;MORF4L2;HDAC2;HUWE1;PHF20;SIN3B;PRMT1;HDAC6;MIDEAS;BAZ1B;TRRAP;MSL3;MTA3;USP21
prerank,phospholipid translocation (GO:0045332),0.32612252151637783,0.8309928660781682,0.7128205128205128,0.9936893666589067,1.0,4/28,3.65%,ATP8B1;PLSCR4;ANO6;ATP9B
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.22029456394655544,-0.8309203372035426,0.791907514450867,0.9151102909840566,1.0,19/50,27.56%,SASH1;NFAT5;TLR4;APP;NR3C2;RHOA;NMI;SPHK1;IFI35;CD86;LAPTM5;TCIM;NOD1;TRADD;ACTN4;ILK;CCL19;NOD2;CD27
prerank,negative regulation of cell division (GO:0051782),0.394431254555733,0.8306854611494976,0.6656441717791411,0.9937682978991178,1.0,3/11,15.96%,MYC;CHMP4C;BLM
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.25234915893156223,-0.8305918772041353,0.7975206611570248,0.9145570578880919,1.0,10/26,21.58%,MFHAS1;WDFY1;CYBA;TIRAP;CAV1;FLOT1;IFI35;NINJ1;NR1H3;RSAD2
prerank,positive regulation of interleukin-4 production (GO:0032753),0.35995129007802196,0.8297193773800142,0.7063037249283668,0.995021750724139,1.0,1/17,1.09%,PRKCQ
prerank,DNA replication (GO:0006260),0.27477686585186123,0.829573686830836,0.7534537725823592,0.9947885189997417,1.0,33/105,24.86%,POLE2;BAZ1A;TIPIN;REV3L;RPA3;BRCA1;POLE3;MCM4;ING4;UPF1;RPA2;ORC1;TOPBP1;POLG2;ATM;BLM;POLG;FAM111A;REV1;WRN;ORC4;DBF4;TOP1;WRNIP1;ORC2;RBMS1;TOP3A;RAD50;KAT7;BARD1;ATR;ORC3;RHNO1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.27917321910330534,-0.8294148499295374,0.7195571955719557,0.9156037442400863,1.0,4/21,10.62%,ADCY9;NPR1;ADCY4;GUCY1B1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.3360815592997305,0.8292767186234226,0.6851595006934813,0.994814171010496,1.0,12/23,24.33%,DYNC1I1;KIF5C;CCDC186;DYNC1I2;MAP6D1;TUBA1A;HOOK2;MAP6;CCDC88A;HOOK3;HOOK1;TUBA1B
prerank,regulation of defense response (GO:0031347),0.2782911346140939,0.8289492149464582,0.7441601779755284,0.9949142856371544,1.0,15/76,17.12%,ADAMTS12;PTPN22;BST1;ELMOD2;IL1RL2;WNT5A;CCR2;UFL1;CASP12;GRN;SHPK;AREL1;XIAP;PTGES;N4BP1
prerank,positive regulation of angiogenesis (GO:0045766),0.2719478924260558,0.8283645849911184,0.7765843179377014,0.9954960410941843,1.0,28/108,18.67%,PRKCA;FGF2;CD34;VEGFA;PAK4;ITGB8;WNT5A;HSPB6;CYP1B1;GATA6;BRCA1;HIF1A;SP1;SIRT6;RUNX1;MYDGF;GRN;BMPER;SMOC2;PDCL3;ITGB1;JUP;GAB1;HYAL1;APLNR;MDK;EMC10;HK2
prerank,cellular response to hexose stimulus (GO:0071331),0.33178940277902724,0.8279305868585538,0.6955345060893099,0.9957946346892442,1.0,10/23,25.44%,ZBTB20;TRA2B;PDK3;PRKACA;PAX2;PCK2;ADCY8;PRKAA1;SLC39A14;SOX4
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.35134175769918513,0.8279198902184173,0.6816074188562596,0.9953136801182372,1.0,3/15,15.14%,FGF2;SMOC2;MET
prerank,B cell mediated immunity (GO:0019724),0.39744036753624035,0.8274800165406737,0.68125,0.995622754599735,1.0,2/10,17.26%,CARD9;CD74
prerank,I-kappaB phosphorylation (GO:0007252),-0.3378251069891671,-0.8273091392689982,0.6685878962536023,0.9186206731841765,1.0,2/10,11.39%,TLR4;MAP3K7
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.3094181189427151,0.8264039583169739,0.7130325814536341,0.9970717791837647,1.0,10/35,19.18%,SEMA3E;SEMA6C;SEMA3A;FLNA;FARP2;NRP2;MET;SEMA6D;SEMA4B;SEMA4D
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.2803340901602609,0.8263459952306962,0.7328843995510662,0.9966656573357888,1.0,30/78,29.18%,PTEN;CDKN2B;EGFR;CCNJ;MEN1;PKMYT1;CDK5R1;PKD1;CDK5R2;BLM;CCND2;MAPRE3;IPO5;BCCIP;PKD2;NR2F2;CCNY;CCNH;CCNT2;CDC37;CCND3;CDK5RAP3;CDKN1A;APC;CCNI;CDKN2D;GTPBP4;CCNE1;CDKN1B;CDKN1C
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.27322245353922875,-0.8261278720641996,0.7198443579766537,0.9197442953342346,1.0,9/20,28.96%,PSMG2;PSMG1;HSP90AA1;HSP90AB1;PSMG3;CLU;HOPX;PFDN6;PTGES3L
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.3883260453933186,0.825971983368137,0.6900149031296572,0.9968537583655865,1.0,2/11,11.36%,PLA2G7;LIPC
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.3098606214167767,-0.8259160916657271,0.6811145510835913,0.9189804530580952,1.0,2/13,2.08%,ABCA1;CDH13
prerank,UV protection (GO:0009650),0.39173627424620205,0.8258395567610092,0.673469387755102,0.9965882891075087,1.0,4/10,20.18%,ERCC5;XPA;CAT;SCARA3
prerank,positive regulation of intracellular transport (GO:0032388),0.307062975659174,0.8257875163048672,0.7121019108280254,0.9961801119488425,1.0,10/38,23.81%,KIF20B;PGAP1;PCM1;TBC1D20;EHD2;PLA2G4E;PCNT;DYNC1H1;EIPR1;STX18
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.3210046773510765,0.8257042372328929,0.6913099870298314,0.9958246603575059,1.0,4/29,9.70%,SLC27A1;ZBTB20;MLXIPL;ELOVL5
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.31857184769494057,0.8256112113797643,0.7084870848708487,0.9954966782140784,1.0,2/33,2.73%,PRKCA;FADD
prerank,dendrite self-avoidance (GO:0070593),0.3564169817117191,0.8255557483379363,0.6876832844574781,0.9950983704449284,1.0,4/16,9.58%,CNTN6;CNTN2;PALLD;DSCAM
prerank,cGMP metabolic process (GO:0046068),0.3809619850575189,0.8254977876514431,0.6941529235382309,0.9947028794234467,1.0,3/12,17.32%,NPR2;PDE9A;NPPC
prerank,acylglycerol catabolic process (GO:0046464),-0.24507161752490836,-0.8247140651344294,0.7207207207207207,0.9200514041022126,1.0,9/30,24.87%,MGLL;ABHD2;DAGLA;ABHD12;PNPLA2;LPL;PNPLA3;FAAH;LIPE
prerank,positive regulation of chromatin organization (GO:1905269),-0.32173765353586103,-0.8247046494673383,0.6861111111111111,0.9188934449424403,1.0,5/12,18.97%,TERF2;UBE2N;TAL1;SIN3A;TINF2
prerank,establishment of protein localization to organelle (GO:0072594),0.2837364591636057,0.8245047871347913,0.7641083521444695,0.9960153158739534,1.0,20/72,20.96%,NUP155;LAMP5;FAM53B;NEURL1B;IPO9;TSPAN17;PRICKLE1;KPNB1;NXT1;IPO13;EIF4ENIF1;POM121;TNPO3;HK2;STAT3;IPO5;CSE1L;PHB2;LAMP2;HEATR3
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.3605989887531453,0.8233888284291855,0.6618075801749271,0.9975332528428515,1.0,3/15,12.97%,TIPIN;ATF2;MDC1
prerank,regulation of chromosome organization (GO:0033044),0.33655058653326564,0.8232123980711342,0.691156462585034,0.9973699269752425,1.0,6/22,18.20%,MYC;SETMAR;UPF1;SMG6;TERF2IP;CENPV
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.27889623251082807,-0.8228399203163512,0.7295373665480427,0.9214665152230641,1.0,3/18,5.65%,NUP93;DDX19B;DDX19A
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.26247038318438537,0.822704001402059,0.8049281314168378,0.9977430688436025,1.0,33/163,21.03%,PRKCQ;BCL2;PTPN22;TEC;PDE4B;PAK1;CSK;EIF2B5;FYN;VAV3;LAX1;PSMB7;PIK3R1;PTPRJ;PDE4D;GATA3;MALT1;NCK1;PSMD2;PSMC1;LAT2;CHUK;PSMB2;RC3H1;EIF2B2;MS4A1;PSMD9;PSME4;BCL10;PSMA8;NFKB1;CD38;PRKD2
prerank,intracellular protein transport (GO:0006886),0.25737856856832275,0.8223296070687793,0.8846539618856569,0.9978803873942393,1.0,74/304,20.96%,TMED6;CCHCR1;TBC1D10A;XPO1;RAB38;C2CD5;RAB14;TGFB1;COPZ2;SNX15;VPS33A;VPS29;NLGN1;NUP155;ARL1;RAB21;COPB2;FAM53B;SEC31B;RABL3;TBCK;TMED10;SNX6;VPS26B;ARL5C;COX18;ARF4;NGFR;IPO9;AKAP6;PRICKLE1;HDAC6;RAB22A;VPS36;RAB1A;KATNB1;USP6NL;KPNB1;RAB3GAP2;NXT1;STX8;IPO13;COPA;SYNDIG1;ARFGAP3;TMED2;TMED3;TRIM23;SNX1;SEC23IP;UNC93B1;PKD1;SGSM1;STX1B;EIF4ENIF1;AP4M1;POM121;CTTN;SURF4;CD74;TRAK2;RAB7A;STX17;TNPO3;ARFIP1;STAT3;IPO5;TBC1D12;CSE1L;PHB2;NAPG;LAMP2;TBC1D8B;HEATR3
prerank,transition metal ion homeostasis (GO:0055076),0.3297469701680973,0.8221963461894172,0.716358839050132,0.9976284003434199,1.0,3/28,5.76%,PRKN;MT3;CYBRD1
prerank,lymphocyte proliferation (GO:0046651),0.33433760345476127,0.822162261576562,0.7083333333333334,0.9971833820092377,1.0,7/22,25.20%,BCL2;PPP3CB;HELLS;MS4A1;HSPD1;CR2;LMBR1L
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.25678358477952357,-0.8220430361938619,0.735632183908046,0.9217549375372093,1.0,12/24,31.36%,POLD3;XRCC1;RFC1;PCNA;LIG1;POLK;RFC3;UBA52;POLD2;POLE;POLD4;POLD1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.32940053433193694,-0.821697607838316,0.6876790830945558,0.9212697269916449,1.0,6/11,33.65%,DCK;SLC19A3;SLC25A19;ENPP3;TPK1;DCTD
prerank,neurotransmitter secretion (GO:0007269),0.2939898735154244,0.8216533820286149,0.7223557692307693,0.9975891149725714,1.0,8/44,13.86%,NRXN1;SYT1;SYN1;RIMS1;DVL1;RAB3A;OTOF;SNCA
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.2894356206875224,0.8214935938722302,0.7494252873563219,0.9973886904330981,1.0,13/54,19.77%,PYCARD;PRKN;FADD;PTPN2;OTULIN;UBE2K;TAX1BP1;PYDC1;RIPK1;CHUK;TRAIP;SPPL2B;CPNE1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.29948473632922845,-0.8210612757459467,0.7138263665594855,0.9213587332846659,1.0,4/16,14.45%,PPARGC1B;DDX5;EGLN2;PADI2
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.289738734253541,0.8209181237377045,0.7365911799761621,0.9979137566499625,1.0,3/51,2.18%,SOSTDC1;HTRA3;CHRDL1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.2931070787977431,0.8207518449135085,0.7208480565371025,0.9977157752170036,1.0,11/48,16.86%,PRDM16;RANBP2;NUP155;EIF6;HIF1A;NDC1;NUP205;NUP160;PNPT1;POM121;AAAS
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.34897869224815253,0.8206359739491206,0.6957163958641064,0.9974338500315251,1.0,6/18,20.64%,DLC1;CUL3;MYOC;MET;KANK1;HEG1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.24709487260411445,-0.8206004295375502,0.7831858407079646,0.9210753343289521,1.0,13/29,30.50%,DGCR8;AGO1;ZC3H7B;TUT7;AGO3;SRRT;TARBP2;LIN28B;MRPL44;PUS10;AGO2;AGO4;DICER1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.34485812365263496,-0.8204605229566272,0.6953125,0.9201791916846362,1.0,6/10,31.53%,RIOK3;UFD1;RNF125;GPATCH3;TKFC;TSPAN6
prerank,phosphate ion homeostasis (GO:0055062),0.390754932246271,0.8203775292999519,0.6753445635528331,0.9973920065421348,1.0,2/10,15.10%,SFRP4;XPR1
prerank,negative regulation of proteolysis (GO:0045861),-0.2374297754495819,-0.8202374769516263,0.7783018867924528,0.9194499974705279,1.0,4/34,6.42%,EPHA4;ROCK1;GAS1;TIMP3
prerank,microtubule bundle formation (GO:0001578),0.29533825223804605,0.8195694111559182,0.732934131736527,0.9982911626514981,1.0,11/42,19.93%,RSPH1;NAV1;CFAP46;CAPN6;CFAP74;CLASP1;AAAS;FOXJ1;RSPH9;DCX;CCDC66
prerank,cellular response to virus (GO:0098586),0.3184519543947149,0.8195558737188887,0.7211155378486056,0.9978149362870978,1.0,6/30,18.08%,CXCL10;GBF1;HIF1A;MAPK14;CHUK;IRF3
prerank,sterol biosynthetic process (GO:0016126),0.3141061971226167,0.8193672227973819,0.7243107769423559,0.9976525238881567,1.0,4/33,8.79%,HSD17B7;SQLE;IDI1;ACLY
prerank,inositol phosphate catabolic process (GO:0071545),0.3792019610683982,0.8191547112958055,0.6944024205748865,0.9975406317175545,1.0,4/12,23.64%,PTEN;NUDT3;INPP5J;INPP5B
prerank,lipoprotein localization (GO:0044872),0.38725027155777103,0.8184901924569856,0.6862123613312203,0.9982682336448954,1.0,6/11,25.66%,LRP1;PPARG;VMP1;UNC119B;MIA3;ZDHHC17
prerank,ceramide catabolic process (GO:0046514),0.36089003238893347,0.8180181013055134,0.7044776119402985,0.9986309713160838,1.0,2/14,6.14%,NAGA;GM2A
prerank,positive regulation of insulin secretion (GO:0032024),-0.23360960096035455,-0.8178851884558634,0.8038277511961722,0.9227537415729035,1.0,10/36,19.48%,MYRIP;RBP4;ANO1;NLGN2;NNAT;AACS;LRRC8A;C2CD2L;GPER1;BAIAP3
prerank,vitamin D metabolic process (GO:0042359),-0.3055968424200365,-0.8178333678236445,0.6701754385964912,0.921680679137117,1.0,3/13,19.03%,CUBN;LGMN;CYP2R1
prerank,N-glycan processing (GO:0006491),0.3448704873877,0.8177532924636538,0.7060478199718706,0.9985987370733733,1.0,6/18,18.41%,GNPTAB;PRKCSH;MAN2A2;ST8SIA1;GANC;MAN1A2
prerank,regulation of RNA splicing (GO:0043484),0.28058296854144654,0.8174908538460549,0.7553551296505073,0.9985473882488224,1.0,17/69,22.54%,PRX;QKI;TRA2B;ZNF326;SON;KHDRBS3;PIK3R1;YTHDC1;SF1;FUS;POLR2A;HNRNPH2;HNRNPL;AFF2;SRSF3;AHNAK;PTBP2
prerank,regulation of primary metabolic process (GO:0080090),0.26424553588419125,0.8166796564337095,0.7963752665245203,0.9994744699559668,1.0,29/126,20.59%,IRS2;NQO1;NCOA1;C1QTNF2;SQLE;ACACA;IDI1;PRKAB2;FASN;ELOVL6;CARM1;PSMB7;NCOA2;CHD9;TGS1;SIN3B;SP1;NCOR2;PSMD2;PSMC1;SREBF2;PSMB2;SC5D;PSMD9;PPARG;PSME4;CERS2;NR1D2;PSMA8
prerank,microtubule depolymerization (GO:0007019),0.3486339594472381,0.8165706331085153,0.6958333333333333,0.9991774281494471,1.0,4/17,13.04%,KIF19;STMN4;KATNB1;CKAP5
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.37746393238246306,0.8164483968950175,0.6921875,0.9988854593879912,1.0,3/12,14.85%,KLF15;MAGI2;IQGAP1
prerank,lipid droplet organization (GO:0034389),-0.26185818683449114,-0.8163845806107956,0.7587548638132295,0.9233034683238214,1.0,9/22,25.99%,ZFYVE1;CDS1;PPIA;BSCL2;AUP1;PNPLA3;FAF2;PLA2G4C;FITM2
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.23055149984718115,-0.815728031348609,0.7949790794979079,0.9233946914511252,1.0,10/33,20.35%,ETS1;ARNT;STAT5B;ACVR1B;PITHD1;NCKAP1L;INHBA;TAL1;ANKRD54;HMGB2
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.3292358960137407,0.815451992944882,0.6998706338939198,1.0,1.0,5/24,12.41%,FBXW7;PRNP;NF1;CDK5R1;GRN
prerank,positive regulation of actin nucleation (GO:0051127),0.3754442201675799,0.815425249012481,0.6873065015479877,0.999707612320042,1.0,6/11,22.95%,GSN;BRK1;WASF1;CYFIP1;NCKAP1;WASF3
prerank,negative regulation of nuclear division (GO:0051784),0.38387371748526045,0.8154228196992395,0.6813353566009105,0.9992182346167156,1.0,3/11,17.44%,AURKAIP1;BMP7;FBXO5
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.27202096368678486,-0.8153797945199996,0.7851851851851852,0.9229295452686891,1.0,7/22,21.95%,ERI1;EXOSC7;URB1;EXOSC10;NOP9;RPS21;PES1
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.36069678418754747,0.8153477982380165,0.6955223880597015,0.998857178172061,1.0,7/15,27.22%,IRS2;GPLD1;PPARG;PRKCE;LDLRAP1;PPARA;ADM
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.2618988194939672,0.8152537152227642,0.8104712041884817,0.9985241305586277,1.0,22/152,17.98%,CXCL10;GNA14;LPAR1;PTGER3;GPR65;PTHLH;PTGFR;PTH2R;LGR5;TSHR;ADGRB3;GPR37;S1PR3;ADGRL3;GLP2R;GNAI1;P2RY12;ADGRG2;MC5R;OPRK1;S1PR2;GPR161
prerank,UV-damage excision repair (GO:0070914),0.3852061744297596,0.8151069041489857,0.6798179059180577,0.9982952967651083,1.0,5/12,22.22%,DDB2;XPA;DDB1;CUL4B;ACTR5
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.31913745191036,0.8148511626412148,0.7213114754098361,0.9982743574009267,1.0,8/30,18.68%,CACNA2D1;ANK2;SCN5A;FGF12;NEDD4L;PKP2;KCNH2;KCNA5
prerank,negative regulation of cellular amide metabolic process (GO:0034249),-0.1965617120640534,-0.814386003690493,0.8924731182795699,0.9236235467755965,1.0,22/84,22.06%,DAPK1;IGF1;SAMD4A;ROCK1;YBX1;CAPRIN1;IGFBP5;CNOT1;RACK1;EIF4A3;BTG2;ORMDL3;SPHK1;IGF2BP3;CNOT9;FXR2;ABCA7;APOE;CHRNA7;CLU;PCIF1;ORMDL1
prerank,protein polyubiquitination (GO:0000209),0.25480224463108875,0.8142373596309239,0.8965863453815262,0.9988804239508979,1.0,92/297,26.57%,UBE2T;BCL2;CBFB;FBXW9;PRKN;UBE2E2;HACE1;FBXW7;RNF6;FBXO7;SPOP;FBXO38;ZNRF2;FBXL15;DDB2;FBXO32;TRIM2;PELI1;HECTD2;BRCA1;UBE2K;FBXL16;PSMB7;FBXO27;LNPEP;CUL3;THOP1;ANAPC7;HUWE1;UBE2J2;MYLIP;FBXO17;ANAPC2;AKTIP;NEDD4L;DDA1;PSMD2;AREL1;UBB;UBE2O;RNF19A;PSMC1;CDC23;UBOX5;UBE2Q1;FBXL4;PSMB2;RNF167;FBXO31;RC3H1;MDM2;FBXO22;ANKRD39;PSMD9;RNF4;TAF1;UBE2L3;FBXL12;CDC27;PSME4;FBXO11;UBE2G1;UBE2E1;NPEPPS;PSMA8;ANAPC4;MKRN1;RNF114;UBE2D3;TTC3;TPP2;FBXO44;ANAPC5;SIAH1;CDC16;RNF187;BARD1;UBE3C;WSB1;TRIM14;CUL1;FBXW8;ANAPC13;PELI2;UBE2Q2;UBE2R2;RNF20;TOPORS;PSMD8;PSMD13;UBE2J1;DZIP3
prerank,regulation of autophagosome assembly (GO:2000785),-0.23340283890561425,-0.8141451847114991,0.7555555555555555,0.9229144145229315,1.0,11/33,22.96%,RAB5A;TBC1D14;FEZ2;SCFD1;NUPR1;LRSAM1;PIP4K2B;SMCR8;PINK1;ADPRH;SH3GLB1
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.29628046765049815,-0.8139866222602079,0.7407407407407407,0.9220702684878456,1.0,1/15,0.24%,OSBPL8
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.2684127202530196,0.8138668450541783,0.7987012987012987,0.9990643029783259,1.0,12/107,12.69%,CCL11;ANK2;ATP2B3;MT3;CCR2;SLC8A2;SLC24A5;SLC10A7;EDN3;HTR2C;ATP2B1;TPCN2
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.3869669986086689,0.8133858560072139,0.7105691056910569,0.9993935356368215,1.0,2/11,8.15%,PRKN;FYN
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.34553115148029107,0.8133604329869966,0.7101648351648352,0.9989499700645,1.0,6/18,18.64%,POR;EDN3;GDNF;RFK;ABL1;PARK7
prerank,megakaryocyte differentiation (GO:0030219),0.3755324122983229,0.8133024533040615,0.6931297709923664,0.9985496024133531,1.0,1/11,2.08%,CDKN2B
prerank,response to iron ion (GO:0010039),-0.32268788745720967,-0.8132886290550645,0.6938202247191011,0.9221804012118844,1.0,1/12,0.02%,BMP6
prerank,glycoprotein metabolic process (GO:0009100),0.29109284789984863,0.8132496324349985,0.7467608951707891,0.9981444039324301,1.0,9/53,11.90%,ST3GAL4;PRKCSH;PCSK6;MAN2A2;ST6GALNAC6;FBXO27;HIF1A;ST8SIA1;FBXO17
prerank,response to X-ray (GO:0010165),0.3614239072240472,0.8127019775565593,0.6827485380116959,0.9986253359410202,1.0,6/14,29.75%,XRCC6;ATM;BLM;LIG4;NUCKS1;XRCC4
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.27571996358317497,-0.8125728356323847,0.7462121212121212,0.9223936270932291,1.0,4/20,6.52%,PPIC;PPIL2;CWC27;PPIA
prerank,nucleotide catabolic process (GO:0009166),0.350722386407467,0.8122573819295312,0.6967095851216023,0.9988927742419643,1.0,3/16,12.73%,NUDT15;NT5C2;NUDT3
prerank,translational elongation (GO:0006414),0.26627210738649554,0.8113852129209459,0.7920685959271169,0.9999504482527604,1.0,26/101,22.77%,MRPL47;MRPS18A;EEF2K;MRPL14;MRPL32;TUFM;MRPL16;MRPL58;MRPS35;MRPS28;AURKAIP1;MRPL35;MRPL28;MRPL30;MRPL46;MRPL51;MRPS30;MRPS14;MRPL1;DAP3;MRPS9;MRPS31;MRPS6;PTCD3;MRPL52;MRPL18
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.31492356583151804,0.8110692681339947,0.7150192554557124,0.9999823593175804,1.0,10/30,23.12%,WAC;UCHL5;BAG5;TLK2;TAF9;USP14;N4BP1;PARK7;SGTA;CAMLG
prerank,regulation of actin nucleation (GO:0051125),0.36372866091790856,0.8099579570829529,0.6742081447963801,1.0,1.0,3/12,19.27%,GSN;CORO1B;ARFIP1
prerank,positive regulation of exocytosis (GO:0045921),0.3073290125173872,0.8098194121807003,0.7292191435768262,1.0,1.0,9/35,17.68%,SDC4;RAB3D;CLASP1;STXBP5;RAB3A;SNCA;PDCD6IP;UNC13D;RAB7A
prerank,regulation of protein localization to nucleus (GO:1900180),-0.21650881437725744,-0.8095739515567387,0.8277777777777777,0.9265927267357861,1.0,12/43,18.30%,MFHAS1;BMP4;LATS2;NVL;GSK3B;FLCN;TFRC;SESN2;SUMO3;ORMDL3;BYSL;SIN3A
prerank,synaptic vesicle cycle (GO:0099504),0.31179943520584996,0.8095672202007154,0.7103896103896103,1.0,1.0,6/30,13.86%,NLGN1;RIMS1;RAB3A;OTOF;SYNDIG1;SNCA
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.2996153661348858,0.8094255442481808,0.7406947890818859,1.0,1.0,11/37,20.97%,WAC;UCHL5;BAG5;TLK2;TAF9;PDCL3;N4BP1;CSNK2A2;PARK7;TAF1;SGTA
prerank,cellular response to alkaloid (GO:0071312),0.34691819399349383,0.8089612900524034,0.7247191011235955,1.0,1.0,5/17,19.21%,CASP6;BLM;SPIDR;CASP7;RYR3
prerank,actin filament network formation (GO:0051639),0.38491168905063167,0.8087304617944034,0.7057010785824345,1.0,1.0,1/11,1.71%,SPIRE1
prerank,protein-DNA complex assembly (GO:0065004),0.266090211598847,0.8085257113686806,0.7947643979057591,1.0,1.0,25/116,20.59%,RAD23B;SOX9;GTF2H2;ERCC5;DDB2;RPA3;ATRX;XPA;PSMB7;ASF1A;MCM4;DDB1;RPA2;ORC1;PSMD2;UBB;PSMC1;CUL4B;PSMB2;CENPV;ORC4;PSMD9;PSME4;ORC2;PSMA8
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.3114189597761968,0.8083328492539528,0.7163029525032092,1.0,1.0,7/31,16.09%,EXOSC8;DCP1B;EXOSC2;EDC4;LSM3;POLR2G;NT5C3B
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.259461648672379,-0.8083317997436997,0.7620967741935484,0.9276770623255397,1.0,10/22,27.17%,MMS19;ISCA1;LYRM4;FXN;CIAO3;ABCB7;NDOR1;CIAPIN1;GLRX5;NUBP1
prerank,carboxylic acid metabolic process (GO:0019752),0.31300245507378954,0.8083289429079806,0.7591888466413181,1.0,1.0,3/33,8.01%,CYP2S1;DAO;CSGALNACT1
prerank,canonical Wnt signaling pathway (GO:0060070),0.2777267289628439,0.8079592146564488,0.7751677852348994,1.0,1.0,15/68,16.10%,PTEN;FRZB;WNT5A;FZD7;RARG;SFRP4;BCL9L;PPP1CA;DVL1;BCL9;CSNK1A1;GATA3;SCYL2;FZD9;CSNK1E
prerank,regulation of cholesterol metabolic process (GO:0090181),0.33752430559828606,0.807851411234287,0.7211796246648794,1.0,1.0,8/20,29.26%,KPNB1;SREBF2;MBTPS1;SEC14L2;EPHX2;LDLRAP1;DGKQ;MBTPS2
prerank,skeletal muscle contraction (GO:0003009),-0.2706271049347036,-0.8077580249975215,0.7413793103448276,0.9275599866723988,1.0,9/19,41.06%,RCSD1;STAC;MYH14;STAC3;TNNI1;TNNC1;TNNI3;CCDC78;TCAP
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.3690929494929275,0.8076566385738297,0.7138686131386861,1.0,1.0,2/13,10.65%,BMS1;RCL1
prerank,regulation of mitotic nuclear division (GO:0007088),0.28561716803778314,0.8075978901724341,0.7421602787456446,0.9996106786175827,1.0,9/55,11.32%,KIF20B;OBSL1;CDK13;BTC;AURKAIP1;EDN3;RCC1;PKMYT1;BMP7
prerank,protein localization to mitochondrion (GO:0070585),0.3718953912336491,0.8074062010746021,0.6987577639751553,0.9994481209443984,1.0,5/11,27.00%,COX18;DNAJA1;HK2;HK1;RALA
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.3000970562299912,-0.8069505325681896,0.7181008902077152,0.9278765631329372,1.0,4/14,14.52%,NFKBIA;KEAP1;TMSB4X;MDFI
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.307408800768199,-0.8069248627653725,0.7192429022082019,0.9256263510664143,1.0,3/12,16.83%,IGF1;CHERP;PTBP1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.307408800768199,-0.8069248627653725,0.7192429022082019,0.9256263510664143,1.0,3/12,16.83%,IGF1;CHERP;PTBP1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.35087373675747896,0.8067483442586983,0.6906158357771262,1.0,1.0,6/15,24.63%,PABPC1;CPEB3;POLR2G;EIF4ENIF1;ZFP36;TNRC6A
prerank,cardiolipin metabolic process (GO:0032048),0.361652088309402,0.8065415364135394,0.7043740573152338,0.9999822199141795,1.0,3/13,13.78%,SLC27A1;HADHA;PNPLA8
prerank,positive regulation of protein import into nucleus (GO:0042307),0.3113742197220061,0.8062678094423561,0.7224435590969456,0.9999729570391301,1.0,5/28,15.37%,TGFB1;PSEN1;FLNA;PIK3R1;JUP
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.36653890877278245,0.8061166589905258,0.6985074626865672,0.9997264399951339,1.0,5/13,19.48%,ALG9;ALG1;ALG8;DPAGT1;ALG6
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.3625420798066925,0.8058923194799872,0.7170953101361573,0.9996276166819197,1.0,3/12,17.26%,BCL2;TAF9;CD74
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.33167594134587136,-0.8058393907019107,0.7008086253369272,0.9263854624875468,1.0,5/10,37.23%,LYN;CCL19;RAPGEF2;GAS6;LILRB1
prerank,regulation of transferase activity (GO:0051338),0.3428231087562034,0.8055852503595399,0.717663421418637,0.9996743946273715,1.0,5/17,15.98%,BAG5;LDB2;PPP1R3F;ATM;SMG6
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.32499730437096197,0.8054912050750179,0.7115902964959568,0.999361293369659,1.0,7/24,21.95%,FGF2;HTR2C;ANXA6;DRD2;RYR3;PKD2;ERO1A
prerank,nucleosome assembly (GO:0006334),0.3166032612348194,0.8050860826668182,0.7471116816431322,0.9995366383438843,1.0,5/31,13.29%,SOX9;HAT1;ATRX;ASF1A;RBBP4
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.35091387055819945,0.804906260675552,0.7147102526002972,0.9993701384709597,1.0,5/15,18.64%,LIMK1;BAG5;ABL1;FBXO5;PARK7
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.3073534704654953,0.8047907280704562,0.7388535031847133,0.9990862156604464,1.0,12/32,24.58%,GTF2H2;TAF1A;POLR2K;POLR1B;POLR1C;POLR1G;TAF1;UBTF;RRN3;CCNH;POLR2F;TBP
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.21083061861130237,-0.8047535086550932,0.8424242424242424,0.9271399703091996,1.0,14/48,19.89%,ADCY9;SLC26A2;AMPD3;NPR1;PANK1;ADCY4;PANK2;GUCY1B1;PANK3;PPCDC;ADCY3;PANK4;IMPDH1;IMPDH2
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.34929504432525815,0.8044720393237497,0.7021897810218978,0.9991401659924853,1.0,4/16,13.86%,PIGC;PIGP;PIGN;PIGA
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.26166239312388107,-0.804389799312179,0.7637795275590551,0.9266905021600669,1.0,7/22,17.79%,CACNA1C;ADGRV1;STIM1;CAP1;GNAI3;GRM3;EDNRB
prerank,regulation of oxidoreductase activity (GO:0051341),-0.30226123262027027,-0.8043655798692975,0.7347560975609756,0.9255982632032831,1.0,5/13,16.67%,ABL2;ATP7A;ECSIT;OXA1L;SIRT4
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.26849558055605954,0.8041759652137809,0.8142076502732241,0.9991561553407826,1.0,20/93,18.98%,PYCARD;VEGFA;SEMA3A;NCF1;TRAF4;PLCB1;CARD9;FZD7;MTURN;PRMT1;TAOK3;ARL6IP5;MAP3K4;RASSF2;KLHDC10;RELL2;RIPK1;MID1;EMC10;MAP3K11
prerank,melanosome localization (GO:0032400),0.3325139521616248,0.804002917158028,0.7191011235955056,0.9989705146033467,1.0,8/21,25.09%,VPS33A;BBS5;MREG;BBS7;MYO5A;BLOC1S6;BBS4;RAB27B
prerank,response to acidic pH (GO:0010447),-0.2988576120276096,-0.8036299445872639,0.7215909090909091,0.9257812870736267,1.0,4/13,15.53%,RAB11B;GPR4;LGMN;CTSS
prerank,negative regulation of telomere maintenance (GO:0032205),0.3539240647393429,0.8031557502370967,0.7099125364431487,0.999949270879419,1.0,5/15,16.30%,ERCC4;RTEL1;ATM;SMG6;TERF2IP
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.2670119016381386,-0.802470845446701,0.7473309608540926,0.9266170204713846,1.0,7/19,29.88%,TLR4;NMI;TIRAP;PIK3AP1;NR1H4;ITGB2;ITGAM
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.3221115006946902,0.8023780536935728,0.7197802197802198,1.0,1.0,3/23,13.06%,AP1G1;CADM1;NECTIN2
prerank,acidic amino acid transport (GO:0015800),0.3518862218522564,0.8020686563960542,0.7264957264957265,1.0,1.0,4/17,13.27%,SLC1A3;LRRC8D;ARL6IP5;PRAF2
prerank,synaptic vesicle localization (GO:0097479),0.3598683357877701,0.8020291660850798,0.706766917293233,1.0,1.0,4/13,13.74%,NLGN1;SPG11;KIF5C;SYNDIG1
prerank,telomere organization (GO:0032200),-0.2142433652085338,-0.8012029488333824,0.8532608695652174,0.9277572162156393,1.0,12/43,18.97%,SP100;POLD3;RIF1;PARP3;TERF2;PARP1;DOT1L;HUS1;PCNA;TERT;DCLRE1B;TINF2
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.28891616761310596,0.8008832342947253,0.7295285359801489,1.0,1.0,9/42,15.41%,UTRN;MAP4K4;VEGFA;TSC1;CDK6;PTPRJ;MYOC;JUP;ABL1
prerank,negative regulation of gene expression (GO:0010629),0.2501281202779589,0.8008220266377165,0.9128256513026052,1.0,1.0,55/302,18.96%,FFAR4;CLDN19;CREB3L1;FGF2;RBMS3;PTPN22;CD34;KAT2B;PRKN;EPRS1;VEGFA;EIF2AK3;RPS6KA4;FBXW7;TGFB1;ITGB8;PSEN1;DXO;SOX11;EED;METTL3;TSC1;SHQ1;CPEB3;SMO;ZFP36L2;HIF1A;SYT11;ESR1;HELLS;DIP2A;CREBZF;RUNX1;JARID2;EPC1;ATP2B1;RBBP4;NDFIP1;PUS7;NCOR2;TTBK1;BMPR1A;CITED2;EIF4ENIF1;PNPT1;PHF19;SNX12;N4BP1;APLNR;SFMBT2;CENPV;PARK7;SYNCRIP;TAF1;GIGYF2
prerank,positive regulation of organelle assembly (GO:1902117),0.29339813606152104,0.8007930616176127,0.7752403846153846,1.0,1.0,16/44,26.14%,GPSM2;RALB;SDC4;RAB3GAP2;PDCD6IP;FSCN1;HTT;RAB3GAP1;CCDC88A;CNOT6L;DYNC1H1;STX18;G3BP2;BBS4;ENTR1;TAPT1
prerank,arachidonic acid metabolic process (GO:0019369),0.3036513964133923,0.8006692702670336,0.7459526774595268,1.0,1.0,3/35,7.25%,CYP2S1;CYP1B1;PTGES2
prerank,regulation of translation (GO:0006417),0.254684737072997,0.8005165031905578,0.8499486125385406,1.0,1.0,59/173,26.94%,ERBB2;EPRS1;EIF2AK3;PLD1;UPF3A;ETF1;NIBAN1;ATXN2;METTL3;TSC1;EIF1B;EIF3C;CPEB3;EIF6;NSUN5;PASK;NCBP1;GRM5;EIF4G1;UPF1;MTG1;DDX25;RBM4B;PRR16;EIF1;PUS7;CYFIP1;EIF4ENIF1;RPS27L;EIF4A2;TRAP1;EIF2B2;SYNCRIP;GIGYF2;CSDE1;BCL3;EIF4G3;RPS6KA3;METAP1;PYM1;DDX6;VIM;GLE1;ALKBH1;RIDA;PAIP2B;MTOR;FMR1;EIF2AK2;PRKDC;SOX4;YTHDF3;CIRBP;RBM4;DAPK3;KLHL25;DDX1;PAIP2;MTG2
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.353138201835248,0.8004578473542896,0.7163958641063516,1.0,1.0,2/13,9.41%,NAGK;MGAT3
prerank,endothelial cell proliferation (GO:0001935),0.3388114940095853,0.7999303157638977,0.7213352685050798,1.0,1.0,2/17,2.92%,CD34;PRKX
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.31443464252715303,0.7998642440647014,0.7287917737789203,1.0,1.0,7/26,21.95%,FGF2;LETM1;HTR2C;DRD2;RYR3;PKD2;ERO1A
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.2673688458301903,0.7998484461051691,0.7809419496166484,0.9996856658739228,1.0,16/80,17.16%,PYCARD;MYC;DPEP1;NGF;VEGFA;MT3;ACVR1C;CARD9;NGFR;DNAJB6;ARL6IP5;MALT1;SNCA;XIAP;NDUFA13;PAX2
prerank,smooth muscle cell differentiation (GO:0051145),-0.29695826293444716,-0.7995475008908902,0.7363344051446945,0.9295272114236367,1.0,6/12,18.89%,BMP4;TMEM204;HEY2;MRTFB;EDNRB;MYOCD
prerank,steroid biosynthetic process (GO:0006694),-0.20273608094365944,-0.7995407471257904,0.8740157480314961,0.9284003026837605,1.0,19/56,29.83%,PRKAG2;OSBP;LBR;OSBPL9;OSBPL2;INSIG2;DHRS11;OSBPL7;OSBPL3;FDXR;EBP;OSBPL6;SLC27A2;STAR;TM7SF2;SRD5A1;HSD11B1;HSD17B10;CH25H
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.28191208649324545,0.7990808045824547,0.7722419928825622,1.0,1.0,8/53,10.34%,MYC;FGF10;EGFR;SPRED2;SPRED1;BRCA1;SPRED3;FBH1
prerank,protein hydroxylation (GO:0018126),-0.28637687038377974,-0.7990041765153134,0.7431192660550459,0.9281990729009646,1.0,6/15,23.87%,OGFOD1;PLOD3;VIPAS39;EGLN3;JMJD4;VPS33B
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.37154819956874907,0.7985268002698916,0.7095238095238096,1.0,1.0,3/11,9.48%,PRKN;RAB21;VPS11
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.3791925311131412,0.7980249741117676,0.7210365853658537,1.0,1.0,3/10,16.84%,NAGK;GNE;GNPDA1
prerank,regulation of store-operated calcium entry (GO:2001256),-0.3243213819595768,-0.797696445558856,0.7131367292225201,0.9292912793577351,1.0,3/10,13.12%,SLC8B1;SARAF;STIM1
prerank,regulation of protein localization to cell surface (GO:2000008),0.3016217320852718,0.7974877320291797,0.7449238578680203,1.0,1.0,6/33,15.35%,TAX1BP3;GPM6B;GBF1;KCNAB2;NEDD4L;RIC3
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.3596246032462215,0.7971136553360202,0.7181008902077152,1.0,1.0,2/13,9.22%,BPNT1;BPNT2
prerank,purine nucleotide metabolic process (GO:0006163),-0.25006049798574614,-0.7971004261370925,0.775,0.9291582009745303,1.0,10/24,22.80%,PRPSAP2;ITPA;XDH;GPX1;PRPS2;GUK1;GART;PRPS1;PRPS1L1;NT5C1A
prerank,establishment of mitotic spindle orientation (GO:0000132),0.3247979964212757,0.7966752909692354,0.7472375690607734,1.0,1.0,3/23,6.28%,GPSM2;INSC;NDE1
prerank,atrial septum development (GO:0003283),-0.29555229348453194,-0.7964807613719889,0.7478510028653295,0.9290591053147955,1.0,2/13,3.86%,NOTCH2;BMPR2
prerank,water transport (GO:0006833),0.3602123444513925,0.7964487505750173,0.7385826771653543,1.0,1.0,1/12,5.28%,AQP4
prerank,regulation of intracellular protein transport (GO:0033157),0.3019981710413654,0.79635772963048,0.7225725094577553,1.0,1.0,4/32,9.51%,KIF20B;TGFB1;PCM1;PTPN1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.32219616495974635,0.7962634902081877,0.7333333333333333,1.0,1.0,5/23,15.94%,SETMAR;REXO4;FBH1;KPNB1;KPNA1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.2730946553716908,0.7961831243790728,0.7909790979097909,1.0,1.0,10/75,11.32%,PYCARD;PTEN;IRAK3;NF1;PRKAR1B;MEN1;UCHL1;PTPN1;PTPRJ;BMP7
prerank,protein localization to centrosome (GO:0071539),0.3407916750187847,0.7961210903496736,0.7294964028776978,1.0,1.0,3/17,11.39%,PCM1;GOLGB1;SNX10
prerank,regulation of neuron projection arborization (GO:0150011),0.3482150779131774,0.7956213034791764,0.7171428571428572,1.0,1.0,5/15,12.02%,WNT5A;NTNG2;NTNG1;MYO9A;DVL1
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.31906012862469224,-0.7953883614357344,0.7465940054495913,0.9298114481493751,1.0,4/11,19.54%,SMAD7;PTPRC;CEACAM1;HFE
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.27070406525991825,0.79489332310334,0.765375854214123,1.0,1.0,20/66,26.36%,CCT7;EIF2AK3;TGFB1;PSEN1;FLNA;PIK3R1;NGFR;WWTR1;JUP;MEPCE;PARK7;TESK1;IPO5;MCRS1;LIMK2;KAT7;MAVS;TCP1;CARD10;CDK5RAP3
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.24477470703265636,-0.7948710698912228,0.7845528455284553,0.929545258922812,1.0,7/25,14.03%,POMT2;RNF185;STUB1;FBXL17;UBE2W;AUP1;UFD1
prerank,coenzyme A metabolic process (GO:0015936),-0.2920010910120636,-0.7948348522874676,0.7632398753894081,0.9284600960888999,1.0,6/14,22.92%,PANK1;PANK2;PANK3;PPCDC;PANK4;CROT
prerank,negative regulation of interleukin-17 production (GO:0032700),0.37530136418684923,0.7947754790536964,0.7095761381475667,1.0,1.0,1/10,4.77%,PRNP
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.30785951065103195,0.7947469541135707,0.7318932655654383,1.0,1.0,7/33,17.10%,PTEN;CDKN2B;JADE1;CDK6;NACC2;DACT1;CDC73
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.38695325981345385,0.7946706893814254,0.7175572519083969,1.0,1.0,6/10,28.35%,NCK1;CITED2;JUN;HSPA1A;HIF1AN;SIRT2
prerank,fatty acid transmembrane transport (GO:1902001),0.3303890177389593,0.7945083093353277,0.726878612716763,1.0,1.0,3/19,6.84%,SLC27A1;ACACA;PRKAB2
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.3667958649911197,0.7944342066340384,0.7456140350877193,0.9996471609858658,1.0,5/12,26.19%,EFNA5;AP1AR;KANK1;SPRY4;CORO1C
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.3667958649911197,0.7944342066340384,0.7456140350877193,0.9996471609858658,1.0,5/12,26.19%,EFNA5;AP1AR;KANK1;SPRY4;CORO1C
prerank,phosphatidylcholine catabolic process (GO:0034638),0.3783769909999326,0.79430724478239,0.7213622291021672,0.9993767195375117,1.0,3/10,13.78%,PLA2G7;LIPC;PNPLA8
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.29567595844504513,0.7942729458306581,0.7548076923076923,0.9989546638247522,1.0,5/38,13.01%,PTEN;THEM4;PTPRJ;MAGI2;DRD2
prerank,peptidyl-lysine monomethylation (GO:0018026),0.3759032702315875,0.7942073327168591,0.7265625,0.998584529281229,1.0,3/10,18.92%,SETD3;SETD2;SETD4
prerank,fatty acid elongation (GO:0030497),-0.3079931758802342,-0.7939218410995845,0.7551622418879056,0.928911650730311,1.0,2/13,3.18%,ELOVL7;HACD4
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.32296890596203226,0.7936909126675383,0.7359781121751026,0.9989701642104981,1.0,4/22,13.01%,HPCA;PDE4B;CACNB4;DRD2
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.323289725952577,0.7936834884759544,0.7448559670781894,0.9985112191361118,1.0,4/24,9.52%,CADM4;MT3;PTPN1;HIF1A
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.3013841022447596,0.7933749059965258,0.7268106734434562,0.9985690112263839,1.0,5/33,10.53%,FBXW7;NCF1;BTC;HIP1;CBL
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.31584902901100975,-0.7932044495067095,0.7507002801120448,0.9289954474853515,1.0,4/11,15.09%,BMP4;JAG1;TGFB2;HEY2
prerank,regulation of defense response to virus by host (GO:0050691),0.3037164931219664,0.7930148678956345,0.7298335467349552,0.9986919441814337,1.0,2/30,3.78%,PTPN22;TRIM44
prerank,regulation of cell cycle process (GO:0010564),0.26287287267580567,0.7929229150718577,0.8259023354564756,0.998376045408156,1.0,15/104,15.36%,KIF20B;CDKN2B;SOX9;TIPIN;KLHL13;OBSL1;CDK13;SETD2;RCC1;MYO19;PKMYT1;ATF5;RAB11FIP3;CALM1;CALM2
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.25402464813423287,-0.7926831179320178,0.7951388888888888,0.9287796491013784,1.0,6/21,18.34%,SAMD4A;CNOT1;TUT7;PAN2;CNOT11;CNOT9
prerank,cell junction organization (GO:0034330),0.2680627788713396,0.7917969017503604,0.7821100917431193,0.9997392494370522,1.0,13/71,12.02%,LRP4;SEMA3E;TGFB1;PSEN1;CLDN1;APBB2;SLC8A2;FLNA;GRM5;PPFIA2;MYO9A;OPHN1;DVL1
prerank,ether lipid metabolic process (GO:0046485),0.3475499176966662,0.7917359764494375,0.7225519287833828,0.9993649277943044,1.0,4/14,12.50%,AGMO;PLA2G7;FAR1;PLAAT3
prerank,defense response to virus (GO:0051607),0.26342013175454926,0.7916108831868225,0.829004329004329,0.9991050662449875,1.0,10/100,10.54%,CXCL10;PYCARD;BCL2;FADD;NDUFAF4;RNASE6;BNIP3;FLNA;SETD2;AGBL4
prerank,negative regulation of cell death (GO:0060548),0.2676026299718017,0.7913442606445134,0.8104575163398693,0.9990785920472566,1.0,15/88,14.39%,FGF2;CD34;PRKN;SOX11;MT3;BNIP3;FYN;ATG5;PACRG;EIF4G1;BMP7;TM7SF3;NCK1;SNCA;SRSF6
prerank,peptidyl-lysine methylation (GO:0018022),0.3113962019169226,0.7908360518597752,0.7506631299734748,0.9994444955806173,1.0,6/26,19.47%,SUV39H1;SETD3;SETD2;TRMT112;SETD4;N6AMT1
prerank,protein import into peroxisome membrane (GO:0045046),0.31793761210031557,0.7907981840820961,0.7446524064171123,0.9990431077632669,1.0,5/22,16.58%,ACBD5;PEX3;PXMP2;GDAP1;ABCD2
prerank,negative regulation of actin filament polymerization (GO:0030837),0.32073915011317955,0.7907902699794864,0.7455048409405256,0.9985908720348794,1.0,7/22,21.65%,KANK4;GSN;SSH3;SSH1;ARFGEF1;KANK1;SSH2
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.2835486838689748,0.7905618938165598,0.7710109622411693,0.9984910861932453,1.0,7/46,17.76%,SLC27A1;PLD1;AGPAT2;PLA2G12A;AGPAT5;GPAT3;GPAT4
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.31829290641842284,-0.7904919190651861,0.7222222222222222,0.9313317427679342,1.0,2/10,5.36%,OSR1;COMMD1
prerank,positive regulation of receptor internalization (GO:0002092),0.3181516862523326,0.7902317762553522,0.7237569060773481,0.9985467596798856,1.0,8/22,26.25%,VEGFA;SFRP4;MAGI2;SCYL2;CD63;ARRB2;FMR1;AHI1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.2961707978682114,0.78954388053619,0.7787286063569682,0.9991650846468317,1.0,11/38,20.25%,HAT1;ATRX;ASF1A;HJURP;OIP5;RBBP4;ITGB3BP;NASP;CENPL;CENPC;RBBP7
prerank,positive regulation of leukocyte activation (GO:0002696),0.33610697815750806,0.7876374338631765,0.7468354430379747,1.0,1.0,6/18,21.38%,WNT5A;NECTIN2;IL33;LBP;HSPD1;TNIP2
prerank,positive regulation of protein processing (GO:0010954),-0.26751741476456015,-0.7870894795572949,0.8191126279863481,0.9359470371292516,1.0,2/19,1.57%,CCBE1;MYH9
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.2827988838405059,-0.7868680977358748,0.7588652482269503,0.9351949415131972,1.0,8/16,28.65%,RIF1;HELB;POLQ;KLHL15;FANCB;MAD2L2;RMI2;PARPBP
prerank,regulation of JNK cascade (GO:0046328),0.25823683190273794,0.7866536565260935,0.8288770053475936,1.0,1.0,11/101,7.80%,PYCARD;PRKN;EGFR;MAP4K4;SEMA3A;NCF1;TRAF4;PLCB1;CARD9;FZD7;MEN1
prerank,cellular response to glucose stimulus (GO:0071333),0.2991963098810151,0.786482752345353,0.7532637075718016,1.0,1.0,10/30,22.01%,ZBTB20;TRA2B;MLXIPL;PDK3;PRKACA;PAX2;PCK2;ADCY8;PTPRN2;PRKAA1
prerank,negative regulation of interleukin-8 production (GO:0032717),0.3361906888243762,0.7862375025892734,0.7206303724928367,1.0,1.0,5/17,20.69%,PTPN22;OTUD7B;SSC5D;MAPKBP1;BCL3
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.29351988352972885,0.78623385415043,0.7490683229813665,1.0,1.0,13/36,26.81%,EED;APAF1;E2F6;BRCA1;EPC1;RBBP4;RBBP7;CBX5;RNF2;CBX3;EHMT2;RBBP8;EZH2
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.29065164713870895,0.7861786235320918,0.7757793764988009,1.0,1.0,5/41,9.70%,FADS2;CYP1B1;SCD5;ACOX1;ELOVL5
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.3152256911565148,0.7861551723611936,0.7534059945504087,1.0,1.0,7/24,15.40%,NUDT15;UCHL5;TMF1;PRKACA;USP14;PKD1;UBB
prerank,histone H3 deacetylation (GO:0070932),0.34236171592089026,0.7860309837552275,0.7397881996974282,1.0,1.0,4/15,13.30%,HDAC2;SFPQ;SIRT6;PER1
prerank,heterochromatin organization (GO:0070828),0.35152731692409145,0.785897784694574,0.7212389380530974,1.0,1.0,6/14,20.67%,PRDM16;EZH1;POLE3;SETDB1;HP1BP3;SNAI1
prerank,transcription by RNA polymerase III (GO:0006383),0.3110324595299437,0.7858139384787588,0.7760814249363868,1.0,1.0,11/27,25.25%,SNAPC2;IVNS1ABP;ZC3H8;POLR2K;ELL;GTF3C1;POLR3G;SNAPC3;POLR3K;TBP;GTF3C5
prerank,positive regulation of stress fiber assembly (GO:0051496),0.285161207170656,0.7853299359303569,0.7712895377128953,1.0,1.0,15/44,21.63%,LPAR1;GPR65;ARHGEF10;PAK1;LIMK1;NF2;ARHGEF10L;RHOC;MYOC;ABL1;TGFB3;PPM1E;TESK1;CCDC88A;PXN
prerank,Golgi localization (GO:0051645),0.37236644278647796,0.785253455543157,0.7125193199381762,1.0,1.0,5/11,24.21%,YWHAZ;ARHGAP21;COPG1;HOOK3;ARCN1
prerank,intracellular pH reduction (GO:0051452),0.3026447028471933,0.7851541669308447,0.7559449311639549,1.0,1.0,12/33,27.11%,RAB38;ATP6V1B2;RAB39A;DMXL1;RAB7A;ATP6V1C1;ATP6V0E2;ATP6V0E1;ATP6V1G2;ATP6V1H;TCIRG1;ATP6V1D
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.2987416921310124,-0.7851470856276435,0.7668711656441718,0.936854869736166,1.0,7/12,27.26%,IFIH1;CAV1;FLOT1;IFIT1;COLEC12;MUL1;ZCCHC3
prerank,keratan sulfate metabolic process (GO:0042339),0.301554426740123,0.7850596226682905,0.7234314980793854,0.9998012039182023,1.0,3/31,7.06%,LUM;ST3GAL4;GALNS
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.27300627582119236,0.7848688760021971,0.8027681660899654,0.9996540254613144,1.0,10/65,12.74%,EGFR;MVB12B;PTPN2;EPS15;BTC;HIP1;PTPRJ;CBL;MVB12A;SH3KBP1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.28593186263709264,-0.7848200805784886,0.7425742574257426,0.9362443162759334,1.0,2/14,4.84%,PKIA;PRKAR1A
prerank,catecholamine biosynthetic process (GO:0042423),0.3681155348877593,0.7840826459964916,0.7132018209408194,1.0,1.0,3/11,13.86%,DAO;GATA3;SNCA
prerank,protein secretion (GO:0009306),0.27403729485507067,0.7840586522287234,0.7901524032825322,1.0,1.0,23/56,28.97%,STEAP3;COPG2;MTTP;RCN3;RAB3D;RAB3A;ARFGAP3;COPG1;TANGO6;RIMS2;PARK7;RAB3B;TANGO2;PORCN;TVP23A;MIA3;SNX19;MON1A;SEL1L;SCG2;LTBP2;RAB13;PREB
prerank,transcription by RNA polymerase I (GO:0006360),0.2952989222810395,0.7837704769246627,0.7726130653266332,1.0,1.0,12/34,24.58%,GTF2H2;TAF1A;POLR2K;POLR1B;POLR1C;POLR1G;TAF1;UBTF;RRN3;CCNH;POLR2F;TBP
prerank,positive regulation of cellular metabolic process (GO:0031325),0.2569312573857203,0.7836523619457196,0.81445523193096,0.9997321278386249,1.0,22/98,19.24%,VEGFA;ACACA;TGFB1;MT3;TGFBR2;FASN;ACLY;SFRP4;EIF4G1;MAPK14;PID1;MAGI2;RAB1A;SCRIB;GATA3;SNCA;SCYL2;TP53;RIPK1;CD63;GRB2;PPARG
prerank,positive regulation of immune system process (GO:0002684),0.33846641073407074,0.7835823920731888,0.75,0.9993989091913708,1.0,1/16,3.17%,VEGFA
prerank,positive regulation of interleukin-13 production (GO:0032736),0.36832762186857504,0.7834282673337695,0.725705329153605,0.9991881112764188,1.0,2/10,13.38%,IL18;GATA3
prerank,negative regulation of protein kinase activity (GO:0006469),0.26245432198580293,0.7826575859395978,0.814489571899012,0.999934941341991,1.0,18/88,19.26%,UBASH3B;PYCARD;PTPRT;DEPTOR;NF1;SPRED1;PTPN1;DVL1;WWTR1;ADARB1;SNCA;TAF7;ABL1;PYDC1;DBNDD2;PARK7;PPM1E;TESK1
prerank,negative regulation of viral release from host cell (GO:1902187),-0.29686604239052244,-0.782283186778387,0.7335243553008596,0.9391091744586836,1.0,4/13,17.93%,CHMP3;TRIM5;PML;TRIM21
prerank,positive regulation of response to stimulus (GO:0048584),0.28641409789835715,0.7818460404457237,0.758578431372549,1.0,1.0,8/40,17.79%,MYC;WNT5A;TAF9;YPEL3;GATA3;CGAS;HOMER1;NSMCE4A
prerank,protein palmitoylation (GO:0018345),-0.2337626919149544,-0.781548508102567,0.8391304347826087,0.9391242752362315,1.0,7/30,15.21%,ZDHHC14;ZDHHC3;CLIP3;ZDHHC18;ZDHHC7;ZDHHC20;ZDHHC4
prerank,receptor metabolic process (GO:0043112),0.2772595202452594,0.7814248893214957,0.7780401416765053,1.0,1.0,10/53,15.04%,DNM1;LRP1;TGFB1;ACKR3;PHETA2;MVB12A;SNCA;CD9;SNX1;ITGB1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.24343885121705516,0.7812092554767214,0.9017223910840932,1.0,1.0,75/241,26.01%,CSTF3;DHX8;TRA2B;PABPC1;RSRC1;POLR2B;METTL3;DHX35;RNPC3;SRSF11;CWF19L2;RBM10;TXNL4A;POLR2K;CASC3;SNRPB2;NCBP1;FIP1L1;SFPQ;SNRNP40;HNRNPA3;LSM3;PRPF6;RBM4B;DDX42;POLR2G;SRSF6;NOVA1;YTHDC1;PAPOLA;PPIH;RAVER2;SNRPA;SF3A1;HNRNPU;RNPS1;SF1;FUS;GEMIN7;SART1;SYNCRIP;DDX23;POLR2A;HNRNPUL1;SRRM1;SF3B3;DBR1;HNRNPH2;HNRNPC;HNRNPL;SRSF3;RBM17;SNIP1;SNRPN;DNAJC8;SYMPK;SNRNP200;PLRG1;RBMX2;SF3B2;WBP4;CTNNBL1;PCBP2;POLR2F;TFIP11;CPSF7;MAGOHB;NONO;U2SURP;SNRPA1;RBM15;SPEN;RBM4;TRA2A;HNRNPA2B1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.2597983335085092,0.7804870545372486,0.8127753303964758,1.0,1.0,15/78,18.71%,DYNLL1;SEC24D;AP1G1;AP1S1;SEC24C;DYNC1I1;DCTN4;DYNC1I2;KIF22;CD74;SEC24A;RAB7A;KIF3A;KIF2A;OSBPL1A
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.2597983335085092,0.7804870545372486,0.8127753303964758,1.0,1.0,15/78,18.71%,DYNLL1;SEC24D;AP1G1;AP1S1;SEC24C;DYNC1I1;DCTN4;DYNC1I2;KIF22;CD74;SEC24A;RAB7A;KIF3A;KIF2A;OSBPL1A
prerank,positive regulation of translational initiation (GO:0045948),-0.267287861997898,-0.7802985136446554,0.7711267605633803,0.9400381783878925,1.0,6/18,23.01%,YTHDF1;HABP4;RPS6KB1;RPS6KB2;KHDRBS1;POLR2D
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.34125763715628793,0.7795397827533037,0.7423312883435583,1.0,1.0,1/14,1.88%,ANK2
prerank,GPI anchor biosynthetic process (GO:0006506),0.3041240023431907,0.7794328305153246,0.7470355731225297,1.0,1.0,8/30,20.22%,PGAP1;PIGC;PIGP;PIGN;PIGA;PIGU;DPM1;PIGO
prerank,cell cycle G1/S phase transition (GO:0044843),0.2710697364441759,0.7792006897964132,0.8048780487804879,1.0,1.0,13/61,18.98%,CRLF3;MYC;ACVR1;CDK6;CUL3;RCC1;PHF8;PIM2;CUL4B;NASP;USP37;DBF4;MAP3K11
prerank,membrane repolarization during action potential (GO:0086011),-0.29441454924743937,-0.7791413052354206,0.756838905775076,0.9407740446098161,1.0,5/13,24.88%,KCNJ2;ATP1A1;ATP1B1;KCNE4;KCNIP2
prerank,lipid modification (GO:0030258),0.2942028797535997,0.77912839527808,0.7658536585365854,1.0,1.0,15/37,28.90%,MBOAT2;PLA2G7;DGKI;PLPP4;PLPPR4;PLPPR2;PLPPR1;PORCN;EPHX2;DGKA;DGKK;SGPP1;DGKD;DGKZ;DGKQ
prerank,phosphatidic acid metabolic process (GO:0046473),0.2766190453227598,0.7788430362579051,0.7852834740651388,1.0,1.0,7/48,17.76%,SLC27A1;PLD1;AGPAT2;PLA2G12A;AGPAT5;GPAT3;GPAT4
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.3180876989764242,0.7785017075826075,0.751696065128901,1.0,1.0,5/23,16.67%,SLC12A3;SLC12A2;SLC12A4;KCNH2;SLC9A1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.24743592888454757,0.7782769229228771,0.8796296296296297,1.0,1.0,48/184,23.83%,DYNLL1;HAUS3;CNTRL;PCM1;NDE1;SDCCAG8;CEP57;PSMB7;ZFP36L2;CUL3;ANAPC7;CLASP1;ANAPC2;PRKACA;DDB1;CKAP5;CEP76;BUB1B;DYNC1I2;PKD1;PSMD2;CDC14A;UBB;PSMC1;CDC23;CSNK1E;ANAPC16;ANLN;PSMB2;CEP63;FBXO5;TUBA1A;PSMD9;CDC27;PSME4;UBE2E1;SSNA1;CEP78;PSMA8;PCNT;ANAPC4;DYNC1H1;CDK5RAP2;ANAPC5;CDC16;PLK5;PPP2R1A;ALMS1
prerank,centromere complex assembly (GO:0034508),0.29367058816486535,0.7780206461648381,0.7649938800489596,1.0,1.0,12/36,22.73%,HELLS;POGZ;HJURP;OIP5;RBBP4;ITGB3BP;NASP;CENPL;CENPV;CENPC;RBBP7;CENPU
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.24234627262512545,0.7778594546467207,0.917087967644085,1.0,1.0,85/264,26.85%,CSTF3;DHX8;TRA2B;PABPC1;RSRC1;POLR2B;CDK13;METTL3;DHX35;RNPC3;SRSF11;CWF19L2;RBM10;TXNL4A;POLR2K;CASC3;SNRPB2;NCBP1;FIP1L1;TGS1;CLNS1A;SFPQ;SNRNP40;HNRNPA3;LSM3;PRPF6;RBM4B;DDX42;POLR2G;SRSF6;NOVA1;YTHDC1;PAPOLA;PPIH;RAVER2;SNRPA;SF3A1;HNRNPU;RNPS1;SF1;FUS;GEMIN7;SART1;SYNCRIP;DDX23;POLR2A;HNRNPUL1;SRRM1;SF3B3;DBR1;HNRNPH2;HNRNPC;CELF4;HNRNPL;SRSF3;RBM17;SNIP1;SNRPN;DNAJC8;SYMPK;SNRNP200;PLRG1;RBMX2;SF3B2;WDR77;WBP4;CTNNBL1;PCBP2;POLR2F;TFIP11;CPSF7;MAGOHB;NONO;SCAF11;U2SURP;SNRPA1;RBM15;SPEN;RBM4;TRA2A;HNRNPA2B1;DDX1;PRPF38A;PRPF40A;UBL5
prerank,establishment of spindle orientation (GO:0051294),0.30642447956459506,0.7777970918570963,0.7777777777777778,1.0,1.0,8/28,22.76%,GPSM2;INSC;NDE1;CLASP1;ITGB1;HTT;LLGL1;CDK5RAP2
prerank,ethanol metabolic process (GO:0006067),0.355589889500441,0.7775714534962549,0.71898355754858,1.0,1.0,2/12,7.30%,ACSS2;ACSS1
prerank,B cell proliferation (GO:0042100),0.33553075411835925,0.7775642737864767,0.7450142450142451,1.0,1.0,1/17,1.69%,BCL2
prerank,atrioventricular valve morphogenesis (GO:0003181),0.32188186305237404,0.7772545721414209,0.7305555555555555,1.0,1.0,8/19,25.44%,ACVR1;TGFBR2;MDM4;BMPR1A;HEYL;BMP2;EFNA1;SOX4
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.3629737040812225,0.7772490915307037,0.7447129909365559,0.9995735831030721,1.0,1/11,4.22%,CCL4
prerank,ganglion development (GO:0061548),0.36483043137454735,0.7770412485770326,0.7560240963855421,0.9994449205488033,1.0,3/11,12.32%,SEMA3A;NRP2;UNC5C
prerank,regulation of astrocyte differentiation (GO:0048710),-0.30169402658356176,-0.7768698421654656,0.7754491017964071,0.9431892826288085,1.0,1/12,0.34%,EPHA4
prerank,positive regulation of binding (GO:0051099),0.2619451961666484,0.7768631644381763,0.8324205914567361,0.999251019880237,1.0,14/84,15.66%,DDX11;NGF;LRP1;PRKN;PSEN1;RALB;MEN1;NCBP1;USP33;AKTIP;PKD1;MET;DACT1;MED25
prerank,dicarboxylic acid catabolic process (GO:0043649),0.35161021856615726,0.7767936994272929,0.7440828402366864,0.9989020351891665,1.0,4/13,21.45%,GOT2;ASPA;ACOT8;GLUD1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.2691933338744647,0.7765639757681674,0.8185993111366245,0.9988060626971584,1.0,14/63,17.91%,WAC;CARM1;PCBP4;PRMT1;CNOT3;RPA2;MDM4;ATM;CASP2;CRADD;RPS27L;TP53;FBXO31;MDM2
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.2534294369537734,0.7764848496884111,0.8528464017185822,0.9984674408515949,1.0,16/110,17.98%,CXCL10;LPAR1;PTGER3;GPR65;PTHLH;PTGFR;LGR5;TSHR;ADGRB3;S1PR3;ADGRL3;DRD2;ADGRG2;MC5R;S1PR2;GPR161
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.25865765129807194,0.776266440837769,0.8265193370165745,0.9983579061815605,1.0,15/79,18.71%,DYNLL1;SEC24D;AP1G1;AP1S1;SEC24C;DYNC1I1;DCTN4;DYNC1I2;KIF22;CD74;SEC24A;RAB7A;KIF3A;KIF2A;OSBPL1A
prerank,cellular protein metabolic process (GO:0044267),0.2407571614330486,0.7760709312196135,0.9418837675350702,0.9982203356776772,1.0,52/396,14.33%,GPC3;MMP2;CHRM3;VCAN;MXRA8;HM13;CHRDL1;LAMC1;PRKN;TGM1;MRPS18A;PARL;ARAF;PRKCSH;PSEN1;NUCB1;SDC2;RPL23A;LTA4H;MRPL32;MMP15;EVA1A;CDKL3;ATP23;GATA6;RCN1;FARSB;SRBD1;MEN1;VWA1;SPCS3;CKAP4;AMELX;EIF4G1;MRPL35;NCSTN;LTBP1;CALU;GSPT2;MRPL28;UBA3;SLC35A1;ATG3;FBXL2;FUCA2;APH1A;HSP90B1;YME1L1;PENK;NEDD8;HARS1;PSEN2
prerank,regulation of regulated secretory pathway (GO:1903305),0.29270950958874714,0.7754987559034185,0.8054474708171206,0.9986525145348891,1.0,11/34,20.37%,SYT1;RAB3D;SYN1;SYT11;SYT12;RIMS1;RAB3A;SYT2;UNC13D;RIMS2;SYT13
prerank,midbody abscission (GO:0061952),-0.26252878373973754,-0.7752046741141355,0.7972027972027972,0.9444723055232249,1.0,6/17,24.37%,CHMP3;VPS4A;CHMP1A;VPS4B;CHMP7;CHMP2B
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.27425468609976034,0.7750378516096093,0.783410138248848,0.998474264624198,1.0,15/56,20.06%,NDUFAF4;NDUFS5;NDUFAF6;NDUFB2;NDUFA8;NDUFS8;ACAD9;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1;NDUFA5
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.27425468609976034,0.7750378516096093,0.783410138248848,0.998474264624198,1.0,15/56,20.06%,NDUFAF4;NDUFS5;NDUFAF6;NDUFB2;NDUFA8;NDUFS8;ACAD9;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1;NDUFA5
prerank,negative regulation of protein processing (GO:0010955),0.3519739622572889,0.7749892746781621,0.7429420505200595,0.9980876944715318,1.0,3/12,16.97%,PRNP;SERPINE2;SNX12
prerank,negative regulation of TORC1 signaling (GO:1904262),0.3574241198175352,0.7749534488861367,0.7462235649546828,0.9976827656592623,1.0,6/13,25.07%,CASTOR2;ATM;SPAAR;DEPDC5;SESN1;ITFG2
prerank,eye photoreceptor cell development (GO:0042462),0.3354385924250347,0.7748295847122786,0.7426470588235294,0.9974144974829366,1.0,1/15,3.17%,VEGFA
prerank,cardiac ventricle development (GO:0003231),0.32326009468148986,0.7744429622011588,0.7510316368638239,0.9975631646193421,1.0,6/20,17.26%,SCN5A;TMEM65;DAND5;GATA3;MDM4;HEYL
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.30501093062738427,0.7741864200719134,0.7735099337748345,0.9974896523913838,1.0,9/28,23.43%,BCL2;TNFRSF10B;PPP1R15A;TMEM117;QRICH1;AIFM1;DNAJC10;ERO1A;CEBPB
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.24968438678780566,0.774056158996783,0.8610240334378265,0.9972494188023199,1.0,16/124,15.69%,ROR2;FRZB;PLCB1;WNT5A;PPP3CB;FZD7;PPP3CA;PRICKLE2;PSMB7;SFRP4;PRICKLE1;DVL1;CALM1;PSMD2;PSMC1;FZD9
prerank,regulation of glycogen metabolic process (GO:0070873),-0.29514109846974723,-0.7739831828919695,0.7810650887573964,0.9453609852506394,1.0,8/12,42.03%,PPP1R3B;PPP1R3C;AKT1;RUBCNL;PPP1R3E;KHK;PPP1R3D;GCGR
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.28930151007842886,-0.7738637176211218,0.7770700636942676,0.9444329387863112,1.0,6/14,23.51%,MMS19;PARP1;WRAP53;ERCC6;FANCB;TIMELESS
prerank,response to zinc ion (GO:0010043),0.3098775923767009,0.7736289782506162,0.7703804347826086,0.9974699765557893,1.0,11/25,28.53%,MT3;SLC30A4;D2HGDH;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,mitotic metaphase plate congression (GO:0007080),-0.2040329868796936,-0.7732693947758075,0.8940397350993378,0.9442733501406876,1.0,27/51,36.69%,CHMP3;BECN1;NUDC;VPS4A;CHMP1A;KIF18A;PINX1;VPS4B;PIBF1;CHMP7;BOD1;CHMP2B;DCTN2;EML4;CENPE;EML3;ZW10;NUP62;NDC80;KIFC1;KIF14;SPDL1;CDCA8;CEP55;MAD1L1;CHMP6;SEH1L
prerank,heart trabecula morphogenesis (GO:0061384),0.32844080809053844,0.7729251522032561,0.7559607293127629,0.9981355823552119,1.0,1/18,0.52%,BMP5
prerank,regulation of cellular localization (GO:0060341),0.2807288158042746,0.7726795838650642,0.7805755395683454,0.9980530591593855,1.0,4/46,2.87%,STXBP4;GSN;PRKN;EFNA5
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.3365411501672907,0.7724986882440583,0.7736131934032984,0.9978556275986429,1.0,5/15,20.78%,ZFP36L2;BCL2L11;HNRNPU;UBE2L3;ZFP36
prerank,chromatin remodeling at centromere (GO:0031055),0.29811217833087883,0.7724151310369478,0.7875,0.9975296895401159,1.0,11/31,22.73%,HELLS;HJURP;OIP5;RBBP4;ITGB3BP;NASP;CENPL;CENPV;CENPC;RBBP7;CENPU
prerank,positive regulation of inflammatory response (GO:0050729),0.2601763354714112,0.7723752421879926,0.8353457738748628,0.9971250990080919,1.0,16/86,19.85%,IL16;GPRC5B;WNT5A;CCR2;PLA2G7;IL18;IL6ST;GRN;SNCA;IL33;ABCC1;LBP;RIPK1;MDK;SETD4;PDCD4
prerank,negative regulation of translational initiation (GO:0045947),-0.2921976393350353,-0.772363080802292,0.7734806629834254,0.9445315991700604,1.0,5/13,28.91%,EIF2AK1;EIF4EBP2;EIF3E;EIF2AK4;AGO2
prerank,vacuolar acidification (GO:0007035),-0.25468701394838306,-0.7707206387359533,0.8074074074074075,0.946009967974809,1.0,11/21,30.19%,ATP6V0D1;DMXL2;ATP6V0A4;TMEM9;CLN5;ATP6V0A2;TMEM199;ATP6AP2;CCDC115;PPT1;SLC11A1
prerank,receptor catabolic process (GO:0032801),-0.23729506427782565,-0.7705801379528667,0.8326359832635983,0.9451065053315978,1.0,6/24,15.80%,ZNRF3;BECN1;LGMN;UVRAG;RNF43;CLTA
prerank,rRNA catabolic process (GO:0016075),-0.27229254570820516,-0.7704697281816894,0.7727272727272727,0.9441672460973942,1.0,5/16,17.94%,XRN1;EXOSC7;DIS3;EXOSC10;DEDD2
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.24671323607387952,0.770174148392438,0.867983367983368,1.0,1.0,36/149,25.00%,ROR1;EDA;PRKCQ;PYCARD;IRAK3;RPS6KA4;WNT5A;CARD9;IL18;MID2;RTKN2;PRDX3;MALT1;DHX33;TICAM1;UBB;TERF2IP;IL1RAP;RIPK1;CHUK;RAB7B;TAB3;STAT3;BCL10;NFKB1;PRKD2;CARD11;FLOT2;TAB2;CARD16;ERC1;IRAK2;TRIM14;HSPA1A;CIB1;EIF2AK2
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.29048001207049956,-0.7699904754612333,0.7485029940119761,0.9438037854140937,1.0,6/13,23.68%,CACNA1G;KCNB1;SYT10;STX1A;SYT4;CACNA1I
prerank,positive regulation of cell aging (GO:0090343),0.36078413055197944,0.7697078681498569,0.7481031866464339,1.0,1.0,3/11,15.42%,YPEL3;CGAS;LMNA
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.3183142417762124,0.7693035880668185,0.7639836289222374,1.0,1.0,3/21,5.98%,EPHB2;SYNGAP1;MAPKAP1
prerank,negative regulation of platelet activation (GO:0010544),0.3343364039331857,0.7688851333916888,0.7610872675250357,1.0,1.0,3/16,13.96%,PDGFRA;SERPINE2;CD9
prerank,positive regulation of peptidase activity (GO:0010952),0.312876815811527,0.7687853256482625,0.7659863945578231,1.0,1.0,5/20,16.57%,RCN3;NCSTN;GRN;APH1A;NDUFA13
prerank,regulation of ERAD pathway (GO:1904292),-0.2945175734712294,-0.7687421505810068,0.7462235649546828,0.9446404902959056,1.0,4/11,12.55%,USP19;RNF185;AQP11;TMEM259
prerank,positive regulation of lipid catabolic process (GO:0050996),0.3326621462775168,0.7685545017032702,0.7696629213483146,1.0,1.0,3/19,16.58%,IRS2;MTLN;ABCD2
prerank,mesoderm development (GO:0007498),0.3312705167296358,0.76844179750799,0.7651195499296765,0.9999276301158341,1.0,2/18,4.77%,VEGFA;MEST
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.3089035063728325,0.7681976540283739,0.7618403247631935,0.9998557510983467,1.0,5/23,17.07%,DERL2;SELENOS;HERPUD1;HSP90B1;SURF4
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.33287644515944875,0.7680427781070076,0.7521865889212828,0.9996364018468498,1.0,6/15,30.71%,ZC3H12B;POP1;ZC3H12C;RPP30;KHNYN;ZC3H12A
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.3511803718916261,0.7674829688575063,0.7619047619047619,1.0,1.0,4/12,21.84%,PDE4D;CALM1;CALM2;CAMK2D
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.3614373110674786,0.7673793160934264,0.7361769352290679,0.9997481899046248,1.0,3/10,24.56%,DRD2;CALM1;FMR1
prerank,glutamine family amino acid catabolic process (GO:0009065),0.34423956940326816,0.7670634773807861,0.7462908011869436,0.999774893557123,1.0,5/13,22.17%,DAO;GLS;GLS2;GLUD1;DDAH1
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.2533334262350962,0.7668886892997596,0.8628944504896626,0.999575381496497,1.0,12/101,9.95%,SLC27A1;FGF2;ERBB2;EGFR;VEGFA;TGFB1;WNT5A;RALB;FGFR1;SLC8A2;EDN3;PIH1D1
prerank,cellular response to cAMP (GO:0071320),-0.22768752156011024,-0.7666465418297176,0.8473895582329317,0.9465818716597373,1.0,4/30,6.91%,RAP1B;IGFBP5;ZFP36L1;SLC5A5
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.24048209716996008,-0.7666208320342099,0.8108108108108109,0.945512502108764,1.0,9/24,26.92%,RNF34;CASP8;MAP3K7;UBE2N;IKBKG;NOD1;UBA52;TNFAIP3;NOD2
prerank,long-chain fatty acid transport (GO:0015909),0.2989746818181278,0.7666137821720618,0.7738562091503268,0.9995351504133412,1.0,4/30,6.84%,SLC27A1;ACACA;SLC27A4;PRKAB2
prerank,maintenance of protein localization in organelle (GO:0072595),0.3154266385143106,0.7663341917148573,0.7465181058495822,0.9994896697630865,1.0,9/19,26.14%,ARL2;HNRNPU;HK2;TAF8;BCL3;HK1;BBS4;TOPORS;TAPT1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.2705824382084376,-0.7659174002718435,0.8079268292682927,0.9453754400781356,1.0,6/16,19.89%,AMPD3;ATIC;LHPP;IMPDH1;GART;IMPDH2
prerank,plasma membrane tubulation (GO:0097320),-0.29391000560760117,-0.7655264829871217,0.7386018237082067,0.9448451397097012,1.0,4/13,16.60%,SNX9;FNBP1L;WHAMM;MICALL1
prerank,positive regulation of glial cell differentiation (GO:0045687),0.32639787007284027,0.7652978247160432,0.7520547945205479,1.0,1.0,5/17,17.28%,TGFB1;SERPINE2;BIN1;PTPRZ1;MDK
prerank,axonal fasciculation (GO:0007413),0.3522765686594718,0.7647767270551582,0.7450381679389313,1.0,1.0,5/12,19.33%,NRCAM;EPHB2;CDK5R1;RTN4;CNTN4
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.33286151313194356,0.7647252782836749,0.75,1.0,1.0,3/15,15.27%,ACVR1;MAGI2;DACT1
prerank,acylglycerol biosynthetic process (GO:0046463),-0.25187674238500835,-0.7647239206480062,0.7947761194029851,0.9449427065907138,1.0,3/23,6.09%,PLA2G4A;GPAM;LPIN2
prerank,protein N-linked glycosylation (GO:0006487),0.26624360154984067,0.7645277691403889,0.8068965517241379,1.0,1.0,15/66,19.51%,GFPT2;UGGT2;ALG9;STT3A;MGAT3;MAGT1;ALG5;TUSC3;ALG1;MOGS;ALG8;DPM1;DPAGT1;ALG6;RPN1
prerank,positive regulation of transmembrane transport (GO:0034764),0.34826661838235123,0.7640366516995107,0.7536656891495601,1.0,1.0,2/13,3.49%,C2CD5;ANO6
prerank,prostaglandin metabolic process (GO:0006693),0.30470846232328697,0.7636479037851102,0.7847133757961784,1.0,1.0,6/26,17.26%,CYP2S1;ACOX1;PNPLA8;PLAA;PTGES;CD74
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.23784268276907483,0.7635910181578867,0.933933933933934,1.0,1.0,82/314,23.35%,ZFAND2B;RAD23B;PRKN;ERLIN2;HACE1;DNAJB9;FBXW7;SPSB4;RHBDD2;SPOP;FBXO38;FBXL15;TRIM2;HECTD3;PELI1;UBE2K;UCHL1;FBXL16;PSMB7;DERL2;FBXO27;SELENOS;CUL3;HERPUD1;FBXO45;ANAPC7;HUWE1;NFE2L2;UBE2J2;RNF121;FBXO17;ANAPC2;TMUB2;FBXL2;DDB1;HSP90B1;BUB1B;NEDD4L;KLHL22;PSMD2;JKAMP;AREL1;PLAA;UBB;PSMC1;ERLIN1;CDC23;ZSWIM8;ANAPC16;FBXL4;CUL4B;PSMB2;FBXO5;FBXO31;MDM2;TRIM9;PSMD9;RNF4;TAF1;DNAJC10;PCNP;FBXL12;CDC27;PSME4;UBE2G1;DCAF11;UBE2E1;PSMA8;SGTA;PTTG1;ANAPC4;UBE2D3;ARRB2;UBQLN1;UBR3;FBXO44;ANAPC5;SIAH1;COP1;CDC16;RNF187;UBQLN2
prerank,regulation of TORC1 signaling (GO:1903432),-0.21594646009103066,-0.7635250552529665,0.8571428571428571,0.9456063241506215,1.0,10/33,20.04%,SIK3;RRAGC;FLCN;SESN2;LARS1;PIP4P1;SMCR8;RRAGB;KPTN;GPR137
prerank,innate immune response in mucosa (GO:0002227),-0.3138019879533739,-0.763361355824917,0.7555555555555555,0.9447475655774652,1.0,1/10,5.93%,DEFA6
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.2668291379864636,0.7626275151114125,0.7847953216374269,1.0,1.0,10/55,17.17%,PYCARD;BCL2;FADD;BMF;TRAF7;CRADD;BCL2L11;TP53;WWOX;RIPK1
prerank,tRNA modification (GO:0006400),0.26638850926807933,0.7619374934794783,0.8203939745075318,1.0,1.0,20/62,23.92%,DTWD1;THUMPD3;PUSL1;TRMT12;THADA;DTWD2;TRMT112;PUS7;THUMPD2;ELP5;PUS1;SSB;TPRKB;TRIT1;NSUN2;LCMT2;ALKBH1;ALKBH8;TRMT1;MOCS3
prerank,triglyceride metabolic process (GO:0006641),0.2750460554999001,0.76176639476373,0.8019559902200489,1.0,1.0,7/48,17.76%,AGMO;LMF1;MOGAT3;LIPC;PLAAT3;GPAT3;GPAT4
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.29589939958785866,0.761280828031696,0.7763157894736842,1.0,1.0,10/30,24.69%,SLC27A4;ACOX1;ELOVL6;ELOVL5;ABCD2;ACSL6;HACD2;TECRL;ELOVL1;HACD3
prerank,neuron remodeling (GO:0016322),0.3579678633581912,0.7607503761028563,0.7367576243980738,1.0,1.0,3/10,12.42%,ADGRB3;FARP2;ANKS1A
prerank,cellular glucan metabolic process (GO:0006073),0.35509940905968734,0.7599104192073596,0.779788838612368,1.0,1.0,2/11,9.14%,PYGL;PHKB
prerank,regulation of mitochondrion organization (GO:0010821),0.27250193756396074,0.7598454496833834,0.7985436893203883,1.0,1.0,7/47,11.38%,PRKN;PARL;FBXW7;RHOT2;MYO19;PID1;HDAC6
prerank,liver development (GO:0001889),0.29308024957323564,0.7595759531883512,0.788659793814433,1.0,1.0,10/32,24.29%,CCDC39;PRKCSH;NF1;COBL;CITED2;MET;PCK2;PKD2;CEBPB;TGFBR3
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.25907048244690273,0.7594114654965787,0.8323895809739524,1.0,1.0,17/72,20.34%,HMGN1;GTF2H2;ERCC5;ERCC4;POLR2B;RPA3;XPA;POLR2K;DDB1;RPA2;POLR2G;UBB;CUL4B;LIG3;POLR2A;COPS6;COPS7A
prerank,sulfation (GO:0051923),-0.30084420909554366,-0.7593512783376353,0.7853107344632768,0.949391691581396,1.0,5/11,44.09%,UST;SULT4A1;CHST5;SULT2B1;SULT6B1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.2968582099501723,0.7592077838052447,0.7960264900662252,1.0,1.0,9/27,19.50%,CRTC1;PPP1CA;PER3;RBM4B;PER1;CRY1;TP53;USP2;FBXL12
prerank,positive regulation of JNK cascade (GO:0046330),0.25847853161734263,0.7585786838045332,0.829021372328459,1.0,1.0,9/70,11.44%,PYCARD;SEMA3A;NCF1;TRAF4;PLCB1;CARD9;FZD7;MTURN;TAOK3
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.33203007097384846,0.7584309155003681,0.7795389048991355,1.0,1.0,4/16,20.67%,ACKR3;FBH1;NACC2;SNAI1
prerank,rRNA methylation (GO:0031167),0.30940609834486527,0.7580980940876653,0.7727910238429172,1.0,1.0,5/22,12.92%,NOP2;NSUN5;FDXACB1;FBL;TRMT112
prerank,clathrin-dependent endocytosis (GO:0072583),0.29960818447613624,0.757294698719958,0.7881136950904393,1.0,1.0,4/26,11.18%,SGIP1;ITSN1;GAK;GPR107
prerank,cellular response to hydrogen peroxide (GO:0070301),0.2834743164839487,0.7569582422483006,0.7819548872180451,1.0,1.0,10/33,20.53%,MAPK7;CYP1B1;NFE2L2;HDAC6;ABL1;PAX2;RIPK1;PARK7;OSER1;SIRPA
prerank,protein localization to cell surface (GO:0034394),0.3010833010808073,0.756863436433784,0.7924281984334204,1.0,1.0,6/26,16.30%,FGF10;ANK2;FLNA;FGF7;RIC3;PIGU
prerank,polyol biosynthetic process (GO:0046173),0.32805505432420967,0.7565045021607464,0.7652050919377652,1.0,1.0,1/16,1.25%,FGF2
prerank,"base-excision repair, gap-filling (GO:0006287)",0.2854747558986165,0.756462021225305,0.8085889570552147,1.0,1.0,8/35,16.07%,MBD4;MPG;RPA3;MUTYH;NEIL1;RPA2;SMUG1;POLG
prerank,response to glucocorticoid (GO:0051384),-0.23322192376495915,-0.7564479192240536,0.8528301886792453,0.9524392596507075,1.0,6/26,20.31%,SLIT2;ZFP36L1;FAM107A;ANXA1;PDCD7;GOT1
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.2772628452502629,-0.7561438768305153,0.806060606060606,0.9517199901480838,1.0,8/14,28.40%,ITPA;ENPP1;AK4;SMPDL3A;AK1;NME2;ENPP3;AK7
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.25605585952220694,0.7555894055651426,0.8553948832035595,1.0,1.0,16/83,18.93%,CRLF3;MYC;ACVR1;CDK6;CDK15;CUL3;RCC1;PHF8;CDK16;ORC1;PIM2;CUL4B;FBXO5;NASP;USP37;DBF4
prerank,ribosomal large subunit assembly (GO:0000027),0.3041390492227068,0.755484968768291,0.776595744680851,1.0,1.0,4/24,7.77%,RPL23A;NOP2;BRIX1;DHX30
prerank,ventricular septum development (GO:0003281),0.2801937463784814,0.7551275652122232,0.8105395232120451,1.0,1.0,11/37,17.26%,ACVR1;SOX11;TGFBR2;DAND5;ZFPM2;GATA3;MDM4;BMPR1A;CITED2;APLNR;HEYL
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.2687299211139858,0.7550675021948048,0.827460510328068,1.0,1.0,8/46,16.20%,TGFB1;PSEN1;CPSF6;FLNA;PIK3R1;EMD;JUP;TP53
prerank,response to progesterone (GO:0032570),-0.25831287165001837,-0.7549777820426863,0.856655290102389,0.9522520312702408,1.0,6/18,20.73%,THBS1;TGFB2;CAV1;ABHD2;CATSPER3;NR1H3
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.2665124411479445,-0.7549417832130177,0.7853107344632768,0.9512013776675566,1.0,8/15,28.40%,ENTPD1;ENTPD7;AK4;AK1;NME2;ENTPD3;ENTPD5;AK7
prerank,T cell activation (GO:0042110),0.2585380635295634,0.7546135018084625,0.8514739229024944,1.0,1.0,11/69,17.28%,PTPN22;PTPN2;PPP3CB;PPP3CA;NHEJ1;RHOH;SCRIB;GATA3;NCK1;CD74;MDK
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.2191270852019347,-0.7544688292716413,0.8888888888888888,0.9507443992236294,1.0,7/31,12.63%,SYT9;STXBP1;CACNA1G;ADRA2A;KCNB1;SYT10;SYT6
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.21444486531008217,-0.7541886137947298,0.8995215311004785,0.9500548318341666,1.0,12/33,18.97%,TERF2;RFC1;DKC1;WRAP53;HSP90AA1;CDK2;TERT;PINX1;DCLRE1B;HSP90AB1;GAR1;TINF2
prerank,visual system development (GO:0150063),-0.21977778395878872,-0.7540785501050344,0.8756476683937824,0.9490847574073454,1.0,9/37,19.43%,SMOC1;RBP4;SIPA1L3;PBX3;TGFB2;PBX4;SMG9;PBX2;C1QA
prerank,cellular response to starvation (GO:0009267),0.2421592579516092,0.75403880263653,0.891640866873065,1.0,1.0,55/147,28.25%,MIOS;NPRL2;EIF2AK3;SIK2;ATP6V1B2;NUPR2;WIPI1;AOC1;RALB;TBL2;ATG5;LAMTOR2;CASTOR2;ASNS;ATF2;USP33;CLEC16A;MAPK1;VPS41;GABARAPL2;XPR1;GCN1;TP53;SREBF2;WRN;RPTOR;ATP6V1C1;FNIP1;RRAGA;LAMP2;ATP6V0E2;PRKAA1;DEPDC5;ATP6V0E1;INHBB;CEBPB;ATP6V1G2;RRP8;MTOR;WDR45B;EHMT2;SESN1;EIF2AK2;ITFG2;SLC38A9;ATP6V1H;CPEB4;TCIRG1;CDKN1A;PPARA;ATP6V1D;PIK3C3;SIRT1;PRKAG1;DAP
prerank,T cell receptor signaling pathway (GO:0050852),0.24232281563292643,0.7537655864883435,0.8782249742002064,1.0,1.0,27/138,21.03%,PRKCQ;PTPN22;TEC;PDE4B;PAK1;CSK;EIF2B5;FYN;PSMB7;PIK3R1;PTPRJ;PDE4D;GATA3;MALT1;NCK1;PSMD2;PSMC1;CHUK;PSMB2;RC3H1;EIF2B2;PSMD9;PSME4;BCL10;PSMA8;NFKB1;PRKD2
prerank,mammary gland epithelium development (GO:0061180),-0.2756733810477321,-0.7537074021226497,0.8102409638554217,0.948529354683168,1.0,10/14,40.37%,WNT4;ID2;EPHA2;AKT1;CSF1R;LATS1;JAK2;WNT2;WNT3;IRF6
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.35043992811313207,0.7531042507377597,0.7782945736434108,1.0,1.0,4/12,25.15%,TSPOAP1;TSPO;CACNA1H;STARD3
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.2662674700020932,0.7526100053525359,0.8061104582843713,1.0,1.0,15/51,21.63%,LPAR1;GPR65;ARHGEF10;PAK1;LIMK1;NF2;ARHGEF10L;RHOC;MYOC;ABL1;TGFB3;PPM1E;TESK1;CCDC88A;PXN
prerank,Wnt signaling pathway (GO:0016055),0.2508554639661915,0.7523782037906399,0.8700322234156821,1.0,1.0,19/92,16.10%,PTEN;FRZB;WNT5A;VPS29;FZD7;RARG;SFRP4;BCL9L;DVL1;BCL9;CSNK1G1;GPC4;CSNK1A1;STRN;KLHL12;UBB;CSNK1G2;FZD9;CSNK1E
prerank,T cell proliferation (GO:0042098),0.3287218653444516,0.7522316018018672,0.7781021897810219,1.0,1.0,2/13,8.44%,PPP3CB;CADM1
prerank,positive regulation by host of viral transcription (GO:0043923),-0.27043619794163193,-0.7521277082015707,0.8012820512820513,0.9496319778295197,1.0,3/15,12.19%,LEF1;SNW1;CTDP1
prerank,central nervous system neuron differentiation (GO:0021953),0.28505646760628867,0.7520639522926026,0.8015075376884422,1.0,1.0,5/33,11.10%,NTRK2;GBA2;GRID2;MDGA2;OPHN1
prerank,negative regulation of lyase activity (GO:0051350),0.32971824517271525,0.7519757399284476,0.7787356321839081,1.0,1.0,3/16,13.01%,CCR2;MTRR;DRD2
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.28405984802379036,0.751890897203306,0.8126550868486352,1.0,1.0,6/37,11.28%,PHLDB1;BICD1;EFNA5;CLASP1;BICD2;STMN4
prerank,regulation of chemokine production (GO:0032642),0.2839682794918936,0.7518498794853444,0.8012345679012346,1.0,1.0,7/36,19.13%,PYCARD;WNT5A;IL18;HIF1A;IL33;CD74;EGR1
prerank,regulation of protein acetylation (GO:1901983),-0.29312015638024735,-0.7518487795545654,0.7964601769911505,0.9489481630843575,1.0,4/12,20.91%,CAMK1;GSK3B;KAT5;CEP295
prerank,protein mannosylation (GO:0035268),0.30185633022873193,0.7517738560678773,0.7848275862068965,1.0,1.0,9/22,18.79%,TMTC2;RXYLT1;POMGNT2;TMTC3;DPY19L2;DPM1;FKTN;FKRP;DPY19L3
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.3278589612968077,0.7514302933122738,0.7722063037249284,1.0,1.0,2/15,9.62%,ETV4;SFRP4
prerank,carbohydrate derivative catabolic process (GO:1901136),0.32538967949420605,0.7511858547889988,0.7735583684950773,1.0,1.0,3/18,11.90%,NAGA;FBXO27;FBXO17
prerank,vitamin transport (GO:0051180),0.2906308407560421,0.7511388898773332,0.7873417721518987,1.0,1.0,2/29,3.97%,SLC27A1;CD320
prerank,regulation of receptor internalization (GO:0002090),0.28026579425474707,0.7510660748204444,0.8163001293661061,1.0,1.0,9/35,22.04%,VEGFA;ATXN2;MKLN1;SFRP4;MAGI2;SCYL2;CD63;DLG4;ARRB2
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.26614390286657447,-0.750774054019444,0.7839721254355401,0.9493368116559688,1.0,8/15,28.94%,IGF1;GPX1;FXN;CLU;HGF;AKT1;PPIF;PSMD10
prerank,regulation of blood circulation (GO:1903522),-0.21730028172489543,-0.7507318336007065,0.8939393939393939,0.9483043147244589,1.0,11/34,26.26%,TPM1;ACE;AGTR1;ECE1;DES;SRI;ACE2;DMPK;AGT;KCNIP2;PLN
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.3018015581388714,0.7506050779057883,0.7959731543624161,1.0,1.0,9/25,20.40%,TRA2B;TXNL4A;SNRNP40;PRPF6;KHSRP;DDX23;SRRM1;SF3B3;DBR1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.3254065411381561,0.750561446832442,0.7592867756315007,1.0,1.0,1/16,2.73%,FADD
prerank,DNA dealkylation (GO:0035510),0.3577258899617103,0.7502398178570111,0.7797147385103012,1.0,1.0,2/10,9.68%,MPG;ALKBH5
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.3577258899617103,0.7502398178570111,0.7797147385103012,1.0,1.0,2/10,9.68%,MPG;ALKBH5
prerank,negative regulation of phagocytosis (GO:0050765),-0.2667960475633313,-0.7500285041641583,0.8033333333333333,0.9481414098096985,1.0,4/17,17.46%,PLSCR1;RACK1;CD300A;APPL1
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.29086336729731616,0.7497148032988743,0.7956298200514139,1.0,1.0,8/29,16.35%,KANK4;PRKN;SSH3;CLASP1;FKBP4;PLEKHH2;SSH1;ARFGEF1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.33707536201735,0.7489506547346979,0.7708333333333334,1.0,1.0,5/12,18.60%,SYT1;RIMS1;DOC2B;SYT2;RIMS2
prerank,positive regulation of T cell proliferation (GO:0042102),0.26459894625319746,0.7488922189959657,0.8544600938967136,1.0,1.0,6/55,13.58%,PYCARD;FADD;CCR2;IL18;IL6ST;NCK1
prerank,sodium ion homeostasis (GO:0055078),0.3089889949632084,0.7488439899807989,0.7759562841530054,1.0,1.0,4/21,16.67%,SLC12A3;SLC12A2;NEDD4L;SLC9A1
prerank,carbohydrate catabolic process (GO:0016052),-0.20410994086457737,-0.7488168806870772,0.9030612244897959,0.9486810100790816,1.0,12/38,23.71%,MANBA;MAN2B1;PGK1;GPI;PGAM1;PGAM4;PFKM;PFKL;ENO1;MAN2B2;GAPDHS;ENO3
prerank,spindle assembly (GO:0051225),0.25741712276829054,0.7485888754127675,0.8561797752808988,1.0,1.0,15/67,20.09%,HAUS3;STARD9;ARHGEF10;STAG2;FLNA;RCC1;TUBGCP5;CLASP1;KPNB1;NEK7;AAAS;CEP63;MAPRE3;KIF2A;BCCIP
prerank,regulation of protein sumoylation (GO:0033233),0.32528296799393097,0.7483161207511957,0.7798036465638148,1.0,1.0,7/17,25.65%,UBA2;ZMIZ1;PARK7;EGR1;GNL3L;GNL3;SAE1
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.2541126812082801,-0.7478203909470957,0.8160535117056856,0.9489576441963182,1.0,5/18,14.30%,DKC1;WRAP53;CCT4;CCT6A;CCT8
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.23232230111796404,-0.7476903894364897,0.8717948717948718,0.9480686511790547,1.0,6/23,18.89%,IGF1;MAML1;PROX1;ATP11A;EDN1;MYOCD
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.2394338502895123,-0.7474121469853452,0.8618181818181818,0.947383245384913,1.0,5/23,18.17%,UACA;C1QTNF3;TMSB4X;NMI;IFI35
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.32453230157928176,0.7473932167548419,0.7746478873239436,1.0,1.0,4/16,15.36%,ANK2;PRKACA;CALM1;CALM2
prerank,regulation of DNA biosynthetic process (GO:2000278),0.29528839392825473,0.747342657250001,0.7968545216251638,1.0,1.0,2/27,1.50%,FGF2;MYC
prerank,pigment granule transport (GO:0051904),0.3180102619082654,0.746976824426453,0.784992784992785,1.0,1.0,7/18,25.09%,BBS5;MREG;BBS7;MYO5A;BLOC1S6;BBS4;RAB27B
prerank,melanosome transport (GO:0032402),0.3180102619082654,0.746976824426453,0.784992784992785,1.0,1.0,7/18,25.09%,BBS5;MREG;BBS7;MYO5A;BLOC1S6;BBS4;RAB27B
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.28239153503050834,0.7466944544606924,0.8167741935483871,1.0,1.0,3/34,4.09%,PDGFRA;FGF2;TGFB1
prerank,tRNA methylation (GO:0030488),0.2823903995100717,0.7466677903165998,0.8053097345132744,1.0,1.0,12/34,25.13%,THUMPD3;TRMT12;THADA;PRORP;TRMT112;DALRD3;THUMPD2;NSUN2;LCMT2;ALKBH8;TRMT1;TRMT61B
prerank,reverse cholesterol transport (GO:0043691),-0.2835390229327511,-0.746565121102311,0.7870370370370371,0.9474287105181638,1.0,4/13,21.70%,ABCA1;ABCG1;APOE;CLU
prerank,protein depolymerization (GO:0051261),-0.22624600273519,-0.7461954522685739,0.8838174273858921,0.9468278107493947,1.0,7/27,16.71%,NCKAP5;MICAL3;MICAL2;NCKAP5L;DSTN;KIF18A;VPS4B
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.25432222116280845,0.7459545417554778,0.8714285714285714,1.0,1.0,26/85,23.05%,PRKN;SOCS5;FBXW7;CBFA2T3;RNFT1;PRICKLE1;DVL1;CSNK1A1;DET1;TMTC3;SUMO1;DDA1;RNF19A;RCHY1;CSNK1E;MDM2;FBXO22;NKD2;ZER1;TAF1;USP5;BBS7;USP13;ZYG11B;COP1;ELOB
prerank,mesenchymal to epithelial transition (GO:0060231),0.3523531500258496,0.7459291271713406,0.7671009771986971,1.0,1.0,3/10,17.16%,FZD7;GATA3;PAX2
prerank,positive regulation of RNA metabolic process (GO:0051254),0.26870625840350837,0.7458978413410902,0.8428571428571429,1.0,1.0,15/45,24.78%,EGFR;TGFB1;DXO;HEATR1;PIK3R1;ZC3H18;TRMT112;TP53;PNPT1;RIPK1;POLR2A;NFKB1;WDR75;HSPA1A;SUPV3L1
prerank,organophosphate biosynthetic process (GO:0090407),0.2751382080370361,0.7457711859339968,0.832089552238806,1.0,1.0,6/37,17.60%,FGF2;PNPO;AGPAT5;GPHN;NFS1;PIP5K1A
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.338223077189139,0.7453701091872323,0.7692307692307693,1.0,1.0,2/13,10.40%,DERL2;EDEM2
prerank,cGMP biosynthetic process (GO:0006182),0.3559760653656823,0.7449484539367748,0.7746913580246914,1.0,1.0,1/10,3.25%,NPR2
prerank,protein glycosylation (GO:0006486),0.24430369754949618,0.7448237543454372,0.8686131386861314,1.0,1.0,26/125,19.51%,GFPT2;ST3GAL4;NPC1;ALG9;B3GNT9;GALNT9;GALNT1;STT3A;PLOD1;MGAT3;MAGT1;ST8SIA1;POMGNT2;ALG5;GALNT7;GALNT6;TUSC3;ALG1;MOGS;TET3;ALG8;DPM1;FKTN;DPAGT1;ALG6;RPN1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.19402450749991004,-0.7447975701574935,0.9402985074626866,0.9475951242032783,1.0,8/49,14.11%,SMAD6;JAM3;GSK3B;PRKCZ;RIOK3;NOP53;LCMT1;CDC42
prerank,protein-containing complex disassembly (GO:0032984),0.2678041628638774,0.7446279395881827,0.8430913348946136,1.0,1.0,15/54,22.16%,MYC;LIX1;VPS33A;SNAP29;PPP1CA;DVL1;CSNK1A1;GABARAPL2;STX17;SNX14;LAMP2;PYM1;DVL3;VPS16;UBQLN1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.35288979113776,0.7439739250487826,0.7737909516380655,0.9996794068511867,1.0,4/10,25.02%,XRCC3;BLM;WRN;SLX4
prerank,t-circle formation (GO:0090656),0.35288979113776,0.7439739250487826,0.7737909516380655,0.9996794068511867,1.0,4/10,25.02%,XRCC3;BLM;WRN;SLX4
prerank,telomere maintenance via telomere trimming (GO:0090737),0.35288979113776,0.7439739250487826,0.7737909516380655,0.9996794068511867,1.0,4/10,25.02%,XRCC3;BLM;WRN;SLX4
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.2531048213631209,-0.743529520308304,0.8566775244299675,0.94823324289679,1.0,4/18,20.69%,ROCK1;SLC39A8;VCAM1;ADD2
prerank,regulation of interferon-alpha production (GO:0032647),0.3051020612278695,0.7428358731830541,0.7870619946091644,1.0,1.0,8/23,25.73%,SETD2;TBK1;CHUK;IRF3;PTPRS;HSPD1;MAVS;IRF5
prerank,positive regulation of histone deacetylation (GO:0031065),0.34047915273601664,0.7426304136829166,0.7829457364341085,1.0,1.0,4/12,21.03%,VEGFA;APLNR;CTBP1;PRKD2
prerank,negative regulation of hydrolase activity (GO:0051346),0.2628904787966387,0.7423461214493932,0.8369047619047619,1.0,1.0,10/49,20.99%,MAPK7;CSTB;URI1;ARL2;NEIL1;TMED2;ARFGEF1;FICD;RDX;ZCCHC9
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.33195682063672866,0.7422320547491027,0.8070175438596491,1.0,1.0,2/15,3.89%,EGFR;TEC
prerank,negative regulation of TOR signaling (GO:0032007),0.2816849505116604,0.7421026813601359,0.7972465581977471,1.0,1.0,11/36,25.07%,NPRL2;DEPTOR;TSC1;CASTOR2;ATM;SPAAR;FNIP1;PRKAA1;DEPDC5;SESN1;ITFG2
prerank,positive regulation of lipid transport (GO:0032370),0.34598159801356704,0.7418009355334517,0.7667161961367014,1.0,1.0,1/12,2.34%,LRP1
prerank,positive regulation of cytokinesis (GO:0032467),0.2861791489280902,0.7416945580259747,0.8223086900129701,0.9997705102794726,1.0,8/32,18.86%,KIF20B;CUL3;CDC25B;DRD2;CDC14A;PKN2;CENPV;SVIL
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.33201715550057215,0.7416847829042009,0.7811158798283262,0.9993439947999073,1.0,4/14,13.58%,PPP3CA;PPP2R2A;PPP1CA;NCK1
prerank,positive regulation of interferon-alpha production (GO:0032727),0.3187905217553645,0.7416845434102891,0.8,0.9989063830884796,1.0,7/19,25.73%,SETD2;TBK1;CHUK;IRF3;HSPD1;MAVS;IRF5
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.3439716802289636,0.7415891685305931,0.7754491017964071,0.9986029235503203,1.0,6/12,28.62%,ATF7IP;APOBEC1;SETDB1;MPHOSPH8;RESF1;DNMT1
prerank,modification-dependent protein catabolic process (GO:0019941),0.23545113740260537,0.7414238958710051,0.923469387755102,0.9983820782531634,1.0,66/193,26.29%,PRKN;HACE1;SPSB4;RNF6;FBXO7;UBE2K;CUL3;HERPUD1;FBXO45;ANAPC7;CBL;USP33;TOLLIP;MYLIP;ANAPC2;PCYOX1L;DDB1;NDFIP1;NEDD8;BUB1B;NEDD4L;AREL1;UBB;RNF19A;RNF111;CDC23;RCHY1;ANAPC16;FBXL4;MIB1;RNF167;UBA1;RC3H1;MDM2;FBXO22;ELOC;PSMD9;TAF1;UBE2L3;CDC27;FBXO11;UBE2G1;UBE2E1;RNF13;PTTG1;ANAPC4;WDR81;RNF114;UBQLN4;TTC3;UBQLN1;UBR3;ANAPC5;SIAH1;CDC16;UBQLN2;UBE3C;KCTD6;RNF130;KCTD21;UBE2R2;UBE2I;RNF20;TOPORS;KLHL25;PSMD13
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.3246831839848105,0.7411267684804898,0.775,0.9983650847767148,1.0,4/15,19.31%,CARD9;HIF1A;TICAM1;STAT3
prerank,nucleotide-excision repair (GO:0006289),0.24445309363746018,0.7410320373316378,0.8873239436619719,0.9980427529819941,1.0,22/101,20.34%,RAD23B;HMGN1;GTF2H2;ERCC5;ERCC4;POLR2B;DDB2;RPA3;XPA;POLR2K;FANCC;DDB1;RPA2;POLR2G;UBB;RNF111;TP53;CUL4B;LIG3;POLR2A;COPS6;COPS7A
prerank,negative regulation of B cell proliferation (GO:0030889),-0.28989911433617976,-0.7407297899424413,0.7886904761904762,0.9506596348004662,1.0,4/11,25.64%,LYN;CD300A;TYROBP;TNFRSF21
prerank,neutrophil activation (GO:0042119),-0.2857893784953822,-0.7405300393697196,0.7964601769911505,0.9498337020263111,1.0,1/12,2.59%,PRKCD
prerank,glucose homeostasis (GO:0042593),0.25241751602292806,0.7396522618213796,0.8687089715536105,0.9995134437976397,1.0,15/83,20.48%,PYGL;BACE2;PTPN2;LRRC8D;MLXIPL;HIF1A;PIK3R1;NGFR;CRY1;PARK7;HK2;KLF7;PPARG;STAT3;ADCY8
prerank,cellular response to pH (GO:0071467),-0.25834806310098857,-0.7392779393132672,0.8277027027027027,0.9503551782162228,1.0,10/17,37.57%,RAB11B;MCOLN1;GPR68;PKD2L1;PKD1L3;IMPACT;RAB11FIP5;HVCN1;KCNK4;ASIC1
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.30299628902663633,0.739098263267874,0.7940379403794038,0.9998358086805897,1.0,2/22,5.38%,WNT5A;CCR2
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.3148965050775492,0.7388914615063703,0.7784256559766763,0.9996911450883751,1.0,6/16,23.35%,PSIP1;PRPF39;SART1;DDX23;SNRNP200;WBP4
prerank,peptide catabolic process (GO:0043171),0.30331567555378497,0.7384284759631892,0.8023872679045093,0.9998954561648336,1.0,4/23,9.92%,DPEP1;LTA4H;TRHDE;LNPEP
prerank,leukotriene biosynthetic process (GO:0019370),0.3270232807580952,0.738289971469734,0.7804511278195488,0.9996501776125617,1.0,3/14,13.34%,LTA4H;ALOX5AP;GGTA1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.3076082887860563,0.7375494038194269,0.7901408450704225,1.0,1.0,9/20,24.71%,PARL;LETM1;PMPCB;SLC25A23;YME1L1;PMPCA;PHB2;MCUR1;SMDT1
prerank,cell junction maintenance (GO:0034331),-0.26868232788682034,-0.7375478415959943,0.8292682926829268,0.951455776076228,1.0,9/14,39.33%,NLGN2;DCTN1;CSF1R;CBLN2;MYADM;F2R;CBLN1;PRTN3;PARD6A
prerank,antibacterial humoral response (GO:0019731),0.32133971223414104,0.7372731132327862,0.782798833819242,1.0,1.0,1/16,4.00%,RNASE6
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.3373352372973548,0.7367815494642833,0.8,1.0,1.0,6/13,24.69%,ELOVL6;ELOVL5;HACD2;TECRL;ELOVL1;HACD3
prerank,response to amino acid (GO:0043200),0.28470135885960546,0.7367097500265898,0.8337662337662337,1.0,1.0,11/31,26.12%,CPEB3;LAMTOR2;CPEB1;RPTOR;SPAAR;IPO5;RRAGA;GLRB;MTOR;SLC38A9;CPEB4
prerank,actin filament depolymerization (GO:0030042),0.3498899632035149,0.7366957430981246,0.768621236133122,0.9997089493077701,1.0,1/11,2.28%,GSN
prerank,positive regulation of translation (GO:0045727),0.24676752221862572,0.7365182142228234,0.8795180722891566,0.9995112435782249,1.0,15/94,14.13%,ERBB2;PLD1;UPF3A;NIBAN1;NGRN;METTL3;EIF3C;EIF2B5;CPEB3;EIF6;NSUN5;PASK;RCC1L;PRR16;POLR2G
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.29031070989243996,0.736256458417223,0.8162450066577897,0.9994136963806859,1.0,9/27,23.12%,DTYMK;AK5;AK6;AK2;TXNRD1;CTPS2;AK8;GLRX;CMPK1
prerank,embryonic organ development (GO:0048568),0.25883808844946044,0.7361416452176168,0.8771331058020477,0.9991382775351225,1.0,12/61,16.50%,GLI2;PKDCC;KMT2A;TGFB1;TGFBR2;RARB;GDNF;GATA3;COBL;BMPR1A;NES;ALDH1A3
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.25784857631575103,0.7360908458793837,0.8663540445486518,0.9987644642944126,1.0,11/59,18.71%,ACACA;OXSM;CYP39A1;CYP7B1;ACLY;LIPC;SRR;CYP27A1;ALDH1A3;PARK7;OSBPL1A
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.18360316392893133,-0.7360472433929796,0.9396551724137931,0.9522954175826024,1.0,20/67,24.12%,ITGB5;PSMD14;TAPBP;PSMB3;PSMD12;CYBA;PSMD6;PSMA1;PSMD7;PSMA5;PSMC5;IKBKB;IKBKG;PSMC4;PSMB6;PSMA4;VAMP8;PSMB9;CALR;PSMB1
prerank,monoacylglycerol metabolic process (GO:0046462),-0.2752518254917574,-0.7358791925414858,0.8076923076923077,0.9514325258638934,1.0,6/13,31.16%,PLA2G4A;MGLL;ABHD12;FAAH;DGAT1;AWAT2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.3020234869051711,0.7357396608878072,0.7997198879551821,0.9988055663719758,1.0,5/22,15.40%,SPRED2;SPRED1;SPRED3;ATM;UBB
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.31689999284653747,0.7356543163424685,0.78954802259887,0.9984836034598332,1.0,6/17,20.87%,ALG9;ALG1;ALG8;DPAGT1;ALG6;DHDDS
prerank,peptidyl-lysine modification (GO:0018205),0.24363600234592028,0.7348220532997474,0.8884165781083954,0.9991684463985585,1.0,13/99,11.48%,CTH;KAT2B;SENP3;RANBP2;UBA2;NUP155;LOXL3;PLOD1;PIAS2;NDC1;NUP205;HDAC6;NUP160
prerank,ncRNA 3'-end processing (GO:0043628),0.3233458086177137,0.734557651813466,0.7925696594427245,0.99909192116813,1.0,4/14,17.56%,INTS6;INTS2;INTS8;SSB
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.32783375879036364,0.7344089507971738,0.8115942028985508,0.9988589999348664,1.0,5/15,23.20%,ANAPC7;CDC23;CDC27;PTTG1;CDC16
prerank,calcium ion transport (GO:0006816),0.23923639933938134,0.7335440263573958,0.898840885142255,0.9995974408524966,1.0,11/113,8.93%,CACNA1E;CACNA2D1;ANK2;CACNG7;ANO6;CACNA1A;CHRNA4;PSEN1;SLC8A2;FYN;SLC24A5
prerank,response to exogenous dsRNA (GO:0043330),0.3134312981452929,0.7334931367259913,0.8255977496483825,0.9992409539331564,1.0,4/18,15.05%,IRAK3;RALB;CGAS;TICAM1
prerank,positive regulation of secretion (GO:0051047),0.34393344804213544,0.7332774864061716,0.776595744680851,0.9990969020261697,1.0,2/11,15.91%,ACSL3;GPLD1
prerank,cardiocyte differentiation (GO:0035051),0.35405533565315667,0.7330773644157007,0.7784711388455539,0.9989286228180356,1.0,2/10,6.91%,AKAP13;GATA6
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.25337232872339005,0.7327357454923494,0.8533034714445689,0.9989254261741313,1.0,14/70,20.59%,CBFB;KMT2A;METTL3;PSMB7;RUNX1;GATA3;PUS7;PSMD2;ABL1;PSMC1;PSMB2;PSMD9;PSME4;PSMA8
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.1786448943555942,-0.732610942939495,0.9809523809523809,0.9544221496737362,1.0,18/74,19.65%,PSMD14;ARNT;PSMB3;PSMD12;EGLN2;HIGD1A;PSMD6;PSMA1;VHL;PSMD7;PSMA5;PSMC5;PSMC4;PSMB6;CUL2;CREBBP;EGLN3;PSMA4
prerank,nuclear membrane reassembly (GO:0031468),0.2607977792967265,0.7324817522361419,0.8662790697674418,0.9988282634323654,1.0,26/54,30.20%,NUP155;PPP2R2A;RCC1;NDC1;NUP205;NUP160;EMD;KPNB1;SUMO1;LMNA;CHMP4C;POM121;AHCTF1;PPP2R1A;IST1;REEP3;NUP35;CHMP4A;CHMP4B;UBE2I;SIRT2;SPAST;CC2D1B;VRK1;SEC13;ANKLE2
prerank,determination of bilateral symmetry (GO:0009855),-0.22998755582543434,-0.732358451306224,0.8487394957983193,0.9536525837796356,1.0,11/24,34.39%,KIF3B;TBX1;ZIC3;DNAH11;DNAH5;STIL;NPHP3;CFAP53;DLL1;ODAD2;ODAD3
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.26930775256097417,-0.7322935131076117,0.8088235294117647,0.9526549448912498,1.0,3/13,12.55%,PRKCD;SOD1;MAPT
prerank,regulation of Notch signaling pathway (GO:0008593),0.2503613648387141,0.7320983970998969,0.8751381215469614,0.9988997523859849,1.0,7/76,8.71%,MAML3;KAT2B;EGFR;MAML2;FBXW7;METTL3;ZMIZ1
prerank,embryonic heart tube development (GO:0035050),0.3252097458365496,0.7320971541767323,0.8098693759071117,0.998467372673495,1.0,1/14,2.70%,ACVR1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.2989738267944918,0.7319234620293075,0.8013888888888889,0.9982888375755569,1.0,5/22,15.28%,MVB12B;VPS37B;VPS36;MVB12A;PLAA
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.26204474774369946,-0.7314501980505745,0.8480243161094225,0.9526351571740048,1.0,2/15,7.78%,PRKCH;AGTR1
prerank,regulation of TOR signaling (GO:0032006),0.25286820934609183,0.7313881529111379,0.8559907834101382,0.9985866070387845,1.0,8/67,9.95%,MIOS;NPRL2;ARAF;DEPTOR;TSC1;LAMTOR2;TBCK;PIH1D1
prerank,B cell receptor signaling pathway (GO:0050853),0.28189192560953924,0.7311470300311155,0.8221092757306226,0.9984722200834921,1.0,3/32,8.26%,BCL2;TEC;VAV3
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.19537108062654224,-0.7311120354399029,0.953757225433526,0.9519499631601074,1.0,20/42,31.36%,POLD3;TRIM25;PRIMPOL;PARP10;RFC1;POLH;POLA1;PCNA;POLK;ISG15;FAAP20;RFC3;UBA52;USP43;POLD2;PCLAF;VCP;POLE;POLD4;POLD1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.28940076529330433,0.7308582522577572,0.8163522012578617,0.9984466361028326,1.0,5/27,13.27%,SLC1A3;SLC25A38;ARL6IP5;SLC7A8;PRAF2
prerank,maturation of 5.8S rRNA (GO:0000460),-0.25337061479507766,-0.7308449843013571,0.8673835125448028,0.9511742001786294,1.0,5/17,15.46%,NSA2;URB1;MAK16;LAS1L;EXOSC10
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.28490344203811974,0.7300464371703429,0.8131443298969072,0.9990864850316971,1.0,6/29,16.09%,EXOSC8;DCP1B;EXOSC2;EDC4;LSM3;NT5C3B
prerank,cellular response to light stimulus (GO:0071482),0.25208195503769093,0.7299115022393181,0.847972972972973,0.9988499587084967,1.0,12/66,19.35%,MYC;RHO;NSMCE3;ERCC4;METTL3;BMF;GPR88;ZBTB1;TP53;N4BP1;TAF1;RUVBL2
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.3065639117617061,0.7289636509982168,0.7833089311859444,0.9996934205202099,1.0,4/18,19.55%,VGLL4;VPS11;DACT1;RDX
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.26050028244200624,-0.7288637704685494,0.832807570977918,0.9525114064423661,1.0,8/15,33.86%,TSEN15;ERN1;ZBTB8OS;CPSF4;CLP1;TSEN54;TRPT1;CSTF2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.2946989555989564,0.7287674932124301,0.8254847645429363,0.9995261733535107,1.0,8/20,26.80%,PRKN;ZMIZ1;HIF1A;WASHC1;EGR1;UBQLN1;HSPA1A;DCUN1D5
prerank,regulation of protein secretion (GO:0050708),0.23591214786777695,0.7283868491808859,0.899364406779661,0.9995953825042403,1.0,15/119,13.01%,PRKCA;CACNA1E;FRMD4A;CACNA1A;TGFB1;SLC12A2;RFX3;PPP3CB;RAP1A;ENSA;PPID;TMED10;SLC2A2;STXBP5;DRD2
prerank,neuron projection organization (GO:0106027),0.31451794279011597,0.7283564566174981,0.823262839879154,0.9992029625653882,1.0,2/15,4.77%,PSEN1;PRNP
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.29759120311164455,-0.7281045130232743,0.8016304347826086,0.9523614629056463,1.0,7/10,38.68%,TLR4;AKT1;MYD88;CD68;TREM2;TLR6;CD36
prerank,glucose transmembrane transport (GO:1904659),0.3080202916283815,0.7278513229849498,0.8143053645116919,0.9994424495013766,1.0,3/18,12.68%,SLC5A3;SLC2A2;RAB4B
prerank,positive regulation of protein depolymerization (GO:1901881),0.3436298835361655,0.7276763624827469,0.7942942942942943,0.9992434919945022,1.0,4/11,26.38%,KATNB1;NES;CFL2;WDR1
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.23117639202557166,-0.7276601131251507,0.864,0.9518372043115835,1.0,9/23,32.32%,TLR4;INHBA;HAVCR2;RARA;LAPTM5;INHA;NR1H4;VSIR;GAS6
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.2281566835108098,-0.7269260440953005,0.8838951310861424,0.9515706309365617,1.0,6/25,19.54%,EPHA4;RPL5;RPL11;PML;HSP90AB1;HFE
prerank,miRNA metabolic process (GO:0010586),-0.2432421437096658,-0.7265955202829093,0.8458781362007168,0.9508776170797436,1.0,9/20,30.50%,DGCR8;TUT7;TENT4B;TARBP2;LIN28B;DDX17;BCDIN3D;AGO2;DICER1
prerank,mitochondrion localization (GO:0051646),-0.24143267926737677,-0.7263816281505757,0.872791519434629,0.9500575674348172,1.0,6/19,23.00%,MARK1;TRAK1;MARK2;ATCAY;MSTO1;MUL1
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.2046961021582675,-0.7253891338880942,0.8928571428571429,0.9501754984002923,1.0,17/36,31.00%,MAP3K20;CLOCK;DOT1L;HUS1;CLSPN;DONSON;ERCC6;DNA2;NBN;TIMELESS;RAD9B;E2F1;CDC45;RAD9A;CHEK2;CHEK1;PRPF19
prerank,regulation of glycolytic process (GO:0006110),0.24658392290357423,0.7251544301107095,0.8695163104611924,1.0,1.0,11/68,11.48%,ZBTB20;PSEN1;RANBP2;NUP155;MLXIPL;CBFA2T3;EIF6;HIF1A;NDC1;NUP205;NUP160
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.30989086501551316,0.7247972954836664,0.8078602620087336,1.0,1.0,7/17,26.28%,EGFR;PKD1;CCND2;MAPRE3;PKD2;CCNY;CCND3
prerank,"DNA-templated transcription, termination (GO:0006353)",0.2498462073717458,0.7245826499421463,0.8568181818181818,1.0,1.0,19/68,24.88%,CSTF3;GTF2H2;TAF1A;POLR2K;NCBP1;FIP1L1;POLR1B;PAPOLA;POLR1C;POLR1G;POLR2A;UBTF;MTERF2;SYMPK;POLR3K;CCNH;POLR2F;TBP;CPSF7
prerank,positive regulation of locomotion (GO:0040017),-0.22544941517254177,-0.7244456255122887,0.8755186721991701,0.9502524558255013,1.0,7/27,19.86%,CCDC25;THBS1;SPOCK2;PDGFRB;CAVIN1;PPM1F;TWIST1
prerank,response to cAMP (GO:0051591),-0.20236292019050034,-0.7242377991013409,0.9138755980861244,0.9494358457682998,1.0,4/37,6.91%,RAP1B;IGFBP5;ZFP36L1;SLC5A5
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.28476190709350735,0.724215628288637,0.819672131147541,1.0,1.0,2/25,5.66%,PSEN1;ATXN2
prerank,positive regulation of hydrolase activity (GO:0051345),0.23302588013626785,0.7237756360826978,0.9373695198329853,1.0,1.0,23/137,17.83%,CCL11;ERBB2;MAP4K4;CCL4;NF1;ALS2;CDKL5;DOCK10;RAP1A;ZC3H15;RCN3;ARHGAP11A;RHOC;USP6NL;TBC1D20;CALM1;ITGB1;CCL14;CALM2;RAP1GAP;NDUFA13;WRN;RGS16
prerank,hexose transmembrane transport (GO:0008645),0.2953297722671071,0.7235599223963164,0.8168249660786974,1.0,1.0,3/21,10.80%,SLC5A3;SLC50A1;SLC2A2
prerank,cellular response to interleukin-6 (GO:0071354),0.2876347219091535,0.7234420691290958,0.8229027962716379,1.0,1.0,8/26,20.84%,PTPRT;CBL;PTPN11;PID1;IL6ST;SELPLG;STAT3;NFKB1
prerank,epithelial cell development (GO:0002064),-0.24022304805059125,-0.723392784769531,0.8487084870848709,0.9494075982381915,1.0,3/20,7.97%,WNT5B;RILPL1;SIPA1L3
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.2583565896332838,0.7230658165371864,0.8511904761904762,1.0,1.0,16/51,25.19%,PRKCQ;CCT7;STN1;MAPK1;NEK7;MAP3K4;ATM;SMG6;HNRNPU;HNRNPC;CTC1;ACD;GNL3L;ATR;PKIB;TCP1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.3334586777814247,0.7228514999221654,0.7993920972644377,1.0,1.0,3/11,21.72%,AKAP6;NOS1AP;LRRC55
prerank,regulation of cell division (GO:0051302),0.24617510394464998,0.7226809661144632,0.8654708520179372,1.0,1.0,11/72,17.58%,EFHC1;MYC;INSC;KLHL13;SETD2;MYO19;RAB11FIP3;CALM1;CALM2;BLM;NCOA3
prerank,positive regulation of protein binding (GO:0032092),0.25499021516845083,0.7225578948210262,0.8703703703703703,1.0,1.0,10/56,15.41%,LRP1;PRKN;PSEN1;RALB;MEN1;USP33;AKTIP;PKD1;DACT1;ABL1
prerank,amide biosynthetic process (GO:0043604),0.25803987247783744,0.7225552062521418,0.8371531966224367,1.0,1.0,3/47,4.52%,SLC25A2;CERS3;CERS6
prerank,sensory perception of taste (GO:0050909),-0.29737982971101656,-0.7223205507512488,0.8116343490304709,0.9495945810857004,1.0,8/10,50.54%,PKD2L1;PKD1L3;ASIC1;CD36;ASIC3;TAS1R1;TAS1R2;GNAT3
prerank,regulation of cellular amide metabolic process (GO:0034248),0.2777097412094296,0.7222740872282495,0.8236808236808236,1.0,1.0,7/32,14.87%,ATXN2;TSC1;TMED10;GRM5;DDX25;RBM4B;CYFIP1
prerank,hepaticobiliary system development (GO:0061008),0.2987995832822858,0.7222536030015778,0.8331015299026425,1.0,1.0,5/20,15.14%,PRKCSH;NF1;COBL;CITED2;MET
prerank,"transcription, DNA-templated (GO:0006351)",0.22765505135390748,0.7220947715694754,0.9544994944388271,1.0,1.0,62/207,24.58%,CBFB;NFX1;GTF2H2;SNAPC2;MBD1;RNGTT;TAF1A;HOXD3;POLR2B;DRAP1;TAF5L;IVNS1ABP;GTF2B;SOX5;TRIP11;TFAM;POLR2K;NCBP1;TAF2;TAF9;TAF11;EPC1;KLF13;POLRMT;TAF7;POLR2G;RNMT;ELL;GTF3C1;TAF4;GTF2E1;TAF4B;GTF2E2;TP53;NFIX;CDC73;RNPS1;POLR1C;TCEA2;MLF1;ELOC;TAF1;POLR2A;MLLT1;UBTF;FUBP3;POLR3G;BCL3;NFKB1;THRA;SSRP1;ARRB2;CDK9;SNAPC3;ELOB;POLR3K;PKNOX1;MEF2A;CCNH;POLR2F;CCNT2;TBP
prerank,translesion synthesis (GO:0019985),0.26364598747809465,0.7218885628324042,0.8552311435523114,0.9998654634432262,1.0,9/42,17.19%,POLN;POLE2;REV3L;RPA3;ZBTB1;RPA2;UBB;RCHY1;REV1
prerank,RNA modification (GO:0009451),0.2564773986219629,0.7217400078628801,0.872093023255814,0.9996470752413129,1.0,15/54,23.37%,DTWD1;NOP2;METTL3;NSUN5;DTWD2;ADARB1;PUS7;ELP5;MEPCE;SSB;TRIT1;NSUN2;LCMT2;ALKBH1;TRMT1
prerank,stress granule assembly (GO:0034063),0.30100336310800724,0.7214164852786912,0.8172804532577904,0.9996229283146216,1.0,8/20,25.68%,BICD1;ATXN2;UBAP2L;CSDE1;DDX6;DYNC1H1;YTHDF3;CIRBP
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.2893796999979923,0.7210441206851864,0.8186666666666667,0.9996794511638949,1.0,3/24,11.21%,BCL2;ACKR3;TAF9
prerank,synaptonemal complex organization (GO:0070193),0.3177848346647726,0.7202087415931708,0.8069908814589666,0.9999171480383113,1.0,3/15,22.51%,TEX11;SYCE2;SYCP2
prerank,synaptonemal complex assembly (GO:0007130),0.3177848346647726,0.7202087415931708,0.8069908814589666,0.9999171480383113,1.0,3/15,22.51%,TEX11;SYCE2;SYCP2
prerank,intracellular protein transmembrane transport (GO:0065002),0.2645150734454591,0.720208509792835,0.8477722772277227,0.9994901979324026,1.0,9/42,18.42%,ZFAND2B;C2CD5;TOMM20;SEC61G;SEC63;DNAJC19;AIFM1;PAM16;PEX1
prerank,response to estrogen (GO:0043627),-0.21465474562559864,-0.7200323016792612,0.8888888888888888,0.9511173893585393,1.0,8/31,20.15%,TRIM25;PELP1;SERPINB9;SRA1;CAV1;ARID5A;RARA;RBBP5
prerank,protein sumoylation (GO:0016925),0.25898625698161104,0.7199666342667571,0.8591715976331361,0.9993666656048031,1.0,17/49,25.98%,RANBP2;UBA2;NUP155;PIAS2;NDC1;NUP205;NUP160;SUMO1;POM121;AAAS;NUP42;TRPM4;NUP35;RAE1;SAE1;UBE2I;TOPORS
prerank,cellular response to amino acid starvation (GO:0034198),0.24984158811004295,0.7195867035638434,0.8731428571428571,0.9994083199019932,1.0,26/71,27.11%,MIOS;NPRL2;EIF2AK3;ATP6V1B2;LAMTOR2;CASTOR2;ATF2;MAPK1;GCN1;RPTOR;ATP6V1C1;RRAGA;ATP6V0E2;DEPDC5;ATP6V0E1;CEBPB;ATP6V1G2;MTOR;SESN1;EIF2AK2;ITFG2;SLC38A9;ATP6V1H;TCIRG1;CDKN1A;ATP6V1D
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.28347703332213925,0.7195556971821928,0.8335607094133697,0.999015960204248,1.0,6/24,19.30%,AUTS2;BRK1;PIK3R1;CYFIP1;FSCN1;NCKAP1
prerank,multivesicular body assembly (GO:0036258),-0.21081708121368814,-0.71950387041356,0.8994974874371859,0.9506739381358125,1.0,5/30,9.92%,CHMP3;TSG101;VPS37C;VPS4A;CHMP1A
prerank,ribonucleoprotein complex assembly (GO:0022618),0.2338424699578475,0.7193024319410978,0.9202518363064008,0.9989245390376043,1.0,27/132,18.87%,CELF5;CPSF6;RPL23A;NOP2;BRIX1;SHQ1;LUC7L2;EIF6;TXNL4A;NCBP1;TGS1;CLNS1A;PRPF18;PRPF6;CELF6;SRSF6;TRAF7;YTHDC1;LUC7L;RPS27L;CDC73;RPSA;SF1;GEMIN7;BOP1;SART1;DDX23
prerank,response to amino acid starvation (GO:1990928),0.24899108217568877,0.7190287543919586,0.8836944127708096,0.9988356688288179,1.0,26/72,27.11%,MIOS;NPRL2;EIF2AK3;ATP6V1B2;LAMTOR2;CASTOR2;ATF2;MAPK1;GCN1;RPTOR;ATP6V1C1;RRAGA;ATP6V0E2;DEPDC5;ATP6V0E1;CEBPB;ATP6V1G2;MTOR;SESN1;EIF2AK2;ITFG2;SLC38A9;ATP6V1H;TCIRG1;CDKN1A;ATP6V1D
prerank,termination of RNA polymerase I transcription (GO:0006363),0.2766299051658652,0.7184048914624549,0.8483290488431876,0.9991852423003815,1.0,10/30,24.58%,GTF2H2;TAF1A;POLR2K;POLR1B;POLR1C;POLR1G;UBTF;CCNH;POLR2F;TBP
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.29927533267807344,0.7181865640487367,0.8321479374110953,0.9990378576815855,1.0,7/20,23.55%,EGFR;TTBK1;PKD1;CCND2;MAPRE3;PKD2;CCNY
prerank,fluid transport (GO:0042044),0.3171438651944265,0.7181717187887325,0.8035714285714286,0.9986345526042147,1.0,1/12,5.28%,AQP4
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.3403790446614614,0.7179082131721924,0.8203957382039574,0.9981370344665761,1.0,3/11,21.03%,CALM1;CALM2;PKD2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.3403790446614614,0.7179082131721924,0.8203957382039574,0.9981370344665761,1.0,3/11,21.03%,CALM1;CALM2;PKD2
prerank,protein localization to nucleus (GO:0034504),0.23664350319951172,0.7177446894277209,0.8979591836734694,0.9979146989636907,1.0,27/102,20.96%,NUP155;NOL8;FAM53B;XPA;ARL2;IPO9;BMP7;PRICKLE1;DVL1;COL1A1;KPNB1;NXT1;IPO13;LMNA;EIF4ENIF1;POM121;HNRNPU;WRN;MDM2;TNPO3;STAT3;IPO5;CSE1L;TAF8;PHB2;BCL3;HEATR3
prerank,myeloid cell activation involved in immune response (GO:0002275),0.3045819609219943,0.7177146873997178,0.8104395604395604,0.997528172418815,1.0,1/18,1.42%,PYCARD
prerank,regulation of vasculogenesis (GO:2001212),0.3269712886983791,0.7169655385049833,0.8165680473372781,0.9980736126380689,1.0,2/14,7.56%,CD34;RAP1A
prerank,cellular response to topologically incorrect protein (GO:0035967),0.27299661027572547,0.7158235923161768,0.8413705583756346,0.9990497208866824,1.0,5/31,13.54%,PRKN;PACRG;PTPN1;HDAC6;TM7SF3
prerank,positive regulation of isotype switching (GO:0045830),-0.25304752222827565,-0.7150454740545141,0.8435374149659864,0.9546381503744282,1.0,7/15,26.53%,RIF1;TFRC;PAXIP1;CD40;MAD2L2;CLCF1;TNFSF13
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.29646604676047106,0.7148830674044624,0.8288770053475936,0.9997910575979666,1.0,5/20,16.67%,ANK2;PRKACA;CALM1;CALM2;SLC9A1
prerank,positive regulation of DNA metabolic process (GO:0051054),0.24753015415533616,0.7146564779038267,0.8831460674157303,0.9996484913768924,1.0,9/61,14.50%,FGF2;MYC;FGF10;EGFR;ATRX;BRCA1;SIRT6;SMOC2;RTEL1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.32069370155438237,0.7146224191835093,0.8210059171597633,0.9992620491221019,1.0,5/14,19.82%,GPRC5B;WNT5A;TICAM1;CD74;BCL10
prerank,apoptotic nuclear changes (GO:0030262),-0.2273016272478497,-0.7141487819511886,0.8773946360153256,0.9545430940011742,1.0,8/24,20.82%,ACIN1;DFFA;H1-0;DNASE2;DEDD2;GPER1;HMGB2;CASP3
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.3060597971806974,0.7135330641449599,0.8235294117647058,1.0,1.0,5/18,20.72%,RNFT1;PIK3R1;NCK1;BCL2L11;USP13
prerank,establishment of epithelial cell polarity (GO:0090162),0.3002237215304473,0.7134377301284455,0.8114285714285714,0.9998881503930288,1.0,5/19,15.29%,CLASP1;MYO9A;OPHN1;FBF1;CYTH3
prerank,ncRNA processing (GO:0034470),0.2269812722017003,0.713090260479927,0.950253807106599,0.9999173892943817,1.0,37/200,17.56%,WDR55;C1D;INTS11;WDR36;SENP3;RPL23A;METTL3;NOB1;XRN2;INTS6;NOL8;BMS1;EXOSC8;TUT4;MRTO4;DDX54;UTP6;HEATR1;FARS2;PIH1D1;EXOSC2;RCL1;INTS4;FBL;EBNA1BP2;HELQ;INTS2;INTS8;TEX10;DDX10;WDR46;DDX27;NOP56;POP1;NOC4L;RPP21;SSB
prerank,regulation of cellular protein metabolic process (GO:0032268),0.2560275634169927,0.7130682103353282,0.8595641646489104,0.9995208433985212,1.0,9/47,14.87%,TGFB1;ATXN2;TSC1;GRM5;EIF4G1;DDX25;RBM4B;SSH1;CYFIP1
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.2575102117074622,0.7129453002397125,0.8513189448441247,0.9992478056480243,1.0,10/45,17.51%,ATXN2;TSC1;GRM5;DDX25;RBM4B;PER1;SPOUT1;YTHDC1;CYFIP1;RC3H1
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.28875977140100756,-0.7129327714036531,0.8454258675078864,0.9548065073166369,1.0,3/11,9.35%,BIRC3;NUPR1;CASP8
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.29348252865499835,-0.7129130134486173,0.8203125,0.9537783428003733,1.0,2/10,6.25%,RIF1;TERF2
prerank,male meiosis I (GO:0007141),-0.25079512967238854,-0.7127480329532065,0.8805031446540881,0.9529244720665985,1.0,5/16,26.57%,ING2;MYBL1;FOXJ2;BRDT;HSF2BP
prerank,positive regulation of protein import (GO:1904591),0.2709786151795496,0.712359999096967,0.8400520156046815,0.9995272007182456,1.0,4/30,10.11%,TGFB1;PSEN1;FLNA;PIK3R1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.2796989990167362,0.7120620453906951,0.8448500651890483,0.9994653657206436,1.0,7/29,18.08%,FADD;TBK1;TICAM1;UBB;RIPK1;CHUK;IRF3
prerank,fibrinolysis (GO:0042730),-0.2694521122442206,-0.7114535003002489,0.8425655976676385,0.9533508836719676,1.0,9/13,52.38%,SERPINE1;PLAUR;PLAU;HRG;PLG;SERPINB2;CPB2;GP1BA;F2
prerank,long-term memory (GO:0007616),0.29872176000086537,0.710997032144115,0.8035961272475796,1.0,1.0,6/19,25.69%,PRNP;CPEB3;SGK1;PJA2;NFATC4;SHANK1
prerank,regulation of translational initiation (GO:0006446),0.24818936396660132,0.7109457562896638,0.8764434180138568,0.9999893570033094,1.0,23/63,26.88%,EIF2AK3;EIF1B;EIF2B5;NCBP1;EIF4G1;NCK1;EIF1;POLR2G;EIF4A2;EIF2B2;CSDE1;EIF4G3;GLE1;ALKBH1;NCK2;PAIP2B;CEBPB;FMR1;YTHDF3;RBM4;KLHL25;DDX1;PAIP2
prerank,microglial cell activation (GO:0001774),-0.23837704314420696,-0.7108775108825762,0.8901960784313725,0.9529193474069044,1.0,11/21,36.47%,APP;MAPT;C1QA;CLU;TYROBP;ITGB2;ITGAM;AGER;JAK2;AIF1;TREM2
prerank,lipid biosynthetic process (GO:0008610),0.23948439504767977,0.7106920266093176,0.8941441441441441,0.9998755450541813,1.0,11/77,17.76%,ACSS2;ACACA;OXSM;SCD5;ACLY;LIPC;PRLR;AGPAT5;ACSL6;PIP5K1A;GPAT4
prerank,regulation of protein transport (GO:0051223),0.28298425421462536,0.7104742798556299,0.8422459893048129,0.9997116235611141,1.0,9/27,22.57%,PTPN1;STXBP5;NDFIP1;SNX12;DNAJA1;ARFIP1;DISP1;LLGL1;P3H1
prerank,histone H2B ubiquitination (GO:0033523),0.34179972736378506,0.7096282330927708,0.8041074249605056,1.0,1.0,3/10,20.20%,WAC;CDC73;UBE2E1
prerank,cellular iron ion homeostasis (GO:0006879),0.25269213969079307,0.7095692654334215,0.8774795799299884,0.9999808524796567,1.0,2/55,1.50%,SCARA5;MYC
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.2770822926900211,0.7092726206780325,0.8443337484433375,0.9998941414852931,1.0,9/32,18.84%,FGF13;CLASP1;FKBP4;APC2;KATNB1;SNCA;NAV3;CAMSAP1;ATXN7
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.2611317238136719,-0.7087887086793786,0.827485380116959,0.9541279321283408,1.0,6/14,22.34%,NMNAT2;ME1;NMNAT1;AK4;AK1;NME2
prerank,negative regulation of GTPase activity (GO:0034260),0.2868276479249082,0.7081441426668659,0.8316970546984572,1.0,1.0,5/22,19.55%,ARL2;TMED2;ARFGEF1;FICD;RDX
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.26325723227928605,-0.708051925207155,0.8520710059171598,0.953879905012351,1.0,5/14,18.97%,TERF2;BRCA2;TERT;PINX1;TINF2
prerank,histone exchange (GO:0043486),0.26819629156080427,0.7076738318422529,0.8599752168525403,1.0,1.0,11/37,22.73%,VPS72;ANP32E;HJURP;OIP5;RBBP4;ITGB3BP;NASP;CENPL;CENPC;RBBP7;CENPU
prerank,nucleus organization (GO:0006997),0.25713621845972745,0.7068862170397355,0.8752997601918465,1.0,1.0,8/47,15.45%,SPAG4;PITPNB;NUP155;BIN1;NDC1;NUP205;PDCD6IP;CHMP4C
prerank,phospholipid biosynthetic process (GO:0008654),0.2654989380156837,0.7065772851525417,0.8655043586550436,1.0,1.0,12/36,21.90%,IDI1;FAR1;AGPAT5;CPNE7;SGMS2;PIP5K1A;AGK;DPAGT1;CPNE1;DHDDS;CPNE3;FDPS
prerank,microtubule polymerization or depolymerization (GO:0031109),0.28700810133027144,0.7064827759349733,0.8449197860962567,1.0,1.0,4/24,13.04%,FGF13;STMN4;KATNB1;CKAP5
prerank,positive regulation of neuron death (GO:1901216),0.25927076756223427,0.705639598655017,0.8695652173913043,1.0,1.0,8/46,13.86%,PRNP;NF1;GRIN2B;WNT5A;FYN;CDK5R1;GRN;SNCA
prerank,glycerophospholipid metabolic process (GO:0006650),0.23903405702873518,0.7055171553225429,0.9079822616407982,1.0,1.0,17/75,19.77%,PRDX6;PLCB1;PLA2G7;PIGC;PIGP;FAR1;ENPP6;PIGN;PIGA;GPLD1;ABHD6;CPNE7;PIP5K1A;AGK;GDPD3;PLA2G4E;CPNE1
prerank,positive regulation of ruffle assembly (GO:1900029),0.3226750702569136,0.7048565252978494,0.8538011695906432,1.0,1.0,3/13,13.60%,NLGN1;EPS8L1;P2RY12
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.3354655360912338,0.7039267769506027,0.8201550387596899,1.0,1.0,2/11,16.79%,TGFB1;EFNB2
prerank,regulation of humoral immune response (GO:0002920),0.25968882878824995,0.7034946671456984,0.8792270531400966,1.0,1.0,3/44,12.23%,C7;GATA6;PROS1
prerank,chromatin assembly or disassembly (GO:0006333),0.33107468749459024,0.7033384399840953,0.8264094955489614,1.0,1.0,3/11,16.20%,MTA2;RBBP4;TP53
prerank,nuclear envelope organization (GO:0006998),0.2895175493348908,0.7022571186622505,0.8401639344262295,1.0,1.0,3/20,11.55%,SPAG4;NUP155;EMD
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.3342653762038965,0.7022098357394707,0.8343283582089552,1.0,1.0,4/11,17.10%,NCBP1;AHCYL1;PAPOLA;CDC73
prerank,protein K63-linked deubiquitination (GO:0070536),0.272963439442732,0.7020959216808479,0.8746803069053708,1.0,1.0,7/31,20.72%,USP50;OTUD7B;USP33;USP25;OTUD4;OTUD7A;USP13
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.3294706044801501,0.7020384567852327,0.8139183055975794,1.0,1.0,3/11,16.33%,KCND3;KCNJ3;KCNH2
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.2532532679668283,-0.7020178171705599,0.8798701298701299,0.9591737142490966,1.0,4/14,24.41%,RIF1;TFRC;PAXIP1;MAD2L2
prerank,signal transduction in response to DNA damage (GO:0042770),-0.18695133653351928,-0.7017560390081438,0.9745222929936306,0.9583995372798486,1.0,24/49,33.25%,MAP3K20;ACER2;CLOCK;NDRG1;DOT1L;SESN2;HUS1;BID;CLSPN;PAXIP1;DONSON;ERCC6;NBN;E2F1;MAD2L2;CASP9;RAD9A;CHEK2;CHEK1;GADD45A;PRPF19;E2F7;TRIAP1;ATRIP
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.2884694473986342,0.7015378237859754,0.8552097428958051,1.0,1.0,8/22,23.40%,VEGFA;NCF1;PRMT1;MAP3K4;RELL2;EMC10;PJA2;BMP2
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.24089236214882628,0.7011982454161355,0.8875878220140515,1.0,1.0,22/64,24.57%,GTF2H2;POLR2B;CDK13;POLR2K;SETD2;NCBP1;ELP2;ELP4;POLR2G;ELL;CDC73;PCID2;TCEA2;ELOC;POLR2A;MLLT1;SSRP1;CDK9;ELOB;CCNH;POLR2F;CCNT2
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.27524256510787576,0.7004189726728659,0.8547120418848168,1.0,1.0,7/30,18.08%,FADD;TBK1;TICAM1;UBB;RIPK1;CHUK;IRF3
prerank,positive regulation of immunoglobulin production (GO:0002639),0.2666402191770027,0.6995896033274822,0.8666666666666667,1.0,1.0,2/31,3.77%,EPHB2;DNAJB9
prerank,TOR signaling (GO:0031929),-0.21493174437415197,-0.6995700458048218,0.9397590361445783,0.9595544509699135,1.0,6/26,14.34%,RICTOR;RPS6KB1;FLCN;RPS6;EIF4EBP2;RPS6KB2
prerank,oligosaccharide biosynthetic process (GO:0009312),0.2899899371476857,0.6993395539520085,0.8497267759562842,1.0,1.0,2/20,8.87%,ST3GAL4;ST6GALNAC6
prerank,glutathione biosynthetic process (GO:0006750),0.32744849021154454,0.6992839454929003,0.8052550231839258,1.0,1.0,2/11,12.65%,GSS;GGCT
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.3052717404602463,0.699091634009651,0.8212209302325582,1.0,1.0,2/15,10.19%,SMOX;PAOX
prerank,negative regulation of cellular catabolic process (GO:0031330),0.24178469158645025,0.6990083489336576,0.8886337543053962,1.0,1.0,15/63,20.88%,BCL2;PTPN22;MT3;BMF;TLK2;EIF4G1;ATRAID;KLHL22;WASHC1;MET;GPLD1;TAB3;STAT3;RRAGA;EIF4G3
prerank,neuromuscular synaptic transmission (GO:0007274),-0.23890919517422313,-0.6989884719350757,0.891156462585034,0.9591225883256342,1.0,2/18,7.00%,FCHSD2;KIF1B
prerank,cellular response to insulin stimulus (GO:0032869),0.22720070248512655,0.6988116773582069,0.9395833333333333,1.0,1.0,13/124,10.11%,SLC27A1;IRS2;KAT2B;C2CD5;PTPN2;EPRS1;SLC27A4;ATP6V1B2;PDE3B;BAIAP2;GRB14;SELENOS;PIK3R1
prerank,multivesicular body organization (GO:0036257),-0.20374649951342855,-0.6986939060270939,0.8939393939393939,0.9583425493151343,1.0,5/31,9.92%,CHMP3;TSG101;VPS37C;VPS4A;CHMP1A
prerank,negative regulation of neuron differentiation (GO:0045665),0.2840577436919651,0.6986465004008967,0.8359788359788359,1.0,1.0,2/22,11.32%,SOX9;BMP7
prerank,eye photoreceptor cell differentiation (GO:0001754),0.32206524665759745,0.6984253403413464,0.8245341614906833,1.0,1.0,2/12,9.58%,VEGFA;DSCAM
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.3161147413902723,0.6983788109176773,0.8262839879154078,1.0,1.0,1/13,2.63%,PTPRT
prerank,regulation of presynapse organization (GO:0099174),0.29006064779741564,0.6980110313284917,0.8422619047619048,1.0,1.0,6/18,21.99%,IL1RAPL1;EIF4G1;GPC4;SNCA;LRFN5;IL1RAPL2
prerank,regulation of presynapse assembly (GO:1905606),0.29006064779741564,0.6980110313284917,0.8422619047619048,1.0,1.0,6/18,21.99%,IL1RAPL1;EIF4G1;GPC4;SNCA;LRFN5;IL1RAPL2
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.2779049901062295,-0.6977010854802632,0.8607954545454546,0.9582737589317778,1.0,2/11,9.50%,ATL2;VAPB
prerank,mitochondrion morphogenesis (GO:0070584),0.32617347799273866,0.6976510822400566,0.8279742765273312,1.0,1.0,5/11,24.78%,PID1;WASF1;PNPT1;MTM1;SUPV3L1
prerank,C4-dicarboxylate transport (GO:0015740),0.3147257176244344,0.6975537651962354,0.8162083936324168,1.0,1.0,3/14,16.23%,LRRC8D;SLC25A10;SLC25A11
prerank,positive regulation of histone acetylation (GO:0035066),0.2834629063936306,0.6967028784703807,0.85,1.0,1.0,3/23,9.95%,RPS6KA4;BRCA1;PIH1D1
prerank,membrane raft organization (GO:0031579),-0.25236601253845015,-0.6963067028642247,0.8806451612903226,0.9585631206226768,1.0,8/15,31.61%,RFTN1;FLOT1;ABCA7;NAXE;S100A10;YJEFN3;PPT1;MYADM
prerank,negative regulation of cellular senescence (GO:2000773),0.319022164404992,0.6960370868361481,0.8053097345132744,1.0,1.0,3/13,9.09%,MAP3K3;CDK6;AKT3
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.29052550799827365,0.6959583699067645,0.8324175824175825,1.0,1.0,6/20,22.01%,RPS6KA4;BRCA1;DIP2A;DIP2B;RUVBL2;PRKAA1
prerank,cellular response to leucine starvation (GO:1990253),-0.287944965452274,-0.6954996590043329,0.8571428571428571,0.9583148317650417,1.0,5/10,31.11%,SESN2;LARS1;RRAGB;EIF2AK4;IMPACT
prerank,positive regulation of phosphatase activity (GO:0010922),0.2909370736618496,0.6953244911370828,0.8363384188626907,1.0,1.0,5/21,15.91%,PPP1R15A;MAGI2;CALM1;CALM2;GPLD1
prerank,positive regulation of organelle organization (GO:0010638),0.26740790420480254,0.6950385792655533,0.8535031847133758,1.0,1.0,13/32,27.46%,C2CD5;ATL3;RAB3GAP2;DOC2B;SURF4;RAB3GAP1;P2RX7;LMAN1;STX18;SORBS3;PFDN2;LIG4;FYCO1
prerank,positive regulation of innate immune response (GO:0045089),0.27049778535400487,0.6948819102459604,0.8614379084967321,1.0,1.0,3/30,8.80%,FADD;WNT5A;UBE2K
prerank,histone methylation (GO:0016571),0.27790415186823036,0.6945851495716246,0.8632707774798928,1.0,1.0,5/26,12.92%,SUV39H1;CARM1;FBL;PRMT1;TRMT112
prerank,autophagosome maturation (GO:0097352),0.26643668204229376,0.6944568513981673,0.8578745198463509,1.0,1.0,11/32,22.16%,LIX1;VPS33A;SNAP29;CALM1;GABARAPL2;STX17;SNX14;VMP1;LAMP2;VPS16;UBQLN1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.22647893305878275,0.6944476463656861,0.9335476956055734,1.0,1.0,11/116,12.70%,CRH;DPEP1;PTHLH;PRKAR1B;PTH2R;FYN;TSHR;SELENOS;MAPK14;GLP2R;PRKACA
prerank,positive regulation of lamellipodium organization (GO:1902745),0.26176254502463797,0.6939971761517716,0.8872870249017037,1.0,1.0,6/32,15.56%,AUTS2;BRK1;PIK3R1;CORO1B;CYFIP1;FSCN1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.2956349901456087,0.6934023433647689,0.8290598290598291,1.0,1.0,9/17,26.99%,EMC10;EMC1;SGTA;EMC8;EMC3;CAMLG;EMC2;EMC6;EMC7
prerank,defense response to symbiont (GO:0140546),0.23137432665640437,0.6931752837255121,0.9204301075268817,1.0,1.0,9/92,10.54%,PYCARD;BCL2;FADD;NDUFAF4;RNASE6;BNIP3;FLNA;SETD2;AGBL4
prerank,regulation of B cell differentiation (GO:0045577),-0.24266670230574366,-0.6929097400863568,0.868421052631579,0.9598435757293852,1.0,4/17,13.46%,ZFP36L1;ID2;NCKAP1L;INHBA
prerank,mitotic chromosome condensation (GO:0007076),-0.21515559587370564,-0.6922834771879136,0.9022556390977443,0.9594154167780129,1.0,11/26,31.51%,CHMP1A;NCAPH2;TENT4A;CSNK2B;MCPH1;NCAPD3;NUSAP1;NCAPD2;KMT5A;NCAPH;TTN
prerank,carbohydrate biosynthetic process (GO:0016051),0.2863001008941505,0.6921136406796823,0.8600823045267489,1.0,1.0,2/21,8.87%,ST3GAL4;ST6GALNAC6
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.22319553442719425,0.6919388238127696,0.9383490073145245,1.0,1.0,27/145,21.05%,DYNLL1;HAUS3;CNTRL;PCM1;NDE1;SDCCAG8;CEP57;PSMB7;CLASP1;CDC25B;PRKACA;CKAP5;CEP76;DYNC1I2;PSMD2;PSMC1;CSNK1E;PSMB2;CEP63;FBXO5;TUBA1A;PSMD9;PSME4;SSNA1;CEP78;PSMA8;PCNT
prerank,protein targeting to peroxisome (GO:0006625),0.2670889423737307,0.6918689107298236,0.8649681528662421,1.0,1.0,7/29,18.42%,ACBD5;PEX3;PXMP2;ZFAND6;GDAP1;ABCD2;PEX1
prerank,receptor signaling pathway via STAT (GO:0097696),-0.20946373482271863,-0.6914609532919215,0.9042145593869731,0.9591802130240333,1.0,9/25,26.67%,IL31RA;CTR9;STAT5B;NMI;STAT2;IFNAR1;IFNAR2;CLCF1;SOCS2
prerank,response to glucagon (GO:0033762),-0.23253964859862247,-0.6913563900418742,0.8993288590604027,0.9582549777076705,1.0,7/19,25.04%,ADCY9;PRKAR1A;ADCY4;ADCY3;CYSLTR2;PRKAR2A;PRKACB
prerank,alanine transport (GO:0032328),0.3323163652903396,0.6913240015222076,0.8307926829268293,1.0,1.0,1/10,5.13%,SLC36A2
prerank,nucleosome disassembly (GO:0006337),0.3070887604549653,0.6910789120341982,0.8168604651162791,1.0,1.0,4/14,20.12%,SMARCC2;SMARCC1;SMARCE1;SMARCA4
prerank,chromatin disassembly (GO:0031498),0.3070887604549653,0.6910789120341982,0.8168604651162791,1.0,1.0,4/14,20.12%,SMARCC2;SMARCC1;SMARCE1;SMARCA4
prerank,positive regulation of protein acetylation (GO:1901985),0.3228471359879877,0.6909071973998104,0.8361934477379095,1.0,1.0,5/12,22.01%,DIP2A;TERF2IP;DIP2B;TAOK1;PRKAA1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.30652199844245165,0.6898098370419576,0.8509036144578314,1.0,1.0,4/14,22.99%,PTPN2;PYDC1;TRAIP;CARD16
prerank,negative regulation of growth (GO:0045926),0.223117133316431,0.6896161980058864,0.9376321353065539,1.0,1.0,8/121,6.05%,DCBLD2;CRLF3;VGLL4;FRZB;JADE1;TGFB1;MT3;APBB2
prerank,filopodium assembly (GO:0046847),0.30122167907415554,0.6894364764818991,0.843441466854725,1.0,1.0,4/16,17.72%,FGD4;SPATA13;ARHGEF4;S1PR2
prerank,positive regulation of myelination (GO:0031643),-0.27313058602704265,-0.6892610139388786,0.8483965014577259,0.9590957507020804,1.0,5/11,31.55%,PARD3;MYRF;TPPP;DICER1;TNFRSF1B
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.26576715867241163,0.6887744035869862,0.8596938775510204,1.0,1.0,2/29,2.73%,PYCARD;FADD
prerank,regulation of establishment of protein localization (GO:0070201),-0.25570345833326324,-0.6886879479683543,0.8785942492012779,0.9585913012751002,1.0,7/13,36.47%,SCFD1;GAPVD1;CEP295;CORO2B;CTSD;PTP4A3;TREM2
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.22109413589841398,0.6885590882281506,0.9436913451511991,1.0,1.0,23/136,17.31%,PTCH1;PYCARD;IRAK3;PRNP;CYP1B1;UFL1;OTULIN;MEN1;FLNA;ERBIN;SFRP4;HDAC2;ESR1;MTURN;BMP7;TAX1BP1;SUMO1;PKD1;PYDC1;SUFU;FOXJ1;HEYL;CHUK
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.26778543057019255,0.6885052340178699,0.8852242744063324,1.0,1.0,8/29,19.29%,FBXW7;LIMK1;BAG5;ABL1;FBXO5;PARK7;MAGEC2;UBE2L3
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.30068382221606693,0.6881112143692079,0.826950354609929,1.0,1.0,3/17,7.87%,NTRK2;PRNP;BIN1
prerank,regulation of complement activation (GO:0030449),0.2576928849192342,0.687489174393028,0.8788627935723115,1.0,1.0,1/40,0.76%,C7
prerank,nucleoside salvage (GO:0043174),-0.28342268076883653,-0.6871499281482549,0.8901098901098901,0.9589841693345293,1.0,5/10,38.32%,TK2;DCK;CDA;TK1;UPP1
prerank,sensory perception of sound (GO:0007605),0.2315804970508637,0.6871157200467415,0.9251626898047722,1.0,1.0,12/88,16.32%,ROR1;LHFPL5;PCDH15;LHFPL3;LHFPL4;COL1A1;HOMER2;LRTOMT;PAX3;CCDC50;CDC14A;LRP2
prerank,mitotic sister chromatid segregation (GO:0000070),-0.15844455080740255,-0.6868704343755784,1.0,0.9582219016768189,1.0,46/98,34.89%,CHMP3;BECN1;NUDC;VPS4A;CHMP1A;KIF18A;NCAPH2;PINX1;VPS4B;TENT4A;PIBF1;KIF23;CENPK;TUBG1;CSNK2B;CHMP7;BOD1;MCPH1;NCAPD3;CHMP2B;DCTN2;DSN1;NUSAP1;EML4;CENPE;NIPBL;EML3;ZW10;NCAPD2;KMT5A;KNSTRN;NCAPH;SPAG5;KIF18B;TTN;NUP62;NDC80;KIFC1;NSL1;REC8;RAD21;KIF14;SPDL1;CDCA8;CEP55;TUBG2
prerank,regulation of immune effector process (GO:0002697),0.2565626228332755,0.6865490545853914,0.8912237330037083,1.0,1.0,1/41,0.76%,C7
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.22900865138258192,-0.686503874520308,0.9074733096085409,0.9575101666365924,1.0,3/19,9.92%,CHMP3;DRG1;CHMP1A
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.2827306590245056,0.6858039572763415,0.8561827956989247,1.0,1.0,6/22,17.28%,TAFA1;SHCBP1;PTPRZ1;NES;FZD9;MDK
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.293265594740718,0.6856177405165836,0.8581765557163531,1.0,1.0,5/17,17.60%,NLGN1;RAB3D;RAB3A;DOC2B;UNC13D
prerank,membrane lipid metabolic process (GO:0006643),0.2819956954062021,0.6851093183275425,0.8563611491108071,1.0,1.0,3/22,8.09%,CYP1B1;AGMO;TEX2
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.2901025621037536,0.6848657232796108,0.825,1.0,1.0,3/18,11.06%,CBL;PTPN11;IL6ST
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.23559986796162594,0.6848401438566911,0.89988358556461,1.0,1.0,21/62,24.57%,GTF2H2;POLR2B;CDK13;POLR2K;SETD2;NCBP1;ELP2;ELP4;POLR2G;ELL;CDC73;PCID2;ELOC;POLR2A;MLLT1;SSRP1;CDK9;ELOB;CCNH;POLR2F;CCNT2
prerank,histone H2A monoubiquitination (GO:0035518),-0.23630638005172205,-0.6847000212751767,0.9094076655052264,0.9582185727542183,1.0,6/17,18.52%,PCGF3;PCGF2;PCGF5;BMI1;RING1;PCGF6
prerank,positive regulation of monooxygenase activity (GO:0032770),0.27410817052847136,0.6841717635782694,0.8703703703703703,1.0,1.0,5/26,18.78%,POR;HIF1A;GDNF;PARK7;NOS1AP
prerank,regulation of T cell cytokine production (GO:0002724),-0.2533902321253738,-0.6838233841872653,0.8653846153846154,0.9580259469380243,1.0,3/15,11.39%,SMAD7;CD55;MAP3K7
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.23924421996758183,0.683455278201223,0.9115958668197475,1.0,1.0,12/58,19.08%,ERCC4;SETMAR;ATP23;BRCA1;NHEJ1;NSD2;XRCC6;MDC1;SUMO1;ATM;CYREN;LIG3
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.295944611926225,0.683417016672508,0.8640915593705293,1.0,1.0,2/15,7.32%,CCT7;SHQ1
prerank,ribosome biogenesis (GO:0042254),0.2182584347099629,0.683154545151331,0.9643947100712106,1.0,1.0,30/187,15.52%,WDR55;XPO1;C1D;WDR36;SENP3;RPL23A;NOB1;TSC1;XRN2;NOL8;BMS1;EXOSC8;MRTO4;DDX54;UTP6;EIF6;HEATR1;PIH1D1;EXOSC2;RCL1;FBL;EBNA1BP2;HELQ;SDAD1;TEX10;DDX10;WDR46;NIP7;DDX27;NOP56
prerank,negative regulation by host of viral transcription (GO:0043922),0.3175498035361414,0.6826092872918857,0.8538011695906432,1.0,1.0,1/12,4.22%,CCL4
prerank,regulation of vacuole organization (GO:0044088),0.2816888151172766,0.6819172076927379,0.8604651162790697,1.0,1.0,2/20,6.33%,NPRL2;LAPTM4B
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.24475601638063454,-0.6817935560334428,0.8884892086330936,0.9588392440025235,1.0,3/17,11.37%,ADCY9;ADRA1B;ADRA2A
prerank,maintenance of protein location in nucleus (GO:0051457),-0.2261002528045976,-0.6817868901923112,0.9124579124579124,0.957817652359746,1.0,4/20,17.83%,SP100;SUPT7L;PML;TAF3
prerank,determination of heart left/right asymmetry (GO:0061371),0.24939733196504646,0.6811422282475044,0.888622754491018,1.0,1.0,5/42,11.11%,CCDC39;TGFBR2;BBS5;SMO;DAND5
prerank,RNA methylation (GO:0001510),0.23700664380082492,0.6810456603667316,0.9174418604651163,1.0,1.0,11/60,15.92%,THUMPD3;NOP2;METTL3;TRMT12;NSUN5;THADA;TGS1;FBL;TRMT112;THUMPD2;MEPCE
prerank,activation of adenylate cyclase activity (GO:0007190),-0.1988218232816826,-0.6804065949019173,0.9671361502347418,0.9580293147012742,1.0,15/35,37.29%,ADCY9;LGR4;ADCY4;CAP1;ADCY3;ADCYAP1;ADRB2;CAP2;ADRB1;LHCGR;ACR;GIPR;CRHR1;ADCY7;GLP1R
prerank,protein lipidation (GO:0006497),0.23844462650902146,0.6801909418275317,0.9083526682134571,1.0,1.0,23/59,28.34%,WIPI1;ATG5;ZDHHC8;PIGC;PIGP;HHAT;PIGN;PIGA;GPLD1;PIGU;DPM1;PIGO;ZDHHC21;PORCN;ZDHHC13;WDR45B;ATG12;ZDHHC15;ZDHHC17;ATG10;PIK3C3;PIGM;ZDHHC5
prerank,zinc ion homeostasis (GO:0055069),0.264358006846389,0.6798215832901425,0.8914209115281502,1.0,1.0,2/28,4.92%,PRKN;MT3
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.2912223031714445,0.678726661986441,0.8538681948424068,1.0,1.0,3/15,16.84%,NAGK;MGAT3;GNPDA1
prerank,mesenchyme development (GO:0060485),0.3017977199332044,0.6785188276299606,0.8558421851289834,1.0,1.0,1/15,0.86%,MEOX1
prerank,mitochondrial membrane organization (GO:0007006),0.2648669587491823,0.6763405920404368,0.8853092783505154,1.0,1.0,6/32,18.26%,BCL2;APOOL;BNIP3;RCC1L;OPA1;HSPA9
prerank,regulation of acute inflammatory response (GO:0002673),0.2871479228145887,0.675266088370202,0.8687845303867403,1.0,1.0,2/18,16.49%,IL6ST;PTGES
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.23043355835084717,-0.674968603150686,0.8963210702341137,0.9617828444768154,1.0,6/18,24.33%,VTI1B;ZDHHC7;VPS4A;APPL1;VAMP8;ZDHHC2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.3172548356516891,0.6740854066928419,0.8444444444444444,1.0,1.0,4/10,16.20%,FOXM1;ING4;RPS27L;TP53
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.25204889715177753,0.6738036166603396,0.9100985221674877,1.0,1.0,10/42,17.80%,MRNIP;SETD2;FBH1;SIRT6;RPA2;RTEL1;CGAS;SPIDR;TERF2IP;FUS
prerank,regulation of exosomal secretion (GO:1903541),0.2802734672068874,0.6735629762390314,0.8536585365853658,1.0,1.0,4/19,17.68%,PRKN;SDC4;PDCD6IP;RAB7A
prerank,positive regulation of ATP metabolic process (GO:1903580),0.25787444454240604,0.6728713444918449,0.8951406649616368,1.0,1.0,5/32,11.05%,ZBTB20;PSEN1;MLXIPL;HIF1A;PID1
prerank,cell differentiation in hindbrain (GO:0021533),0.31086368199576714,0.6728531203578646,0.859375,1.0,1.0,4/11,23.33%,GRID2;OPHN1;FAIM2;KNDC1
prerank,regulation of cellular response to stress (GO:0080135),0.22002565925751,0.6727539596212142,0.9517313746065058,1.0,1.0,22/115,17.75%,HSPH1;PRKN;RANBP2;MAPKAPK2;NUP155;RPA3;BAG5;CRYAB;EIF4G1;NDC1;NUP205;FKBP4;DNAJB6;MAPK1;NUP160;RPA2;ATM;ABL1;PNPT1;POM121;AAAS;RPTOR
prerank,protein neddylation (GO:0045116),0.3055214173910871,0.6727145844135795,0.8776119402985074,1.0,1.0,3/13,13.83%,NAE1;UBA3;NEDD8
prerank,pre-replicative complex assembly (GO:0036388),-0.1717210278837799,-0.672463806483645,0.9923664122137404,0.9628880500480945,1.0,26/64,34.08%,PSMD14;PSMB3;PSMD12;MCM6;PSMD6;PSMA1;PSMD7;ORC6;PSMA5;PSMC5;PSMC4;PSMB6;PSMA4;PSMB9;PSMB1;UBA52;MCM8;PSMD3;PSMC6;PSMD10;PSME3;MCM3;PSME2;MCM2;PSMA6;MCM5
prerank,negative regulation of stem cell differentiation (GO:2000737),0.30709501804568395,0.672444563222554,0.8525073746312685,1.0,1.0,2/12,16.71%,ZFP36L2;HNRNPU
prerank,response to chemokine (GO:1990868),0.30051948770333375,0.6723390700149687,0.841799709724238,1.0,1.0,2/13,9.24%,SLC12A2;STK39
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.2899554914067286,0.6718037256040879,0.8633720930232558,1.0,1.0,7/17,23.40%,ACVR1;TGFB1;BMPR1A;HEYL;GALNT11;SNAI1;BMP2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.2627341944143174,-0.6717814985084531,0.8818181818181818,0.9624292203643982,1.0,5/12,24.29%,INSIG2;RER1;GPAA1;KDELR1;OS9
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.27863448498578036,0.6717346583516267,0.8743093922651933,1.0,1.0,4/20,18.64%,TGFB1;GTF2B;GATA3;PARK7
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.27774357218023754,0.6715421272818798,0.8850889192886456,1.0,1.0,6/22,22.33%,MED13;ESR1;MED12;TP53;MED30;MED24
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.281268339206448,0.6715068729765403,0.871191135734072,1.0,1.0,2/20,7.80%,PTEN;MEN1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.2971113334705812,0.6710201216286231,0.8622754491017964,1.0,1.0,4/13,18.64%,GPR37;NFE2L2;MET;PARK7
prerank,aerobic electron transport chain (GO:0019646),0.2312621116676052,0.6709978571953633,0.9331823329558324,1.0,1.0,17/68,20.06%,UQCRQ;SDHC;NDUFS5;AFG1L;NDUFA4;NDUFB2;NDUFA8;NDUFS8;COX10;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1;NDUFA5
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.31033874598383304,0.6704102410242092,0.8504672897196262,1.0,1.0,4/12,22.95%,PPP3CB;GPLD1;ADCY8;TRPM4
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.2254136092338723,-0.670191518470549,0.8938356164383562,0.962788571606014,1.0,6/18,25.89%,VPS4B;CDK4;CDC7;RAD51C;MECP2;STOX1
prerank,peroxisomal membrane transport (GO:0015919),0.26007862701258666,0.6694962122720335,0.8914728682170543,1.0,1.0,6/27,18.42%,ACBD5;PEX3;PXMP2;GDAP1;ABCD2;PEX1
prerank,secondary palate development (GO:0062009),0.29618686712624487,0.669180042931407,0.8637724550898204,1.0,1.0,2/14,6.42%,WNT5A;TGFBR2
prerank,regulation of type I interferon production (GO:0032479),0.22491110180771856,0.6686382634516449,0.9385474860335196,1.0,1.0,28/84,28.05%,PTPN22;DTX4;NLRX1;LRRFIP1;POLR2K;TAX1BP1;TBK1;XRCC6;DHX33;CGAS;POLR1C;IRF3;POLR3G;NFKB1;IRF8;STAT6;CYLD;POLR3K;PCBP2;POLR2F;MAVS;PRKDC;IRF5;POLR3F;PIN1;IRAK1;RELA;ACOD1
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.2460783878220008,-0.6685592012988958,0.9090909090909091,0.9631070472030209,1.0,8/14,29.14%,FASTKD1;SLC25A33;EARS2;MRPL12;TFB2M;TEFM;TWNK;FASTKD5
prerank,aminoglycan metabolic process (GO:0006022),-0.2743376658955193,-0.6678265332981043,0.8771428571428571,0.9626435594810043,1.0,4/10,29.06%,B4GALT7;B3GAT1;B3GALT6;CHST9
prerank,negative regulation of establishment of protein localization (GO:1904950),0.32529738189653334,0.6675361014156252,0.864297253634895,1.0,1.0,3/10,18.23%,NDFIP1;SNX12;DNAJA1
prerank,positive regulation of cilium assembly (GO:0045724),-0.2236800371788032,-0.6674252491719849,0.9305019305019305,0.9619173767525873,1.0,4/18,17.90%,ARHGAP35;CCP110;FUZ;CROCC
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.26730336615834693,-0.6669809761178037,0.8835820895522388,0.9612385992090771,1.0,5/11,29.88%,CAMK4;TYROBP;ITGB2;SPI1;ITGAM
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.27090026539996026,0.6666627321380327,0.86593707250342,1.0,1.0,2/23,5.84%,PTPN2;SOCS1
prerank,ovarian follicle development (GO:0001541),0.2999526487456791,0.6665314918075896,0.8460410557184751,1.0,1.0,5/13,23.43%,VEGFA;EIF2B5;EIF2B2;INHBB;CEBPB
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.26710852675991464,-0.6665278894567999,0.8760806916426513,0.9606012024642945,1.0,3/11,17.32%,PDPN;ARPIN;RREB1
prerank,negative regulation of viral transcription (GO:0032897),0.3022772136080992,0.665972163565187,0.8888888888888888,1.0,1.0,5/13,24.53%,TRIM11;MID2;ZFP36;UBP1;TRIM14
prerank,termination of RNA polymerase II transcription (GO:0006369),0.2538014920659824,0.6651240176429751,0.8873056994818653,1.0,1.0,3/33,10.12%,CSTF3;NCBP1;FIP1L1
prerank,negative regulation of endopeptidase activity (GO:0010951),0.24092897093954507,0.6643867836035184,0.9171528588098017,1.0,1.0,4/47,7.87%,RECK;MT3;SERPINE2;BIN1
prerank,lipoprotein biosynthetic process (GO:0042158),0.31402107370814586,0.6639436898938952,0.8809160305343512,1.0,1.0,5/11,27.40%,WIPI1;PORCN;WDR45B;ATG10;PIK3C3
prerank,axonal transport of mitochondrion (GO:0019896),0.3111844213938731,0.6639377838275566,0.8485804416403786,1.0,1.0,6/11,29.84%,HIF1A;OPA1;TRAK2;SYBU;SPAST;ACTR10
prerank,heme biosynthetic process (GO:0006783),0.27401819805595884,0.6636091325468276,0.8863328822733424,1.0,1.0,10/22,27.18%,SLC25A38;UROS;COX10;FECH;PGRMC1;TSPO;CPOX;ALAD;UROD;ABCB10
prerank,nuclear pore complex assembly (GO:0051292),0.3142295605974691,0.6636038658311423,0.8613707165109035,1.0,1.0,4/10,21.23%,NDC1;NUP205;RTN4;AHCTF1
prerank,regulation of lysosomal lumen pH (GO:0035751),0.3072665828973693,0.6636018011304422,0.8525345622119815,1.0,1.0,2/12,12.41%,VPS33A;GRN
prerank,oxoacid metabolic process (GO:0043436),0.26718663578254254,0.6635347655187562,0.8952134540750324,1.0,1.0,3/27,9.22%,DAO;BPNT1;BPNT2
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2116251777398765,0.6627198421564626,0.9644351464435147,1.0,1.0,53/148,26.85%,NOP2;MAPKAP1;MTA2;RPA3;PRKAB2;CHD3;PPP1R13L;BRCA1;HDAC2;PHF20;MAPK14;TAF2;TAF9;TAF11;CDK5R1;RBBP4;RPA2;TAF7;TOPBP1;MDM4;ATM;TAF4;TAF4B;BLM;TP53;SGK1;USP2;WRN;MDM2;TP53RK;BOP1;CSNK2A2;TAF1;RBBP7;TTC5;SSRP1;TOP3A;PRKAA1;RAD50;BARD1;ATR;MTOR;TBP;EHMT2;BRPF1;RHNO1;RBBP8;HDAC1;PPP2R5C;CDK5RAP3;RFC2;MAP2K6;PIN1
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.24226917219059044,0.6625062704566558,0.916058394160584,1.0,1.0,9/41,16.86%,RANBP2;NUP155;EIF6;HIF1A;NDC1;NUP205;NUP160;POM121;AAAS
prerank,rRNA metabolic process (GO:0016072),0.21343848945604693,0.6615028585729567,0.9723643807574207,1.0,1.0,27/160,16.52%,WDR55;C1D;WDR36;SENP3;RPL23A;NOB1;XRN2;NOL8;BMS1;EXOSC8;MRTO4;DDX54;UTP6;HEATR1;PIH1D1;EXOSC2;RCL1;FBL;EBNA1BP2;HELQ;TEX10;DDX10;WDR46;DDX27;NOP56;NIFK;NOC4L
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.22110316463828913,0.6614755627865994,0.9518599562363238,1.0,1.0,31/94,28.14%,MAP3K3;IRAK3;RPS6KA4;PLCB1;PELI1;PSMB7;TOLLIP;PSMD2;UBB;PSMC1;IL1RAP;CHUK;PSMB2;PSMD9;EGR1;TAB3;PSME4;PSMA8;NFKB1;TNIP2;TAB2;IRAK2;CUL1;PELI2;PSMD8;PSMD13;IRAK1;RELA;TRAF6;TAB1;PSMD4
prerank,telomere capping (GO:0016233),0.28114084521598404,0.661392993537526,0.8737151248164464,1.0,1.0,7/16,25.03%,STN1;TERF2IP;CTC1;RAD50;ACD;TFIP11;PRKDC
prerank,protein O-linked mannosylation (GO:0035269),0.279496081618848,0.661242423078168,0.8742690058479532,1.0,1.0,7/18,18.76%,TMTC2;RXYLT1;POMGNT2;TMTC3;DPM1;FKTN;FKRP
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.19344273443703225,-0.6607773579880903,0.9382716049382716,0.9640732456645285,1.0,9/29,26.67%,IL31RA;CTR9;STAT5B;NMI;STAT2;IFNAR1;IFNAR2;CLCF1;SOCS2
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.2746281489278807,0.6605907535331114,0.876577840112202,1.0,1.0,5/20,21.76%,ADSS1;NT5C2;AK3;ADSL;PFAS
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.22709438311675675,0.6605898378226276,0.9377123442808607,1.0,1.0,16/69,18.56%,UQCRQ;SDHC;NDUFS5;AFG1L;NDUFA4;NDUFB2;NDUFA8;NDUFS8;COX10;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1
prerank,establishment of melanosome localization (GO:0032401),0.2780980329529785,0.6605115938160898,0.8912732474964234,1.0,1.0,7/19,25.09%,BBS5;MREG;BBS7;MYO5A;BLOC1S6;BBS4;RAB27B
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.2741819393939189,-0.6605066106490758,0.8804347826086957,0.9632618873406614,1.0,1/10,2.49%,SMAD7
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.2269201516701651,0.660327002006861,0.9200887902330743,1.0,1.0,14/73,20.59%,CBFB;KMT2A;METTL3;PSMB7;RUNX1;GATA3;PUS7;PSMD2;ABL1;PSMC1;PSMB2;PSMD9;PSME4;PSMA8
prerank,DNA-dependent DNA replication (GO:0006261),0.21553472368784013,0.6600150010363561,0.9652265542676501,1.0,1.0,29/128,21.28%,LRWD1;POLE2;BAZ1A;REV3L;RPA3;POLE3;PSMB7;GINS2;MCM4;RPA2;ORC1;TOPBP1;POLG2;PSMD2;UBB;PSMC1;BLM;POLG;PSMB2;WRN;ORC4;PSMD9;DDX23;DBF4;PSME4;WRNIP1;ORC2;PSMA8;SSBP1
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.2638805321383452,0.6599578442625538,0.8897849462365591,1.0,1.0,7/23,24.01%,PTEN;MTMR12;INPP5J;MTMR7;INPP5B;MTM1;MTMR1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.263984923899511,0.6599262927148394,0.8691460055096418,1.0,1.0,4/23,15.45%,SETMAR;ZWINT;BUB1B;CHMP4C
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.3100198427664322,0.6598045385886716,0.8694968553459119,1.0,1.0,1/11,3.85%,SOCS5
prerank,rRNA processing (GO:0006364),0.211025199042302,0.6595405445284287,0.9775280898876404,1.0,1.0,29/172,16.55%,WDR55;C1D;WDR36;SENP3;RPL23A;NOP2;NOB1;XRN2;NOL8;BMS1;EXOSC8;MRTO4;DDX54;UTP6;EIF6;HEATR1;PIH1D1;EXOSC2;RCL1;FBL;EBNA1BP2;HELQ;TEX10;DDX10;WDR46;DDX27;NOP56;NOC4L;RRP15
prerank,pseudouridine synthesis (GO:0001522),0.3025074330589711,0.6594016467778716,0.868995633187773,1.0,1.0,3/13,16.00%,PUSL1;PUS7;PUS1
prerank,mitochondrial fusion (GO:0008053),-0.22421482283843952,-0.6592989022068647,0.926829268292683,0.9631688496671382,1.0,3/18,11.35%,SPG7;STOML2;MFF
prerank,regulation of phagocytosis (GO:0050764),0.23716315222848594,0.6592935336649252,0.9200940070505288,1.0,1.0,2/53,1.56%,PYCARD;OLFM4
prerank,negative regulation of catalytic activity (GO:0043086),0.26591415698888227,0.6590550662221909,0.8850267379679144,1.0,1.0,4/24,16.20%,MT3;HDAC6;NES;TP53
prerank,heart looping (GO:0001947),0.24461783084190025,0.6583693788995864,0.9106487148102815,1.0,1.0,4/39,8.53%,CCDC39;TGFBR2;BBS5;SMO
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.22584023942657147,0.6578535766990847,0.9480812641083521,1.0,1.0,15/76,16.74%,FBXW7;NSMCE3;UBA2;BRCA1;CUL3;HUWE1;PRICKLE1;MALT1;NDFIP1;SENP2;CRY1;UBB;RCHY1;XIAP;FANCI
prerank,peptide cross-linking (GO:0018149),0.25956501290795386,0.6576750718064603,0.9037940379403794,1.0,1.0,2/25,8.09%,TGM1;COL3A1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.26349965050293456,-0.6572068675428908,0.8802228412256268,0.9627368230963838,1.0,6/11,29.98%,AGO1;NOTCH4;AGO3;TNRC6C;AGO2;AGO4
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.26349965050293456,-0.6572068675428908,0.8802228412256268,0.9627368230963838,1.0,6/11,29.98%,AGO1;NOTCH4;AGO3;TNRC6C;AGO2;AGO4
prerank,lipoprotein catabolic process (GO:0042159),0.31236888783552763,0.6571911363182252,0.849925705794948,1.0,1.0,3/11,17.67%,LYPLA1;LYPLA2;ABHD10
prerank,female gonad development (GO:0008585),0.27584669064631107,0.6570297983867649,0.8777777777777778,1.0,1.0,7/19,23.43%,VEGFA;EIF2B5;EIF2B2;NR5A1;NR2F2;INHBB;CEBPB
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.20991382889976565,0.6565847144849931,0.96900826446281,1.0,1.0,30/151,21.41%,SLC27A1;SLC25A2;CERS3;ST3GAL4;CERS6;SLC44A2;ELOVL6;ELOVL5;SPTSSA;VAPA;PCYT1B;CHPT1;GPHN;SLC25A15;NFS1;CHAT;CSNK1G2;SGMS2;GSTZ1;GPAT4;GSTT1;SLC44A1;CSNK2A2;LPCAT2;HACD2;STARD7;CERS2;PRKD2;FURIN;LCMT2
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.3090105548019869,0.6565044238242437,0.8588588588588588,1.0,1.0,1/11,4.06%,GTF2H2
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.2799646624631917,0.6562683140979524,0.8824343015214384,1.0,1.0,3/19,7.87%,NTRK2;PRNP;BIN1
prerank,melanosome organization (GO:0032438),0.2585338779595395,0.6558607504776747,0.8918205804749341,1.0,1.0,6/26,23.50%,RAB38;AP1G1;TRAPPC6A;HPS1;KIF13A;BLOC1S6
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.3162064080012984,0.6558283673207344,0.864696734059098,1.0,1.0,2/10,8.52%,RARB;RARG
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.23927644901426012,0.6553889803403868,0.9179926560587516,1.0,1.0,9/41,16.86%,RANBP2;NUP155;EIF6;HIF1A;NDC1;NUP205;NUP160;POM121;AAAS
prerank,negative regulation of ATP metabolic process (GO:1903579),0.2815160610635644,0.6549262945817799,0.8764705882352941,1.0,1.0,3/17,11.05%,MLXIPL;CBFA2T3;PID1
prerank,mitochondrial transport (GO:0006839),0.236964178227787,0.6544365671332103,0.9501187648456056,1.0,1.0,10/53,17.02%,BCL2;FBXO7;BNIP3;TOMM22;AIP;TOMM20;COX18;GDAP1;SLC25A24;DNAJC19
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.2963220938356686,0.6537908979007648,0.8647845468053492,1.0,1.0,7/14,28.05%,UMPS;NT5C;DHODH;DPYD;NT5C3A;NT5E;CAD
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.23285212183644546,0.6533610442934398,0.9278959810874704,1.0,1.0,14/52,22.68%,EXOSC8;TUT4;DCP1B;EXOSC2;PNLDC1;EDC4;LSM3;CNOT3;NT5C3B;RC3H1;ZFP36;DDX6;CNOT6L;EXOSC3
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.2267463929040473,0.6531057567680648,0.9332603938730853,1.0,1.0,16/72,19.62%,FGF13;KANK4;PRKN;SSH3;CRYAB;CLASP1;PLEKHH2;APC2;KATNB1;SSH1;SNCA;NAV3;ARFGEF1;CAMSAP1;ATXN7;KANK1
prerank,AMP metabolic process (GO:0046033),0.2945167122809817,0.652818181807932,0.8776758409785933,1.0,1.0,5/13,27.29%,ADSS1;AK3;ADSL;NUDT2;NT5E
prerank,tyrosine metabolic process (GO:0006570),0.30288032827175654,0.6526867724167996,0.8786936236391913,1.0,1.0,2/11,17.54%,IL4I1;GSTZ1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.2901496069975809,0.652559263125941,0.8849431818181818,1.0,1.0,4/15,18.68%,KCND3;KCNJ3;KCNH2;KCNA5
prerank,rRNA 3'-end processing (GO:0031125),0.31449336617625234,0.6523512431654749,0.8697749196141479,1.0,1.0,2/10,10.02%,EXOSC8;EXOSC2
prerank,phospholipid dephosphorylation (GO:0046839),0.24336675632206922,0.6521541700373258,0.9044665012406948,1.0,1.0,12/37,24.66%,PTEN;PLPP4;MTMR12;PLPPR4;PLPPR2;INPP5J;PLPPR1;MTMR7;INPP5B;MTM1;MTMR1;EPHX2
prerank,fatty acid catabolic process (GO:0009062),0.22794554000575942,0.6521046698603996,0.9453302961275627,1.0,1.0,20/67,25.76%,CEL;SLC27A4;ACBD5;HADHA;AIG1;ACOX1;MTLN;ABCD2;ILVBL;EHHADH;AUH;ACAA2;DECR1;ACOT8;ACADS;SCP2;ABHD3;HSD17B4;NUDT19;NUDT7
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.2359559523878917,0.6519481982880156,0.9423076923076923,0.9999053177188245,1.0,14/44,25.24%,SQLE;PSAT1;CYP39A1;PNPO;CYP7B1;CYP27A1;SC5D;PARK7;OSBPL1A;ACOT8;SCP2;HMGCR;HSD17B4;AMACR
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.26683171325432803,0.6516238469600838,0.8950953678474114,0.9998127460128073,1.0,2/22,7.80%,PTEN;MEN1
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.25029042398103546,-0.6514734995161694,0.8888888888888888,0.9660015260056684,1.0,6/12,29.12%,VBP1;APOE;CLU;PFDN5;PFDN6;LDLR
prerank,lipid phosphorylation (GO:0046834),0.3056714433951459,0.650361955505158,0.8651515151515151,1.0,1.0,6/10,28.90%,DGKI;DGKA;DGKK;DGKD;DGKZ;DGKQ
prerank,regulation of superoxide anion generation (GO:0032928),-0.23413384615978586,-0.6503074422959676,0.9279279279279279,0.9658593518947032,1.0,3/14,12.55%,PRKCD;SOD1;MAPT
prerank,cellular response to leucine (GO:0071233),0.31284042375791865,0.6494227971228326,0.8614173228346457,1.0,1.0,5/10,29.17%,KLHL22;RPTOR;MTOR;SESN1;UBR1
prerank,response to leucine (GO:0043201),0.31284042375791865,0.6494227971228326,0.8614173228346457,1.0,1.0,5/10,29.17%,KLHL22;RPTOR;MTOR;SESN1;UBR1
prerank,sterol metabolic process (GO:0016125),0.22828464276906416,0.6488955997071063,0.9394285714285714,1.0,1.0,7/60,11.01%,SQLE;GBA2;CYP39A1;OSBPL5;CYP1B1;CYP7B1;ABCA5
prerank,response to ionizing radiation (GO:0010212),0.22325674955612912,0.6487355209505434,0.9351230425055929,1.0,1.0,13/70,16.20%,MYC;MRNIP;MEN1;BRCA1;NHEJ1;MAPK14;BRAT1;TOPBP1;ATM;AEN;BLM;SPIDR;TP53
prerank,heterotypic cell-cell adhesion (GO:0034113),0.25837181290852523,0.6482946708057915,0.8965986394557823,1.0,1.0,6/25,17.24%,DSG2;CTNNA3;ITGB1;JUP;PKP2;ITGB7
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.23131034369816614,0.6481376007881002,0.9341176470588235,1.0,1.0,9/48,17.95%,KAT2B;TAF1A;ZMIZ1;POLR2K;ASF1A;POLR1B;BAZ1B;POLR1C;POLR1G
prerank,positive regulation of hormone secretion (GO:0046887),0.2794306828323859,0.648030194468108,0.901685393258427,0.999878722525684,1.0,2/17,9.69%,SOX11;EDN3
prerank,regulation of amyloid-beta clearance (GO:1900221),0.28202277575843243,0.6475293531959374,0.8885714285714286,0.9999407205229962,1.0,1/16,2.34%,LRP1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.20089197757778757,0.6470287642197321,0.990990990990991,0.9999893133311245,1.0,86/341,23.35%,ZFAND2B;RAD23B;PRKN;MVB12B;HACE1;FBXW7;SPSB4;RNF6;FBXO7;SPOP;OTUD7B;TRIM2;HECTD3;PELI1;UBE2K;UCHL1;PSMB7;CUL3;HERPUD1;FBXO45;ANAPC7;VPS37B;CBL;HUWE1;NFE2L2;USP33;TOLLIP;MYLIP;ANAPC2;MVB12A;DDB1;NDFIP1;NEDD8;BUB1B;NEDD4L;KLHL22;PSMD2;AREL1;PLAA;RNF19A;PSMC1;RNF111;CDC23;RCHY1;ZSWIM8;ANAPC16;FBXL4;MIB1;PSMB2;RNF167;UBA1;RC3H1;MDM2;FBXO22;TRIM9;OTUD7A;ELOC;PSMD9;RNF4;TAF1;PCNP;UBE2L3;CDC27;PSME4;FBXO11;UBE2G1;DCAF11;UBE2E1;PSMA8;RNF13;PTTG1;ANAPC4;WDR81;RNF114;UBE2D3;UBQLN4;TTC3;ARRB2;UBQLN1;UBR3;ANAPC5;SIAH1;COP1;CDC16;RNF187;UBQLN2
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.2798120455550542,0.6464113643167915,0.886002886002886,1.0,1.0,4/16,15.98%,ERCC4;RTEL1;ATM;SMG6
prerank,import into nucleus (GO:0051170),0.22228689745841418,0.6463111165794801,0.9562289562289562,0.9998629381002423,1.0,17/73,20.96%,NUP155;FAM53B;IPO9;PRICKLE1;KPNB1;NXT1;IPO13;EIF4ENIF1;HTATIP2;POM121;GEMIN7;TNPO3;STAT3;IPO5;CSE1L;PHB2;HEATR3
prerank,positive regulation of defense response (GO:0031349),0.21691624925814473,0.6458422338058917,0.9534127843986999,0.9999130287443975,1.0,15/89,20.51%,IL16;GPRC5B;WNT5A;CCR2;PLA2G7;IL18;GRN;SNCA;IL33;ABCC1;RIPK1;MDK;SETD4;PDCD4;POLR3G
prerank,autophagosome assembly (GO:0000045),0.2269110682647672,0.6444685147350565,0.9397590361445783,1.0,1.0,15/52,25.20%,PACS2;WIPI1;ATG5;RAB1A;ATG3;GABARAPL2;RAB7A;STX17;VMP1;UBQLN1;TMEM41B;UBQLN2;EMC6;WDR45B;ATG12
prerank,positive regulation of type I interferon production (GO:0032481),0.2225235776357701,0.6436705979560442,0.9471910112359551,1.0,1.0,24/73,27.49%,PTPN22;LRRFIP1;POLR2K;SETD2;PTPN11;TBK1;XRCC6;DHX33;CGAS;CHUK;POLR1C;IRF3;POLR3G;HSPD1;NFKB1;STAT6;POLR3K;POLR2F;MAVS;PRKDC;IRF5;POLR3F;IRAK1;RELA
prerank,oligosaccharide metabolic process (GO:0009311),0.23418432106901593,0.643612257314845,0.9294258373205742,1.0,1.0,5/46,10.62%,ST3GAL4;NAGA;MAN2C1;ST6GALNAC6;ST8SIA1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.2816420728773949,0.643520177012654,0.888558692421991,1.0,1.0,2/14,13.43%,TNFRSF10B;MALT1
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.21321335283854076,-0.6428881152826901,0.9501915708812261,0.9700433535048585,1.0,5/21,20.53%,CTNNB1;GSK3B;FZD1;CAV1;DVL2
prerank,mitochondrion organization (GO:0007005),0.2054425036312454,0.6427813189630376,0.983402489626556,1.0,1.0,45/165,24.33%,DNM1;PRKN;RAB38;FBXO7;ATP23;BNIP3;TFAM;TOMM22;AKT3;AIP;TOMM20;RHOT2;AFG1L;PID1;WASF1;PRDX3;YME1L1;POLRMT;POLG2;OPA1;GDAP1;PNPT1;GABPB1;DNAJC19;ADCK1;TRAK2;AIFM1;CLUH;RHOT1;PARK7;HK2;TSPO;PHB2;HSPD1;AIFM2;SSBP1;WDR81;MTFR1;MIGA2;BNIP3L;MGME1;IMMP2L;MTM1;SLC25A36;MEF2A
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.28554788102656364,0.6427730596383835,0.8910741301059002,1.0,1.0,5/14,27.49%,NECTIN2;BCL10;PRKD2;CARD11;RELA
prerank,icosanoid biosynthetic process (GO:0046456),0.31381379306194207,0.6427298780152039,0.8766666666666667,0.9999265452085404,1.0,2/10,11.78%,LTA4H;ALOX5AP
prerank,regulation of immune response (GO:0050776),0.2075469554732964,0.6423342770707586,0.9685534591194969,0.9998818436507284,1.0,17/135,17.38%,PTPN22;CD34;FGL1;ELMOD2;CSK;COL3A1;COL1A2;IL4I1;COL1A1;AHR;NECTIN2;ITGB1;CD300LB;XIAP;N4BP1;ITGB7;CLEC2D
prerank,maturation of LSU-rRNA (GO:0000470),-0.1963794257405524,-0.6422367460588009,0.9504132231404959,0.9694492679928456,1.0,12/26,31.11%,NSA2;URB1;MAK16;LAS1L;RPL7A;PES1;SNU13;RPF2;RPF1;NHP2;ZNHIT3;DDX18
prerank,positive regulation of viral life cycle (GO:1903902),0.26692374943679076,0.6421997275154059,0.9106145251396648,0.9996054931206912,1.0,6/22,19.10%,TRIM11;VPS37B;DDB1;KPNA6;CD74;AXL
prerank,primary alcohol metabolic process (GO:0034308),0.25780145187575243,0.6417493366418294,0.9075067024128687,0.9995970204370426,1.0,3/25,8.23%,CYP1B1;RDH10;DHRS3
prerank,cellular response to ionizing radiation (GO:0071479),0.23044269858518385,0.6410806886762928,0.9314420803782506,0.9997779308641126,1.0,19/47,29.27%,CRYAB;TLK2;MAPK14;XRCC6;ATM;BLM;SPIDR;TP53;WRN;MDM2;GRB2;ATR;RHNO1;TNKS1BP1;LIG4;CDKN1A;SIRT1;NUCKS1;INTS7
prerank,double-strand break repair via break-induced replication (GO:0000727),0.29572835502443484,0.6407692075940714,0.8687782805429864,0.9996271360325278,1.0,2/12,11.00%,GINS2;MCM4
prerank,protein targeting to lysosome (GO:0006622),0.2707760803762346,0.640597833011426,0.8926630434782609,0.9993801389649252,1.0,5/20,20.44%,GNPTAB;AP4M1;RAB7A;SNX16;LAMP2
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.2412072404833428,-0.6401187976861947,0.9029126213592233,0.9698060301714332,1.0,2/13,7.10%,MMS19;ISCA1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.2027484973568622,-0.6396763771844963,0.9301470588235294,0.9690671461846062,1.0,7/24,20.51%,ERAP1;TAPBP;ACE;SAR1B;HFE;TAPBPL;FCER1G
prerank,iron-sulfur cluster assembly (GO:0016226),-0.20201833633609728,-0.6389538821036175,0.960352422907489,0.9685699038202031,1.0,10/24,27.17%,MMS19;ISCA1;LYRM4;FXN;CIAO3;ABCB7;NDOR1;CIAPIN1;GLRX5;NUBP1
prerank,regulation of viral entry into host cell (GO:0046596),0.2479487737063537,0.638533469025837,0.916010498687664,1.0,1.0,5/30,17.26%,GSN;TRIM11;MID2;NECTIN2;CD74
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.2550213331253188,0.6380616575117198,0.9134487350199734,1.0,1.0,4/26,19.48%,ST3GAL4;SCCPDH;ALG8;ALG6
prerank,polarized epithelial cell differentiation (GO:0030859),0.28444472728620895,0.6378586101761813,0.888208269525268,1.0,1.0,3/13,12.71%,MYO9A;OPHN1;SCRIB
prerank,regulation of cytokinesis (GO:0032465),0.21449060619949065,0.6372995555809442,0.9556541019955654,1.0,1.0,15/78,18.86%,KIF20B;KLHL13;SETD2;CUL3;MYO19;CDC25B;DRD2;RAB11FIP3;CALM1;CDC14A;CALM2;CHMP4C;PKN2;CENPV;SVIL
prerank,arachidonic acid secretion (GO:0050482),0.303388140827851,0.6369064207020608,0.878740157480315,1.0,1.0,2/10,13.78%,DRD2;PNPLA8
prerank,arachidonate transport (GO:1903963),0.303388140827851,0.6369064207020608,0.878740157480315,1.0,1.0,2/10,13.78%,DRD2;PNPLA8
prerank,regulation of biosynthetic process (GO:0009889),-0.24841373107966694,-0.6365988340275937,0.9393063583815029,0.9690585512855835,1.0,3/11,24.48%,SLC25A33;MID1IP1;SPHK2
prerank,cellular response to interleukin-12 (GO:0071349),0.22837269386175604,0.6364590873906432,0.948051948051948,1.0,1.0,15/48,27.00%,HNRNPDL;PLCB1;AIP;TYK2;SOD2;MTAP;HSPA9;PDCD4;TALDO1;SIRPA;BOLA2;TCP1;SNRPA1;HNRNPA2B1;RALA
prerank,negative regulation of type I interferon production (GO:0032480),0.2341386650536551,0.6358148982707933,0.9301143583227446,1.0,1.0,11/40,24.51%,PYCARD;NLRX1;PPM1B;TAX1BP1;TBK1;IRF3;PTPRS;SIRPA;CYLD;PCBP2;MAVS
prerank,establishment of vesicle localization (GO:0051650),0.2701395565449022,0.63555061156966,0.8896848137535817,1.0,1.0,6/18,22.07%,SPG11;SYT11;KIF5C;CCDC186;TESK1;LIMK2
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.206726533171782,0.6349256643916417,0.9744136460554371,1.0,1.0,19/117,22.38%,CRH;DPEP1;PTHLH;PRKAR1B;PTH2R;FYN;TSHR;MAPK14;GLP2R;PRKACA;MC5R;VIPR2;GPR45;ADCY8;YES1;ADCYAP1R1;FURIN;HRH2;INSL3
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.2943058879655935,0.6344953233434408,0.8823529411764706,1.0,1.0,4/11,16.20%,FOXM1;ING4;RPS27L;TP53
prerank,negative regulation of protein ubiquitination (GO:0031397),0.2241931390114067,0.6344751291395158,0.9397163120567376,0.9998292905434991,1.0,18/50,25.44%,UFL1;LIMK1;IVNS1ABP;BAG5;SENP2;CRY1;ABL1;N4BP1;FBXO5;DNAJA1;PARK7;TAF1;ARRB2;CAMLG;PRKCG;GNL3L;HSPA1A;SOX4
prerank,positive regulation of wound healing (GO:0090303),0.2346401998524965,0.6344207725091185,0.9334975369458128,0.9994797117358302,1.0,10/36,24.24%,ST3GAL4;CLDN1;SMOC2;ITGB1;ARFGEF1;HBEGF;KANK1;INSL3;MTOR;PRKCE
prerank,regulation of mRNA catabolic process (GO:0061013),0.20821133114573603,0.634412312859202,0.9757894736842105,0.999098725355844,1.0,24/121,20.78%,PRKCA;XPO1;PABPC1;MAPKAPK2;YWHAZ;EXOSC8;PSMB7;ZFP36L2;EXOSC2;EIF4G1;PCBP4;UPF1;KHSRP;PSMD2;UBB;PSMC1;PNPT1;PSMB2;RC3H1;PCID2;PSMD9;PSME4;PSMA8;ZFP36
prerank,protein homotetramerization (GO:0051289),0.22704815816808824,0.6341148508119837,0.9427890345649583,0.9989574294306995,1.0,10/49,21.28%,CTH;ACACA;AQP4;SOD2;ALDH1A3;GLS;RYR3;HCN1;PKD2;SSBP1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.29512709279973437,0.6329662014372466,0.8936507936507937,0.9994949518519283,1.0,1/12,2.79%,ADSS1
prerank,negative regulation of receptor internalization (GO:0002091),-0.23825506150165326,-0.6315738421866892,0.9187675070028011,0.9712383391648179,1.0,4/12,19.77%,RIN3;MTMR2;ANKRD13B;ANKRD13A
prerank,glycosphingolipid metabolic process (GO:0006687),0.23097629847467155,0.6311258963233891,0.9419753086419753,1.0,1.0,6/42,13.94%,GBA2;GM2A;ST6GALNAC6;GALC;ST8SIA1;SUMF1
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.23091620332655105,0.6307438380127572,0.9436450839328537,1.0,1.0,8/43,15.96%,MRNIP;NAE1;BRCA1;TAOK3;ORC1;TOPBP1;ATM;BLM
prerank,regulation of spindle assembly (GO:0090169),0.2510045911811551,0.6304171441916395,0.910427807486631,1.0,1.0,10/25,25.82%,GPSM2;PDCD6IP;CHMP4C;HNRNPU;RNF4;CHMP1B;DYNC1H1;CEP97;HSPA1A;CHMP4B
prerank,T cell activation involved in immune response (GO:0002286),-0.2405449948237502,-0.6303670858592061,0.9337539432176656,0.9709427245708443,1.0,5/12,30.19%,ICAM1;FCER1G;LCP1;EIF2AK4;SLC11A1
prerank,peptidyl-methionine modification (GO:0018206),0.28379968199627215,0.6298931372051363,0.8794435857805255,1.0,1.0,4/12,22.86%,NAA16;NAA15;METAP1;METAP1D
prerank,regulation of JUN kinase activity (GO:0043506),0.24034978538745888,0.629791590130933,0.9305555555555556,1.0,1.0,10/33,24.31%,PTPN22;PAK1;TAOK3;MAP3K4;DNAJA1;MAP3K11;PDCD4;DVL3;AIDA;PPEF2
prerank,DNA recombination (GO:0006310),0.23511698846037032,0.6297048072292398,0.9343065693430657,0.9997900097574587,1.0,12/37,26.31%,FBH1;XRCC3;RTEL1;RAD52;BLM;WRN;RAD50;SUPV3L1;RHNO1;RECQL;TSN;LIG4
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.24897919588910866,0.6296624842431132,0.9329032258064516,0.9994346636326296,1.0,11/27,29.10%,IRAK3;TLR1;UBB;TAB3;HSPD1;TAB2;IRAK2;IRAK1;TRAF6;TAB1;IRAK4
prerank,positive regulation of cell development (GO:0010720),0.2444043903461552,0.6293672992225228,0.9232736572890026,0.9992847147762302,1.0,3/31,6.22%,SOX11;NUMBL;RFX3
prerank,regulation of multicellular organismal development (GO:2000026),0.2523426492556468,0.6286470048237451,0.9089673913043478,0.9994563395685707,1.0,4/25,13.38%,RAB14;DUSP6;MYSM1;GATA3
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.2929871058117303,0.6284544490501675,0.889751552795031,0.9992164054546883,1.0,1/12,6.39%,B3GNT9
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.2506317936020209,0.6276113864639762,0.9131614654002713,0.9990919374838023,1.0,4/23,16.20%,BCL2;YWHAZ;PPP3CC;TP53
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.2506317936020209,0.6276113864639762,0.9131614654002713,0.9990919374838023,1.0,4/23,16.20%,BCL2;YWHAZ;PPP3CC;TP53
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.24806982814484865,0.6275596168228015,0.9381578947368421,0.9987451873544055,1.0,7/27,20.67%,SPRED2;SPRED1;SPRED3;ATM;CD74;MDM2;SNAI1
prerank,proteasomal protein catabolic process (GO:0010498),0.1974598584893761,0.6273097924123512,0.9887983706720977,0.9985497529987353,1.0,46/201,23.29%,ZFAND2B;RAD23B;PRKN;HACE1;FBXW7;SPSB4;SPOP;TRIM2;HECTD3;PELI1;UBE2K;UCHL1;RCN3;PSMB7;CUL3;FBXO45;HUWE1;NFE2L2;DDB1;CCDC47;NEDD4L;KLHL22;PSMD2;AREL1;PLAA;PSMC1;ZSWIM8;CUL4B;PSMB2;MDM2;TRIM9;PSMD9;RNF4;PCNP;PSME4;UBE2G1;DCAF11;PSMA8;RHBDD1;UBXN6;UBE2D3;ARRB2;FBXO44;SIAH1;COP1;RNF187
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.21196107538415926,0.6269097468006355,0.9538968166849616,0.9984661191483636,1.0,23/84,23.82%,PSMB7;CUL3;ANAPC7;ANAPC2;BUB1B;PSMD2;UBB;PSMC1;CDC23;ANAPC16;PSMB2;FBXO5;FBXO31;PSMD9;CDC27;PSME4;UBE2E1;PSMA8;PTTG1;ANAPC4;ANAPC5;CDC16;RB1
prerank,dendritic cell chemotaxis (GO:0002407),0.2772921433944561,0.6266592108118761,0.8903318903318903,0.9982694460908271,1.0,1/14,5.38%,CCR2
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.21319445683642962,-0.625312876123143,0.964516129032258,0.9729577515289989,1.0,2/18,6.75%,LYN;BCAR1
prerank,telomere maintenance (GO:0000723),0.22220557890965256,0.6242106795163362,0.9421686746987952,0.999791664819965,1.0,17/50,25.03%,ERCC4;STN1;RPA3;XRCC3;XRCC6;RPA2;RTEL1;ATM;BLM;TERF2IP;WRN;TPRKB;CTC1;RAD50;ACD;ATR;PRKDC
prerank,positive regulation of immune response (GO:0050778),0.21622728559828663,0.6239518485503627,0.9590443686006825,0.9995957538236748,1.0,2/64,2.73%,PYCARD;FADD
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.24866197523363412,0.6232544792808351,0.9183400267737617,0.9997430275052546,1.0,6/25,24.77%,DNAJB4;GAK;SDF2;HSPA9;ERO1A;HSPA1A
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.26339328865699735,-0.6228903472988604,0.8985915492957747,0.9733347821289646,1.0,5/10,28.16%,LYN;MAP2K1;FAS;MAP2K2;GREM1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.25629581096018095,0.6220467752058519,0.9282639885222381,1.0,1.0,6/19,26.27%,ZC3H8;ELL;RPTOR;POLR3G;MTOR;POLR3F
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.29219760215931223,0.6218257087824639,0.9203252032520325,1.0,1.0,11/11,70.80%,IL6ST;STAT3;EBI3;IL12A;STAT1;IL27RA;JAK1;STAT4;IL12RB2;JAK2;CANX
prerank,positive regulation of protein ubiquitination (GO:0031398),0.20885828397676662,0.6215488840777914,0.9766407119021134,0.999874784981531,1.0,19/80,20.66%,FBXW7;SPSB4;NSMCE3;BRCA1;CUL3;HUWE1;PRICKLE1;MALT1;NDFIP1;SENP2;CRY1;UBB;RCHY1;XIAP;FANCI;MAGEC2;UBE2L3;BCL10;PEF1
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.2559496036631887,0.6199629991849641,0.9107391910739191,1.0,1.0,2/23,4.65%,TGFB1;DSG2
prerank,activation of protein kinase A activity (GO:0034199),0.26828970392855145,0.6193286580832809,0.9174041297935103,1.0,1.0,3/16,12.70%,PRKAR1B;PRRC1;PRKACA
prerank,cardiac ventricle morphogenesis (GO:0003208),0.2301216061468079,0.6189448395610636,0.9236545682102628,1.0,1.0,8/41,17.36%,TGFB1;SOX11;TGFBR2;GATA3;BMPR1A;PKP2;HEYL;MYH6
prerank,purine-containing compound salvage (GO:0043101),0.2831717050305303,0.6189176882912447,0.9089481946624803,1.0,1.0,2/12,12.81%,ADK;DGUOK
prerank,response to peptide hormone (GO:0043434),0.2257962215345225,0.6186832472975857,0.9412484700122399,1.0,1.0,13/43,25.21%,SLC27A1;TSC1;EIF2B5;EIF6;GNAI1;CRY1;EIF2B2;STAT3;STAT5A;STAT6;ZBED3;TGFBR3;EPM2AIP1
prerank,adrenergic receptor signaling pathway (GO:0071875),0.25863701070399514,0.618550746176427,0.9185082872928176,0.9998276020315696,1.0,3/20,13.01%,AKAP13;PDE4D;DRD2
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.24033548661362797,0.6174122226976164,0.9487179487179487,0.9998938722761986,1.0,9/29,22.73%,HJURP;OIP5;RBBP4;ITGB3BP;NASP;CENPL;CENPC;RBBP7;CENPU
prerank,CENP-A containing chromatin organization (GO:0061641),0.24033548661362797,0.6174122226976164,0.9487179487179487,0.9998938722761986,1.0,9/29,22.73%,HJURP;OIP5;RBBP4;ITGB3BP;NASP;CENPL;CENPC;RBBP7;CENPU
prerank,positive regulation of protein sumoylation (GO:0033235),0.2998377530272254,0.6168340977444804,0.9041731066460588,0.9999096546704571,1.0,1/10,5.44%,UBA2
prerank,regulation of mRNA stability (GO:0043488),0.19936458219420203,0.6154617494320128,0.988421052631579,1.0,1.0,34/145,22.68%,PRKCA;XPO1;PABPC1;MAPKAPK2;YWHAZ;METTL3;EXOSC8;PSMB7;ZFP36L2;EXOSC2;EIF4G1;GDNF;PCBP4;KHSRP;PSMD2;UBB;EIF4ENIF1;PSMC1;HNRNPU;PSMB2;RC3H1;PCID2;FUS;PSMD9;GIGYF2;TENT5A;TENT5D;PSME4;PSMA8;ZFP36;VIM;TENT5C;RIDA;EXOSC3
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.25320080276932966,0.6147079959938945,0.9135802469135802,1.0,1.0,6/21,22.33%,MED13;MED12;MED30;JUN;MITF;MED24
prerank,regulation of cholesterol transport (GO:0032374),0.2511727345283589,0.6141545416653905,0.9246088193456614,1.0,1.0,4/20,20.84%,LRP1;ABCA5;TSPO;NFKB1
prerank,regulation of chromosome segregation (GO:0051983),-0.21760116673107643,-0.6135532342108594,0.9601328903654485,0.9776390977771919,1.0,9/16,43.67%,NUMA1;RAD18;RMI2;SMC6;MKI67;CDC6;BUB1;IHO1;KIF2C
prerank,positive regulation of cell division (GO:0051781),0.22975388889980045,0.613025038159617,0.9459119496855346,1.0,1.0,8/38,18.86%,KIF20B;CUL3;CDC25B;DRD2;CDC14A;PKN2;CENPV;SVIL
prerank,mucosal immune response (GO:0002385),0.2724089640515116,0.6126343127939727,0.9142441860465116,1.0,1.0,1/15,6.23%,OTUD7B
prerank,histone ubiquitination (GO:0016574),0.2525522564473167,0.6094110526405736,0.9340659340659341,1.0,1.0,4/21,20.20%,WAC;HUWE1;CDC73;UBE2E1
prerank,mitochondrial transcription (GO:0006390),0.29150143943743023,0.6088880431556476,0.9050535987748851,1.0,1.0,3/10,21.18%,TFAM;POLRMT;MTERF2
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.21979078012049105,0.6083948975821791,0.9727164887307236,1.0,1.0,14/46,27.00%,HNRNPDL;PLCB1;AIP;TYK2;SOD2;MTAP;HSPA9;PDCD4;TALDO1;BOLA2;TCP1;SNRPA1;HNRNPA2B1;RALA
prerank,regulation of cell aging (GO:0090342),0.28492184977749035,0.6077707339899993,0.9173419773095624,1.0,1.0,3/11,16.26%,FOXM1;LMNA;PNPT1
prerank,cardiac cell development (GO:0055006),0.28529320856495655,0.6067548559338263,0.9062980030721967,1.0,1.0,1/11,3.17%,VEGFA
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.21402733313505207,0.606663028043829,0.9563679245283019,1.0,1.0,5/49,11.06%,CRLF1;VEGFA;IL18;ERBB4;IL6ST
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.2822380317511718,0.606592112488663,0.8944099378881988,1.0,1.0,2/10,11.10%,MYO9A;OPHN1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.25031767186667847,0.6061970244917679,0.9282758620689655,1.0,1.0,5/21,17.44%,ZWINT;BUB1B;KLHL22;ATM;FBXO5
prerank,gene expression (GO:0010467),0.18847369596500474,0.6059004171832224,0.9989949748743718,1.0,1.0,78/348,22.77%,BICD1;DHX8;MRPS18A;THOC6;ELAVL4;RANBP2;TSPAN32;RPL23A;RNGTT;HOXD3;POLR2B;MRPL32;NUP155;XRN2;FARSB;SRBD1;DDX54;SRSF11;MCM3AP;APOBEC1;POLR2K;LMF1;CASC3;ALKBH5;NCBP1;FIP1L1;EIF4G1;MRPL35;ADARB2;DUSP11;NDC1;NUP205;TSPAN17;GSPT2;NUP160;MRPL28;SNRNP40;UPF1;DDX25;EPC1;ADARB1;NXT1;HARS1;POLR2G;SRSF6;NOVA1;YTHDC1;MRPL51;SMG6;POM121;HNRNPU;AAAS;NXF1;RPSA;ABCF1;RNPS1;MLF1;SYNCRIP;THOC7;POLR2A;HNRNPUL1;SRRM1;MRPS14;RBMS1;FUBP3;HSPD1;BCL3;HNRNPL;MRPS6;HARS2;FYTTD1;SRSF3;MRPL52;RPS11;GLE1;NUP42;SYMPK;MRPL18
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.27893890531721827,0.6054114763716919,0.9054878048780488,1.0,1.0,2/12,12.65%,GSS;GGCT
prerank,regulation of protein ubiquitination (GO:0031396),0.19657676595804177,0.6040739139481611,0.9893048128342246,1.0,1.0,36/108,26.69%,PRKN;FBXW7;NSMCE3;UFL1;IVNS1ABP;BAG5;BRCA1;CUL3;HUWE1;PRICKLE1;MALT1;NDFIP1;SENP2;CRY1;WASHC1;UBB;RCHY1;XIAP;FANCI;N4BP1;DNAJA1;PARK7;UBE2L3;BCL10;ARRB2;UBQLN1;CAMLG;PRKCG;GNL3L;HSPA1A;MYCBP2;SOX4;CDK5RAP3;CENPX;PER2;PTTG1IP
prerank,regulation of secretion by cell (GO:1903530),0.21302770225930076,0.6038440825718383,0.9584323040380047,1.0,1.0,14/54,22.57%,SYT1;RAB21;RAB3D;SYN1;MCTP1;RIMS1;STXBP5;RAB3A;RIMS2;RAB3B;ARFIP1;DISP1;LLGL1;P3H1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.2415187566000431,0.6023812261386341,0.9339498018494056,1.0,1.0,11/26,28.10%,ALPK1;UBB;TAB3;AAMP;TAB2;CYLD;IRAK2;MAP2K6;IRAK1;TRAF6;TAB1
prerank,acute inflammatory response (GO:0002526),0.23994744279089586,0.6007449367213545,0.9384615384615385,1.0,1.0,1/23,3.49%,ANO6
prerank,regulation of amyloid fibril formation (GO:1905906),0.2665210287324449,0.5992925632731734,0.9314685314685315,1.0,1.0,2/15,9.21%,PSEN1;CRYAB
prerank,regulation of centrosome cycle (GO:0046605),-0.19396381382993366,-0.599189238072831,0.9691119691119691,0.984029998590674,1.0,3/21,9.92%,CHMP3;NPM1;CHMP1A
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.2376426586157686,0.5989339301387123,0.9345794392523364,1.0,1.0,5/26,18.64%,SLC5A3;SNCA;ABCD2;TRAP1;PARK7
prerank,regulation of organelle organization (GO:0033043),0.20223304488454918,0.598806528720065,0.9812154696132597,1.0,1.0,19/80,21.84%,PRKN;PARL;VPS11;RHOT2;SYT11;CAPN6;CLEC16A;TMEM33;MAPK1;USP6NL;ZEB2;RBSN;SURF4;CENPV;RHOT1;RDX;MYO5A;LMAN1;TAOK1
prerank,cholesterol efflux (GO:0033344),0.24389387398628606,0.598257181402774,0.9241379310344827,1.0,1.0,3/20,16.45%,NPC1;ABCA5;ABCG4
prerank,defense response to Gram-negative bacterium (GO:0050829),0.22295105558689865,0.5979662249388843,0.9568965517241379,1.0,1.0,2/42,4.00%,PYCARD;RNASE6
prerank,high-density lipoprotein particle assembly (GO:0034380),0.29080793794141113,0.597645416805593,0.9248366013071896,1.0,1.0,2/10,12.70%,ZDHHC8;PRKACA
prerank,negative regulation of cell cycle (GO:0045786),0.20400715500605107,0.5975183149012155,0.9756637168141593,1.0,1.0,20/73,23.82%,PTEN;TGFB1;NUPR2;CDK6;MEN1;BMP7;SCRIB;GATA3;RPS6KA2;NPPC;RNF167;NUDT6;IPO5;TRIM35;PDCD4;DUSP1;HECA;NR2F2;BMP2;RB1
prerank,ncRNA catabolic process (GO:0034661),0.23496573274444765,0.5971935371955941,0.9463350785340314,1.0,1.0,5/28,16.16%,EXOSC8;TUT4;EXOSC2;RBM7;POP1
prerank,negative regulation of transposition (GO:0010529),0.2601934593363785,0.5953424719768887,0.9321074964639321,1.0,1.0,2/16,9.47%,TUT4;TEX15
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.27370357607037055,0.5952407253896084,0.9276923076923077,1.0,1.0,1/13,6.39%,B3GNT9
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.23949246515244038,0.5951693718284198,0.9458333333333333,1.0,1.0,2/26,8.39%,IRAK3;PPM1B
prerank,mitotic recombination (GO:0006312),0.26178479920820913,0.5945990774922651,0.9289855072463769,1.0,1.0,4/15,22.82%,XRCC3;RAD52;TPRKB;RAD50
prerank,renal water homeostasis (GO:0003091),0.239436831195322,0.5938256203751641,0.9465020576131687,1.0,1.0,3/23,12.70%,PRKAR1B;AQP4;PRKACA
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.2189421581674204,-0.5925336277765353,0.9504643962848297,0.9861334395649421,1.0,7/14,33.86%,TSEN15;ZBTB8OS;CPSF4;CLP1;TSEN54;TRPT1;CSTF2
prerank,autophagosome organization (GO:1905037),0.20813462162071375,0.5909665597124732,0.9711538461538461,1.0,1.0,14/50,25.20%,PACS2;WIPI1;ATG5;RAB1A;ATG3;GABARAPL2;RAB7A;VMP1;UBQLN1;TMEM41B;UBQLN2;EMC6;WDR45B;ATG12
prerank,regulation of cell cycle phase transition (GO:1901987),0.19676396408219277,0.5907691386895028,0.9836423118865867,1.0,1.0,33/91,29.67%,FBXW7;PSMB7;ANAPC7;ANAPC2;DDB1;BUB1B;PSMD2;PSMC1;CDC23;TP53;ANAPC16;PSMB2;FBXO5;PSMD9;TAF1;DBF4;CDC27;PSME4;UBE2E1;PSMA8;ANAPC4;ANAPC5;CDC16;CUL1;PSMD8;PSMD13;CDKN1A;TRIM39;PSMD4;UBE2S;CDKN1B;PSMD5;ATP2B4
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.2562236161551645,0.5904023679317015,0.929745889387145,1.0,1.0,2/15,11.36%,ABCA5;LIPC
prerank,leukocyte tethering or rolling (GO:0050901),-0.2013080952492167,-0.590102065072641,0.9691358024691358,0.9861999110931434,1.0,1/17,1.75%,ROCK1
prerank,tRNA metabolic process (GO:0006399),0.2568793419934856,0.5897665641429047,0.9437229437229437,1.0,1.0,7/17,24.48%,FARS2;POP1;RPP21;SSB;DTD1;RPP30;DARS2
prerank,positive regulation of mitochondrial translation (GO:0070131),0.26642173482271037,0.5896273926290819,0.9209370424597365,1.0,1.0,2/14,12.19%,NGRN;RCC1L
prerank,negative regulation of insulin secretion (GO:0046676),0.2564185188374819,0.5895915235906104,0.9340974212034384,1.0,1.0,1/17,2.42%,PRKN
prerank,ncRNA metabolic process (GO:0034660),0.21844105735236932,0.5886466487793935,0.9553349875930521,1.0,1.0,9/37,23.55%,FKBP6;TUT4;KHSRP;NIFK;MEPCE;DTD1;TDRKH;DDX4;XPO5
prerank,pancreas development (GO:0031016),0.2733731758122116,0.5881432724565535,0.9085173501577287,1.0,1.0,1/12,3.01%,CCDC39
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.19911219682349576,0.5878958606832981,0.9834254143646409,1.0,1.0,15/72,17.91%,FOXM1;ATRX;CARM1;PCBP4;PRMT1;ING4;CNOT3;MDM4;ATM;CASP2;CRADD;RPS27L;TP53;BATF;MDM2
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.2684075073755571,0.5867071700952796,0.912106135986733,1.0,1.0,11/11,73.18%,SELENOS;AXL;MERTK;CCR7;CXCL12;LILRB1;IRF7;GAS6;HCLS1;NOD2;CCL19
prerank,bile acid biosynthetic process (GO:0006699),0.23165377013397864,0.5867053603741603,0.9566360052562418,1.0,1.0,8/24,25.24%,CYP39A1;CYP7B1;CYP27A1;OSBPL1A;ACOT8;SCP2;HSD17B4;AMACR
prerank,negative regulation of cell cycle process (GO:0010948),0.2056074202526709,0.5861257289102075,0.9746543778801844,1.0,1.0,18/61,27.49%,EED;APAF1;E2F6;BRCA1;AURKAIP1;BMP7;EPC1;RBBP4;CHMP4C;FBXO5;RBBP7;CBX5;RNF2;CBX3;EHMT2;RBBP8;EZH2;NME6
prerank,protein deacylation (GO:0035601),0.2359166909984635,0.5857913363835557,0.946236559139785,1.0,1.0,5/23,17.67%,LYPLA1;HDAC6;SIRT6;LYPLA2;ABHD10
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.23731092359333647,0.5847326472433767,0.9375830013280213,1.0,1.0,2/23,8.04%,LTA4H;ELOVL6
prerank,negative regulation of peptidase activity (GO:0010466),0.2095366874795573,0.5841941822594447,0.9677047289504037,1.0,1.0,3/47,7.57%,LRP1;CSTB;SERPINE2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.20629176967550533,0.5835998606004166,0.965962441314554,1.0,1.0,10/54,17.91%,CARM1;PCBP4;PRMT1;CNOT3;MDM4;ATM;CASP2;CRADD;TP53;MDM2
prerank,protein catabolic process (GO:0030163),0.20542526946508177,0.5829009404399902,0.9670454545454545,1.0,1.0,17/59,24.09%,PRKN;FBXO27;UCHL3;FBXO17;DDB1;CUL4B;RIPK1;MAGEC2;UBE2G1;LAMP2;PSMA8;FBXO44;CLN6;SIAH1;OGA;TPP1;MTOR
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.2376641459303797,0.5827729140108442,0.9418282548476454,1.0,1.0,1/23,1.72%,RHO
prerank,protein acylation (GO:0043543),0.2178129207744461,0.5827454622920293,0.969173859432799,1.0,1.0,5/38,12.08%,KAT2B;GTF2B;ZDHHC8;ING4;HHAT
prerank,cristae formation (GO:0042407),0.23120978662286198,0.5822460838579927,0.9389920424403183,1.0,1.0,10/27,27.84%,LETM1;APOOL;ATP5MG;DMAC2L;CHCHD6;ATP5PO;ATP5MC2;ATP5PF;ATP5ME;ATP5F1B
prerank,negative regulation of defense response to virus (GO:0050687),0.27276611006296225,0.5817024271639563,0.9207317073170732,1.0,1.0,1/10,8.39%,PPM1B
prerank,mitotic spindle assembly (GO:0090307),0.21444607848735298,0.5813753810143723,0.966501240694789,1.0,1.0,11/42,24.30%,ARHGEF10;STAG2;FLNA;CLASP1;KPNB1;AAAS;KIF2A;BCCIP;SMC1A;WRAP73;KIFC2
prerank,negative regulation of inclusion body assembly (GO:0090084),0.27385136831534024,0.5809530467670442,0.9152542372881356,1.0,1.0,10/10,72.63%,DNAJB6;HSPA1A;DNAJB2;SACS;DNAJB8;DNAJA4;HSPA2;SORL1;HSPA1B;DNAJB1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.20812202877428676,0.5802479764590975,0.9685990338164251,1.0,1.0,18/46,29.02%,FBXO7;TOMM22;AIP;TOMM20;GDAP1;DNAJC19;AIFM1;PAM16;HK2;TSPO;HSPD1;HK1;CHCHD4;TIMM13;RALA;TOMM34;TIMM50;FIS1
prerank,thyroid hormone generation (GO:0006590),0.2807172808240316,0.5800917728513529,0.919431279620853,1.0,1.0,1/10,6.67%,CTSK
prerank,regulation of spindle organization (GO:0090224),0.24420293925775502,0.5797362773685802,0.9384615384615385,1.0,1.0,5/18,25.47%,GPSM2;GNAI1;RNF4;DYNC1H1;RAE1
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.2612901320304829,0.5794288781334649,0.9276218611521418,1.0,1.0,1/13,6.42%,TGFBR2
prerank,glutathione metabolic process (GO:0006749),0.21615512463165207,0.5791084779526053,0.9682151589242054,1.0,1.0,6/38,18.64%,DPEP1;GSS;GGCT;GSTZ1;GSTT1;PARK7
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.19399327826646398,0.5789002263912155,0.991140642303433,1.0,1.0,18/88,20.59%,FBXW7;FBXO38;FBXL15;FBXL16;PSMB7;FBXO27;FBXO17;FBXL2;PSMD2;PSMC1;FBXL4;CUL4B;PSMB2;FBXO31;PSMD9;FBXL12;PSME4;PSMA8
prerank,negative regulation of mitochondrion organization (GO:0010823),0.22245093755361817,0.5778753479856442,0.973384030418251,1.0,1.0,8/33,18.77%,PRKN;BNIP3;HUWE1;OPA1;FZD9;MPV17L;ADCK1;ACAA2
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.20744139481473844,0.5768529475951054,0.9774346793349169,1.0,1.0,7/45,14.17%,TGFB1;AURKAIP1;ZFP36L2;BMP7;SCRIB;ZWINT;BUB1B
prerank,negative regulation of biosynthetic process (GO:0009890),0.24817562550418215,0.5761335611878508,0.948948948948949,1.0,1.0,4/16,18.64%,ASXL3;ABCD2;TRAP1;PARK7
prerank,glycine metabolic process (GO:0006544),0.2624230730428596,0.5761290421627785,0.928462709284627,1.0,1.0,3/12,22.65%,AMT;GLYAT;RIDA
prerank,error-free translesion synthesis (GO:0070987),0.23709504473006665,0.5760185733434657,0.9552845528455285,1.0,1.0,5/22,17.19%,RPA3;RPA2;UBB;RCHY1;REV1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.26681853301515757,0.5752446540748349,0.9390243902439024,1.0,1.0,2/12,15.44%,MTTP;ACSL3
prerank,regulation of lipid kinase activity (GO:0043550),-0.22662465294832157,-0.5745346052246472,0.9502923976608187,0.9916322822348529,1.0,1/11,1.89%,PIK3R3
prerank,innate immune response (GO:0045087),0.18053099989103852,0.5739941185673805,0.9989878542510121,1.0,1.0,39/217,24.53%,CXCL10;KYNU;ALPK1;RNASE6;NCF1;ANKHD1;CARD9;TRIM11;OTULIN;FYN;SETD2;NCF2;STYK1;MID2;TBK1;MALT1;SNCA;CLPB;CD300LB;PYDC1;AKAP1;LBP;CD74;CHUK;MASP2;PPARG;TRIM35;BCL10;PHB2;YES1;RARRES2;PJA2;CR2;RNF187;CYLD;RPL39;MAVS;HCK;TRIM14
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.27293054384255755,0.5731888469605608,0.9377845220030349,1.0,1.0,2/11,10.93%,EXOSC2;FBL
prerank,negative regulation of glycolytic process (GO:0045820),-0.2268082368820667,-0.5731073934437122,0.9431524547803618,0.9900971140344876,1.0,3/10,18.02%,NUPR1;HDAC4;GIT1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.2268082368820667,-0.5731073934437122,0.9431524547803618,0.9900971140344876,1.0,3/10,18.02%,NUPR1;HDAC4;GIT1
prerank,heart contraction (GO:0060047),0.21227941645274123,0.5729661549659716,0.9710843373493976,1.0,1.0,3/41,6.02%,SGCD;SCN5A;SGCZ
prerank,positive regulation of cellular senescence (GO:2000774),0.27512119536828616,0.5722583252999751,0.926791277258567,1.0,1.0,2/10,14.96%,YPEL3;CGAS
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.186918132560371,0.5709708439421427,0.9913700107874865,1.0,1.0,32/104,28.14%,PAK1;CARD9;FYN;PSMB7;PRKACA;MALT1;PSMD2;MUC3B;MUC3A;PSMC1;CHUK;PSMB2;PSMD9;NRAS;KRAS;TAB3;PSME4;BCL10;PSMA8;NFKB1;CARD11;TAB2;CUL1;PAK3;RAF1;PSMD8;PSMD13;SYK;RELA;TRAF6;TAB1;PSMD4
prerank,cellular response to lectin (GO:1990858),0.186918132560371,0.5709708439421427,0.9913700107874865,1.0,1.0,32/104,28.14%,PAK1;CARD9;FYN;PSMB7;PRKACA;MALT1;PSMD2;MUC3B;MUC3A;PSMC1;CHUK;PSMB2;PSMD9;NRAS;KRAS;TAB3;PSME4;BCL10;PSMA8;NFKB1;CARD11;TAB2;CUL1;PAK3;RAF1;PSMD8;PSMD13;SYK;RELA;TRAF6;TAB1;PSMD4
prerank,signal transduction by p53 class mediator (GO:0072331),0.21974086424318215,0.5689647980423911,0.9612903225806452,1.0,1.0,6/30,17.89%,PYCARD;ATRX;HINT1;MDM4;TP53;BATF
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.16071975238153868,-0.5684217864256935,1.0,0.9908194399041081,1.0,12/32,32.49%,POLA1;TFDP2;ID2;PCNA;NPAT;ZPR1;E2F1;KLF11;CDC45;E2F7;CDK18;CDK14
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.18588618148838573,0.5668421825844565,0.9945945945945946,1.0,1.0,32/105,28.14%,PAK1;CARD9;FYN;PSMB7;PRKACA;MALT1;PSMD2;MUC3B;MUC3A;PSMC1;CHUK;PSMB2;PSMD9;NRAS;KRAS;TAB3;PSME4;BCL10;PSMA8;NFKB1;CARD11;TAB2;CUL1;PAK3;RAF1;PSMD8;PSMD13;SYK;RELA;TRAF6;TAB1;PSMD4
prerank,positive regulation of exosomal secretion (GO:1903543),0.24826118860665589,0.5663667334168139,0.9472934472934473,1.0,1.0,3/15,17.68%,SDC4;PDCD6IP;RAB7A
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.21756881530699687,0.56555477585341,0.9672774869109948,1.0,1.0,5/32,16.20%,PYCARD;HINT1;AEN;RPS27L;TP53
prerank,regulation of lipid catabolic process (GO:0050994),0.23911956999029682,0.563317858872486,0.941747572815534,1.0,1.0,4/19,22.01%,PDE3B;TYSND1;RARRES2;PRKAA1
prerank,response to prostaglandin E (GO:0034695),0.26839066030630176,0.5632595149223011,0.9559543230016313,1.0,1.0,10/10,73.18%,TGFBR3;ADCY6;GNG2;PTGER4;TNFSF4;CCR7;PTGER2;SFRP1;GNB1;CCL19
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.2229200416590693,0.562946331567551,0.9650259067357513,1.0,1.0,9/25,25.82%,LAPTM4B;MVB12A;TMEM50B;CHMP4C;DENND10;CHMP1B;UBXN6;CHMP4A;CHMP4B
prerank,protein localization to microtubule organizing center (GO:1905508),0.24604989179132364,0.5623053230343888,0.9530791788856305,1.0,1.0,2/15,11.39%,PCM1;SNX10
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.20292370958453035,-0.5620589102100504,0.9682539682539683,0.9920180740778923,1.0,7/15,32.52%,ATL2;ZFYVE27;REEP1;RAB10;REEP2;REEP4;TMEM170A
prerank,cellular defense response (GO:0006968),0.20750886032467195,0.5615843628009378,0.9784263959390863,1.0,1.0,5/40,17.12%,NCF1;IL1RL2;NCF2;ITGB1;LBP
prerank,acylglycerol metabolic process (GO:0006639),0.20868903240721973,0.5611847496153455,0.9673776662484316,1.0,1.0,14/37,28.90%,LMF1;DGKI;PLAAT3;LYPLA2;ABHD6;DGAT2;DGKA;DGKK;PGS1;GK;DGKD;SEL1L;DGKZ;DGKQ
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.23095224730146724,0.5608175381098597,0.9596662030598053,1.0,1.0,5/22,20.59%,PSMB7;NFE2L2;PSMB2;PSME4;PSMA8
prerank,regulation of myoblast fusion (GO:1901739),0.2598791912600806,0.5607533760711114,0.9320987654320988,1.0,1.0,2/11,14.63%,MAPK14;EHD2
prerank,macromolecule catabolic process (GO:0009057),0.22277650901001367,0.5599105846815144,0.9574468085106383,1.0,1.0,7/26,24.09%,TGFB1;UCHL3;MVB12A;CLN6;SIAH1;TPP1;MTOR
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.21427198473407122,0.5597073295735708,0.9657360406091371,1.0,1.0,8/32,21.84%,MRNIP;BRCA1;TAOK3;TOPBP1;ATM;BLM;RINT1;TAOK1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.26940529985507866,0.5582844978459657,0.9324116743471582,1.0,1.0,3/10,21.28%,ATRX;DBF4;SSBP1
prerank,modulation by host of symbiont process (GO:0051851),0.21383339565713513,0.5576792822449413,0.9627249357326478,1.0,1.0,4/31,11.45%,CCL4;CARD9;SP1;TAF11
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.21844861730044496,0.5574704772229233,0.9723618090452262,1.0,1.0,12/30,30.12%,ACKR3;RTEL1;CD74;FBXO5;MDM2;SNAI1;THOC5;PTTG1IP;SIRT1;CDKN2D;BCL2L1;TMEM161A
prerank,positive regulation of lipid storage (GO:0010884),0.2316078952324219,0.5572665943675309,0.9679572763684913,0.9998335995793849,1.0,1/21,3.81%,PLIN3
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.23085971616155204,0.5571382697322558,0.9528432732316228,0.9987765089325954,1.0,4/20,15.05%,ZWINT;BUB1B;KLHL22;ATM
prerank,spindle assembly checkpoint signaling (GO:0071173),0.23085971616155204,0.5571382697322558,0.9528432732316228,0.9987765089325954,1.0,4/20,15.05%,ZWINT;BUB1B;KLHL22;ATM
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.23085971616155204,0.5571382697322558,0.9528432732316228,0.9987765089325954,1.0,4/20,15.05%,ZWINT;BUB1B;KLHL22;ATM
prerank,response to UV-B (GO:0010224),-0.20845930440853777,-0.5567011050400459,0.9703264094955489,0.992789449866056,1.0,5/12,29.46%,MFAP4;HYAL2;STK11;MSH2;MME
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.21980888127775694,0.5566757413666252,0.9581151832460733,0.9986067926416408,1.0,7/26,24.56%,THADA;DRD2;CALM1;CALM2;PKD2;UBQLN1;FMR1
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.23023074407667707,0.5563060660920448,0.9731638418079096,0.9983966257007766,1.0,8/22,24.92%,VEGFA;CALM1;RASSF2;CALM2;RAP2A;RAD50;RAP2C;TNKS1BP1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.22304049552527183,0.5549448212688284,0.9637305699481865,0.998599409664348,1.0,2/25,4.42%,TGFB1;SOX11
prerank,cellular response to ketone (GO:1901655),0.20428888504172293,0.5527186464375794,0.9776674937965261,0.9991612209898112,1.0,6/35,20.48%,PTGFR;GNAI1;AHR;KLF9;PCK2;ADCY8
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.23530206692773334,0.5525290460664506,0.9515418502202643,0.9988700192345602,1.0,1/18,3.91%,FBXW7
prerank,positive regulation of phagocytosis (GO:0050766),0.20228781259401368,0.552161460510616,0.9786223277909739,0.9986500268356905,1.0,2/47,3.49%,PYCARD;ANO6
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.23549720291692422,0.5515177909679058,0.958041958041958,0.9985398740175707,1.0,3/16,15.45%,VPS36;TMEM50B;CHMP4C
prerank,sensory perception of chemical stimulus (GO:0007606),0.23763300018700032,0.55088459049606,0.9578488372093024,0.9984423428528669,1.0,5/15,29.14%,DRD2;SLC24A4;UBR3;BBS4;GNAL
prerank,regulation of microtubule nucleation (GO:0010968),0.26101159977091926,0.550023772035222,0.9535256410256411,0.998419380093173,1.0,2/10,13.04%,PAK1;CKAP5
prerank,primary miRNA processing (GO:0031053),0.26123601005396674,0.549490138235059,0.9503875968992248,0.9982732746966944,1.0,1/10,6.31%,METTL3
prerank,phosphate ion transmembrane transport (GO:0035435),0.2538350021260117,0.5494273267959338,0.9535603715170279,0.9979325853892853,1.0,4/12,22.34%,SLC25A10;XPR1;SLC25A11;SLC20A1
prerank,macrophage activation involved in immune response (GO:0002281),0.25184079346023003,0.548578942908645,0.9385964912280702,0.9979112676553242,1.0,3/13,17.51%,GRN;LBP;DYSF
prerank,regulation of mitotic spindle organization (GO:0060236),0.20683052954471207,0.5463497088623321,0.9786163522012579,0.998416032240062,1.0,11/35,25.82%,GPSM2;GNAI1;PDCD6IP;CHMP4C;HNRNPU;CHMP1B;DYNC1H1;CEP97;HSPA1A;RAE1;CHMP4B
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.1951474443859886,-0.5456607537848123,0.9871794871794872,0.9951813207872034,1.0,6/15,30.02%,CAMK1;FLOT1;CD53;RIPOR2;TYROBP;EHD1
prerank,gluconeogenesis (GO:0006094),0.20416321312718513,0.5455378190519212,0.9778869778869779,0.9983645221956826,1.0,7/39,20.64%,PGM1;GOT2;SLC25A10;CRY1;SLC25A11;PCK2;PFKFB1
prerank,mitotic nuclear division (GO:0140014),0.18659492671397068,0.5454157646926646,0.9920273348519362,0.9980528914721306,1.0,13/71,20.09%,ARHGEF10;NDE1;STAG2;FLNA;CLASP1;SGO1;ZWINT;KPNB1;KLHL22;AAAS;SMC4;KIF2A;BCCIP
prerank,positive regulation of heart rate (GO:0010460),-0.1919704787709618,-0.545040628847445,0.9697986577181208,0.9943080579960056,1.0,2/17,6.44%,ADRA1B;TPM1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.2473321532105982,0.5449187218481568,0.9487554904831625,0.9978597336821399,1.0,2/13,13.01%,CCR2;DRD2
prerank,inorganic ion transmembrane transport (GO:0098660),-0.21042059008160702,-0.5431959066428143,0.9768115942028985,0.9938122522872541,1.0,12/12,78.98%,ABCC9;KCNJ8;PKD2L1;ABCC8;P2RX3;KCNJ11;RHAG;ATP1B4;ASIC2;TRPM4;CACNA1H;PKD2
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.1812488552542485,0.5425690757821415,0.9967320261437909,0.9984041239439069,1.0,23/88,26.88%,EPRS1;EIF2AK3;CSTB;TSC1;SERPINE2;CPEB3;HDAC6;ATRAID;PUS7;EIF4ENIF1;SYNCRIP;GIGYF2;PLAT;NFKB1;DDX6;RIDA;PAIP2B;FMR1;EIF2AK2;RBM4;DAPK3;CDK5RAP3;PAIP2
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.23082506529332703,0.5422006480918743,0.9539748953974896,0.9981827788411108,1.0,3/18,11.00%,POLE3;GINS2;MCM4
prerank,organelle fusion (GO:0048284),0.22431194113395714,0.5419237231210088,0.9690140845070423,0.9979194906645301,1.0,7/22,29.02%,VPS11;OPA1;GDAP1;MIGA2;VPS18;EEA1;FIS1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.18304928083903196,0.5418612308442265,0.9955106621773289,0.9975675778428188,1.0,13/76,20.69%,PTPN22;EGFR;TRIM44;PPM1B;TRIP6;BMP7;RTKN2;RASSF2;TERF2IP;CPNE1;PDCD4;PHB2;BCL3
prerank,regulation of response to stress (GO:0080134),-0.22357770538759192,-0.5416318087962324,0.9646739130434783,0.9932071595555721,1.0,5/10,29.25%,OPRM1;SLC38A2;STOX1;MLC1;CORO2B
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.18586870082789567,0.541301207948835,0.9943117178612059,0.997410611980046,1.0,13/70,20.94%,SNAP23;NCF1;PSMB7;LNPEP;NCF2;PSMD2;PSMC1;CHUK;PSMB2;PSMD9;PSME4;PSMA8;TAP1
prerank,negative regulation of cyclase activity (GO:0031280),0.24309402844776468,0.5403128369458525,0.9532163742690059,0.9974006147344772,1.0,2/14,13.01%,CCR2;DRD2
prerank,regulation of DNA damage checkpoint (GO:2000001),0.25710188814505236,0.5402453117275371,0.959375,0.9970613963499748,1.0,2/10,14.48%,RPA2;CRY1
prerank,cAMP metabolic process (GO:0046058),0.24644183584063012,0.5398086565336415,0.9470499243570348,0.9968559940264554,1.0,2/13,12.27%,PTHLH;PDE4D
prerank,regulation of membrane depolarization (GO:0003254),0.22787682051324337,0.5396925140097646,0.9641319942611191,0.9965275511150139,1.0,2/18,14.43%,SCN5A;NEDD4L
prerank,kinetochore organization (GO:0051383),0.2444131153118503,0.5374881013110391,0.9573529411764706,0.996937160907815,1.0,3/13,19.78%,POGZ;NUF2;CENPC
prerank,response to purine-containing compound (GO:0014074),-0.18435703373808235,-0.5361854417363552,0.9792387543252595,0.9936654882418106,1.0,4/17,25.36%,ABCC9;TRPC3;TRPM2;VGF
prerank,positive regulation of type 2 immune response (GO:0002830),-0.1963760359678559,-0.5339329725452719,0.9763313609467456,0.9932365559723424,1.0,5/14,26.92%,PRKCZ;CD86;RARA;RSAD2;NOD2
prerank,phosphate ion transport (GO:0006817),0.2301521687224931,0.5333318961097742,0.9756795422031473,0.9979989767654827,1.0,4/16,22.34%,SLC25A10;XPR1;SLC25A11;SLC20A1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.18956423458495544,-0.5318937558198823,0.9773462783171522,0.9927744929064598,1.0,16/16,81.07%,UPB1;NT5M;DPYSL5;NT5C1A;UPP1;DPYS;DPYSL4;CRMP1;DPYSL3;UPP2;DPYSL2;NT5E;NT5C3A;TET2;DPYD;NT5C
prerank,regulation of mitochondrial translation (GO:0070129),0.22154467443543474,0.5310796464259602,0.9655172413793104,0.9983679112815506,1.0,3/21,12.19%,NGRN;MTG1;RCC1L
prerank,cellular response to purine-containing compound (GO:0071415),0.25349636854893187,0.5300988595766767,0.9684044233807267,0.9983312792915515,1.0,2/10,19.21%,P2RY1;RYR3
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.23162215011382625,0.5292172101058673,0.9655172413793104,0.9982434978253562,1.0,2/15,9.70%,MLXIPL;ELOVL5
prerank,mRNA methylation (GO:0080009),-0.19308690165675693,-0.5290924702395124,0.978328173374613,0.9924707979464149,1.0,2/15,6.68%,WTAP;METTL14
prerank,rRNA transcription (GO:0009303),0.2241370859156832,0.5287159132753743,0.967741935483871,0.9980399657165216,1.0,4/17,17.95%,SPIN1;GTF3C1;NIFK;POLR1G
prerank,tetrahydrofolate metabolic process (GO:0046653),0.2524211483738172,0.5285607756470938,0.9513343799058085,0.9977176142676515,1.0,1/10,11.76%,MTHFD2L
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.1761052252837735,0.5284233702164702,0.9967105263157895,0.9973905294020704,1.0,16/86,21.29%,VEGFA;MAPK7;PSMB7;HIF1A;NFE2L2;PSMD2;UBB;GCN1;PSMC1;TP53;PSMB2;ELOC;PSMD9;PSME4;PSMA8;LIMD1
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.2505044552983924,0.5275634023714332,0.9593373493975904,0.9972872526892026,1.0,5/10,26.91%,GABRG2;GABRA3;GABRA2;GABRG3;GABRA4
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.2551083111265223,0.5274266186470651,0.9649390243902439,0.996968015064715,1.0,3/10,26.44%,DERL2;ERLEC1;UBE2J1
prerank,nuclear pore organization (GO:0006999),0.23343607257647866,0.5271695823761731,0.9586523736600306,0.9966819902113028,1.0,5/14,25.34%,NDC1;NUP205;RTN4;AHCTF1;NUP35
prerank,regulation of DNA metabolic process (GO:0051052),0.19344449090829127,0.5263541611635943,0.98531211750306,0.9965549820231968,1.0,16/44,30.39%,MYC;UPF1;KPNA1;SMG6;TERF2IP;USP1;WRNIP1;CDK9;MPHOSPH8;KAT7;WDR18;SMG1;MPV17;NUCKS1;HNRNPD;UBE2V1
prerank,cell cycle checkpoint signaling (GO:0000075),0.23639961803792742,0.526180438289472,0.9622356495468278,0.9962349460396253,1.0,2/12,14.17%,ZWINT;BUB1B
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.2507532011046949,0.5255200735082575,0.9602543720190779,0.9957039287062843,1.0,10/10,74.94%,CACNA2D4;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1;CNGB1;TULP1;CEP250
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.2507532011046949,0.5255200735082575,0.9602543720190779,0.9957039287062843,1.0,10/10,74.94%,CACNA2D4;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1;CNGB1;TULP1;CEP250
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.24887573792937434,0.524889415729378,0.9607843137254902,0.9955335730887102,1.0,3/10,19.55%,SERPINE2;CD9;RDX
prerank,negative regulation of macroautophagy (GO:0016242),0.20866265620701085,0.5233834797091486,0.9802110817941952,0.9956464074780625,1.0,11/26,27.39%,TSC1;CLEC16A;UBQLN4;NRBP2;MTM1;MTOR;CHMP4A;CHMP4B;SMG1;TMEM39A;PIK3CA
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.22787728981470062,0.5230036885262161,0.9673295454545454,0.9953913088996666,1.0,4/17,20.67%,PRKN;CD74;MDM2;SNAI1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.20537531911183457,0.5208238147202543,0.9868421052631579,0.9956763028971146,1.0,12/28,28.10%,OTULIN;UBB;TAB3;AAMP;TAB2;CYLD;IRAK2;MAP2K6;IRAK1;RELA;TRAF6;TAB1
prerank,B cell homeostasis (GO:0001782),0.24734089716859298,0.5207566297993846,0.9574132492113565,0.9953358463791893,1.0,1/10,6.64%,DOCK10
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.22554695576971803,0.5198744843379122,0.9788135593220338,0.995204800920846,1.0,5/16,24.94%,MCM4;BLM;WRN;SSBP1;RECQL
prerank,protein autoprocessing (GO:0016540),-0.1801380726068736,-0.5192205615039344,0.9798657718120806,0.9937753983589283,1.0,5/17,25.98%,CASP4;FXN;MYRF;HTRA2;OMA1
prerank,peptidyl-amino acid modification (GO:0018193),0.245525536766864,0.5187004810904139,0.9735202492211839,0.9951621476059213,1.0,3/10,22.86%,TTLL4;METAP1;METAP1D
prerank,tRNA processing (GO:0008033),0.18126084461813097,0.5173533530991257,0.9919816723940436,0.9951911959794764,1.0,16/61,24.32%,TRMT10B;DTWD1;FARS2;DTWD2;TSEN2;ELP5;POP1;RPP21;SSB;TRIT1;NSUN2;TSEN34;LCMT2;TRMT1;RPP30;PTCD1
prerank,cardiac muscle contraction (GO:0060048),0.19693144342616703,0.516492754532027,0.98375,0.9950621113626407,1.0,2/34,5.68%,GSN;SCN5A
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.20781468077521237,-0.514846040874138,0.9912280701754386,0.993705254710401,1.0,1/10,7.72%,ACTN2
prerank,mitochondrion distribution (GO:0048311),0.24090656692709164,0.5146480603094937,0.9682779456193353,0.9952068932351943,1.0,5/12,24.33%,ARMC1;TRAK2;CLUH;MTM1;MEF2A
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.1904579890066234,-0.5131315642262274,0.959375,0.993018789478947,1.0,2/13,10.88%,KDM1A;YJU2
prerank,dendritic cell migration (GO:0036336),0.22290897702297932,0.5119795932531271,0.9742120343839542,0.9955455384741534,1.0,1/16,5.38%,CCR2
prerank,regulation of peptidase activity (GO:0052547),0.213920505948339,0.510611926872701,0.9709944751381215,0.9955546624169133,1.0,4/19,21.06%,CSTB;RCN3;NDUFA13;FURIN
prerank,defense response to protozoan (GO:0042832),0.2322033898305083,0.5092167599089801,0.9696048632218845,0.9955574362630762,1.0,12/12,76.80%,BATF;GBP2;GBP4;LYST;GBP7;IRF4;GBP6;PF4;BATF2;SLC11A1;MYD88;CD40
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.23097732636440713,0.5071272722108995,0.9680851063829787,0.9957240208425002,1.0,4/12,22.45%,UMPS;CTPS2;DPYD;ALDH6A1
prerank,heterocycle biosynthetic process (GO:0018130),0.22300806836163384,0.5059907709425995,0.9611360239162929,0.9956464391644866,1.0,5/14,31.13%,GPHN;NFS1;MOCS3;PYCR2;MOCS2
prerank,chromosome condensation (GO:0030261),0.19042885880300078,0.5045739119764994,0.9936708860759493,0.9956379116536646,1.0,5/36,18.42%,BANF2;PHF8;AIFM1;SMC4;CSNK2A2
prerank,protein kinase A signaling (GO:0010737),0.22431186964772185,0.4955421102309623,0.9715142428785607,0.9973501864337129,1.0,2/12,19.55%,PRKACA;RDX
prerank,non-motile cilium assembly (GO:1905515),0.1939497396569542,0.4933225723138888,0.98828125,0.9974930115491861,1.0,4/30,15.12%,PCM1;DISC1;CEP89;IFT57
prerank,ruffle organization (GO:0031529),0.21201128461375718,0.49276753474508533,0.9778434268833087,0.9972461099421954,1.0,3/16,17.60%,CORO1B;CYFIP1;PIP5K1A
prerank,regulation of Golgi organization (GO:1903358),0.20854227839991846,0.49064303795681913,0.9811046511627907,0.9973069655183037,1.0,5/17,23.81%,MAPK1;USP6NL;RBSN;MYO5A;STX18
prerank,regulation of phosphate metabolic process (GO:0019220),0.21245126893494598,0.48730108483534923,0.9787535410764873,0.99761093858548,1.0,1/16,4.26%,PSEN1
prerank,negative regulation of phosphatase activity (GO:0010923),0.19322750906786637,0.485602398559223,0.9932975871313673,0.997573615355295,1.0,2/25,5.80%,PPP1R15A;URI1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.21839296924042684,0.48490161379171515,0.9788838612368024,0.9973333633925491,1.0,12/12,78.18%,NUF2;CENPC;MIS12;CDT1;CHAMP1;KIF2C;RMDN1;SEH1L;MAD1L1;NDC80;CENPE;BOD1
prerank,regulation of protein kinase A signaling (GO:0010738),0.19834132648363662,0.48052256263701587,0.9872159090909091,0.997739841118323,1.0,2/20,11.02%,PRKAR1B;AKAP6
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.22051280350333635,0.4778801741817754,0.9848942598187311,0.9978249688410099,1.0,5/12,28.05%,UMPS;DHODH;UCK1;UCK2;CAD
prerank,triglyceride catabolic process (GO:0019433),0.19977391195126526,0.4764420562865217,0.9891304347826086,0.9977065982634685,1.0,19/19,80.05%,LIPC;FABP7;APOC3;FABP2;FABP6;PNPLA5;PNLIPRP2;PNPLA1;LIPI;CPS1;LIPG;FABP5;FABP12;FABP4;LIPH;FABP3;PNPLA3;LPL;PNPLA2
prerank,mRNA modification (GO:0016556),0.194909332589218,0.4747559490426024,0.9889958734525447,0.997626181054827,1.0,5/22,20.26%,METTL3;PUS7;PUS1;VIRMA;NSUN2
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.21606998997988705,0.4742332342683902,0.990909090909091,0.9973572539071048,1.0,4/13,22.76%,XRCC3;PCID2;DUSP1;CDK5RAP2
prerank,'de novo' posttranslational protein folding (GO:0051084),0.18365539513972146,0.4737837516417763,0.996078431372549,0.9970667985249744,1.0,7/30,25.74%,DNAJB4;GAK;SDF2;HSPA9;ERO1A;HSPA1A;CHCHD4
prerank,negative regulation of lipid catabolic process (GO:0050995),0.20127458185471392,0.4734034347018614,0.9858356940509915,0.9967716500390529,1.0,3/17,22.01%,PDE3B;GPLD1;PRKAA1
prerank,homeostasis of number of cells (GO:0048872),0.2131141789895042,0.4729140577141549,0.9751937984496124,0.9964889693256826,1.0,1/12,6.98%,CARD9
prerank,nucleoside catabolic process (GO:0009164),-0.19670967818073531,-0.4725687725115008,0.9850746268656716,0.9983589908075443,1.0,3/11,22.80%,UPB1;NT5M;NT5C1A
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.20011260261981295,-0.46914230315927463,0.9828571428571429,0.9977097443973107,1.0,3/10,22.80%,UPB1;NT5M;NT5C1A
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.2238641279909956,0.46857832459098075,0.9794721407624634,0.9964574151491241,1.0,1/10,11.80%,MYLIP
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.2238641279909956,0.46857832459098075,0.9794721407624634,0.9964574151491241,1.0,1/10,11.80%,MYLIP
prerank,regulation of actin filament depolymerization (GO:0030834),-0.17775690539932767,-0.4676171565248275,0.9968354430379747,0.9968693414329791,1.0,2/12,14.76%,MTPN;LIMA1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.1840696516885511,0.4657488618969355,0.9871630295250321,0.9965217452286033,1.0,9/28,26.87%,MRNIP;SETMAR;CYREN;ACTR2;TFIP11;PRKDC;SMCHD1;KMT5B;KMT5C
prerank,regulation of centrosome duplication (GO:0010824),0.18143043903938985,0.46319493543039103,0.9923469387755102,0.9965014227448771,1.0,11/29,27.71%,CEP295NL;XRCC3;CEP76;PDCD6IP;CHMP4C;CHMP1B;ALMS1;CHMP4B;TMEM67;FBXW5;SIRT1
prerank,sister chromatid segregation (GO:0000819),0.1727088183473654,0.4526250478628625,0.9933155080213903,0.9975564819348295,1.0,7/31,23.82%,SGO1;ZWINT;KLHL22;SMC4;SMC1A;WRAP73;RB1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.18797889712347685,0.45012572378165777,0.9959677419354839,0.9974792042336247,1.0,20/20,81.23%,TSPOAP1;TSPO;STARD3;STARD3NL;FDX1;DHRS2;HSD3B1;CYP17A1;AKR1B1;CYP11A1;CYP11B1;AKR1D1;DHRS9;AKR1C1;HSD3B2;FDX2;CYP46A1;HSD17B10;STAR;FDXR
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.16512836170037848,-0.44580302936430405,1.0,0.9977072215213074,1.0,5/14,31.11%,URB1;PES1;RPF2;ZNHIT3;DDX18
prerank,defense response to Gram-positive bacterium (GO:0050830),0.16553789267274654,0.4420434730560796,1.0,0.9980092988606492,1.0,10/40,26.45%,RNASE6;MR1;LBP;RARRES2;GBP2;RPL39;RNASE7;RNASE3;DROSHA;GBP4
prerank,protein deneddylation (GO:0000338),0.2150809728804371,0.43966194464785413,0.9918166939443536,0.9978942099486312,1.0,5/10,32.22%,COPS6;COPS7A;COPS2;TOR1A;COPS4
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.17278419535328557,0.43166946513786136,0.9920634920634921,0.9982897636075944,1.0,5/25,20.83%,HIP1;CBL;RTN4;CCDC88A;BCAR3
prerank,regulation of mast cell degranulation (GO:0043304),0.18910629856047212,0.4248677938870845,0.9899280575539569,0.9984969989291765,1.0,3/14,20.91%,GAB2;UNC13D;CD84
prerank,regulation of transposition (GO:0010528),0.19301306801405432,0.4218463667511793,0.992603550295858,0.9983863921563593,1.0,1/13,9.47%,TEX15
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.15390035133098293,0.4044828322244354,1.0,0.9991215782814168,1.0,7/31,28.67%,PRLR;GPHN;NFS1;SCP2;MOCS3;CYP51A1;PYCR2
prerank,dendritic cell differentiation (GO:0097028),0.16226775933266735,0.3979219371074097,0.9986033519553073,0.999111884931685,1.0,4/22,22.36%,TGFBR2;BATF;AXL;IRF8
prerank,natural killer cell activation (GO:0030101),0.15834686563736589,0.39107945050655996,0.9986357435197817,0.9990422818670247,1.0,4/23,23.61%,RABL3;AXL;PBX1;KAT7
prerank,ATP transport (GO:0015867),0.17825382916094767,0.37560137026684065,0.9969418960244648,0.9992130058787765,1.0,4/10,31.73%,SLC25A24;SLC17A9;SLC25A17;CD47
